code,description,code_type,source,year
0001F,Heart failure composite,Other,RVU2026A,2026
0005F,Osteoarthritis composite,Other,RVU2026A,2026
00100,Anes px salivary gland w/bx,CPT,RVU2026A,2026
00102,Anes px plstc rpr cleft lip,CPT,RVU2026A,2026
00103,Anes rcnstv px eyelid,CPT,RVU2026A,2026
00104,Anes electroconvulsive ther,CPT,RVU2026A,2026
00120,Anes px ear w/bx nos,CPT,RVU2026A,2026
00124,Anes px ear otoscopy,CPT,RVU2026A,2026
00126,Anes px ear tympanotomy,CPT,RVU2026A,2026
0012F,Cap bacterial assess,Other,RVU2026A,2026
00140,Anes procedures on eye nos,CPT,RVU2026A,2026
00142,Anes px on eye lens surgery,CPT,RVU2026A,2026
00144,Anes px eye corneal trnspl,CPT,RVU2026A,2026
00145,Anes px eye vitreortnl surg,CPT,RVU2026A,2026
00147,Anes px on eye iridectomy,CPT,RVU2026A,2026
00148,Anes px eye ophthalmoscopy,CPT,RVU2026A,2026
0014F,Comp preop assess cat surg,Other,RVU2026A,2026
0015F,Melan follow-up complete,Other,RVU2026A,2026
00160,Anes px nose&sinus nos,CPT,RVU2026A,2026
00162,Anes px nose&sinus rad surg,CPT,RVU2026A,2026
00164,Anes px nose&sins bx sft tis,CPT,RVU2026A,2026
00170,Anes intraoral px nos,CPT,RVU2026A,2026
00172,Anes ntroral px rpr clft pal,CPT,RVU2026A,2026
00174,Anes ntrorl exc rtrphrng tum,CPT,RVU2026A,2026
00176,Anes intraoral px rad surg,CPT,RVU2026A,2026
00190,Anes px facial b1/skull nos,CPT,RVU2026A,2026
00192,Anes px fcl b1/skl rad surg,CPT,RVU2026A,2026
00210,Anes intracranial px nos,CPT,RVU2026A,2026
00211,Anes icr px crnec/crnot hmtm,CPT,RVU2026A,2026
00212,Anes icr px subdural taps,CPT,RVU2026A,2026
00214,Anes icr px burr holes,CPT,RVU2026A,2026
00215,Anes icr px crnop/elvtn fx,CPT,RVU2026A,2026
00216,Anes icr px vascular px,CPT,RVU2026A,2026
00218,Anes icr px in sitting pos,CPT,RVU2026A,2026
00220,Anes icr px csf shunting px,CPT,RVU2026A,2026
00222,Anes icr px ecoag icr nrv,CPT,RVU2026A,2026
00300,Anes all px integ h/n/ptrunk,CPT,RVU2026A,2026
00320,Anes all px neck nos 1yr/>,CPT,RVU2026A,2026
00322,Anes all px nck ndl bx thyr,CPT,RVU2026A,2026
00326,Anes all px larynx&trach<1yr,CPT,RVU2026A,2026
00350,Anes px major vsl neck nos,CPT,RVU2026A,2026
00352,Anes px maj vsl nck smpl lig,CPT,RVU2026A,2026
00400,Anes integumentary sys nos,CPT,RVU2026A,2026
00402,Anes integ sys rcnstv breast,CPT,RVU2026A,2026
00404,Anes integ sys rad/modf brst,CPT,RVU2026A,2026
00406,Anes integ sys rad brst dsj,CPT,RVU2026A,2026
00410,Anes integ sys conv arrhyt,CPT,RVU2026A,2026
00450,Anes px clav&scapula nos,CPT,RVU2026A,2026
00454,Anes px clav&scapula bx clav,CPT,RVU2026A,2026
00470,Anes partial rib rescj nos,CPT,RVU2026A,2026
00472,Anes prtl rib rescj thoracop,CPT,RVU2026A,2026
00474,Anes prtl rib rescj rad px,CPT,RVU2026A,2026
00500,Anes all px on esophagus,CPT,RVU2026A,2026
00520,Anes closed chest px nos,CPT,RVU2026A,2026
00522,Anes clsd ch px ndl bx pleur,CPT,RVU2026A,2026
00524,Anes clsd ch px pneumocents,CPT,RVU2026A,2026
00528,Anes clsd ch mediast&thrc wo,CPT,RVU2026A,2026
00529,Anes clsd ch mediast&thrc w/,CPT,RVU2026A,2026
00530,Anes perm transvns pm insj,CPT,RVU2026A,2026
00532,Anes access ctr venous crcj,CPT,RVU2026A,2026
00534,Anes insertion/rplcmt cvdfb,CPT,RVU2026A,2026
00537,Anes cardiac ep procedures,CPT,RVU2026A,2026
00539,Anes tracheobronchial rcnstj,CPT,RVU2026A,2026
00540,Anes thoracotomy px nos,CPT,RVU2026A,2026
00541,Anes thrcm px 1 lung vntj,CPT,RVU2026A,2026
00542,Anes thrcm px decortication,CPT,RVU2026A,2026
00546,Anes thrcm px pulm rescj,CPT,RVU2026A,2026
00548,Anes thrcm px trach&bronchi,CPT,RVU2026A,2026
0054T,Bone srgry cmptr fluor image,Other,RVU2026A,2026
00550,Anes for sternal debridement,CPT,RVU2026A,2026
0055T,Bone srgry cmptr ct/mri imag,Other,RVU2026A,2026
00560,Anes px heart w/o pump oxtj,CPT,RVU2026A,2026
00561,Anes px heart w/pump<1 yr,CPT,RVU2026A,2026
00562,Anes px hrt w/pump age 1yr+,CPT,RVU2026A,2026
00563,Anes px heart w/pmp crc arst,CPT,RVU2026A,2026
00566,Anes direct cabg w/o pump,CPT,RVU2026A,2026
00567,Anes direct cabg w/pump,CPT,RVU2026A,2026
00580,Anes heart/lung transplant,CPT,RVU2026A,2026
00600,Anes px crv spine&cord nos,CPT,RVU2026A,2026
00604,Anes px crv spn&cord sitting,CPT,RVU2026A,2026
00620,Anes px thrc spine&cord nos,CPT,RVU2026A,2026
00625,Anes thrc spine wo 1lng vent,CPT,RVU2026A,2026
00626,Anes thrc spine w/1 lng vent,CPT,RVU2026A,2026
00630,Anes px lumbar region nos,CPT,RVU2026A,2026
00632,Anes px lumbar sympathectomy,CPT,RVU2026A,2026
00635,Anes dx/ther lumbar pnxr,CPT,RVU2026A,2026
00640,Anes spine manipulation,CPT,RVU2026A,2026
00670,Anes xtnsv sp&spi cord px,CPT,RVU2026A,2026
00700,Anes px upr ant abd wall nos,CPT,RVU2026A,2026
00702,Anes upr ant abd wall lvr bx,CPT,RVU2026A,2026
0071T,Us leiomyomata ablate <200,Other,RVU2026A,2026
0072T,Fcsd us abltj leiomyom>=200,Other,RVU2026A,2026
00730,Anes px upper pst abdl wall,CPT,RVU2026A,2026
00731,Anes upr gi ndsc px nos,CPT,RVU2026A,2026
00732,Anes upr gi ndsc px ercp,CPT,RVU2026A,2026
00750,Anes hrna rpr upr abd nos,CPT,RVU2026A,2026
00752,Anes hrna rpr lmbr&vnt&/dehs,CPT,RVU2026A,2026
00754,Anes hrna rpr omphalocele,CPT,RVU2026A,2026
00756,Anes hrna rpr diphrg hrna,CPT,RVU2026A,2026
0075T,Perq stent/chest vert art,Other,RVU2026A,2026
0076T,S&i stent/chest vert art,Other,RVU2026A,2026
00770,Anes px maj abd blood vessel,CPT,RVU2026A,2026
00790,Anes iper upr abd nos,CPT,RVU2026A,2026
00792,Anes iper upr abd prtl hptc,CPT,RVU2026A,2026
00794,Anes iper upr abd pncrtect,CPT,RVU2026A,2026
00796,Anes iper upr abd lvr trnspl,CPT,RVU2026A,2026
00797,Anes iper upr abd gstr px mo,CPT,RVU2026A,2026
00800,Anes px lwr ant abdl wal nos,CPT,RVU2026A,2026
00802,Anes px lwr abdl wal pannic,CPT,RVU2026A,2026
00811,Anes lwr intst ndsc nos,CPT,RVU2026A,2026
00812,Anes lwr intst scr colsc,CPT,RVU2026A,2026
00813,Anes upr lwr gi ndsc px,CPT,RVU2026A,2026
00820,Anes px lwr post abdl wall,CPT,RVU2026A,2026
00830,Anes hernia rpr lwr abd nos,CPT,RVU2026A,2026
00832,Anes hernia repair vnt&incal,CPT,RVU2026A,2026
00834,Anes hernia repair<1 yr age,CPT,RVU2026A,2026
00836,Anes hrna rpr<37wk brth<50,CPT,RVU2026A,2026
00840,Anes iper px lower abd nos,CPT,RVU2026A,2026
00842,Anes iper px amniocentesis,CPT,RVU2026A,2026
00844,Anes iper px abdmnprnl rescj,CPT,RVU2026A,2026
00846,Anes iper px rad hystrectomy,CPT,RVU2026A,2026
00848,Anes iper px pel exentration,CPT,RVU2026A,2026
00851,Anes iper px tubal ligation,CPT,RVU2026A,2026
00860,Anes xtrprtl px lwr abd nos,CPT,RVU2026A,2026
00862,Anes xtrprtl lwr abd rnl px,CPT,RVU2026A,2026
00864,Anes xtrprt lwr abd tot cstc,CPT,RVU2026A,2026
00865,Anes xtrprt lwr abd prst8ect,CPT,RVU2026A,2026
00866,Anes xtrprt lw abd adrnlctmy,CPT,RVU2026A,2026
00868,Anes xtrprtl px rnl transpl,CPT,RVU2026A,2026
00870,Anes xtrprtl cystolithotomy,CPT,RVU2026A,2026
00872,Anes lithotrp esw water bath,CPT,RVU2026A,2026
00873,Anes lithotrp esw wo wtr bth,CPT,RVU2026A,2026
00880,Anes maj lwr abd vessel nos,CPT,RVU2026A,2026
00882,Anes maj lwr adb vsl ivc lig,CPT,RVU2026A,2026
00902,Anes anorectal px,CPT,RVU2026A,2026
00904,Anes radical perineal px,CPT,RVU2026A,2026
00906,Anes vulvectomy,CPT,RVU2026A,2026
00908,Anes perineal prostatectomy,CPT,RVU2026A,2026
00910,Anes transurethral px nos,CPT,RVU2026A,2026
00912,Anes trurl px rescj bldr tum,CPT,RVU2026A,2026
00914,Anes trurl px rescj prst8,CPT,RVU2026A,2026
00916,Anes trurl px rescj bleeding,CPT,RVU2026A,2026
00918,Anes trurl px urtrl cal rmvl,CPT,RVU2026A,2026
00920,Anes px male genitalia nos,CPT,RVU2026A,2026
00921,Anes px male genitalia vasec,CPT,RVU2026A,2026
00922,Anes px male gent sem ves,CPT,RVU2026A,2026
00924,Anes male gent undscnd tstis,CPT,RVU2026A,2026
00926,Anes male gent rad orch ing,CPT,RVU2026A,2026
00928,Anes male gent rad orch abd,CPT,RVU2026A,2026
00930,Anes px male gent orchiopexy,CPT,RVU2026A,2026
00932,Anes male gent compl amp pns,CPT,RVU2026A,2026
00934,Anes rad amp penis ingun lym,CPT,RVU2026A,2026
00936,Anes rad amp pns ingun&ilac,CPT,RVU2026A,2026
00938,Anes insj penile prosthesis,CPT,RVU2026A,2026
00940,Anes vaginal px nos,CPT,RVU2026A,2026
00942,Anes vag px clptmy vgnc clpr,CPT,RVU2026A,2026
00944,Anes vag px vag hysterectomy,CPT,RVU2026A,2026
00948,Anes vag px crv cerclage,CPT,RVU2026A,2026
00950,Anes vag px culdoscopy,CPT,RVU2026A,2026
00952,Anes vag px hystsc&/hsg,CPT,RVU2026A,2026
0095T,Rmvl artific disc addl crvcl,Other,RVU2026A,2026
0098T,Rev artific disc addl,Other,RVU2026A,2026
0100T,Prosth retina receive&gen,Other,RVU2026A,2026
0101T,Esw muscskel sys nos,Other,RVU2026A,2026
0102T,Esw phy anes lat hmrl epcndl,Other,RVU2026A,2026
0106T,Touch quant sensory test,Other,RVU2026A,2026
0107T,Vibrate quant sensory test,Other,RVU2026A,2026
0108T,Cool quant sensory test,Other,RVU2026A,2026
0109T,Heat quant sensory test,Other,RVU2026A,2026
0110T,Nos quant sensory test,Other,RVU2026A,2026
01112,Anes bone marrow aspir&/bx,CPT,RVU2026A,2026
01120,Anes px on bony pelvis,CPT,RVU2026A,2026
01130,Anes body cast appl/revj,CPT,RVU2026A,2026
01140,Anes ntrplvabdmnl amputation,CPT,RVU2026A,2026
01150,Anes rad px tumor of pelvis,CPT,RVU2026A,2026
01160,Anes clsd px symph pub/si jt,CPT,RVU2026A,2026
01170,Anes opn px symph pub/si jt,CPT,RVU2026A,2026
01173,Anes opn rpr fx disrpj plvs,CPT,RVU2026A,2026
01200,Anes all closed px hip joint,CPT,RVU2026A,2026
01202,Anes arthroscopic px hip jt,CPT,RVU2026A,2026
01210,Anes open px hip joint nos,CPT,RVU2026A,2026
01212,Anes open px hip jt disrtcj,CPT,RVU2026A,2026
01214,Anes open px tot hip arthrp,CPT,RVU2026A,2026
01215,Anes opn revj tot hip arthrp,CPT,RVU2026A,2026
01220,Anes clsd px upper 2/3 femur,CPT,RVU2026A,2026
01230,Anes opn upper 2/3 femur nos,CPT,RVU2026A,2026
01232,Anes opn px upr 2/3 fem amp,CPT,RVU2026A,2026
01234,Anes opn upr 2/3 fem rad res,CPT,RVU2026A,2026
01250,Anes all px nrv musc upr leg,CPT,RVU2026A,2026
01260,Anes all px veins upper leg,CPT,RVU2026A,2026
01270,Anes px arteries upr leg nos,CPT,RVU2026A,2026
01272,Anes px art femoral art lig,CPT,RVU2026A,2026
01274,Anes px art fem art emblc,CPT,RVU2026A,2026
01320,Anes all px nrv msc kne&/pop,CPT,RVU2026A,2026
01340,Anes clsd px lower 1/3 femur,CPT,RVU2026A,2026
01360,Anes open px lower 1/3 femur,CPT,RVU2026A,2026
01380,Anes all clsd px knee joint,CPT,RVU2026A,2026
01382,Anes dx arthrs px knee jt,CPT,RVU2026A,2026
01390,Anes cls px upr tib fib&/pat,CPT,RVU2026A,2026
01392,Anes opn px upr tib fib&/pat,CPT,RVU2026A,2026
01400,Anes opn/arthrs knee jt nos,CPT,RVU2026A,2026
01402,Anes opn/arth tot kne arthrp,CPT,RVU2026A,2026
01404,Anes opn/arthrs disrtcj knee,CPT,RVU2026A,2026
01420,Anes cst appl rmv/rpr kne jt,CPT,RVU2026A,2026
01430,Anes px veins knee&pop nos,CPT,RVU2026A,2026
01432,Anes px vn knee&pop av fstl,CPT,RVU2026A,2026
01440,Anes px art knee&pop nos,CPT,RVU2026A,2026
01442,Anes px art knee&pop teaec,CPT,RVU2026A,2026
01444,Anes px art knee&pop exc&grf,CPT,RVU2026A,2026
01462,Anes clsd px lower l/a/f,CPT,RVU2026A,2026
01464,Anes arthrs px ankle&/foot,CPT,RVU2026A,2026
01470,Anes px nrv msc lw l/a/f nos,CPT,RVU2026A,2026
01472,Anes rpr rpt achilles tendon,CPT,RVU2026A,2026
01474,Anes gastrocnemius recession,CPT,RVU2026A,2026
01480,Anes open px lower l/a/f nos,CPT,RVU2026A,2026
01482,Anes opn lwr l/a/f rad rescj,CPT,RVU2026A,2026
01484,Anes opn lw l/a/f oste/ostpl,CPT,RVU2026A,2026
01486,Anes open total ankle rplcmt,CPT,RVU2026A,2026
01490,Anes lwr leg cst app rmv/rpr,CPT,RVU2026A,2026
01500,Anes px art lower leg nos,CPT,RVU2026A,2026
01502,Anes px art lower leg emblc,CPT,RVU2026A,2026
01520,Anes px veins lower leg nos,CPT,RVU2026A,2026
01522,Anes px vn lwr leg ven thrmb,CPT,RVU2026A,2026
01610,Anes all px nrv musc sho&ax,CPT,RVU2026A,2026
01620,Anes clsd px shoulder joint,CPT,RVU2026A,2026
01622,Anes dx arthr px shoulder jt,CPT,RVU2026A,2026
01630,Anes opn/arthr px sho jt nos,CPT,RVU2026A,2026
01634,Anes open/arthrs sho disrtcj,CPT,RVU2026A,2026
01636,Anes open/arthr ntrthrc amp,CPT,RVU2026A,2026
01638,Anes opn/arthr tot sho rplcm,CPT,RVU2026A,2026
0164T,Remove lumb artif disc addl,Other,RVU2026A,2026
01650,Anes art sho&ax nos,CPT,RVU2026A,2026
01652,Anes art sho&ax ax-brch arsm,CPT,RVU2026A,2026
01654,Anes art sho&ax bypass grf,CPT,RVU2026A,2026
01656,Anes art sho&ax ax-fem bpg,CPT,RVU2026A,2026
0165T,Revise lumb artif disc addl,Other,RVU2026A,2026
01670,Anes all px vn shoulder&ax,CPT,RVU2026A,2026
01680,Anes sho cast appl rmvl/rpr,CPT,RVU2026A,2026
01710,Anes px nrv musc upr a&e nos,CPT,RVU2026A,2026
01712,Anes px nrv msc upr a&e tnot,CPT,RVU2026A,2026
01714,Anes nrv msc upr a&e tnplsty,CPT,RVU2026A,2026
01716,Anes nrv msc upr a&e tndsis,CPT,RVU2026A,2026
01730,Anes clsd px humerus&elbow,CPT,RVU2026A,2026
01732,Anes dx arthrs px elbow jt,CPT,RVU2026A,2026
01740,Anes opn/arthrs px elbw nos,CPT,RVU2026A,2026
01742,Anes opn/arthrs elbw osteot,CPT,RVU2026A,2026
01744,Anes opn/arthrs elbw rpr hum,CPT,RVU2026A,2026
0174T,Cad cxr with interp,Other,RVU2026A,2026
01756,Anes opn/arthrs elbw rad px,CPT,RVU2026A,2026
01758,Anes opn/arthrs elbw exc cst,CPT,RVU2026A,2026
0175T,Cad cxr remote,Other,RVU2026A,2026
01760,Anes opn/arthr elb tot rplct,CPT,RVU2026A,2026
01770,Anes px art upr arm&elbw nos,CPT,RVU2026A,2026
01772,Anes art upr arm&elbw emblc,CPT,RVU2026A,2026
01780,Anes px vn upr arm&elbw nos,CPT,RVU2026A,2026
01782,Anes vn upr arm&elbw phlbrpy,CPT,RVU2026A,2026
01810,Anes px nrv musc f/arm wrst,CPT,RVU2026A,2026
01820,Anes clsd px rds u/w/h bones,CPT,RVU2026A,2026
01829,Anes dx arthroscopic px wrst,CPT,RVU2026A,2026
01830,Anes arthr/ndsc wrst/hnd nos,CPT,RVU2026A,2026
01832,Anes arthr/ndsc tot wrst rpl,CPT,RVU2026A,2026
01840,Anes art f/arm wrst&hnd nos,CPT,RVU2026A,2026
01842,Anes art farm wrst&hnd emblc,CPT,RVU2026A,2026
01844,Anes vasc shunt/shunt revj,CPT,RVU2026A,2026
0184T,Exc rectal tumor endoscopic,Other,RVU2026A,2026
01850,Anes vein f/arm wrst&hnd nos,CPT,RVU2026A,2026
01852,Anes px vn f/arm phlbrrhaphy,CPT,RVU2026A,2026
01860,Anes forearm wrist/hand cast,CPT,RVU2026A,2026
01916,Anes dx arteriography/vngrph,CPT,RVU2026A,2026
01920,Anes cardiac catheterization,CPT,RVU2026A,2026
01922,Anes n-invas img/radj ther,CPT,RVU2026A,2026
01924,Anes ther ivntl rad artl nos,CPT,RVU2026A,2026
01925,Anes ivntl rad artl crtd/c,CPT,RVU2026A,2026
01926,Anes ivntl rad icr icar/aort,CPT,RVU2026A,2026
01930,Anes ther ivntl rad ven nos,CPT,RVU2026A,2026
01931,Anes ivnt rad ntrhpt/prt crc,CPT,RVU2026A,2026
01932,Anes th ivnt rad ntrthrc/jug,CPT,RVU2026A,2026
01933,Anes ther ivntl rad px icr,CPT,RVU2026A,2026
01937,Anes drg/aspir crv/thrc,CPT,RVU2026A,2026
01938,Anes drg/aspir lmbr/sac,CPT,RVU2026A,2026
01939,Anes nulyt agt crv/thrc,CPT,RVU2026A,2026
01940,Anes nulyt agt lmbr/sac,CPT,RVU2026A,2026
01941,Anes neuromd/ntrvrt crv/thrc,CPT,RVU2026A,2026
01942,Anes neuromd/ntrvrt lmbr/sac,CPT,RVU2026A,2026
01951,Anes 2&3 burn less 4 % tbsa,CPT,RVU2026A,2026
01952,Anes 2&3 burn 4-9% tbsa,CPT,RVU2026A,2026
01953,Anes 2&3 burn ea add 9% tbsa,CPT,RVU2026A,2026
01958,Anes xtrnl cephalic version,CPT,RVU2026A,2026
01960,Anes vaginal delivery only,CPT,RVU2026A,2026
01961,Anes cesarean delivery only,CPT,RVU2026A,2026
01962,Anes urgent hysterectomy,CPT,RVU2026A,2026
01963,Anes cesarean hysterectomy,CPT,RVU2026A,2026
01965,Anes incompl/missed ab px,CPT,RVU2026A,2026
01966,Anes induced abortion px,CPT,RVU2026A,2026
01967,Neuraxl lbr anes vag dlvr,CPT,RVU2026A,2026
01968,Anes/analg cs dlvr neuraxial,CPT,RVU2026A,2026
01969,Anes c hyst flwg neuraxial,CPT,RVU2026A,2026
0198T,Ocular blood flow measure,Other,RVU2026A,2026
01990,Physiol support hrvg organs,CPT,RVU2026A,2026
01991,Anes dx/ther nrv blk&inj oth,CPT,RVU2026A,2026
01992,Anes dx/ther nrv blk&inj prn,CPT,RVU2026A,2026
01996,Dly hosp mgmt edrl rx admin,CPT,RVU2026A,2026
01999,Unlisted anes procedure,CPT,RVU2026A,2026
0200T,Perq sacral augmt unilat inj,Other,RVU2026A,2026
0201T,Perq sacral augmt bilat inj,Other,RVU2026A,2026
0202T,Post vert arthrplst 1 lumbar,Other,RVU2026A,2026
0207T,Clear eyelid gland w/heat,Other,RVU2026A,2026
0208T,Audiometry air only,Other,RVU2026A,2026
0209T,Audiometry air & bone,Other,RVU2026A,2026
0210T,Speech audiometry threshold,Other,RVU2026A,2026
0211T,Speech audiom thresh & recog,Other,RVU2026A,2026
0212T,Compre audiometry evaluation,Other,RVU2026A,2026
0213T,Njx paravert w/us cer/thor,Other,RVU2026A,2026
0214T,Njx paravert w/us cer/thor,Other,RVU2026A,2026
0215T,Njx paravert w/us cer/thor,Other,RVU2026A,2026
0216T,Njx paravert w/us lumb/sac,Other,RVU2026A,2026
0217T,Njx paravert w/us lumb/sac,Other,RVU2026A,2026
0218T,Njx paravert w/us lumb/sac,Other,RVU2026A,2026
0219T,Plmt post facet implt cerv,Other,RVU2026A,2026
0220T,Plmt post facet implt thor,Other,RVU2026A,2026
0221T,Plmt post facet implt lumb,Other,RVU2026A,2026
0222T,Plmt post facet implt addl,Other,RVU2026A,2026
0232T,Njx platelet plasma,Other,RVU2026A,2026
0234T,Trluml perip athrc renal art,Other,RVU2026A,2026
0235T,Trluml perip athrc visceral,Other,RVU2026A,2026
0236T,Trluml perip athrc abd aorta,Other,RVU2026A,2026
0237T,Trluml perip athrc brchiocph,Other,RVU2026A,2026
0238T,Trluml perip athrc iliac art,Other,RVU2026A,2026
0253T,Insert aqueous drain device,Other,RVU2026A,2026
0263T,Im b1 mrw cel ther cmpl,Other,RVU2026A,2026
0264T,Im b1 mrw cel ther xcl hrvst,Other,RVU2026A,2026
0265T,Im b1 mrw cel ther hrvst onl,Other,RVU2026A,2026
0274T,Prq lamot/lam dcmpr crv/thrc,Other,RVU2026A,2026
0278T,Tempr,Other,RVU2026A,2026
0308T,Insj ocular telescope prosth,Other,RVU2026A,2026
0329T,Mntr io press 24hrs/> uni/bi,Other,RVU2026A,2026
0330T,Tear film img uni/bi w/i&r,Other,RVU2026A,2026
0331T,Heart symp image plnr,Other,RVU2026A,2026
0332T,Heart symp image plnr spect,Other,RVU2026A,2026
0333T,Visual ep scr acuity auto,Other,RVU2026A,2026
0335T,Insj sinus tarsi implant,Other,RVU2026A,2026
0338T,Trnscth renal symp denrv unl,Other,RVU2026A,2026
0339T,Trnscth renal symp denrv bil,Other,RVU2026A,2026
0342T,Thxp apheresis w/hdl delip,Other,RVU2026A,2026
0345T,Transcath mtral vlve repair,Other,RVU2026A,2026
0347T,Ins bone device for rsa,Other,RVU2026A,2026
0348T,Rsa spine exam,Other,RVU2026A,2026
0349T,Rsa upper extr exam,Other,RVU2026A,2026
0350T,Rsa lower extr exam,Other,RVU2026A,2026
0351T,Intraop oct brst/node spec,Other,RVU2026A,2026
0352T,Oct brst/node i&r per spec,Other,RVU2026A,2026
0353T,Intraop oct breast cavity,Other,RVU2026A,2026
0354T,Oct breast surg cavity i&r,Other,RVU2026A,2026
0358T,Bia whole body,Other,RVU2026A,2026
0362T,Bhv id suprt assmt ea 15 min,Other,RVU2026A,2026
0373T,Adapt bhv tx ea 15 min,Other,RVU2026A,2026
0378T,Visual field assmnt rev/rprt,Other,RVU2026A,2026
0379T,Vis field assmnt tech suppt,Other,RVU2026A,2026
0395T,Hdr elctr ntrst/ntrcv brchtx,Other,RVU2026A,2026
0397T,Ercp w/optical endomicroscpy,Other,RVU2026A,2026
0402T,Colgn crs-link crn&pachymtry,Other,RVU2026A,2026
0403T,Diabetes prev standard curr,Other,RVU2026A,2026
0408T,Insj/rplc cardiac modulj sys,Other,RVU2026A,2026
0409T,Insj/rplc car modulj pls gn,Other,RVU2026A,2026
0410T,Insj/rplc car modulj atr elt,Other,RVU2026A,2026
0411T,Insj/rplc car modulj vnt elt,Other,RVU2026A,2026
0412T,Rmvl cardiac modulj pls gen,Other,RVU2026A,2026
0413T,Rmvl car modulj tranvns elt,Other,RVU2026A,2026
0414T,Rmvl & rpl car modulj pls gn,Other,RVU2026A,2026
0415T,Repos car modulj tranvns elt,Other,RVU2026A,2026
0416T,Reloc skin pocket pls gen,Other,RVU2026A,2026
0417T,Prgrmg eval cardiac modulj,Other,RVU2026A,2026
0418T,Interro eval cardiac modulj,Other,RVU2026A,2026
0419T,Dstrj neurofibroma xtnsv,Other,RVU2026A,2026
0420T,Dstrj neurofibroma xtnsv,Other,RVU2026A,2026
0422T,Tactile breast img uni/bi,Other,RVU2026A,2026
0437T,Impltj synth rnfcmt abdl wal,Other,RVU2026A,2026
0439T,Myocrd contrast prfuj echo,Other,RVU2026A,2026
0440T,Abltj perc uxtr/perph nrv,Other,RVU2026A,2026
0441T,Abltj perc lxtr/perph nrv,Other,RVU2026A,2026
0442T,Abltj perc plex/trncl nrv,Other,RVU2026A,2026
0443T,R-t spctrl alys prst8 tiss,Other,RVU2026A,2026
0444T,1st plmt drug elut oc ins,Other,RVU2026A,2026
0445T,Sbsqt plmt drug elut oc ins,Other,RVU2026A,2026
0446T,Insj impltbl glucose sensor,Other,RVU2026A,2026
0447T,Rmvl impltbl glucose sensor,Other,RVU2026A,2026
0448T,Remvl insj impltbl gluc sens,Other,RVU2026A,2026
0449T,Insj aqueous drain dev 1st,Other,RVU2026A,2026
0450T,Insj aqueous drain dev each,Other,RVU2026A,2026
0464T,Visual ep test for glaucoma,Other,RVU2026A,2026
0469T,Rta polarize scan oc scr bi,Other,RVU2026A,2026
0472T,Prgrmg io rta eltrd ra,Other,RVU2026A,2026
0473T,Reprgrmg io rta eltrd ra,Other,RVU2026A,2026
0474T,Insj aqueous drg dev io rsvr,Other,RVU2026A,2026
0479T,Fxjl abl lsr 1st 100 sq cm,Other,RVU2026A,2026
0480T,Fxjl abl lsr ea addl 100sqcm,Other,RVU2026A,2026
0481T,Njx autol wbc concentrate,Other,RVU2026A,2026
0483T,Tmvi percutaneous approach,Other,RVU2026A,2026
0484T,Tmvi transthoracic exposure,Other,RVU2026A,2026
0485T,Oct mid ear i&r unilateral,Other,RVU2026A,2026
0486T,Oct mid ear i&r bilateral,Other,RVU2026A,2026
0488T,Diabetes prev online/elec,Other,RVU2026A,2026
0489T,Regn cell tx scldr hands,Other,RVU2026A,2026
0490T,Regn cell tx scldr h mlt inj,Other,RVU2026A,2026
0494T,Prep & cannulj cdvr don lung,Other,RVU2026A,2026
0495T,Mntr cdvr don lng 1st 2 hrs,Other,RVU2026A,2026
0496T,Mntr cdvr don lng ea addl hr,Other,RVU2026A,2026
0500F,Initial prenatal care visit,Other,RVU2026A,2026
0501F,Prenatal flow sheet,Other,RVU2026A,2026
0502F,Subsequent prenatal care,Other,RVU2026A,2026
0503F,Postpartum care visit,Other,RVU2026A,2026
0505F,Hemodialysis plan docd,Other,RVU2026A,2026
0505T,Ev fempop artl revsc,Other,RVU2026A,2026
0506T,Mac pgmt opt dns meas hfp,Other,RVU2026A,2026
0507F,Periton dialysis plan docd,Other,RVU2026A,2026
0507T,Near ifr 2img mibmn glnd i&r,Other,RVU2026A,2026
0509F,Urine incon plan docd,Other,RVU2026A,2026
0509T,Pattern erg w/i&r,Other,RVU2026A,2026
0510T,Rmvl sinus tarsi implant,Other,RVU2026A,2026
0511T,Rmvl&rinsj sinus tarsi implt,Other,RVU2026A,2026
0512T,Esw integ wnd hlg 1st wnd,Other,RVU2026A,2026
0513F,Elev bp plan of care docd,Other,RVU2026A,2026
0513T,Esw integ wnd hlg ea addl,Other,RVU2026A,2026
0514F,Care plan hgb docd esa pt,Other,RVU2026A,2026
0515T,Insj wcs lv compl sys,Other,RVU2026A,2026
0516F,Anemia plan of care docd,Other,RVU2026A,2026
0516T,Insj wcs lv eltrd only,Other,RVU2026A,2026
0517F,Glaucoma plan of care docd,Other,RVU2026A,2026
0517T,Insj wcs lv both compnt pg,Other,RVU2026A,2026
0518F,Fall plan of care docd,Other,RVU2026A,2026
0518T,Rmvl pg wcs lv battery only,Other,RVU2026A,2026
0519F,Pland chemo docd b/4 txmnt,Other,RVU2026A,2026
0519T,Rmv&rplcmt pg wcs lv both,Other,RVU2026A,2026
0520F,Rad dos limts b/4 3d rad,Other,RVU2026A,2026
0520T,Rmv&rplcmt pg wcs lv battery,Other,RVU2026A,2026
0521F,Plan of care 4 pain docd,Other,RVU2026A,2026
0521T,Interrog dev eval wcs ip,Other,RVU2026A,2026
0522T,Prgrmg dev eval wcs ip,Other,RVU2026A,2026
0523T,Ntrapx c ffr w/3d funcjl map,Other,RVU2026A,2026
0524T,Ev cath dir chem abltj w/img,Other,RVU2026A,2026
0525F,Initial visit for episode,Other,RVU2026A,2026
0525T,Insj/rplcmt compl iims,Other,RVU2026A,2026
0526F,Subs visit for episode,Other,RVU2026A,2026
0526T,Insj/rplcmt iims eltrd only,Other,RVU2026A,2026
0527T,Insj/rplcmt iims implt mntr,Other,RVU2026A,2026
0528F,Rcmnd flw-up 10 yrs docd,Other,RVU2026A,2026
0528T,Prgrmg dev eval iims ip,Other,RVU2026A,2026
0529F,Intrvl 3/>yr pts clnscp docd,Other,RVU2026A,2026
0529T,Interrog dev eval iims ip,Other,RVU2026A,2026
0530T,Removal complete iims,Other,RVU2026A,2026
0531T,Removal iims electrode only,Other,RVU2026A,2026
0532T,Removal iims implt mntr only,Other,RVU2026A,2026
0535F,Dyspnea mngmnt plan docd,Other,RVU2026A,2026
0540F,Gluco mngmnt plan docd,Other,RVU2026A,2026
0541T,Myocardial imaging mcg,Other,RVU2026A,2026
0542T,Myocardial imaging mcg i&r,Other,RVU2026A,2026
0543T,Ta mv rpr w/artif chord tend,Other,RVU2026A,2026
0544T,Tcat mv annulus rcnstj,Other,RVU2026A,2026
0545F,Follow up care plan mdd docd,Other,RVU2026A,2026
0545T,Tcat tv annulus rcnstj,Other,RVU2026A,2026
0546T,Rf spectrsc ntraop mrgn asmt,Other,RVU2026A,2026
0547T,B1 matrl qual tst mcrind tib,Other,RVU2026A,2026
0550F,Cytopath report nongyn spcmn,Other,RVU2026A,2026
0551F,Cytopath report non routine,Other,RVU2026A,2026
0552T,Low-level laser therapy,Other,RVU2026A,2026
0554T,B1 str & fx rsk analysis,Other,RVU2026A,2026
0555F,Symptom mgmnt plan care docd,Other,RVU2026A,2026
0555T,B1 str&fx rsk transmis data,Other,RVU2026A,2026
0556F,Plan care lipid control docd,Other,RVU2026A,2026
0556T,B1 str & fx rsk assessment,Other,RVU2026A,2026
0557F,Plan caremng angnl symptdocd,Other,RVU2026A,2026
0557T,B1 str & fx rsk i&r,Other,RVU2026A,2026
0558T,Ct scan f/biomchn ct alys,Other,RVU2026A,2026
0559T,Antmc mdl 3d print 1st cmpnt,Other,RVU2026A,2026
0560T,Antmc mdl 3d print ea addl,Other,RVU2026A,2026
0561T,Antmc guide 3d print 1st gd,Other,RVU2026A,2026
0562T,Antmc guide 3d print ea addl,Other,RVU2026A,2026
0563T,Evac meibomian glnd heat bi,Other,RVU2026A,2026
0565T,Autol cell implt adps hrvg,Other,RVU2026A,2026
0566T,Autol cell implt adps njx,Other,RVU2026A,2026
0569T,Ttvr perq appr 1st prosth,Other,RVU2026A,2026
0570T,Ttvr perq ea addl prosth,Other,RVU2026A,2026
0571T,Insj/rplcmt icds ss eltrd,Other,RVU2026A,2026
0572T,Insertion ss dfb electrode,Other,RVU2026A,2026
0573T,Removal ss dfb electrode,Other,RVU2026A,2026
0574T,Repos prev ss impl dfb eltrd,Other,RVU2026A,2026
0575F,Hiv rna plan care docd,Other,RVU2026A,2026
0575T,Prgrmg dev eval icds ss ip,Other,RVU2026A,2026
0576T,Interrog dev eval icds ss ip,Other,RVU2026A,2026
0577T,Ephys eval icds ss,Other,RVU2026A,2026
0578T,Rem interrog dev icds phys,Other,RVU2026A,2026
0579T,Rem interrog dev icds tech,Other,RVU2026A,2026
0580F,Multidisciplinary care plan,Other,RVU2026A,2026
0580T,Rmvl ss impl dfb pg only,Other,RVU2026A,2026
0581F,Pt trnsfrd from anesth to cc,Other,RVU2026A,2026
0581T,Abltj mal brst tum perq crtx,Other,RVU2026A,2026
0582F,No trnsfr from anesth to cc,Other,RVU2026A,2026
0582T,Trurl abltj mal prst8 tiss,Other,RVU2026A,2026
0583F,Transfer care checklist used,Other,RVU2026A,2026
0583T,Tmpst auto tube dlvr sys,Other,RVU2026A,2026
0584F,No transfercare chklist used,Other,RVU2026A,2026
0584T,Perq islet cell transplant,Other,RVU2026A,2026
0585T,Laps islet cell transplant,Other,RVU2026A,2026
0586T,Open islet cell transplant,Other,RVU2026A,2026
0587T,Perq impltj/rplcmt isdns ptn,Other,RVU2026A,2026
0588T,Revision/removal isdns ptn,Other,RVU2026A,2026
0589T,Elec alys smpl prgrmg iins,Other,RVU2026A,2026
0590T,Elec alys cplx prgrmg iins,Other,RVU2026A,2026
0591T,Hlth&wb coaching indiv 1st,Other,RVU2026A,2026
0592T,Hlth&wb coaching indiv f-up,Other,RVU2026A,2026
0593T,Hlth&wb coaching group,Other,RVU2026A,2026
0594T,Osteot hum xtrnl lngth dev,Other,RVU2026A,2026
0596T,Temp fml iu vlv-pmp 1st insj,Other,RVU2026A,2026
0597T,Temp fml iu valve-pmp rplcmt,Other,RVU2026A,2026
0598T,R-t fluor wound img 1st site,Other,RVU2026A,2026
0599T,R-t fluor wound img ea addl,Other,RVU2026A,2026
0600T,Ablt ire 1+ o/t lv/prst8 prq,Other,RVU2026A,2026
0601T,Abltj ire 1+tumors open,Other,RVU2026A,2026
0602T,Transdermal gfr measurements,Other,RVU2026A,2026
0603T,Transdermal gfr monitoring,Other,RVU2026A,2026
0604T,Rem oct rta dev setup&educaj,Other,RVU2026A,2026
0605T,Rem oct rta techl sprt min 8,Other,RVU2026A,2026
0606T,Rem oct rta phys/qhp ea 30d,Other,RVU2026A,2026
0607T,Rem mntr pulm flu mntr setup,Other,RVU2026A,2026
0608T,Rem mntr pulm flu mntr alys,Other,RVU2026A,2026
0609T,Mrs disc pain acquisj data,Other,RVU2026A,2026
0610T,Mrs disc pain transmis data,Other,RVU2026A,2026
0611T,Mrs disc pain alg alys data,Other,RVU2026A,2026
0612T,Mrs discogenic pain i&r,Other,RVU2026A,2026
0613T,Perq tcat intratrl septl sht,Other,RVU2026A,2026
0614T,Rmvl&rplcmt ss impl dfb pg,Other,RVU2026A,2026
0615T,Auto alys binocular eye mvmt,Other,RVU2026A,2026
0620T,Evasc ven artlz tibl/prnl vn,Other,RVU2026A,2026
0621T,Trabeculostomy interno laser,Other,RVU2026A,2026
0622T,Trabeculostomy int lsr w/scp,Other,RVU2026A,2026
0627T,Perq njx algc fluor lmbr 1st,Other,RVU2026A,2026
0628T,Perq njx algc fluor lmbr ea,Other,RVU2026A,2026
0629T,Perq njx algc ct lmbr 1st,Other,RVU2026A,2026
0630T,Perq njx algc ct lmbr ea,Other,RVU2026A,2026
0632T,Perq tcat us abltj nrv p-art,Other,RVU2026A,2026
0633T,Ct breast w/3d uni c-,Other,RVU2026A,2026
0634T,Ct breast w/3d uni c+,Other,RVU2026A,2026
0635T,Ct breast w/3d uni c-/c+,Other,RVU2026A,2026
0636T,Ct breast w/3d bi c-,Other,RVU2026A,2026
0637T,Ct breast w/3d bi c+,Other,RVU2026A,2026
0638T,Ct breast w/3d bi c-/c+,Other,RVU2026A,2026
0639T,Wrls skn snr anisotropy meas,Other,RVU2026A,2026
0640T,Ncntc ifr spctrsc o/t pad 1,Other,RVU2026A,2026
0643T,Tcat l ventr rstrj dev implt,Other,RVU2026A,2026
0644T,Tcat rmvl/dblk icar mas perq,Other,RVU2026A,2026
0645T,Tcat impltj c sins rdctj dev,Other,RVU2026A,2026
0646T,Ttvi/rplcmt w/prstc vlv perq,Other,RVU2026A,2026
0647T,Insj gtube perq mag gastrpxy,Other,RVU2026A,2026
0648T,Quan mr tis wo mri 1orgn,Other,RVU2026A,2026
0649T,Quan mr tiss w/mri 1orgn,Other,RVU2026A,2026
0650T,Prgrmg dev eval scrms remote,Other,RVU2026A,2026
0651T,Mag ctrld capsule endoscopy,Other,RVU2026A,2026
0652T,Egd flx transnasal dx br/wa,Other,RVU2026A,2026
0653T,Egd flx transnasal bx 1/mlt,Other,RVU2026A,2026
0654T,Egd flx transnasal tube/cath,Other,RVU2026A,2026
0655T,Tprnl focal abltj mal prst8,Other,RVU2026A,2026
0656T,Ant lmbr vrt bdy teth <7 seg,Other,RVU2026A,2026
0657T,Ant lmbr vrt bdy teth 8+ seg,Other,RVU2026A,2026
0658T,Elec impd spectrsc 1+skn les,Other,RVU2026A,2026
0659T,Tcat intra-c nfs supersat o2,Other,RVU2026A,2026
0660T,Implt ant sgm io nbio rx sys,Other,RVU2026A,2026
0661T,Rmvl&rimpltj ant sgm implt,Other,RVU2026A,2026
0664T,Don hysterectomy open cdvr,Other,RVU2026A,2026
0665T,Don hysterectomy open liv,Other,RVU2026A,2026
0666T,Don hysterectomy laps liv,Other,RVU2026A,2026
0667T,Don hysterectomy rcp uter,Other,RVU2026A,2026
0668T,Bkbench prep don uter algrft,Other,RVU2026A,2026
0669T,Bkbench rcnstj don uter ven,Other,RVU2026A,2026
0670T,Bkbench rcnstj don uter artl,Other,RVU2026A,2026
0671T,Insj ant sgm aq drg dev 1+,Other,RVU2026A,2026
0672T,Ndovag cryg rf remdl tiss,Other,RVU2026A,2026
0673T,Abltj b9 thyr ndul perq lasr,Other,RVU2026A,2026
0674T,Laps insj nw/rpcmt prm isdss,Other,RVU2026A,2026
0675T,Laps insj nw/rpcmt isdss 1ld,Other,RVU2026A,2026
0676T,Laps insj nw/rpcmt isdss ea,Other,RVU2026A,2026
0677T,Laps repos lead isdss 1st ld,Other,RVU2026A,2026
0678T,Laps repos lead isdss ea add,Other,RVU2026A,2026
0679T,Laps rmvl lead isdss,Other,RVU2026A,2026
0680T,Insj/rplcmt pg only isdss,Other,RVU2026A,2026
0681T,Rlcj pulse gen only isdss,Other,RVU2026A,2026
0682T,Removal pulse gen only isdss,Other,RVU2026A,2026
0683T,Prgrmg dev eval isdss ip,Other,RVU2026A,2026
0684T,Peri-px dev eval isdss ip,Other,RVU2026A,2026
0685T,Interrog dev eval isdss ip,Other,RVU2026A,2026
0686T,Histotripsy mal hepatcel tis,Other,RVU2026A,2026
0687T,Tx amblyopia dev setup 1st,Other,RVU2026A,2026
0688T,Tx amblyopia assmt w/report,Other,RVU2026A,2026
0689T,Quan us tis charac w/o dx us,Other,RVU2026A,2026
0690T,Quan us tis charac w/dx us,Other,RVU2026A,2026
0691T,Auto alys xst ct std vrt fx,Other,RVU2026A,2026
0692T,Therapeutic ultrafiltration,Other,RVU2026A,2026
0693T,Compre ful bdy 3d mtn alys,Other,RVU2026A,2026
0694T,3d vol img&rcnstj brst/ax,Other,RVU2026A,2026
0695T,Bdy srf mpg pm/cvdfb tm impl,Other,RVU2026A,2026
0696T,Bdy surf mapg pm/cvdfb f/up,Other,RVU2026A,2026
0697T,Quan mr tis wo mri mlt orgn,Other,RVU2026A,2026
0698T,Quan mr tiss w/mri mlt orgn,Other,RVU2026A,2026
0699T,Njx pst chmbr eye medication,Other,RVU2026A,2026
0700T,Molec fluor img sus nev 1st,Other,RVU2026A,2026
0701T,Molec fluor img sus nev ea,Other,RVU2026A,2026
0704T,Rem tx amblyopia setup&edu,Other,RVU2026A,2026
0705T,Rem tx amblyopia tech sprt,Other,RVU2026A,2026
0706T,Rem tx amblyopia i&r phy/qhp,Other,RVU2026A,2026
0707T,Njx b1 sub mtrl sbchdrl dfct,Other,RVU2026A,2026
0708T,Id ca immntx prep & 1st njx,Other,RVU2026A,2026
0709T,Id ca immntx each addl njx,Other,RVU2026A,2026
0710T,N-invas artl plaq alys,Other,RVU2026A,2026
0711T,N-nvs artl plaq alys dat prp,Other,RVU2026A,2026
0712T,N-nvs artl plaq alys quan,Other,RVU2026A,2026
0713T,N-nvs artl plaq alys rvw i&r,Other,RVU2026A,2026
0714T,Tpla b9 prst8 hyprplsa<50ml,Other,RVU2026A,2026
0716T,Car acous wavfrm rec cad rsk,Other,RVU2026A,2026
0717T,Adrc ther prtl rc tear,Other,RVU2026A,2026
0718T,Adrc ther prtl rc tear njx,Other,RVU2026A,2026
0719T,Pst vrt jt rplcmt lmbr 1 sgm,Other,RVU2026A,2026
0721T,Quan ct tiss charac w/o ct,Other,RVU2026A,2026
0722T,Quan ct tiss charac w/ct,Other,RVU2026A,2026
0723T,Qmrcp w/o dx mri sm anat ses,Other,RVU2026A,2026
0724T,Qmrcp w/dx mri same anatomy,Other,RVU2026A,2026
0725T,Vestibular dev impltj uni,Other,RVU2026A,2026
0726T,Rmvl implt vstibular dev uni,Other,RVU2026A,2026
0727T,Rmvl&rplcmt implt vstblr dev,Other,RVU2026A,2026
0728T,Dx alys vstblr implt uni 1st,Other,RVU2026A,2026
0729T,Dx alys vstblr implt uni sbq,Other,RVU2026A,2026
0730T,Trabeculotomy lsr w/oct gdn,Other,RVU2026A,2026
0731T,Augmnt ai-based fcl phnt a/r,Other,RVU2026A,2026
0732T,Immntx admn electroporatn im,Other,RVU2026A,2026
0733T,Rem r-t mtn nrehab ther sply,Other,RVU2026A,2026
0734T,Rem r-t mtn nrehab tx mgmt,Other,RVU2026A,2026
0735T,Prep tum cav iort prim crnot,Other,RVU2026A,2026
0736T,Colonic lavage 35+l water,Other,RVU2026A,2026
0737T,Xenograft impltj artclr surf,Other,RVU2026A,2026
0738T,Tx pln mag fld abltj prst8,Other,RVU2026A,2026
0739T,Abltj mal prst8 mag fld ndct,Other,RVU2026A,2026
0740T,Rem auton alg nsln cal setup,Other,RVU2026A,2026
0741T,Rem auton alg nsln data coll,Other,RVU2026A,2026
0742T,Aqmbf spect xers/strs & rest,Other,RVU2026A,2026
0743T,B1 str & fx rsk vrt fx assmt,Other,RVU2026A,2026
0744T,Insj bioprostc vlv fem vn,Other,RVU2026A,2026
0745T,Car ablt rad arr n-invas loc,Other,RVU2026A,2026
0746T,Car ablt rad arr cnv loc map,Other,RVU2026A,2026
0747T,Car ablt rad arrhyt dlvr rad,Other,RVU2026A,2026
0748T,Njx stm cl prdct anl sft tis,Other,RVU2026A,2026
0749T,B1 str&fx rsk assmt dxr-bmd,Other,RVU2026A,2026
0750T,B1 str&fx rsk asmt dxrbmd1vw,Other,RVU2026A,2026
0751T,Dgtz gls mcrscp sld level ii,Other,RVU2026A,2026
0752T,Dgtz gls mcrscp sld lvl iii,Other,RVU2026A,2026
0753T,Dgtz gls mcrscp sld level iv,Other,RVU2026A,2026
0754T,Dgtz gls mcrscp sld level v,Other,RVU2026A,2026
0755T,Dgtz gls mcrscp sld level vi,Other,RVU2026A,2026
0756T,Dgtz gls mcrscp sld spc grpi,Other,RVU2026A,2026
0757T,Dgtz gls mcrscp sl spc grpii,Other,RVU2026A,2026
0758T,Dgtz gls mcrscp sl spc hchem,Other,RVU2026A,2026
0759T,Dgtz gls mcrscp sl sp grpiii,Other,RVU2026A,2026
0760T,Dgtz gls mcrscp sl imm 1st,Other,RVU2026A,2026
0761T,Dgtz gls mcrscp sl imm ea 1,Other,RVU2026A,2026
0762T,Dgtz gls mcrscp sl imm ea m,Other,RVU2026A,2026
0763T,Dgtz gls mcrscp mphmtrc alys,Other,RVU2026A,2026
0764T,Asstv alg ecg rsk asmt cncrt,Other,RVU2026A,2026
0765T,Asstv alg ecg rsk asmt prev,Other,RVU2026A,2026
0766T,Tc mag stimj pn 1st nerve,Other,RVU2026A,2026
0767T,Tc mag stimj pn ea addl nrv,Other,RVU2026A,2026
0770T,Vr technology assist therapy,Other,RVU2026A,2026
0771T,Vr px dissoc svc sm phy 1st,Other,RVU2026A,2026
0772T,Vr px dissoc svc sm phy ea,Other,RVU2026A,2026
0773T,Vr px dissoc svc oth phy 1st,Other,RVU2026A,2026
0774T,Vr px dissoc svc oth phy ea,Other,RVU2026A,2026
0776T,Ther indctj ntrabrn hypthrm,Other,RVU2026A,2026
0777T,R-t prs sensing edrl gdn sys,Other,RVU2026A,2026
0778T,Smmg cncrnt appl imu snr,Other,RVU2026A,2026
0779T,Gi myoelectrical actv study,Other,RVU2026A,2026
0780T,Instlj fecal microbiota ssp,Other,RVU2026A,2026
0781T,Brnchsc rf dstrj pulm nrv bi,Other,RVU2026A,2026
0782T,Brnchsc rf dstrj plm nrv uni,Other,RVU2026A,2026
0783T,Tc auriculr neurostimulation,Other,RVU2026A,2026
0784T,Ins/rplmt eltrd ra spi nstim,Other,RVU2026A,2026
0785T,Revj/rmvl nea spi w/nstim,Other,RVU2026A,2026
0786T,Insj/rplcmt prq ra sac nstim,Other,RVU2026A,2026
0787T,Revj/rmvl nea sac w/nstim,Other,RVU2026A,2026
0788T,Elec aly smp iins sp/sac nrv,Other,RVU2026A,2026
0789T,Elec aly cpx iins sp/sac nrv,Other,RVU2026A,2026
0790T,Revj rplcmt/rmvl vrt tethrg,Other,RVU2026A,2026
0791T,Motr cog vr gait train ea 15,Other,RVU2026A,2026
0792T,Appl slvr diamn fluoride 38%,Other,RVU2026A,2026
0793T,Prq tcat thrm ablt nrv p-art,Other,RVU2026A,2026
0794T,Pt spec alg rx-onc tx option,Other,RVU2026A,2026
0795T,Tcat ins 2chmbr ldls pm cmpl,Other,RVU2026A,2026
0796T,Tcat ins 2chmbr ldls pm ra,Other,RVU2026A,2026
0797T,Tcat ins 2chmbr ldls pm rv,Other,RVU2026A,2026
0798T,Tcat rmv 2chmbr ldls pm cmpl,Other,RVU2026A,2026
0799T,Tcat rmvl 2chmbr ldls pm ra,Other,RVU2026A,2026
0800T,Tcat rmvl 2chmbr ldls pm rv,Other,RVU2026A,2026
0801T,Tcat rmv&rpl 2chmbr ldls pm,Other,RVU2026A,2026
0802T,Tcat rmv&rpl2chmb ldls pm ra,Other,RVU2026A,2026
0803T,Tcat rmv&rpl2chmb ldls pm rv,Other,RVU2026A,2026
0804T,Prgrmg evl ldls pm 2chmbr ip,Other,RVU2026A,2026
0805T,Tcat s&ivc prstc vl impl prq,Other,RVU2026A,2026
0806T,Tcat s&ivc prstc vl impl opn,Other,RVU2026A,2026
0807T,Pulm tiss vntj alys prev ct,Other,RVU2026A,2026
0808T,Pulm tiss vntj alys w/ct,Other,RVU2026A,2026
0810T,Subrta njx rx agt w/vtrc,Other,RVU2026A,2026
0811T,Rem mlt day uroflow setup,Other,RVU2026A,2026
0812T,Rem mlt day uroflow dev sply,Other,RVU2026A,2026
0813T,Egd vol adjmt bariatric balo,Other,RVU2026A,2026
0814T,Prq njx biod osteo matrl fem,Other,RVU2026A,2026
0815T,Us rems b1 dns hips plvs/spi,Other,RVU2026A,2026
0816T,Opn insj/rplcmt ins ptn subq,Other,RVU2026A,2026
0817T,Opn insj/rplcmt ins ptn subf,Other,RVU2026A,2026
0818T,Revj/rmvl ins ptn subq,Other,RVU2026A,2026
0819T,Revj/rmvl ins ptn subf,Other,RVU2026A,2026
0820T,Mntr psychdlc med 1stphy/qhp,Other,RVU2026A,2026
0821T,Mntr psychdlc med 2ndphy/qhp,Other,RVU2026A,2026
0822T,Mntr psychdlc med cln staff,Other,RVU2026A,2026
0823T,Tcat ins 1chmbr ldls pm ra,Other,RVU2026A,2026
0824T,Tcat rmv 1chmbr ldls pm ra,Other,RVU2026A,2026
0825T,Tcat rmv&rpl1chmb ldls pm ra,Other,RVU2026A,2026
0826T,Prgrmg evl ldls pm 1chmbr ip,Other,RVU2026A,2026
0827T,Dgtz gls mcrscp cytp smears,Other,RVU2026A,2026
0828T,Dgtz gls mcrscp cytp smpl fl,Other,RVU2026A,2026
0829T,Dgtz gls mcrscp cytp conctrj,Other,RVU2026A,2026
0830T,Dgtz gls mcrscp cytp slctv,Other,RVU2026A,2026
0831T,Dgtz gls mcrscp cytp c/v,Other,RVU2026A,2026
0832T,Dgtz gls mcrscp cytp oth scr,Other,RVU2026A,2026
0833T,Dgtz gls mcrscp cytp oth prp,Other,RVU2026A,2026
0834T,Dgtz gls mcrscp cytp oth xtn,Other,RVU2026A,2026
0835T,Dgtz gls mcrscp fna 1st ea,Other,RVU2026A,2026
0836T,Dgtz gls mcrscp fna ea addl,Other,RVU2026A,2026
0837T,Dgtz gls mcrscp fna i&r,Other,RVU2026A,2026
0838T,Dgtz gls mcrscp cslt sld els,Other,RVU2026A,2026
0839T,Dgtz gls mcrscp cslt mat prp,Other,RVU2026A,2026
0840T,Dgtz gls mcrscp cslt compre,Other,RVU2026A,2026
0841T,Dgtz gls mcrscp pth cslt 1st,Other,RVU2026A,2026
0842T,Dgtz gls mcrscp pth cslt ea,Other,RVU2026A,2026
0843T,Dgtz gls mcrscp cslt cyt 1st,Other,RVU2026A,2026
0844T,Dgtz gls mcrscp cslt cyt ea,Other,RVU2026A,2026
0845T,Dgtz gls mcrscp imfluor 1st,Other,RVU2026A,2026
0846T,Dgtz gls mcrscp imfluor ea,Other,RVU2026A,2026
0847T,Dgtz gls mcrscp xm arch tiss,Other,RVU2026A,2026
0848T,Dgtz gls mcrscp ish 1st,Other,RVU2026A,2026
0849T,Dgtz gls mcrscp ish ea adl 1,Other,RVU2026A,2026
0850T,Dgtz gls mcrscp ish ea mult,Other,RVU2026A,2026
0851T,Dgtz gls mcrscp mphmtrc 1st,Other,RVU2026A,2026
0852T,Dgtz gls mcrscp mphmtrc ea 1,Other,RVU2026A,2026
0853T,Dgtz gls mcrscp mphmtrc ea m,Other,RVU2026A,2026
0854T,Dgtz gls mcrscp bld smr prph,Other,RVU2026A,2026
0855T,Dgtz gls mcrscp b1 marow smr,Other,RVU2026A,2026
0856T,Dgtz gls mcrscp electron mic,Other,RVU2026A,2026
0857T,Opto-acoustic img breast uni,Other,RVU2026A,2026
0858T,Ext trnscranl mag stimj meas,Other,RVU2026A,2026
0859T,Ncntc ifr spctrsc o/t pad ea,Other,RVU2026A,2026
0860T,Ncntc ifr spctrsc scr pad,Other,RVU2026A,2026
0861T,Rmvl pg wcs lv both compnt,Other,RVU2026A,2026
0862T,Rlcj pg wcs lv battery only,Other,RVU2026A,2026
0863T,Rlcj pg wcs lv trnsmtr only,Other,RVU2026A,2026
0864T,Low ntsty eswt corpus cvrnsm,Other,RVU2026A,2026
0865T,Quan mri alys brn w/o dx mri,Other,RVU2026A,2026
0866T,Quan mri alys brn w/dx mri,Other,RVU2026A,2026
0867T,Tpla b9 prst8 hyprplsa>=50ml,Other,RVU2026A,2026
0868T,Hi-res gastric ep mapping,Other,RVU2026A,2026
0869T,Njx b1 sub mtrl hw fixj aug,Other,RVU2026A,2026
0870T,Imp subq prtl ascts pmp sys,Other,RVU2026A,2026
0871T,Rplcmt subq prtl ascites pmp,Other,RVU2026A,2026
0872T,Rplcmt ndwllg bldr&prtl cath,Other,RVU2026A,2026
0873T,Revj subq prtl asct pmp sys,Other,RVU2026A,2026
0874T,Rmvl pertl ascites pmp sys,Other,RVU2026A,2026
0875T,Prgrm subq prtl asct pmp sys,Other,RVU2026A,2026
0876T,Duplex scan hemo fstl lmtd,Other,RVU2026A,2026
0877T,Augmnt alys ch ct ild w/o ct,Other,RVU2026A,2026
0878T,Augmnt alys ch ct ild w/ct,Other,RVU2026A,2026
0879T,Augmnt alys ch ct ild prep,Other,RVU2026A,2026
0880T,Augmnt alys ch ct ild i&r,Other,RVU2026A,2026
0881T,Cryotherapy oral cavity,Other,RVU2026A,2026
0882T,Intraop ther estim pn ue 1st,Other,RVU2026A,2026
0883T,Intraop ther estim pn ue ea,Other,RVU2026A,2026
0884T,Esphgsc flx 1st tndsc dilat,Other,RVU2026A,2026
0885T,Colsc flx 1st tndsc dilat,Other,RVU2026A,2026
0886T,Sgmdsc flx 1st tndsc dilat,Other,RVU2026A,2026
0887T,End-tidal ctrl inhaled anes,Other,RVU2026A,2026
0888T,Histotripsy mal renal tissue,Other,RVU2026A,2026
0889T,Prsnlz trgt dvl arhfcmrigtbs,Other,RVU2026A,2026
0890T,Arhfcmrigtbs 1st tx day,Other,RVU2026A,2026
0891T,Arhfcmrigtbs sbsq tx day,Other,RVU2026A,2026
0892T,Arhfcmrigtbs sbsq per tx day,Other,RVU2026A,2026
0893T,N-invas assmt bld oxygnation,Other,RVU2026A,2026
0894T,Cannulation liver allograft,Other,RVU2026A,2026
0895T,Connj lvr algrft prfu dev 1,Other,RVU2026A,2026
0896T,Connj lvr algrft prfu dev ea,Other,RVU2026A,2026
0897T,N-invas augmnt arrhyt alys,Other,RVU2026A,2026
0898T,N-invas prst8 cancer est map,Other,RVU2026A,2026
0899T,N-invas deter aqmbf aug cmr,Other,RVU2026A,2026
0900T,N-invas est aqmbf asstv cmr,Other,RVU2026A,2026
0901T,Plmt bone marrow smplg port,Other,RVU2026A,2026
0902T,Qtc ntrvl augmnt alg aly ecg,Other,RVU2026A,2026
0903T,Ecg alg 12 lead reduced i&r,Other,RVU2026A,2026
0904T,Ecg alg 12 ld rdcd trcg only,Other,RVU2026A,2026
0905T,Ecg alg 12 ld rdcd i&r only,Other,RVU2026A,2026
0906T,Coms ther 1st appl<=50 sq cm,Other,RVU2026A,2026
0907T,Coms ther ea addl<=50 sq cm,Other,RVU2026A,2026
0908T,Opn imp int nstm sys vgs nrv,Other,RVU2026A,2026
0909T,Rplcmt int nstim sys vgs nrv,Other,RVU2026A,2026
0910T,Rmvl int nstim sys vagus nrv,Other,RVU2026A,2026
0911T,Elec aly nstm sys vgs nrv wo,Other,RVU2026A,2026
0912T,Elec alys nstim sys vgs smpl,Other,RVU2026A,2026
0913T,Prq tcat ther rx ntrac balo1,Other,RVU2026A,2026
0914T,Prq tcat thr rx ntrc bal sep,Other,RVU2026A,2026
0915T,Insj perm ccm-d sys pg&eltrd,Other,RVU2026A,2026
0916T,Insj perm ccm-d sys pg only,Other,RVU2026A,2026
0917T,Insj perm ccm-d sys 1 lead,Other,RVU2026A,2026
0918T,Insj perm ccm-d sys dual ld,Other,RVU2026A,2026
0919T,Rmvl perm ccm-d sys pg only,Other,RVU2026A,2026
0920T,Rmvl perm ccm-d sys 1 pac ld,Other,RVU2026A,2026
0921T,Rmvl perm ccm-d sys 1 dfb ld,Other,RVU2026A,2026
0922T,Rmvl perm ccm-d sys dual ld,Other,RVU2026A,2026
0923T,Rmvl&rplcmt perm ccm-d pg,Other,RVU2026A,2026
0924T,Rpos prv ccm-d trnsvns eltrd,Other,RVU2026A,2026
0925T,Rlcj skin pocket ccm-d pg,Other,RVU2026A,2026
0926T,Prgrmg dev eval ccm-d ip,Other,RVU2026A,2026
0927T,Interrog dev eval ccm-d ip,Other,RVU2026A,2026
0928T,Rem interrog dev ccm-d phys,Other,RVU2026A,2026
0929T,Rem interrog dev ccm-d tech,Other,RVU2026A,2026
0930T,Ephys eval ccm-d ld 1st impl,Other,RVU2026A,2026
0931T,Ephys eval ccm-d ld separate,Other,RVU2026A,2026
0932T,N-invs det hrt fail aug echo,Other,RVU2026A,2026
0933T,Tcat impl wrls l atr prs snr,Other,RVU2026A,2026
0934T,Rem mntr wrls l atr prs snr,Other,RVU2026A,2026
0935T,Cysto w/rnl pel symp dnrvtj,Other,RVU2026A,2026
0936T,Photobiomodulation ther rta,Other,RVU2026A,2026
0937T,Xtrnl ecg rec>15d<30d,Other,RVU2026A,2026
0938T,Xtrnl ecg rec>15d<30d rec,Other,RVU2026A,2026
0939T,Xtrnl ecg rec>15d<30d scan,Other,RVU2026A,2026
0940T,Xtrnl ecg rec>15d<30d r&i,Other,RVU2026A,2026
0941T,Cysto flx ins&xpns urtl scaf,Other,RVU2026A,2026
0942T,Cysto flx rmv&rplc urtl scaf,Other,RVU2026A,2026
0943T,Cysto flx rmvl urtl scaffold,Other,RVU2026A,2026
0944T,3d cntr simula trgt lvr les,Other,RVU2026A,2026
0945T,Intraop assmt abnl tum tiss,Other,RVU2026A,2026
0946T,Ortho impl mvmt alys pair ct,Other,RVU2026A,2026
0947T,Mrgfus strtctc bl-br disrpj,Other,RVU2026A,2026
0948T,Rem interrog dev ccm phys,Other,RVU2026A,2026
0949T,Rem interrog dev ccm tech,Other,RVU2026A,2026
0950T,Abltj b9 prst8 tissue hifu,Other,RVU2026A,2026
0951T,Tot impl amei 1st plmt,Other,RVU2026A,2026
0952T,Tot impl amei rev/rplc mstdc,Other,RVU2026A,2026
0953T,Tot impl amei rev/rplc w/o,Other,RVU2026A,2026
0954T,Tot impl amei rplc snd proc,Other,RVU2026A,2026
0955T,Tot impl amei removal,Other,RVU2026A,2026
0956T,Prt crn ch cr&tun elt s-sclp,Other,RVU2026A,2026
0957T,Rev s-sclp eltr ra rcvr&tlmt,Other,RVU2026A,2026
0958T,Rmv s-sclp eltr ra rcvr&tlmt,Other,RVU2026A,2026
0959T,Rmv/rplc magnet coil assem,Other,RVU2026A,2026
0960T,Rpl s-sclp eltr ra rcvr&tlmt,Other,RVU2026A,2026
0961T,Shortwave ifr radiation img,Other,RVU2026A,2026
0962T,Asstv alg alys acous&ecg rec,Other,RVU2026A,2026
0963T,Anosc sbmcsl njx bulking agt,Other,RVU2026A,2026
0964T,I&cust prep jaw xpnsj 1arch,Other,RVU2026A,2026
0965T,I&cst prp jw xpn dl arch non,Other,RVU2026A,2026
0966T,I&cst prp jw xpn dl arch fxd,Other,RVU2026A,2026
0967T,Tranal ins tmp clrc anst dev,Other,RVU2026A,2026
0968T,Insj/rplcmt epcrnl nstim sys,Other,RVU2026A,2026
0969T,Removal epicranial nstim sys,Other,RVU2026A,2026
0970T,Ablt b9 brst tum perq lsr ea,Other,RVU2026A,2026
0971T,Ablt mal brst tum pq lsr uni,Other,RVU2026A,2026
0972T,Asstv alg clsfctn burn hlg,Other,RVU2026A,2026
0973T,Slctv nzmtc dbrdmt t/a/l 1st,Other,RVU2026A,2026
0974T,Slctv nzmtc dbrdmt t/a/l ea,Other,RVU2026A,2026
0975T,Slctv nzmtc dbrdmt s/n/hf 1,Other,RVU2026A,2026
0976T,Slctv nzmtc dbrdmt s/n/hf ea,Other,RVU2026A,2026
0977T,Upr gi bld detcj snr capsule,Other,RVU2026A,2026
0978T,Submucosal cryolysis therapy,Other,RVU2026A,2026
0979T,Sbmcsl crylys ther sft palt,Other,RVU2026A,2026
0980T,Sbmcsl crylys ther tng&tnsl,Other,RVU2026A,2026
0981T,Tcat impl wrls ivc snr,Other,RVU2026A,2026
0982T,Rem mntr impl ivc snr set-up,Other,RVU2026A,2026
0983T,Rem mntr impl ivc snr phys,Other,RVU2026A,2026
0984T,Iv img xtrc cere vsl oct 1st,Other,RVU2026A,2026
0985T,Iv img xtrc cere vsl oct ea,Other,RVU2026A,2026
0986T,Iv img icr cere vsl oct 1st,Other,RVU2026A,2026
0987T,Iv img icr cere vsl oct ea,Other,RVU2026A,2026
0988T,Opn ins/rplc ins ptn sbq&sbf,Other,RVU2026A,2026
0989T,Revj/rmvl ins ptn subq&subf,Other,RVU2026A,2026
0990T,Trncrv inst biod hydrgl mtrl,Other,RVU2026A,2026
0991T,Cysto lo-nrg lithtrp&mcrsphr,Other,RVU2026A,2026
0992T,N-invas assmt car rsk w/o ct,Other,RVU2026A,2026
0993T,N-invas assmt car rsk w/ct,Other,RVU2026A,2026
0994T,Evasc dlvr a-wal stbl rx prq,Other,RVU2026A,2026
0995T,Evasc dlvr a-wal stbl rx opn,Other,RVU2026A,2026
0996T,Ins&sclr fix caps bag prosth,Other,RVU2026A,2026
0997T,Precuneus mag stimj tx plng,Other,RVU2026A,2026
0998T,Precuneus mag stimj tx dlvr,Other,RVU2026A,2026
0999T,Autol musc cell therapy hrvg,Other,RVU2026A,2026
10004,Fna bx w/o img gdn ea addl,CPT,RVU2026A,2026
10005,Fna bx w/us gdn 1st les,CPT,RVU2026A,2026
10006,Fna bx w/us gdn ea addl,CPT,RVU2026A,2026
10007,Fna bx w/fluor gdn 1st les,CPT,RVU2026A,2026
10008,Fna bx w/fluor gdn ea addl,CPT,RVU2026A,2026
10009,Fna bx w/ct gdn 1st les,CPT,RVU2026A,2026
1000F,Tobacco use assessed,Other,RVU2026A,2026
1000T,Autol musc cell therapy admn,Other,RVU2026A,2026
10010,Fna bx w/ct gdn ea addl,CPT,RVU2026A,2026
10011,Fna bx w/mr gdn 1st les,CPT,RVU2026A,2026
10012,Fna bx w/mr gdn ea addl,CPT,RVU2026A,2026
1001T,Autol musc cell therapy njx,Other,RVU2026A,2026
10021,Fna bx w/o img gdn 1st les,CPT,RVU2026A,2026
1002F,Assess anginal symptom/level,Other,RVU2026A,2026
1002T,Air displacmnt plethysmograp,Other,RVU2026A,2026
10030,Img gid flu coll drg sft tis,CPT,RVU2026A,2026
10035,Plmt sft tiss loclzj dev 1st,CPT,RVU2026A,2026
10036,Plmt sft tiss loclzj dev ea,CPT,RVU2026A,2026
1003F,Level of activity assess,Other,RVU2026A,2026
1003T,Arthrp 1st crp/mtcrpl prostc,Other,RVU2026A,2026
10040,Extraction,CPT,RVU2026A,2026
1004F,Clin symp vol ovrld assess,Other,RVU2026A,2026
1004T,Elec alys s-scl eeg wo prgrm,Other,RVU2026A,2026
1005F,Asthma symptoms evaluate,Other,RVU2026A,2026
1005T,Elec alys s-scl eeg prgr 1st,Other,RVU2026A,2026
10060,I&d abscess simple/single,CPT,RVU2026A,2026
10061,I&d abscess comp/multiple,CPT,RVU2026A,2026
1006F,Osteoarthritis assess,Other,RVU2026A,2026
1006T,Elec alys s-scl eeg prgrm ea,Other,RVU2026A,2026
1007F,Anti-inflm/anlgsc otc assess,Other,RVU2026A,2026
1007T,Eeg impl s-sclp eeg w/o vid,Other,RVU2026A,2026
10080,I&d pilonidal cyst simple,CPT,RVU2026A,2026
10081,I&d pilonidal cyst comp,CPT,RVU2026A,2026
1008F,Gi/renal risk assess,Other,RVU2026A,2026
1008T,Rem mntr s-scl eeg sys setup,Other,RVU2026A,2026
1009T,Rem mntr s-sclp cont eeg sys,Other,RVU2026A,2026
1010F,Severity angina by actvty,Other,RVU2026A,2026
1010T,Cptr oph alys monoc eye mvmt,Other,RVU2026A,2026
1011F,Angina present,Other,RVU2026A,2026
1011T,Pbm therapy of oral cavity,Other,RVU2026A,2026
10120,Inc&rmvl fb subq tiss smpl,CPT,RVU2026A,2026
10121,Inc&rmvl fb subq tiss comp,CPT,RVU2026A,2026
1012F,Angina absent,Other,RVU2026A,2026
1012T,Mtrz ab ntrno trph scl/tr mw,Other,RVU2026A,2026
1013T,Lap srg imp/rpl eso nea&pg/r,Other,RVU2026A,2026
10140,I&d hmtma seroma/fluid collj,CPT,RVU2026A,2026
1014T,Lap rv/rmv eso sph nstm eltr,Other,RVU2026A,2026
1015F,Copd symptoms assess,Other,RVU2026A,2026
1015T,Rev/rmv lw esoph sphnc npg/r,Other,RVU2026A,2026
10160,Pnxr aspir absc hmtma bulla,CPT,RVU2026A,2026
1016T,Elec alys npgs esoph intraop,Other,RVU2026A,2026
1017T,Elec aly npgs esoph sbsq w/o,Other,RVU2026A,2026
10180,I&d complex po wound infctj,CPT,RVU2026A,2026
1018F,Assess dyspnea not present,Other,RVU2026A,2026
1018T,Elec alys npgs esoph sbsq w/,Other,RVU2026A,2026
1019F,Assess dyspnea present,Other,RVU2026A,2026
1019T,Lymphovenous bypass per xtr,Other,RVU2026A,2026
1020T,Raman spectroscopy 1+skn les,Other,RVU2026A,2026
1021T,Active thrc irrigation spx,Other,RVU2026A,2026
1022F,Pneumo imm status assess,Other,RVU2026A,2026
1022T,Prq tis dsplmt ntra-abdl/pel,Other,RVU2026A,2026
1023T,Prq tis dsplmt intrathoracic,Other,RVU2026A,2026
1024T,Perq tiss dsplmt soft tissue,Other,RVU2026A,2026
1025T,Alt elec fld dos&dlv sim mdl,Other,RVU2026A,2026
1026F,Co-morbid condition assess,Other,RVU2026A,2026
1030F,Influenza imm status assess,Other,RVU2026A,2026
1031F,Smoking & 2nd hand assessed,Other,RVU2026A,2026
1032F,Smoker/exposed 2nd hnd smoke,Other,RVU2026A,2026
1033F,Tobacco nonsmoker nor 2ndhnd,Other,RVU2026A,2026
1034F,Current tobacco smoker,Other,RVU2026A,2026
1035F,Smokeless tobacco user,Other,RVU2026A,2026
1036F,Tobacco non-user,Other,RVU2026A,2026
1038F,Persistent asthma,Other,RVU2026A,2026
1039F,Intermittent asthma,Other,RVU2026A,2026
1040F,Dsm-5 info mdd docd,Other,RVU2026A,2026
1050F,History of mole changes,Other,RVU2026A,2026
1052F,Type location activityassess,Other,RVU2026A,2026
1055F,Visual funct status assess,Other,RVU2026A,2026
1060F,Doc perm/cont/parox atr fib,Other,RVU2026A,2026
1061F,Doc lack perm&cont&parox fib,Other,RVU2026A,2026
1065F,Ischm stroke symp lt3 hrsb/4,Other,RVU2026A,2026
1066F,Ischm stroke sx onset>=3hr,Other,RVU2026A,2026
1070F,Alarm symp assessed-absent,Other,RVU2026A,2026
1071F,Alarm symp assessed-1+ prsnt,Other,RVU2026A,2026
1090F,Pres/absn urine incon assess,Other,RVU2026A,2026
1091F,Urine incon characterized,Other,RVU2026A,2026
11000,Dbrdmt ecz/infected skin<10%,CPT,RVU2026A,2026
11001,Dbrdmt ecz/infct skn ea addl,CPT,RVU2026A,2026
11004,Dbrdmt skin xtrnl gent&per,CPT,RVU2026A,2026
11005,Dbrdmt skin abdominal wall,CPT,RVU2026A,2026
11006,Dbrdmt skin xtrnl gent per,CPT,RVU2026A,2026
11008,Rmv prstc mtrl/mesh abd wall,CPT,RVU2026A,2026
1100F,Ptfalls assess-docd ge2>/yr,Other,RVU2026A,2026
11010,Debride skin at fx site,CPT,RVU2026A,2026
11011,Debride skin musc at fx site,CPT,RVU2026A,2026
11012,Deb skin bone at fx site,CPT,RVU2026A,2026
1101F,Pt falls assess-docd le1/yr,Other,RVU2026A,2026
11042,Dbrdmt subq tis 1st 20sqcm/<,CPT,RVU2026A,2026
11043,Dbrdmt musc&/fsca 1st 20/<,CPT,RVU2026A,2026
11044,Dbrdmt bone 1st 20 sq cm/<,CPT,RVU2026A,2026
11045,Dbrdmt subq tiss each addl,CPT,RVU2026A,2026
11046,Dbrdmt musc&/fsca ea addl,CPT,RVU2026A,2026
11047,Dbrdmt bone each addl,CPT,RVU2026A,2026
11055,Paring/cutg b9 hyprker les 1,CPT,RVU2026A,2026
11056,Parng/cutg b9 hyprkr les 2-4,CPT,RVU2026A,2026
11057,Parng/cutg b9 hyprkr les >4,CPT,RVU2026A,2026
11102,Tangntl bx skin single les,CPT,RVU2026A,2026
11103,Tangntl bx skin ea sep/addl,CPT,RVU2026A,2026
11104,Punch bx skin single lesion,CPT,RVU2026A,2026
11105,Punch bx skin ea sep/addl,CPT,RVU2026A,2026
11106,Incal bx skn single les,CPT,RVU2026A,2026
11107,Incal bx skn ea sep/addl,CPT,RVU2026A,2026
1110F,Pt lft inpt fac w/in 60 days,Other,RVU2026A,2026
1111F,Dschrg med/current med merge,Other,RVU2026A,2026
1116F,Auric/peri pain assessed,Other,RVU2026A,2026
1118F,Gerd symps assessed 12 month,Other,RVU2026A,2026
1119F,Init eval for condition,Other,RVU2026A,2026
11200,Rmvl skin tags up to&inc 15,CPT,RVU2026A,2026
11201,Rmvl skin tags ea addl 10,CPT,RVU2026A,2026
1121F,Subs eval for condition,Other,RVU2026A,2026
1123F,Acp discuss/dscn mkr docd,Other,RVU2026A,2026
1124F,Acp discuss-no dscnmkr docd,Other,RVU2026A,2026
1125F,Amnt pain noted pain prsnt,Other,RVU2026A,2026
1126F,Amnt pain noted none prsnt,Other,RVU2026A,2026
1127F,New episode for condition,Other,RVU2026A,2026
1128F,Subs episode for condition,Other,RVU2026A,2026
11300,Shave skin lesion 0.5 cm/<,CPT,RVU2026A,2026
11301,Shave skin lesion 0.6-1.0 cm,CPT,RVU2026A,2026
11302,Shave skin lesion 1.1-2.0 cm,CPT,RVU2026A,2026
11303,Shave skin lesion >2.0 cm,CPT,RVU2026A,2026
11305,Shave skin lesion 0.5 cm/<,CPT,RVU2026A,2026
11306,Shave skin lesion 0.6-1.0 cm,CPT,RVU2026A,2026
11307,Shave skin lesion 1.1-2.0 cm,CPT,RVU2026A,2026
11308,Shave skin lesion >2.0 cm,CPT,RVU2026A,2026
1130F,Bk pain & fxn assessed,Other,RVU2026A,2026
11310,Shave skin lesion 0.5 cm/<,CPT,RVU2026A,2026
11311,Shave skin lesion 0.6-1.0 cm,CPT,RVU2026A,2026
11312,Shave skin lesion 1.1-2.0 cm,CPT,RVU2026A,2026
11313,Shave skin lesion >2.0 cm,CPT,RVU2026A,2026
1134F,Epsd bk pain for 6 wks/<,Other,RVU2026A,2026
1135F,Epsd bk pain for >6 wks,Other,RVU2026A,2026
1136F,Epsd bk pain for 12 wks/<,Other,RVU2026A,2026
1137F,Epsd bk pain for >12 wks,Other,RVU2026A,2026
11400,Exc tr-ext b9+marg 0.5 cm<,CPT,RVU2026A,2026
11401,Exc tr-ext b9+marg 0.6-1 cm,CPT,RVU2026A,2026
11402,Exc tr-ext b9+marg 1.1-2 cm,CPT,RVU2026A,2026
11403,Exc tr-ext b9+marg 2.1-3cm,CPT,RVU2026A,2026
11404,Exc tr-ext b9+marg 3.1-4 cm,CPT,RVU2026A,2026
11406,Exc tr-ext b9+marg >4.0 cm,CPT,RVU2026A,2026
11420,Exc h-f-nk-sp b9+marg 0.5/<,CPT,RVU2026A,2026
11421,Exc h-f-nk-sp b9+marg 0.6-1,CPT,RVU2026A,2026
11422,Exc h-f-nk-sp b9+marg 1.1-2,CPT,RVU2026A,2026
11423,Exc h-f-nk-sp b9+marg 2.1-3,CPT,RVU2026A,2026
11424,Exc h-f-nk-sp b9+marg 3.1-4,CPT,RVU2026A,2026
11426,Exc h-f-nk-sp b9+marg >4 cm,CPT,RVU2026A,2026
11440,Exc face-mm b9+marg 0.5 cm/<,CPT,RVU2026A,2026
11441,Exc face-mm b9+marg 0.6-1 cm,CPT,RVU2026A,2026
11442,Exc face-mm b9+marg 1.1-2 cm,CPT,RVU2026A,2026
11443,Exc face-mm b9+marg 2.1-3 cm,CPT,RVU2026A,2026
11444,Exc face-mm b9+marg 3.1-4 cm,CPT,RVU2026A,2026
11446,Exc face-mm b9+marg >4 cm,CPT,RVU2026A,2026
11450,Exc skn hdrdnt ax smpl/ntrm,CPT,RVU2026A,2026
11451,Exc skn hdrdnt ax complex,CPT,RVU2026A,2026
11462,Exc skn hdrdnt ing smpl/ntrm,CPT,RVU2026A,2026
11463,Exc skn hdrdnt ing complex,CPT,RVU2026A,2026
11470,Exc skn h/p/p/u smpl/ntrm,CPT,RVU2026A,2026
11471,Exc skn h/p/p/u complex,CPT,RVU2026A,2026
1150F,Doc pt rsk death w/in 1yr,Other,RVU2026A,2026
1151F,Doc no pt rsk death w/in 1yr,Other,RVU2026A,2026
1152F,Doc advncd dis comfort 1st,Other,RVU2026A,2026
1153F,Doc advncd dis cmfrt not 1st,Other,RVU2026A,2026
1157F,Advnc care plan in rcrd,Other,RVU2026A,2026
1158F,Advnc care plan tlk docd,Other,RVU2026A,2026
1159F,Med list docd in rcrd,Other,RVU2026A,2026
11600,Exc tr-ext mal+marg 0.5 cm/<,CPT,RVU2026A,2026
11601,Exc tr-ext mal+marg 0.6-1 cm,CPT,RVU2026A,2026
11602,Exc tr-ext mal+marg 1.1-2 cm,CPT,RVU2026A,2026
11603,Exc tr-ext mal+marg 2.1-3 cm,CPT,RVU2026A,2026
11604,Exc tr-ext mal+marg 3.1-4 cm,CPT,RVU2026A,2026
11606,Exc tr-ext mal+marg >4 cm,CPT,RVU2026A,2026
1160F,Rvw meds by rx/dr in rcrd,Other,RVU2026A,2026
11620,Exc h-f-nk-sp mal+marg 0.5/<,CPT,RVU2026A,2026
11621,Exc s/n/h/f/g mal+mrg 0.6-1,CPT,RVU2026A,2026
11622,Exc s/n/h/f/g mal+mrg 1.1-2,CPT,RVU2026A,2026
11623,Exc s/n/h/f/g mal+mrg 2.1-3,CPT,RVU2026A,2026
11624,Exc s/n/h/f/g mal+mrg 3.1-4,CPT,RVU2026A,2026
11626,Exc s/n/h/f/g mal+mrg >4 cm,CPT,RVU2026A,2026
11640,Exc f/e/e/n/l mal+mrg 0.5cm<,CPT,RVU2026A,2026
11641,Exc f/e/e/n/l mal+mrg 0.6-1,CPT,RVU2026A,2026
11642,Exc f/e/e/n/l mal+mrg 1.1-2,CPT,RVU2026A,2026
11643,Exc f/e/e/n/l mal+mrg 2.1-3,CPT,RVU2026A,2026
11644,Exc f/e/e/n/l mal+mrg 3.1-4,CPT,RVU2026A,2026
11646,Exc f/e/e/n/l mal+mrg >4 cm,CPT,RVU2026A,2026
1170F,Fxnl status assessed,Other,RVU2026A,2026
11719,Trim nail(s) any number,CPT,RVU2026A,2026
11720,Debride nail 1-5,CPT,RVU2026A,2026
11721,Debride nail 6 or more,CPT,RVU2026A,2026
11730,Avulsion nail plate simple 1,CPT,RVU2026A,2026
11732,Avlsn nail plate simple each,CPT,RVU2026A,2026
11740,Evacuation subungual hmtma,CPT,RVU2026A,2026
11750,Excision nail&nail matrix,CPT,RVU2026A,2026
11755,Biopsy nail unit,CPT,RVU2026A,2026
1175F,Function stat assessed rvwd,Other,RVU2026A,2026
11760,Repair of nail bed,CPT,RVU2026A,2026
11762,Reconstruction of nail bed,CPT,RVU2026A,2026
11765,Wedge excision skn nail fold,CPT,RVU2026A,2026
11770,Exc pilonidal cyst simple,CPT,RVU2026A,2026
11771,Exc pilonidal cyst xtnsv,CPT,RVU2026A,2026
11772,Exc pilonidal cyst comp,CPT,RVU2026A,2026
1180F,Thromboemb risk assessed,Other,RVU2026A,2026
1181F,Neuropsychia sympts assessed,Other,RVU2026A,2026
1182F,Neuropsychi sympt 1+present,Other,RVU2026A,2026
1183F,Neuropsychiatric symp absent,Other,RVU2026A,2026
11900,Inject skin lesions </w 7,CPT,RVU2026A,2026
11901,Inject skin lesions >7,CPT,RVU2026A,2026
11920,Correct skin color 6.0 cm/<,CPT,RVU2026A,2026
11921,Correct skn color 6.1-20.0cm,CPT,RVU2026A,2026
11922,Correct skin color ea 20.0cm,CPT,RVU2026A,2026
11950,Subq njx filling matrl 1cc/<,CPT,RVU2026A,2026
11951,Subq njx fil matrl 1.1-5.0cc,CPT,RVU2026A,2026
11952,Subq njx fil matrl 5.1-10cc,CPT,RVU2026A,2026
11954,Subq njx fil matrl>10.0 cc,CPT,RVU2026A,2026
11960,Insert tissue expander(s),CPT,RVU2026A,2026
11970,Rplcmt tiss xpndr perm implt,CPT,RVU2026A,2026
11971,Rmvl tis xpndr wo insj implt,CPT,RVU2026A,2026
11976,Remove contraceptive capsule,CPT,RVU2026A,2026
11980,Implant hormone pellet(s),CPT,RVU2026A,2026
11981,Insertion drug dlvr implant,CPT,RVU2026A,2026
11982,Remove drug implant device,CPT,RVU2026A,2026
11983,Remove/insert drug implant,CPT,RVU2026A,2026
12001,Rpr s/n/ax/gen/trnk 2.5cm/<,CPT,RVU2026A,2026
12002,Rpr s/n/ax/gen/trnk2.6-7.5cm,CPT,RVU2026A,2026
12004,Rpr s/n/ax/gen/trk7.6-12.5cm,CPT,RVU2026A,2026
12005,Rpr s/n/a/gen/trk12.6-20.0cm,CPT,RVU2026A,2026
12006,Rpr s/n/a/gen/trk20.1-30.0cm,CPT,RVU2026A,2026
12007,Rpr s/n/ax/gen/trnk >30.0 cm,CPT,RVU2026A,2026
1200F,Seizure type& frequ docd,Other,RVU2026A,2026
12011,Rpr f/e/e/n/l/m 2.5 cm/<,CPT,RVU2026A,2026
12013,Rpr f/e/e/n/l/m 2.6-5.0 cm,CPT,RVU2026A,2026
12014,Rpr f/e/e/n/l/m 5.1-7.5 cm,CPT,RVU2026A,2026
12015,Rpr f/e/e/n/l/m 7.6-12.5 cm,CPT,RVU2026A,2026
12016,Rpr fe/e/en/l/m 12.6-20.0 cm,CPT,RVU2026A,2026
12017,Rpr fe/e/en/l/m 20.1-30.0 cm,CPT,RVU2026A,2026
12018,Rpr f/e/e/n/l/m >30.0 cm,CPT,RVU2026A,2026
12020,Tx supfc wnd dehsn smpl clsr,CPT,RVU2026A,2026
12021,Tx supfc wnd dehsn w/packing,CPT,RVU2026A,2026
12031,Intmd rpr s/a/t/ext 2.5 cm/<,CPT,RVU2026A,2026
12032,Intmd rpr s/a/t/ext 2.6-7.5,CPT,RVU2026A,2026
12034,Intmd rpr s/tr/ext 7.6-12.5,CPT,RVU2026A,2026
12035,Intmd rpr s/a/t/ext 12.6-20,CPT,RVU2026A,2026
12036,Intmd rpr s/a/t/ext 20.1-30,CPT,RVU2026A,2026
12037,Intmd rpr s/tr/ext >30.0 cm,CPT,RVU2026A,2026
12041,Intmd rpr n-hf/genit 2.5cm/<,CPT,RVU2026A,2026
12042,Intmd rpr n-hf/genit2.6-7.5,CPT,RVU2026A,2026
12044,Intmd rpr n-hf/genit7.6-12.5,CPT,RVU2026A,2026
12045,Intmd rpr n-hf/genit12.6-20,CPT,RVU2026A,2026
12046,Intmd rpr n-hf/genit20.1-30,CPT,RVU2026A,2026
12047,Intmd rpr n-hf/genit >30.0cm,CPT,RVU2026A,2026
12051,Intmd rpr face/mm 2.5 cm/<,CPT,RVU2026A,2026
12052,Intmd rpr face/mm 2.6-5.0 cm,CPT,RVU2026A,2026
12053,Intmd rpr face/mm 5.1-7.5 cm,CPT,RVU2026A,2026
12054,Intmd rpr face/mm 7.6-12.5cm,CPT,RVU2026A,2026
12055,Intmd rpr face/mm 12.6-20 cm,CPT,RVU2026A,2026
12056,Intmd rpr face/mm 20.1-30.0,CPT,RVU2026A,2026
12057,Intmd rpr face/mm >30.0 cm,CPT,RVU2026A,2026
1205F,Epi etiol synd rvwd and docd,Other,RVU2026A,2026
1220F,Pt screened for depression,Other,RVU2026A,2026
13100,Cmplx rpr trunk 1.1-2.5 cm,CPT,RVU2026A,2026
13101,Cmplx rpr trunk 2.6-7.5 cm,CPT,RVU2026A,2026
13102,Cmplx rpr trunk addl 5cm/<,CPT,RVU2026A,2026
13120,Cmplx rpr s/a/l 1.1-2.5 cm,CPT,RVU2026A,2026
13121,Cmplx rpr s/a/l 2.6-7.5 cm,CPT,RVU2026A,2026
13122,Cmplx rpr s/a/l addl 5 cm/>,CPT,RVU2026A,2026
13131,Cmplx rpr f/c/c/m/n/ax/g/h/f,CPT,RVU2026A,2026
13132,Cmplx rpr f/c/c/m/n/ax/g/h/f,CPT,RVU2026A,2026
13133,Cmplx rpr f/c/c/m/n/ax/g/h/f,CPT,RVU2026A,2026
13151,Cmplx rpr e/n/e/l 1.1-2.5 cm,CPT,RVU2026A,2026
13152,Cmplx rpr e/n/e/l 2.6-7.5 cm,CPT,RVU2026A,2026
13153,Cmplx rpr e/n/e/l addl 5cm/<,CPT,RVU2026A,2026
13160,Sec clsr surg wnd/dehsn xtn,CPT,RVU2026A,2026
14000,Tis trnfr trunk 10 sq cm/<,CPT,RVU2026A,2026
14001,Tis trnfr trunk 10.1-30sqcm,CPT,RVU2026A,2026
1400F,Prkns diag rviewed,Other,RVU2026A,2026
14020,Tis trnfr s/a/l 10 sq cm/<,CPT,RVU2026A,2026
14021,Tis trnfr s/a/l 10.1-30 sqcm,CPT,RVU2026A,2026
14040,Tis trnfr f/c/c/m/n/a/g/h/f,CPT,RVU2026A,2026
14041,Tis trnfr f/c/c/m/n/a/g/h/f,CPT,RVU2026A,2026
14060,Tis trnfr e/n/e/l 10 sq cm/<,CPT,RVU2026A,2026
14061,Tis trnfr e/n/e/l10.1-30sqcm,CPT,RVU2026A,2026
14301,Tis trnfr any 30.1-60 sq cm,CPT,RVU2026A,2026
14302,Tis trnfr addl 30 sq cm,CPT,RVU2026A,2026
14350,Filleted finger/toe flap,CPT,RVU2026A,2026
1450F,Symptoms improved/consist,Other,RVU2026A,2026
1451F,Sympt show clin import drop,Other,RVU2026A,2026
1460F,Qual card diag prior 12 mons,Other,RVU2026A,2026
1461F,No qual card diag prior12mon,Other,RVU2026A,2026
1490F,Dem severity classified mild,Other,RVU2026A,2026
1491F,Dem severity classified mod,Other,RVU2026A,2026
1493F,Dem severity class severe,Other,RVU2026A,2026
1494F,Cognit assessed and reviewed,Other,RVU2026A,2026
15002,Wound prep trk/arm/leg,CPT,RVU2026A,2026
15003,Wound prep addl 100 cm,CPT,RVU2026A,2026
15004,Wound prep f/n/hf/g,CPT,RVU2026A,2026
15005,Wnd prep f/n/hf/g addl cm,CPT,RVU2026A,2026
1500F,Symptom&sign symm polyneuro,Other,RVU2026A,2026
15011,Hrv skn cll ssp agrft 1st 25,CPT,RVU2026A,2026
15012,Hrv skn cll ssp agrft ea add,CPT,RVU2026A,2026
15013,Prepj skn cll ssp agrft 1st,CPT,RVU2026A,2026
15014,Prepj skn cll ssp agrft ea,CPT,RVU2026A,2026
15015,App skn cl ssp agrft t/a/l 1,CPT,RVU2026A,2026
15016,App skn cl ssp agrf t/a/l ea,CPT,RVU2026A,2026
15017,App skn cll ssp f/n/g/hf 1st,CPT,RVU2026A,2026
15018,App skn cll ssp f/n/g/hf ea,CPT,RVU2026A,2026
1501F,Not initial eval for cond,Other,RVU2026A,2026
1502F,Pt queried pain fxn w/ instr,Other,RVU2026A,2026
1503F,Pt queried symp resp insuff,Other,RVU2026A,2026
15040,Harvest cultured skin graft,CPT,RVU2026A,2026
1504F,Pt has resp insufficiency,Other,RVU2026A,2026
15050,Pinch graft up to 2 cm diam,CPT,RVU2026A,2026
1505F,Pt has no resp insufficiency,Other,RVU2026A,2026
15100,Splt agrft t/a/l 1st 100sqcm,CPT,RVU2026A,2026
15101,Splt agrft t/a/l ea addl 100,CPT,RVU2026A,2026
15110,Epidrm agrft t/a/l 1st 100,CPT,RVU2026A,2026
15111,Epidrm agrft t/a/l ea addl,CPT,RVU2026A,2026
15115,Epdrm agrft f/s/n/h/f/g/m 1,CPT,RVU2026A,2026
15116,Epdrm agrft f/s/n/h/f/g/m ea,CPT,RVU2026A,2026
15120,Splt agrft f/s/n/h/f/g/m 1st,CPT,RVU2026A,2026
15121,Splt agrft f/s/n/h/f/g/m ea,CPT,RVU2026A,2026
15130,Drm agrft t/a/l 1st 100 sqcm,CPT,RVU2026A,2026
15131,Drm agrft t/a/l ea addl,CPT,RVU2026A,2026
15135,Drm agrft f/s/n/h/f/g/m 1st,CPT,RVU2026A,2026
15136,Drm agrft f/s/n/h/f/g/m ea,CPT,RVU2026A,2026
15150,Tis cltr skn agrft t/a/l 1st,CPT,RVU2026A,2026
15151,Tis cltr skn agrft t/a/l add,CPT,RVU2026A,2026
15152,Tis cltr skn agrft t/a/l ea,CPT,RVU2026A,2026
15155,Tis cltr agrft f/s/n/h/f/g 1,CPT,RVU2026A,2026
15156,Tis clt agrft f/s/n/h/f/g ad,CPT,RVU2026A,2026
15157,Tis clt agrft f/s/n/h/f/g ea,CPT,RVU2026A,2026
15200,Fth/gft fr trnk 20 sq cm/<,CPT,RVU2026A,2026
15201,Fth/gft fr trnk each addl,CPT,RVU2026A,2026
15220,Fth/gft fr s/a/l 20 sq cm/<,CPT,RVU2026A,2026
15221,Fth/gft fr s/a/l each addl,CPT,RVU2026A,2026
15240,Fth/gft f/c/c/m/n/ax/g/h/f20,CPT,RVU2026A,2026
15241,Fth/gft f/c/c/m/n/a/g/h/f ea,CPT,RVU2026A,2026
15260,Fth/gft fr n/e/e/l 20 sqcm/<,CPT,RVU2026A,2026
15261,Fth/gft fr n/e/e/l each addl,CPT,RVU2026A,2026
15271,Skin sub graft trnk/arm/leg,CPT,RVU2026A,2026
15272,Skin sub graft t/a/l add-on,CPT,RVU2026A,2026
15273,Skin sub grft t/arm/lg child,CPT,RVU2026A,2026
15274,Skn sub grft t/a/l child add,CPT,RVU2026A,2026
15275,Skin sub graft face/nk/hf/g,CPT,RVU2026A,2026
15276,Skin sub graft f/n/hf/g addl,CPT,RVU2026A,2026
15277,Skn sub grft f/n/hf/g child,CPT,RVU2026A,2026
15278,Skn sub grft f/n/hf/g ch add,CPT,RVU2026A,2026
15570,Skin pedicle flap trunk,CPT,RVU2026A,2026
15572,Skin pedicle flap arms/legs,CPT,RVU2026A,2026
15574,Pedcle fh/ch/ch/m/n/ax/g/h/f,CPT,RVU2026A,2026
15576,Pedicle e/n/e/l/ntroral,CPT,RVU2026A,2026
15600,Delay flap trunk,CPT,RVU2026A,2026
15610,Delay flap arms/legs,CPT,RVU2026A,2026
15620,Delay flap f/c/c/n/ax/g/h/f,CPT,RVU2026A,2026
15630,Delay flap eye/nos/ear/lip,CPT,RVU2026A,2026
15650,Transfer skin pedicle flap,CPT,RVU2026A,2026
15730,Mdfc flap w/prsrv vasc pedcl,CPT,RVU2026A,2026
15731,Forehead flap w/vasc pedicle,CPT,RVU2026A,2026
15733,Musc myoq/fscq flp h&n pedcl,CPT,RVU2026A,2026
15734,Muscle-skin graft trunk,CPT,RVU2026A,2026
15736,Muscle-skin graft arm,CPT,RVU2026A,2026
15738,Muscle-skin graft leg,CPT,RVU2026A,2026
15740,Island pedicle flap graft,CPT,RVU2026A,2026
15750,Neurovascular pedicle flap,CPT,RVU2026A,2026
15756,Free myo/skin flap microvasc,CPT,RVU2026A,2026
15757,Free skin flap microvasc,CPT,RVU2026A,2026
15758,Free fascial flap microvasc,CPT,RVU2026A,2026
15760,Composite skin graft,CPT,RVU2026A,2026
15769,Grfg autol soft tiss dir exc,CPT,RVU2026A,2026
15770,Derma-fat-fascia graft,CPT,RVU2026A,2026
15771,Grfg autol fat lipo 50 cc/<,CPT,RVU2026A,2026
15772,Grfg autol fat lipo ea addl,CPT,RVU2026A,2026
15773,Grfg autol fat lipo 25 cc/<,CPT,RVU2026A,2026
15774,Gfrg autol fat lipo ea addl,CPT,RVU2026A,2026
15775,Hair trnspl 1-15 punch grfts,CPT,RVU2026A,2026
15776,Hair trnspl >15 punch grafts,CPT,RVU2026A,2026
15777,Acellular derm matrix implt,CPT,RVU2026A,2026
15778,Impl absrb msh/prsth dly cls,CPT,RVU2026A,2026
15780,Dermabrasion total face,CPT,RVU2026A,2026
15781,Dermabrasion segmental face,CPT,RVU2026A,2026
15782,Dermabrasion other than face,CPT,RVU2026A,2026
15783,Dermabrasion suprfl any site,CPT,RVU2026A,2026
15786,Abrasion lesion single,CPT,RVU2026A,2026
15787,Abrasion lesions add-on,CPT,RVU2026A,2026
15788,Chemical peel facial epidrm,CPT,RVU2026A,2026
15789,Chemical peel facial dermal,CPT,RVU2026A,2026
15792,Chem peel nonfacial epidrm,CPT,RVU2026A,2026
15793,Chemical peel nonfacial drm,CPT,RVU2026A,2026
15820,Blepharoplasty lower eyelid,CPT,RVU2026A,2026
15821,Blepharp lwr eyelid fat pad,CPT,RVU2026A,2026
15822,Blepharoplasty upper eyelid,CPT,RVU2026A,2026
15823,Blepharp upr eyelid xcsv skn,CPT,RVU2026A,2026
15824,Rhytidectomy forehead,CPT,RVU2026A,2026
15825,Rhytdct nck pltysml tghtg,CPT,RVU2026A,2026
15826,Rhytidectomy glblr frn lines,CPT,RVU2026A,2026
15828,Rhytidectomy cheek chn & nck,CPT,RVU2026A,2026
15829,Rhytidectomy smas flap,CPT,RVU2026A,2026
15830,Exc excessive skin abdomen,CPT,RVU2026A,2026
15832,Exc excessive skin thigh,CPT,RVU2026A,2026
15833,Exc excessive skin leg,CPT,RVU2026A,2026
15834,Exc excessive skin hip,CPT,RVU2026A,2026
15835,Exc excessive skin buttock,CPT,RVU2026A,2026
15836,Exc excessive skin arm,CPT,RVU2026A,2026
15837,Exc excsv skin forearm/hand,CPT,RVU2026A,2026
15838,Exc excsv submental fat pad,CPT,RVU2026A,2026
15839,Exc excessive skn other area,CPT,RVU2026A,2026
15840,Nerve palsy fascial graft,CPT,RVU2026A,2026
15841,Nerve palsy muscle graft,CPT,RVU2026A,2026
15842,Nerve palsy microsurg graft,CPT,RVU2026A,2026
15845,Skin and muscle repair face,CPT,RVU2026A,2026
15847,Exc skin abd add-on,CPT,RVU2026A,2026
15851,Removal sutr/staple req anes,CPT,RVU2026A,2026
15852,Dressing change not for burn,CPT,RVU2026A,2026
15853,Removal sutr/stapl xreq anes,CPT,RVU2026A,2026
15854,Removal sutr&stapl xreq anes,CPT,RVU2026A,2026
15860,Iv njx tst vasc flo flap/grf,CPT,RVU2026A,2026
15876,Suction lipectomy head&neck,CPT,RVU2026A,2026
15877,Suction lipectomy trunk,CPT,RVU2026A,2026
15878,Suction lipectomy upr extrem,CPT,RVU2026A,2026
15879,Suction lipectomy lwr extrem,CPT,RVU2026A,2026
15920,Exc coccygl pr ulc prim sutr,CPT,RVU2026A,2026
15922,Exc coccygl pr ulc flap clsr,CPT,RVU2026A,2026
15931,Exc sacral pr ulc prim sutr,CPT,RVU2026A,2026
15933,Exc sac pr ulc prim str ostc,CPT,RVU2026A,2026
15934,Exc sacral pr ulc skn flap,CPT,RVU2026A,2026
15935,Exc sac pr ulc skn flp ostc,CPT,RVU2026A,2026
15936,Exc sac pr ulc prep mus flap,CPT,RVU2026A,2026
15937,Exc sac pr ulc prep mus ostc,CPT,RVU2026A,2026
15940,Exc ischial pr ulc prim sutr,CPT,RVU2026A,2026
15941,Exc isch pr ulc prm sut ostc,CPT,RVU2026A,2026
15944,Exc isch pr ulc skn flp clsr,CPT,RVU2026A,2026
15945,Exc isch pr ulc skn flp ostc,CPT,RVU2026A,2026
15946,Exc isch pr ulc prep mus flp,CPT,RVU2026A,2026
15950,Exc trchntr pr ulc prim sutr,CPT,RVU2026A,2026
15951,Exc trchntr pr ulc ostc,CPT,RVU2026A,2026
15952,Exc trchntr pr ulc flp clsr,CPT,RVU2026A,2026
15953,Exc trchntr pr ulc flp ostc,CPT,RVU2026A,2026
15956,Exc trchntr pr ulc prep flap,CPT,RVU2026A,2026
15958,Exc trchntr pr ulc prep ostc,CPT,RVU2026A,2026
15999,Unlisted px exc pressure ulc,CPT,RVU2026A,2026
16000,Initial treatment of burn(s),CPT,RVU2026A,2026
16020,Dress/debrid p-thick burn s,CPT,RVU2026A,2026
16025,Dress/debrid p-thick burn m,CPT,RVU2026A,2026
16030,Dress/debrid p-thick burn l,CPT,RVU2026A,2026
16035,Escharotomy 1st incision,CPT,RVU2026A,2026
16036,Escharotomy ea addl incision,CPT,RVU2026A,2026
17000,Destruct premalg lesion,CPT,RVU2026A,2026
17003,Destruct premalg les 2-14,CPT,RVU2026A,2026
17004,Destroy premal lesions 15/>,CPT,RVU2026A,2026
17106,Dstr cut vsc prlf les<10sqcm,CPT,RVU2026A,2026
17107,Dstr cut vsc prlf les10-50sq,CPT,RVU2026A,2026
17108,Dstr cut vsc prlf les>50sqcm,CPT,RVU2026A,2026
17110,Destruction b9 les up to 14,CPT,RVU2026A,2026
17111,Destruction b9 lesions 15/>,CPT,RVU2026A,2026
17250,Chem caut of granltj tissue,CPT,RVU2026A,2026
17260,Dstrj mal les t/a/l 0.5 cm/<,CPT,RVU2026A,2026
17261,Dstrj mal les t/a/l .6-1.0cm,CPT,RVU2026A,2026
17262,Dstrj mal les t/a/l 1.1-2.0,CPT,RVU2026A,2026
17263,Dstrj mal les t/a/l 2.1-3.0,CPT,RVU2026A,2026
17264,Dstrj mal les t/a/l 3.1-4.0,CPT,RVU2026A,2026
17266,Dstrj mal les t/a/l >4.0 cm,CPT,RVU2026A,2026
17270,Dstr mal les s/n/h/f/g .5 /<,CPT,RVU2026A,2026
17271,Dstr mal les s/n/h/f/g 0.6-1,CPT,RVU2026A,2026
17272,Dstr mal les s/n/h/f/g 1.1-2,CPT,RVU2026A,2026
17273,Dstr mal les s/n/h/f/g 2.1-3,CPT,RVU2026A,2026
17274,Dstr mal les s/n/h/f/g 3.1-4,CPT,RVU2026A,2026
17276,Dstr mal les s/n/h/f/g >4.0,CPT,RVU2026A,2026
17280,Dstr mal ls f/e/e/n/l/m .5/<,CPT,RVU2026A,2026
17281,Dstr mal ls f/e/e/n/l/m .6-1,CPT,RVU2026A,2026
17282,Dstr mal ls f/e/e/n/l/m1.1-2,CPT,RVU2026A,2026
17283,Dstr mal ls f/e/e/n/l/m2.1-3,CPT,RVU2026A,2026
17284,Dstr mal ls f/e/e/n/l/m3.1-4,CPT,RVU2026A,2026
17286,Dstr mal ls f/e/e/n/l/m>4.0,CPT,RVU2026A,2026
17311,Mohs 1 stage h/n/hf/g,CPT,RVU2026A,2026
17312,Mohs addl stage,CPT,RVU2026A,2026
17313,Mohs 1 stage t/a/l,CPT,RVU2026A,2026
17314,Mohs addl stage t/a/l,CPT,RVU2026A,2026
17315,Mohs surg addl block,CPT,RVU2026A,2026
17340,Cryotherapy for acne,CPT,RVU2026A,2026
17360,Chemical exfoliation acne,CPT,RVU2026A,2026
17380,Electrolysis epilation ea 30,CPT,RVU2026A,2026
17999,Unlistd px skn muc memb subq,CPT,RVU2026A,2026
19000,Puncture aspir cyst breast,CPT,RVU2026A,2026
19001,Puncture aspir cyst brst ea,CPT,RVU2026A,2026
19020,Mastotomy expl drg absc dp,CPT,RVU2026A,2026
19030,Njx px only mam ducto/glcto,CPT,RVU2026A,2026
19081,Bx breast 1st lesion strtctc,CPT,RVU2026A,2026
19082,Bx breast add lesion strtctc,CPT,RVU2026A,2026
19083,Bx breast 1st lesion us imag,CPT,RVU2026A,2026
19084,Bx breast add lesion us imag,CPT,RVU2026A,2026
19085,Bx breast 1st lesion mr imag,CPT,RVU2026A,2026
19086,Bx breast add lesion mr imag,CPT,RVU2026A,2026
19100,Bx breast percut w/o image,CPT,RVU2026A,2026
19101,Biopsy of breast open,CPT,RVU2026A,2026
19105,Cryosurg ablate fa each,CPT,RVU2026A,2026
19110,Nipple exploration,CPT,RVU2026A,2026
19112,Excise breast duct fistula,CPT,RVU2026A,2026
19120,Removal of breast lesion,CPT,RVU2026A,2026
19125,Excision breast lesion,CPT,RVU2026A,2026
19126,Excision addl breast lesion,CPT,RVU2026A,2026
19281,Perq device breast 1st imag,CPT,RVU2026A,2026
19282,Perq device breast ea imag,CPT,RVU2026A,2026
19283,Perq dev breast 1st strtctc,CPT,RVU2026A,2026
19284,Perq dev breast add strtctc,CPT,RVU2026A,2026
19285,Perq dev breast 1st us imag,CPT,RVU2026A,2026
19286,Perq dev breast add us imag,CPT,RVU2026A,2026
19287,Perq dev breast 1st mr guide,CPT,RVU2026A,2026
19288,Perq dev breast add mr guide,CPT,RVU2026A,2026
19294,Prepj tum cav iort prtl mast,CPT,RVU2026A,2026
19296,Place po breast cath for rad,CPT,RVU2026A,2026
19297,Place breast cath for rad,CPT,RVU2026A,2026
19298,Place breast rad tube/caths,CPT,RVU2026A,2026
19300,Mastectomy for gynecomastia,CPT,RVU2026A,2026
19301,Partial mastectomy,CPT,RVU2026A,2026
19302,P-mastectomy w/ln removal,CPT,RVU2026A,2026
19303,Mast simple complete,CPT,RVU2026A,2026
19305,Mast radical,CPT,RVU2026A,2026
19306,Mast rad urban type,CPT,RVU2026A,2026
19307,Mast mod rad,CPT,RVU2026A,2026
19316,Mastopexy,CPT,RVU2026A,2026
19318,Breast reduction,CPT,RVU2026A,2026
19325,Breast augmentation w/implt,CPT,RVU2026A,2026
19328,Rmvl intact breast implant,CPT,RVU2026A,2026
19330,Rmvl ruptured breast implant,CPT,RVU2026A,2026
19340,Insj breast implt sm d mast,CPT,RVU2026A,2026
19342,Insj/rplcmt brst implt sep d,CPT,RVU2026A,2026
19350,Nipple/areola reconstruction,CPT,RVU2026A,2026
19355,Correct inverted nipple(s),CPT,RVU2026A,2026
19357,Tiss xpndr plmt brst rcnstj,CPT,RVU2026A,2026
19361,Brst rcnstj latsms drsi flap,CPT,RVU2026A,2026
19364,Brst rcnstj free flap,CPT,RVU2026A,2026
19367,Brst rcnstj 1 pdcl tram flap,CPT,RVU2026A,2026
19368,Brst rcnstj 1pdcl tram anast,CPT,RVU2026A,2026
19369,Brst rcnstj 2 pdcl tram flap,CPT,RVU2026A,2026
19370,Revj peri-implt capsule brst,CPT,RVU2026A,2026
19371,Peri-implt capslc brst compl,CPT,RVU2026A,2026
19380,Revj reconstructed breast,CPT,RVU2026A,2026
19396,Design custom breast implant,CPT,RVU2026A,2026
19499,Unlisted procedure breast,CPT,RVU2026A,2026
2000F,Blood pressure measure,Other,RVU2026A,2026
2001F,Weight record,Other,RVU2026A,2026
2002F,Clin sign vol ovrld assess,Other,RVU2026A,2026
2004F,Initial exam involved joints,Other,RVU2026A,2026
20100,Expl pentrg wound neck,CPT,RVU2026A,2026
20101,Expl pentrg wound chest,CPT,RVU2026A,2026
20102,Expl pentrg wnd abd/flnk/bk,CPT,RVU2026A,2026
20103,Expl pentrg wound extremity,CPT,RVU2026A,2026
2010F,Vital signs recorded,Other,RVU2026A,2026
2014F,Mental status assess,Other,RVU2026A,2026
20150,Excision epiphyseal bar,CPT,RVU2026A,2026
2015F,Asthma impairment assessed,Other,RVU2026A,2026
2016F,Asthma risk assessed,Other,RVU2026A,2026
2018F,Hydration status assess,Other,RVU2026A,2026
2019F,Dilated macul exam done,Other,RVU2026A,2026
20200,Muscle biopsy superficial,CPT,RVU2026A,2026
20205,Deep muscle biopsy,CPT,RVU2026A,2026
20206,Biopsy muscle perq needle,CPT,RVU2026A,2026
2020F,Dilated fundus eval done,Other,RVU2026A,2026
2021F,Dilat macular exam done,Other,RVU2026A,2026
20220,Bone biopsy trocar/ndl supfc,CPT,RVU2026A,2026
20225,Bone biopsy trocar/ndl deep,CPT,RVU2026A,2026
2022F,Dilat rta xm evc rtnopthy,Other,RVU2026A,2026
2023F,Dilat rta xm w/o rtnopthy,Other,RVU2026A,2026
20240,Bone biopsy open superficial,CPT,RVU2026A,2026
20245,Bone biopsy open deep,CPT,RVU2026A,2026
2024F,7 fld rta photo evc rtnopthy,Other,RVU2026A,2026
20250,Biopsy vrt bdy open thoracic,CPT,RVU2026A,2026
20251,Biopsy vrt bdy open lmbr/crv,CPT,RVU2026A,2026
2025F,7 fld rta photo w/o rtnopthy,Other,RVU2026A,2026
2026F,Eye img valid evc rtnopthy,Other,RVU2026A,2026
2027F,Optic nerve head eval done,Other,RVU2026A,2026
2028F,Foot exam performed,Other,RVU2026A,2026
2029F,Complete phys skin exam done,Other,RVU2026A,2026
2030F,H2o stat docd normal,Other,RVU2026A,2026
2031F,H2o stat docd dehydrated,Other,RVU2026A,2026
2033F,Eye img valid w/o rtnopthy,Other,RVU2026A,2026
2035F,Tymp memb motion examd,Other,RVU2026A,2026
2040F,Bk pn xm on init visit date,Other,RVU2026A,2026
2044F,Doc mntl tst b/4 bk trxmnt,Other,RVU2026A,2026
20500,Njx sinus tract therapeutic,CPT,RVU2026A,2026
20501,Njx sinus tract diagnostic,CPT,RVU2026A,2026
2050F,Wound char size etc docd,Other,RVU2026A,2026
20520,Rmvl fb musc/tdn simple,CPT,RVU2026A,2026
20525,Rmvl fb musc/tdn deep/comp,CPT,RVU2026A,2026
20526,Ther injection carp tunnel,CPT,RVU2026A,2026
20527,Njx nzm palmar fascial cord,CPT,RVU2026A,2026
20550,Njx 1 tendon sheath/ligament,CPT,RVU2026A,2026
20551,Njx 1 tendon origin/insj,CPT,RVU2026A,2026
20552,Njx 1/mlt trigger point 1/2,CPT,RVU2026A,2026
20553,Njx 1/mlt trigger points 3/>,CPT,RVU2026A,2026
20555,Place ndl musc/tis for rt,CPT,RVU2026A,2026
20560,Ndl insj w/o njx 1 or 2 musc,CPT,RVU2026A,2026
20561,Ndl insj w/o njx 3+ musc,CPT,RVU2026A,2026
20600,Drain/inj joint/bursa w/o us,CPT,RVU2026A,2026
20604,Drain/inj joint/bursa w/us,CPT,RVU2026A,2026
20605,Drain/inj joint/bursa w/o us,CPT,RVU2026A,2026
20606,Drain/inj joint/bursa w/us,CPT,RVU2026A,2026
2060F,Pt intrvwd on/before dx mdd,Other,RVU2026A,2026
20610,Drain/inj joint/bursa w/o us,CPT,RVU2026A,2026
20611,Drain/inj joint/bursa w/us,CPT,RVU2026A,2026
20612,Aspirate/inj ganglion cyst,CPT,RVU2026A,2026
20615,Treatment of bone cyst,CPT,RVU2026A,2026
20650,Insert and remove bone pin,CPT,RVU2026A,2026
20660,Apply rem fixation device,CPT,RVU2026A,2026
20661,Application halo cranial,CPT,RVU2026A,2026
20662,Application halo pelvic,CPT,RVU2026A,2026
20663,Application halo femoral,CPT,RVU2026A,2026
20664,Appl halo cranial 6+pins,CPT,RVU2026A,2026
20665,Rmvl tongs/halo anthr indiv,CPT,RVU2026A,2026
20670,Removal implant superficial,CPT,RVU2026A,2026
20680,Removal of implant deep,CPT,RVU2026A,2026
20690,Appl unipln uni ext fixj sys,CPT,RVU2026A,2026
20692,Appl mltpln uni ext fixj sys,CPT,RVU2026A,2026
20693,Adjmt/revj ext fixj sys anes,CPT,RVU2026A,2026
20694,Rmvl ext fixj sys under anes,CPT,RVU2026A,2026
20696,App mltpln uni xtrnl fix 1st,CPT,RVU2026A,2026
20697,App mltpln uni xtrnl fix xch,CPT,RVU2026A,2026
20700,Mnl prep&insj dp rx dlvr dev,CPT,RVU2026A,2026
20701,Rmvl deep rx delivery device,CPT,RVU2026A,2026
20702,Mnl prep&insj imed rx dev,CPT,RVU2026A,2026
20703,Rmvl imed rx delivery device,CPT,RVU2026A,2026
20704,Mnl prep&insj i-artic rx dev,CPT,RVU2026A,2026
20705,Rmvl i-artic rx delivery dev,CPT,RVU2026A,2026
20802,Replantation arm complete,CPT,RVU2026A,2026
20805,Replant forearm complete,CPT,RVU2026A,2026
20808,Replantation hand complete,CPT,RVU2026A,2026
20816,Replantation digit complete,CPT,RVU2026A,2026
20822,Replantation digit complete,CPT,RVU2026A,2026
20824,Replantation thumb complete,CPT,RVU2026A,2026
20827,Replantation thumb complete,CPT,RVU2026A,2026
20838,Replantation foot complete,CPT,RVU2026A,2026
20900,Removal of bone for graft,CPT,RVU2026A,2026
20902,Removal of bone for graft,CPT,RVU2026A,2026
20910,Remove cartilage for graft,CPT,RVU2026A,2026
20912,Remove cartilage for graft,CPT,RVU2026A,2026
20920,Removal of fascia for graft,CPT,RVU2026A,2026
20922,Removal of fascia for graft,CPT,RVU2026A,2026
20924,Removal of tendon for graft,CPT,RVU2026A,2026
20930,Sp bone algrft morsel add-on,CPT,RVU2026A,2026
20931,Sp bone algrft struct add-on,CPT,RVU2026A,2026
20932,Osteoart algrft w/surf & b1,CPT,RVU2026A,2026
20933,Hemicrt intrclry algrft prtl,CPT,RVU2026A,2026
20934,Intercalary algrft compl,CPT,RVU2026A,2026
20936,Sp bone agrft local add-on,CPT,RVU2026A,2026
20937,Sp bone agrft morsel add-on,CPT,RVU2026A,2026
20938,Sp bone agrft struct add-on,CPT,RVU2026A,2026
20939,Bone marrow aspir bone grfg,CPT,RVU2026A,2026
20950,Mntr intrstitial fluid press,CPT,RVU2026A,2026
20955,Fibula bone graft microvasc,CPT,RVU2026A,2026
20956,Iliac bone graft microvasc,CPT,RVU2026A,2026
20957,Mt bone graft microvasc,CPT,RVU2026A,2026
20962,Other bone graft microvasc,CPT,RVU2026A,2026
20969,Bone/skin graft microvasc,CPT,RVU2026A,2026
20970,Bone/skin graft iliac crest,CPT,RVU2026A,2026
20972,Bone/skin graft metatarsal,CPT,RVU2026A,2026
20973,Bone/skin graft great toe,CPT,RVU2026A,2026
20974,Estim aid bone healg n-invas,CPT,RVU2026A,2026
20975,Estim aid bone healg invasiv,CPT,RVU2026A,2026
20979,Lw ntsty us stimj bone healg,CPT,RVU2026A,2026
20982,Ablate bone tumor(s) perq,CPT,RVU2026A,2026
20983,Ablate bone tumor(s) perq,CPT,RVU2026A,2026
20985,Cptr-asst dir ms px,CPT,RVU2026A,2026
20999,Unlisted px muscskel general,CPT,RVU2026A,2026
21010,Incision of jaw joint,CPT,RVU2026A,2026
21011,Exc face les sc <2 cm,CPT,RVU2026A,2026
21012,Exc face les sbq 2 cm/>,CPT,RVU2026A,2026
21013,Exc face tum deep < 2 cm,CPT,RVU2026A,2026
21014,Exc face tum deep 2 cm/>,CPT,RVU2026A,2026
21015,Resect face/scalp tum < 2 cm,CPT,RVU2026A,2026
21016,Resect face/scalp tum 2 cm/>,CPT,RVU2026A,2026
21025,Excision of bone lower jaw,CPT,RVU2026A,2026
21026,Excision of facial bone(s),CPT,RVU2026A,2026
21029,Contour of face bone lesion,CPT,RVU2026A,2026
21030,Excise max/zygoma b9 tumor,CPT,RVU2026A,2026
21031,Remove exostosis mandible,CPT,RVU2026A,2026
21032,Remove exostosis maxilla,CPT,RVU2026A,2026
21034,Excise max/zygoma mal tumor,CPT,RVU2026A,2026
21040,Excise mandible lesion,CPT,RVU2026A,2026
21044,Removal of jaw bone lesion,CPT,RVU2026A,2026
21045,Extensive jaw surgery,CPT,RVU2026A,2026
21046,Remove mandible cyst complex,CPT,RVU2026A,2026
21047,Excise lwr jaw cyst w/repair,CPT,RVU2026A,2026
21048,Remove maxilla cyst complex,CPT,RVU2026A,2026
21049,Excis uppr jaw cyst w/repair,CPT,RVU2026A,2026
21050,Removal of jaw joint,CPT,RVU2026A,2026
21060,Remove jaw joint cartilage,CPT,RVU2026A,2026
21070,Remove coronoid process,CPT,RVU2026A,2026
21073,Mnpj of tmj w/anesth,CPT,RVU2026A,2026
21076,Impres&prep surg obt prosth,CPT,RVU2026A,2026
21077,Impres&prep orbital prosth,CPT,RVU2026A,2026
21079,Impres&prep intrm obt prosth,CPT,RVU2026A,2026
21080,Impres&prep def obt prosth,CPT,RVU2026A,2026
21081,Impres&prep mndbl res prosth,CPT,RVU2026A,2026
21082,Impres&prep paltl aug prosth,CPT,RVU2026A,2026
21083,Impres&prep paltl lft prosth,CPT,RVU2026A,2026
21084,Impres&prep sp aid prosth,CPT,RVU2026A,2026
21085,Impres&prep oral surg splint,CPT,RVU2026A,2026
21086,Impres&prep auricular prosth,CPT,RVU2026A,2026
21087,Impres&prep nasal prosth,CPT,RVU2026A,2026
21088,Impres&prep facial prosth,CPT,RVU2026A,2026
21089,Unlisted maxlfcl prosth px,CPT,RVU2026A,2026
21100,Maxillofacial fixation,CPT,RVU2026A,2026
21110,Interdental fixation,CPT,RVU2026A,2026
21116,Injection jaw joint x-ray,CPT,RVU2026A,2026
21120,Genioplasty augmentation,CPT,RVU2026A,2026
21121,Geniop sldg osteot 1,CPT,RVU2026A,2026
21122,Geniop sldg osteot 2/>,CPT,RVU2026A,2026
21123,Geniop sldg augmentation,CPT,RVU2026A,2026
21125,Augmentation mndblr prostc,CPT,RVU2026A,2026
21127,Augmentation mndblr b1 grf,CPT,RVU2026A,2026
21137,Rdctj forehead cntrg only,CPT,RVU2026A,2026
21138,Rdctj forehead cntrg&prostc,CPT,RVU2026A,2026
21139,Rdctj forehead cntrg&setback,CPT,RVU2026A,2026
21141,Rcnstj midface lefort i 1pc,CPT,RVU2026A,2026
21142,Rcnstj midface lefort i 2pcs,CPT,RVU2026A,2026
21143,Rcnstj mdface lefort i 3/>pc,CPT,RVU2026A,2026
21145,Rcnstj mdfc lefort i 1 w/grf,CPT,RVU2026A,2026
21146,Rcnstj mdfc lefort i 2 w/grf,CPT,RVU2026A,2026
21147,Rcnstj mdfc lefort i 3/>grf,CPT,RVU2026A,2026
21150,Rcnstj mdfc lefrtii ant ntru,CPT,RVU2026A,2026
21151,Rcnstj mdfc lefrtii w/b1 grf,CPT,RVU2026A,2026
21154,Rcnstj mdfc lefort iii w/o i,CPT,RVU2026A,2026
21155,Rcnstj mdfc lefort iii w/i,CPT,RVU2026A,2026
21159,Rcnst mdfc lfrtiii advm wo i,CPT,RVU2026A,2026
21160,Rcnst mdfc lfrtiii advm w/i,CPT,RVU2026A,2026
21172,Rcnst supr-lat orb rm&lw fhd,CPT,RVU2026A,2026
21175,Rcnst bfrnt sp orb rm&lw fhd,CPT,RVU2026A,2026
21179,Rcnstj forehead with grafts,CPT,RVU2026A,2026
21180,Rcnstj forehead w/autograft,CPT,RVU2026A,2026
21181,Rcnst cntrg b9 tum crnl xtrc,CPT,RVU2026A,2026
21182,Reconstruct cranial bone,CPT,RVU2026A,2026
21183,Reconstruct cranial bone,CPT,RVU2026A,2026
21184,Reconstruct cranial bone,CPT,RVU2026A,2026
21188,Reconstruction of midface,CPT,RVU2026A,2026
21193,Reconst lwr jaw w/o graft,CPT,RVU2026A,2026
21194,Reconst lwr jaw w/graft,CPT,RVU2026A,2026
21195,Reconst lwr jaw w/o fixation,CPT,RVU2026A,2026
21196,Reconst lwr jaw w/fixation,CPT,RVU2026A,2026
21198,Reconstr lwr jaw segment,CPT,RVU2026A,2026
21199,Reconstr lwr jaw w/advance,CPT,RVU2026A,2026
21206,Reconstruct upper jaw bone,CPT,RVU2026A,2026
21208,Augmentation of facial bones,CPT,RVU2026A,2026
21209,Reduction of facial bones,CPT,RVU2026A,2026
21210,Face bone graft,CPT,RVU2026A,2026
21215,Lower jaw bone graft,CPT,RVU2026A,2026
21230,Rib cartilage graft,CPT,RVU2026A,2026
21235,Ear cartilage graft,CPT,RVU2026A,2026
21240,Reconstruction of jaw joint,CPT,RVU2026A,2026
21242,Reconstruction of jaw joint,CPT,RVU2026A,2026
21243,Reconstruction of jaw joint,CPT,RVU2026A,2026
21244,Reconstruction of lower jaw,CPT,RVU2026A,2026
21245,Reconstruction of jaw,CPT,RVU2026A,2026
21246,Reconstruction of jaw,CPT,RVU2026A,2026
21247,Reconstruct lower jaw bone,CPT,RVU2026A,2026
21248,Reconstruction of jaw,CPT,RVU2026A,2026
21249,Reconstruction of jaw,CPT,RVU2026A,2026
21255,Reconstruct lower jaw bone,CPT,RVU2026A,2026
21256,Reconstruction of orbit,CPT,RVU2026A,2026
21260,Revise eye sockets,CPT,RVU2026A,2026
21261,Revise eye sockets,CPT,RVU2026A,2026
21263,Revise eye sockets,CPT,RVU2026A,2026
21267,Revise eye sockets,CPT,RVU2026A,2026
21268,Revise eye sockets,CPT,RVU2026A,2026
21270,Augmentation cheek bone,CPT,RVU2026A,2026
21275,Revision orbitofacial bones,CPT,RVU2026A,2026
21280,Medial canthopexy,CPT,RVU2026A,2026
21282,Lateral canthopexy,CPT,RVU2026A,2026
21295,Revision of jaw muscle/bone,CPT,RVU2026A,2026
21296,Revision of jaw muscle/bone,CPT,RVU2026A,2026
21299,Unlisted cranfcl&maxlfcl px,CPT,RVU2026A,2026
21315,Clsd tx nsl fx mnpj wo stblj,CPT,RVU2026A,2026
21320,Clsd tx nsl fx w/mnpj&stablj,CPT,RVU2026A,2026
21325,Open tx nose fx uncomplicatd,CPT,RVU2026A,2026
21330,Open tx nose fx w/skele fixj,CPT,RVU2026A,2026
21335,Open tx nose & septal fx,CPT,RVU2026A,2026
21336,Open tx septal fx w/wo stabj,CPT,RVU2026A,2026
21337,Closed tx septal&nose fx,CPT,RVU2026A,2026
21338,Open nasoethmoid fx w/o fixj,CPT,RVU2026A,2026
21339,Open nasoethmoid fx w/ fixj,CPT,RVU2026A,2026
21340,Perq tx nasoethmoid fx,CPT,RVU2026A,2026
21343,Open tx dprsd front sinus fx,CPT,RVU2026A,2026
21344,Open tx compl front sinus fx,CPT,RVU2026A,2026
21345,Closed tx nose/jaw fx,CPT,RVU2026A,2026
21346,Opn tx nasomax fx w/fixj,CPT,RVU2026A,2026
21347,Opn tx nasomax fx multple,CPT,RVU2026A,2026
21348,Opn tx nasomax fx w/graft,CPT,RVU2026A,2026
21355,Perq tx malar fracture,CPT,RVU2026A,2026
21356,Opn tx dprsd zygomatic arch,CPT,RVU2026A,2026
21360,Opn tx dprsd malar fracture,CPT,RVU2026A,2026
21365,Opn tx complx malar fx,CPT,RVU2026A,2026
21366,Opn tx complx malar w/grft,CPT,RVU2026A,2026
21385,Opn tx orbit fx transantral,CPT,RVU2026A,2026
21386,Opn tx orbit fx periorbital,CPT,RVU2026A,2026
21387,Opn tx orbit fx combined,CPT,RVU2026A,2026
21390,Opn tx orbit periorbtl implt,CPT,RVU2026A,2026
21395,Opn tx orbit periorbt w/grft,CPT,RVU2026A,2026
21400,Closed tx orbit w/o manipulj,CPT,RVU2026A,2026
21401,Closed tx orbit w/manipulj,CPT,RVU2026A,2026
21406,Opn tx orbit fx w/o implant,CPT,RVU2026A,2026
21407,Opn tx orbit fx w/implant,CPT,RVU2026A,2026
21408,Opn tx orbit fx w/bone grft,CPT,RVU2026A,2026
21421,Cltx palatal/max fx wire fix,CPT,RVU2026A,2026
21422,Optx palatal/max fracture,CPT,RVU2026A,2026
21423,Optx palatal/max fx comp,CPT,RVU2026A,2026
21431,Cltx craniofacial separation,CPT,RVU2026A,2026
21432,Optx cranfcl sep w/wiring,CPT,RVU2026A,2026
21433,Optx cranfcl sep comp mlt,CPT,RVU2026A,2026
21435,Optx crnfc sep comp int&/xtr,CPT,RVU2026A,2026
21436,Optx crnfcl sep comp mlt int,CPT,RVU2026A,2026
21440,Cltx mndblr/max alv ridge fx,CPT,RVU2026A,2026
21445,Optx mndblr/max alv ridge fx,CPT,RVU2026A,2026
21450,Cltx mndblr fx w/o mnpj,CPT,RVU2026A,2026
21451,Cltx mndblr fx w/mnpj,CPT,RVU2026A,2026
21452,Perq tx mndblr fx xtrnl fixj,CPT,RVU2026A,2026
21453,Cltx mndblr fx ntrdntl fixj,CPT,RVU2026A,2026
21454,Optx mndblr fx xtrnl fixj,CPT,RVU2026A,2026
21461,Optx mndblr fx wo ntrdntl,CPT,RVU2026A,2026
21462,Optx mndblr fx w/ntrdntl,CPT,RVU2026A,2026
21465,Optx mndblr cndylr fx,CPT,RVU2026A,2026
21470,Optx complicated mndblr fx,CPT,RVU2026A,2026
21480,Cltx tmprmand dislc 1st/sbsq,CPT,RVU2026A,2026
21485,Cltx tmprmand dislc comp,CPT,RVU2026A,2026
21490,Optx tmprmand dislocation,CPT,RVU2026A,2026
21497,Interdental wirg oth/thn fx,CPT,RVU2026A,2026
21499,Unlisted muscskel px head,CPT,RVU2026A,2026
21501,I&d dp absc/hmtma sft ts nck,CPT,RVU2026A,2026
21502,I&d dp abs/hmtm nck rib ostc,CPT,RVU2026A,2026
21510,Inc deep opng b1 crtx thorax,CPT,RVU2026A,2026
21550,Biopsy of neck/chest,CPT,RVU2026A,2026
21552,Exc neck les sc 3 cm/>,CPT,RVU2026A,2026
21554,Exc neck tum deep 5 cm/>,CPT,RVU2026A,2026
21555,Exc neck les sc < 3 cm,CPT,RVU2026A,2026
21556,Exc neck tum deep < 5 cm,CPT,RVU2026A,2026
21557,Resect neck thorax tumor<5cm,CPT,RVU2026A,2026
21558,Resect neck tumor 5 cm/>,CPT,RVU2026A,2026
21600,Partial removal of rib,CPT,RVU2026A,2026
21601,Exc chest wall tumor w/ribs,CPT,RVU2026A,2026
21602,Exc ch wal tum w/o lymphadec,CPT,RVU2026A,2026
21603,Exc ch wal tum w/lymphadec,CPT,RVU2026A,2026
21610,Costotransversectomy,CPT,RVU2026A,2026
21615,Excision 1st &/cervical rib,CPT,RVU2026A,2026
21616,Exc 1st&/crv rib w/sympth,CPT,RVU2026A,2026
21620,Ostectomy sternum partial,CPT,RVU2026A,2026
21627,Sternal debridement,CPT,RVU2026A,2026
21630,Radical resection sternum,CPT,RVU2026A,2026
21685,Hyoid myotomy & suspension,CPT,RVU2026A,2026
21700,Revision of neck muscle,CPT,RVU2026A,2026
21705,Revision of neck muscle/rib,CPT,RVU2026A,2026
21720,Revision of neck muscle,CPT,RVU2026A,2026
21725,Revision of neck muscle,CPT,RVU2026A,2026
21740,Reconstruction of sternum,CPT,RVU2026A,2026
21742,Repair stern/nuss w/o scope,CPT,RVU2026A,2026
21743,Repair sternum/nuss w/scope,CPT,RVU2026A,2026
21750,Repair of sternum separation,CPT,RVU2026A,2026
21811,Optx of rib fx w/fixj scope,CPT,RVU2026A,2026
21812,Treatment of rib fracture,CPT,RVU2026A,2026
21813,Treatment of rib fracture,CPT,RVU2026A,2026
21820,Treat sternum fracture,CPT,RVU2026A,2026
21825,Treat sternum fracture,CPT,RVU2026A,2026
21899,Unlisted px neck/thorax,CPT,RVU2026A,2026
21920,Biopsy soft tissue of back,CPT,RVU2026A,2026
21925,Biopsy soft tissue of back,CPT,RVU2026A,2026
21930,Exc back les sc < 3 cm,CPT,RVU2026A,2026
21931,Exc back les sc 3 cm/>,CPT,RVU2026A,2026
21932,Exc back tum deep < 5 cm,CPT,RVU2026A,2026
21933,Exc back tum deep 5 cm/>,CPT,RVU2026A,2026
21935,Resect back tum < 5 cm,CPT,RVU2026A,2026
21936,Resect back tum 5 cm/>,CPT,RVU2026A,2026
22010,I&d p-spine c/t/cerv-thor,CPT,RVU2026A,2026
22015,I&d abscess p-spine l/s/ls,CPT,RVU2026A,2026
22100,Remove part of neck vertebra,CPT,RVU2026A,2026
22101,Remove part thorax vertebra,CPT,RVU2026A,2026
22102,Remove part lumbar vertebra,CPT,RVU2026A,2026
22103,Remove extra spine segment,CPT,RVU2026A,2026
22110,Remove part of neck vertebra,CPT,RVU2026A,2026
22112,Remove part thorax vertebra,CPT,RVU2026A,2026
22114,Remove part lumbar vertebra,CPT,RVU2026A,2026
22116,Remove extra spine segment,CPT,RVU2026A,2026
22206,Incis spine 3 column thorac,CPT,RVU2026A,2026
22207,Incis spine 3 column lumbar,CPT,RVU2026A,2026
22208,Incis spine 3 column adl seg,CPT,RVU2026A,2026
22210,Incis 1 vertebral seg cerv,CPT,RVU2026A,2026
22212,Incis 1 vertebral seg thorac,CPT,RVU2026A,2026
22214,Incis 1 vertebral seg lumbar,CPT,RVU2026A,2026
22216,Incis addl spine segment,CPT,RVU2026A,2026
22220,Osteot dsc ant 1 vrt sgm crv,CPT,RVU2026A,2026
22222,Osteot dsc ant 1vrt sgm thrc,CPT,RVU2026A,2026
22224,Osteot dsc ant 1vrt sgm lmbr,CPT,RVU2026A,2026
22226,Osteot dsc ant 1vrt sgm ea,CPT,RVU2026A,2026
22310,Closed tx vert fx w/o manj,CPT,RVU2026A,2026
22315,Closed tx vert fx w/manj,CPT,RVU2026A,2026
22318,Treat odontoid fx w/o graft,CPT,RVU2026A,2026
22319,Treat odontoid fx w/graft,CPT,RVU2026A,2026
22325,Treat spine fracture,CPT,RVU2026A,2026
22326,Treat neck spine fracture,CPT,RVU2026A,2026
22327,Treat thorax spine fracture,CPT,RVU2026A,2026
22328,Treat each add spine fx,CPT,RVU2026A,2026
22505,Manipulation of spine,CPT,RVU2026A,2026
22510,Perq cervicothoracic inject,CPT,RVU2026A,2026
22511,Perq lumbosacral injection,CPT,RVU2026A,2026
22512,Vertebroplasty addl inject,CPT,RVU2026A,2026
22513,Perq vertebral augmentation,CPT,RVU2026A,2026
22514,Perq vertebral augmentation,CPT,RVU2026A,2026
22515,Perq vertebral augmentation,CPT,RVU2026A,2026
22526,Idet single level,CPT,RVU2026A,2026
22527,Idet 1 or more levels,CPT,RVU2026A,2026
22532,Arthrd lat xtrcvtry tq thrc,CPT,RVU2026A,2026
22533,Arthrd lat xtrcvtry tq lmbr,CPT,RVU2026A,2026
22534,Arthrd lat xtrcvtry tq ea ad,CPT,RVU2026A,2026
22548,Arthrd ant toral/xoral c1-c2,CPT,RVU2026A,2026
22551,Arthrd ant ntrbdy cervical,CPT,RVU2026A,2026
22552,Arthrd ant ntrbd cervical ea,CPT,RVU2026A,2026
22554,Arthrd ant ntrbd min dsc crv,CPT,RVU2026A,2026
22556,Arthrd ant ntrbd min dsc thc,CPT,RVU2026A,2026
22558,Arthrd ant ntrbd min dsc lum,CPT,RVU2026A,2026
22585,Arthrd ant ntrbd min dsc ea,CPT,RVU2026A,2026
22586,Arthrd pre-sac ntrbdy l5-s1,CPT,RVU2026A,2026
22590,Arthrd pst tq craniocervical,CPT,RVU2026A,2026
22595,Arthrd pst tq atlas-axis,CPT,RVU2026A,2026
22600,Arthrd pst tq 1ntrspc crv,CPT,RVU2026A,2026
22610,Arthrd pst tq 1ntrspc thrc,CPT,RVU2026A,2026
22612,Arthrd pst tq 1ntrspc lumbar,CPT,RVU2026A,2026
22614,Arthrd pst tq 1ntrspc ea add,CPT,RVU2026A,2026
22630,Arthrd pst tq 1ntrspc lum,CPT,RVU2026A,2026
22632,Arthrd pst tq 1ntrspc lm ea,CPT,RVU2026A,2026
22633,Arthrd cmbn 1ntrspc lumbar,CPT,RVU2026A,2026
22634,Arthrd cmbn 1ntrspc ea addl,CPT,RVU2026A,2026
22800,Arthrd pst dfrm<6 vrt sgm,CPT,RVU2026A,2026
22802,Arthrd pst dfrm 7-12 vrt sgm,CPT,RVU2026A,2026
22804,Arthrd pst dfrm 13+ vrt sgm,CPT,RVU2026A,2026
22808,Arthrd ant dfrm 2-3 vrt sgm,CPT,RVU2026A,2026
22810,Arthrd ant dfrm 4-7 vrt sgm,CPT,RVU2026A,2026
22812,Arthrd ant dfrm 8+ vrt sgm,CPT,RVU2026A,2026
22818,Kyphectomy 1-2 segments,CPT,RVU2026A,2026
22819,Kyphectomy 3 or more,CPT,RVU2026A,2026
22830,Exploration of spinal fusion,CPT,RVU2026A,2026
22836,Ant thrc vrt body tethrg <7,CPT,RVU2026A,2026
22837,Ant thrc vrt body tethrg 8+,CPT,RVU2026A,2026
22838,Rev rplc/rmv thrc vrt tethrg,CPT,RVU2026A,2026
22840,Insert spine fixation device,CPT,RVU2026A,2026
22841,Insert spine fixation device,CPT,RVU2026A,2026
22842,Insert spine fixation device,CPT,RVU2026A,2026
22843,Insert spine fixation device,CPT,RVU2026A,2026
22844,Insert spine fixation device,CPT,RVU2026A,2026
22845,Insert spine fixation device,CPT,RVU2026A,2026
22846,Insert spine fixation device,CPT,RVU2026A,2026
22847,Insert spine fixation device,CPT,RVU2026A,2026
22848,Insert pelv fixation device,CPT,RVU2026A,2026
22849,Reinsert spinal fixation,CPT,RVU2026A,2026
22850,Remove spine fixation device,CPT,RVU2026A,2026
22852,Remove spine fixation device,CPT,RVU2026A,2026
22853,Insj biomechanical device,CPT,RVU2026A,2026
22854,Insj biomechanical device,CPT,RVU2026A,2026
22855,Removal anterior instrmj,CPT,RVU2026A,2026
22856,Tot disc arthrp 1ntrspc crv,CPT,RVU2026A,2026
22857,Tot disc arthrp 1ntrspc lmbr,CPT,RVU2026A,2026
22858,Tot disc arthrp 2nd lvl crv,CPT,RVU2026A,2026
22859,Insj biomechanical device,CPT,RVU2026A,2026
22860,Tot disc arthrp 2ntrspc lmbr,CPT,RVU2026A,2026
22861,Rev rplcm arthrp 1ntrspc crv,CPT,RVU2026A,2026
22862,Rev rplcm rthrp 1ntrspc lmbr,CPT,RVU2026A,2026
22864,Rmvl tot arthrp 1ntrspc crv,CPT,RVU2026A,2026
22865,Rmvl tot arthrp 1ntrspc lmbr,CPT,RVU2026A,2026
22867,Insj stablj dev w/dcmprn,CPT,RVU2026A,2026
22868,Insj stablj dev w/dcmprn,CPT,RVU2026A,2026
22869,Insj stablj dev w/o dcmprn,CPT,RVU2026A,2026
22870,Insj stablj dev w/o dcmprn,CPT,RVU2026A,2026
22899,Unlisted procedure spine,CPT,RVU2026A,2026
22900,Exc abdl tum deep < 5 cm,CPT,RVU2026A,2026
22901,Exc abdl tum deep 5 cm/>,CPT,RVU2026A,2026
22902,Exc abd les sc < 3 cm,CPT,RVU2026A,2026
22903,Exc abd les sc 3 cm/>,CPT,RVU2026A,2026
22904,Radical resect abd tumor<5cm,CPT,RVU2026A,2026
22905,Rad resect abd tumor 5 cm/>,CPT,RVU2026A,2026
22999,Unlisted px abdomen muscskel,CPT,RVU2026A,2026
23000,Rmvl sbdltd clcreous dep opn,CPT,RVU2026A,2026
23020,Capsular contracture release,CPT,RVU2026A,2026
23030,I&d shoulder deep absc/hmtma,CPT,RVU2026A,2026
23031,I&d shoulder infected bursa,CPT,RVU2026A,2026
23035,Incision bone cortex sho,CPT,RVU2026A,2026
23040,Arthrt gh jt expl/drg/rmv fb,CPT,RVU2026A,2026
23044,Arthrt ac sc jt exp/rmvl fb,CPT,RVU2026A,2026
23065,Biopsy shoulder tissues,CPT,RVU2026A,2026
23066,Biopsy shoulder tissues,CPT,RVU2026A,2026
23071,Exc shoulder les sc 3 cm/>,CPT,RVU2026A,2026
23073,Exc shoulder tum deep 5 cm/>,CPT,RVU2026A,2026
23075,Exc shoulder les sc < 3 cm,CPT,RVU2026A,2026
23076,Exc shoulder tum deep < 5 cm,CPT,RVU2026A,2026
23077,Rad rescj tum shoulder<5 cm,CPT,RVU2026A,2026
23078,Rad rescj tum shoulder 5cm/>,CPT,RVU2026A,2026
23100,Arthrotomy glenhumrl jt w/bx,CPT,RVU2026A,2026
23101,Arthrt acrmclv/strnclav jt,CPT,RVU2026A,2026
23105,Arthrotomy glenohumeral jt,CPT,RVU2026A,2026
23106,Arthrotomy strnclav joint,CPT,RVU2026A,2026
23107,Arthrt glenhumrl jt w/expl,CPT,RVU2026A,2026
23120,Claviculectomy partial,CPT,RVU2026A,2026
23125,Claviculectomy total,CPT,RVU2026A,2026
23130,Acromp/acromionectomy prtl,CPT,RVU2026A,2026
23140,Removal of bone lesion,CPT,RVU2026A,2026
23145,Removal of bone lesion,CPT,RVU2026A,2026
23146,Removal of bone lesion,CPT,RVU2026A,2026
23150,Removal of humerus lesion,CPT,RVU2026A,2026
23155,Removal of humerus lesion,CPT,RVU2026A,2026
23156,Removal of humerus lesion,CPT,RVU2026A,2026
23170,Sequestrectomy clavicle,CPT,RVU2026A,2026
23172,Sequestrectomy scapula,CPT,RVU2026A,2026
23174,Sqstrctmy humrl head srg nck,CPT,RVU2026A,2026
23180,Prtl excision bone clavicle,CPT,RVU2026A,2026
23182,Prtl excision bone scapula,CPT,RVU2026A,2026
23184,Prtl excision bone prox hum,CPT,RVU2026A,2026
23190,Ostectomy scapula partial,CPT,RVU2026A,2026
23195,Resection humeral head,CPT,RVU2026A,2026
23200,Radical rescj tumor clavicle,CPT,RVU2026A,2026
23210,Radical rescj tumor scapula,CPT,RVU2026A,2026
23220,Radical rescj tumor prox hum,CPT,RVU2026A,2026
23330,Remove shoulder foreign body,CPT,RVU2026A,2026
23333,Remove shoulder fb deep,CPT,RVU2026A,2026
23334,Shoulder prosthesis removal,CPT,RVU2026A,2026
23335,Shoulder prosthesis removal,CPT,RVU2026A,2026
23350,Injection for shoulder x-ray,CPT,RVU2026A,2026
23395,Muscle transfer shoulder/arm,CPT,RVU2026A,2026
23397,Muscle transfers,CPT,RVU2026A,2026
23400,Fixation of shoulder blade,CPT,RVU2026A,2026
23405,Incision of tendon & muscle,CPT,RVU2026A,2026
23406,Incise tendon(s) & muscle(s),CPT,RVU2026A,2026
23410,Repair rotator cuff acute,CPT,RVU2026A,2026
23412,Repair rotator cuff chronic,CPT,RVU2026A,2026
23415,Release of shoulder ligament,CPT,RVU2026A,2026
23420,Repair of shoulder,CPT,RVU2026A,2026
23430,Repair biceps tendon,CPT,RVU2026A,2026
23440,Remove/transplant tendon,CPT,RVU2026A,2026
23450,Repair shoulder capsule,CPT,RVU2026A,2026
23455,Repair shoulder capsule,CPT,RVU2026A,2026
23460,Repair shoulder capsule,CPT,RVU2026A,2026
23462,Repair shoulder capsule,CPT,RVU2026A,2026
23465,Repair shoulder capsule,CPT,RVU2026A,2026
23466,Repair shoulder capsule,CPT,RVU2026A,2026
23470,Reconstruct shoulder joint,CPT,RVU2026A,2026
23472,Reconstruct shoulder joint,CPT,RVU2026A,2026
23473,Revis reconst shoulder joint,CPT,RVU2026A,2026
23474,Revis reconst shoulder joint,CPT,RVU2026A,2026
23480,Revision of collar bone,CPT,RVU2026A,2026
23485,Revision of collar bone,CPT,RVU2026A,2026
23490,Reinforce clavicle,CPT,RVU2026A,2026
23491,Reinforce shoulder bones,CPT,RVU2026A,2026
23500,Cltx clavicular fx w/o mnpj,CPT,RVU2026A,2026
23505,Cltx clavicular fx w/mnpj,CPT,RVU2026A,2026
23515,Optx clavicular fx w/int fix,CPT,RVU2026A,2026
23520,Cltx strnclav dislc w/o mnpj,CPT,RVU2026A,2026
23525,Cltx strnclav dislc w/mnpj,CPT,RVU2026A,2026
23530,Optx strnclav dislc aqt/chrn,CPT,RVU2026A,2026
23532,Optx strclv dslc aq/chrn grf,CPT,RVU2026A,2026
23540,Cltx acromclav dislc wo mnpj,CPT,RVU2026A,2026
23545,Cltx acromclav dislc w/mnpj,CPT,RVU2026A,2026
23550,Optx acromclv dislc aqt/chrn,CPT,RVU2026A,2026
23552,Optx acrclv dslc aq/chrn grf,CPT,RVU2026A,2026
23570,Cltx scapular fx w/o mnpj,CPT,RVU2026A,2026
23575,Cltx scap fx w/mnpj +-tractj,CPT,RVU2026A,2026
23585,Optx scapular fx w/int fixj,CPT,RVU2026A,2026
23600,Cltx prox humrl fx w/o mnpj,CPT,RVU2026A,2026
23605,Cltx prx hmrl fx mnpj+-tract,CPT,RVU2026A,2026
23615,Optx prox humrl fx w/int fix,CPT,RVU2026A,2026
23616,Optx prx hmrl fx fix rpr rpl,CPT,RVU2026A,2026
23620,Cltx gr hmrl tbrs fx wo mnpj,CPT,RVU2026A,2026
23625,Cltx gr hmrl tbrs fx w/mnpj,CPT,RVU2026A,2026
23630,Optx gr hmrl tbrs fx int fix,CPT,RVU2026A,2026
23650,Cltx sho dslc w/mnpj wo anes,CPT,RVU2026A,2026
23655,Cltx sho dslc w/mnpj w/anes,CPT,RVU2026A,2026
23660,Optx acute shoulder dislc,CPT,RVU2026A,2026
23665,Cltx sho dslc fx gr hmrl tbr,CPT,RVU2026A,2026
23670,Optx sho dislc fx,CPT,RVU2026A,2026
23675,Cltx sho dislc neck fx mnpj,CPT,RVU2026A,2026
23680,Optx sho dislc neck fx fixj,CPT,RVU2026A,2026
23700,Mnpj anes sho jt fixj aprats,CPT,RVU2026A,2026
23800,Arthrodesis glenohumeral jt,CPT,RVU2026A,2026
23802,Arthrd glenohumeral jt w/grf,CPT,RVU2026A,2026
23900,Interthoracoscplr amputation,CPT,RVU2026A,2026
23920,Disarticulation shoulder,CPT,RVU2026A,2026
23921,Disarticulation sho sec clsr,CPT,RVU2026A,2026
23929,Unlisted procedure shoulder,CPT,RVU2026A,2026
23930,I&d upr a/e dp absc/hmtma,CPT,RVU2026A,2026
23931,I&d upr a/e bursa,CPT,RVU2026A,2026
23935,Inc dp opn b1 crtx hum/elbw,CPT,RVU2026A,2026
24000,Arthrt elbw expl drg/rmvl fb,CPT,RVU2026A,2026
24006,Arthrt elbw capsl exc rls,CPT,RVU2026A,2026
24065,Biopsy arm/elbow soft tissue,CPT,RVU2026A,2026
24066,Biopsy arm/elbow soft tissue,CPT,RVU2026A,2026
24071,Exc arm/elbow les sc 3 cm/>,CPT,RVU2026A,2026
24073,Ex arm/elbow tum deep 5 cm/>,CPT,RVU2026A,2026
24075,Exc arm/elbow les sc < 3 cm,CPT,RVU2026A,2026
24076,Ex arm/elbow tum deep < 5 cm,CPT,RVU2026A,2026
24077,Rad rescj tum tiss a/e <5cm,CPT,RVU2026A,2026
24079,Rad rescj tum tiss a/e 5 cm+,CPT,RVU2026A,2026
24100,Arthrt elbw synovial bx only,CPT,RVU2026A,2026
24101,Arthrt elbw jt expl bx rmvl,CPT,RVU2026A,2026
24102,Arthrt elbow w/synovectomy,CPT,RVU2026A,2026
24105,Excision olecranon bursa,CPT,RVU2026A,2026
24110,Exc/curtg b1 cst/b9 tum hum,CPT,RVU2026A,2026
24115,Exc/crtg b1 cst/tum hum agrf,CPT,RVU2026A,2026
24116,Exc/crtg b1 cst/tum hum algr,CPT,RVU2026A,2026
24120,Exc/crtg b1 cst/b9 tum rds,CPT,RVU2026A,2026
24125,Exc/crtg b1 cst/tum rds agrf,CPT,RVU2026A,2026
24126,Exc/crtg b1 cst/tum rds algr,CPT,RVU2026A,2026
24130,Excision radial head,CPT,RVU2026A,2026
24134,Sequestrectomy shft/dstl hum,CPT,RVU2026A,2026
24136,Sequestrectomy radial h/n,CPT,RVU2026A,2026
24138,Sequestrectomy olecrn proces,CPT,RVU2026A,2026
24140,Partial exc bone humerus,CPT,RVU2026A,2026
24145,Prtl exc bone radial h/n,CPT,RVU2026A,2026
24147,Prtl exc bone olecrn process,CPT,RVU2026A,2026
24149,Radical resection of elbow,CPT,RVU2026A,2026
24150,Rad rescj tum dstl/shft hum,CPT,RVU2026A,2026
24152,Rad resection tum radial h/n,CPT,RVU2026A,2026
24155,Resection of elbow joint,CPT,RVU2026A,2026
24160,Rmvl prosthhumrl&ulnar cmpnt,CPT,RVU2026A,2026
24164,Removal prosth radial head,CPT,RVU2026A,2026
24200,Rmvl fb upper arm/elbw subq,CPT,RVU2026A,2026
24201,Rmvl fb upper arm/elbw deep,CPT,RVU2026A,2026
24220,Injection px for elbow arthg,CPT,RVU2026A,2026
24300,Mnpj elbow under anes,CPT,RVU2026A,2026
24301,Musc/tdn transfer upr a/e 1,CPT,RVU2026A,2026
24305,Tendon lngth upr a/e ea tdn,CPT,RVU2026A,2026
24310,Tnot opn elbw to sho ea tdn,CPT,RVU2026A,2026
24320,Tenoplasty elbow to sho 1,CPT,RVU2026A,2026
24330,Flexor-plasty elbow,CPT,RVU2026A,2026
24331,Flexor-plasty elbw w/advmnt,CPT,RVU2026A,2026
24332,Tenolysis triceps,CPT,RVU2026A,2026
24340,Tenodesis biceps tdn at elbw,CPT,RVU2026A,2026
24341,Rpr tdn/musc upr a/e each,CPT,RVU2026A,2026
24342,Repair of ruptured tendon,CPT,RVU2026A,2026
24343,Repr elbow lat ligmnt w/tiss,CPT,RVU2026A,2026
24344,Reconstruct elbow lat ligmnt,CPT,RVU2026A,2026
24345,Repr elbw med ligmnt w/tissu,CPT,RVU2026A,2026
24346,Reconstruct elbow med ligmnt,CPT,RVU2026A,2026
24357,Repair elbow perc,CPT,RVU2026A,2026
24358,Repair elbow w/deb open,CPT,RVU2026A,2026
24359,Repair elbow deb/attch open,CPT,RVU2026A,2026
24360,Reconstruct elbow joint,CPT,RVU2026A,2026
24361,Reconstruct elbow joint,CPT,RVU2026A,2026
24362,Reconstruct elbow joint,CPT,RVU2026A,2026
24363,Replace elbow joint,CPT,RVU2026A,2026
24365,Reconstruct head of radius,CPT,RVU2026A,2026
24366,Reconstruct head of radius,CPT,RVU2026A,2026
24370,Revise reconst elbow joint,CPT,RVU2026A,2026
24371,Revise reconst elbow joint,CPT,RVU2026A,2026
24400,Osteot humerus w/wo int fixj,CPT,RVU2026A,2026
24410,Mlt osteot rlgnm imed rd hum,CPT,RVU2026A,2026
24420,Osteoplasty humerus,CPT,RVU2026A,2026
24430,Rpr non/mal humerus wo graft,CPT,RVU2026A,2026
24435,Rpr non/mal hum with agrft,CPT,RVU2026A,2026
24470,Hemiepiphyseal arrest,CPT,RVU2026A,2026
24495,Decompression fasct forearm,CPT,RVU2026A,2026
24498,Proph tx w/wo mthylmthcrylt,CPT,RVU2026A,2026
24500,Cltx humrl shft fx w/o mnpj,CPT,RVU2026A,2026
24505,Cltx humrl shft fx w/mnpj,CPT,RVU2026A,2026
24515,Optx humrl shft fx plate/scr,CPT,RVU2026A,2026
24516,Tx humrl shaft fx imed implt,CPT,RVU2026A,2026
24530,Cltx sprcndylr humeral fx wo,CPT,RVU2026A,2026
24535,Cltx sprcndylr humeral fx w/,CPT,RVU2026A,2026
24538,Prq skel fix sprcndlr hum fx,CPT,RVU2026A,2026
24545,Optx hum fx wo ntrcndylr xtn,CPT,RVU2026A,2026
24546,Optx hum fx w/ntrcndylr xtn,CPT,RVU2026A,2026
24560,Cltx hum epcndylr fx wo mnpj,CPT,RVU2026A,2026
24565,Cltx hum epcndylr fx w/mnpj,CPT,RVU2026A,2026
24566,Prq skel fix epcndylr hum fx,CPT,RVU2026A,2026
24575,Optx humeral epcndylr fx,CPT,RVU2026A,2026
24576,Cltx humrl cndylr fx wo mnpj,CPT,RVU2026A,2026
24577,Cltx humrl cndylr fx w/mnpj,CPT,RVU2026A,2026
24579,Optx humrl cndylr fracture,CPT,RVU2026A,2026
24582,Prq skel fix humrl cndylr fx,CPT,RVU2026A,2026
24586,Optx partclr fx&/dislc elbow,CPT,RVU2026A,2026
24587,Optx partclr fx&/dslc elbw w,CPT,RVU2026A,2026
24600,Tx clsd elbow dislc w/o anes,CPT,RVU2026A,2026
24605,Tx clsd elbow dislc req anes,CPT,RVU2026A,2026
24615,Optx aqt/chrnc elbow dislc,CPT,RVU2026A,2026
24620,Cltx monteggia fx dislc elbw,CPT,RVU2026A,2026
24635,Optx monteggia fx dislc elbw,CPT,RVU2026A,2026
24640,Cltx rdl head sublxtj nrsemd,CPT,RVU2026A,2026
24650,Cltx rdl head/nck fx wo mnpj,CPT,RVU2026A,2026
24655,Cltx rdl head/nck fx w/mnpj,CPT,RVU2026A,2026
24665,Optx radial head/neck fx,CPT,RVU2026A,2026
24666,Optx radial head/nck fx rplc,CPT,RVU2026A,2026
24670,Cltx ulnar fx prox w/o mnpj,CPT,RVU2026A,2026
24675,Cltx ulnar fx prox w/mnpj,CPT,RVU2026A,2026
24685,Optx ulnar fx prox end w/fix,CPT,RVU2026A,2026
24800,Arthrodesis elbw joint local,CPT,RVU2026A,2026
24802,Arthrd elbow jt autog graft,CPT,RVU2026A,2026
24900,Amputation of upper arm,CPT,RVU2026A,2026
24920,Amputation of upper arm,CPT,RVU2026A,2026
24925,Amputation follow-up surgery,CPT,RVU2026A,2026
24930,Amputation follow-up surgery,CPT,RVU2026A,2026
24931,Amputate upper arm & implant,CPT,RVU2026A,2026
24935,Revision of amputation,CPT,RVU2026A,2026
24940,Revision of upper arm,CPT,RVU2026A,2026
24999,Unlisted px humerus/elbow,CPT,RVU2026A,2026
25000,Incision of tendon sheath,CPT,RVU2026A,2026
25001,Incise flexor carpi radialis,CPT,RVU2026A,2026
25020,Decompress forearm 1 space,CPT,RVU2026A,2026
25023,Decompress forearm 1 space,CPT,RVU2026A,2026
25024,Decompress forearm 2 spaces,CPT,RVU2026A,2026
25025,Decompress forearm 2 spaces,CPT,RVU2026A,2026
25028,I&d f/arm&/wrst dp absc/hmtm,CPT,RVU2026A,2026
25031,I&d forearm&/wrist bursa,CPT,RVU2026A,2026
25035,Inc dp bone crtx f/arm&/wrst,CPT,RVU2026A,2026
25040,Arthrt rdcrpl/midcarpl jt,CPT,RVU2026A,2026
25065,Biopsy forearm soft tissues,CPT,RVU2026A,2026
25066,Biopsy forearm soft tissues,CPT,RVU2026A,2026
25071,Exc forearm les sc 3 cm/>,CPT,RVU2026A,2026
25073,Exc forearm tum deep 3 cm/>,CPT,RVU2026A,2026
25075,Exc forearm les sc < 3 cm,CPT,RVU2026A,2026
25076,Exc forearm tum deep < 3 cm,CPT,RVU2026A,2026
25077,Resect forearm/wrist tum<3cm,CPT,RVU2026A,2026
25078,Resect forarm/wrist tum 3cm>,CPT,RVU2026A,2026
25085,Incision of wrist capsule,CPT,RVU2026A,2026
25100,Biopsy of wrist joint,CPT,RVU2026A,2026
25101,Explore/treat wrist joint,CPT,RVU2026A,2026
25105,Remove wrist joint lining,CPT,RVU2026A,2026
25107,Remove wrist joint cartilage,CPT,RVU2026A,2026
25109,Excise tendon forearm/wrist,CPT,RVU2026A,2026
25110,Remove wrist tendon lesion,CPT,RVU2026A,2026
25111,Remove wrist tendon lesion,CPT,RVU2026A,2026
25112,Reremove wrist tendon lesion,CPT,RVU2026A,2026
25115,Remove wrist/forearm lesion,CPT,RVU2026A,2026
25116,Remove wrist/forearm lesion,CPT,RVU2026A,2026
25118,Excise wrist tendon sheath,CPT,RVU2026A,2026
25119,Partial removal of ulna,CPT,RVU2026A,2026
25120,Removal of forearm lesion,CPT,RVU2026A,2026
25125,Remove/graft forearm lesion,CPT,RVU2026A,2026
25126,Remove/graft forearm lesion,CPT,RVU2026A,2026
25130,Removal of wrist lesion,CPT,RVU2026A,2026
25135,Remove & graft wrist lesion,CPT,RVU2026A,2026
25136,Remove & graft wrist lesion,CPT,RVU2026A,2026
25145,Remove forearm bone lesion,CPT,RVU2026A,2026
25150,Partial removal of ulna,CPT,RVU2026A,2026
25151,Partial removal of radius,CPT,RVU2026A,2026
25170,Resect radius/ulnar tumor,CPT,RVU2026A,2026
25210,Removal of wrist bone,CPT,RVU2026A,2026
25215,Removal of wrist bones,CPT,RVU2026A,2026
25230,Partial removal of radius,CPT,RVU2026A,2026
25240,Partial removal of ulna,CPT,RVU2026A,2026
25246,Injection for wrist x-ray,CPT,RVU2026A,2026
25248,Remove forearm foreign body,CPT,RVU2026A,2026
25250,Removal of wrist prosthesis,CPT,RVU2026A,2026
25251,Removal of wrist prosthesis,CPT,RVU2026A,2026
25259,Manipulate wrist w/anesthes,CPT,RVU2026A,2026
25260,Repair forearm tendon/muscle,CPT,RVU2026A,2026
25263,Repair forearm tendon/muscle,CPT,RVU2026A,2026
25265,Repair forearm tendon/muscle,CPT,RVU2026A,2026
25270,Repair forearm tendon/muscle,CPT,RVU2026A,2026
25272,Repair forearm tendon/muscle,CPT,RVU2026A,2026
25274,Repair forearm tendon/muscle,CPT,RVU2026A,2026
25275,Repair forearm tendon sheath,CPT,RVU2026A,2026
25280,Revise wrist/forearm tendon,CPT,RVU2026A,2026
25290,Incise wrist/forearm tendon,CPT,RVU2026A,2026
25295,Release wrist/forearm tendon,CPT,RVU2026A,2026
25300,Fusion of tendons at wrist,CPT,RVU2026A,2026
25301,Fusion of tendons at wrist,CPT,RVU2026A,2026
25310,Transplant forearm tendon,CPT,RVU2026A,2026
25312,Transplant forearm tendon,CPT,RVU2026A,2026
25315,Revise palsy hand tendon(s),CPT,RVU2026A,2026
25316,Revise palsy hand tendon(s),CPT,RVU2026A,2026
25320,Repair/revise wrist joint,CPT,RVU2026A,2026
25332,Revise wrist joint,CPT,RVU2026A,2026
25335,Centralization wrist on ulna,CPT,RVU2026A,2026
25337,Reconstruct ulna/radioulnar,CPT,RVU2026A,2026
25350,Revision of radius,CPT,RVU2026A,2026
25355,Revision of radius,CPT,RVU2026A,2026
25360,Revision of ulna,CPT,RVU2026A,2026
25365,Revise radius & ulna,CPT,RVU2026A,2026
25370,Revise radius or ulna,CPT,RVU2026A,2026
25375,Revise radius & ulna,CPT,RVU2026A,2026
25390,Shorten radius or ulna,CPT,RVU2026A,2026
25391,Lengthen radius or ulna,CPT,RVU2026A,2026
25392,Shorten radius & ulna,CPT,RVU2026A,2026
25393,Lengthen radius & ulna,CPT,RVU2026A,2026
25394,Repair carpal bone shorten,CPT,RVU2026A,2026
25400,Repair radius or ulna,CPT,RVU2026A,2026
25405,Repair/graft radius or ulna,CPT,RVU2026A,2026
25415,Repair radius & ulna,CPT,RVU2026A,2026
25420,Repair/graft radius & ulna,CPT,RVU2026A,2026
25425,Repair/graft radius or ulna,CPT,RVU2026A,2026
25426,Repair/graft radius & ulna,CPT,RVU2026A,2026
25430,Vasc graft into carpal bone,CPT,RVU2026A,2026
25431,Repair nonunion carpal bone,CPT,RVU2026A,2026
25440,Repair nonu scphd carpl b1,CPT,RVU2026A,2026
25441,Arthrp w/prostc dstl rds,CPT,RVU2026A,2026
25442,Arthrp w/prostc dstl ulna,CPT,RVU2026A,2026
25443,Arthrp prostc dstl scph crpl,CPT,RVU2026A,2026
25444,Arthrp w/prostc lunate,CPT,RVU2026A,2026
25445,Arthrp w/prostc trapezium,CPT,RVU2026A,2026
25446,Arthrp w/prostc dst rds&crps,CPT,RVU2026A,2026
25447,Arthrp ntrcrp/crp/mtcr ntrps,CPT,RVU2026A,2026
25448,Arthrp ntrcrpl/crp/mtcrp ssp,CPT,RVU2026A,2026
25449,Revj arthrp wrist joint,CPT,RVU2026A,2026
25450,Epiphysl arrst dstl rds/ulna,CPT,RVU2026A,2026
25455,Epiphysl arrst dstl rds&ulna,CPT,RVU2026A,2026
25490,Prophylactic tx radius,CPT,RVU2026A,2026
25491,Prophylactic tx ulna,CPT,RVU2026A,2026
25492,Prophylactic tx radius&ulna,CPT,RVU2026A,2026
25500,Cltx rdl shft fx w/o mnpj,CPT,RVU2026A,2026
25505,Cltx rdl shft fx w/mnpj,CPT,RVU2026A,2026
25515,Optx radial shaft fracture,CPT,RVU2026A,2026
25520,Cltx rdl shft fx&dislc,CPT,RVU2026A,2026
25525,Optx rdl shft fx&cltx rad/ul,CPT,RVU2026A,2026
25526,Optx rdl shft fx&dstl rad/ul,CPT,RVU2026A,2026
25530,Cltx ulnar shft fx w/o mnpj,CPT,RVU2026A,2026
25535,Cltx ulnar shft fx w/mnpj,CPT,RVU2026A,2026
25545,Optx ulnar shft fx int fixj,CPT,RVU2026A,2026
25560,Cltx rdl&uln shft fx wo mnpj,CPT,RVU2026A,2026
25565,Cltx rdl&uln shft fx w/mnpj,CPT,RVU2026A,2026
25574,Optx rdl&uln shft fx rds/uln,CPT,RVU2026A,2026
25575,Optx rdl&uln shft fx rds&uln,CPT,RVU2026A,2026
25600,Cltx dst rdl fx/ephys sep wo,CPT,RVU2026A,2026
25605,Cltx dst rdl fx/ephys sep w/,CPT,RVU2026A,2026
25606,Perq skel fixj dstl rdl fx,CPT,RVU2026A,2026
25607,Optx dst rd xartc fx/epi sep,CPT,RVU2026A,2026
25608,Optx dst rd xart fx/epi sep2,CPT,RVU2026A,2026
25609,Optx dst rd xart fx/ep sep3+,CPT,RVU2026A,2026
25622,Cltx carpl scphd fx w/o mnpj,CPT,RVU2026A,2026
25624,Cltx carpl scphd fx w/mnpj,CPT,RVU2026A,2026
25628,Optx carpl scphd fx int fixj,CPT,RVU2026A,2026
25630,Cltx carpl fx w/o mnpj ea b1,CPT,RVU2026A,2026
25635,Cltx carpl fx w/mnpj ea b1,CPT,RVU2026A,2026
25645,Optx crpl fx oth/thn scph ea,CPT,RVU2026A,2026
25650,Cltx ulnar styloid fracture,CPT,RVU2026A,2026
25651,Perq skel fix ulnar styld fx,CPT,RVU2026A,2026
25652,Optx ulnar styloid fracture,CPT,RVU2026A,2026
25660,Cltx rdcrpl/ntrcrpl dislc 1+,CPT,RVU2026A,2026
25670,Optx rdcrpl/ntrcrpl dislc 1+,CPT,RVU2026A,2026
25671,Perq skel fix rad/uln dislc,CPT,RVU2026A,2026
25675,Cltx dstl rad/uln dislc mnpj,CPT,RVU2026A,2026
25676,Optx rad/uln dislc aqt/chrnc,CPT,RVU2026A,2026
25680,Cltx trns-scphprlnr fx mnpj,CPT,RVU2026A,2026
25685,Optx trns-scphprlnr fx dislc,CPT,RVU2026A,2026
25690,Cltx lunate dislc w/mnpj,CPT,RVU2026A,2026
25695,Optx lunate dislocation,CPT,RVU2026A,2026
25800,Arthrd wrist complete wo grf,CPT,RVU2026A,2026
25805,Arthrd wrist w/sliding graft,CPT,RVU2026A,2026
25810,Arthrd wrst iliac/oth agrft,CPT,RVU2026A,2026
25820,Arthrd wrist lmtd w/o b1 grf,CPT,RVU2026A,2026
25825,Arthrd wrist with autograft,CPT,RVU2026A,2026
25830,Arthrd dst rad/ul jt sgm rsc,CPT,RVU2026A,2026
25900,Amputation of forearm,CPT,RVU2026A,2026
25905,Amputation of forearm,CPT,RVU2026A,2026
25907,Amputation follow-up surgery,CPT,RVU2026A,2026
25909,Amputation follow-up surgery,CPT,RVU2026A,2026
25915,Amputation of forearm,CPT,RVU2026A,2026
25920,Amputate hand at wrist,CPT,RVU2026A,2026
25922,Amputate hand at wrist,CPT,RVU2026A,2026
25924,Amputation follow-up surgery,CPT,RVU2026A,2026
25927,Amputation of hand,CPT,RVU2026A,2026
25929,Amputation follow-up surgery,CPT,RVU2026A,2026
25931,Amputation follow-up surgery,CPT,RVU2026A,2026
25999,Unlisted px forearm/wrist,CPT,RVU2026A,2026
26010,Drainage of finger abscess,CPT,RVU2026A,2026
26011,Drainage of finger abscess,CPT,RVU2026A,2026
26020,Drain hand tendon sheath,CPT,RVU2026A,2026
26025,Drainage of palm bursa,CPT,RVU2026A,2026
26030,Drainage of palm bursas,CPT,RVU2026A,2026
26034,Treat hand bone lesion,CPT,RVU2026A,2026
26035,Decompress fingers/hand,CPT,RVU2026A,2026
26037,Decompress fingers/hand,CPT,RVU2026A,2026
26040,Release palm contracture,CPT,RVU2026A,2026
26045,Release palm contracture,CPT,RVU2026A,2026
26055,Incise finger tendon sheath,CPT,RVU2026A,2026
26060,Incision of finger tendon,CPT,RVU2026A,2026
26070,Explore/treat hand joint,CPT,RVU2026A,2026
26075,Explore/treat finger joint,CPT,RVU2026A,2026
26080,Explore/treat finger joint,CPT,RVU2026A,2026
26100,Biopsy hand joint lining,CPT,RVU2026A,2026
26105,Biopsy finger joint lining,CPT,RVU2026A,2026
26110,Biopsy finger joint lining,CPT,RVU2026A,2026
26111,Exc hand les sc 1.5 cm/>,CPT,RVU2026A,2026
26113,Exc hand tum deep 1.5 cm/>,CPT,RVU2026A,2026
26115,Exc hand les sc < 1.5 cm,CPT,RVU2026A,2026
26116,Exc hand tum deep < 1.5 cm,CPT,RVU2026A,2026
26117,Rad resect hand tumor < 3 cm,CPT,RVU2026A,2026
26118,Rad resect hand tumor 3 cm/>,CPT,RVU2026A,2026
26121,Release palm contracture,CPT,RVU2026A,2026
26123,Release palm contracture,CPT,RVU2026A,2026
26125,Release palm contracture,CPT,RVU2026A,2026
26130,Remove wrist joint lining,CPT,RVU2026A,2026
26135,Revise finger joint each,CPT,RVU2026A,2026
26140,Revise finger joint each,CPT,RVU2026A,2026
26145,Tendon excision palm/finger,CPT,RVU2026A,2026
26160,Remove tendon sheath lesion,CPT,RVU2026A,2026
26170,Removal of palm tendon each,CPT,RVU2026A,2026
26180,Removal of finger tendon,CPT,RVU2026A,2026
26185,Remove finger bone,CPT,RVU2026A,2026
26200,Remove hand bone lesion,CPT,RVU2026A,2026
26205,Remove/graft bone lesion,CPT,RVU2026A,2026
26210,Removal of finger lesion,CPT,RVU2026A,2026
26215,Remove/graft finger lesion,CPT,RVU2026A,2026
26230,Partial removal of hand bone,CPT,RVU2026A,2026
26235,Partial removal finger bone,CPT,RVU2026A,2026
26236,Partial removal finger bone,CPT,RVU2026A,2026
26250,Extensive hand surgery,CPT,RVU2026A,2026
26260,Resect prox finger tumor,CPT,RVU2026A,2026
26262,Resect distal finger tumor,CPT,RVU2026A,2026
26320,Removal of implant from hand,CPT,RVU2026A,2026
26340,Manipulate finger w/anesth,CPT,RVU2026A,2026
26341,Manipulat palm cord post inj,CPT,RVU2026A,2026
26350,Repair finger/hand tendon,CPT,RVU2026A,2026
26352,Repair/graft hand tendon,CPT,RVU2026A,2026
26356,Repair finger/hand tendon,CPT,RVU2026A,2026
26357,Repair finger/hand tendon,CPT,RVU2026A,2026
26358,Repair/graft hand tendon,CPT,RVU2026A,2026
26370,Repair finger/hand tendon,CPT,RVU2026A,2026
26372,Repair/graft hand tendon,CPT,RVU2026A,2026
26373,Repair finger/hand tendon,CPT,RVU2026A,2026
26390,Revise hand/finger tendon,CPT,RVU2026A,2026
26392,Repair/graft hand tendon,CPT,RVU2026A,2026
26410,Repair hand tendon,CPT,RVU2026A,2026
26412,Repair/graft hand tendon,CPT,RVU2026A,2026
26415,Excision hand/finger tendon,CPT,RVU2026A,2026
26416,Graft hand or finger tendon,CPT,RVU2026A,2026
26418,Repair finger tendon,CPT,RVU2026A,2026
26420,Repair/graft finger tendon,CPT,RVU2026A,2026
26426,Repair finger/hand tendon,CPT,RVU2026A,2026
26428,Repair/graft finger tendon,CPT,RVU2026A,2026
26432,Repair finger tendon,CPT,RVU2026A,2026
26433,Repair finger tendon,CPT,RVU2026A,2026
26434,Repair/graft finger tendon,CPT,RVU2026A,2026
26437,Realignment of tendons,CPT,RVU2026A,2026
26440,Release palm/finger tendon,CPT,RVU2026A,2026
26442,Release palm & finger tendon,CPT,RVU2026A,2026
26445,Release hand/finger tendon,CPT,RVU2026A,2026
26449,Release forearm/hand tendon,CPT,RVU2026A,2026
26450,Incision of palm tendon,CPT,RVU2026A,2026
26455,Incision of finger tendon,CPT,RVU2026A,2026
26460,Incise hand/finger tendon,CPT,RVU2026A,2026
26471,Fusion of finger tendons,CPT,RVU2026A,2026
26474,Fusion of finger tendons,CPT,RVU2026A,2026
26476,Tendon lengthening,CPT,RVU2026A,2026
26477,Tendon shortening,CPT,RVU2026A,2026
26478,Lengthening of hand tendon,CPT,RVU2026A,2026
26479,Shortening of hand tendon,CPT,RVU2026A,2026
26480,Transplant hand tendon,CPT,RVU2026A,2026
26483,Transplant/graft hand tendon,CPT,RVU2026A,2026
26485,Transplant palm tendon,CPT,RVU2026A,2026
26489,Transplant/graft palm tendon,CPT,RVU2026A,2026
26490,Revise thumb tendon,CPT,RVU2026A,2026
26492,Tendon transfer with graft,CPT,RVU2026A,2026
26494,Hand tendon/muscle transfer,CPT,RVU2026A,2026
26496,Revise thumb tendon,CPT,RVU2026A,2026
26497,Finger tendon transfer,CPT,RVU2026A,2026
26498,Finger tendon transfer,CPT,RVU2026A,2026
26499,Correction claw finger other,CPT,RVU2026A,2026
26500,Hand tendon reconstruction,CPT,RVU2026A,2026
26502,Hand tendon reconstruction,CPT,RVU2026A,2026
26508,Release thumb contracture,CPT,RVU2026A,2026
26510,Thumb tendon transfer,CPT,RVU2026A,2026
26516,Fusion of knuckle joint,CPT,RVU2026A,2026
26517,Fusion of knuckle joints,CPT,RVU2026A,2026
26518,Fusion of knuckle joints,CPT,RVU2026A,2026
26520,Release knuckle contracture,CPT,RVU2026A,2026
26525,Release finger contracture,CPT,RVU2026A,2026
26530,Revise knuckle joint,CPT,RVU2026A,2026
26531,Revise knuckle with implant,CPT,RVU2026A,2026
26535,Revise finger joint,CPT,RVU2026A,2026
26536,Revise/implant finger joint,CPT,RVU2026A,2026
26540,Repair hand joint,CPT,RVU2026A,2026
26541,Repair hand joint with graft,CPT,RVU2026A,2026
26542,Repair hand joint with graft,CPT,RVU2026A,2026
26545,Reconstruct finger joint,CPT,RVU2026A,2026
26546,Repair nonunion hand,CPT,RVU2026A,2026
26548,Reconstruct finger joint,CPT,RVU2026A,2026
26550,Pollicization digit,CPT,RVU2026A,2026
26551,Great toe-hand transfer,CPT,RVU2026A,2026
26553,Single transfer toe-hand,CPT,RVU2026A,2026
26554,Double transfer toe-hand,CPT,RVU2026A,2026
26555,Positional change of finger,CPT,RVU2026A,2026
26556,Toe joint transfer,CPT,RVU2026A,2026
26560,Repair of web finger,CPT,RVU2026A,2026
26561,Repair of web finger,CPT,RVU2026A,2026
26562,Repair of web finger,CPT,RVU2026A,2026
26565,Correct metacarpal flaw,CPT,RVU2026A,2026
26567,Correct finger deformity,CPT,RVU2026A,2026
26568,Lengthen metacarpal/finger,CPT,RVU2026A,2026
26580,Repair cleft hand,CPT,RVU2026A,2026
26587,Reconstruct extra finger,CPT,RVU2026A,2026
26590,Repair finger deformity,CPT,RVU2026A,2026
26591,Repair muscles of hand,CPT,RVU2026A,2026
26593,Release muscles of hand,CPT,RVU2026A,2026
26596,Excision constricting tissue,CPT,RVU2026A,2026
26600,Treat metacarpal fracture,CPT,RVU2026A,2026
26605,Treat metacarpal fracture,CPT,RVU2026A,2026
26607,Treat metacarpal fracture,CPT,RVU2026A,2026
26608,Treat metacarpal fracture,CPT,RVU2026A,2026
26615,Treat metacarpal fracture,CPT,RVU2026A,2026
26641,Treat thumb dislocation,CPT,RVU2026A,2026
26645,Treat thumb fracture,CPT,RVU2026A,2026
26650,Treat thumb fracture,CPT,RVU2026A,2026
26665,Treat thumb fracture,CPT,RVU2026A,2026
26670,Treat hand dislocation,CPT,RVU2026A,2026
26675,Treat hand dislocation,CPT,RVU2026A,2026
26676,Pin hand dislocation,CPT,RVU2026A,2026
26685,Treat hand dislocation,CPT,RVU2026A,2026
26686,Treat hand dislocation,CPT,RVU2026A,2026
26700,Treat knuckle dislocation,CPT,RVU2026A,2026
26705,Treat knuckle dislocation,CPT,RVU2026A,2026
26706,Pin knuckle dislocation,CPT,RVU2026A,2026
26715,Treat knuckle dislocation,CPT,RVU2026A,2026
26720,Treat finger fracture each,CPT,RVU2026A,2026
26725,Treat finger fracture each,CPT,RVU2026A,2026
26727,Treat finger fracture each,CPT,RVU2026A,2026
26735,Treat finger fracture each,CPT,RVU2026A,2026
26740,Treat finger fracture each,CPT,RVU2026A,2026
26742,Treat finger fracture each,CPT,RVU2026A,2026
26746,Treat finger fracture each,CPT,RVU2026A,2026
26750,Treat finger fracture each,CPT,RVU2026A,2026
26755,Treat finger fracture each,CPT,RVU2026A,2026
26756,Pin finger fracture each,CPT,RVU2026A,2026
26765,Treat finger fracture each,CPT,RVU2026A,2026
26770,Treat finger dislocation,CPT,RVU2026A,2026
26775,Treat finger dislocation,CPT,RVU2026A,2026
26776,Pin finger dislocation,CPT,RVU2026A,2026
26785,Treat finger dislocation,CPT,RVU2026A,2026
26820,Thumb fusion with graft,CPT,RVU2026A,2026
26841,Fusion of thumb,CPT,RVU2026A,2026
26842,Thumb fusion with graft,CPT,RVU2026A,2026
26843,Fusion of hand joint,CPT,RVU2026A,2026
26844,Fusion/graft of hand joint,CPT,RVU2026A,2026
26850,Fusion of knuckle,CPT,RVU2026A,2026
26852,Fusion of knuckle with graft,CPT,RVU2026A,2026
26860,Fusion of finger joint,CPT,RVU2026A,2026
26861,Fusion of finger jnt add-on,CPT,RVU2026A,2026
26862,Fusion/graft of finger joint,CPT,RVU2026A,2026
26863,Fuse/graft added joint,CPT,RVU2026A,2026
26910,Amputate metacarpal bone,CPT,RVU2026A,2026
26951,Amputation of finger/thumb,CPT,RVU2026A,2026
26952,Amputation of finger/thumb,CPT,RVU2026A,2026
26989,Unlisted px hands/fingers,CPT,RVU2026A,2026
26990,Drainage of pelvis lesion,CPT,RVU2026A,2026
26991,Drainage of pelvis bursa,CPT,RVU2026A,2026
26992,Drainage of bone lesion,CPT,RVU2026A,2026
27000,Tenotomy adductor hip perq,CPT,RVU2026A,2026
27001,Tenotomy adductor hip open,CPT,RVU2026A,2026
27003,Tnot adductr subq opn neurct,CPT,RVU2026A,2026
27005,Tenotomy hip flexor open,CPT,RVU2026A,2026
27006,Tenotomy abductor&/xtnsr hip,CPT,RVU2026A,2026
27025,Fasciotomy hip/thigh any typ,CPT,RVU2026A,2026
27027,Dcmprn fasct pel compartment,CPT,RVU2026A,2026
27030,Arthrotomy hip w/drainage,CPT,RVU2026A,2026
27033,Arthrt hip expl/rmv loose/fb,CPT,RVU2026A,2026
27035,Denervation of hip joint,CPT,RVU2026A,2026
27036,Capsulectomy/capsulotomy hip,CPT,RVU2026A,2026
27040,Biopsy of soft tissues,CPT,RVU2026A,2026
27041,Biopsy of soft tissues,CPT,RVU2026A,2026
27043,Exc hip pelvis les sc 3 cm/>,CPT,RVU2026A,2026
27045,Exc hip/pelv tum deep 5 cm/>,CPT,RVU2026A,2026
27047,Exc hip/pelvis les sc < 3 cm,CPT,RVU2026A,2026
27048,Exc hip/pelv tum deep < 5 cm,CPT,RVU2026A,2026
27049,Resect hip/pelv tum < 5 cm,CPT,RVU2026A,2026
27050,Biopsy of sacroiliac joint,CPT,RVU2026A,2026
27052,Biopsy of hip joint,CPT,RVU2026A,2026
27054,Removal of hip joint lining,CPT,RVU2026A,2026
27057,Buttock fasciotomy w/dbrdmt,CPT,RVU2026A,2026
27059,Resect hip/pelv tum 5 cm/>,CPT,RVU2026A,2026
27060,Removal of ischial bursa,CPT,RVU2026A,2026
27062,Remove femur lesion/bursa,CPT,RVU2026A,2026
27065,Remove hip bone les super,CPT,RVU2026A,2026
27066,Remove hip bone les deep,CPT,RVU2026A,2026
27067,Remove/graft hip bone lesion,CPT,RVU2026A,2026
27070,Part remove hip bone super,CPT,RVU2026A,2026
27071,Part removal hip bone deep,CPT,RVU2026A,2026
27075,Resect hip tumor,CPT,RVU2026A,2026
27076,Resect hip tum incl acetabul,CPT,RVU2026A,2026
27077,Resect hip tum w/innom bone,CPT,RVU2026A,2026
27078,Rsect hip tum incl femur,CPT,RVU2026A,2026
27080,Removal of tail bone,CPT,RVU2026A,2026
27086,Remove hip foreign body,CPT,RVU2026A,2026
27087,Remove hip foreign body,CPT,RVU2026A,2026
27090,Removal of hip prosthesis,CPT,RVU2026A,2026
27091,Removal of hip prosthesis,CPT,RVU2026A,2026
27093,Injection for hip x-ray,CPT,RVU2026A,2026
27095,Injection for hip x-ray,CPT,RVU2026A,2026
27096,Inject sacroiliac joint,CPT,RVU2026A,2026
27097,Revision of hip tendon,CPT,RVU2026A,2026
27098,Transfer tendon to pelvis,CPT,RVU2026A,2026
27100,Transfer of abdominal muscle,CPT,RVU2026A,2026
27105,Transfer of spinal muscle,CPT,RVU2026A,2026
27110,Transfer of iliopsoas muscle,CPT,RVU2026A,2026
27111,Transfer of iliopsoas muscle,CPT,RVU2026A,2026
27120,Reconstruction of hip socket,CPT,RVU2026A,2026
27122,Reconstruction of hip socket,CPT,RVU2026A,2026
27125,Partial hip replacement,CPT,RVU2026A,2026
27130,Total hip arthroplasty,CPT,RVU2026A,2026
27132,Total hip arthroplasty,CPT,RVU2026A,2026
27134,Revise hip joint replacement,CPT,RVU2026A,2026
27137,Revise hip joint replacement,CPT,RVU2026A,2026
27138,Revise hip joint replacement,CPT,RVU2026A,2026
27140,Transplant femur ridge,CPT,RVU2026A,2026
27146,Incision of hip bone,CPT,RVU2026A,2026
27147,Revision of hip bone,CPT,RVU2026A,2026
27151,Incision of hip bones,CPT,RVU2026A,2026
27156,Revision of hip bones,CPT,RVU2026A,2026
27158,Revision of pelvis,CPT,RVU2026A,2026
27161,Incision of neck of femur,CPT,RVU2026A,2026
27165,Incision/fixation of femur,CPT,RVU2026A,2026
27170,Repair/graft femur head/neck,CPT,RVU2026A,2026
27175,Treat slipped epiphysis,CPT,RVU2026A,2026
27176,Treat slipped epiphysis,CPT,RVU2026A,2026
27177,Treat slipped epiphysis,CPT,RVU2026A,2026
27178,Treat slipped epiphysis,CPT,RVU2026A,2026
27179,Revise head/neck of femur,CPT,RVU2026A,2026
27181,Treat slipped epiphysis,CPT,RVU2026A,2026
27185,Revision of femur epiphysis,CPT,RVU2026A,2026
27187,Reinforce hip bones,CPT,RVU2026A,2026
27197,Clsd tx pelvic ring fx,CPT,RVU2026A,2026
27198,Clsd tx pelvic ring fx,CPT,RVU2026A,2026
27200,Treat tail bone fracture,CPT,RVU2026A,2026
27202,Treat tail bone fracture,CPT,RVU2026A,2026
27215,Treat pelvic fracture(s),CPT,RVU2026A,2026
27216,Treat pelvic ring fracture,CPT,RVU2026A,2026
27217,Treat pelvic ring fracture,CPT,RVU2026A,2026
27218,Treat pelvic ring fracture,CPT,RVU2026A,2026
27220,Treat hip socket fracture,CPT,RVU2026A,2026
27222,Treat hip socket fracture,CPT,RVU2026A,2026
27226,Treat hip wall fracture,CPT,RVU2026A,2026
27227,Treat hip fracture(s),CPT,RVU2026A,2026
27228,Treat hip fracture(s),CPT,RVU2026A,2026
27230,Treat thigh fracture,CPT,RVU2026A,2026
27232,Treat thigh fracture,CPT,RVU2026A,2026
27235,Treat thigh fracture,CPT,RVU2026A,2026
27236,Treat thigh fracture,CPT,RVU2026A,2026
27238,Treat thigh fracture,CPT,RVU2026A,2026
27240,Treat thigh fracture,CPT,RVU2026A,2026
27244,Treat thigh fracture,CPT,RVU2026A,2026
27245,Treat thigh fracture,CPT,RVU2026A,2026
27246,Treat thigh fracture,CPT,RVU2026A,2026
27248,Treat thigh fracture,CPT,RVU2026A,2026
27250,Treat hip dislocation,CPT,RVU2026A,2026
27252,Treat hip dislocation,CPT,RVU2026A,2026
27253,Treat hip dislocation,CPT,RVU2026A,2026
27254,Treat hip dislocation,CPT,RVU2026A,2026
27256,Treat hip dislocation,CPT,RVU2026A,2026
27257,Treat hip dislocation,CPT,RVU2026A,2026
27258,Treat hip dislocation,CPT,RVU2026A,2026
27259,Treat hip dislocation,CPT,RVU2026A,2026
27265,Treat hip dislocation,CPT,RVU2026A,2026
27266,Treat hip dislocation,CPT,RVU2026A,2026
27267,Cltx thigh fx,CPT,RVU2026A,2026
27268,Cltx thigh fx w/mnpj,CPT,RVU2026A,2026
27269,Optx thigh fx,CPT,RVU2026A,2026
27275,Manipulation of hip joint,CPT,RVU2026A,2026
27278,Arthrd si jt plmt iartic dev,CPT,RVU2026A,2026
27279,Arthrd si jt plmt tartclr dv,CPT,RVU2026A,2026
27280,Arthr si jt opn b1grf instrm,CPT,RVU2026A,2026
27282,Arthrodesis symphysis pubis,CPT,RVU2026A,2026
27284,Arthrodesis hip joint,CPT,RVU2026A,2026
27286,Arthrd hip jt sbtrchc osteot,CPT,RVU2026A,2026
27290,Amputation of leg at hip,CPT,RVU2026A,2026
27295,Amputation of leg at hip,CPT,RVU2026A,2026
27299,Unlisted px pelvis/hip joint,CPT,RVU2026A,2026
27301,Drain thigh/knee lesion,CPT,RVU2026A,2026
27303,Drainage of bone lesion,CPT,RVU2026A,2026
27305,Incise thigh tendon & fascia,CPT,RVU2026A,2026
27306,Incision of thigh tendon,CPT,RVU2026A,2026
27307,Incision of thigh tendons,CPT,RVU2026A,2026
27310,Exploration of knee joint,CPT,RVU2026A,2026
27323,Biopsy thigh soft tissues,CPT,RVU2026A,2026
27324,Biopsy thigh soft tissues,CPT,RVU2026A,2026
27325,Neurectomy hamstring,CPT,RVU2026A,2026
27326,Neurectomy popliteal,CPT,RVU2026A,2026
27327,Exc thigh/knee les sc < 3 cm,CPT,RVU2026A,2026
27328,Exc thigh/knee tum deep <5cm,CPT,RVU2026A,2026
27329,Resect thigh/knee tum < 5 cm,CPT,RVU2026A,2026
27330,Biopsy knee joint lining,CPT,RVU2026A,2026
27331,Explore/treat knee joint,CPT,RVU2026A,2026
27332,Removal of knee cartilage,CPT,RVU2026A,2026
27333,Removal of knee cartilage,CPT,RVU2026A,2026
27334,Remove knee joint lining,CPT,RVU2026A,2026
27335,Remove knee joint lining,CPT,RVU2026A,2026
27337,Exc thigh/knee les sc 3 cm/>,CPT,RVU2026A,2026
27339,Exc thigh/knee tum dep 5cm/>,CPT,RVU2026A,2026
27340,Removal of kneecap bursa,CPT,RVU2026A,2026
27345,Removal of knee cyst,CPT,RVU2026A,2026
27347,Remove knee cyst,CPT,RVU2026A,2026
27350,Removal of kneecap,CPT,RVU2026A,2026
27355,Remove femur lesion,CPT,RVU2026A,2026
27356,Remove femur lesion/graft,CPT,RVU2026A,2026
27357,Remove femur lesion/graft,CPT,RVU2026A,2026
27358,Remove femur lesion/fixation,CPT,RVU2026A,2026
27360,Partial removal leg bone(s),CPT,RVU2026A,2026
27364,Resect thigh/knee tum 5 cm/>,CPT,RVU2026A,2026
27365,Resect femur/knee tumor,CPT,RVU2026A,2026
27369,Njx cntrst kne arthg/ct/mri,CPT,RVU2026A,2026
27372,Removal of foreign body,CPT,RVU2026A,2026
27380,Repair of kneecap tendon,CPT,RVU2026A,2026
27381,Repair/graft kneecap tendon,CPT,RVU2026A,2026
27385,Repair of thigh muscle,CPT,RVU2026A,2026
27386,Repair/graft of thigh muscle,CPT,RVU2026A,2026
27390,Incision of thigh tendon,CPT,RVU2026A,2026
27391,Incision of thigh tendons,CPT,RVU2026A,2026
27392,Incision of thigh tendons,CPT,RVU2026A,2026
27393,Lengthening of thigh tendon,CPT,RVU2026A,2026
27394,Lengthening of thigh tendons,CPT,RVU2026A,2026
27395,Lengthening of thigh tendons,CPT,RVU2026A,2026
27396,Transplant of thigh tendon,CPT,RVU2026A,2026
27397,Transplants of thigh tendons,CPT,RVU2026A,2026
27400,Revise thigh muscles/tendons,CPT,RVU2026A,2026
27403,Repair of knee cartilage,CPT,RVU2026A,2026
27405,Repair of knee ligament,CPT,RVU2026A,2026
27407,Repair of knee ligament,CPT,RVU2026A,2026
27409,Repair of knee ligaments,CPT,RVU2026A,2026
27412,Autochondrocyte implant knee,CPT,RVU2026A,2026
27415,Osteochondral knee allograft,CPT,RVU2026A,2026
27416,Osteochondral knee autograft,CPT,RVU2026A,2026
27418,Repair degenerated kneecap,CPT,RVU2026A,2026
27420,Revision of unstable kneecap,CPT,RVU2026A,2026
27422,Revision of unstable kneecap,CPT,RVU2026A,2026
27424,Revision/removal of kneecap,CPT,RVU2026A,2026
27425,Lat retinacular release open,CPT,RVU2026A,2026
27427,Reconstruction knee,CPT,RVU2026A,2026
27428,Reconstruction knee,CPT,RVU2026A,2026
27429,Reconstruction knee,CPT,RVU2026A,2026
27430,Revision of thigh muscles,CPT,RVU2026A,2026
27435,Incision of knee joint,CPT,RVU2026A,2026
27437,Revise kneecap,CPT,RVU2026A,2026
27438,Revise kneecap with implant,CPT,RVU2026A,2026
27440,Revision of knee joint,CPT,RVU2026A,2026
27441,Revision of knee joint,CPT,RVU2026A,2026
27442,Revision of knee joint,CPT,RVU2026A,2026
27443,Revision of knee joint,CPT,RVU2026A,2026
27446,Revision of knee joint,CPT,RVU2026A,2026
27447,Total knee arthroplasty,CPT,RVU2026A,2026
27448,Incision of thigh,CPT,RVU2026A,2026
27450,Incision of thigh,CPT,RVU2026A,2026
27454,Realignment of thigh bone,CPT,RVU2026A,2026
27455,Realignment of knee,CPT,RVU2026A,2026
27457,Realignment of knee,CPT,RVU2026A,2026
27458,Osteot femur imed lngth dev,CPT,RVU2026A,2026
27465,Shortening of thigh bone,CPT,RVU2026A,2026
27466,Lengthening of thigh bone,CPT,RVU2026A,2026
27470,Repair of thigh,CPT,RVU2026A,2026
27472,Repair/graft of thigh,CPT,RVU2026A,2026
27475,Surgery to stop leg growth,CPT,RVU2026A,2026
27477,Surgery to stop leg growth,CPT,RVU2026A,2026
27479,Surgery to stop leg growth,CPT,RVU2026A,2026
27485,Surgery to stop leg growth,CPT,RVU2026A,2026
27486,Revise/replace knee joint,CPT,RVU2026A,2026
27487,Revise/replace knee joint,CPT,RVU2026A,2026
27488,Removal of knee prosthesis,CPT,RVU2026A,2026
27495,Reinforce thigh,CPT,RVU2026A,2026
27496,Decompression of thigh/knee,CPT,RVU2026A,2026
27497,Decompression of thigh/knee,CPT,RVU2026A,2026
27498,Decompression of thigh/knee,CPT,RVU2026A,2026
27499,Decompression of thigh/knee,CPT,RVU2026A,2026
27500,Treatment of thigh fracture,CPT,RVU2026A,2026
27501,Treatment of thigh fracture,CPT,RVU2026A,2026
27502,Treatment of thigh fracture,CPT,RVU2026A,2026
27503,Treatment of thigh fracture,CPT,RVU2026A,2026
27506,Treatment of thigh fracture,CPT,RVU2026A,2026
27507,Treatment of thigh fracture,CPT,RVU2026A,2026
27508,Treatment of thigh fracture,CPT,RVU2026A,2026
27509,Treatment of thigh fracture,CPT,RVU2026A,2026
27510,Treatment of thigh fracture,CPT,RVU2026A,2026
27511,Treatment of thigh fracture,CPT,RVU2026A,2026
27513,Treatment of thigh fracture,CPT,RVU2026A,2026
27514,Treatment of thigh fracture,CPT,RVU2026A,2026
27516,Treat thigh fx growth plate,CPT,RVU2026A,2026
27517,Treat thigh fx growth plate,CPT,RVU2026A,2026
27519,Treat thigh fx growth plate,CPT,RVU2026A,2026
27520,Treat kneecap fracture,CPT,RVU2026A,2026
27524,Treat kneecap fracture,CPT,RVU2026A,2026
27530,Treat knee fracture,CPT,RVU2026A,2026
27532,Treat knee fracture,CPT,RVU2026A,2026
27535,Treat knee fracture,CPT,RVU2026A,2026
27536,Treat knee fracture,CPT,RVU2026A,2026
27538,Treat knee fracture(s),CPT,RVU2026A,2026
27540,Treat knee fracture,CPT,RVU2026A,2026
27550,Treat knee dislocation,CPT,RVU2026A,2026
27552,Treat knee dislocation,CPT,RVU2026A,2026
27556,Treat knee dislocation,CPT,RVU2026A,2026
27557,Treat knee dislocation,CPT,RVU2026A,2026
27558,Treat knee dislocation,CPT,RVU2026A,2026
27560,Treat kneecap dislocation,CPT,RVU2026A,2026
27562,Treat kneecap dislocation,CPT,RVU2026A,2026
27566,Treat kneecap dislocation,CPT,RVU2026A,2026
27570,Fixation of knee joint,CPT,RVU2026A,2026
27580,Fusion of knee,CPT,RVU2026A,2026
27590,Amputate leg at thigh,CPT,RVU2026A,2026
27591,Amputate leg at thigh,CPT,RVU2026A,2026
27592,Amputate leg at thigh,CPT,RVU2026A,2026
27594,Amputation follow-up surgery,CPT,RVU2026A,2026
27596,Amputation follow-up surgery,CPT,RVU2026A,2026
27598,Amputate lower leg at knee,CPT,RVU2026A,2026
27599,Unlisted px femur/knee,CPT,RVU2026A,2026
27600,Decompression of lower leg,CPT,RVU2026A,2026
27601,Decompression of lower leg,CPT,RVU2026A,2026
27602,Decompression of lower leg,CPT,RVU2026A,2026
27603,Drain lower leg lesion,CPT,RVU2026A,2026
27604,Drain lower leg bursa,CPT,RVU2026A,2026
27605,Incision of achilles tendon,CPT,RVU2026A,2026
27606,Incision of achilles tendon,CPT,RVU2026A,2026
27607,Treat lower leg bone lesion,CPT,RVU2026A,2026
27610,Explore/treat ankle joint,CPT,RVU2026A,2026
27612,Exploration of ankle joint,CPT,RVU2026A,2026
27613,Biopsy lower leg soft tissue,CPT,RVU2026A,2026
27614,Biopsy lower leg soft tissue,CPT,RVU2026A,2026
27615,Resect leg/ankle tum < 5 cm,CPT,RVU2026A,2026
27616,Resect leg/ankle tum 5 cm/>,CPT,RVU2026A,2026
27618,Exc leg/ankle tum < 3 cm,CPT,RVU2026A,2026
27619,Exc leg/ankle tum deep <5 cm,CPT,RVU2026A,2026
27620,Explore/treat ankle joint,CPT,RVU2026A,2026
27625,Remove ankle joint lining,CPT,RVU2026A,2026
27626,Remove ankle joint lining,CPT,RVU2026A,2026
27630,Removal of tendon lesion,CPT,RVU2026A,2026
27632,Exc leg/ankle les sc 3 cm/>,CPT,RVU2026A,2026
27634,Exc leg/ankle tum dep 5 cm/>,CPT,RVU2026A,2026
27635,Remove lower leg bone lesion,CPT,RVU2026A,2026
27637,Remove/graft leg bone lesion,CPT,RVU2026A,2026
27638,Remove/graft leg bone lesion,CPT,RVU2026A,2026
27640,Partial removal of tibia,CPT,RVU2026A,2026
27641,Partial removal of fibula,CPT,RVU2026A,2026
27645,Resect tibia tumor,CPT,RVU2026A,2026
27646,Resect fibula tumor,CPT,RVU2026A,2026
27647,Resect talus/calcaneus tum,CPT,RVU2026A,2026
27648,Injection for ankle x-ray,CPT,RVU2026A,2026
27650,Repair achilles tendon,CPT,RVU2026A,2026
27652,Repair/graft achilles tendon,CPT,RVU2026A,2026
27654,Repair of achilles tendon,CPT,RVU2026A,2026
27656,Repair leg fascia defect,CPT,RVU2026A,2026
27658,Repair of leg tendon each,CPT,RVU2026A,2026
27659,Repair of leg tendon each,CPT,RVU2026A,2026
27664,Repair of leg tendon each,CPT,RVU2026A,2026
27665,Repair of leg tendon each,CPT,RVU2026A,2026
27675,Repair lower leg tendons,CPT,RVU2026A,2026
27676,Repair lower leg tendons,CPT,RVU2026A,2026
27680,Release of lower leg tendon,CPT,RVU2026A,2026
27681,Release of lower leg tendons,CPT,RVU2026A,2026
27685,Revision of lower leg tendon,CPT,RVU2026A,2026
27686,Revise lower leg tendons,CPT,RVU2026A,2026
27687,Revision of calf tendon,CPT,RVU2026A,2026
27690,Revise lower leg tendon,CPT,RVU2026A,2026
27691,Revise lower leg tendon,CPT,RVU2026A,2026
27692,Revise additional leg tendon,CPT,RVU2026A,2026
27695,Repair of ankle ligament,CPT,RVU2026A,2026
27696,Repair of ankle ligaments,CPT,RVU2026A,2026
27698,Repair of ankle ligament,CPT,RVU2026A,2026
27700,Revision of ankle joint,CPT,RVU2026A,2026
27702,Reconstruct ankle joint,CPT,RVU2026A,2026
27703,Reconstruction ankle joint,CPT,RVU2026A,2026
27704,Removal of ankle implant,CPT,RVU2026A,2026
27705,Osteotomy tibia,CPT,RVU2026A,2026
27707,Osteotomy fibula,CPT,RVU2026A,2026
27709,Osteotomy tibia & fibula,CPT,RVU2026A,2026
27712,Osteot mlt relignmt imed rod,CPT,RVU2026A,2026
27713,Osteot tibia imed lngth dev,CPT,RVU2026A,2026
27715,Ostpl tibfib lngth/shrt,CPT,RVU2026A,2026
27720,Repair of tibia,CPT,RVU2026A,2026
27722,Repair/graft of tibia,CPT,RVU2026A,2026
27724,Repair/graft of tibia,CPT,RVU2026A,2026
27725,Repair of lower leg,CPT,RVU2026A,2026
27726,Repair fibula nonunion,CPT,RVU2026A,2026
27727,Repair of lower leg,CPT,RVU2026A,2026
27730,Repair of tibia epiphysis,CPT,RVU2026A,2026
27732,Repair of fibula epiphysis,CPT,RVU2026A,2026
27734,Repair lower leg epiphyses,CPT,RVU2026A,2026
27740,Repair of leg epiphyses,CPT,RVU2026A,2026
27742,Repair of leg epiphyses,CPT,RVU2026A,2026
27745,Reinforce tibia,CPT,RVU2026A,2026
27750,Treatment of tibia fracture,CPT,RVU2026A,2026
27752,Treatment of tibia fracture,CPT,RVU2026A,2026
27756,Treatment of tibia fracture,CPT,RVU2026A,2026
27758,Treatment of tibia fracture,CPT,RVU2026A,2026
27759,Treatment of tibia fracture,CPT,RVU2026A,2026
27760,Cltx medial ankle fx,CPT,RVU2026A,2026
27762,Cltx med ankle fx w/mnpj,CPT,RVU2026A,2026
27766,Optx medial ankle fx,CPT,RVU2026A,2026
27767,Cltx post ankle fx,CPT,RVU2026A,2026
27768,Cltx post ankle fx w/mnpj,CPT,RVU2026A,2026
27769,Optx post ankle fx,CPT,RVU2026A,2026
27780,Treatment of fibula fracture,CPT,RVU2026A,2026
27781,Treatment of fibula fracture,CPT,RVU2026A,2026
27784,Treatment of fibula fracture,CPT,RVU2026A,2026
27786,Treatment of ankle fracture,CPT,RVU2026A,2026
27788,Treatment of ankle fracture,CPT,RVU2026A,2026
27792,Treatment of ankle fracture,CPT,RVU2026A,2026
27808,Treatment of ankle fracture,CPT,RVU2026A,2026
27810,Treatment of ankle fracture,CPT,RVU2026A,2026
27814,Treatment of ankle fracture,CPT,RVU2026A,2026
27816,Treatment of ankle fracture,CPT,RVU2026A,2026
27818,Treatment of ankle fracture,CPT,RVU2026A,2026
27822,Treatment of ankle fracture,CPT,RVU2026A,2026
27823,Treatment of ankle fracture,CPT,RVU2026A,2026
27824,Treat lower leg fracture,CPT,RVU2026A,2026
27825,Treat lower leg fracture,CPT,RVU2026A,2026
27826,Treat lower leg fracture,CPT,RVU2026A,2026
27827,Treat lower leg fracture,CPT,RVU2026A,2026
27828,Treat lower leg fracture,CPT,RVU2026A,2026
27829,Treat lower leg joint,CPT,RVU2026A,2026
27830,Treat lower leg dislocation,CPT,RVU2026A,2026
27831,Treat lower leg dislocation,CPT,RVU2026A,2026
27832,Treat lower leg dislocation,CPT,RVU2026A,2026
27840,Treat ankle dislocation,CPT,RVU2026A,2026
27842,Treat ankle dislocation,CPT,RVU2026A,2026
27846,Treat ankle dislocation,CPT,RVU2026A,2026
27848,Treat ankle dislocation,CPT,RVU2026A,2026
27860,Fixation of ankle joint,CPT,RVU2026A,2026
27870,Fusion of ankle joint open,CPT,RVU2026A,2026
27871,Fusion of tibiofibular joint,CPT,RVU2026A,2026
27880,Amputation of lower leg,CPT,RVU2026A,2026
27881,Amputation of lower leg,CPT,RVU2026A,2026
27882,Amputation of lower leg,CPT,RVU2026A,2026
27884,Amputation follow-up surgery,CPT,RVU2026A,2026
27886,Amputation follow-up surgery,CPT,RVU2026A,2026
27888,Amputation of foot at ankle,CPT,RVU2026A,2026
27889,Ankle disarticulation,CPT,RVU2026A,2026
27892,Decompression of leg,CPT,RVU2026A,2026
27893,Decompression of leg,CPT,RVU2026A,2026
27894,Decompression of leg,CPT,RVU2026A,2026
27899,Unlisted px leg/ankle,CPT,RVU2026A,2026
28001,Drainage of bursa of foot,CPT,RVU2026A,2026
28002,Treatment of foot infection,CPT,RVU2026A,2026
28003,Treatment of foot infection,CPT,RVU2026A,2026
28005,Treat foot bone lesion,CPT,RVU2026A,2026
28008,Incision of foot fascia,CPT,RVU2026A,2026
28010,Incision of toe tendon,CPT,RVU2026A,2026
28011,Incision of toe tendons,CPT,RVU2026A,2026
28020,Exploration of foot joint,CPT,RVU2026A,2026
28022,Exploration of foot joint,CPT,RVU2026A,2026
28024,Exploration of toe joint,CPT,RVU2026A,2026
28035,Decompression of tibia nerve,CPT,RVU2026A,2026
28039,Exc foot/toe tum sc 1.5 cm/>,CPT,RVU2026A,2026
28041,Exc foot/toe tum dep 1.5cm/>,CPT,RVU2026A,2026
28043,Exc foot/toe tum sc < 1.5 cm,CPT,RVU2026A,2026
28045,Exc foot/toe tum deep <1.5cm,CPT,RVU2026A,2026
28046,Resect foot/toe tumor < 3 cm,CPT,RVU2026A,2026
28047,Resect foot/toe tumor 3 cm/>,CPT,RVU2026A,2026
28050,Biopsy of foot joint lining,CPT,RVU2026A,2026
28052,Biopsy of foot joint lining,CPT,RVU2026A,2026
28054,Biopsy of toe joint lining,CPT,RVU2026A,2026
28055,Neurectomy foot,CPT,RVU2026A,2026
28060,Partial removal foot fascia,CPT,RVU2026A,2026
28062,Removal of foot fascia,CPT,RVU2026A,2026
28070,Removal of foot joint lining,CPT,RVU2026A,2026
28072,Removal of foot joint lining,CPT,RVU2026A,2026
28080,Removal of foot lesion,CPT,RVU2026A,2026
28086,Excise foot tendon sheath,CPT,RVU2026A,2026
28088,Excise foot tendon sheath,CPT,RVU2026A,2026
28090,Removal of foot lesion,CPT,RVU2026A,2026
28092,Removal of toe lesions,CPT,RVU2026A,2026
28100,Removal of ankle/heel lesion,CPT,RVU2026A,2026
28102,Remove/graft foot lesion,CPT,RVU2026A,2026
28103,Remove/graft foot lesion,CPT,RVU2026A,2026
28104,Removal of foot lesion,CPT,RVU2026A,2026
28106,Remove/graft foot lesion,CPT,RVU2026A,2026
28107,Remove/graft foot lesion,CPT,RVU2026A,2026
28108,Removal of toe lesions,CPT,RVU2026A,2026
28110,Part removal of metatarsal,CPT,RVU2026A,2026
28111,Part removal of metatarsal,CPT,RVU2026A,2026
28112,Part removal of metatarsal,CPT,RVU2026A,2026
28113,Part removal of metatarsal,CPT,RVU2026A,2026
28114,Removal of metatarsal heads,CPT,RVU2026A,2026
28116,Revision of foot,CPT,RVU2026A,2026
28118,Removal of heel bone,CPT,RVU2026A,2026
28119,Removal of heel spur,CPT,RVU2026A,2026
28120,Part removal of ankle/heel,CPT,RVU2026A,2026
28122,Partial removal of foot bone,CPT,RVU2026A,2026
28124,Partial removal of toe,CPT,RVU2026A,2026
28126,Partial removal of toe,CPT,RVU2026A,2026
28130,Removal of ankle bone,CPT,RVU2026A,2026
28140,Removal of metatarsal,CPT,RVU2026A,2026
28150,Removal of toe,CPT,RVU2026A,2026
28153,Partial removal of toe,CPT,RVU2026A,2026
28160,Partial removal of toe,CPT,RVU2026A,2026
28171,Resect tarsal tumor,CPT,RVU2026A,2026
28173,Resect metatarsal tumor,CPT,RVU2026A,2026
28175,Resect phalanx of toe tumor,CPT,RVU2026A,2026
28190,Removal of foot foreign body,CPT,RVU2026A,2026
28192,Removal of foot foreign body,CPT,RVU2026A,2026
28193,Removal of foot foreign body,CPT,RVU2026A,2026
28200,Repair of foot tendon,CPT,RVU2026A,2026
28202,Repair/graft of foot tendon,CPT,RVU2026A,2026
28208,Repair of foot tendon,CPT,RVU2026A,2026
28210,Repair/graft of foot tendon,CPT,RVU2026A,2026
28220,Release of foot tendon,CPT,RVU2026A,2026
28222,Release of foot tendons,CPT,RVU2026A,2026
28225,Release of foot tendon,CPT,RVU2026A,2026
28226,Release of foot tendons,CPT,RVU2026A,2026
28230,Incision of foot tendon(s),CPT,RVU2026A,2026
28232,Incision of toe tendon,CPT,RVU2026A,2026
28234,Incision of foot tendon,CPT,RVU2026A,2026
28238,Revision of foot tendon,CPT,RVU2026A,2026
28240,Release of big toe,CPT,RVU2026A,2026
28250,Revision of foot fascia,CPT,RVU2026A,2026
28260,Release of midfoot joint,CPT,RVU2026A,2026
28261,Revision of foot tendon,CPT,RVU2026A,2026
28262,Revision of foot and ankle,CPT,RVU2026A,2026
28264,Release of midfoot joint,CPT,RVU2026A,2026
28270,Release of foot contracture,CPT,RVU2026A,2026
28272,Release of toe joint each,CPT,RVU2026A,2026
28280,Fusion of toes,CPT,RVU2026A,2026
28285,Repair of hammertoe,CPT,RVU2026A,2026
28286,Repair of hammertoe,CPT,RVU2026A,2026
28288,Partial removal of foot bone,CPT,RVU2026A,2026
28289,Corrj halux rigdus w/o implt,CPT,RVU2026A,2026
28291,Corrj halux rigdus w/implt,CPT,RVU2026A,2026
28292,Cor hlx vlgs rsc prx phlx bs,CPT,RVU2026A,2026
28295,Cor hlx vlgs prx mtar osteot,CPT,RVU2026A,2026
28296,Cor hlx vlgs dstl mtar osteo,CPT,RVU2026A,2026
28297,Cor hlx vlgs jt arthrd,CPT,RVU2026A,2026
28298,Cor hlx vlgs prx phlx osteot,CPT,RVU2026A,2026
28299,Cor hlx vlgs double osteot,CPT,RVU2026A,2026
28300,Incision of heel bone,CPT,RVU2026A,2026
28302,Incision of ankle bone,CPT,RVU2026A,2026
28304,Incision of midfoot bones,CPT,RVU2026A,2026
28305,Incise/graft midfoot bones,CPT,RVU2026A,2026
28306,Incision of metatarsal,CPT,RVU2026A,2026
28307,Incision of metatarsal,CPT,RVU2026A,2026
28308,Incision of metatarsal,CPT,RVU2026A,2026
28309,Incision of metatarsals,CPT,RVU2026A,2026
28310,Revision of big toe,CPT,RVU2026A,2026
28312,Revision of toe,CPT,RVU2026A,2026
28313,Repair deformity of toe,CPT,RVU2026A,2026
28315,Removal of sesamoid bone,CPT,RVU2026A,2026
28320,Repair of foot bones,CPT,RVU2026A,2026
28322,Repair of metatarsals,CPT,RVU2026A,2026
28340,Resect enlarged toe tissue,CPT,RVU2026A,2026
28341,Resect enlarged toe,CPT,RVU2026A,2026
28344,Repair extra toe(s),CPT,RVU2026A,2026
28345,Repair webbed toe(s),CPT,RVU2026A,2026
28360,Reconstruct cleft foot,CPT,RVU2026A,2026
28400,Cltx calcaneal fx w/o mnpj,CPT,RVU2026A,2026
28405,Cltx calcaneal fx w/mnpj,CPT,RVU2026A,2026
28406,Prq skel fix clcnl fx w/mnpj,CPT,RVU2026A,2026
28415,Optx calcaneal fracture,CPT,RVU2026A,2026
28420,Optx calcaneal fx w/bone grf,CPT,RVU2026A,2026
28430,Cltx talus fracture w/o mnpj,CPT,RVU2026A,2026
28435,Cltx talus fracture w/mnpj,CPT,RVU2026A,2026
28436,Prq skel fix talus fx w/mnpj,CPT,RVU2026A,2026
28445,Optx talus fracture,CPT,RVU2026A,2026
28446,Opn osteochondrl agrft talus,CPT,RVU2026A,2026
28450,Tx tarsal b1 fx w/o mnpj ea,CPT,RVU2026A,2026
28455,Tx tarsal b1 fx w/mnpj each,CPT,RVU2026A,2026
28456,Prq skel fix tarsl fx w/mnpj,CPT,RVU2026A,2026
28465,Optx tarsal bone fx each,CPT,RVU2026A,2026
28470,Cltx metatarsal fx wo mnp ea,CPT,RVU2026A,2026
28475,Cltx metatarsal fx w/mnpj ea,CPT,RVU2026A,2026
28476,Prq skel fix metar fx w/mnpj,CPT,RVU2026A,2026
28485,Optx metatarsal fx each,CPT,RVU2026A,2026
28490,Treat big toe fracture,CPT,RVU2026A,2026
28495,Treat big toe fracture,CPT,RVU2026A,2026
28496,Treat big toe fracture,CPT,RVU2026A,2026
28505,Treat big toe fracture,CPT,RVU2026A,2026
28510,Treatment of toe fracture,CPT,RVU2026A,2026
28515,Treatment of toe fracture,CPT,RVU2026A,2026
28525,Treat toe fracture,CPT,RVU2026A,2026
28530,Treat sesamoid bone fracture,CPT,RVU2026A,2026
28531,Treat sesamoid bone fracture,CPT,RVU2026A,2026
28540,Treat foot dislocation,CPT,RVU2026A,2026
28545,Treat foot dislocation,CPT,RVU2026A,2026
28546,Treat foot dislocation,CPT,RVU2026A,2026
28555,Repair foot dislocation,CPT,RVU2026A,2026
28570,Treat foot dislocation,CPT,RVU2026A,2026
28575,Treat foot dislocation,CPT,RVU2026A,2026
28576,Treat foot dislocation,CPT,RVU2026A,2026
28585,Repair foot dislocation,CPT,RVU2026A,2026
28600,Treat foot dislocation,CPT,RVU2026A,2026
28605,Treat foot dislocation,CPT,RVU2026A,2026
28606,Treat foot dislocation,CPT,RVU2026A,2026
28615,Repair foot dislocation,CPT,RVU2026A,2026
28630,Treat toe dislocation,CPT,RVU2026A,2026
28635,Treat toe dislocation,CPT,RVU2026A,2026
28636,Treat toe dislocation,CPT,RVU2026A,2026
28645,Repair toe dislocation,CPT,RVU2026A,2026
28660,Treat toe dislocation,CPT,RVU2026A,2026
28665,Treat toe dislocation,CPT,RVU2026A,2026
28666,Treat toe dislocation,CPT,RVU2026A,2026
28675,Repair of toe dislocation,CPT,RVU2026A,2026
28705,Arthrodesis pantalar,CPT,RVU2026A,2026
28715,Arthrodesis triple,CPT,RVU2026A,2026
28725,Arthrodesis subtalar,CPT,RVU2026A,2026
28730,Fusion of foot bones,CPT,RVU2026A,2026
28735,Fusion of foot bones,CPT,RVU2026A,2026
28737,Revision of foot bones,CPT,RVU2026A,2026
28740,Fusion of foot bones,CPT,RVU2026A,2026
28750,Fusion of big toe joint,CPT,RVU2026A,2026
28755,Fusion of big toe joint,CPT,RVU2026A,2026
28760,Fusion of big toe joint,CPT,RVU2026A,2026
28800,Amputation of midfoot,CPT,RVU2026A,2026
28805,Amputation thru metatarsal,CPT,RVU2026A,2026
28810,Amputation toe & metatarsal,CPT,RVU2026A,2026
28820,Amputation of toe,CPT,RVU2026A,2026
28825,Partial amputation of toe,CPT,RVU2026A,2026
28890,Hi enrgy eswt plantar fascia,CPT,RVU2026A,2026
28899,Unlisted px foot/toes,CPT,RVU2026A,2026
29000,Appl halo type body cast,CPT,RVU2026A,2026
29010,Appl risser jacket body only,CPT,RVU2026A,2026
29015,Appl rissr jacket bdy w/head,CPT,RVU2026A,2026
29035,Appl body cast sho to hips,CPT,RVU2026A,2026
29040,Appl bdy cst sho to hip head,CPT,RVU2026A,2026
29044,Appl bdy cst sho to hip 1thi,CPT,RVU2026A,2026
29046,Appl bdy cst sho to hip b th,CPT,RVU2026A,2026
29049,Appl cast figure-of-eight,CPT,RVU2026A,2026
29055,Appl cast shoulder spica,CPT,RVU2026A,2026
29058,Appl cast plaster velpeau,CPT,RVU2026A,2026
29065,Appl cst sho to hand lng arm,CPT,RVU2026A,2026
29075,Appl cst elbw fngr short arm,CPT,RVU2026A,2026
29085,Appl cast hand&lwr forearm,CPT,RVU2026A,2026
29086,Application cast finger,CPT,RVU2026A,2026
29105,Application long arm splint,CPT,RVU2026A,2026
29125,Appl short arm splint static,CPT,RVU2026A,2026
29126,Appl short arm splint dyn,CPT,RVU2026A,2026
29130,Appl finger splint static,CPT,RVU2026A,2026
29131,Appl finger splint dynamic,CPT,RVU2026A,2026
29200,Strapping thorax,CPT,RVU2026A,2026
29240,Strapping of shoulder,CPT,RVU2026A,2026
29260,Strapping of elbow or wrist,CPT,RVU2026A,2026
29280,Strapping of hand or finger,CPT,RVU2026A,2026
29305,Appl hip spica cast 1 leg,CPT,RVU2026A,2026
29325,Appl hip spica cast1&1/2,CPT,RVU2026A,2026
29345,Application of long leg cast,CPT,RVU2026A,2026
29355,Appl long leg cast walker,CPT,RVU2026A,2026
29358,Appl long leg cast brace,CPT,RVU2026A,2026
29365,Appl cylinder cast,CPT,RVU2026A,2026
29405,Appl short leg cast,CPT,RVU2026A,2026
29425,Appl short leg cast walking,CPT,RVU2026A,2026
29435,Appl patllr tdn bearing cast,CPT,RVU2026A,2026
29440,Adding walker to prev cast,CPT,RVU2026A,2026
29445,Appl rigid tot cntc leg cast,CPT,RVU2026A,2026
29450,Application clubfoot cast,CPT,RVU2026A,2026
29505,Application long leg splint,CPT,RVU2026A,2026
29515,Application short leg splint,CPT,RVU2026A,2026
29520,Strapping of hip,CPT,RVU2026A,2026
29530,Strapping of knee,CPT,RVU2026A,2026
29540,Strapping ankle &/foot,CPT,RVU2026A,2026
29550,Strapping of toes,CPT,RVU2026A,2026
29580,Strapping unna boot,CPT,RVU2026A,2026
29581,Appl multlayer cmprn sys leg,CPT,RVU2026A,2026
29584,Appl mltlay cmprn sys up arm,CPT,RVU2026A,2026
29700,Rmvl/bivlv gauntlet boot/cst,CPT,RVU2026A,2026
29705,Rmvl/bivlv full arm/leg cast,CPT,RVU2026A,2026
29710,Rmvl/bivlv sho/hip spica,CPT,RVU2026A,2026
29720,Repair spica body cst/jacket,CPT,RVU2026A,2026
29730,Windowing of cast,CPT,RVU2026A,2026
29740,Wedging of cast,CPT,RVU2026A,2026
29750,Wedging of clubfoot cast,CPT,RVU2026A,2026
29799,Unlisted px casting/strpg,CPT,RVU2026A,2026
29800,Jaw arthroscopy/surgery,CPT,RVU2026A,2026
29804,Jaw arthroscopy/surgery,CPT,RVU2026A,2026
29805,Sho arthrs dx +- synovial bx,CPT,RVU2026A,2026
29806,Sho arthrs srg capsulorraphy,CPT,RVU2026A,2026
29807,Sho arthrs srg rpr slap les,CPT,RVU2026A,2026
29819,Sho arthrs srg rmvl loose/fb,CPT,RVU2026A,2026
29820,Sho arthrs srg prtl synvct,CPT,RVU2026A,2026
29821,Sho arthrs srg compl synvct,CPT,RVU2026A,2026
29822,Sho arthrs srg lmtd dbrdmt,CPT,RVU2026A,2026
29823,Sho arthrs srg xtnsv dbrdmt,CPT,RVU2026A,2026
29824,Sho arthrs srg dstl claviclc,CPT,RVU2026A,2026
29825,Sho arthrs srg lss&rescj ads,CPT,RVU2026A,2026
29826,Sho arthrs srg decompression,CPT,RVU2026A,2026
29827,Sho arthrs srg rt8tr cuf rpr,CPT,RVU2026A,2026
29828,Sho arthrs srg bicp tenodsis,CPT,RVU2026A,2026
29830,Elbow arthroscopy,CPT,RVU2026A,2026
29834,Elbow arthroscopy/surgery,CPT,RVU2026A,2026
29835,Elbow arthroscopy/surgery,CPT,RVU2026A,2026
29836,Elbow arthroscopy/surgery,CPT,RVU2026A,2026
29837,Elbow arthroscopy/surgery,CPT,RVU2026A,2026
29838,Elbow arthroscopy/surgery,CPT,RVU2026A,2026
29840,Wrist arthroscopy,CPT,RVU2026A,2026
29843,Wrist arthroscopy/surgery,CPT,RVU2026A,2026
29844,Wrist arthroscopy/surgery,CPT,RVU2026A,2026
29845,Wrist arthroscopy/surgery,CPT,RVU2026A,2026
29846,Wrist arthroscopy/surgery,CPT,RVU2026A,2026
29847,Wrist arthroscopy/surgery,CPT,RVU2026A,2026
29848,Wrist endoscopy/surgery,CPT,RVU2026A,2026
29850,Knee arthroscopy/surgery,CPT,RVU2026A,2026
29851,Knee arthroscopy/surgery,CPT,RVU2026A,2026
29855,Tibial arthroscopy/surgery,CPT,RVU2026A,2026
29856,Tibial arthroscopy/surgery,CPT,RVU2026A,2026
29860,Hip arthroscopy dx,CPT,RVU2026A,2026
29861,Hip arthro w/fb removal,CPT,RVU2026A,2026
29862,Hip arthr0 w/debridement,CPT,RVU2026A,2026
29863,Hip arthr0 w/synovectomy,CPT,RVU2026A,2026
29866,Autgrft implnt knee w/scope,CPT,RVU2026A,2026
29867,Allgrft implnt knee w/scope,CPT,RVU2026A,2026
29868,Meniscal trnspl knee w/scpe,CPT,RVU2026A,2026
29870,Arthrs knee dx w/wo syn bx,CPT,RVU2026A,2026
29871,Arthrs knee surg for infctj,CPT,RVU2026A,2026
29873,Arthrs knee surg w/lat rls,CPT,RVU2026A,2026
29874,Arthrs knee surg rmv loos/fb,CPT,RVU2026A,2026
29875,Arthrs knee surg synvct lmtd,CPT,RVU2026A,2026
29876,Arthrs knee surg synvct maj,CPT,RVU2026A,2026
29877,Arthrs knee surg dbrdmt/shvg,CPT,RVU2026A,2026
29879,Arthrs kne srg abrasj arthrp,CPT,RVU2026A,2026
29880,Arthrs kne srg mnisectmy m&l,CPT,RVU2026A,2026
29881,Arthrs kne srg mnisectmy m/l,CPT,RVU2026A,2026
29882,Arthrs kne srg mnisc rpr m/l,CPT,RVU2026A,2026
29883,Arthrs kne srg mnisc rpr m&l,CPT,RVU2026A,2026
29884,Arthrs knee surg lysis ads,CPT,RVU2026A,2026
29885,Arthrs kne srg drlg ost diss,CPT,RVU2026A,2026
29886,Arthrs knee surg drlg od les,CPT,RVU2026A,2026
29887,Arthrs knee srg drlg od fixj,CPT,RVU2026A,2026
29888,Arthrs aid acl rpr/agmntj,CPT,RVU2026A,2026
29889,Arthrs aid pcl rpr/agmntj,CPT,RVU2026A,2026
29891,Arthr ank ostchn df tal&/tib,CPT,RVU2026A,2026
29892,Arthrs aid rpr od les/tib fx,CPT,RVU2026A,2026
29893,Endoscopic plantr fasciotomy,CPT,RVU2026A,2026
29894,Ankle arthroscopy/surgery,CPT,RVU2026A,2026
29895,Ankle arthroscopy/surgery,CPT,RVU2026A,2026
29897,Ankle arthroscopy/surgery,CPT,RVU2026A,2026
29898,Ankle arthroscopy/surgery,CPT,RVU2026A,2026
29899,Ankle arthroscopy/surgery,CPT,RVU2026A,2026
29900,Mcp joint arthroscopy dx,CPT,RVU2026A,2026
29901,Mcp joint arthroscopy surg,CPT,RVU2026A,2026
29902,Mcp joint arthroscopy surg,CPT,RVU2026A,2026
29904,Subtalar arthro w/fb rmvl,CPT,RVU2026A,2026
29905,Subtalar arthro w/exc,CPT,RVU2026A,2026
29906,Subtalar arthro w/deb,CPT,RVU2026A,2026
29907,Subtalar arthro w/fusion,CPT,RVU2026A,2026
29914,Hip arthro w/femoroplasty,CPT,RVU2026A,2026
29915,Hip arthro acetabuloplasty,CPT,RVU2026A,2026
29916,Hip arthro w/labral repair,CPT,RVU2026A,2026
29999,Unlisted px arthroscopy,CPT,RVU2026A,2026
30000,Drainage of nose lesion,CPT,RVU2026A,2026
30020,Drainage of nose lesion,CPT,RVU2026A,2026
3006F,Cxr doc rev,Other,RVU2026A,2026
3008F,Body mass index docd,Other,RVU2026A,2026
30100,Intranasal biopsy,CPT,RVU2026A,2026
30110,Removal of nose polyp(s),CPT,RVU2026A,2026
30115,Removal of nose polyp(s),CPT,RVU2026A,2026
30117,Removal of intranasal lesion,CPT,RVU2026A,2026
30118,Removal of intranasal lesion,CPT,RVU2026A,2026
3011F,Lipid panel doc rev,Other,RVU2026A,2026
30120,Revision of nose,CPT,RVU2026A,2026
30124,Removal of nose lesion,CPT,RVU2026A,2026
30125,Removal of nose lesion,CPT,RVU2026A,2026
30130,Excise inferior turbinate,CPT,RVU2026A,2026
30140,Resect inferior turbinate,CPT,RVU2026A,2026
3014F,Screen mammo doc rev,Other,RVU2026A,2026
30150,Rhinectomy partial,CPT,RVU2026A,2026
3015F,Cerv cancer screen docd,Other,RVU2026A,2026
30160,Rhinectomy total,CPT,RVU2026A,2026
3016F,Pt scrnd unhlthy oh use,Other,RVU2026A,2026
3017F,Colorectal ca screen doc rev,Other,RVU2026A,2026
3018F,Pre-prxd rsk et al docd,Other,RVU2026A,2026
3019F,Lvef assess planpost dschrge,Other,RVU2026A,2026
30200,Injection treatment of nose,CPT,RVU2026A,2026
3020F,Lvf assess,Other,RVU2026A,2026
30210,Nasal sinus therapy,CPT,RVU2026A,2026
3021F,Lvef mod/sever deprs syst,Other,RVU2026A,2026
30220,Insert nasal septal button,CPT,RVU2026A,2026
3022F,Lvef >=40% systolic,Other,RVU2026A,2026
3023F,Spirom doc rev,Other,RVU2026A,2026
3025F,Spirom fev/fvc <70% w/copd,Other,RVU2026A,2026
3027F,Spirom fev/fvc>=70%/w/ocopd,Other,RVU2026A,2026
3028F,O2 saturation doc rev,Other,RVU2026A,2026
30300,Remove nasal foreign body,CPT,RVU2026A,2026
30310,Remove nasal foreign body,CPT,RVU2026A,2026
30320,Remove nasal foreign body,CPT,RVU2026A,2026
3035F,O2 saturation<=88%/pao<=55,Other,RVU2026A,2026
3037F,O2 saturation >88%/pao>55 hg,Other,RVU2026A,2026
3038F,Pulm fx w/in 12 mon b/4 surg,Other,RVU2026A,2026
30400,Reconstruction of nose,CPT,RVU2026A,2026
3040F,Fev <40% predicted value,Other,RVU2026A,2026
30410,Reconstruction of nose,CPT,RVU2026A,2026
30420,Reconstruction of nose,CPT,RVU2026A,2026
3042F,Fev >=40% predicted value,Other,RVU2026A,2026
30430,Revision of nose,CPT,RVU2026A,2026
30435,Revision of nose,CPT,RVU2026A,2026
3044F,Hg a1c level lt 7.0%,Other,RVU2026A,2026
30450,Revision of nose,CPT,RVU2026A,2026
30460,Revision of nose,CPT,RVU2026A,2026
30462,Revision of nose,CPT,RVU2026A,2026
30465,Repair nasal stenosis,CPT,RVU2026A,2026
30468,Rpr nsl vlv collapse w/implt,CPT,RVU2026A,2026
30469,Rpr nsl vlv collapse w/rmdlg,CPT,RVU2026A,2026
3046F,Hemoglobin a1c level >9.0%,Other,RVU2026A,2026
3048F,Ldl-c <100 mg/dl,Other,RVU2026A,2026
3049F,Ldl-c 100-129 mg/dl,Other,RVU2026A,2026
3050F,Ldl-c >= 130 mg/dl,Other,RVU2026A,2026
3051F,Hg a1c>equal 7.0%<8.0%,Other,RVU2026A,2026
30520,Repair of nasal septum,CPT,RVU2026A,2026
3052F,Hg a1c>equal 8.0%<equal 9.0%,Other,RVU2026A,2026
30540,Rpr choanal atresia ntranasl,CPT,RVU2026A,2026
30545,Rpr choanal atresia trsnpltn,CPT,RVU2026A,2026
3055F,Lvef less than/equal to 35%,Other,RVU2026A,2026
30560,Lysis intranasal synechia,CPT,RVU2026A,2026
3056F,Lvef greater than 35%,Other,RVU2026A,2026
30580,Repair upper jaw fistula,CPT,RVU2026A,2026
30600,Repair mouth/nose fistula,CPT,RVU2026A,2026
3060F,Pos microalbuminuria rev,Other,RVU2026A,2026
3061F,Neg microalbuminuria rev,Other,RVU2026A,2026
30620,Intranasal reconstruction,CPT,RVU2026A,2026
3062F,Pos macroalbuminuria rev,Other,RVU2026A,2026
30630,Repair nasal septum defect,CPT,RVU2026A,2026
3066F,Nephropathy doc tx,Other,RVU2026A,2026
3072F,Low risk for retinopathy,Other,RVU2026A,2026
3073F,Pre-surg eye measures docd,Other,RVU2026A,2026
3074F,Syst bp lt 130 mm hg,Other,RVU2026A,2026
3075F,Syst bp ge 130 - 139mm hg,Other,RVU2026A,2026
3077F,Syst bp >= 140 mm hg,Other,RVU2026A,2026
3078F,Diast bp <80 mm hg,Other,RVU2026A,2026
3079F,Diast bp 80-89 mm hg,Other,RVU2026A,2026
30801,Ablate inf turbinate superf,CPT,RVU2026A,2026
30802,Ablate inf turbinate submuc,CPT,RVU2026A,2026
3080F,Diast bp >= 90 mm hg,Other,RVU2026A,2026
3082F,Kt/v <1.2,Other,RVU2026A,2026
3083F,Kt/v =/> 1.2 & <1.7,Other,RVU2026A,2026
3084F,Kt/v >= 1.7,Other,RVU2026A,2026
3085F,Suicide risk assessed,Other,RVU2026A,2026
3088F,Mdd mild,Other,RVU2026A,2026
3089F,Mdd moderate,Other,RVU2026A,2026
30901,Control of nosebleed,CPT,RVU2026A,2026
30903,Control of nosebleed,CPT,RVU2026A,2026
30905,Control of nosebleed,CPT,RVU2026A,2026
30906,Repeat control of nosebleed,CPT,RVU2026A,2026
3090F,Mdd severe w/o psych,Other,RVU2026A,2026
30915,Ligation nasal sinus artery,CPT,RVU2026A,2026
3091F,Mdd severe w/psych,Other,RVU2026A,2026
30920,Ligation upper jaw artery,CPT,RVU2026A,2026
3092F,Mdd in remission,Other,RVU2026A,2026
30930,Ther fx nasal inf turbinate,CPT,RVU2026A,2026
3093F,Doc new diag 1st/addl mdd,Other,RVU2026A,2026
3095F,Central dexa results docd,Other,RVU2026A,2026
3096F,Central dexa ordered,Other,RVU2026A,2026
30999,Unlisted procedure nose,CPT,RVU2026A,2026
31000,Irrigation maxillary sinus,CPT,RVU2026A,2026
31002,Irrigation sphenoid sinus,CPT,RVU2026A,2026
3100F,Image test ref carot diam,Other,RVU2026A,2026
31020,Exploration maxillary sinus,CPT,RVU2026A,2026
31030,Exploration maxillary sinus,CPT,RVU2026A,2026
31032,Explore sinus remove polyps,CPT,RVU2026A,2026
31040,Exploration behind upper jaw,CPT,RVU2026A,2026
31050,Exploration sphenoid sinus,CPT,RVU2026A,2026
31051,Sphenoid sinus surgery,CPT,RVU2026A,2026
31070,Exploration of frontal sinus,CPT,RVU2026A,2026
31075,Exploration of frontal sinus,CPT,RVU2026A,2026
31080,Removal of frontal sinus,CPT,RVU2026A,2026
31081,Removal of frontal sinus,CPT,RVU2026A,2026
31084,Removal of frontal sinus,CPT,RVU2026A,2026
31085,Removal of frontal sinus,CPT,RVU2026A,2026
31086,Removal of frontal sinus,CPT,RVU2026A,2026
31087,Removal of frontal sinus,CPT,RVU2026A,2026
31090,Exploration of sinuses,CPT,RVU2026A,2026
3110F,Pres/absn hmrhg/lesion docd,Other,RVU2026A,2026
3111F,Ct/mri brain done w/in 24hrs,Other,RVU2026A,2026
3112F,Ct/mri brain done 24 hrs,Other,RVU2026A,2026
3115F,Quant results activity &symp,Other,RVU2026A,2026
3117F,Hf assessment tool completed,Other,RVU2026A,2026
3118F,Ny heart assoc class docd,Other,RVU2026A,2026
3119F,No eval activity clin symp,Other,RVU2026A,2026
31200,Removal of ethmoid sinus,CPT,RVU2026A,2026
31201,Removal of ethmoid sinus,CPT,RVU2026A,2026
31205,Removal of ethmoid sinus,CPT,RVU2026A,2026
3120F,12-lead ecg performed,Other,RVU2026A,2026
31225,Removal of upper jaw,CPT,RVU2026A,2026
31230,Removal of upper jaw,CPT,RVU2026A,2026
31231,Nasal endoscopy dx,CPT,RVU2026A,2026
31233,Nsl/sins ndsc dx max sinusc,CPT,RVU2026A,2026
31235,Nsl/sins ndsc dx sphn sinusc,CPT,RVU2026A,2026
31237,Nsl/sins ndsc surg bx polypc,CPT,RVU2026A,2026
31238,Nsl/sins ndsc srg nsl hemrrg,CPT,RVU2026A,2026
31239,Nsl/sinus endoscopy surg dcr,CPT,RVU2026A,2026
31240,Nsl/sns ndsc cnch bull rescj,CPT,RVU2026A,2026
31241,Nsl/sns ndsc lig sphnptn art,CPT,RVU2026A,2026
31242,Nsl/sinus ndsc rf abltj pnn,CPT,RVU2026A,2026
31243,Nsl/sinus ndsc cryoabltj pnn,CPT,RVU2026A,2026
31253,Nsl/sins ndsc total,CPT,RVU2026A,2026
31254,Nsl/sins ndsc w/prtl ethmdct,CPT,RVU2026A,2026
31255,Nsl/sins ndsc w/tot ethmdct,CPT,RVU2026A,2026
31256,Exploration maxillary sinus,CPT,RVU2026A,2026
31257,Nsl/sins ndsc tot w/sphendt,CPT,RVU2026A,2026
31259,Nsl/sins ndsc sphn tiss rmvl,CPT,RVU2026A,2026
31267,Endoscopy maxillary sinus,CPT,RVU2026A,2026
3126F,Esoph bx rprt w/dyspl info,Other,RVU2026A,2026
31276,Nsl/sins ndsc frnt tiss rmvl,CPT,RVU2026A,2026
31287,Nasal/sinus endoscopy surg,CPT,RVU2026A,2026
31288,Nasal/sinus endoscopy surg,CPT,RVU2026A,2026
31290,Nasal/sinus endoscopy surg,CPT,RVU2026A,2026
31291,Nasal/sinus endoscopy surg,CPT,RVU2026A,2026
31292,Nsl/sins ndsc med/inf dcmprn,CPT,RVU2026A,2026
31293,Nsl/sins ndsc med&inf dcmprn,CPT,RVU2026A,2026
31294,Nsl/sins ndsc surg on dcmprn,CPT,RVU2026A,2026
31295,Nsl/sins ndsc surg max sins,CPT,RVU2026A,2026
31296,Nsl/sins ndsc surg frnt sins,CPT,RVU2026A,2026
31297,Nsl/sins ndsc surg sphn sins,CPT,RVU2026A,2026
31298,Nsl/sins ndsc surg frnt&sphn,CPT,RVU2026A,2026
31299,Unlisted px accessory sinus,CPT,RVU2026A,2026
31300,Removal of larynx lesion,CPT,RVU2026A,2026
3130F,Upper gi endoscopy performed,Other,RVU2026A,2026
3132F,Doc ref upper gi endoscopy,Other,RVU2026A,2026
31360,Removal of larynx,CPT,RVU2026A,2026
31365,Removal of larynx,CPT,RVU2026A,2026
31367,Partial removal of larynx,CPT,RVU2026A,2026
31368,Partial removal of larynx,CPT,RVU2026A,2026
31370,Partial removal of larynx,CPT,RVU2026A,2026
31375,Partial removal of larynx,CPT,RVU2026A,2026
31380,Partial removal of larynx,CPT,RVU2026A,2026
31382,Partial removal of larynx,CPT,RVU2026A,2026
31390,Removal of larynx & pharynx,CPT,RVU2026A,2026
31395,Reconstruct larynx & pharynx,CPT,RVU2026A,2026
31400,Revision of larynx,CPT,RVU2026A,2026
3140F,Upper gi endo shows barrtts,Other,RVU2026A,2026
3141F,Upper gi endo not barrtts,Other,RVU2026A,2026
31420,Epiglottidectomy,CPT,RVU2026A,2026
3142F,Barium swallow test ordered,Other,RVU2026A,2026
31500,Insert emergency airway,CPT,RVU2026A,2026
31502,Change of windpipe airway,CPT,RVU2026A,2026
31505,Diagnostic laryngoscopy,CPT,RVU2026A,2026
3150F,Forceps esoph biopsy done,Other,RVU2026A,2026
31510,Laryngoscopy with biopsy,CPT,RVU2026A,2026
31511,Remove foreign body larynx,CPT,RVU2026A,2026
31512,Removal of larynx lesion,CPT,RVU2026A,2026
31513,Injection into vocal cord,CPT,RVU2026A,2026
31515,Laryngoscopy for aspiration,CPT,RVU2026A,2026
31520,Dx laryngoscopy newborn,CPT,RVU2026A,2026
31525,Dx laryngoscopy excl nb,CPT,RVU2026A,2026
31526,Dx laryngoscopy w/oper scope,CPT,RVU2026A,2026
31527,Laryngoscopy for treatment,CPT,RVU2026A,2026
31528,Laryngoscopy and dilation,CPT,RVU2026A,2026
31529,Laryngoscopy and dilation,CPT,RVU2026A,2026
31530,Laryngoscopy w/fb removal,CPT,RVU2026A,2026
31531,Laryngoscopy w/fb & op scope,CPT,RVU2026A,2026
31535,Laryngoscopy w/biopsy,CPT,RVU2026A,2026
31536,Laryngoscopy w/bx & op scope,CPT,RVU2026A,2026
31540,Laryngoscopy w/exc of tumor,CPT,RVU2026A,2026
31541,Larynscop w/tumr exc + scope,CPT,RVU2026A,2026
31545,Remove vc lesion w/scope,CPT,RVU2026A,2026
31546,Remove vc lesion scope/graft,CPT,RVU2026A,2026
31551,Laryngoplasty laryngeal sten,CPT,RVU2026A,2026
31552,Laryngoplasty laryngeal sten,CPT,RVU2026A,2026
31553,Laryngoplasty laryngeal sten,CPT,RVU2026A,2026
31554,Laryngoplasty laryngeal sten,CPT,RVU2026A,2026
3155F,Cytogen test marrow b/4 tx,Other,RVU2026A,2026
31560,Laryngoscop w/arytenoidectom,CPT,RVU2026A,2026
31561,Larynscop remve cart + scop,CPT,RVU2026A,2026
31570,Laryngoscope w/vc inj,CPT,RVU2026A,2026
31571,Laryngoscop w/vc inj + scope,CPT,RVU2026A,2026
31572,Largsc w/laser dstrj les,CPT,RVU2026A,2026
31573,Largsc w/ther injection,CPT,RVU2026A,2026
31574,Largsc w/njx augmentation,CPT,RVU2026A,2026
31575,Diagnostic laryngoscopy,CPT,RVU2026A,2026
31576,Laryngoscopy with biopsy,CPT,RVU2026A,2026
31577,Largsc w/rmvl foreign bdy(s),CPT,RVU2026A,2026
31578,Largsc w/removal lesion,CPT,RVU2026A,2026
31579,Laryngoscopy telescopic,CPT,RVU2026A,2026
31580,Laryngoplasty laryngeal web,CPT,RVU2026A,2026
31584,Laryngoplasty fx rdctj fixj,CPT,RVU2026A,2026
31587,Laryngoplasty cricoid split,CPT,RVU2026A,2026
31590,Reinnervate larynx,CPT,RVU2026A,2026
31591,Laryngoplasty medialization,CPT,RVU2026A,2026
31592,Cricotracheal resection,CPT,RVU2026A,2026
31599,Unlisted procedure larynx,CPT,RVU2026A,2026
31600,Planned tracheostomy,CPT,RVU2026A,2026
31601,Planned tracheostomy<2 yrs,CPT,RVU2026A,2026
31603,Emer tracheostomy ttrach,CPT,RVU2026A,2026
31605,Emer tracheostomy cthyr mem,CPT,RVU2026A,2026
3160F,Doc fe+ stores b/4 epo thx,Other,RVU2026A,2026
31610,Tracheostomy fenest skin flp,CPT,RVU2026A,2026
31611,Constj trachesophgl fstl,CPT,RVU2026A,2026
31612,Perq trchl pnxr ttrach aspir,CPT,RVU2026A,2026
31613,Tracheostoma revj simple,CPT,RVU2026A,2026
31614,Tracheostoma revj complex,CPT,RVU2026A,2026
31615,Trcheobrnchsc est trachs inc,CPT,RVU2026A,2026
31622,Dx bronchoscope/wash,CPT,RVU2026A,2026
31623,Dx bronchoscope/brush,CPT,RVU2026A,2026
31624,Dx bronchoscope/lavage,CPT,RVU2026A,2026
31625,Bronchoscopy w/biopsy(s),CPT,RVU2026A,2026
31626,Bronchoscopy w/markers,CPT,RVU2026A,2026
31627,Navigational bronchoscopy,CPT,RVU2026A,2026
31628,Bronchoscopy/lung bx each,CPT,RVU2026A,2026
31629,Bronchoscopy/needle bx each,CPT,RVU2026A,2026
31630,Bronchoscopy dilate/fx repr,CPT,RVU2026A,2026
31631,Bronchoscopy dilate w/stent,CPT,RVU2026A,2026
31632,Bronchoscopy/lung bx addl,CPT,RVU2026A,2026
31633,Bronchoscopy/needle bx addl,CPT,RVU2026A,2026
31634,Bronch w/balloon occlusion,CPT,RVU2026A,2026
31635,Bronchoscopy w/fb removal,CPT,RVU2026A,2026
31636,Bronchoscopy bronch stents,CPT,RVU2026A,2026
31637,Bronchoscopy stent add-on,CPT,RVU2026A,2026
31638,Bronchoscopy revise stent,CPT,RVU2026A,2026
31640,Bronchoscopy w/tumor excise,CPT,RVU2026A,2026
31641,Bronchoscopy treat blockage,CPT,RVU2026A,2026
31643,Diag bronchoscope/catheter,CPT,RVU2026A,2026
31645,Brnchsc w/ther aspir 1st,CPT,RVU2026A,2026
31646,Brnchsc w/ther aspir sbsq,CPT,RVU2026A,2026
31647,Bronchial valve init insert,CPT,RVU2026A,2026
31648,Bronchial valve remov init,CPT,RVU2026A,2026
31649,Bronchial valve remov addl,CPT,RVU2026A,2026
31651,Bronchial valve addl insert,CPT,RVU2026A,2026
31652,Bronch ebus samplng 1/2 node,CPT,RVU2026A,2026
31653,Bronch ebus samplng 3/> node,CPT,RVU2026A,2026
31654,Bronch ebus ivntj perph les,CPT,RVU2026A,2026
31660,Bronch thermoplsty 1 lobe,CPT,RVU2026A,2026
31661,Bronch thermoplsty 2/> lobes,CPT,RVU2026A,2026
3170F,Baselin flo cytometry b/4 tx,Other,RVU2026A,2026
31717,Bronchial brush biopsy,CPT,RVU2026A,2026
31720,Clearance of airways,CPT,RVU2026A,2026
31725,Clearance of airways,CPT,RVU2026A,2026
31730,Intro windpipe wire/tube,CPT,RVU2026A,2026
31750,Tracheoplasty cervical,CPT,RVU2026A,2026
31755,Trachplsty trchphryngl fstlj,CPT,RVU2026A,2026
31760,Tracheoplasty intrathoracic,CPT,RVU2026A,2026
31766,Carinal reconstruction,CPT,RVU2026A,2026
31770,Repair/graft of bronchus,CPT,RVU2026A,2026
31775,Reconstruct bronchus,CPT,RVU2026A,2026
31780,Reconstruct windpipe,CPT,RVU2026A,2026
31781,Reconstruct windpipe,CPT,RVU2026A,2026
31785,Remove windpipe lesion,CPT,RVU2026A,2026
31786,Remove windpipe lesion,CPT,RVU2026A,2026
31800,Repair of windpipe injury,CPT,RVU2026A,2026
31805,Repair of windpipe injury,CPT,RVU2026A,2026
31820,Closure of windpipe lesion,CPT,RVU2026A,2026
31825,Repair of windpipe defect,CPT,RVU2026A,2026
31830,Revise windpipe scar,CPT,RVU2026A,2026
31899,Unlisted px trachea bronchi,CPT,RVU2026A,2026
3200F,Barium swallow test not req,Other,RVU2026A,2026
32035,Thoracostomy w/rib resection,CPT,RVU2026A,2026
32036,Thoracostomy w/flap drainage,CPT,RVU2026A,2026
32096,Open wedge/bx lung infiltr,CPT,RVU2026A,2026
32097,Open wedge/bx lung nodule,CPT,RVU2026A,2026
32098,Open biopsy of lung pleura,CPT,RVU2026A,2026
32100,Exploration of chest,CPT,RVU2026A,2026
3210F,Grp a strep test performed,Other,RVU2026A,2026
32110,Explore/repair chest,CPT,RVU2026A,2026
32120,Re-exploration of chest,CPT,RVU2026A,2026
32124,Explore chest free adhesions,CPT,RVU2026A,2026
32140,Removal of lung lesion(s),CPT,RVU2026A,2026
32141,Remove/treat lung lesions,CPT,RVU2026A,2026
32150,Removal of lung lesion(s),CPT,RVU2026A,2026
32151,Remove lung foreign body,CPT,RVU2026A,2026
3215F,Pt immunity to hep a docd,Other,RVU2026A,2026
32160,Open chest heart massage,CPT,RVU2026A,2026
3216F,Pt immunity to hep b docd,Other,RVU2026A,2026
3218F,Rna tstng hep c docd done,Other,RVU2026A,2026
32200,Drain open lung lesion,CPT,RVU2026A,2026
3220F,Hep c quant rna tstng docd,Other,RVU2026A,2026
32215,Treat chest lining,CPT,RVU2026A,2026
32220,Release of lung,CPT,RVU2026A,2026
32225,Partial release of lung,CPT,RVU2026A,2026
3230F,Note hring tst w/in 6 mon,Other,RVU2026A,2026
32310,Removal of chest lining,CPT,RVU2026A,2026
32320,Free/remove chest lining,CPT,RVU2026A,2026
32400,Needle biopsy chest lining,CPT,RVU2026A,2026
32408,Core ndl bx lng/med perq,CPT,RVU2026A,2026
32440,Remove lung pneumonectomy,CPT,RVU2026A,2026
32442,Sleeve pneumonectomy,CPT,RVU2026A,2026
32445,Removal of lung extrapleural,CPT,RVU2026A,2026
32480,Partial removal of lung,CPT,RVU2026A,2026
32482,Bilobectomy,CPT,RVU2026A,2026
32484,Segmentectomy,CPT,RVU2026A,2026
32486,Sleeve lobectomy,CPT,RVU2026A,2026
32488,Completion pneumonectomy,CPT,RVU2026A,2026
32491,Lung volume reduction,CPT,RVU2026A,2026
32501,Repair bronchus add-on,CPT,RVU2026A,2026
32503,Resect apical lung tumor,CPT,RVU2026A,2026
32504,Resect apical lung tum/chest,CPT,RVU2026A,2026
32505,Wedge resect of lung initial,CPT,RVU2026A,2026
32506,Wedge resect of lung add-on,CPT,RVU2026A,2026
32507,Wedge resect of lung diag,CPT,RVU2026A,2026
3250F,Nonprim loc anat bx site tum,Other,RVU2026A,2026
32540,Removal of lung lesion,CPT,RVU2026A,2026
32550,Insert pleural cath,CPT,RVU2026A,2026
32551,Insertion of chest tube,CPT,RVU2026A,2026
32552,Remove lung catheter,CPT,RVU2026A,2026
32553,Ins mark thor for rt perq,CPT,RVU2026A,2026
32554,Aspirate pleura w/o imaging,CPT,RVU2026A,2026
32555,Aspirate pleura w/ imaging,CPT,RVU2026A,2026
32556,Insert cath pleura w/o image,CPT,RVU2026A,2026
32557,Insert cath pleura w/ image,CPT,RVU2026A,2026
32560,Treat pleurodesis w/agent,CPT,RVU2026A,2026
32561,Lyse chest fibrin init day,CPT,RVU2026A,2026
32562,Lyse chest fibrin subq day,CPT,RVU2026A,2026
32601,Thoracoscopy diagnostic,CPT,RVU2026A,2026
32604,Thoracoscopy wbx sac,CPT,RVU2026A,2026
32606,Thoracoscopy w/bx med space,CPT,RVU2026A,2026
32607,Thoracoscopy w/bx infiltrate,CPT,RVU2026A,2026
32608,Thoracoscopy w/bx nodule,CPT,RVU2026A,2026
32609,Thoracoscopy w/bx pleura,CPT,RVU2026A,2026
3260F,Pt cat/pn cat/hist grd docd,Other,RVU2026A,2026
32650,Thoracoscopy w/pleurodesis,CPT,RVU2026A,2026
32651,Thoracoscopy remove cortex,CPT,RVU2026A,2026
32652,Thoracoscopy rem totl cortex,CPT,RVU2026A,2026
32653,Thoracoscopy remov fb/fibrin,CPT,RVU2026A,2026
32654,Thoracoscopy contrl bleeding,CPT,RVU2026A,2026
32655,Thoracoscopy resect bullae,CPT,RVU2026A,2026
32656,Thoracoscopy w/pleurectomy,CPT,RVU2026A,2026
32658,Thoracoscopy w/sac fb remove,CPT,RVU2026A,2026
32659,Thoracoscopy w/sac drainage,CPT,RVU2026A,2026
3265F,Rna tstng hepc vir ord/docd,Other,RVU2026A,2026
32661,Thoracoscopy w/pericard exc,CPT,RVU2026A,2026
32662,Thoracoscopy w/mediast exc,CPT,RVU2026A,2026
32663,Thoracoscopy w/lobectomy,CPT,RVU2026A,2026
32664,Thoracoscopy w/ th nrv exc,CPT,RVU2026A,2026
32665,Thoracoscop w/esoph musc exc,CPT,RVU2026A,2026
32666,Thoracoscopy w/wedge resect,CPT,RVU2026A,2026
32667,Thoracoscopy w/w resect addl,CPT,RVU2026A,2026
32668,Thoracoscopy w/w resect diag,CPT,RVU2026A,2026
32669,Thoracoscopy remove segment,CPT,RVU2026A,2026
3266F,Hepc gn tstng docd b/4txmnt,Other,RVU2026A,2026
32670,Thoracoscopy bilobectomy,CPT,RVU2026A,2026
32671,Thoracoscopy pneumonectomy,CPT,RVU2026A,2026
32672,Thoracoscopy for lvrs,CPT,RVU2026A,2026
32673,Thoracoscopy w/thymus resect,CPT,RVU2026A,2026
32674,Thoracoscopy lymph node exc,CPT,RVU2026A,2026
3267F,Path rprt w/ pt pn cat et al,Other,RVU2026A,2026
3268F,Psa/t/glsc docd b/4 txmnt,Other,RVU2026A,2026
3269F,Bone scn b/4 txmnt/aftr dx,Other,RVU2026A,2026
32701,Thorax stereo rad targetw/tx,CPT,RVU2026A,2026
3270F,No bone scn b/4 txmnt/aftrdx,Other,RVU2026A,2026
3271F,Low risk prostate cancer,Other,RVU2026A,2026
3272F,Med risk prostate cancer,Other,RVU2026A,2026
3273F,High risk prostate cancer,Other,RVU2026A,2026
3274F,Prost cncr rsk not lw/md/hgh,Other,RVU2026A,2026
3278F,Serum lvls ca/ipth/lpd ord,Other,RVU2026A,2026
3279F,Hgb lvl >= 13 g/dl,Other,RVU2026A,2026
32800,Repair lung hernia,CPT,RVU2026A,2026
3280F,Hgb lvl 11-12.9 g/dl,Other,RVU2026A,2026
32810,Close chest after drainage,CPT,RVU2026A,2026
32815,Close bronchial fistula,CPT,RVU2026A,2026
3281F,Hgb lvl <11 g/dl,Other,RVU2026A,2026
32820,Reconstruct injured chest,CPT,RVU2026A,2026
3284F,Iop red >=15% pre-ntrv lvl,Other,RVU2026A,2026
32850,Donor pneumonectomy,CPT,RVU2026A,2026
32851,Lung transplant single,CPT,RVU2026A,2026
32852,Lung transplant with bypass,CPT,RVU2026A,2026
32853,Lung transplant double,CPT,RVU2026A,2026
32854,Lung transplant with bypass,CPT,RVU2026A,2026
32855,Prepare donor lung single,CPT,RVU2026A,2026
32856,Prepare donor lung double,CPT,RVU2026A,2026
3285F,Iop down <15% of pre-svc lvl,Other,RVU2026A,2026
3288F,Fall risk assessment docd,Other,RVU2026A,2026
32900,Removal of rib(s),CPT,RVU2026A,2026
32905,Revise & repair chest wall,CPT,RVU2026A,2026
32906,Revise & repair chest wall,CPT,RVU2026A,2026
3290F,Pt=d(rh)- and unsensitized,Other,RVU2026A,2026
3291F,Pt=d(rh)+ or sensitized,Other,RVU2026A,2026
3292F,Hiv tstng asked/docd/revwd,Other,RVU2026A,2026
3293F,Abo rh blood typing docd,Other,RVU2026A,2026
32940,Revision of lung,CPT,RVU2026A,2026
3294F,Grp b strep screening docd,Other,RVU2026A,2026
32960,Therapeutic pneumothorax,CPT,RVU2026A,2026
32994,Ablate pulm tumor perq crybl,CPT,RVU2026A,2026
32997,Total lung lavage,CPT,RVU2026A,2026
32998,Ablate pulm tumor perq rf,CPT,RVU2026A,2026
32999,Unlisted px lungs & pleura,CPT,RVU2026A,2026
3300F,Ajcc stage docd b/4 thxpy,Other,RVU2026A,2026
33016,Pericardiocentesis w/imaging,CPT,RVU2026A,2026
33017,Prcrd drg 6yr+ w/o cgen car,CPT,RVU2026A,2026
33018,Prcrd drg 0-5yr or w/anomly,CPT,RVU2026A,2026
33019,Perq prcrd drg insj cath ct,CPT,RVU2026A,2026
3301F,Cancer stage docd metast,Other,RVU2026A,2026
33020,Incision of heart sac,CPT,RVU2026A,2026
33025,Incision of heart sac,CPT,RVU2026A,2026
33030,Partial removal of heart sac,CPT,RVU2026A,2026
33031,Partial removal of heart sac,CPT,RVU2026A,2026
33050,Resect heart sac lesion,CPT,RVU2026A,2026
33120,Exc icar tum resc w/card byp,CPT,RVU2026A,2026
33130,Rescj external cardiac tumor,CPT,RVU2026A,2026
33140,Heart revascularize (tmr),CPT,RVU2026A,2026
33141,Heart tmr w/other procedure,CPT,RVU2026A,2026
3315F,Er+ or pr+ breast cancer,Other,RVU2026A,2026
3316F,Er- or pr- breast cancer,Other,RVU2026A,2026
3317F,Path rpt malig cancer docd,Other,RVU2026A,2026
3318F,Path rpt malig cancer docd,Other,RVU2026A,2026
3319F,X-ray/ct/ultrsnd et al ord,Other,RVU2026A,2026
33202,Insert epicard eltrd open,CPT,RVU2026A,2026
33203,Insert epicard eltrd endo,CPT,RVU2026A,2026
33206,Insert heart pm atrial,CPT,RVU2026A,2026
33207,Insert heart pm ventricular,CPT,RVU2026A,2026
33208,Insrt heart pm atrial & vent,CPT,RVU2026A,2026
3320F,No xray/ct/ et al ordd,Other,RVU2026A,2026
33210,Insert electrd/pm cath sngl,CPT,RVU2026A,2026
33211,Insert card electrodes dual,CPT,RVU2026A,2026
33212,Insert pulse gen sngl lead,CPT,RVU2026A,2026
33213,Insert pulse gen dual leads,CPT,RVU2026A,2026
33214,Upgrade of pacemaker system,CPT,RVU2026A,2026
33215,Reposition pacing-defib lead,CPT,RVU2026A,2026
33216,Insert 1 electrode pm-defib,CPT,RVU2026A,2026
33217,Insert 2 electrode pm-defib,CPT,RVU2026A,2026
33218,Repair lead pace-defib one,CPT,RVU2026A,2026
3321F,Ajcc cncr 0/ia melan docd,Other,RVU2026A,2026
33220,Repair lead pace-defib dual,CPT,RVU2026A,2026
33221,Insert pulse gen mult leads,CPT,RVU2026A,2026
33222,Relocation pocket pacemaker,CPT,RVU2026A,2026
33223,Relocate pocket for defib,CPT,RVU2026A,2026
33224,Insert pacing lead & connect,CPT,RVU2026A,2026
33225,L ventric pacing lead add-on,CPT,RVU2026A,2026
33226,Reposition l ventric lead,CPT,RVU2026A,2026
33227,Remove&replace pm gen singl,CPT,RVU2026A,2026
33228,Remv&replc pm gen dual lead,CPT,RVU2026A,2026
33229,Remv&replc pm gen mult leads,CPT,RVU2026A,2026
3322F,Melanomaajcc stage 0 or ia,Other,RVU2026A,2026
33230,Insrt pulse gen w/dual leads,CPT,RVU2026A,2026
33231,Insrt pulse gen w/mult leads,CPT,RVU2026A,2026
33233,Removal of pm generator,CPT,RVU2026A,2026
33234,Removal of pacemaker system,CPT,RVU2026A,2026
33235,Removal pacemaker electrode,CPT,RVU2026A,2026
33236,Remove electrode/thoracotomy,CPT,RVU2026A,2026
33237,Remove electrode/thoracotomy,CPT,RVU2026A,2026
33238,Remove electrode/thoracotomy,CPT,RVU2026A,2026
3323F,Clin node stgng docdb/4 surg,Other,RVU2026A,2026
33240,Insrt pulse gen w/singl lead,CPT,RVU2026A,2026
33241,Remove pulse generator,CPT,RVU2026A,2026
33243,Remove eltrd/thoracotomy,CPT,RVU2026A,2026
33244,Remove elctrd transvenously,CPT,RVU2026A,2026
33249,Insj/rplcmt defib w/lead(s),CPT,RVU2026A,2026
3324F,Mri ct scan ord rvwd rqstd,Other,RVU2026A,2026
33250,Ablate heart dysrhythm focus,CPT,RVU2026A,2026
33251,Ablate heart dysrhythm focus,CPT,RVU2026A,2026
33254,Ablate atria lmtd,CPT,RVU2026A,2026
33255,Ablate atria w/o bypass ext,CPT,RVU2026A,2026
33256,Ablate atria w/bypass exten,CPT,RVU2026A,2026
33257,Ablate atria lmtd add-on,CPT,RVU2026A,2026
33258,Ablate atria x10sv add-on,CPT,RVU2026A,2026
33259,Ablate atria w/bypass add-on,CPT,RVU2026A,2026
3325F,Preop asses 4 cataract surg,Other,RVU2026A,2026
33261,Ablate heart dysrhythm focus,CPT,RVU2026A,2026
33262,Rmvl& replc pulse gen 1 lead,CPT,RVU2026A,2026
33263,Rmvl & rplcmt dfb gen 2 lead,CPT,RVU2026A,2026
33264,Rmvl & rplcmt dfb gen mlt ld,CPT,RVU2026A,2026
33265,Ablate atria lmtd endo,CPT,RVU2026A,2026
33266,Ablate atria x10sv endo,CPT,RVU2026A,2026
33267,Excl laa open any method,CPT,RVU2026A,2026
33268,Excl laa opn oth px any meth,CPT,RVU2026A,2026
33269,Excl laa thrscp any method,CPT,RVU2026A,2026
33270,Ins/rep subq defibrillator,CPT,RVU2026A,2026
33271,Insj subq impltbl dfb elctrd,CPT,RVU2026A,2026
33272,Rmvl of subq defibrillator,CPT,RVU2026A,2026
33273,Repos prev impltbl subq dfb,CPT,RVU2026A,2026
33274,Tcat insj/rpl perm ldls pm,CPT,RVU2026A,2026
33275,Tcat rmvl perm ldls pm w/img,CPT,RVU2026A,2026
33276,Insj phrnc nrv stim sys,CPT,RVU2026A,2026
33277,Insj phrnc nrv stim transvns,CPT,RVU2026A,2026
33278,Rmvl phrnc nrv stim sys,CPT,RVU2026A,2026
33279,Rmvl phrnc nrv stim transvns,CPT,RVU2026A,2026
33280,Rmvl phrnc nrv stim pg only,CPT,RVU2026A,2026
33281,Reposg phrnc nrv stim trnsvn,CPT,RVU2026A,2026
33285,Insj subq car rhythm mntr,CPT,RVU2026A,2026
33286,Rmvl subq car rhythm mntr,CPT,RVU2026A,2026
33287,Rmv&rplcmt phrnc nrv stim pg,CPT,RVU2026A,2026
33288,Rmv&rplcmt phrnc nrv stim ld,CPT,RVU2026A,2026
33289,Tcat impl wrls p-art prs snr,CPT,RVU2026A,2026
3328F,Prfrmnc docd 2 wks b/4 surg,Other,RVU2026A,2026
33300,Repair of heart wound,CPT,RVU2026A,2026
33305,Repair of heart wound,CPT,RVU2026A,2026
3330F,Imaging study ordered (bkp),Other,RVU2026A,2026
33310,Exploratory heart surgery,CPT,RVU2026A,2026
33315,Exploratory heart surgery,CPT,RVU2026A,2026
3331F,Bk imaging tst not ordered,Other,RVU2026A,2026
33320,Repair major blood vessel(s),CPT,RVU2026A,2026
33321,Repair major vessel,CPT,RVU2026A,2026
33322,Repair major blood vessel(s),CPT,RVU2026A,2026
33330,Insert major vessel graft,CPT,RVU2026A,2026
33335,Insert major vessel graft,CPT,RVU2026A,2026
33340,Perq clsr tcat l atr apndge,CPT,RVU2026A,2026
33361,Replace aortic valve perq,CPT,RVU2026A,2026
33362,Replace aortic valve open,CPT,RVU2026A,2026
33363,Replace aortic valve open,CPT,RVU2026A,2026
33364,Replace aortic valve open,CPT,RVU2026A,2026
33365,Replace aortic valve open,CPT,RVU2026A,2026
33366,Trcath replace aortic valve,CPT,RVU2026A,2026
33367,Replace aortic valve w/byp,CPT,RVU2026A,2026
33368,Replace aortic valve w/byp,CPT,RVU2026A,2026
33369,Replace aortic valve w/byp,CPT,RVU2026A,2026
33370,Tcat plmt&rmvl cepd perq,CPT,RVU2026A,2026
33390,Valvuloplasty aortic valve,CPT,RVU2026A,2026
33391,Valvuloplasty aortic valve,CPT,RVU2026A,2026
33404,Prepare heart-aorta conduit,CPT,RVU2026A,2026
33405,Replacement aortic valve opn,CPT,RVU2026A,2026
33406,Replacement aortic valve opn,CPT,RVU2026A,2026
3340F,Mammo assess inc xray docd,Other,RVU2026A,2026
33410,Replacement aortic valve opn,CPT,RVU2026A,2026
33411,Replacement of aortic valve,CPT,RVU2026A,2026
33412,Replacement of aortic valve,CPT,RVU2026A,2026
33413,Replacement of aortic valve,CPT,RVU2026A,2026
33414,Repair of aortic valve,CPT,RVU2026A,2026
33415,Revision subvalvular tissue,CPT,RVU2026A,2026
33416,Revise ventricle muscle,CPT,RVU2026A,2026
33417,Repair of aortic valve,CPT,RVU2026A,2026
33418,Repair tcat mitral valve,CPT,RVU2026A,2026
33419,Repair tcat mitral valve,CPT,RVU2026A,2026
3341F,Mammo assess negative docd,Other,RVU2026A,2026
33420,Revision of mitral valve,CPT,RVU2026A,2026
33422,Revision of mitral valve,CPT,RVU2026A,2026
33425,Repair of mitral valve,CPT,RVU2026A,2026
33426,Repair of mitral valve,CPT,RVU2026A,2026
33427,Repair of mitral valve,CPT,RVU2026A,2026
3342F,Mammo assess bengn docd,Other,RVU2026A,2026
33430,Replacement of mitral valve,CPT,RVU2026A,2026
3343F,Mammo probably bengn docd,Other,RVU2026A,2026
33440,Rplcmt a-valve tlcj autol pv,CPT,RVU2026A,2026
3344F,Mammo assess susp docd,Other,RVU2026A,2026
3345F,Mammo assess hghlymalig doc,Other,RVU2026A,2026
33460,Revision of tricuspid valve,CPT,RVU2026A,2026
33463,Valvuloplasty tricuspid,CPT,RVU2026A,2026
33464,Valvuloplasty tricuspid,CPT,RVU2026A,2026
33465,Replace tricuspid valve,CPT,RVU2026A,2026
33468,Revision of tricuspid valve,CPT,RVU2026A,2026
33474,Revision of pulmonary valve,CPT,RVU2026A,2026
33475,Replacement pulmonary valve,CPT,RVU2026A,2026
33476,Revision of heart chamber,CPT,RVU2026A,2026
33477,Implant tcat pulm vlv perq,CPT,RVU2026A,2026
33478,Revision of heart chamber,CPT,RVU2026A,2026
33496,Repair prosth valve clot,CPT,RVU2026A,2026
33500,Repair heart vessel fistula,CPT,RVU2026A,2026
33501,Repair heart vessel fistula,CPT,RVU2026A,2026
33502,Coronary artery correction,CPT,RVU2026A,2026
33503,Coronary artery graft,CPT,RVU2026A,2026
33504,Coronary artery graft,CPT,RVU2026A,2026
33505,Repair artery w/tunnel,CPT,RVU2026A,2026
33506,Repair artery translocation,CPT,RVU2026A,2026
33507,Repair art intramural,CPT,RVU2026A,2026
33508,Endoscopic vein harvest,CPT,RVU2026A,2026
33509,Ndsc hrv uxtr art 1 sgm cab,CPT,RVU2026A,2026
3350F,Mammo bx proven malig docd,Other,RVU2026A,2026
33510,Cabg vein single,CPT,RVU2026A,2026
33511,Cabg vein two,CPT,RVU2026A,2026
33512,Cabg vein three,CPT,RVU2026A,2026
33513,Cabg vein four,CPT,RVU2026A,2026
33514,Cabg vein five,CPT,RVU2026A,2026
33516,Cabg vein six or more,CPT,RVU2026A,2026
33517,Cabg artery-vein single,CPT,RVU2026A,2026
33518,Cabg artery-vein two,CPT,RVU2026A,2026
33519,Cabg artery-vein three,CPT,RVU2026A,2026
3351F,Neg scrn dep symp by deptool,Other,RVU2026A,2026
33521,Cabg artery-vein four,CPT,RVU2026A,2026
33522,Cabg artery-vein five,CPT,RVU2026A,2026
33523,Cabg art-vein six or more,CPT,RVU2026A,2026
3352F,No sig dep symp by dep tool,Other,RVU2026A,2026
33530,Coronary artery bypass/reop,CPT,RVU2026A,2026
33533,Cabg arterial single,CPT,RVU2026A,2026
33534,Cabg arterial two,CPT,RVU2026A,2026
33535,Cabg arterial three,CPT,RVU2026A,2026
33536,Cabg arterial four or more,CPT,RVU2026A,2026
3353F,Mild-mod dep symp by deptool,Other,RVU2026A,2026
33542,Removal of heart lesion,CPT,RVU2026A,2026
33545,Repair of heart damage,CPT,RVU2026A,2026
33548,Restore/remodel ventricle,CPT,RVU2026A,2026
3354F,Clin sig dep sym by dep tool,Other,RVU2026A,2026
33572,Open coronary endarterectomy,CPT,RVU2026A,2026
33600,Closure of valve,CPT,RVU2026A,2026
33602,Closure of valve,CPT,RVU2026A,2026
33606,Anastomosis/artery-aorta,CPT,RVU2026A,2026
33608,Repair anomaly w/conduit,CPT,RVU2026A,2026
33610,Repair by enlargement,CPT,RVU2026A,2026
33611,Repair double ventricle,CPT,RVU2026A,2026
33612,Repair double ventricle,CPT,RVU2026A,2026
33615,Repair modified fontan,CPT,RVU2026A,2026
33617,Repair single ventricle,CPT,RVU2026A,2026
33619,Repair single ventricle,CPT,RVU2026A,2026
33620,Apply r&l pulm art bands,CPT,RVU2026A,2026
33621,Transthor cath for stent,CPT,RVU2026A,2026
33622,Redo compl cardiac anomaly,CPT,RVU2026A,2026
33641,Repair heart septum defect,CPT,RVU2026A,2026
33645,Revision of heart veins,CPT,RVU2026A,2026
33647,Repair heart septum defects,CPT,RVU2026A,2026
33660,Repair of heart defects,CPT,RVU2026A,2026
33665,Repair of heart defects,CPT,RVU2026A,2026
33670,Repair of heart chambers,CPT,RVU2026A,2026
33675,Close mult vsd,CPT,RVU2026A,2026
33676,Close mult vsd w/resection,CPT,RVU2026A,2026
33677,Cl mult vsd w/rem pul band,CPT,RVU2026A,2026
33681,Closure 1 vsd w/wo patch,CPT,RVU2026A,2026
33684,Clsr 1 vsd w/wo patch w/vlvt,CPT,RVU2026A,2026
33688,Clsr 1vsd w/wo ptch rmvl bnd,CPT,RVU2026A,2026
33690,Banding pulmonary artery,CPT,RVU2026A,2026
33692,Comp rpr tof wo pulm atresia,CPT,RVU2026A,2026
33694,Cmp rpr tof wo plm atrs ptch,CPT,RVU2026A,2026
33697,Compl rpr tof w/pulm atresia,CPT,RVU2026A,2026
33702,Repair of heart defects,CPT,RVU2026A,2026
3370F,Ajcc brst cncr stage 0 docd,Other,RVU2026A,2026
33710,Repair of heart defects,CPT,RVU2026A,2026
33720,Repair of heart defect,CPT,RVU2026A,2026
33724,Repair venous anomaly,CPT,RVU2026A,2026
33726,Repair pul venous stenosis,CPT,RVU2026A,2026
3372F,Ajcc brst cncr stage 1 docd,Other,RVU2026A,2026
33730,Repair heart-vein defect(s),CPT,RVU2026A,2026
33732,Repair heart-vein defect,CPT,RVU2026A,2026
33735,Revision of heart chamber,CPT,RVU2026A,2026
33736,Revision of heart chamber,CPT,RVU2026A,2026
33741,Tas congenital car anomal,CPT,RVU2026A,2026
33745,Tis cgen car anomal 1st shnt,CPT,RVU2026A,2026
33746,Tis cgen car anomal ea addl,CPT,RVU2026A,2026
3374F,Ajcc brst cncr stage 1 docd,Other,RVU2026A,2026
33750,Shunt subclavian to pulm art,CPT,RVU2026A,2026
33755,Shunt as-aort to pulm art,CPT,RVU2026A,2026
33762,Shunt desc aorta to pulm art,CPT,RVU2026A,2026
33764,Shunt central w/prostc graft,CPT,RVU2026A,2026
33766,Shunt supr v/c p-art 1 lung,CPT,RVU2026A,2026
33767,Shunt supr v/c p-art bth lng,CPT,RVU2026A,2026
33768,Anast cavopulm sec sup v/c,CPT,RVU2026A,2026
3376F,Ajcc brstcncr stage 2 docd,Other,RVU2026A,2026
33770,Rpr tga w/o surg enlgmnt vsd,CPT,RVU2026A,2026
33771,Rpr tga w/surg enlgmnt vsd,CPT,RVU2026A,2026
33774,Rpr tga atrial baffle px,CPT,RVU2026A,2026
33775,Rpr tga atr bfl rmvl plm bnd,CPT,RVU2026A,2026
33776,Rpr tga atr bfl clsr vsd,CPT,RVU2026A,2026
33777,Rpr tga bfl rpr sbpulm obstr,CPT,RVU2026A,2026
33778,Rpr tga aortic pulm art rcns,CPT,RVU2026A,2026
33779,Rpr tga rcnstj rmvl plm bnd,CPT,RVU2026A,2026
33780,Rpr tga rcnstj clsr vsd,CPT,RVU2026A,2026
33781,Rpr tga rcnstj rpr sbpl obst,CPT,RVU2026A,2026
33782,Nikaidoh proc,CPT,RVU2026A,2026
33783,Nikaidoh proc w/ostia implt,CPT,RVU2026A,2026
33786,Repair arterial trunk,CPT,RVU2026A,2026
33788,Revision of pulmonary artery,CPT,RVU2026A,2026
3378F,Ajcc brstcncr stage 3 docd,Other,RVU2026A,2026
33800,Aortic suspension,CPT,RVU2026A,2026
33802,Division aberrant vessel,CPT,RVU2026A,2026
33803,Div aberrant vsl w/reanast,CPT,RVU2026A,2026
3380F,Ajcc brstcncr stage 4 docd,Other,RVU2026A,2026
33814,Obltrj a-pulm sep def w/byp,CPT,RVU2026A,2026
33820,Repair pda by ligation,CPT,RVU2026A,2026
33822,Repair pda div<18 years,CPT,RVU2026A,2026
33824,Repair pda div 18 yrs&older,CPT,RVU2026A,2026
3382F,Ajcc cln cncr stage 0 docd,Other,RVU2026A,2026
33840,Exc coa w/direct anastomosis,CPT,RVU2026A,2026
33845,Excision coa w/graft,CPT,RVU2026A,2026
3384F,Ajcc cln cncr stage 1 docd,Other,RVU2026A,2026
33851,Exc coa rpr l subcl art/prst,CPT,RVU2026A,2026
33852,Rpr hypopl a-arch wo byp,CPT,RVU2026A,2026
33853,Rpr hypopl a-arch w/byp,CPT,RVU2026A,2026
33858,As-aort grf f/aortic dsj,CPT,RVU2026A,2026
33859,As-aort grf f/ds oth/thn dsj,CPT,RVU2026A,2026
33863,Ascending aortic graft,CPT,RVU2026A,2026
33864,Ascending aortic graft,CPT,RVU2026A,2026
33866,Aortic hemiarch graft,CPT,RVU2026A,2026
3386F,Ajcc cln cncr stage 2 docd,Other,RVU2026A,2026
33871,Transvrs a-arch grf hypthrm,CPT,RVU2026A,2026
33875,Thoracic aortic graft,CPT,RVU2026A,2026
33877,Thoracoabdominal graft,CPT,RVU2026A,2026
33880,Evasc rpr ta ndgft cov lsa,CPT,RVU2026A,2026
33881,Evasc rpr ta ndgft xcov lsa,CPT,RVU2026A,2026
33882,Evasc rpr ta dplmt mltpc sys,CPT,RVU2026A,2026
33883,Delayed plmt prox xtn prosth,CPT,RVU2026A,2026
33886,Delayed plmt dstl xtn prosth,CPT,RVU2026A,2026
3388F,Ajcc cln cncr stage 3 docd,Other,RVU2026A,2026
33894,Evasc st rpr thrc/aa acrs br,CPT,RVU2026A,2026
33895,Evasc st rpr thrc/aa x crsg,CPT,RVU2026A,2026
33897,Perq trluml angp nt/recr coa,CPT,RVU2026A,2026
33900,Perq p-art revsc 1 nm nt uni,CPT,RVU2026A,2026
33901,Perq p-art revsc 1 nm nt bi,CPT,RVU2026A,2026
33902,Perq p-art revsc 1 abnor uni,CPT,RVU2026A,2026
33903,Perq p-art revsc 1 abnor bi,CPT,RVU2026A,2026
33904,Perq p-art revsc each addl,CPT,RVU2026A,2026
3390F,Ajcc cln cncr stage 4 docd,Other,RVU2026A,2026
33910,Remove lung artery emboli,CPT,RVU2026A,2026
33915,Remove lung artery emboli,CPT,RVU2026A,2026
33916,Surgery of great vessel,CPT,RVU2026A,2026
33917,Repair pulmonary artery,CPT,RVU2026A,2026
33920,Repair pulmonary atresia,CPT,RVU2026A,2026
33922,Transect pulmonary artery,CPT,RVU2026A,2026
33924,Remove pulmonary shunt,CPT,RVU2026A,2026
33925,Rpr pul art unifocal w/o cpb,CPT,RVU2026A,2026
33926,Repr pul art unifocal w/cpb,CPT,RVU2026A,2026
33927,Impltj tot rplcmt hrt sys,CPT,RVU2026A,2026
33928,Rmvl & rplcmt tot hrt sys,CPT,RVU2026A,2026
33929,Rmvl rplcmt hrt sys f/trnspl,CPT,RVU2026A,2026
33930,Removal of donor heart/lung,CPT,RVU2026A,2026
33933,Prepare donor heart/lung,CPT,RVU2026A,2026
33935,Transplantation heart/lung,CPT,RVU2026A,2026
33940,Removal of donor heart,CPT,RVU2026A,2026
33944,Prepare donor heart,CPT,RVU2026A,2026
33945,Transplantation of heart,CPT,RVU2026A,2026
33946,Ecmo/ecls initiation venous,CPT,RVU2026A,2026
33947,Ecmo/ecls initiation artery,CPT,RVU2026A,2026
33948,Ecmo/ecls daily mgmt-venous,CPT,RVU2026A,2026
33949,Ecmo/ecls daily mgmt artery,CPT,RVU2026A,2026
3394F,Quant her2 ihc eval brst cx,Other,RVU2026A,2026
33951,Ecmo/ecls insj prph cannula,CPT,RVU2026A,2026
33952,Ecmo/ecls insj prph cannula,CPT,RVU2026A,2026
33953,Ecmo/ecls insj prph cannula,CPT,RVU2026A,2026
33954,Ecmo/ecls insj prph cannula,CPT,RVU2026A,2026
33955,Ecmo/ecls insj ctr cannula,CPT,RVU2026A,2026
33956,Ecmo/ecls insj ctr cannula,CPT,RVU2026A,2026
33957,Ecmo/ecls repos perph cnula,CPT,RVU2026A,2026
33958,Ecmo/ecls repos perph cnula,CPT,RVU2026A,2026
33959,Ecmo/ecls repos perph cnula,CPT,RVU2026A,2026
3395F,Quant nonher2 ihc brst cx,Other,RVU2026A,2026
33962,Ecmo/ecls repos perph cnula,CPT,RVU2026A,2026
33963,Ecmo/ecls repos perph cnula,CPT,RVU2026A,2026
33964,Ecmo/ecls repos perph cnula,CPT,RVU2026A,2026
33965,Ecmo/ecls rmvl perph cannula,CPT,RVU2026A,2026
33966,Ecmo/ecls rmvl prph cannula,CPT,RVU2026A,2026
33967,Insert i-aort percut device,CPT,RVU2026A,2026
33968,Remove aortic assist device,CPT,RVU2026A,2026
33969,Ecmo/ecls rmvl perph cannula,CPT,RVU2026A,2026
33970,Aortic circulation assist,CPT,RVU2026A,2026
33971,Aortic circulation assist,CPT,RVU2026A,2026
33973,Insert balloon device,CPT,RVU2026A,2026
33974,Remove intra-aortic balloon,CPT,RVU2026A,2026
33975,Implant ventricular device,CPT,RVU2026A,2026
33976,Implant ventricular device,CPT,RVU2026A,2026
33977,Remove ventricular device,CPT,RVU2026A,2026
33978,Remove ventricular device,CPT,RVU2026A,2026
33979,Insert intracorporeal device,CPT,RVU2026A,2026
33980,Remove intracorporeal device,CPT,RVU2026A,2026
33981,Replace vad pump ext,CPT,RVU2026A,2026
33982,Replace vad intra w/o bp,CPT,RVU2026A,2026
33983,Replace vad intra w/bp,CPT,RVU2026A,2026
33984,Ecmo/ecls rmvl prph cannula,CPT,RVU2026A,2026
33985,Ecmo/ecls rmvl ctr cannula,CPT,RVU2026A,2026
33986,Ecmo/ecls rmvl ctr cannula,CPT,RVU2026A,2026
33987,Artery expos/graft artery,CPT,RVU2026A,2026
33988,Insertion of left heart vent,CPT,RVU2026A,2026
33989,Removal of left heart vent,CPT,RVU2026A,2026
33990,Insj perq vad l hrt arterial,CPT,RVU2026A,2026
33991,Insj perq vad l hrt artl&ven,CPT,RVU2026A,2026
33992,Rmvl perq left heart vad,CPT,RVU2026A,2026
33993,Reposg perq r/l hrt vad,CPT,RVU2026A,2026
33995,Insj perq vad r hrt venous,CPT,RVU2026A,2026
33997,Rmvl perq right heart vad,CPT,RVU2026A,2026
33999,Unlisted px cardiac surgery,CPT,RVU2026A,2026
34001,Removal of artery clot,CPT,RVU2026A,2026
34051,Removal of artery clot,CPT,RVU2026A,2026
34101,Removal of artery clot,CPT,RVU2026A,2026
34111,Removal of arm artery clot,CPT,RVU2026A,2026
34151,Removal of artery clot,CPT,RVU2026A,2026
34201,Removal of artery clot,CPT,RVU2026A,2026
34203,Removal of leg artery clot,CPT,RVU2026A,2026
34401,Removal of vein clot,CPT,RVU2026A,2026
34421,Removal of vein clot,CPT,RVU2026A,2026
34451,Removal of vein clot,CPT,RVU2026A,2026
34471,Removal of vein clot,CPT,RVU2026A,2026
34490,Removal of vein clot,CPT,RVU2026A,2026
34501,Repair valve femoral vein,CPT,RVU2026A,2026
34502,Reconstruct vena cava,CPT,RVU2026A,2026
3450F,Dyspnea scrnd no-mild dysp,Other,RVU2026A,2026
34510,Transposition of vein valve,CPT,RVU2026A,2026
3451F,Dyspnea scrnd mod-high dysp,Other,RVU2026A,2026
34520,Cross-over vein graft,CPT,RVU2026A,2026
3452F,Dyspnea not screened,Other,RVU2026A,2026
34530,Leg vein fusion,CPT,RVU2026A,2026
3455F,Tb scr pfrmd&interpd 6 mo,Other,RVU2026A,2026
34701,Evasc rpr a-ao ndgft,CPT,RVU2026A,2026
34702,Evasc rpr a-ao ndgft rpt,CPT,RVU2026A,2026
34703,Evasc rpr a-unilac ndgft,CPT,RVU2026A,2026
34704,Evasc rpr a-unilac ndgft rpt,CPT,RVU2026A,2026
34705,Evac rpr a-biiliac ndgft,CPT,RVU2026A,2026
34706,Evasc rpr a-biiliac rpt,CPT,RVU2026A,2026
34707,Evasc rpr ilio-iliac ndgft,CPT,RVU2026A,2026
34708,Evasc rpr ilio-iliac rpt,CPT,RVU2026A,2026
34709,Plmt xtn prosth evasc rpr,CPT,RVU2026A,2026
3470F,Ra disease activity low,Other,RVU2026A,2026
34710,Dlyd plmt xtn prosth 1st vsl,CPT,RVU2026A,2026
34711,Dlyd plmt xtn prosth ea addl,CPT,RVU2026A,2026
34712,Tcat dlvr enhncd fixj dev,CPT,RVU2026A,2026
34713,Perq access & clsr fem art,CPT,RVU2026A,2026
34714,Opn fem art expos cndt crtj,CPT,RVU2026A,2026
34715,Opn ax/subcla art expos,CPT,RVU2026A,2026
34716,Opn ax/subcla art expos cndt,CPT,RVU2026A,2026
34717,Evasc rpr a-iliac ndgft,CPT,RVU2026A,2026
34718,Evasc rpr n/a a-iliac ndgft,CPT,RVU2026A,2026
3471F,Ra disease activity mod,Other,RVU2026A,2026
3472F,Ra disease activity high,Other,RVU2026A,2026
3475F,Disease progn ra poor docd,Other,RVU2026A,2026
3476F,Disease progn ra good docd,Other,RVU2026A,2026
34808,Endovas iliac a device addon,CPT,RVU2026A,2026
34812,Opn fem art expos,CPT,RVU2026A,2026
34813,Femoral endovas graft add-on,CPT,RVU2026A,2026
34820,Opn iliac art expos,CPT,RVU2026A,2026
34830,Open aortic tube prosth repr,CPT,RVU2026A,2026
34831,Open aortoiliac prosth repr,CPT,RVU2026A,2026
34832,Open aortofemor prosth repr,CPT,RVU2026A,2026
34833,Opn ilac art expos cndt crtj,CPT,RVU2026A,2026
34834,Opn brach art expos,CPT,RVU2026A,2026
34839,Plnning pt spec fenest graft,CPT,RVU2026A,2026
34841,Endovasc visc aorta 1 graft,CPT,RVU2026A,2026
34842,Endovasc visc aorta 2 graft,CPT,RVU2026A,2026
34843,Endovasc visc aorta 3 graft,CPT,RVU2026A,2026
34844,Endovasc visc aorta 4 graft,CPT,RVU2026A,2026
34845,Visc & infraren abd 1 prosth,CPT,RVU2026A,2026
34846,Visc & infraren abd 2 prosth,CPT,RVU2026A,2026
34847,Visc & infraren abd 3 prosth,CPT,RVU2026A,2026
34848,Visc & infraren abd 4+ prost,CPT,RVU2026A,2026
3490F,History aids-defining cond,Other,RVU2026A,2026
3491F,Hiv unsure baby of hiv+moms,Other,RVU2026A,2026
3492F,History cd4+ cell count <350,Other,RVU2026A,2026
3493F,No hist cd4+ cell count <350,Other,RVU2026A,2026
3494F,Cd4+cell count <200cells/mm3,Other,RVU2026A,2026
3495F,Cd4+cell cnt 200-499 cells,Other,RVU2026A,2026
3496F,Cd4+ cell count >= 500 cells,Other,RVU2026A,2026
3497F,Cd4+ cell percentage <15%,Other,RVU2026A,2026
3498F,Cd4+ cell >=15% (hiv),Other,RVU2026A,2026
35001,Repair defect of artery,CPT,RVU2026A,2026
35002,Repair artery rupture neck,CPT,RVU2026A,2026
35005,Repair defect of artery,CPT,RVU2026A,2026
3500F,Cd4+cell cnt/% docd as done,Other,RVU2026A,2026
35011,Repair defect of artery,CPT,RVU2026A,2026
35013,Repair artery rupture arm,CPT,RVU2026A,2026
35021,Repair defect of artery,CPT,RVU2026A,2026
35022,Repair artery rupture chest,CPT,RVU2026A,2026
3502F,Hiv rna vrl ld <lmts quantif,Other,RVU2026A,2026
3503F,Hiv rna vrl ldnot<lmts quntf,Other,RVU2026A,2026
35045,Repair defect of arm artery,CPT,RVU2026A,2026
35081,Repair defect of artery,CPT,RVU2026A,2026
35082,Repair artery rupture aorta,CPT,RVU2026A,2026
35091,Repair defect of artery,CPT,RVU2026A,2026
35092,Repair artery rupture aorta,CPT,RVU2026A,2026
35102,Repair defect of artery,CPT,RVU2026A,2026
35103,Repair artery rupture aorta,CPT,RVU2026A,2026
3510F,Doc tb scrng-rslts interpd,Other,RVU2026A,2026
35111,Repair defect of artery,CPT,RVU2026A,2026
35112,Repair artery rupture spleen,CPT,RVU2026A,2026
3511F,Chlmyd/gonrh tsts docd done,Other,RVU2026A,2026
35121,Repair defect of artery,CPT,RVU2026A,2026
35122,Repair artery rupture belly,CPT,RVU2026A,2026
3512F,Syph scrng docd as done,Other,RVU2026A,2026
35131,Repair defect of artery,CPT,RVU2026A,2026
35132,Repair artery rupture groin,CPT,RVU2026A,2026
3513F,Hep b scrng docd as done,Other,RVU2026A,2026
35141,Repair defect of artery,CPT,RVU2026A,2026
35142,Repair artery rupture thigh,CPT,RVU2026A,2026
3514F,Hep c scrng docd as done,Other,RVU2026A,2026
35151,Repair defect of artery,CPT,RVU2026A,2026
35152,Repair ruptd popliteal art,CPT,RVU2026A,2026
3515F,Pt has docd immun to hep c,Other,RVU2026A,2026
3517F,Hbv assess&results intrp 1yr,Other,RVU2026A,2026
35180,Rpr cgen av fistula head&nck,CPT,RVU2026A,2026
35182,Rpr cgen av fistula thrx&abd,CPT,RVU2026A,2026
35184,Rpr cgen av fistula xtr,CPT,RVU2026A,2026
35188,Rpr acq av fistula head&neck,CPT,RVU2026A,2026
35189,Rpr acq av fistula thrx&abd,CPT,RVU2026A,2026
35190,Repair acq av fistula xtr,CPT,RVU2026A,2026
35201,Repair blood vessel dir neck,CPT,RVU2026A,2026
35206,Repair blood vessel dir uxtr,CPT,RVU2026A,2026
35207,Rpr bld vsl dir hand finger,CPT,RVU2026A,2026
3520F,Cdifficile testing performed,Other,RVU2026A,2026
35211,Rpr blvsl dir ntrathrc w/byp,CPT,RVU2026A,2026
35216,Rpr blvsl dir ntrthrc wo byp,CPT,RVU2026A,2026
35221,Rpr bld vsl dir intra-abdl,CPT,RVU2026A,2026
35226,Repair blood vessel dir lxtr,CPT,RVU2026A,2026
35231,Repair blvsl vn grf neck,CPT,RVU2026A,2026
35236,Repair blvsl vn grf uxtr,CPT,RVU2026A,2026
35241,Rpr blvsl vn grf ntrthrc w/b,CPT,RVU2026A,2026
35246,Rpr blvsl vn grf ntrthrc w/o,CPT,RVU2026A,2026
35251,Rpr blvsl vn grf intra-abdl,CPT,RVU2026A,2026
35256,Repair blvsl vn grf lxtr,CPT,RVU2026A,2026
35261,Rpr blvsl grf oth/thn vn nck,CPT,RVU2026A,2026
35266,Rpr blvsl grf oth/th vn uxtr,CPT,RVU2026A,2026
35271,Rpr blvs gr ot/th vn ntrth w,CPT,RVU2026A,2026
35276,Rpr blvs gr ot/t vn ntrth wo,CPT,RVU2026A,2026
35281,Rpr blvsl gr ot/th vn ntr-ab,CPT,RVU2026A,2026
35286,Rpr blvsl grf oth/th vn lxtr,CPT,RVU2026A,2026
35301,Rechanneling of artery,CPT,RVU2026A,2026
35302,Rechanneling of artery,CPT,RVU2026A,2026
35303,Rechanneling of artery,CPT,RVU2026A,2026
35304,Rechanneling of artery,CPT,RVU2026A,2026
35305,Rechanneling of artery,CPT,RVU2026A,2026
35306,Rechanneling of artery,CPT,RVU2026A,2026
35311,Rechanneling of artery,CPT,RVU2026A,2026
35321,Rechanneling of artery,CPT,RVU2026A,2026
35331,Rechanneling of artery,CPT,RVU2026A,2026
35341,Rechanneling of artery,CPT,RVU2026A,2026
35351,Rechanneling of artery,CPT,RVU2026A,2026
35355,Rechanneling of artery,CPT,RVU2026A,2026
35361,Rechanneling of artery,CPT,RVU2026A,2026
35363,Rechanneling of artery,CPT,RVU2026A,2026
35371,Rechanneling of artery,CPT,RVU2026A,2026
35372,Rechanneling of artery,CPT,RVU2026A,2026
35390,Reoperation carotid add-on,CPT,RVU2026A,2026
35400,Angioscopy,CPT,RVU2026A,2026
35500,Harvest vein for bypass,CPT,RVU2026A,2026
35501,Art byp grft ipsilat carotid,CPT,RVU2026A,2026
35506,Art byp grft subclav-carotid,CPT,RVU2026A,2026
35508,Art byp grft carotid-vertbrl,CPT,RVU2026A,2026
35509,Art byp grft contral carotid,CPT,RVU2026A,2026
3550F,Low rsk thromboembolism,Other,RVU2026A,2026
35510,Art byp grft carotid-brchial,CPT,RVU2026A,2026
35511,Art byp grft subclav-subclav,CPT,RVU2026A,2026
35512,Art byp grft subclav-brchial,CPT,RVU2026A,2026
35515,Art byp grft subclav-vertbrl,CPT,RVU2026A,2026
35516,Art byp grft subclav-axilary,CPT,RVU2026A,2026
35518,Art byp grft axillary-axilry,CPT,RVU2026A,2026
3551F,Intrmed rsk thromboembolism,Other,RVU2026A,2026
35521,Art byp grft axill-femoral,CPT,RVU2026A,2026
35522,Art byp grft axill-brachial,CPT,RVU2026A,2026
35523,Art byp grft brchl-ulnr-rdl,CPT,RVU2026A,2026
35525,Art byp grft brachial-brchl,CPT,RVU2026A,2026
35526,Art byp grft aor/carot/innom,CPT,RVU2026A,2026
3552F,Hgh risk for thromboembolism,Other,RVU2026A,2026
35531,Art byp grft aorcel/aormesen,CPT,RVU2026A,2026
35533,Art byp grft axill/fem/fem,CPT,RVU2026A,2026
35535,Art byp grft hepatorenal,CPT,RVU2026A,2026
35536,Art byp grft splenorenal,CPT,RVU2026A,2026
35537,Art byp grft aortoiliac,CPT,RVU2026A,2026
35538,Art byp grft aortobi-iliac,CPT,RVU2026A,2026
35539,Art byp grft aortofemoral,CPT,RVU2026A,2026
35540,Art byp grft aortbifemoral,CPT,RVU2026A,2026
35556,Art byp grft fem-popliteal,CPT,RVU2026A,2026
35558,Art byp grft fem-femoral,CPT,RVU2026A,2026
3555F,Pt inr measurement performed,Other,RVU2026A,2026
35560,Art byp grft aortorenal,CPT,RVU2026A,2026
35563,Art byp grft ilioiliac,CPT,RVU2026A,2026
35565,Art byp grft iliofemoral,CPT,RVU2026A,2026
35566,Art byp fem-ant-post tib/prl,CPT,RVU2026A,2026
35570,Art byp tibial-tib/peroneal,CPT,RVU2026A,2026
35571,Art byp pop-tibl-prl-other,CPT,RVU2026A,2026
35572,Harvest femoropopliteal vein,CPT,RVU2026A,2026
35583,Vein byp grft fem-popliteal,CPT,RVU2026A,2026
35585,Vein byp fem-tibial peroneal,CPT,RVU2026A,2026
35587,Vein byp pop-tibl peroneal,CPT,RVU2026A,2026
35600,Open hrv uxtr art 1 sgm cab,CPT,RVU2026A,2026
35601,Bpg com crtd-ipsi int crtd,CPT,RVU2026A,2026
35602,Bpg crtd-clat crtd,CPT,RVU2026A,2026
35606,Bpg carotid-subclavian,CPT,RVU2026A,2026
35612,Bpg subclavian-subclavian,CPT,RVU2026A,2026
35616,Bpg subclavian-axillary,CPT,RVU2026A,2026
35621,Bpg axillary-femoral,CPT,RVU2026A,2026
35623,Bpg axillary-pop/-tibial,CPT,RVU2026A,2026
35626,Bpg aor-subcla/innom/carotid,CPT,RVU2026A,2026
35631,Bpg aor-celiac-msn-renal,CPT,RVU2026A,2026
35632,Bpg ilio-celiac,CPT,RVU2026A,2026
35633,Bpg ilio-mesenteric,CPT,RVU2026A,2026
35634,Bpg iliorenal,CPT,RVU2026A,2026
35636,Bpg splenorenal,CPT,RVU2026A,2026
35637,Bpg aortoiliac,CPT,RVU2026A,2026
35638,Bpg aortobi-iliac,CPT,RVU2026A,2026
35642,Bpg carotid-vertebral,CPT,RVU2026A,2026
35645,Bpg subclavian-vertebral,CPT,RVU2026A,2026
35646,Bpg aortobifemoral,CPT,RVU2026A,2026
35647,Bpg aortofemoral,CPT,RVU2026A,2026
35650,Bpg axillary-axillary,CPT,RVU2026A,2026
35654,Bpg axillary-femoral-femoral,CPT,RVU2026A,2026
35656,Bpg femoral-popliteal,CPT,RVU2026A,2026
35661,Bpg femoral-femoral,CPT,RVU2026A,2026
35663,Bpg ilioiliac,CPT,RVU2026A,2026
35665,Bpg iliofemoral,CPT,RVU2026A,2026
35666,Bpg fem-ant tib pst tib/prnl,CPT,RVU2026A,2026
35671,Bpg pop-tibl/-prnl artery,CPT,RVU2026A,2026
35681,Composite byp grft pros&vein,CPT,RVU2026A,2026
35682,Composite byp grft 2 veins,CPT,RVU2026A,2026
35683,Composite byp grft 3/> segmt,CPT,RVU2026A,2026
35685,Bypass graft patency/patch,CPT,RVU2026A,2026
35686,Bypass graft/av fist patency,CPT,RVU2026A,2026
35691,Art trnsposj vertbrl carotid,CPT,RVU2026A,2026
35693,Art trnsposj subclavian,CPT,RVU2026A,2026
35694,Art trnsposj subclav carotid,CPT,RVU2026A,2026
35695,Art trnsposj carotid subclav,CPT,RVU2026A,2026
35697,Reimplant artery each,CPT,RVU2026A,2026
35700,Reoperation bypass graft,CPT,RVU2026A,2026
35701,Expl n/flwd surg neck art,CPT,RVU2026A,2026
35702,Expl n/flwd surg uxtr art,CPT,RVU2026A,2026
35703,Expl n/flwd surg lxtr art,CPT,RVU2026A,2026
3570F,Rprt bone scint xref w xray,Other,RVU2026A,2026
3572F,Pt consid poss risk fx,Other,RVU2026A,2026
3573F,Pt not consid poss risk fx,Other,RVU2026A,2026
35800,Explore neck vessels,CPT,RVU2026A,2026
35820,Explore chest vessels,CPT,RVU2026A,2026
35840,Explore abdominal vessels,CPT,RVU2026A,2026
35860,Explore limb vessels,CPT,RVU2026A,2026
35870,Repair vessel graft defect,CPT,RVU2026A,2026
35875,Removal of clot in graft,CPT,RVU2026A,2026
35876,Removal of clot in graft,CPT,RVU2026A,2026
35879,Revise graft w/vein,CPT,RVU2026A,2026
35881,Revise graft w/vein,CPT,RVU2026A,2026
35883,Revj fem anast nonautog grf,CPT,RVU2026A,2026
35884,Revj fem anast autog vn grf,CPT,RVU2026A,2026
35901,Excision graft neck,CPT,RVU2026A,2026
35903,Excision graft extremity,CPT,RVU2026A,2026
35905,Excision graft thorax,CPT,RVU2026A,2026
35907,Excision graft abdomen,CPT,RVU2026A,2026
36000,Place needle in vein,CPT,RVU2026A,2026
36002,Pseudoaneurysm injection trt,CPT,RVU2026A,2026
36005,Injection ext venography,CPT,RVU2026A,2026
36010,Place catheter in vein,CPT,RVU2026A,2026
36011,Place catheter in vein,CPT,RVU2026A,2026
36012,Place catheter in vein,CPT,RVU2026A,2026
36013,Place catheter in artery,CPT,RVU2026A,2026
36014,Place catheter in artery,CPT,RVU2026A,2026
36015,Place catheter in artery,CPT,RVU2026A,2026
36100,Establish access to artery,CPT,RVU2026A,2026
36140,Intro ndl icath upr/lxtr art,CPT,RVU2026A,2026
36160,Establish access to aorta,CPT,RVU2026A,2026
36200,Place catheter in aorta,CPT,RVU2026A,2026
36215,Place catheter in artery,CPT,RVU2026A,2026
36216,Place catheter in artery,CPT,RVU2026A,2026
36217,Place catheter in artery,CPT,RVU2026A,2026
36218,Place catheter in artery,CPT,RVU2026A,2026
36221,Place cath thoracic aorta,CPT,RVU2026A,2026
36222,Place cath carotid/inom art,CPT,RVU2026A,2026
36223,Place cath carotid/inom art,CPT,RVU2026A,2026
36224,Place cath carotd art,CPT,RVU2026A,2026
36225,Place cath subclavian art,CPT,RVU2026A,2026
36226,Place cath vertebral art,CPT,RVU2026A,2026
36227,Place cath xtrnl carotid,CPT,RVU2026A,2026
36228,Place cath intracranial art,CPT,RVU2026A,2026
36245,Ins cath abd/l-ext art 1st,CPT,RVU2026A,2026
36246,Ins cath abd/l-ext art 2nd,CPT,RVU2026A,2026
36247,Ins cath abd/l-ext art 3rd,CPT,RVU2026A,2026
36248,Ins cath abd/l-ext art addl,CPT,RVU2026A,2026
36251,Ins cath ren art 1st unilat,CPT,RVU2026A,2026
36252,Ins cath ren art 1st bilat,CPT,RVU2026A,2026
36253,Ins cath ren art 2nd+ unilat,CPT,RVU2026A,2026
36254,Ins cath ren art 2nd+ bilat,CPT,RVU2026A,2026
36260,Insertion of infusion pump,CPT,RVU2026A,2026
36261,Revision of infusion pump,CPT,RVU2026A,2026
36262,Removal of infusion pump,CPT,RVU2026A,2026
36299,Unlisted px vascular njx,CPT,RVU2026A,2026
36400,Vnpnxr<3yrs phy/qhp fem/jug,CPT,RVU2026A,2026
36405,Vnpnxr<3yrs phy/qhp scalp vn,CPT,RVU2026A,2026
36406,Vnpnxr<3yrs phy/qhp other vn,CPT,RVU2026A,2026
36410,Vnpnxr 3yr/> phy/qhp dx/ther,CPT,RVU2026A,2026
36415,Coll venous bld venipuncture,CPT,RVU2026A,2026
36416,Collj capillary blood spec,CPT,RVU2026A,2026
36420,Venipuncture cutdown < 1 yr,CPT,RVU2026A,2026
36425,Venipuncture cutdown 1 yr/>,CPT,RVU2026A,2026
36430,Transfusion bld/bld compnt,CPT,RVU2026A,2026
36440,Bld push tfuj 2 yr/<,CPT,RVU2026A,2026
36450,Bld exchange truj newborn,CPT,RVU2026A,2026
36455,Bld exchange truj oth thn nb,CPT,RVU2026A,2026
36456,Prtl exchange transfuse nb,CPT,RVU2026A,2026
36460,Intrauterine transfusion ftl,CPT,RVU2026A,2026
36465,Njx noncmpnd sclrsnt 1 vein,CPT,RVU2026A,2026
36466,Njx noncmpnd sclrsnt mlt vn,CPT,RVU2026A,2026
36468,Njx sclrsnt spider veins,CPT,RVU2026A,2026
36470,Njx sclrsnt 1 incmptnt vein,CPT,RVU2026A,2026
36471,Njx sclrsnt mlt incmptnt vn,CPT,RVU2026A,2026
36473,Endovenous mchnchem 1st vein,CPT,RVU2026A,2026
36474,Endovenous mchnchem add-on,CPT,RVU2026A,2026
36475,Endovenous rf 1st vein,CPT,RVU2026A,2026
36476,Endovenous rf vein add-on,CPT,RVU2026A,2026
36478,Endovenous laser 1st vein,CPT,RVU2026A,2026
36479,Endovenous laser vein addon,CPT,RVU2026A,2026
36481,Insertion of catheter vein,CPT,RVU2026A,2026
36482,Endoven ther chem adhes 1st,CPT,RVU2026A,2026
36483,Endoven ther chem adhes sbsq,CPT,RVU2026A,2026
36500,Insertion of catheter vein,CPT,RVU2026A,2026
3650F,Eeg ordered rvwd reqstd,Other,RVU2026A,2026
36510,Insertion of catheter vein,CPT,RVU2026A,2026
36511,Apheresis wbc,CPT,RVU2026A,2026
36512,Apheresis rbc,CPT,RVU2026A,2026
36513,Apheresis platelets,CPT,RVU2026A,2026
36514,Apheresis plasma,CPT,RVU2026A,2026
36516,Apheresis immunoads slctv,CPT,RVU2026A,2026
36522,Photopheresis,CPT,RVU2026A,2026
36555,Insert non-tunnel cv cath,CPT,RVU2026A,2026
36556,Insert non-tunnel cv cath,CPT,RVU2026A,2026
36557,Insert tunneled cv cath,CPT,RVU2026A,2026
36558,Insert tunneled cv cath,CPT,RVU2026A,2026
36560,Insert tunneled cv cath,CPT,RVU2026A,2026
36561,Insert tunneled cv cath,CPT,RVU2026A,2026
36563,Insert tunneled cv cath,CPT,RVU2026A,2026
36565,Insert tunneled cv cath,CPT,RVU2026A,2026
36566,Insert tunneled cv cath,CPT,RVU2026A,2026
36568,Insj picc <5 yr w/o imaging,CPT,RVU2026A,2026
36569,Insj picc 5 yr+ w/o imaging,CPT,RVU2026A,2026
36570,Insert picvad cath,CPT,RVU2026A,2026
36571,Insert picvad cath,CPT,RVU2026A,2026
36572,Insj picc rs&i <5 yr,CPT,RVU2026A,2026
36573,Insj picc rs&i 5 yr+,CPT,RVU2026A,2026
36575,Repair tunneled cv cath,CPT,RVU2026A,2026
36576,Repair tunneled cv cath,CPT,RVU2026A,2026
36578,Replace tunneled cv cath,CPT,RVU2026A,2026
36580,Replace cvad cath,CPT,RVU2026A,2026
36581,Replace tunneled cv cath,CPT,RVU2026A,2026
36582,Replace tunneled cv cath,CPT,RVU2026A,2026
36583,Replace tunneled cv cath,CPT,RVU2026A,2026
36584,Compl rplcmt picc rs&i,CPT,RVU2026A,2026
36585,Replace picvad cath,CPT,RVU2026A,2026
36589,Removal tunneled cv cath,CPT,RVU2026A,2026
36590,Removal tunneled cv cath,CPT,RVU2026A,2026
36591,Draw blood off venous device,CPT,RVU2026A,2026
36592,Collect blood from picc,CPT,RVU2026A,2026
36593,Declot vascular device,CPT,RVU2026A,2026
36595,Mech remov tunneled cv cath,CPT,RVU2026A,2026
36596,Mech remov tunneled cv cath,CPT,RVU2026A,2026
36597,Reposition venous catheter,CPT,RVU2026A,2026
36598,Inj w/fluor eval cv device,CPT,RVU2026A,2026
36600,Withdrawal of arterial blood,CPT,RVU2026A,2026
36620,Insertion catheter artery,CPT,RVU2026A,2026
36625,Insertion catheter artery,CPT,RVU2026A,2026
36640,Insertion catheter artery,CPT,RVU2026A,2026
36660,Insertion catheter artery,CPT,RVU2026A,2026
36680,Insert needle bone cavity,CPT,RVU2026A,2026
36800,Insertion of cannula,CPT,RVU2026A,2026
36810,Insertion of cannula,CPT,RVU2026A,2026
36815,Insertion of cannula,CPT,RVU2026A,2026
36818,Av fuse uppr arm cephalic,CPT,RVU2026A,2026
36819,Av fuse uppr arm basilic,CPT,RVU2026A,2026
36820,Av fusion/forearm vein,CPT,RVU2026A,2026
36821,Av fusion direct any site,CPT,RVU2026A,2026
36823,Insertion of cannula(s),CPT,RVU2026A,2026
36825,Artery-vein autograft,CPT,RVU2026A,2026
36830,Artery-vein nonautograft,CPT,RVU2026A,2026
36831,Open thrombect av fistula,CPT,RVU2026A,2026
36832,Av fistula revision open,CPT,RVU2026A,2026
36833,Av fistula revision,CPT,RVU2026A,2026
36835,Insertion thomas shunt,CPT,RVU2026A,2026
36836,Prq av fstl crtj uxtr 1 acs,CPT,RVU2026A,2026
36837,Prq av fstl crt uxtr sep acs,CPT,RVU2026A,2026
36838,Dist revas ligation hemo,CPT,RVU2026A,2026
36860,External cannula declotting,CPT,RVU2026A,2026
36861,Cannula declotting,CPT,RVU2026A,2026
36901,Intro cath dialysis circuit,CPT,RVU2026A,2026
36902,Intro cath dialysis circuit,CPT,RVU2026A,2026
36903,Intro cath dialysis circuit,CPT,RVU2026A,2026
36904,Thrmbc/nfs dialysis circuit,CPT,RVU2026A,2026
36905,Thrmbc/nfs dialysis circuit,CPT,RVU2026A,2026
36906,Thrmbc/nfs dialysis circuit,CPT,RVU2026A,2026
36907,Balo angiop ctr dialysis seg,CPT,RVU2026A,2026
36908,Stent plmt ctr dialysis seg,CPT,RVU2026A,2026
36909,Dialysis circuit embolj,CPT,RVU2026A,2026
3700F,Psych disorders assessed,Other,RVU2026A,2026
37140,Revision of circulation,CPT,RVU2026A,2026
37145,Revision of circulation,CPT,RVU2026A,2026
37160,Revision of circulation,CPT,RVU2026A,2026
37180,Revision of circulation,CPT,RVU2026A,2026
37181,Splice spleen/kidney veins,CPT,RVU2026A,2026
37182,Insert hepatic shunt (tips),CPT,RVU2026A,2026
37183,Revision tips,CPT,RVU2026A,2026
37184,Prim art m-thrmbc 1st vsl,CPT,RVU2026A,2026
37185,Prim art m-thrmbc sbsq vsl,CPT,RVU2026A,2026
37186,Sec art thrombectomy add-on,CPT,RVU2026A,2026
37187,Venous mech thrombectomy,CPT,RVU2026A,2026
37188,Ven mechnl thrmbc repeat tx,CPT,RVU2026A,2026
37191,Ins endovas vena cava filtr,CPT,RVU2026A,2026
37192,Redo endovas vena cava filtr,CPT,RVU2026A,2026
37193,Rem endovas vena cava filter,CPT,RVU2026A,2026
37195,Thrombolytic therapy stroke,CPT,RVU2026A,2026
37197,Remove intrvas foreign body,CPT,RVU2026A,2026
37200,Transcatheter biopsy,CPT,RVU2026A,2026
3720F,Cognit impairment assessed,Other,RVU2026A,2026
37211,Thrombolytic art therapy,CPT,RVU2026A,2026
37212,Thrombolytic venous therapy,CPT,RVU2026A,2026
37213,Thromblytic art/ven therapy,CPT,RVU2026A,2026
37214,Cessj therapy cath removal,CPT,RVU2026A,2026
37215,Transcath stent cca w/eps,CPT,RVU2026A,2026
37216,Transcath stent cca w/o eps,CPT,RVU2026A,2026
37217,Stent placemt retro carotid,CPT,RVU2026A,2026
37218,Stent placemt ante carotid,CPT,RVU2026A,2026
37236,Open/perq place stent 1st,CPT,RVU2026A,2026
37237,Open/perq place stent ea add,CPT,RVU2026A,2026
37238,Open/perq place stent same,CPT,RVU2026A,2026
37239,Open/perq place stent ea add,CPT,RVU2026A,2026
37241,Vasc embolize/occlude venous,CPT,RVU2026A,2026
37242,Vasc embolize/occlude artery,CPT,RVU2026A,2026
37243,Vasc embolize/occlude organ,CPT,RVU2026A,2026
37244,Vasc embolize/occlude bleed,CPT,RVU2026A,2026
37246,Trluml balo angiop 1st art,CPT,RVU2026A,2026
37247,Trluml balo angiop addl art,CPT,RVU2026A,2026
37248,Trluml balo angiop 1st vein,CPT,RVU2026A,2026
37249,Trluml balo angiop addl vein,CPT,RVU2026A,2026
37252,Intrvasc us noncoronary 1st,CPT,RVU2026A,2026
37253,Intrvasc us noncoronary addl,CPT,RVU2026A,2026
37254,Revsc evasc ivt angio sf 1st,CPT,RVU2026A,2026
37255,Revsc evasc ivt angio sf ea,CPT,RVU2026A,2026
37256,Revsc evasc ivt angio cplx 1,CPT,RVU2026A,2026
37257,Revsc evsc ivt angio cplx ea,CPT,RVU2026A,2026
37258,Revsc evasc ivt stent sf 1st,CPT,RVU2026A,2026
37259,Revsc evasc ivt stent sf ea,CPT,RVU2026A,2026
3725F,Screen depression performed,Other,RVU2026A,2026
37260,Revsc evasc ivt st cplx 1st,CPT,RVU2026A,2026
37261,Revsc evasc ivt st cplx ea,CPT,RVU2026A,2026
37262,Iv lithotrp ivt w/in sm art,CPT,RVU2026A,2026
37263,Revsc evasc fpvt angio sf 1,CPT,RVU2026A,2026
37264,Revsc evasc fpvt angio sf ea,CPT,RVU2026A,2026
37265,Revsc evsc fpvt angio cplx 1,CPT,RVU2026A,2026
37266,Rvsc evsc fpvt angio cplx ea,CPT,RVU2026A,2026
37267,Revsc evsc fpvt stent sf 1st,CPT,RVU2026A,2026
37268,Revsc evasc fpvt stent sf ea,CPT,RVU2026A,2026
37269,Revsc evasc fpvt st cplx 1st,CPT,RVU2026A,2026
37270,Revsc evasc fpvt st cplx ea,CPT,RVU2026A,2026
37271,Revsc evsc fpvt athrc sf 1st,CPT,RVU2026A,2026
37272,Revsc evsc fpvt athrc sf ea,CPT,RVU2026A,2026
37273,Revsc evsc fpvt athrc cplx 1,CPT,RVU2026A,2026
37274,Rvsc evsc fpvt athrc cplx ea,CPT,RVU2026A,2026
37275,Rvsc evsc fpvt st athrc sf 1,CPT,RVU2026A,2026
37276,Rvsc evsc fpvt st athr sf ea,CPT,RVU2026A,2026
37277,Rvsc evsc fpvt st athr cpx 1,CPT,RVU2026A,2026
37278,Rvsc evsc fpvt st ath cpx ea,CPT,RVU2026A,2026
37279,Iv lithotrp fpvt w/in sm art,CPT,RVU2026A,2026
37280,Revsc evsc tpvt angio sf 1st,CPT,RVU2026A,2026
37281,Revsc evsc tpvt angio sf ea,CPT,RVU2026A,2026
37282,Rvsc evsc tpvt angio cplx 1,CPT,RVU2026A,2026
37283,Rvsc evsc tpvt angio cplx ea,CPT,RVU2026A,2026
37284,Revsc evasc tpvt st sf 1st,CPT,RVU2026A,2026
37285,Revsc evasc tpvt st sf ea,CPT,RVU2026A,2026
37286,Revsc evasc tpvt st cplx 1st,CPT,RVU2026A,2026
37287,Revsc evasc tpvt st cplx ea,CPT,RVU2026A,2026
37288,Revsc evsc tpvt athrc sf 1st,CPT,RVU2026A,2026
37289,Revsc evsc tpvt athrc sf ea,CPT,RVU2026A,2026
37290,Revsc evsc tpvt athrc cplx 1,CPT,RVU2026A,2026
37291,Revsc evsc tpvt athr cplx ea,CPT,RVU2026A,2026
37292,Rvsc evsc tpvt st athrc sf 1,CPT,RVU2026A,2026
37293,Rvsc evsc tpvt st athr sf ea,CPT,RVU2026A,2026
37294,Rvsc evsc tpvt st athr cpx 1,CPT,RVU2026A,2026
37295,Rvsc evsc tpvt st ath cpx ea,CPT,RVU2026A,2026
37296,Revsc evasc imvt angio sf 1,CPT,RVU2026A,2026
37297,Revsc evasc imvt angio sf ea,CPT,RVU2026A,2026
37298,Revsc evsc imvt angio cplx 1,CPT,RVU2026A,2026
37299,Revsc evsc imvt angio cpx ea,CPT,RVU2026A,2026
37501,Unlisted vasc endoscopy px,CPT,RVU2026A,2026
3750F,Ptnotrcvngsteroid>=10mg/day,Other,RVU2026A,2026
3751F,Electrodiag polyneuro 6 mn,Other,RVU2026A,2026
3752F,No electrodiag polyneuro 6mn,Other,RVU2026A,2026
3753F,Pt has symp&signs neuropathy,Other,RVU2026A,2026
3754F,Screening tests dm done,Other,RVU2026A,2026
3755F,Cog&behav imprmnt scrng done,Other,RVU2026A,2026
37565,Ligation int jugular vein,CPT,RVU2026A,2026
3756F,Pt w/pseudobulb affect/als,Other,RVU2026A,2026
3757F,Pt w/o pseudobulbaffect/als,Other,RVU2026A,2026
3758F,Pt ref pulm fx test/peakflow,Other,RVU2026A,2026
3759F,Pt scrn dysphag/wt loss/nutr,Other,RVU2026A,2026
37600,Ligation xtrnl carotid art,CPT,RVU2026A,2026
37605,Ligation int/com carotid art,CPT,RVU2026A,2026
37606,Lig int/com carotid art occl,CPT,RVU2026A,2026
37607,Lig/banding angioacs av fstl,CPT,RVU2026A,2026
37609,Ligation/bx temporal artery,CPT,RVU2026A,2026
3760F,Pt w/dysphag/wt loss/nutr,Other,RVU2026A,2026
37615,Ligation major artery neck,CPT,RVU2026A,2026
37616,Ligation major artery chest,CPT,RVU2026A,2026
37617,Ligation major artery abd,CPT,RVU2026A,2026
37618,Ligation major artery xtr,CPT,RVU2026A,2026
37619,Ligation of inf vena cava,CPT,RVU2026A,2026
3761F,Pt w/o dysphag/wt loss/nutr,Other,RVU2026A,2026
3762F,Patient is dysarthric,Other,RVU2026A,2026
3763F,Patient is not dysarthric,Other,RVU2026A,2026
37650,Ligation of femoral vein,CPT,RVU2026A,2026
37660,Ligation common iliac vein,CPT,RVU2026A,2026
37700,Ligation&div long saph vein,CPT,RVU2026A,2026
37718,Lig div&strpg short saph vn,CPT,RVU2026A,2026
37722,Lig div&strpg long saph vein,CPT,RVU2026A,2026
37735,Lig&div&compl strpg saph vn,CPT,RVU2026A,2026
3775F,Adenoma detected screening,Other,RVU2026A,2026
37760,Lig prfratr vn radical 1 leg,CPT,RVU2026A,2026
37761,Ligate leg veins open,CPT,RVU2026A,2026
37765,Stab phleb veins xtr 10-20,CPT,RVU2026A,2026
37766,Phleb veins - extrem 20+,CPT,RVU2026A,2026
3776F,Adenoma not detect screening,Other,RVU2026A,2026
37780,Revision of leg vein,CPT,RVU2026A,2026
37785,Ligate/divide/excise vein,CPT,RVU2026A,2026
37788,Revascularization penis,CPT,RVU2026A,2026
37790,Penile venous occlusion,CPT,RVU2026A,2026
37799,Unlisted px vascular surgery,CPT,RVU2026A,2026
38100,Removal of spleen total,CPT,RVU2026A,2026
38101,Removal of spleen partial,CPT,RVU2026A,2026
38102,Removal of spleen total,CPT,RVU2026A,2026
38115,Repair of ruptured spleen,CPT,RVU2026A,2026
38120,Laparoscopy splenectomy,CPT,RVU2026A,2026
38129,Unlisted laps px spleen,CPT,RVU2026A,2026
38200,Injection for spleen x-ray,CPT,RVU2026A,2026
38204,Bl donor search management,CPT,RVU2026A,2026
38205,Harvest allogeneic stem cell,CPT,RVU2026A,2026
38206,Harvest auto stem cells,CPT,RVU2026A,2026
38207,Cryopreserve stem cells,CPT,RVU2026A,2026
38208,Thaw preserved stem cells,CPT,RVU2026A,2026
38209,Wash harvest stem cells,CPT,RVU2026A,2026
38210,T-cell depletion of harvest,CPT,RVU2026A,2026
38211,Tumor cell deplete of harvst,CPT,RVU2026A,2026
38212,Rbc depletion of harvest,CPT,RVU2026A,2026
38213,Platelet deplete of harvest,CPT,RVU2026A,2026
38214,Volume deplete of harvest,CPT,RVU2026A,2026
38215,Harvest stem cell concentrte,CPT,RVU2026A,2026
38220,Dx bone marrow aspirations,CPT,RVU2026A,2026
38221,Dx bone marrow biopsies,CPT,RVU2026A,2026
38222,Dx bone marrow bx & aspir,CPT,RVU2026A,2026
38225,Car-t hrv bld-drv t lymphcyt,CPT,RVU2026A,2026
38226,Car-t prep t lymphcyt f/trns,CPT,RVU2026A,2026
38227,Car-t receipt&prepj admn,CPT,RVU2026A,2026
38228,Car-t admn autologous,CPT,RVU2026A,2026
38230,Bone marrow harvest allogen,CPT,RVU2026A,2026
38232,Bone marrow harvest autolog,CPT,RVU2026A,2026
38240,Transplt allo hct/donor,CPT,RVU2026A,2026
38241,Transplt autol hct/donor,CPT,RVU2026A,2026
38242,Transplt allo lymphocytes,CPT,RVU2026A,2026
38243,Transplj hematopoietic boost,CPT,RVU2026A,2026
38300,Drainage lymph node lesion,CPT,RVU2026A,2026
38305,Drainage lymph node lesion,CPT,RVU2026A,2026
38308,Incision of lymph channels,CPT,RVU2026A,2026
38380,Thoracic duct procedure,CPT,RVU2026A,2026
38381,Thoracic duct procedure,CPT,RVU2026A,2026
38382,Thoracic duct procedure,CPT,RVU2026A,2026
38500,Biopsy/removal lymph nodes,CPT,RVU2026A,2026
38505,Needle biopsy lymph nodes,CPT,RVU2026A,2026
38510,Biopsy/removal lymph nodes,CPT,RVU2026A,2026
38520,Biopsy/removal lymph nodes,CPT,RVU2026A,2026
38525,Biopsy/removal lymph nodes,CPT,RVU2026A,2026
38530,Biopsy/removal lymph nodes,CPT,RVU2026A,2026
38531,Open bx/exc inguinofem nodes,CPT,RVU2026A,2026
38542,Explore deep node(s) neck,CPT,RVU2026A,2026
38550,Removal neck/armpit lesion,CPT,RVU2026A,2026
38555,Removal neck/armpit lesion,CPT,RVU2026A,2026
38562,Removal pelvic lymph nodes,CPT,RVU2026A,2026
38564,Removal abdomen lymph nodes,CPT,RVU2026A,2026
38570,Laparoscopy lymph node biop,CPT,RVU2026A,2026
38571,Laparoscopy lymphadenectomy,CPT,RVU2026A,2026
38572,Laparoscopy lymphadenectomy,CPT,RVU2026A,2026
38573,Laps pelvic lymphadec,CPT,RVU2026A,2026
38589,Unlisted laps px lymphtc sys,CPT,RVU2026A,2026
38700,Removal of lymph nodes neck,CPT,RVU2026A,2026
38720,Removal of lymph nodes neck,CPT,RVU2026A,2026
38724,Removal of lymph nodes neck,CPT,RVU2026A,2026
38740,Remove armpit lymph nodes,CPT,RVU2026A,2026
38745,Remove armpit lymph nodes,CPT,RVU2026A,2026
38746,Remove thoracic lymph nodes,CPT,RVU2026A,2026
38747,Remove abdominal lymph nodes,CPT,RVU2026A,2026
38760,Remove groin lymph nodes,CPT,RVU2026A,2026
38765,Remove groin lymph nodes,CPT,RVU2026A,2026
38770,Remove pelvis lymph nodes,CPT,RVU2026A,2026
38780,Remove abdomen lymph nodes,CPT,RVU2026A,2026
38790,Inject for lymphatic x-ray,CPT,RVU2026A,2026
38792,Ra tracer id of sentinl node,CPT,RVU2026A,2026
38794,Access thoracic lymph duct,CPT,RVU2026A,2026
38900,Io map of sent lymph node,CPT,RVU2026A,2026
38999,Unlistd px hemic/lymphtc sys,CPT,RVU2026A,2026
39000,Exploration of chest,CPT,RVU2026A,2026
39010,Exploration of chest,CPT,RVU2026A,2026
39200,Resect mediastinal cyst,CPT,RVU2026A,2026
39220,Resect mediastinal tumor,CPT,RVU2026A,2026
39401,Mediastinoscpy w/medstnl bx,CPT,RVU2026A,2026
39402,Mediastinoscpy w/lmph nod bx,CPT,RVU2026A,2026
39499,Unlisted px mediastinum,CPT,RVU2026A,2026
39501,Repair diaphragm laceration,CPT,RVU2026A,2026
39503,Repair of diaphragm hernia,CPT,RVU2026A,2026
39540,Repair of diaphragm hernia,CPT,RVU2026A,2026
39541,Repair of diaphragm hernia,CPT,RVU2026A,2026
39545,Revision of diaphragm,CPT,RVU2026A,2026
39560,Resect diaphragm simple,CPT,RVU2026A,2026
39561,Resect diaphragm complex,CPT,RVU2026A,2026
39599,Unlisted px diaphragm,CPT,RVU2026A,2026
4000F,Tobacco use txmnt counseling,Other,RVU2026A,2026
4001F,Tobacco use txmnt pharmacol,Other,RVU2026A,2026
4003F,Pt ed write/oral pts w/ hf,Other,RVU2026A,2026
4004F,Pt tobacco screen rcvd tlk,Other,RVU2026A,2026
4005F,Pharm thx for op rxd,Other,RVU2026A,2026
4008F,Beta-blocker therapy rxd/tkn,Other,RVU2026A,2026
4010F,Ace/arb therapy rxd/taken,Other,RVU2026A,2026
4011F,Oral antiplatelet therapy rx,Other,RVU2026A,2026
4012F,Warfarin therapy rx,Other,RVU2026A,2026
4013F,Statin therapy/currently tkn,Other,RVU2026A,2026
4014F,Written discharge instr prvd,Other,RVU2026A,2026
4015F,Persist asthma medicine ctrl,Other,RVU2026A,2026
4016F,Anti-inflm/anlgsc agent rx,Other,RVU2026A,2026
4017F,Gi prophylaxis for nsaid rx,Other,RVU2026A,2026
4018F,Therapy exercise joint rx,Other,RVU2026A,2026
4019F,Doc recpt counsl vit d/calc+,Other,RVU2026A,2026
4025F,Inhaled bronchodilator rx,Other,RVU2026A,2026
4030F,Oxygen therapy rx,Other,RVU2026A,2026
4033F,Pulmonary rehab rec,Other,RVU2026A,2026
4035F,Influenza imm rec,Other,RVU2026A,2026
4037F,Influenza imm order/admin,Other,RVU2026A,2026
4040F,Pneumoc vac/admin/rcvd,Other,RVU2026A,2026
4041F,Doc order cefazolin/cefurox,Other,RVU2026A,2026
4042F,Doc antibio not given,Other,RVU2026A,2026
4043F,Doc order given stop antibio,Other,RVU2026A,2026
4044F,Doc order given vte prophylx,Other,RVU2026A,2026
4045F,Empiric antibiotic rx,Other,RVU2026A,2026
4046F,Doc antibio given b/4 surg,Other,RVU2026A,2026
4047F,Doc antibio given b/4 surg,Other,RVU2026A,2026
4048F,Doc antibio given b/4 surg,Other,RVU2026A,2026
40490,Biopsy of lip,CPT,RVU2026A,2026
4049F,Doc order given stop antibio,Other,RVU2026A,2026
40500,Partial excision of lip,CPT,RVU2026A,2026
4050F,Ht care plan doc,Other,RVU2026A,2026
40510,Partial excision of lip,CPT,RVU2026A,2026
4051F,Referred for an av fistula,Other,RVU2026A,2026
40520,Partial excision of lip,CPT,RVU2026A,2026
40525,Reconstruct lip with flap,CPT,RVU2026A,2026
40527,Reconstruct lip with flap,CPT,RVU2026A,2026
4052F,Hemodialysis via av fistula,Other,RVU2026A,2026
40530,Partial removal of lip,CPT,RVU2026A,2026
4053F,Hemodialysis via av graft,Other,RVU2026A,2026
4054F,Hemodialysis via catheter,Other,RVU2026A,2026
4055F,Pt rcvng periton dialysis,Other,RVU2026A,2026
4056F,Approp oral rehyd recommd,Other,RVU2026A,2026
4058F,Ped gastro ed given caregvr,Other,RVU2026A,2026
4060F,Psych svcs provided,Other,RVU2026A,2026
4062F,Pt referral psych docd,Other,RVU2026A,2026
4063F,Antidepres rxthxpy not rxd,Other,RVU2026A,2026
4064F,Antidepressant rx,Other,RVU2026A,2026
40650,Rpr lip fth vermilion only,CPT,RVU2026A,2026
40652,Rpr lip fth<half ver height,CPT,RVU2026A,2026
40654,Rpr lip fth>1half ver ht/cpx,CPT,RVU2026A,2026
4065F,Antipsychotic rx,Other,RVU2026A,2026
4066F,Ect provided,Other,RVU2026A,2026
4067F,Pt referral for ect docd,Other,RVU2026A,2026
4069F,Vte prophylaxis rcvd,Other,RVU2026A,2026
40700,Repair cleft lip/nasal,CPT,RVU2026A,2026
40701,Repair cleft lip/nasal,CPT,RVU2026A,2026
40702,Repair cleft lip/nasal,CPT,RVU2026A,2026
4070F,Dvt prophylx recvd day 2,Other,RVU2026A,2026
40720,Repair cleft lip/nasal,CPT,RVU2026A,2026
4073F,Oral antiplat thx rx dischrg,Other,RVU2026A,2026
4075F,Anticoag thx rx at dischrg,Other,RVU2026A,2026
40761,Repair cleft lip/nasal,CPT,RVU2026A,2026
4077F,Doc t-pa admin considered,Other,RVU2026A,2026
40799,Unlisted procedure lips,CPT,RVU2026A,2026
4079F,Doc rehab svcs considered,Other,RVU2026A,2026
40800,Drainage of mouth lesion,CPT,RVU2026A,2026
40801,Drainage of mouth lesion,CPT,RVU2026A,2026
40804,Removal foreign body mouth,CPT,RVU2026A,2026
40805,Removal foreign body mouth,CPT,RVU2026A,2026
40806,Incision of lip fold,CPT,RVU2026A,2026
40808,Biopsy of mouth lesion,CPT,RVU2026A,2026
40810,Excision of mouth lesion,CPT,RVU2026A,2026
40812,Excise/repair mouth lesion,CPT,RVU2026A,2026
40814,Excise/repair mouth lesion,CPT,RVU2026A,2026
40816,Excision of mouth lesion,CPT,RVU2026A,2026
40818,Excise oral mucosa for graft,CPT,RVU2026A,2026
40819,Excise lip or cheek fold,CPT,RVU2026A,2026
40820,Treatment of mouth lesion,CPT,RVU2026A,2026
40830,Repair mouth laceration,CPT,RVU2026A,2026
40831,Repair mouth laceration,CPT,RVU2026A,2026
40840,Reconstruction of mouth,CPT,RVU2026A,2026
40842,Reconstruction of mouth,CPT,RVU2026A,2026
40843,Reconstruction of mouth,CPT,RVU2026A,2026
40844,Reconstruction of mouth,CPT,RVU2026A,2026
40845,Reconstruction of mouth,CPT,RVU2026A,2026
4084F,Aspirin recvd w/in 24 hrs,Other,RVU2026A,2026
4086F,Aspirin/clopidogrel rxd,Other,RVU2026A,2026
40899,Unlisted px vestibule mouth,CPT,RVU2026A,2026
4090F,Pt rcvng epo thxpy,Other,RVU2026A,2026
4095F,Pt not rcvng epo thxpy,Other,RVU2026A,2026
41000,Drainage of mouth lesion,CPT,RVU2026A,2026
41005,Drainage of mouth lesion,CPT,RVU2026A,2026
41006,Drainage of mouth lesion,CPT,RVU2026A,2026
41007,Drainage of mouth lesion,CPT,RVU2026A,2026
41008,Drainage of mouth lesion,CPT,RVU2026A,2026
41009,Drainage of mouth lesion,CPT,RVU2026A,2026
4100F,Biphos thxpy vein ord/recvd,Other,RVU2026A,2026
41010,Incision of tongue fold,CPT,RVU2026A,2026
41015,Drainage of mouth lesion,CPT,RVU2026A,2026
41016,Drainage of mouth lesion,CPT,RVU2026A,2026
41017,Drainage of mouth lesion,CPT,RVU2026A,2026
41018,Drainage of mouth lesion,CPT,RVU2026A,2026
41019,Place needles h&n for rt,CPT,RVU2026A,2026
41100,Biopsy of tongue,CPT,RVU2026A,2026
41105,Biopsy of tongue,CPT,RVU2026A,2026
41108,Biopsy of floor of mouth,CPT,RVU2026A,2026
4110F,Int mam art used for cabg,Other,RVU2026A,2026
41110,Excision of tongue lesion,CPT,RVU2026A,2026
41112,Excision of tongue lesion,CPT,RVU2026A,2026
41113,Excision of tongue lesion,CPT,RVU2026A,2026
41114,Excision of tongue lesion,CPT,RVU2026A,2026
41115,Excision of tongue fold,CPT,RVU2026A,2026
41116,Excision of mouth lesion,CPT,RVU2026A,2026
41120,Partial removal of tongue,CPT,RVU2026A,2026
41130,Partial removal of tongue,CPT,RVU2026A,2026
41135,Tongue and neck surgery,CPT,RVU2026A,2026
41140,Removal of tongue,CPT,RVU2026A,2026
41145,Tongue removal neck surgery,CPT,RVU2026A,2026
41150,Tongue mouth jaw surgery,CPT,RVU2026A,2026
41153,Tongue mouth neck surgery,CPT,RVU2026A,2026
41155,Tongue jaw & neck surgery,CPT,RVU2026A,2026
4115F,Beta blckr admin w/in 24 hrs,Other,RVU2026A,2026
4120F,Antibiot rxd/given,Other,RVU2026A,2026
4124F,Antibiot not rxd/given,Other,RVU2026A,2026
41250,Repair tongue laceration,CPT,RVU2026A,2026
41251,Repair tongue laceration,CPT,RVU2026A,2026
41252,Repair tongue laceration,CPT,RVU2026A,2026
4130F,Topical prep rx aoe,Other,RVU2026A,2026
4131F,Syst antimicrobial thx rx,Other,RVU2026A,2026
4132F,No syst antimicrobial thx rx,Other,RVU2026A,2026
4133F,Antihist/decong rx/recom,Other,RVU2026A,2026
4134F,No antihist/decong rx/recom,Other,RVU2026A,2026
4135F,Systemic corticosteroids rx,Other,RVU2026A,2026
4136F,Syst corticosteroids not rx,Other,RVU2026A,2026
4140F,Inhaled corticosteroids rxd,Other,RVU2026A,2026
4142F,Corticoster sparng thrpy rxd,Other,RVU2026A,2026
4144F,Alt long-term cntrl med rxd,Other,RVU2026A,2026
4145F,2+ anti-hyprtnsv agents tkn,Other,RVU2026A,2026
4148F,Hep a vac injxn admin/recvd,Other,RVU2026A,2026
4149F,Hep b vac injxn admin/recvd,Other,RVU2026A,2026
4150F,Pt recvng antivir txmnt hepc,Other,RVU2026A,2026
41510,Tongue to lip surgery,CPT,RVU2026A,2026
41512,Tongue suspension,CPT,RVU2026A,2026
4151F,Pt not recvng antiv hep c,Other,RVU2026A,2026
41520,Reconstruction tongue fold,CPT,RVU2026A,2026
41530,Tongue base vol reduction,CPT,RVU2026A,2026
4153F,Combo pegintf/rib rx,Other,RVU2026A,2026
4155F,Hep a vac series prev recvd,Other,RVU2026A,2026
4157F,Hep b vac series prev recvd,Other,RVU2026A,2026
4158F,Pt edu re alcoh drnkng done,Other,RVU2026A,2026
41599,Unlisted px tongue flr mouth,CPT,RVU2026A,2026
4159F,Contrcp talk b/4 antiv txmnt,Other,RVU2026A,2026
4163F,Pt couns 4 txmnt opt prost,Other,RVU2026A,2026
4164F,Adjv hrmnl thxpy rxd,Other,RVU2026A,2026
4165F,3d-crt/imrt received,Other,RVU2026A,2026
4167F,Hd bed tilted 1st day vent,Other,RVU2026A,2026
4168F,Pt care icu&vent w/in 24hrs,Other,RVU2026A,2026
4169F,No pt care icu/vent in 24hrs,Other,RVU2026A,2026
4171F,Pt rcvng esa thxpy,Other,RVU2026A,2026
4172F,Pt not rcvng esa thxpy,Other,RVU2026A,2026
4174F,Couns potent glauc impct,Other,RVU2026A,2026
4175F,Vis 20/40/> w/in 90 days,Other,RVU2026A,2026
4176F,Talk re uv light pt/crgvr,Other,RVU2026A,2026
4177F,Talk pt/crgvr re areds prev,Other,RVU2026A,2026
4178F,Antid glbln rcvd w/in 26wks,Other,RVU2026A,2026
4179F,Tamoxifen/ai prescribed,Other,RVU2026A,2026
41800,Drainage of gum lesion,CPT,RVU2026A,2026
41805,Removal foreign body gum,CPT,RVU2026A,2026
41806,Removal foreign body jawbone,CPT,RVU2026A,2026
4180F,Adjv thxpyrxd/rcvd colon ca,Other,RVU2026A,2026
4181F,Conformal radn thxpy rcvd,Other,RVU2026A,2026
41820,Excision gum each quadrant,CPT,RVU2026A,2026
41821,Excision of gum flap,CPT,RVU2026A,2026
41822,Excision of gum lesion,CPT,RVU2026A,2026
41823,Excision of gum lesion,CPT,RVU2026A,2026
41825,Excision of gum lesion,CPT,RVU2026A,2026
41826,Excision of gum lesion,CPT,RVU2026A,2026
41827,Excision of gum lesion,CPT,RVU2026A,2026
41828,Excision of gum lesion,CPT,RVU2026A,2026
4182F,No conformal radn thxpy,Other,RVU2026A,2026
41830,Removal of gum tissue,CPT,RVU2026A,2026
41850,Treatment of gum lesion,CPT,RVU2026A,2026
4185F,Continuous ppi or h2ra rcvd,Other,RVU2026A,2026
4186F,No cont ppi or h2ra rcvd,Other,RVU2026A,2026
41870,Periodontal mucosal grafting,CPT,RVU2026A,2026
41872,Gingivoplasty each quadrant,CPT,RVU2026A,2026
41874,Alveoloplasty each quadrant,CPT,RVU2026A,2026
4187F,Anti rheum drugthxpyrxd/gvn,Other,RVU2026A,2026
4188F,Approp ace/arb tstng done,Other,RVU2026A,2026
41899,Unlisted px dentalvlr strux,CPT,RVU2026A,2026
4189F,Approp digoxin tstng done,Other,RVU2026A,2026
4190F,Approp diuretic tstng done,Other,RVU2026A,2026
4191F,Approp anticonvuls tstng,Other,RVU2026A,2026
4192F,Pt not rcvng glucoco thxpy,Other,RVU2026A,2026
4193F,Pt rcv <10mg daily predniso,Other,RVU2026A,2026
4194F,Pt rcv >=10mg daily predniso,Other,RVU2026A,2026
4195F,Pt rcvng anti-rheum thxpy ra,Other,RVU2026A,2026
4196F,Ptnot rcvng anti-rhm thxpyra,Other,RVU2026A,2026
42000,Drainage mouth roof lesion,CPT,RVU2026A,2026
4200F,External beam to prost only,Other,RVU2026A,2026
4201F,Extrnl beam other than prost,Other,RVU2026A,2026
42100,Biopsy roof of mouth,CPT,RVU2026A,2026
42104,Excision lesion mouth roof,CPT,RVU2026A,2026
42106,Excision lesion mouth roof,CPT,RVU2026A,2026
42107,Excision lesion mouth roof,CPT,RVU2026A,2026
4210F,Ace/arb thxpy for mos/>,Other,RVU2026A,2026
42120,Remove palate/lesion,CPT,RVU2026A,2026
42140,Excision of uvula,CPT,RVU2026A,2026
42145,Repair palate pharynx/uvula,CPT,RVU2026A,2026
42160,Treatment mouth roof lesion,CPT,RVU2026A,2026
42180,Repair lac palate<2 cm,CPT,RVU2026A,2026
42182,Repair palate,CPT,RVU2026A,2026
42200,Reconstruct cleft palate,CPT,RVU2026A,2026
42205,Reconstruct cleft palate,CPT,RVU2026A,2026
4220F,Digoxin thxpy for 6 mos/>,Other,RVU2026A,2026
42210,Reconstruct cleft palate,CPT,RVU2026A,2026
42215,Reconstruct cleft palate,CPT,RVU2026A,2026
4221F,Diuretic thxpy for 6 mos/>,Other,RVU2026A,2026
42220,Reconstruct cleft palate,CPT,RVU2026A,2026
42225,Reconstruct cleft palate,CPT,RVU2026A,2026
42226,Lengthening of palate,CPT,RVU2026A,2026
42227,Lengthening of palate,CPT,RVU2026A,2026
42235,Repair palate,CPT,RVU2026A,2026
42260,Repair nose to lip fistula,CPT,RVU2026A,2026
42280,Preparation palate mold,CPT,RVU2026A,2026
42281,Insertion palate prosthesis,CPT,RVU2026A,2026
42299,Unlisted px palate uvula,CPT,RVU2026A,2026
42300,Drainage of salivary gland,CPT,RVU2026A,2026
42305,Drainage of salivary gland,CPT,RVU2026A,2026
4230F,Anticonv thxpy for 6 mos/>,Other,RVU2026A,2026
42310,Drainage of salivary gland,CPT,RVU2026A,2026
42320,Drainage of salivary gland,CPT,RVU2026A,2026
42330,Removal of salivary stone,CPT,RVU2026A,2026
42335,Removal of salivary stone,CPT,RVU2026A,2026
42340,Removal of salivary stone,CPT,RVU2026A,2026
42400,Biopsy of salivary gland,CPT,RVU2026A,2026
42405,Biopsy of salivary gland,CPT,RVU2026A,2026
42408,Excision of salivary cyst,CPT,RVU2026A,2026
42409,Drainage of salivary cyst,CPT,RVU2026A,2026
4240F,Instr xrcz back pain 12 wks,Other,RVU2026A,2026
42410,Excise parotid gland/lesion,CPT,RVU2026A,2026
42415,Excise parotid gland/lesion,CPT,RVU2026A,2026
42420,Excise parotid gland/lesion,CPT,RVU2026A,2026
42425,Excise parotid gland/lesion,CPT,RVU2026A,2026
42426,Excise parotid gland/lesion,CPT,RVU2026A,2026
4242F,Sprvsd xrcz back pn >12 wks,Other,RVU2026A,2026
42440,Excise submaxillary gland,CPT,RVU2026A,2026
42450,Excise sublingual gland,CPT,RVU2026A,2026
4245F,Pt instr nrml activities,Other,RVU2026A,2026
4248F,Pt instr no bd rest 4 days/>,Other,RVU2026A,2026
42500,Repair salivary duct,CPT,RVU2026A,2026
42505,Repair salivary duct,CPT,RVU2026A,2026
42507,Parotid duct diversion,CPT,RVU2026A,2026
42509,Parotid duct diversion,CPT,RVU2026A,2026
4250F,Wrmng 4 surg normothermia,Other,RVU2026A,2026
42510,Parotid duct diversion,CPT,RVU2026A,2026
42550,Injection for salivary x-ray,CPT,RVU2026A,2026
4255F,Anesth 60 min/> as docd,Other,RVU2026A,2026
4256F,Anesthe <60 min as docd,Other,RVU2026A,2026
42600,Closure of salivary fistula,CPT,RVU2026A,2026
4260F,Wound srfc culturetech used,Other,RVU2026A,2026
4261F,Tech other than surfc cultr,Other,RVU2026A,2026
42650,Dilation of salivary duct,CPT,RVU2026A,2026
4265F,Wet-dry dressings rx recmd,Other,RVU2026A,2026
42660,Dilation of salivary duct,CPT,RVU2026A,2026
42665,Ligation of salivary duct,CPT,RVU2026A,2026
4266F,No wet-dry drssings rx recmd,Other,RVU2026A,2026
4267F,Comprssion thxpy prescribed,Other,RVU2026A,2026
4268F,Pt ed re comp thxpy rcvd,Other,RVU2026A,2026
42699,Unlisted px salivry glnd/dux,CPT,RVU2026A,2026
4269F,Appropos mthd offloading rxd,Other,RVU2026A,2026
42700,I&d abscess peritonsillar,CPT,RVU2026A,2026
4270F,Pt rcvng anti r-viral thxpy,Other,RVU2026A,2026
4271F,Pt rcvng anti r-viral thxpy,Other,RVU2026A,2026
42720,I&d absc phrngl ntraorl appr,CPT,RVU2026A,2026
42725,I&d absc phrngl xtrnl appr,CPT,RVU2026A,2026
4274F,Flu immuno admind rcvd,Other,RVU2026A,2026
4276F,Potent antivir thxpy rxd,Other,RVU2026A,2026
4279F,Pcp prophylaxis rxd,Other,RVU2026A,2026
42800,Biopsy of throat,CPT,RVU2026A,2026
42804,Biopsy of upper nose/throat,CPT,RVU2026A,2026
42806,Biopsy of upper nose/throat,CPT,RVU2026A,2026
42808,Excise pharynx lesion,CPT,RVU2026A,2026
42809,Remove pharynx foreign body,CPT,RVU2026A,2026
4280F,Pcp prophylax rxd 3mon low %,Other,RVU2026A,2026
42810,Excision of neck cyst,CPT,RVU2026A,2026
42815,Excision of neck cyst,CPT,RVU2026A,2026
42820,Remove tonsils and adenoids,CPT,RVU2026A,2026
42821,Remove tonsils and adenoids,CPT,RVU2026A,2026
42825,Removal of tonsils,CPT,RVU2026A,2026
42826,Removal of tonsils,CPT,RVU2026A,2026
42830,Removal of adenoids,CPT,RVU2026A,2026
42831,Removal of adenoids,CPT,RVU2026A,2026
42835,Removal of adenoids,CPT,RVU2026A,2026
42836,Removal of adenoids,CPT,RVU2026A,2026
42842,Extensive surgery of throat,CPT,RVU2026A,2026
42844,Extensive surgery of throat,CPT,RVU2026A,2026
42845,Extensive surgery of throat,CPT,RVU2026A,2026
42860,Excision of tonsil tags,CPT,RVU2026A,2026
42870,Excision of lingual tonsil,CPT,RVU2026A,2026
42890,Limited pharyngectomy,CPT,RVU2026A,2026
42892,Revision of pharyngeal walls,CPT,RVU2026A,2026
42894,Revision of pharyngeal walls,CPT,RVU2026A,2026
42900,Repair throat wound,CPT,RVU2026A,2026
4290F,Pt scrned for inj drug use,Other,RVU2026A,2026
4293F,Pt scrnd hgh-risk sex behav,Other,RVU2026A,2026
42950,Reconstruction of throat,CPT,RVU2026A,2026
42953,Repair throat esophagus,CPT,RVU2026A,2026
42955,Surgical opening of throat,CPT,RVU2026A,2026
42960,Control throat bleeding,CPT,RVU2026A,2026
42961,Control throat bleeding,CPT,RVU2026A,2026
42962,Control throat bleeding,CPT,RVU2026A,2026
42970,Control nose/throat bleeding,CPT,RVU2026A,2026
42971,Control nose/throat bleeding,CPT,RVU2026A,2026
42972,Control nose/throat bleeding,CPT,RVU2026A,2026
42975,Dise eval slp do brth flx dx,CPT,RVU2026A,2026
42999,Unlisted px phrnx adnd/tnsl,CPT,RVU2026A,2026
4300F,Pt rcvng warf thxpy,Other,RVU2026A,2026
4301F,Pt not rcvng warf thxpy,Other,RVU2026A,2026
43020,Incision of esophagus,CPT,RVU2026A,2026
43030,Cricopharyngeal myotomy,CPT,RVU2026A,2026
43045,Esophagotomy thrc rmvl fb,CPT,RVU2026A,2026
4305F,Pt ed re ft care inspct rcvd,Other,RVU2026A,2026
4306F,Pt tlk psych & rx opd addic,Other,RVU2026A,2026
43100,Excision of esophagus lesion,CPT,RVU2026A,2026
43101,Excision of esophagus lesion,CPT,RVU2026A,2026
43107,Removal of esophagus,CPT,RVU2026A,2026
43108,Removal of esophagus,CPT,RVU2026A,2026
43112,Esphg tot w/thrcm,CPT,RVU2026A,2026
43113,Removal of esophagus,CPT,RVU2026A,2026
43116,Partial removal of esophagus,CPT,RVU2026A,2026
43117,Partial removal of esophagus,CPT,RVU2026A,2026
43118,Partial removal of esophagus,CPT,RVU2026A,2026
43121,Partial removal of esophagus,CPT,RVU2026A,2026
43122,Partial removal of esophagus,CPT,RVU2026A,2026
43123,Partial removal of esophagus,CPT,RVU2026A,2026
43124,Removal of esophagus,CPT,RVU2026A,2026
43130,Removal of esophagus pouch,CPT,RVU2026A,2026
43135,Removal of esophagus pouch,CPT,RVU2026A,2026
43180,Esophagoscopy rigid trnso,CPT,RVU2026A,2026
43191,Esophagoscopy rigid trnso dx,CPT,RVU2026A,2026
43192,Esophagoscp rig trnso inject,CPT,RVU2026A,2026
43193,Esophagoscp rig trnso biopsy,CPT,RVU2026A,2026
43194,Esophagoscp rig trnso rem fb,CPT,RVU2026A,2026
43195,Esophagoscopy rigid balloon,CPT,RVU2026A,2026
43196,Esophagoscp guide wire dilat,CPT,RVU2026A,2026
43197,Esophagoscopy flex dx brush,CPT,RVU2026A,2026
43198,Esophagosc flex trnsn biopsy,CPT,RVU2026A,2026
43200,Esophagoscopy flexible brush,CPT,RVU2026A,2026
43201,Esoph scope w/submucous inj,CPT,RVU2026A,2026
43202,Esophagoscopy flex biopsy,CPT,RVU2026A,2026
43204,Esoph scope w/sclerosis inj,CPT,RVU2026A,2026
43205,Esophagus endoscopy/ligation,CPT,RVU2026A,2026
43206,Esoph optical endomicroscopy,CPT,RVU2026A,2026
4320F,Pt talk psychsoc&rx oh dpnd,Other,RVU2026A,2026
43210,Egd esophagogastrc fndoplsty,CPT,RVU2026A,2026
43211,Esophagoscop mucosal resect,CPT,RVU2026A,2026
43212,Esophagoscop stent placement,CPT,RVU2026A,2026
43213,Esophagoscopy retro balloon,CPT,RVU2026A,2026
43214,Esophagosc dilate balloon 30,CPT,RVU2026A,2026
43215,Esophagoscopy flex remove fb,CPT,RVU2026A,2026
43216,Esophagoscopy lesion removal,CPT,RVU2026A,2026
43217,Esophagoscopy snare les remv,CPT,RVU2026A,2026
43220,Esophagoscopy balloon <30mm,CPT,RVU2026A,2026
43226,Esoph endoscopy dilation,CPT,RVU2026A,2026
43227,Esophagoscopy control bleed,CPT,RVU2026A,2026
43229,Esophagoscopy lesion ablate,CPT,RVU2026A,2026
4322F,Crgvr prov w/ ed addl rsrcs,Other,RVU2026A,2026
43231,Esophagoscop ultrasound exam,CPT,RVU2026A,2026
43232,Esophagoscopy w/us needle bx,CPT,RVU2026A,2026
43233,Egd balloon dil esoph30 mm/>,CPT,RVU2026A,2026
43235,Egd diagnostic brush wash,CPT,RVU2026A,2026
43236,Uppr gi scope w/submuc inj,CPT,RVU2026A,2026
43237,Endoscopic us exam esoph,CPT,RVU2026A,2026
43238,Egd us fine needle bx/aspir,CPT,RVU2026A,2026
43239,Egd biopsy single/multiple,CPT,RVU2026A,2026
43240,Egd w/transmural drain cyst,CPT,RVU2026A,2026
43241,Egd tube/cath insertion,CPT,RVU2026A,2026
43242,Egd us fine needle bx/aspir,CPT,RVU2026A,2026
43243,Egd injection varices,CPT,RVU2026A,2026
43244,Egd varices ligation,CPT,RVU2026A,2026
43245,Egd dilate stricture,CPT,RVU2026A,2026
43246,Egd place gastrostomy tube,CPT,RVU2026A,2026
43247,Egd remove foreign body,CPT,RVU2026A,2026
43248,Egd guide wire insertion,CPT,RVU2026A,2026
43249,Esoph egd dilation <30 mm,CPT,RVU2026A,2026
4324F,Pt queried prkns complic,Other,RVU2026A,2026
43250,Egd cautery tumor polyp,CPT,RVU2026A,2026
43251,Egd remove lesion snare,CPT,RVU2026A,2026
43252,Egd optical endomicroscopy,CPT,RVU2026A,2026
43253,Egd us transmural injxn/mark,CPT,RVU2026A,2026
43254,Egd endo mucosal resection,CPT,RVU2026A,2026
43255,Egd control bleeding any,CPT,RVU2026A,2026
43257,Egd w/thrml txmnt gerd,CPT,RVU2026A,2026
43259,Egd us exam duodenum/jejunum,CPT,RVU2026A,2026
4325F,Med txmnt options rvwd w/pt,Other,RVU2026A,2026
43260,Ercp w/specimen collection,CPT,RVU2026A,2026
43261,Endo cholangiopancreatograph,CPT,RVU2026A,2026
43262,Endo cholangiopancreatograph,CPT,RVU2026A,2026
43263,Ercp sphincter pressure meas,CPT,RVU2026A,2026
43264,Ercp remove duct calculi,CPT,RVU2026A,2026
43265,Ercp lithotripsy calculi,CPT,RVU2026A,2026
43266,Egd endoscopic stent place,CPT,RVU2026A,2026
4326F,Pt asked re symp auto dysfxn,Other,RVU2026A,2026
43270,Egd lesion ablation,CPT,RVU2026A,2026
43273,Endoscopic pancreatoscopy,CPT,RVU2026A,2026
43274,Ercp duct stent placement,CPT,RVU2026A,2026
43275,Ercp remove forgn body duct,CPT,RVU2026A,2026
43276,Ercp stent exchange w/dilate,CPT,RVU2026A,2026
43277,Ercp ea duct/ampulla dilate,CPT,RVU2026A,2026
43278,Ercp lesion ablate w/dilate,CPT,RVU2026A,2026
43279,Lap myotomy heller,CPT,RVU2026A,2026
43280,Laparoscopy fundoplasty,CPT,RVU2026A,2026
43281,Lap paraesophag hern repair,CPT,RVU2026A,2026
43282,Lap paraesoph her rpr w/mesh,CPT,RVU2026A,2026
43283,Lap esoph lengthening,CPT,RVU2026A,2026
43284,Laps esophgl sphnctr agmntj,CPT,RVU2026A,2026
43285,Rmvl esophgl sphnctr dev,CPT,RVU2026A,2026
43286,Esphg tot w/laps moblj,CPT,RVU2026A,2026
43287,Esphg dstl 2/3 w/laps moblj,CPT,RVU2026A,2026
43288,Esphg thrsc moblj,CPT,RVU2026A,2026
43289,Unlisted laps px esoph,CPT,RVU2026A,2026
4328F,Pt asked re sleep disturb,Other,RVU2026A,2026
43290,Egd flx trnsorl dplmnt balo,CPT,RVU2026A,2026
43291,Egd flx trnsorl rmvl balo,CPT,RVU2026A,2026
43300,Repair of esophagus,CPT,RVU2026A,2026
43305,Repair esophagus and fistula,CPT,RVU2026A,2026
4330F,Cnslng epi spec sfty issues,Other,RVU2026A,2026
43310,Repair of esophagus,CPT,RVU2026A,2026
43312,Repair esophagus and fistula,CPT,RVU2026A,2026
43313,Esophagoplasty congenital,CPT,RVU2026A,2026
43314,Tracheo-esophagoplasty cong,CPT,RVU2026A,2026
43320,Fuse esophagus & stomach,CPT,RVU2026A,2026
43325,Revise esophagus & stomach,CPT,RVU2026A,2026
43327,Esoph fundoplasty lap,CPT,RVU2026A,2026
43328,Esoph fundoplasty thor,CPT,RVU2026A,2026
43330,Esophagomyotomy abdominal,CPT,RVU2026A,2026
43331,Esophagomyotomy thoracic,CPT,RVU2026A,2026
43332,Transab esoph hiat hern rpr,CPT,RVU2026A,2026
43333,Transab esoph hiat hern rpr,CPT,RVU2026A,2026
43334,Transthor diaphrag hern rpr,CPT,RVU2026A,2026
43335,Transthor diaphrag hern rpr,CPT,RVU2026A,2026
43336,Thorabd diaphr hern repair,CPT,RVU2026A,2026
43337,Thorabd diaphr hern repair,CPT,RVU2026A,2026
43338,Esoph lengthening,CPT,RVU2026A,2026
43340,Fuse esophagus & intestine,CPT,RVU2026A,2026
43341,Fuse esophagus & intestine,CPT,RVU2026A,2026
43351,Surgical opening esophagus,CPT,RVU2026A,2026
43352,Surgical opening esophagus,CPT,RVU2026A,2026
43360,Gastrointestinal repair,CPT,RVU2026A,2026
43361,Gastrointestinal repair,CPT,RVU2026A,2026
43400,Ligate esophagus veins,CPT,RVU2026A,2026
43405,Ligate/staple esophagus,CPT,RVU2026A,2026
4340F,Cnslng chldbrng women epi,Other,RVU2026A,2026
43410,Repair esophagus wound,CPT,RVU2026A,2026
43415,Repair esophagus wound,CPT,RVU2026A,2026
43420,Repair esophagus opening,CPT,RVU2026A,2026
43425,Repair esophagus opening,CPT,RVU2026A,2026
43450,Dilate esophagus 1/mult pass,CPT,RVU2026A,2026
43453,Dilate esophagus,CPT,RVU2026A,2026
43460,Pressure treatment esophagus,CPT,RVU2026A,2026
43496,Free jejunum flap microvasc,CPT,RVU2026A,2026
43497,Transorl lwr esophgl myotomy,CPT,RVU2026A,2026
43499,Unlisted procedure esophagus,CPT,RVU2026A,2026
43500,Surgical opening of stomach,CPT,RVU2026A,2026
43501,Surgical repair of stomach,CPT,RVU2026A,2026
43502,Surgical repair of stomach,CPT,RVU2026A,2026
4350F,Cnslng provided symp mngmnt,Other,RVU2026A,2026
43510,Surgical opening of stomach,CPT,RVU2026A,2026
43520,Incision of pyloric muscle,CPT,RVU2026A,2026
43605,Biopsy of stomach,CPT,RVU2026A,2026
43610,Excision of stomach lesion,CPT,RVU2026A,2026
43611,Excision of stomach lesion,CPT,RVU2026A,2026
43620,Removal of stomach,CPT,RVU2026A,2026
43621,Removal of stomach,CPT,RVU2026A,2026
43622,Removal of stomach,CPT,RVU2026A,2026
43631,Removal of stomach partial,CPT,RVU2026A,2026
43632,Removal of stomach partial,CPT,RVU2026A,2026
43633,Removal of stomach partial,CPT,RVU2026A,2026
43634,Removal of stomach partial,CPT,RVU2026A,2026
43635,Removal of stomach partial,CPT,RVU2026A,2026
43640,Vagotomy & pylorus repair,CPT,RVU2026A,2026
43641,Vagotomy & pylorus repair,CPT,RVU2026A,2026
43644,Lap gastric bypass/roux-en-y,CPT,RVU2026A,2026
43645,Lap gastr bypass incl smll i,CPT,RVU2026A,2026
43647,Lap impl electrode antrum,CPT,RVU2026A,2026
43648,Lap revise/remv eltrd antrum,CPT,RVU2026A,2026
43651,Laparoscopy vagus nerve,CPT,RVU2026A,2026
43652,Laparoscopy vagus nerve,CPT,RVU2026A,2026
43653,Laparoscopy gastrostomy,CPT,RVU2026A,2026
43659,Unlisted laps px stomach,CPT,RVU2026A,2026
43752,Nasal/orogastric w/tube plmt,CPT,RVU2026A,2026
43753,Tx gastro intub w/asp,CPT,RVU2026A,2026
43754,Dx gastr intub w/asp spec,CPT,RVU2026A,2026
43755,Dx gastr intub w/asp specs,CPT,RVU2026A,2026
43756,Dx duod intub w/asp spec,CPT,RVU2026A,2026
43757,Dx duod intub w/asp specs,CPT,RVU2026A,2026
43761,Reposition gastrostomy tube,CPT,RVU2026A,2026
43762,Rplc gtube no revj trc,CPT,RVU2026A,2026
43763,Rplc gtube revj gstrst trc,CPT,RVU2026A,2026
43770,Lap place gastr adj device,CPT,RVU2026A,2026
43771,Lap revise gastr adj device,CPT,RVU2026A,2026
43772,Lap rmvl gastr adj device,CPT,RVU2026A,2026
43773,Lap replace gastr adj device,CPT,RVU2026A,2026
43774,Lap rmvl gastr adj all parts,CPT,RVU2026A,2026
43775,Lap sleeve gastrectomy,CPT,RVU2026A,2026
43800,Pyloroplasty,CPT,RVU2026A,2026
43810,Gastroduodenostomy,CPT,RVU2026A,2026
43820,Gastrojejunostomy wo vagotmy,CPT,RVU2026A,2026
43825,Gastrojejunostomy w/vagotomy,CPT,RVU2026A,2026
43830,Gstrst open wo constj tube,CPT,RVU2026A,2026
43831,Gastrostomy open neonatal,CPT,RVU2026A,2026
43832,Gstrst open w/constj tube,CPT,RVU2026A,2026
43840,Gstrrphy sutr duol/gstr ulcr,CPT,RVU2026A,2026
43842,Gstr rstcv px v-banded gstp,CPT,RVU2026A,2026
43843,Gstr rstcv oth/thn v-band,CPT,RVU2026A,2026
43845,Gastroplasty duodenal switch,CPT,RVU2026A,2026
43846,Gstr rstcv px shrt roux-en-y,CPT,RVU2026A,2026
43847,Gstr rstcv px sm int rcnstj,CPT,RVU2026A,2026
43848,Revj open gstr rstcv px,CPT,RVU2026A,2026
43860,Revj gstr/jj anast w/o vgtmy,CPT,RVU2026A,2026
43865,Revj gstr/jj anast w/vgtmy,CPT,RVU2026A,2026
43870,Closure gastrostomy surgical,CPT,RVU2026A,2026
43880,Closure gastrocolic fistula,CPT,RVU2026A,2026
43881,Impl/rplcmt gstr nstim eltrd,CPT,RVU2026A,2026
43882,Rev/rmvl gstr nstim eltrd,CPT,RVU2026A,2026
43886,Gstr rstcv px opn revj port,CPT,RVU2026A,2026
43887,Gstr rstcv px opn rmvl port,CPT,RVU2026A,2026
43888,Gstr rstcv px opn rmvl&rplc,CPT,RVU2026A,2026
43889,Gstr rstcv px trnsorl esg,CPT,RVU2026A,2026
43999,Unlisted procedure stomach,CPT,RVU2026A,2026
44005,Freeing of bowel adhesion,CPT,RVU2026A,2026
4400F,Rehab thxpy options w/pt,Other,RVU2026A,2026
44010,Incision of small bowel,CPT,RVU2026A,2026
44015,Insert needle cath bowel,CPT,RVU2026A,2026
44020,Explore small intestine,CPT,RVU2026A,2026
44021,Decompress small bowel,CPT,RVU2026A,2026
44025,Incision of large bowel,CPT,RVU2026A,2026
44050,Reduce bowel obstruction,CPT,RVU2026A,2026
44055,Correct malrotation of bowel,CPT,RVU2026A,2026
44100,Biopsy of bowel,CPT,RVU2026A,2026
44110,Excise intestine lesion(s),CPT,RVU2026A,2026
44111,Excision of bowel lesion(s),CPT,RVU2026A,2026
44120,Removal of small intestine,CPT,RVU2026A,2026
44121,Removal of small intestine,CPT,RVU2026A,2026
44125,Removal of small intestine,CPT,RVU2026A,2026
44126,Enterectomy w/o taper cong,CPT,RVU2026A,2026
44127,Enterectomy w/taper cong,CPT,RVU2026A,2026
44128,Enterectomy cong add-on,CPT,RVU2026A,2026
44130,Bowel to bowel fusion,CPT,RVU2026A,2026
44132,Enterectomy cadaver donor,CPT,RVU2026A,2026
44133,Enterectomy live donor,CPT,RVU2026A,2026
44135,Intestine transplnt cadaver,CPT,RVU2026A,2026
44136,Intestine transplant live,CPT,RVU2026A,2026
44137,Remove intestinal allograft,CPT,RVU2026A,2026
44139,Mobilization of colon,CPT,RVU2026A,2026
44140,Partial removal of colon,CPT,RVU2026A,2026
44141,Partial removal of colon,CPT,RVU2026A,2026
44143,Partial removal of colon,CPT,RVU2026A,2026
44144,Partial removal of colon,CPT,RVU2026A,2026
44145,Partial removal of colon,CPT,RVU2026A,2026
44146,Partial removal of colon,CPT,RVU2026A,2026
44147,Partial removal of colon,CPT,RVU2026A,2026
44150,Removal of colon,CPT,RVU2026A,2026
44151,Removal of colon/ileostomy,CPT,RVU2026A,2026
44155,Removal of colon/ileostomy,CPT,RVU2026A,2026
44156,Removal of colon/ileostomy,CPT,RVU2026A,2026
44157,Colectomy w/ileoanal anast,CPT,RVU2026A,2026
44158,Colectomy w/neo-rectum pouch,CPT,RVU2026A,2026
44160,Removal of colon,CPT,RVU2026A,2026
44180,Lap enterolysis,CPT,RVU2026A,2026
44186,Lap jejunostomy,CPT,RVU2026A,2026
44187,Lap ileo/jejuno-stomy,CPT,RVU2026A,2026
44188,Lap colostomy,CPT,RVU2026A,2026
44202,Lap enterectomy,CPT,RVU2026A,2026
44203,Lap resect s/intestine addl,CPT,RVU2026A,2026
44204,Laparo partial colectomy,CPT,RVU2026A,2026
44205,Lap colectomy part w/ileum,CPT,RVU2026A,2026
44206,Lap part colectomy w/stoma,CPT,RVU2026A,2026
44207,L colectomy/coloproctostomy,CPT,RVU2026A,2026
44208,L colectomy/coloproctostomy,CPT,RVU2026A,2026
44210,Laparo total proctocolectomy,CPT,RVU2026A,2026
44211,Lap colectomy w/proctectomy,CPT,RVU2026A,2026
44212,Laparo total proctocolectomy,CPT,RVU2026A,2026
44213,Lap mobil splenic fl add-on,CPT,RVU2026A,2026
44227,Lap close enterostomy,CPT,RVU2026A,2026
44238,Unlisted laps px intestine,CPT,RVU2026A,2026
44300,Open bowel to skin,CPT,RVU2026A,2026
44310,Ileostomy/jejunostomy,CPT,RVU2026A,2026
44312,Revision of ileostomy,CPT,RVU2026A,2026
44314,Revision of ileostomy,CPT,RVU2026A,2026
44316,Devise bowel pouch,CPT,RVU2026A,2026
44320,Colostomy,CPT,RVU2026A,2026
44322,Colostomy with biopsies,CPT,RVU2026A,2026
44340,Revision of colostomy,CPT,RVU2026A,2026
44345,Revision of colostomy,CPT,RVU2026A,2026
44346,Revision of colostomy,CPT,RVU2026A,2026
44360,Small bowel endoscopy,CPT,RVU2026A,2026
44361,Small bowel endoscopy/biopsy,CPT,RVU2026A,2026
44363,Small bowel endoscopy,CPT,RVU2026A,2026
44364,Small bowel endoscopy,CPT,RVU2026A,2026
44365,Small bowel endoscopy,CPT,RVU2026A,2026
44366,Small bowel endoscopy,CPT,RVU2026A,2026
44369,Small bowel endoscopy,CPT,RVU2026A,2026
44370,Small bowel endoscopy/stent,CPT,RVU2026A,2026
44372,Small bowel endoscopy,CPT,RVU2026A,2026
44373,Small bowel endoscopy,CPT,RVU2026A,2026
44376,Small bowel endoscopy,CPT,RVU2026A,2026
44377,Small bowel endoscopy/biopsy,CPT,RVU2026A,2026
44378,Small bowel endoscopy,CPT,RVU2026A,2026
44379,S bowel endoscope w/stent,CPT,RVU2026A,2026
44380,Small bowel endoscopy br/wa,CPT,RVU2026A,2026
44381,Small bowel endoscopy br/wa,CPT,RVU2026A,2026
44382,Small bowel endoscopy,CPT,RVU2026A,2026
44384,Small bowel endoscopy,CPT,RVU2026A,2026
44385,Endoscopy of bowel pouch,CPT,RVU2026A,2026
44386,Endoscopy bowel pouch/biop,CPT,RVU2026A,2026
44388,Colonoscopy thru stoma spx,CPT,RVU2026A,2026
44389,Colonoscopy with biopsy,CPT,RVU2026A,2026
44390,Colonoscopy for foreign body,CPT,RVU2026A,2026
44391,Colonoscopy for bleeding,CPT,RVU2026A,2026
44392,Colonoscopy & polypectomy,CPT,RVU2026A,2026
44394,Colonoscopy w/snare,CPT,RVU2026A,2026
44401,Colonoscopy with ablation,CPT,RVU2026A,2026
44402,Colonoscopy w/stent plcmt,CPT,RVU2026A,2026
44403,Colonoscopy w/resection,CPT,RVU2026A,2026
44404,Colonoscopy w/injection,CPT,RVU2026A,2026
44405,Colonoscopy w/dilation,CPT,RVU2026A,2026
44406,Colonoscopy w/ultrasound,CPT,RVU2026A,2026
44407,Colonoscopy w/ndl aspir/bx,CPT,RVU2026A,2026
44408,Colonoscopy w/decompression,CPT,RVU2026A,2026
44500,Intro gastrointestinal tube,CPT,RVU2026A,2026
4450F,Self-care ed provided to pt,Other,RVU2026A,2026
44602,Suture small intestine,CPT,RVU2026A,2026
44603,Suture small intestine,CPT,RVU2026A,2026
44604,Suture large intestine,CPT,RVU2026A,2026
44605,Repair of bowel lesion,CPT,RVU2026A,2026
44615,Intestinal stricturoplasty,CPT,RVU2026A,2026
44620,Repair bowel opening,CPT,RVU2026A,2026
44625,Repair bowel opening,CPT,RVU2026A,2026
44626,Repair bowel opening,CPT,RVU2026A,2026
44640,Repair bowel-skin fistula,CPT,RVU2026A,2026
44650,Repair bowel fistula,CPT,RVU2026A,2026
44660,Repair bowel-bladder fistula,CPT,RVU2026A,2026
44661,Repair bowel-bladder fistula,CPT,RVU2026A,2026
44680,Surgical revision intestine,CPT,RVU2026A,2026
44700,Suspend bowel w/prosthesis,CPT,RVU2026A,2026
44701,Intraop colon lavage add-on,CPT,RVU2026A,2026
44705,Prepare fecal microbiota,CPT,RVU2026A,2026
4470F,Icd counseling provided,Other,RVU2026A,2026
44715,Prepare donor intestine,CPT,RVU2026A,2026
44720,Prep donor intestine/venous,CPT,RVU2026A,2026
44721,Prep donor intestine/artery,CPT,RVU2026A,2026
44799,Unlisted px small intestine,CPT,RVU2026A,2026
44800,Excision of bowel pouch,CPT,RVU2026A,2026
4480F,Pt rcvng ace/arb b-blockertx,Other,RVU2026A,2026
4481F,Pt rcvng ace/arb blker <3mos,Other,RVU2026A,2026
44820,Excision of mesentery lesion,CPT,RVU2026A,2026
44850,Repair of mesentery,CPT,RVU2026A,2026
44899,Unlisted px meckel's dvrtclm,CPT,RVU2026A,2026
44900,I&d appendix abscess open,CPT,RVU2026A,2026
44950,Appendectomy,CPT,RVU2026A,2026
44955,Appendectomy add-on,CPT,RVU2026A,2026
44960,Appendectomy,CPT,RVU2026A,2026
44970,Laparoscopy appendectomy,CPT,RVU2026A,2026
44979,Unlisted laps px appendix,CPT,RVU2026A,2026
45000,Drainage of pelvic abscess,CPT,RVU2026A,2026
45005,Drainage of rectal abscess,CPT,RVU2026A,2026
4500F,Ref to outpt card rehab prog,Other,RVU2026A,2026
45020,Drainage of rectal abscess,CPT,RVU2026A,2026
45100,Biopsy of rectum,CPT,RVU2026A,2026
45108,Anorectal myomectomy,CPT,RVU2026A,2026
4510F,Prev cardrehab qualcardevent,Other,RVU2026A,2026
45110,Removal of rectum,CPT,RVU2026A,2026
45111,Partial removal of rectum,CPT,RVU2026A,2026
45112,Removal of rectum,CPT,RVU2026A,2026
45113,Partial proctectomy,CPT,RVU2026A,2026
45114,Partial removal of rectum,CPT,RVU2026A,2026
45116,Partial removal of rectum,CPT,RVU2026A,2026
45119,Remove rectum w/reservoir,CPT,RVU2026A,2026
45120,Removal of rectum,CPT,RVU2026A,2026
45121,Removal of rectum and colon,CPT,RVU2026A,2026
45123,Partial proctectomy,CPT,RVU2026A,2026
45126,Pelvic exenteration,CPT,RVU2026A,2026
45130,Excision of rectal prolapse,CPT,RVU2026A,2026
45135,Excision of rectal prolapse,CPT,RVU2026A,2026
45136,Excise ileoanal reservior,CPT,RVU2026A,2026
45150,Excision of rectal stricture,CPT,RVU2026A,2026
45160,Excision of rectal lesion,CPT,RVU2026A,2026
45171,Exc rect tum transanal part,CPT,RVU2026A,2026
45172,Exc rect tum transanal full,CPT,RVU2026A,2026
45190,Destruction rectal tumor,CPT,RVU2026A,2026
4525F,Neuropsychia interven order,Other,RVU2026A,2026
4526F,Neuropsychia interven rcvd,Other,RVU2026A,2026
45300,Proctosigmoidoscopy dx,CPT,RVU2026A,2026
45303,Proctosigmoidoscopy dilate,CPT,RVU2026A,2026
45305,Proctosigmoidoscopy w/bx,CPT,RVU2026A,2026
45307,Proctosigmoidoscopy fb,CPT,RVU2026A,2026
45308,Proctosigmoidoscopy removal,CPT,RVU2026A,2026
45309,Proctosigmoidoscopy removal,CPT,RVU2026A,2026
45315,Proctosigmoidoscopy removal,CPT,RVU2026A,2026
45317,Proctosigmoidoscopy bleed,CPT,RVU2026A,2026
45320,Proctosigmoidoscopy ablate,CPT,RVU2026A,2026
45321,Proctosigmoidoscopy volvul,CPT,RVU2026A,2026
45327,Proctosigmoidoscopy w/stent,CPT,RVU2026A,2026
45330,Diagnostic sigmoidoscopy,CPT,RVU2026A,2026
45331,Sigmoidoscopy and biopsy,CPT,RVU2026A,2026
45332,Sigmoidoscopy w/fb removal,CPT,RVU2026A,2026
45333,Sigmoidoscopy & polypectomy,CPT,RVU2026A,2026
45334,Sigmoidoscopy for bleeding,CPT,RVU2026A,2026
45335,Sigmoidoscopy w/submuc inj,CPT,RVU2026A,2026
45337,Sigmoidoscopy & decompress,CPT,RVU2026A,2026
45338,Sigmoidoscopy w/tumr remove,CPT,RVU2026A,2026
45340,Sig w/tndsc balloon dilation,CPT,RVU2026A,2026
45341,Sigmoidoscopy w/ultrasound,CPT,RVU2026A,2026
45342,Sigmoidoscopy w/us guide bx,CPT,RVU2026A,2026
45346,Sigmoidoscopy w/ablation,CPT,RVU2026A,2026
45347,Sigmoidoscopy w/plcmt stent,CPT,RVU2026A,2026
45349,Sigmoidoscopy w/resection,CPT,RVU2026A,2026
45350,Sgmdsc w/band ligation,CPT,RVU2026A,2026
45378,Diagnostic colonoscopy,CPT,RVU2026A,2026
45379,Colonoscopy w/fb removal,CPT,RVU2026A,2026
45380,Colonoscopy and biopsy,CPT,RVU2026A,2026
45381,Colonoscopy submucous njx,CPT,RVU2026A,2026
45382,Colonoscopy w/control bleed,CPT,RVU2026A,2026
45384,Colonoscopy w/lesion removal,CPT,RVU2026A,2026
45385,Colonoscopy w/lesion removal,CPT,RVU2026A,2026
45386,Colonoscopy w/balloon dilat,CPT,RVU2026A,2026
45388,Colonoscopy w/ablation,CPT,RVU2026A,2026
45389,Colonoscopy w/stent plcmt,CPT,RVU2026A,2026
45390,Colonoscopy w/resection,CPT,RVU2026A,2026
45391,Colonoscopy w/endoscope us,CPT,RVU2026A,2026
45392,Colonoscopy w/endoscopic fnb,CPT,RVU2026A,2026
45393,Colonoscopy w/decompression,CPT,RVU2026A,2026
45395,Lap removal of rectum,CPT,RVU2026A,2026
45397,Lap remove rectum w/pouch,CPT,RVU2026A,2026
45398,Colonoscopy w/band ligation,CPT,RVU2026A,2026
45399,Unlisted procedure colon,CPT,RVU2026A,2026
45400,Laparoscopic proc,CPT,RVU2026A,2026
45402,Lap proctopexy w/sig resect,CPT,RVU2026A,2026
4540F,Disease modif pharmacothxpy,Other,RVU2026A,2026
4541F,Pt offered tx for pseudobulb,Other,RVU2026A,2026
45499,Laparoscope proc rectum,CPT,RVU2026A,2026
45500,Repair of rectum,CPT,RVU2026A,2026
45505,Repair of rectum,CPT,RVU2026A,2026
4550F,Noninvas resp support talk,Other,RVU2026A,2026
4551F,Nutritional support offered,Other,RVU2026A,2026
45520,Treatment of rectal prolapse,CPT,RVU2026A,2026
4552F,Pt ref for speech lang path,Other,RVU2026A,2026
4553F,Pt asst re end life issues,Other,RVU2026A,2026
45540,Correct rectal prolapse,CPT,RVU2026A,2026
45541,Correct rectal prolapse,CPT,RVU2026A,2026
4554F,Pt recvd inhal anesthetic,Other,RVU2026A,2026
45550,Repair rectum/remove sigmoid,CPT,RVU2026A,2026
4555F,Pt recvd no inhal anesthic,Other,RVU2026A,2026
45560,Repair of rectocele,CPT,RVU2026A,2026
45562,Exploration/repair of rectum,CPT,RVU2026A,2026
45563,Exploration/repair of rectum,CPT,RVU2026A,2026
4556F,Pt w/3+ post-op nausea&vom,Other,RVU2026A,2026
4557F,Pt w/o 3+ post-opnausea&vom,Other,RVU2026A,2026
4558F,Pt recvd 2 rx anti-emet agt,Other,RVU2026A,2026
4559F,1 bodytemp >=35.5cw/in 30min,Other,RVU2026A,2026
4560F,Anesth w/o gen/neurax anesth,Other,RVU2026A,2026
4561F,Pt w/ coronary artery stent,Other,RVU2026A,2026
4562F,Pt w/o coronary artery stent,Other,RVU2026A,2026
4563F,Pt recvd aspirin w/in 24 hrs,Other,RVU2026A,2026
45800,Repair rect/bladder fistula,CPT,RVU2026A,2026
45805,Repair fistula w/colostomy,CPT,RVU2026A,2026
45820,Repair rectourethral fistula,CPT,RVU2026A,2026
45825,Repair fistula w/colostomy,CPT,RVU2026A,2026
45900,Reduction of rectal prolapse,CPT,RVU2026A,2026
45905,Dilation of anal sphincter,CPT,RVU2026A,2026
45910,Dilation of rectal narrowing,CPT,RVU2026A,2026
45915,Remove rectal obstruction,CPT,RVU2026A,2026
45990,Surg dx exam anorectal,CPT,RVU2026A,2026
45999,Unlisted procedure rectum,CPT,RVU2026A,2026
46020,Placement of seton,CPT,RVU2026A,2026
46030,Removal anal seton oth mrk,CPT,RVU2026A,2026
46040,I&d ischiorct&/perirct absc,CPT,RVU2026A,2026
46045,I&d absc tranal under anes,CPT,RVU2026A,2026
46050,I&d perianal abscess supfc,CPT,RVU2026A,2026
46060,I&d ischiorectal/ntrmrl absc,CPT,RVU2026A,2026
46070,Incision anal septum infant,CPT,RVU2026A,2026
46080,Sphnctrotmy anal div sphnctr,CPT,RVU2026A,2026
46083,Inc thrombosed hroid xtrnl,CPT,RVU2026A,2026
46200,Removal of anal fissure,CPT,RVU2026A,2026
46220,Excise anal ext tag/papilla,CPT,RVU2026A,2026
46221,Ligation of hemorrhoid(s),CPT,RVU2026A,2026
46230,Removal of anal tags,CPT,RVU2026A,2026
46250,Remove ext hem groups 2+,CPT,RVU2026A,2026
46255,Remove int/ext hem 1 group,CPT,RVU2026A,2026
46257,Remove in/ex hem grp & fiss,CPT,RVU2026A,2026
46258,Remove in/ex hem grp w/fistu,CPT,RVU2026A,2026
46260,Remove in/ex hem groups 2+,CPT,RVU2026A,2026
46261,Remove in/ex hem grps & fiss,CPT,RVU2026A,2026
46262,Remove in/ex hem grps w/fist,CPT,RVU2026A,2026
46270,Remove anal fist subq,CPT,RVU2026A,2026
46275,Remove anal fist inter,CPT,RVU2026A,2026
46280,Remove anal fist complex,CPT,RVU2026A,2026
46285,Remove anal fist 2 stage,CPT,RVU2026A,2026
46288,Repair anal fistula,CPT,RVU2026A,2026
46320,Removal of hemorrhoid clot,CPT,RVU2026A,2026
46500,Injection into hemorrhoid(s),CPT,RVU2026A,2026
46505,Chemodenervation anal musc,CPT,RVU2026A,2026
46600,Diagnostic anoscopy spx,CPT,RVU2026A,2026
46601,Diagnostic anoscopy,CPT,RVU2026A,2026
46604,Anoscopy and dilation,CPT,RVU2026A,2026
46606,Anoscopy and biopsy,CPT,RVU2026A,2026
46607,Diagnostic anoscopy & biopsy,CPT,RVU2026A,2026
46608,Anoscopy remove for body,CPT,RVU2026A,2026
46610,Anoscopy remove lesion,CPT,RVU2026A,2026
46611,Anoscopy,CPT,RVU2026A,2026
46612,Anoscopy remove lesions,CPT,RVU2026A,2026
46614,Anoscopy control bleeding,CPT,RVU2026A,2026
46615,Anoscopy,CPT,RVU2026A,2026
46700,Repair of anal stricture,CPT,RVU2026A,2026
46705,Repair of anal stricture,CPT,RVU2026A,2026
46706,Repr of anal fistula w/glue,CPT,RVU2026A,2026
46707,Repair anorectal fist w/plug,CPT,RVU2026A,2026
46710,Repr per/vag pouch sngl proc,CPT,RVU2026A,2026
46712,Repr per/vag pouch dbl proc,CPT,RVU2026A,2026
46715,Rep perf anoper fistu,CPT,RVU2026A,2026
46716,Rep perf anoper/vestib fistu,CPT,RVU2026A,2026
46730,Construction of absent anus,CPT,RVU2026A,2026
46735,Construction of absent anus,CPT,RVU2026A,2026
46740,Construction of absent anus,CPT,RVU2026A,2026
46742,Repair of imperforated anus,CPT,RVU2026A,2026
46744,Repair of cloacal anomaly,CPT,RVU2026A,2026
46746,Repair of cloacal anomaly,CPT,RVU2026A,2026
46748,Repair of cloacal anomaly,CPT,RVU2026A,2026
46750,Repair of anal sphincter,CPT,RVU2026A,2026
46751,Repair of anal sphincter,CPT,RVU2026A,2026
46753,Reconstruction of anus,CPT,RVU2026A,2026
46754,Removal of suture from anus,CPT,RVU2026A,2026
46760,Repair of anal sphincter,CPT,RVU2026A,2026
46761,Repair of anal sphincter,CPT,RVU2026A,2026
46900,Destruction anal lesion(s),CPT,RVU2026A,2026
46910,Destruction anal lesion(s),CPT,RVU2026A,2026
46916,Cryosurgery anal lesion(s),CPT,RVU2026A,2026
46917,Laser surgery anal lesions,CPT,RVU2026A,2026
46922,Excision of anal lesion(s),CPT,RVU2026A,2026
46924,Destruction anal lesion(s),CPT,RVU2026A,2026
46930,Destroy internal hemorrhoids,CPT,RVU2026A,2026
46940,Treatment of anal fissure,CPT,RVU2026A,2026
46942,Treatment of anal fissure,CPT,RVU2026A,2026
46945,Int hrhc lig 1 hroid w/o img,CPT,RVU2026A,2026
46946,Int hrhc lig 2+hroid w/o img,CPT,RVU2026A,2026
46947,Hemorrhoidopexy by stapling,CPT,RVU2026A,2026
46948,Int hrhc tranal dartlzj 2+,CPT,RVU2026A,2026
46999,Unlisted procedure anus,CPT,RVU2026A,2026
47000,Needle biopsy of liver perq,CPT,RVU2026A,2026
47001,Ndl biopsy lvr tm oth maj px,CPT,RVU2026A,2026
47010,Hepatot opn drg absc/cst 1/2,CPT,RVU2026A,2026
47015,Lapt aspir&/njx hep prst cst,CPT,RVU2026A,2026
47100,Wedge biopsy of liver,CPT,RVU2026A,2026
47120,Partial removal of liver,CPT,RVU2026A,2026
47122,Extensive removal of liver,CPT,RVU2026A,2026
47125,Partial removal of liver,CPT,RVU2026A,2026
47130,Partial removal of liver,CPT,RVU2026A,2026
47133,Removal of donor liver,CPT,RVU2026A,2026
47135,Transplantation of liver,CPT,RVU2026A,2026
47140,Partial removal donor liver,CPT,RVU2026A,2026
47141,Partial removal donor liver,CPT,RVU2026A,2026
47142,Partial removal donor liver,CPT,RVU2026A,2026
47143,Prep donor liver whole,CPT,RVU2026A,2026
47144,Prep donor liver 3-segment,CPT,RVU2026A,2026
47145,Prep donor liver lobe split,CPT,RVU2026A,2026
47146,Prep donor liver/venous,CPT,RVU2026A,2026
47147,Prep donor liver/arterial,CPT,RVU2026A,2026
47300,Surgery for liver lesion,CPT,RVU2026A,2026
47350,Repair liver wound,CPT,RVU2026A,2026
47360,Repair liver wound,CPT,RVU2026A,2026
47361,Repair liver wound,CPT,RVU2026A,2026
47362,Repair liver wound,CPT,RVU2026A,2026
47370,Laparo ablate liver tumor rf,CPT,RVU2026A,2026
47371,Laparo ablate liver cryosurg,CPT,RVU2026A,2026
47379,Unlisted laps px liver,CPT,RVU2026A,2026
47380,Open ablate liver tumor rf,CPT,RVU2026A,2026
47381,Open ablate liver tumor cryo,CPT,RVU2026A,2026
47382,Percut ablate liver rf,CPT,RVU2026A,2026
47383,Perq abltj lvr cryoablation,CPT,RVU2026A,2026
47384,Abltj ire liver 1+ tum perq,CPT,RVU2026A,2026
47399,Unlisted procedure liver,CPT,RVU2026A,2026
47400,Incision of liver duct,CPT,RVU2026A,2026
47420,Incision of bile duct,CPT,RVU2026A,2026
47425,Incision of bile duct,CPT,RVU2026A,2026
47460,Incise bile duct sphincter,CPT,RVU2026A,2026
47480,Incision of gallbladder,CPT,RVU2026A,2026
47490,Incision of gallbladder,CPT,RVU2026A,2026
47531,Injection for cholangiogram,CPT,RVU2026A,2026
47532,Injection for cholangiogram,CPT,RVU2026A,2026
47533,Plmt biliary drainage cath,CPT,RVU2026A,2026
47534,Plmt biliary drainage cath,CPT,RVU2026A,2026
47535,Conversion ext bil drg cath,CPT,RVU2026A,2026
47536,Exchange biliary drg cath,CPT,RVU2026A,2026
47537,Removal biliary drg cath,CPT,RVU2026A,2026
47538,Perq plmt bile duct stent,CPT,RVU2026A,2026
47539,Perq plmt bile duct stent,CPT,RVU2026A,2026
47540,Perq plmt bile duct stent,CPT,RVU2026A,2026
47541,Plmt access bil tree sm bwl,CPT,RVU2026A,2026
47542,Dilate biliary duct/ampulla,CPT,RVU2026A,2026
47543,Endoluminal bx biliary tree,CPT,RVU2026A,2026
47544,Removal duct glbldr calculi,CPT,RVU2026A,2026
47550,Bile duct endoscopy add-on,CPT,RVU2026A,2026
47552,Biliary endo perq dx w/speci,CPT,RVU2026A,2026
47553,Biliary endoscopy thru skin,CPT,RVU2026A,2026
47554,Biliary endoscopy thru skin,CPT,RVU2026A,2026
47555,Biliary endoscopy thru skin,CPT,RVU2026A,2026
47556,Biliary endoscopy thru skin,CPT,RVU2026A,2026
47562,Laparoscopic cholecystectomy,CPT,RVU2026A,2026
47563,Laparo cholecystectomy/graph,CPT,RVU2026A,2026
47564,Laparo cholecystectomy/explr,CPT,RVU2026A,2026
47570,Laparo cholecystoenterostomy,CPT,RVU2026A,2026
47579,Unlisted laps px biliary trc,CPT,RVU2026A,2026
47600,Cholecystectomy,CPT,RVU2026A,2026
47605,Cholecystectomy w/cholang,CPT,RVU2026A,2026
47610,Removal of gallbladder,CPT,RVU2026A,2026
47612,Removal of gallbladder,CPT,RVU2026A,2026
47620,Removal of gallbladder,CPT,RVU2026A,2026
47700,Exploration of bile ducts,CPT,RVU2026A,2026
47701,Bile duct revision,CPT,RVU2026A,2026
47711,Excision of bile duct tumor,CPT,RVU2026A,2026
47712,Excision of bile duct tumor,CPT,RVU2026A,2026
47715,Excision of bile duct cyst,CPT,RVU2026A,2026
47720,Fuse gallbladder & bowel,CPT,RVU2026A,2026
47721,Fuse upper gi structures,CPT,RVU2026A,2026
47740,Fuse gallbladder & bowel,CPT,RVU2026A,2026
47741,Fuse gallbladder & bowel,CPT,RVU2026A,2026
47760,Fuse bile ducts and bowel,CPT,RVU2026A,2026
47765,Fuse liver ducts & bowel,CPT,RVU2026A,2026
47780,Fuse bile ducts and bowel,CPT,RVU2026A,2026
47785,Fuse bile ducts and bowel,CPT,RVU2026A,2026
47800,Reconstruction of bile ducts,CPT,RVU2026A,2026
47801,Placement bile duct support,CPT,RVU2026A,2026
47900,Suture bile duct injury,CPT,RVU2026A,2026
47999,Unlisted px biliary tract,CPT,RVU2026A,2026
48000,Drainage of abdomen,CPT,RVU2026A,2026
48001,Placement of drain pancreas,CPT,RVU2026A,2026
48020,Removal of pancreatic stone,CPT,RVU2026A,2026
48100,Biopsy of pancreas open,CPT,RVU2026A,2026
48102,Needle biopsy pancreas,CPT,RVU2026A,2026
48105,Resect/debride pancreas,CPT,RVU2026A,2026
48120,Removal of pancreas lesion,CPT,RVU2026A,2026
48140,Partial removal of pancreas,CPT,RVU2026A,2026
48145,Partial removal of pancreas,CPT,RVU2026A,2026
48146,Pancreatectomy,CPT,RVU2026A,2026
48148,Removal of pancreatic duct,CPT,RVU2026A,2026
48150,Partial removal of pancreas,CPT,RVU2026A,2026
48152,Pancreatectomy,CPT,RVU2026A,2026
48153,Pancreatectomy,CPT,RVU2026A,2026
48154,Pancreatectomy,CPT,RVU2026A,2026
48155,Removal of pancreas,CPT,RVU2026A,2026
48160,Pancreas removal/transplant,CPT,RVU2026A,2026
48400,Injection intraop add-on,CPT,RVU2026A,2026
48500,Surgery of pancreatic cyst,CPT,RVU2026A,2026
48510,Drain pancreatic pseudocyst,CPT,RVU2026A,2026
48520,Fuse pancreas cyst and bowel,CPT,RVU2026A,2026
48540,Fuse pancreas cyst and bowel,CPT,RVU2026A,2026
48545,Pancreatorrhaphy,CPT,RVU2026A,2026
48547,Duodenal exclusion,CPT,RVU2026A,2026
48548,Fuse pancreas and bowel,CPT,RVU2026A,2026
48550,Donor pancreatectomy,CPT,RVU2026A,2026
48551,Prep donor pancreas,CPT,RVU2026A,2026
48552,Prep donor pancreas/venous,CPT,RVU2026A,2026
48554,Transpl allograft pancreas,CPT,RVU2026A,2026
48556,Removal allograft pancreas,CPT,RVU2026A,2026
48999,Unlisted procedure pancreas,CPT,RVU2026A,2026
49000,Exploration of abdomen,CPT,RVU2026A,2026
49002,Reopening of abdomen,CPT,RVU2026A,2026
49010,Exploration behind abdomen,CPT,RVU2026A,2026
49013,Prpertl pel pack hemrrg trma,CPT,RVU2026A,2026
49014,Reexploration pelvic wound,CPT,RVU2026A,2026
49020,Drainage abdom abscess open,CPT,RVU2026A,2026
49040,Drain open abdom abscess,CPT,RVU2026A,2026
49060,Drain open retroperi abscess,CPT,RVU2026A,2026
49062,Drain to peritoneal cavity,CPT,RVU2026A,2026
49082,Abd paracentesis,CPT,RVU2026A,2026
49083,Abd paracentesis w/imaging,CPT,RVU2026A,2026
49084,Peritoneal lavage,CPT,RVU2026A,2026
49180,Biopsy abdominal mass,CPT,RVU2026A,2026
49185,Sclerotx fluid collection,CPT,RVU2026A,2026
49186,Opn exc/dstr ntra-abd 5 cm/<,CPT,RVU2026A,2026
49187,Opn exc/dstr ntra-abd 5.1-10,CPT,RVU2026A,2026
49188,Opn exc/dst ntra-abd 10.1-20,CPT,RVU2026A,2026
49189,Opn exc/dst ntra-abd 20.1-30,CPT,RVU2026A,2026
49190,Opn exc/dstr ntra-abd >30 cm,CPT,RVU2026A,2026
49215,Excise sacral spine tumor,CPT,RVU2026A,2026
49250,Excision of umbilicus,CPT,RVU2026A,2026
49255,Removal of omentum,CPT,RVU2026A,2026
49320,Diag laparo separate proc,CPT,RVU2026A,2026
49321,Laparoscopy biopsy,CPT,RVU2026A,2026
49322,Laparoscopy aspiration,CPT,RVU2026A,2026
49323,Laparo drain lymphocele,CPT,RVU2026A,2026
49324,Lap insert tunnel ip cath,CPT,RVU2026A,2026
49325,Lap revision perm ip cath,CPT,RVU2026A,2026
49326,Lap w/omentopexy add-on,CPT,RVU2026A,2026
49327,Lap ins device for rt,CPT,RVU2026A,2026
49329,Unlstd laps px abd pertm&omn,CPT,RVU2026A,2026
49400,Air injection into abdomen,CPT,RVU2026A,2026
49402,Remove foreign body adbomen,CPT,RVU2026A,2026
49405,Image cath fluid colxn visc,CPT,RVU2026A,2026
49406,Image cath fluid peri/retro,CPT,RVU2026A,2026
49407,Image cath fluid trns/vgnl,CPT,RVU2026A,2026
49411,Ins mark abd/pel for rt perq,CPT,RVU2026A,2026
49412,Ins device for rt guide open,CPT,RVU2026A,2026
49418,Insert tun ip cath perc,CPT,RVU2026A,2026
49419,Insert tun ip cath w/port,CPT,RVU2026A,2026
49421,Ins tun ip cath for dial opn,CPT,RVU2026A,2026
49422,Remove tunneled ip cath,CPT,RVU2026A,2026
49423,Exchange drainage catheter,CPT,RVU2026A,2026
49424,Assess cyst contrast inject,CPT,RVU2026A,2026
49425,Insert abdomen-venous drain,CPT,RVU2026A,2026
49426,Revise abdomen-venous shunt,CPT,RVU2026A,2026
49427,Injection abdominal shunt,CPT,RVU2026A,2026
49428,Ligation of shunt,CPT,RVU2026A,2026
49429,Removal of shunt,CPT,RVU2026A,2026
49435,Insert subq exten to ip cath,CPT,RVU2026A,2026
49436,Embedded ip cath exit-site,CPT,RVU2026A,2026
49440,Place gastrostomy tube perc,CPT,RVU2026A,2026
49441,Place duod/jej tube perc,CPT,RVU2026A,2026
49442,Place cecostomy tube perc,CPT,RVU2026A,2026
49446,Change g-tube to g-j perc,CPT,RVU2026A,2026
49450,Replace g/c tube perc,CPT,RVU2026A,2026
49451,Replace duod/jej tube perc,CPT,RVU2026A,2026
49452,Replace g-j tube perc,CPT,RVU2026A,2026
49460,Fix g/colon tube w/device,CPT,RVU2026A,2026
49465,Fluoro exam of g/colon tube,CPT,RVU2026A,2026
49491,Rpr hern preemie reduc,CPT,RVU2026A,2026
49492,Rpr ing hern premie blocked,CPT,RVU2026A,2026
49495,Rpr ing hernia baby reduc,CPT,RVU2026A,2026
49496,Rpr ing hernia baby blocked,CPT,RVU2026A,2026
49500,Rpr ing hernia init reduce,CPT,RVU2026A,2026
49501,Rpr ing hernia init blocked,CPT,RVU2026A,2026
49505,Prp i/hern init reduc >5 yr,CPT,RVU2026A,2026
49507,Prp i/hern init block >5 yr,CPT,RVU2026A,2026
49520,Rerepair ing hernia reduce,CPT,RVU2026A,2026
49521,Rerepair ing hernia blocked,CPT,RVU2026A,2026
49525,Repair ing hernia sliding,CPT,RVU2026A,2026
49540,Repair lumbar hernia,CPT,RVU2026A,2026
49550,Rpr rem hernia init reduce,CPT,RVU2026A,2026
49553,Rpr fem hernia init blocked,CPT,RVU2026A,2026
49555,Rerepair fem hernia reduce,CPT,RVU2026A,2026
49557,Rerepair fem hernia blocked,CPT,RVU2026A,2026
49591,Rpr aa hrn 1st < 3 cm rdc,CPT,RVU2026A,2026
49592,Rpr aa hrn 1st < 3 ncr/strn,CPT,RVU2026A,2026
49593,Rpr aa hrn 1st 3-10 rdc,CPT,RVU2026A,2026
49594,Rpr aa hrn 1st 3-10 ncr/strn,CPT,RVU2026A,2026
49595,Rpr aa hrn 1st > 10 rdc,CPT,RVU2026A,2026
49596,Rpr aa hrn 1st > 10 ncr/strn,CPT,RVU2026A,2026
49600,Repair umbilical lesion,CPT,RVU2026A,2026
49605,Repair umbilical lesion,CPT,RVU2026A,2026
49606,Repair umbilical lesion,CPT,RVU2026A,2026
49610,Repair umbilical lesion,CPT,RVU2026A,2026
49611,Repair umbilical lesion,CPT,RVU2026A,2026
49613,Rpr aa hrn rcr < 3 rdc,CPT,RVU2026A,2026
49614,Rpr aa hrn rcr < 3 ncr/strn,CPT,RVU2026A,2026
49615,Rpr aa hrn rcr 3-10 rdc,CPT,RVU2026A,2026
49616,Rpr aa hrn rcr 3-10 ncr/strn,CPT,RVU2026A,2026
49617,Rpr aa hrn rcr > 10 rdc,CPT,RVU2026A,2026
49618,Rpr aa hrn rcr > 10 ncr/strn,CPT,RVU2026A,2026
49621,Rpr parastomal hernia rdc,CPT,RVU2026A,2026
49622,Rpr parastomal hrna ncr/strn,CPT,RVU2026A,2026
49623,Rmvl ninfct mesh hernia rpr,CPT,RVU2026A,2026
49650,Lap ing hernia repair init,CPT,RVU2026A,2026
49651,Lap ing hernia repair recur,CPT,RVU2026A,2026
49659,Unlstd laps px hrnap hrnrphy,CPT,RVU2026A,2026
49900,Repair of abdominal wall,CPT,RVU2026A,2026
49904,Omental flap extra-abdom,CPT,RVU2026A,2026
49905,Omental flap intra-abdom,CPT,RVU2026A,2026
49906,Free omental flap microvasc,CPT,RVU2026A,2026
49999,Unlisted px abd pertm&omn,CPT,RVU2026A,2026
50010,Renal exploration,CPT,RVU2026A,2026
50020,Drg perirnl/renal absc open,CPT,RVU2026A,2026
50040,Nfros nfrot w/drg,CPT,RVU2026A,2026
50045,Nephrotomy w/exploration,CPT,RVU2026A,2026
5005F,Pt counsld on exam for moles,Other,RVU2026A,2026
50060,Nl removal calculus,CPT,RVU2026A,2026
50065,Nl sec surg operj calculus,CPT,RVU2026A,2026
50070,Nl comp cgen kdn abnormality,CPT,RVU2026A,2026
50075,Nl rmvl lg staghorn calculus,CPT,RVU2026A,2026
50080,Perq nl/pl lithotrp smpl<2cm,CPT,RVU2026A,2026
50081,Perq nl/pl lithotrp cplx>2cm,CPT,RVU2026A,2026
50100,Trnsxj/repos abrrnt rnl vsls,CPT,RVU2026A,2026
5010F,Macul result phy/qhp mng dm,Other,RVU2026A,2026
50120,Pyelotomy w/exploration,CPT,RVU2026A,2026
50125,Pyelotomy w/drg pyelostomy,CPT,RVU2026A,2026
50130,Pyelotomy w/removal calculus,CPT,RVU2026A,2026
5015F,Doc fx & test/txmnt for op,Other,RVU2026A,2026
50200,Renal biopsy perq,CPT,RVU2026A,2026
50205,Renal bx surg exposure kdn,CPT,RVU2026A,2026
5020F,Txmnts 2 phys/qhp by 1 mon,Other,RVU2026A,2026
50220,Remove kidney open,CPT,RVU2026A,2026
50225,Removal kidney open complex,CPT,RVU2026A,2026
50230,Removal kidney open radical,CPT,RVU2026A,2026
50234,Removal of kidney & ureter,CPT,RVU2026A,2026
50236,Removal of kidney & ureter,CPT,RVU2026A,2026
50240,Nephrectomy partial,CPT,RVU2026A,2026
50250,Opn abltj 1/> rnl mas crysrg,CPT,RVU2026A,2026
50280,Exc/unroofing cyst kidney,CPT,RVU2026A,2026
50290,Excision perinephric cyst,CPT,RVU2026A,2026
50300,Remove cadaver donor kidney,CPT,RVU2026A,2026
50320,Remove kidney living donor,CPT,RVU2026A,2026
50323,Prep cadaver renal allograft,CPT,RVU2026A,2026
50325,Prep donor renal graft,CPT,RVU2026A,2026
50327,Prep renal graft/venous,CPT,RVU2026A,2026
50328,Prep renal graft/arterial,CPT,RVU2026A,2026
50329,Prep renal graft/ureteral,CPT,RVU2026A,2026
50340,Recipient nephrectomy,CPT,RVU2026A,2026
50360,Rnl altrnsplj w/o rcp nfrct,CPT,RVU2026A,2026
50365,Rnl altrnsplj w/rcp nfrct,CPT,RVU2026A,2026
50370,Rmvl transplanted rnl algrft,CPT,RVU2026A,2026
50380,Rnl autotrnsplj rimpltj kdn,CPT,RVU2026A,2026
50382,Change ureter stent percut,CPT,RVU2026A,2026
50384,Remove ureter stent percut,CPT,RVU2026A,2026
50385,Change stent via transureth,CPT,RVU2026A,2026
50386,Remove stent via transureth,CPT,RVU2026A,2026
50387,Change nephroureteral cath,CPT,RVU2026A,2026
50389,Remove renal tube w/fluoro,CPT,RVU2026A,2026
50390,Drainage of kidney lesion,CPT,RVU2026A,2026
50391,Instll rx agnt into rnal tub,CPT,RVU2026A,2026
50396,Measure kidney pressure,CPT,RVU2026A,2026
50400,Revision of kidney/ureter,CPT,RVU2026A,2026
50405,Revision of kidney/ureter,CPT,RVU2026A,2026
50430,Njx px nfrosgrm &/urtrgrm,CPT,RVU2026A,2026
50431,Njx px nfrosgrm &/urtrgrm,CPT,RVU2026A,2026
50432,Plmt nephrostomy catheter,CPT,RVU2026A,2026
50433,Plmt nephroureteral catheter,CPT,RVU2026A,2026
50434,Convert nephrostomy catheter,CPT,RVU2026A,2026
50435,Exchange nephrostomy cath,CPT,RVU2026A,2026
50436,Dilat xst trc ndurlgc px,CPT,RVU2026A,2026
50437,Dilat xst trc new access rcs,CPT,RVU2026A,2026
50500,Repair of kidney wound,CPT,RVU2026A,2026
5050F,Plan 2 main dr by 1 month,Other,RVU2026A,2026
50520,Close kidney-skin fistula,CPT,RVU2026A,2026
50525,Close nephrovisceral fistula,CPT,RVU2026A,2026
50526,Close nephrovisceral fistula,CPT,RVU2026A,2026
50540,Revision of horseshoe kidney,CPT,RVU2026A,2026
50541,Laparo ablate renal cyst,CPT,RVU2026A,2026
50542,Laparo ablate renal mass,CPT,RVU2026A,2026
50543,Laparo partial nephrectomy,CPT,RVU2026A,2026
50544,Laparoscopy pyeloplasty,CPT,RVU2026A,2026
50545,Laparo radical nephrectomy,CPT,RVU2026A,2026
50546,Laparoscopic nephrectomy,CPT,RVU2026A,2026
50547,Laparo removal donor kidney,CPT,RVU2026A,2026
50548,Laparo remove w/ureter,CPT,RVU2026A,2026
50549,Unlisted laps px renal,CPT,RVU2026A,2026
50551,Kidney endoscopy,CPT,RVU2026A,2026
50553,Kidney endoscopy,CPT,RVU2026A,2026
50555,Kidney endoscopy & biopsy,CPT,RVU2026A,2026
50557,Kidney endoscopy & treatment,CPT,RVU2026A,2026
50561,Kidney endoscopy & treatment,CPT,RVU2026A,2026
50562,Renal scope w/tumor resect,CPT,RVU2026A,2026
50570,Kidney endoscopy,CPT,RVU2026A,2026
50572,Kidney endoscopy,CPT,RVU2026A,2026
50574,Kidney endoscopy & biopsy,CPT,RVU2026A,2026
50575,Kidney endoscopy,CPT,RVU2026A,2026
50576,Kidney endoscopy & treatment,CPT,RVU2026A,2026
50580,Kidney endoscopy & treatment,CPT,RVU2026A,2026
50590,Fragmenting of kidney stone,CPT,RVU2026A,2026
50592,Perc rf ablate renal tumor,CPT,RVU2026A,2026
50593,Perc cryo ablate renal tum,CPT,RVU2026A,2026
50600,Exploration of ureter,CPT,RVU2026A,2026
50605,Insert ureteral support,CPT,RVU2026A,2026
50606,Endoluminal bx urtr rnl plvs,CPT,RVU2026A,2026
5060F,Fndngs mammo 2pt w/in 3 days,Other,RVU2026A,2026
50610,Removal of ureter stone,CPT,RVU2026A,2026
50620,Removal of ureter stone,CPT,RVU2026A,2026
5062F,Mammo result com to pt 5 day,Other,RVU2026A,2026
50630,Removal of ureter stone,CPT,RVU2026A,2026
50650,Removal of ureter,CPT,RVU2026A,2026
50660,Removal of ureter,CPT,RVU2026A,2026
50684,Injection for ureter x-ray,CPT,RVU2026A,2026
50686,Measure ureter pressure,CPT,RVU2026A,2026
50688,Change of ureter tube/stent,CPT,RVU2026A,2026
50690,Injection for ureter x-ray,CPT,RVU2026A,2026
50693,Plmt ureteral stent prq,CPT,RVU2026A,2026
50694,Plmt ureteral stent prq,CPT,RVU2026A,2026
50695,Plmt ureteral stent prq,CPT,RVU2026A,2026
50700,Revision of ureter,CPT,RVU2026A,2026
50705,Ureteral embolization/occl,CPT,RVU2026A,2026
50706,Balloon dilate urtrl strix,CPT,RVU2026A,2026
50715,Release of ureter,CPT,RVU2026A,2026
50722,Release of ureter,CPT,RVU2026A,2026
50725,Release/revise ureter,CPT,RVU2026A,2026
50727,Revise ureter,CPT,RVU2026A,2026
50728,Revise ureter,CPT,RVU2026A,2026
50740,Fusion of ureter & kidney,CPT,RVU2026A,2026
50750,Fusion of ureter & kidney,CPT,RVU2026A,2026
50760,Ureteroureterostomy,CPT,RVU2026A,2026
50770,Splicing of ureters,CPT,RVU2026A,2026
50780,Reimplant ureter in bladder,CPT,RVU2026A,2026
50782,Reimplant ureter in bladder,CPT,RVU2026A,2026
50783,Reimplant ureter in bladder,CPT,RVU2026A,2026
50785,Reimplant ureter in bladder,CPT,RVU2026A,2026
50800,Implant ureter in bowel,CPT,RVU2026A,2026
50810,Fusion of ureter & bowel,CPT,RVU2026A,2026
50815,Urine shunt to intestine,CPT,RVU2026A,2026
50820,Construct bowel bladder,CPT,RVU2026A,2026
50825,Construct bowel bladder,CPT,RVU2026A,2026
50830,Revise urine flow,CPT,RVU2026A,2026
50840,Replace ureter by bowel,CPT,RVU2026A,2026
50845,Appendico-vesicostomy,CPT,RVU2026A,2026
50860,Transplant ureter to skin,CPT,RVU2026A,2026
50900,Repair of ureter,CPT,RVU2026A,2026
50920,Closure ureter/skin fistula,CPT,RVU2026A,2026
50930,Closure ureter/bowel fistula,CPT,RVU2026A,2026
50940,Release of ureter,CPT,RVU2026A,2026
50945,Laparoscopy ureterolithotomy,CPT,RVU2026A,2026
50947,Laparo new ureter/bladder,CPT,RVU2026A,2026
50948,Laparo new ureter/bladder,CPT,RVU2026A,2026
50949,Unlisted laps px ureter,CPT,RVU2026A,2026
50951,Endoscopy of ureter,CPT,RVU2026A,2026
50953,Endoscopy of ureter,CPT,RVU2026A,2026
50955,Ureter endoscopy & biopsy,CPT,RVU2026A,2026
50957,Ureter endoscopy & treatment,CPT,RVU2026A,2026
50961,Ureter endoscopy & treatment,CPT,RVU2026A,2026
50970,Ureter endoscopy,CPT,RVU2026A,2026
50972,Ureter endoscopy & catheter,CPT,RVU2026A,2026
50974,Ureter endoscopy & biopsy,CPT,RVU2026A,2026
50976,Ureter endoscopy & treatment,CPT,RVU2026A,2026
50980,Ureter endoscopy & treatment,CPT,RVU2026A,2026
5100F,Rsk fx ref w/n 24 hrs xray,Other,RVU2026A,2026
51020,Cystotomy/cystostomy w/fulg,CPT,RVU2026A,2026
51040,Incise & drain bladder,CPT,RVU2026A,2026
51045,Incise bladder/drain ureter,CPT,RVU2026A,2026
51050,Removal of bladder stone,CPT,RVU2026A,2026
51060,Removal of ureter stone,CPT,RVU2026A,2026
51065,Remove ureter calculus,CPT,RVU2026A,2026
51080,Drainage of bladder abscess,CPT,RVU2026A,2026
51100,Drain bladder by needle,CPT,RVU2026A,2026
51101,Drain bladder by trocar/cath,CPT,RVU2026A,2026
51102,Drain bl w/cath insertion,CPT,RVU2026A,2026
51500,Removal of bladder cyst,CPT,RVU2026A,2026
51520,Removal of bladder lesion,CPT,RVU2026A,2026
51525,Removal of bladder lesion,CPT,RVU2026A,2026
51530,Removal of bladder lesion,CPT,RVU2026A,2026
51535,Repair of ureter lesion,CPT,RVU2026A,2026
51550,Partial removal of bladder,CPT,RVU2026A,2026
51555,Partial removal of bladder,CPT,RVU2026A,2026
51565,Revise bladder & ureter(s),CPT,RVU2026A,2026
51570,Removal of bladder,CPT,RVU2026A,2026
51575,Removal of bladder & nodes,CPT,RVU2026A,2026
51580,Remove bladder/revise tract,CPT,RVU2026A,2026
51585,Removal of bladder & nodes,CPT,RVU2026A,2026
51590,Remove bladder/revise tract,CPT,RVU2026A,2026
51595,Remove bladder/revise tract,CPT,RVU2026A,2026
51596,Remove bladder/create pouch,CPT,RVU2026A,2026
51597,Removal of pelvic structures,CPT,RVU2026A,2026
51600,Injection for bladder x-ray,CPT,RVU2026A,2026
51605,Preparation for bladder xray,CPT,RVU2026A,2026
51610,Injection for bladder x-ray,CPT,RVU2026A,2026
51700,Irrigation of bladder,CPT,RVU2026A,2026
51701,Insert bladder catheter,CPT,RVU2026A,2026
51702,Insert temp bladder cath,CPT,RVU2026A,2026
51703,Insert bladder cath complex,CPT,RVU2026A,2026
51705,Change of bladder tube,CPT,RVU2026A,2026
51710,Change of bladder tube,CPT,RVU2026A,2026
51715,Endoscopic injection/implant,CPT,RVU2026A,2026
51720,Treatment of bladder lesion,CPT,RVU2026A,2026
51721,Ins trurl ablt trnsdc thr us,CPT,RVU2026A,2026
51725,Simple cystometrogram,CPT,RVU2026A,2026
51726,Complex cystometrogram,CPT,RVU2026A,2026
51727,Cystometrogram w/up,CPT,RVU2026A,2026
51728,Cystometrogram w/vp,CPT,RVU2026A,2026
51729,Cystometrogram w/vp&up,CPT,RVU2026A,2026
51736,Urine flow measurement,CPT,RVU2026A,2026
51741,Electro-uroflowmetry first,CPT,RVU2026A,2026
51784,Anal/urinary muscle study,CPT,RVU2026A,2026
51785,Anal/urinary muscle study,CPT,RVU2026A,2026
51792,Urinary reflex study,CPT,RVU2026A,2026
51797,Intraabdominal pressure test,CPT,RVU2026A,2026
51798,Us urine capacity measure,CPT,RVU2026A,2026
51800,Revision of bladder/urethra,CPT,RVU2026A,2026
51820,Revision of urinary tract,CPT,RVU2026A,2026
51840,Attach bladder/urethra,CPT,RVU2026A,2026
51841,Attach bladder/urethra,CPT,RVU2026A,2026
51845,Repair bladder neck,CPT,RVU2026A,2026
51860,Repair of bladder wound,CPT,RVU2026A,2026
51865,Repair of bladder wound,CPT,RVU2026A,2026
51880,Repair of bladder opening,CPT,RVU2026A,2026
51900,Repair bladder/vagina lesion,CPT,RVU2026A,2026
51920,Close bladder-uterus fistula,CPT,RVU2026A,2026
51925,Hysterectomy/bladder repair,CPT,RVU2026A,2026
51940,Correction of bladder defect,CPT,RVU2026A,2026
51960,Revision of bladder & bowel,CPT,RVU2026A,2026
51980,Construct bladder opening,CPT,RVU2026A,2026
51990,Laparo urethral suspension,CPT,RVU2026A,2026
51992,Laparo sling operation,CPT,RVU2026A,2026
51999,Unlisted laps px bladder,CPT,RVU2026A,2026
52000,Cystourethroscopy,CPT,RVU2026A,2026
52001,Cysto w/irrg&evac mlt clots,CPT,RVU2026A,2026
52005,Cysto w/urtrl cathj,CPT,RVU2026A,2026
52007,Cysto urtrl cathj brush bx,CPT,RVU2026A,2026
5200F,Eval appros surg thxpy epi,Other,RVU2026A,2026
52010,Cystoscopy & duct catheter,CPT,RVU2026A,2026
52204,Cystoscopy w/biopsy(s),CPT,RVU2026A,2026
52214,Cystoscopy and treatment,CPT,RVU2026A,2026
52224,Cystoscopy and treatment,CPT,RVU2026A,2026
52234,Cystoscopy and treatment,CPT,RVU2026A,2026
52235,Cystoscopy and treatment,CPT,RVU2026A,2026
52240,Cystoscopy and treatment,CPT,RVU2026A,2026
52250,Cystoscopy and radiotracer,CPT,RVU2026A,2026
52260,Cystoscopy and treatment,CPT,RVU2026A,2026
52265,Cystoscopy and treatment,CPT,RVU2026A,2026
52270,Cystoscopy & revise urethra,CPT,RVU2026A,2026
52275,Cystoscopy & revise urethra,CPT,RVU2026A,2026
52276,Cystoscopy and treatment,CPT,RVU2026A,2026
52277,Cystoscopy and treatment,CPT,RVU2026A,2026
52281,Cystoscopy and treatment,CPT,RVU2026A,2026
52282,Cystoscopy implant stent,CPT,RVU2026A,2026
52283,Cystoscopy and treatment,CPT,RVU2026A,2026
52284,Cysto rx balo cath urtl strx,CPT,RVU2026A,2026
52285,Cystoscopy and treatment,CPT,RVU2026A,2026
52287,Cystoscopy chemodenervation,CPT,RVU2026A,2026
52290,Cystoscopy and treatment,CPT,RVU2026A,2026
52300,Cystoscopy and treatment,CPT,RVU2026A,2026
52301,Cystoscopy and treatment,CPT,RVU2026A,2026
52305,Cystoscopy and treatment,CPT,RVU2026A,2026
52310,Cystoscopy and treatment,CPT,RVU2026A,2026
52315,Cystoscopy and treatment,CPT,RVU2026A,2026
52317,Remove bladder stone,CPT,RVU2026A,2026
52318,Remove bladder stone,CPT,RVU2026A,2026
52320,Cystoscopy and treatment,CPT,RVU2026A,2026
52325,Cystoscopy stone removal,CPT,RVU2026A,2026
52327,Cystoscopy inject material,CPT,RVU2026A,2026
52330,Cystoscopy and treatment,CPT,RVU2026A,2026
52332,Cystoscopy and treatment,CPT,RVU2026A,2026
52334,Create passage to kidney,CPT,RVU2026A,2026
52341,Cysto w/ureter stricture tx,CPT,RVU2026A,2026
52342,Cysto w/up stricture tx,CPT,RVU2026A,2026
52343,Cysto w/renal stricture tx,CPT,RVU2026A,2026
52344,Cysto/uretero stricture tx,CPT,RVU2026A,2026
52345,Cysto/uretero w/up stricture,CPT,RVU2026A,2026
52346,Cystouretero w/renal strict,CPT,RVU2026A,2026
52351,Cystouretero & or pyeloscope,CPT,RVU2026A,2026
52352,Cystouretero w/stone remove,CPT,RVU2026A,2026
52353,Cystouretero w/lithotripsy,CPT,RVU2026A,2026
52354,Cystouretero w/biopsy,CPT,RVU2026A,2026
52355,Cystouretero w/excise tumor,CPT,RVU2026A,2026
52356,Cysto/uretero w/lithotripsy,CPT,RVU2026A,2026
52400,Cysto cgen post urtl valves,CPT,RVU2026A,2026
52402,Cysto trurl rescj ejacul dux,CPT,RVU2026A,2026
52441,Cysto insj trnsprstc 1 implt,CPT,RVU2026A,2026
52442,Cysto ins trnsprstc implt ea,CPT,RVU2026A,2026
52443,Cysto 1st trurl prst8 comis,CPT,RVU2026A,2026
52450,Transurethral inc prostate,CPT,RVU2026A,2026
52500,Trurl resection bladder neck,CPT,RVU2026A,2026
5250F,Asthma discharge plan presnt,Other,RVU2026A,2026
52597,Trurl rbtc wtrjt rescj prst8,CPT,RVU2026A,2026
52601,Prostatectomy (turp),CPT,RVU2026A,2026
52630,Remove prostate regrowth,CPT,RVU2026A,2026
52640,Relieve bladder contracture,CPT,RVU2026A,2026
52648,Laser surgery of prostate,CPT,RVU2026A,2026
52649,Prostate laser enucleation,CPT,RVU2026A,2026
52700,Drainage of prostate abscess,CPT,RVU2026A,2026
53000,Incision of urethra,CPT,RVU2026A,2026
53010,Incision of urethra,CPT,RVU2026A,2026
53020,Incision of urethra,CPT,RVU2026A,2026
53025,Incision of urethra,CPT,RVU2026A,2026
53040,Drainage of urethra abscess,CPT,RVU2026A,2026
53060,Drainage of urethra abscess,CPT,RVU2026A,2026
53080,Drainage of urinary leakage,CPT,RVU2026A,2026
53085,Drainage of urinary leakage,CPT,RVU2026A,2026
53200,Biopsy of urethra,CPT,RVU2026A,2026
53210,Removal of urethra,CPT,RVU2026A,2026
53215,Removal of urethra,CPT,RVU2026A,2026
53220,Treatment of urethra lesion,CPT,RVU2026A,2026
53230,Removal of urethra lesion,CPT,RVU2026A,2026
53235,Removal of urethra lesion,CPT,RVU2026A,2026
53240,Surgery for urethra pouch,CPT,RVU2026A,2026
53250,Removal of urethra gland,CPT,RVU2026A,2026
53260,Treatment of urethra lesion,CPT,RVU2026A,2026
53265,Treatment of urethra lesion,CPT,RVU2026A,2026
53270,Removal of urethra gland,CPT,RVU2026A,2026
53275,Repair of urethra defect,CPT,RVU2026A,2026
53400,Revise urethra stage 1,CPT,RVU2026A,2026
53405,Revise urethra stage 2,CPT,RVU2026A,2026
53410,Reconstruction of urethra,CPT,RVU2026A,2026
53415,Reconstruction of urethra,CPT,RVU2026A,2026
53420,Reconstruct urethra stage 1,CPT,RVU2026A,2026
53425,Reconstruct urethra stage 2,CPT,RVU2026A,2026
53430,Reconstruction of urethra,CPT,RVU2026A,2026
53431,Reconstruct urethra/bladder,CPT,RVU2026A,2026
53440,Male sling procedure,CPT,RVU2026A,2026
53442,Remove/revise male sling,CPT,RVU2026A,2026
53444,Insert tandem cuff,CPT,RVU2026A,2026
53445,Insert uro/ves nck sphincter,CPT,RVU2026A,2026
53446,Remove uro sphincter,CPT,RVU2026A,2026
53447,Remove/replace ur sphincter,CPT,RVU2026A,2026
53448,Remov/replc ur sphinctr comp,CPT,RVU2026A,2026
53449,Repair uro sphincter,CPT,RVU2026A,2026
53450,Revision of urethra,CPT,RVU2026A,2026
53451,Tprnl balo cntnc dev bi,CPT,RVU2026A,2026
53452,Tprnl balo cntnc dev uni,CPT,RVU2026A,2026
53453,Tprnl balo cntnc dev rmvl ea,CPT,RVU2026A,2026
53454,Tprnl balo cntnc dev adjmt,CPT,RVU2026A,2026
53460,Revision of urethra,CPT,RVU2026A,2026
53500,Urethrlys transvag w/ scope,CPT,RVU2026A,2026
53502,Repair of urethra injury,CPT,RVU2026A,2026
53505,Repair of urethra injury,CPT,RVU2026A,2026
53510,Repair of urethra injury,CPT,RVU2026A,2026
53515,Repair of urethra injury,CPT,RVU2026A,2026
53520,Repair of urethra defect,CPT,RVU2026A,2026
53600,Dilate urethra stricture,CPT,RVU2026A,2026
53601,Dilate urethra stricture,CPT,RVU2026A,2026
53605,Dilate urethra stricture,CPT,RVU2026A,2026
53620,Dilate urethra stricture,CPT,RVU2026A,2026
53621,Dilate urethra stricture,CPT,RVU2026A,2026
53660,Dilation of urethra,CPT,RVU2026A,2026
53661,Dilation of urethra,CPT,RVU2026A,2026
53665,Dilation of urethra,CPT,RVU2026A,2026
53850,Prostatic microwave thermotx,CPT,RVU2026A,2026
53852,Prostatic rf thermotx,CPT,RVU2026A,2026
53854,Trurl dstrj prst8 tiss rf wv,CPT,RVU2026A,2026
53855,Insert prost urethral stent,CPT,RVU2026A,2026
53860,Transurethral rf treatment,CPT,RVU2026A,2026
53865,Cysto insj dev ischmc rmdlg,CPT,RVU2026A,2026
53866,Cathj rmvl dev ischmc rmdlg,CPT,RVU2026A,2026
53899,Unlisted px urinary system,CPT,RVU2026A,2026
54000,Slitting of prepuce,CPT,RVU2026A,2026
54001,Slitting of prepuce,CPT,RVU2026A,2026
54015,I&d penis deep,CPT,RVU2026A,2026
54050,Destruction penis lesion(s),CPT,RVU2026A,2026
54055,Destruction penis lesion(s),CPT,RVU2026A,2026
54056,Cryosurgery penis lesion(s),CPT,RVU2026A,2026
54057,Laser surg penis lesion(s),CPT,RVU2026A,2026
54060,Excision of penis lesion(s),CPT,RVU2026A,2026
54065,Destruction penis lesion(s),CPT,RVU2026A,2026
54100,Biopsy of penis,CPT,RVU2026A,2026
54105,Biopsy of penis,CPT,RVU2026A,2026
54110,Treatment of penis lesion,CPT,RVU2026A,2026
54111,Treat penis lesion graft,CPT,RVU2026A,2026
54112,Treat penis lesion graft,CPT,RVU2026A,2026
54115,Treatment of penis lesion,CPT,RVU2026A,2026
54120,Partial removal of penis,CPT,RVU2026A,2026
54125,Removal of penis,CPT,RVU2026A,2026
54130,Remove penis & nodes,CPT,RVU2026A,2026
54135,Remove penis & nodes,CPT,RVU2026A,2026
54150,Circumcision w/regionl block,CPT,RVU2026A,2026
54160,Circumcision neonate,CPT,RVU2026A,2026
54161,Circum 28 days or older,CPT,RVU2026A,2026
54162,Lysis penil circumic lesion,CPT,RVU2026A,2026
54163,Repair of circumcision,CPT,RVU2026A,2026
54164,Frenulotomy of penis,CPT,RVU2026A,2026
54200,Injection px peyronie ds,CPT,RVU2026A,2026
54205,Njx px peyronie ds exps plaq,CPT,RVU2026A,2026
54220,Irrg crpra cavrnosa priapism,CPT,RVU2026A,2026
54230,Njx corpora cavernosograpy,CPT,RVU2026A,2026
54231,Dynamic cavernosometry,CPT,RVU2026A,2026
54235,Njx corpora cavernosa rx agt,CPT,RVU2026A,2026
54240,Penile plethysmography,CPT,RVU2026A,2026
54250,Nctrnl pen tmscn&/rgdity tst,CPT,RVU2026A,2026
54300,Revision of penis,CPT,RVU2026A,2026
54304,Revision of penis,CPT,RVU2026A,2026
54308,Reconstruction of urethra,CPT,RVU2026A,2026
54312,Reconstruction of urethra,CPT,RVU2026A,2026
54316,Reconstruction of urethra,CPT,RVU2026A,2026
54318,Reconstruction of urethra,CPT,RVU2026A,2026
54322,Reconstruction of urethra,CPT,RVU2026A,2026
54324,Reconstruction of urethra,CPT,RVU2026A,2026
54326,Reconstruction of urethra,CPT,RVU2026A,2026
54328,Revise penis/urethra,CPT,RVU2026A,2026
54332,Revise penis/urethra,CPT,RVU2026A,2026
54336,Revise penis/urethra,CPT,RVU2026A,2026
54340,Rpr hypspad comp simple,CPT,RVU2026A,2026
54344,Rrp hypspad comp moblj&urtp,CPT,RVU2026A,2026
54348,Rpr hypspad comp dsj & urtp,CPT,RVU2026A,2026
54352,Revj prior hypspad repair,CPT,RVU2026A,2026
54360,Penis plastic surgery,CPT,RVU2026A,2026
54380,Repair penis,CPT,RVU2026A,2026
54385,Repair penis,CPT,RVU2026A,2026
54390,Repair penis and bladder,CPT,RVU2026A,2026
54400,Insert semi-rigid prosthesis,CPT,RVU2026A,2026
54401,Insert self-contd prosthesis,CPT,RVU2026A,2026
54405,Insert multi-comp penis pros,CPT,RVU2026A,2026
54406,Remove muti-comp penis pros,CPT,RVU2026A,2026
54408,Repair multi-comp penis pros,CPT,RVU2026A,2026
54410,Remove/replace penis prosth,CPT,RVU2026A,2026
54411,Remov/replc penis pros comp,CPT,RVU2026A,2026
54415,Remove self-contd penis pros,CPT,RVU2026A,2026
54416,Remv/repl penis contain pros,CPT,RVU2026A,2026
54417,Remv/replc penis pros compl,CPT,RVU2026A,2026
54420,Revision of penis,CPT,RVU2026A,2026
54430,Revision of penis,CPT,RVU2026A,2026
54435,Revision of penis,CPT,RVU2026A,2026
54437,Repair corporeal tear,CPT,RVU2026A,2026
54440,Repair of penis,CPT,RVU2026A,2026
54450,Preputial stretching,CPT,RVU2026A,2026
54500,Biopsy of testis,CPT,RVU2026A,2026
54505,Biopsy of testis,CPT,RVU2026A,2026
54512,Excise lesion testis,CPT,RVU2026A,2026
54520,Removal of testis,CPT,RVU2026A,2026
54522,Orchiectomy partial,CPT,RVU2026A,2026
54530,Removal of testis,CPT,RVU2026A,2026
54535,Extensive testis surgery,CPT,RVU2026A,2026
54550,Exploration for testis,CPT,RVU2026A,2026
54560,Exploration for testis,CPT,RVU2026A,2026
54600,Reduce testis torsion,CPT,RVU2026A,2026
54620,Suspension of testis,CPT,RVU2026A,2026
54640,Orchiopexy ingun/scrot appr,CPT,RVU2026A,2026
54650,Orchiopexy (fowler-stephens),CPT,RVU2026A,2026
54660,Revision of testis,CPT,RVU2026A,2026
54670,Repair testis injury,CPT,RVU2026A,2026
54680,Relocation of testis(es),CPT,RVU2026A,2026
54690,Laparoscopy orchiectomy,CPT,RVU2026A,2026
54692,Laparoscopy orchiopexy,CPT,RVU2026A,2026
54699,Unlisted laps px testis,CPT,RVU2026A,2026
54700,I&d epdidyms tstis&/scrot sp,CPT,RVU2026A,2026
54800,Biopsy of epididymis,CPT,RVU2026A,2026
54830,Remove epididymis lesion,CPT,RVU2026A,2026
54840,Remove epididymis lesion,CPT,RVU2026A,2026
54860,Removal of epididymis,CPT,RVU2026A,2026
54861,Removal of epididymis,CPT,RVU2026A,2026
54865,Explore epididymis,CPT,RVU2026A,2026
54900,Fusion of spermatic ducts,CPT,RVU2026A,2026
54901,Fusion of spermatic ducts,CPT,RVU2026A,2026
55000,Drainage of hydrocele,CPT,RVU2026A,2026
55040,Removal of hydrocele,CPT,RVU2026A,2026
55041,Removal of hydroceles,CPT,RVU2026A,2026
55060,Repair of hydrocele,CPT,RVU2026A,2026
55100,Drainage of scrotum abscess,CPT,RVU2026A,2026
55110,Explore scrotum,CPT,RVU2026A,2026
55120,Removal of scrotum lesion,CPT,RVU2026A,2026
55150,Removal of scrotum,CPT,RVU2026A,2026
55175,Revision of scrotum,CPT,RVU2026A,2026
55180,Revision of scrotum,CPT,RVU2026A,2026
55200,Incision of sperm duct,CPT,RVU2026A,2026
55250,Removal of sperm duct(s),CPT,RVU2026A,2026
55300,Prepare sperm duct x-ray,CPT,RVU2026A,2026
55400,Repair of sperm duct,CPT,RVU2026A,2026
55500,Removal of hydrocele,CPT,RVU2026A,2026
55520,Removal of sperm cord lesion,CPT,RVU2026A,2026
55530,Revise spermatic cord veins,CPT,RVU2026A,2026
55535,Revise spermatic cord veins,CPT,RVU2026A,2026
55540,Revise hernia & sperm veins,CPT,RVU2026A,2026
55550,Laparo ligate spermatic vein,CPT,RVU2026A,2026
55559,Unlstd laps px sprmatic cord,CPT,RVU2026A,2026
55600,Vesiculotomy,CPT,RVU2026A,2026
55605,Vesiculotomy complicated,CPT,RVU2026A,2026
55650,Remove sperm duct pouch,CPT,RVU2026A,2026
55680,Remove sperm pouch lesion,CPT,RVU2026A,2026
55705,Bx prst8 any approach nonimg,CPT,RVU2026A,2026
55706,Bx prst8 ndl sat sampling,CPT,RVU2026A,2026
55707,Bx prst8 trct us guided,CPT,RVU2026A,2026
55708,Bx prst8 trct us w/mri fus 1,CPT,RVU2026A,2026
55709,Bx prst8 tprnl us guided,CPT,RVU2026A,2026
55710,Bx prst8 tprn us w/mri fus 1,CPT,RVU2026A,2026
55711,Bx prst8 trct mri-us 1st,CPT,RVU2026A,2026
55712,Bx prst8 tprnl mri-us 1st,CPT,RVU2026A,2026
55713,Bx prst8 in-bore ct/mri bx 1,CPT,RVU2026A,2026
55714,Bx prst8 in-bore ct/mri 1,CPT,RVU2026A,2026
55715,Bx prst8 ea add mri-us/ct/mr,CPT,RVU2026A,2026
55720,Drainage of prostate abscess,CPT,RVU2026A,2026
55725,Drainage of prostate abscess,CPT,RVU2026A,2026
55801,Removal of prostate,CPT,RVU2026A,2026
55810,Extensive prostate surgery,CPT,RVU2026A,2026
55812,Extensive prostate surgery,CPT,RVU2026A,2026
55815,Extensive prostate surgery,CPT,RVU2026A,2026
55821,Removal of prostate,CPT,RVU2026A,2026
55831,Removal of prostate,CPT,RVU2026A,2026
55840,Extensive prostate surgery,CPT,RVU2026A,2026
55842,Extensive prostate surgery,CPT,RVU2026A,2026
55845,Extensive prostate surgery,CPT,RVU2026A,2026
55860,Surgical exposure prostate,CPT,RVU2026A,2026
55862,Extensive prostate surgery,CPT,RVU2026A,2026
55865,Extensive prostate surgery,CPT,RVU2026A,2026
55866,Laps surg prst8ect rpbic rad,CPT,RVU2026A,2026
55867,Laps surg prst8ect smpl stot,CPT,RVU2026A,2026
55868,Lap srg prst8ct lymph nod bx,CPT,RVU2026A,2026
55869,Lap srg prst8ct bi pl lmphad,CPT,RVU2026A,2026
55870,Electroejaculation,CPT,RVU2026A,2026
55873,Cryoablate prostate,CPT,RVU2026A,2026
55874,Tprnl plmt biodegrdabl matrl,CPT,RVU2026A,2026
55875,Transperi needle place pros,CPT,RVU2026A,2026
55876,Place rt device/marker pros,CPT,RVU2026A,2026
55877,Abltj ire prst8 1+ tum perq,CPT,RVU2026A,2026
55880,Abltj mal prst8 tiss hifu,CPT,RVU2026A,2026
55881,Ablt trurl prst8 tis thrm us,CPT,RVU2026A,2026
55882,Ablt trurl prst8 tis trnsdcr,CPT,RVU2026A,2026
55899,Unlisted px male genital sys,CPT,RVU2026A,2026
55920,Place needles pelvic for rt,CPT,RVU2026A,2026
55970,Sex transformation m to f,CPT,RVU2026A,2026
55980,Sex transformation f to m,CPT,RVU2026A,2026
56405,I&d vulva/perineal abscess,CPT,RVU2026A,2026
56420,I&d bartholins gland abscess,CPT,RVU2026A,2026
56440,Mrsplzatn brthlns glnd cst,CPT,RVU2026A,2026
56441,Lysis of labial adhesions,CPT,RVU2026A,2026
56442,Hymenotomy,CPT,RVU2026A,2026
56501,Destroy vulva lesions sim,CPT,RVU2026A,2026
56515,Destroy vulva lesion/s compl,CPT,RVU2026A,2026
56605,Biopsy of vulva/perineum,CPT,RVU2026A,2026
56606,Biopsy of vulva/perineum,CPT,RVU2026A,2026
56620,Vulvectomy simple partial,CPT,RVU2026A,2026
56625,Vulvectomy simple complete,CPT,RVU2026A,2026
56630,Vulvectomy radical partial,CPT,RVU2026A,2026
56631,Vlvctmy rad prtl uni lymphad,CPT,RVU2026A,2026
56632,Vlvctmy rad prtl bi lymphad,CPT,RVU2026A,2026
56633,Vulvectomy radical complete,CPT,RVU2026A,2026
56634,Vlvctmy rad comp uni lymphad,CPT,RVU2026A,2026
56637,Vlvctmy rad comp bi lymphad,CPT,RVU2026A,2026
56640,Vlvctmy rad comp w/lymphadec,CPT,RVU2026A,2026
56700,Prtl hymnctmy/revj hymnl rng,CPT,RVU2026A,2026
56740,Exc bartholins gland/cyst,CPT,RVU2026A,2026
56800,Plastic repair introitus,CPT,RVU2026A,2026
56805,Clitoroplasty intersex state,CPT,RVU2026A,2026
56810,Perineoplasty rpr per nonob,CPT,RVU2026A,2026
56820,Colposcopy vulva,CPT,RVU2026A,2026
56821,Colposcopy vulva w/biopsy,CPT,RVU2026A,2026
57000,Colpotomy w/exploration,CPT,RVU2026A,2026
57010,Colpotomy drg pel abscess,CPT,RVU2026A,2026
57020,Colpocentesis sep px,CPT,RVU2026A,2026
57022,I&d vaginal hematoma ob/pp,CPT,RVU2026A,2026
57023,I&d vaginal hematoma non-ob,CPT,RVU2026A,2026
57061,Destruction vag lesions smpl,CPT,RVU2026A,2026
57065,Destruction vag lesion xtnsv,CPT,RVU2026A,2026
57100,Biopsy vaginal mucosa simple,CPT,RVU2026A,2026
57105,Biopsy vaginal mucosa xtnsv,CPT,RVU2026A,2026
57106,Vagnc prtl rmvl vag wall,CPT,RVU2026A,2026
57107,Vagnc compl rmvl paravag tis,CPT,RVU2026A,2026
57109,Vagnc bi total pel lymphadec,CPT,RVU2026A,2026
57110,Vagnc compl rmvl vag wall,CPT,RVU2026A,2026
57111,Vagnc compl rmvl paravag tis,CPT,RVU2026A,2026
57120,Colpocleisis le fort type,CPT,RVU2026A,2026
57130,Excision vaginal septum,CPT,RVU2026A,2026
57135,Excision vaginal cyst/tumor,CPT,RVU2026A,2026
57150,Treat vagina infection,CPT,RVU2026A,2026
57155,Insert uteri tandem/ovoids,CPT,RVU2026A,2026
57156,Ins vag brachytx device,CPT,RVU2026A,2026
57160,Insert pessary/other device,CPT,RVU2026A,2026
57170,Fitting of diaphragm/cap,CPT,RVU2026A,2026
57180,Treat vaginal bleeding,CPT,RVU2026A,2026
57200,Repair of vagina,CPT,RVU2026A,2026
57210,Repair vagina/perineum,CPT,RVU2026A,2026
57220,Revision of urethra,CPT,RVU2026A,2026
57230,Repair of urethral lesion,CPT,RVU2026A,2026
57240,Anterior colporrhaphy,CPT,RVU2026A,2026
57250,Repair rectum & vagina,CPT,RVU2026A,2026
57260,Cmbn ant pst colprhy,CPT,RVU2026A,2026
57265,Cmbn ap colprhy w/ntrcl rpr,CPT,RVU2026A,2026
57267,Insert mesh/pelvic flr addon,CPT,RVU2026A,2026
57268,Repair of bowel bulge,CPT,RVU2026A,2026
57270,Repair of bowel pouch,CPT,RVU2026A,2026
57280,Suspension of vagina,CPT,RVU2026A,2026
57282,Colpopexy extraperitoneal,CPT,RVU2026A,2026
57283,Colpopexy intraperitoneal,CPT,RVU2026A,2026
57284,Repair paravag defect open,CPT,RVU2026A,2026
57285,Repair paravag defect vag,CPT,RVU2026A,2026
57287,Revise/remove sling repair,CPT,RVU2026A,2026
57288,Repair bladder defect,CPT,RVU2026A,2026
57289,Repair bladder & vagina,CPT,RVU2026A,2026
57291,Construction of vagina,CPT,RVU2026A,2026
57292,Construct vagina with graft,CPT,RVU2026A,2026
57295,Revise vag graft via vagina,CPT,RVU2026A,2026
57296,Revise vag graft open abd,CPT,RVU2026A,2026
57300,Repair rectum-vagina fistula,CPT,RVU2026A,2026
57305,Repair rectum-vagina fistula,CPT,RVU2026A,2026
57307,Fistula repair & colostomy,CPT,RVU2026A,2026
57308,Fistula repair transperine,CPT,RVU2026A,2026
57310,Repair urethrovaginal lesion,CPT,RVU2026A,2026
57311,Repair urethrovaginal lesion,CPT,RVU2026A,2026
57320,Repair bladder-vagina lesion,CPT,RVU2026A,2026
57330,Repair bladder-vagina lesion,CPT,RVU2026A,2026
57335,Repair vagina,CPT,RVU2026A,2026
57400,Dilation of vagina,CPT,RVU2026A,2026
57410,Pelvic examination,CPT,RVU2026A,2026
57415,Remove vaginal foreign body,CPT,RVU2026A,2026
57420,Exam of vagina w/scope,CPT,RVU2026A,2026
57421,Exam/biopsy of vag w/scope,CPT,RVU2026A,2026
57423,Repair paravag defect lap,CPT,RVU2026A,2026
57425,Laparoscopy surg colpopexy,CPT,RVU2026A,2026
57426,Revise prosth vag graft lap,CPT,RVU2026A,2026
57452,Exam of cervix w/scope,CPT,RVU2026A,2026
57454,Bx/curett of cervix w/scope,CPT,RVU2026A,2026
57455,Biopsy of cervix w/scope,CPT,RVU2026A,2026
57456,Endocerv curettage w/scope,CPT,RVU2026A,2026
57460,Bx of cervix w/scope leep,CPT,RVU2026A,2026
57461,Conz of cervix w/scope leep,CPT,RVU2026A,2026
57465,Cam cervix uteri drg colp,CPT,RVU2026A,2026
57500,Biopsy of cervix,CPT,RVU2026A,2026
57505,Endocervical curettage,CPT,RVU2026A,2026
57510,Cauterization of cervix,CPT,RVU2026A,2026
57511,Cryocautery of cervix,CPT,RVU2026A,2026
57513,Laser surgery of cervix,CPT,RVU2026A,2026
57520,Conization of cervix,CPT,RVU2026A,2026
57522,Conization of cervix,CPT,RVU2026A,2026
57530,Removal of cervix,CPT,RVU2026A,2026
57531,Removal of cervix radical,CPT,RVU2026A,2026
57540,Removal of residual cervix,CPT,RVU2026A,2026
57545,Remove cervix/repair pelvis,CPT,RVU2026A,2026
57550,Removal of residual cervix,CPT,RVU2026A,2026
57555,Remove cervix/repair vagina,CPT,RVU2026A,2026
57556,Remove cervix repair bowel,CPT,RVU2026A,2026
57558,D&c of cervical stump,CPT,RVU2026A,2026
57700,Revision of cervix,CPT,RVU2026A,2026
57720,Revision of cervix,CPT,RVU2026A,2026
57800,Dilation of cervical canal,CPT,RVU2026A,2026
58100,Biopsy of uterus lining,CPT,RVU2026A,2026
58110,Bx done w/colposcopy add-on,CPT,RVU2026A,2026
58120,Dilation and curettage,CPT,RVU2026A,2026
58140,Myomectomy abdom method,CPT,RVU2026A,2026
58145,Myomectomy vag method,CPT,RVU2026A,2026
58146,Myomectomy abdom complex,CPT,RVU2026A,2026
58150,Total hysterectomy,CPT,RVU2026A,2026
58152,Total hysterectomy,CPT,RVU2026A,2026
58180,Partial hysterectomy,CPT,RVU2026A,2026
58200,Extensive hysterectomy,CPT,RVU2026A,2026
58210,Extensive hysterectomy,CPT,RVU2026A,2026
58240,Removal of pelvis contents,CPT,RVU2026A,2026
58260,Vaginal hysterectomy,CPT,RVU2026A,2026
58262,Vag hyst including t/o,CPT,RVU2026A,2026
58263,Vag hyst w/t/o & vag repair,CPT,RVU2026A,2026
58267,Vag hyst w/urinary repair,CPT,RVU2026A,2026
58270,Vag hyst w/enterocele repair,CPT,RVU2026A,2026
58275,Hysterectomy/revise vagina,CPT,RVU2026A,2026
58280,Hysterectomy/revise vagina,CPT,RVU2026A,2026
58285,Extensive hysterectomy,CPT,RVU2026A,2026
58290,Vag hyst complex,CPT,RVU2026A,2026
58291,Vag hyst incl t/o complex,CPT,RVU2026A,2026
58292,Vag hyst t/o & repair compl,CPT,RVU2026A,2026
58294,Vag hyst w/enterocele compl,CPT,RVU2026A,2026
58300,Insert intrauterine device,CPT,RVU2026A,2026
58301,Remove intrauterine device,CPT,RVU2026A,2026
58321,Artificial insemination,CPT,RVU2026A,2026
58322,Artificial insemination,CPT,RVU2026A,2026
58323,Sperm washing,CPT,RVU2026A,2026
58340,Catheter for hysterography,CPT,RVU2026A,2026
58345,Reopen fallopian tube,CPT,RVU2026A,2026
58346,Insert heyman uteri capsule,CPT,RVU2026A,2026
58350,Reopen fallopian tube,CPT,RVU2026A,2026
58353,Endometr ablate thermal,CPT,RVU2026A,2026
58356,Endometrial cryoablation,CPT,RVU2026A,2026
58400,Suspension of uterus,CPT,RVU2026A,2026
58410,Suspension of uterus,CPT,RVU2026A,2026
58520,Repair of ruptured uterus,CPT,RVU2026A,2026
58540,Revision of uterus,CPT,RVU2026A,2026
58541,Lsh uterus 250 g or less,CPT,RVU2026A,2026
58542,Lsh w/t/o ut 250 g or less,CPT,RVU2026A,2026
58543,Lsh uterus above 250 g,CPT,RVU2026A,2026
58544,Lsh w/t/o uterus above 250 g,CPT,RVU2026A,2026
58545,Laparoscopic myomectomy,CPT,RVU2026A,2026
58546,Laparo-myomectomy complex,CPT,RVU2026A,2026
58548,Lap radical hyst,CPT,RVU2026A,2026
58550,Laparo-asst vag hysterectomy,CPT,RVU2026A,2026
58552,Laparo-vag hyst incl t/o,CPT,RVU2026A,2026
58553,Laparo-vag hyst complex,CPT,RVU2026A,2026
58554,Laparo-vag hyst w/t/o compl,CPT,RVU2026A,2026
58555,Hysteroscopy dx sep proc,CPT,RVU2026A,2026
58558,Hysteroscopy biopsy,CPT,RVU2026A,2026
58559,Hysteroscopy lysis,CPT,RVU2026A,2026
58560,Hysteroscopy resect septum,CPT,RVU2026A,2026
58561,Hysteroscopy remove myoma,CPT,RVU2026A,2026
58562,Hysteroscopy remove fb,CPT,RVU2026A,2026
58563,Hysteroscopy ablation,CPT,RVU2026A,2026
58565,Hysteroscopy sterilization,CPT,RVU2026A,2026
58570,Tlh uterus 250 g or less,CPT,RVU2026A,2026
58571,Tlh w/t/o 250 g or less,CPT,RVU2026A,2026
58572,Tlh uterus over 250 g,CPT,RVU2026A,2026
58573,Tlh w/t/o uterus over 250 g,CPT,RVU2026A,2026
58575,Laps tot hyst resj mal,CPT,RVU2026A,2026
58578,Unlisted laps px uterus,CPT,RVU2026A,2026
58579,Unlisted hystsc px uterus,CPT,RVU2026A,2026
58580,Transcrv abltj utrn fibrd rf,CPT,RVU2026A,2026
58600,Division of fallopian tube,CPT,RVU2026A,2026
58605,Division of fallopian tube,CPT,RVU2026A,2026
58611,Ligate oviduct(s) add-on,CPT,RVU2026A,2026
58615,Occlude fallopian tube(s),CPT,RVU2026A,2026
58660,Laparoscopy lysis,CPT,RVU2026A,2026
58661,Laparoscopy remove adnexa,CPT,RVU2026A,2026
58662,Laparoscopy excise lesions,CPT,RVU2026A,2026
58670,Laparoscopy tubal cautery,CPT,RVU2026A,2026
58671,Laparoscopy tubal block,CPT,RVU2026A,2026
58672,Laparoscopy fimbrioplasty,CPT,RVU2026A,2026
58673,Laparoscopy salpingostomy,CPT,RVU2026A,2026
58674,Laps abltj uterine fibroids,CPT,RVU2026A,2026
58679,Unlisted laps px ovidct ovry,CPT,RVU2026A,2026
58700,Removal of fallopian tube,CPT,RVU2026A,2026
58720,Removal of ovary/tube(s),CPT,RVU2026A,2026
58740,Adhesiolysis tube ovary,CPT,RVU2026A,2026
58750,Repair oviduct,CPT,RVU2026A,2026
58752,Revise ovarian tube(s),CPT,RVU2026A,2026
58760,Fimbrioplasty,CPT,RVU2026A,2026
58770,Create new tubal opening,CPT,RVU2026A,2026
58800,Drainage of ovarian cyst(s),CPT,RVU2026A,2026
58805,Drainage of ovarian cyst(s),CPT,RVU2026A,2026
58820,Drain ovary abscess open,CPT,RVU2026A,2026
58822,Drain ovary abscess percut,CPT,RVU2026A,2026
58825,Transposition ovary(s),CPT,RVU2026A,2026
58900,Biopsy of ovary(s),CPT,RVU2026A,2026
58920,Partial removal of ovary(s),CPT,RVU2026A,2026
58925,Removal of ovarian cyst(s),CPT,RVU2026A,2026
58940,Removal of ovary(s),CPT,RVU2026A,2026
58943,Removal of ovary(s),CPT,RVU2026A,2026
58950,Resect ovarian malignancy,CPT,RVU2026A,2026
58951,Resect ovarian malignancy,CPT,RVU2026A,2026
58952,Resect ovarian malignancy,CPT,RVU2026A,2026
58953,Tah rad dissect for debulk,CPT,RVU2026A,2026
58954,Tah rad debulk/lymph remove,CPT,RVU2026A,2026
58956,Bso omentectomy w/tah,CPT,RVU2026A,2026
58958,Resc recr ovr tbl pp utr mal,CPT,RVU2026A,2026
58960,Exploration of abdomen,CPT,RVU2026A,2026
58970,Retrieval of oocyte,CPT,RVU2026A,2026
58974,Embryo transfer intrauterine,CPT,RVU2026A,2026
58976,Transfer of embryo,CPT,RVU2026A,2026
58999,Unlisted px fml genital sys,CPT,RVU2026A,2026
59000,Amniocentesis diagnostic,CPT,RVU2026A,2026
59001,Amniocentesis therapeutic,CPT,RVU2026A,2026
59012,Fetal cord puncture prenatal,CPT,RVU2026A,2026
59015,Chorion biopsy,CPT,RVU2026A,2026
59020,Fetal contract stress test,CPT,RVU2026A,2026
59025,Fetal non-stress test,CPT,RVU2026A,2026
59030,Fetal scalp blood sampling,CPT,RVU2026A,2026
59050,Fetal monitor w/report,CPT,RVU2026A,2026
59051,Fetal monitor/interpret only,CPT,RVU2026A,2026
59070,Transabdom amnioinfus w/us,CPT,RVU2026A,2026
59072,Umbilical cord occlud w/us,CPT,RVU2026A,2026
59074,Fetal fluid drainage w/us,CPT,RVU2026A,2026
59076,Fetal shunt placement w/us,CPT,RVU2026A,2026
59100,Remove uterus lesion,CPT,RVU2026A,2026
59120,Treat ectopic pregnancy,CPT,RVU2026A,2026
59121,Treat ectopic pregnancy,CPT,RVU2026A,2026
59130,Treat ectopic pregnancy,CPT,RVU2026A,2026
59136,Treat ectopic pregnancy,CPT,RVU2026A,2026
59140,Treat ectopic pregnancy,CPT,RVU2026A,2026
59150,Treat ectopic pregnancy,CPT,RVU2026A,2026
59151,Treat ectopic pregnancy,CPT,RVU2026A,2026
59160,D & c after delivery,CPT,RVU2026A,2026
59200,Insert cervical dilator,CPT,RVU2026A,2026
59300,Episiotomy or vaginal repair,CPT,RVU2026A,2026
59320,Revision of cervix,CPT,RVU2026A,2026
59325,Revision of cervix,CPT,RVU2026A,2026
59350,Repair of uterus,CPT,RVU2026A,2026
59400,Obstetrical care,CPT,RVU2026A,2026
59409,Obstetrical care,CPT,RVU2026A,2026
59410,Obstetrical care,CPT,RVU2026A,2026
59412,Antepartum manipulation,CPT,RVU2026A,2026
59414,Deliver placenta,CPT,RVU2026A,2026
59425,Antepartum care only,CPT,RVU2026A,2026
59426,Antepartum care only,CPT,RVU2026A,2026
59430,Care after delivery,CPT,RVU2026A,2026
59510,Cesarean delivery,CPT,RVU2026A,2026
59514,Cesarean delivery only,CPT,RVU2026A,2026
59515,Cesarean delivery,CPT,RVU2026A,2026
59525,Remove uterus after cesarean,CPT,RVU2026A,2026
59610,Vbac delivery,CPT,RVU2026A,2026
59612,Vbac delivery only,CPT,RVU2026A,2026
59614,Vbac care after delivery,CPT,RVU2026A,2026
59618,Attempted vbac delivery,CPT,RVU2026A,2026
59620,Attempted vbac delivery only,CPT,RVU2026A,2026
59622,Attempted vbac after care,CPT,RVU2026A,2026
59812,Treatment of miscarriage,CPT,RVU2026A,2026
59820,Care of miscarriage,CPT,RVU2026A,2026
59821,Treatment of miscarriage,CPT,RVU2026A,2026
59830,Treat uterus infection,CPT,RVU2026A,2026
59840,Induced abortion d&c,CPT,RVU2026A,2026
59841,Induced abortion dilat&evac,CPT,RVU2026A,2026
59850,Induced abortion 1+ njx,CPT,RVU2026A,2026
59851,Induced abortion 1+njx d&c,CPT,RVU2026A,2026
59852,Induced abortion 1+njx hyst,CPT,RVU2026A,2026
59855,Induced abortion 1+vag supp,CPT,RVU2026A,2026
59856,Induced ab 1+vag supp d&c,CPT,RVU2026A,2026
59857,Induced ab 1+vag supp hyst,CPT,RVU2026A,2026
59866,Abortion (mpr),CPT,RVU2026A,2026
59870,Evacuate mole of uterus,CPT,RVU2026A,2026
59871,Remove cerclage suture,CPT,RVU2026A,2026
59897,Unlisted fetal invas px w/us,CPT,RVU2026A,2026
59898,Unlstd laps px mat care&dlvr,CPT,RVU2026A,2026
59899,Unlisted px mat care&dlvr,CPT,RVU2026A,2026
60000,I&d thyroglssl dux cst infct,CPT,RVU2026A,2026
6005F,Care level rationale doc,Other,RVU2026A,2026
60100,Biopsy of thyroid,CPT,RVU2026A,2026
6010F,Dysphag test done b/4 eating,Other,RVU2026A,2026
6015F,Dysphag test done b/4 eating,Other,RVU2026A,2026
60200,Remove thyroid lesion,CPT,RVU2026A,2026
6020F,Npo (nothing-mouth) ordered,Other,RVU2026A,2026
60210,Partial thyroid excision,CPT,RVU2026A,2026
60212,Partial thyroid excision,CPT,RVU2026A,2026
60220,Partial removal of thyroid,CPT,RVU2026A,2026
60225,Partial removal of thyroid,CPT,RVU2026A,2026
60240,Removal of thyroid,CPT,RVU2026A,2026
60252,Removal of thyroid,CPT,RVU2026A,2026
60254,Extensive thyroid surgery,CPT,RVU2026A,2026
60260,Repeat thyroid surgery,CPT,RVU2026A,2026
60270,Removal of thyroid,CPT,RVU2026A,2026
60271,Removal of thyroid,CPT,RVU2026A,2026
60280,Remove thyroid duct lesion,CPT,RVU2026A,2026
60281,Remove thyroid duct lesion,CPT,RVU2026A,2026
60300,Aspir/inj thyroid cyst,CPT,RVU2026A,2026
6030F,Max sterile barriers flwd,Other,RVU2026A,2026
6040F,Appro rad ds dvcs techs docd,Other,RVU2026A,2026
6045F,Radxps in end rprt4fluro pxd,Other,RVU2026A,2026
60500,Explore parathyroid glands,CPT,RVU2026A,2026
60502,Re-explore parathyroids,CPT,RVU2026A,2026
60505,Explore parathyroid glands,CPT,RVU2026A,2026
60512,Autotransplant parathyroid,CPT,RVU2026A,2026
60520,Removal of thymus gland,CPT,RVU2026A,2026
60521,Removal of thymus gland,CPT,RVU2026A,2026
60522,Removal of thymus gland,CPT,RVU2026A,2026
60540,Explore adrenal gland,CPT,RVU2026A,2026
60545,Explore adrenal gland,CPT,RVU2026A,2026
60600,Remove carotid body lesion,CPT,RVU2026A,2026
60605,Remove carotid body lesion,CPT,RVU2026A,2026
60650,Laparoscopy adrenalectomy,CPT,RVU2026A,2026
60659,Unlisted laps px endoc sys,CPT,RVU2026A,2026
60660,Abltj 1/+thyr ndul 1lobe prq,CPT,RVU2026A,2026
60661,Abltj 1/+thyr ndul addl prq,CPT,RVU2026A,2026
60699,Unlisted px endocrine system,CPT,RVU2026A,2026
6070F,Pt asked/cnsld aed effects,Other,RVU2026A,2026
6080F,Pt/caregiver queried falls,Other,RVU2026A,2026
6090F,Pt/caregiver counsel safety,Other,RVU2026A,2026
61000,Remove cranial cavity fluid,CPT,RVU2026A,2026
61001,Remove cranial cavity fluid,CPT,RVU2026A,2026
6100F,Verify pt site pxd docd,Other,RVU2026A,2026
6101F,Safety counseling dementia,Other,RVU2026A,2026
61020,Remove brain cavity fluid,CPT,RVU2026A,2026
61026,Injection into brain canal,CPT,RVU2026A,2026
6102F,Safety counseling dem order,Other,RVU2026A,2026
61050,Remove brain canal fluid,CPT,RVU2026A,2026
61055,Injection into brain canal,CPT,RVU2026A,2026
61070,Brain canal shunt procedure,CPT,RVU2026A,2026
61105,Tdh sdrl/ventr pnxr,CPT,RVU2026A,2026
61107,Tdh pnxr implt ventr cath,CPT,RVU2026A,2026
61108,Tdh pnxr evac&/drg sdrl hmta,CPT,RVU2026A,2026
6110F,Counsel prov driving risks,Other,RVU2026A,2026
61120,Burr hole for ventr puncture,CPT,RVU2026A,2026
61140,Burr hole/treph bx brain/les,CPT,RVU2026A,2026
61150,Bur hol/trph drg brn abs/cst,CPT,RVU2026A,2026
61151,Burr hole/treph sbsq tapping,CPT,RVU2026A,2026
61154,Burr hole w/evac&/drg hmtma,CPT,RVU2026A,2026
61156,Burr hol aspir hmtm/cst icer,CPT,RVU2026A,2026
61210,Burr hole implt ventr cath,CPT,RVU2026A,2026
61215,Ins subq rsvr pmp/nfs sys,CPT,RVU2026A,2026
61250,Burr hole/treph sttl expl,CPT,RVU2026A,2026
61253,Burr hole treph ittl uni/bi,CPT,RVU2026A,2026
61304,Crnec/crnot expl supratntorl,CPT,RVU2026A,2026
61305,Crnec/crnot expl infratntorl,CPT,RVU2026A,2026
61312,Crnec/crnot sttl xdrl/sdrl,CPT,RVU2026A,2026
61313,Crnec/crnot sttl icere,CPT,RVU2026A,2026
61314,Crnec/crnot ittl xdrl/sdrl,CPT,RVU2026A,2026
61315,Crnec/crnot ittl ntracereblr,CPT,RVU2026A,2026
61316,Inc&subq plmt crnl bone grf,CPT,RVU2026A,2026
61320,Crnec/crnot drg icr abs sttl,CPT,RVU2026A,2026
61321,Crnec/crnot drg icr abs ittl,CPT,RVU2026A,2026
61322,Crnec/crnot dcmprv w/o lobec,CPT,RVU2026A,2026
61323,Crnec/crnot dcmprv w/lobec,CPT,RVU2026A,2026
61330,Dcmprn orbit only transcrnl,CPT,RVU2026A,2026
61333,Expl orbit w/removal lesion,CPT,RVU2026A,2026
61340,Subtemporal cranial dcmprn,CPT,RVU2026A,2026
61343,Crnec sopl crv lam dcmprn,CPT,RVU2026A,2026
61345,Oth cranial dcmprn pst fossa,CPT,RVU2026A,2026
61450,Crnec stpl sctj cmprn/dcmprn,CPT,RVU2026A,2026
61458,Crnec sopl xpl/dcmpr crl nrv,CPT,RVU2026A,2026
61460,Crnec sopl sctj 1+crnl nrv,CPT,RVU2026A,2026
61500,Crnec exc tum/bone les skull,CPT,RVU2026A,2026
61501,Craniectomy f/osteomyelitis,CPT,RVU2026A,2026
6150F,Pt notrcvng1st antitnf txmnt,Other,RVU2026A,2026
61510,Crnec treph exc brn tum sttl,CPT,RVU2026A,2026
61512,Crnec treph exc mngioma sttl,CPT,RVU2026A,2026
61514,Crnec treph exc brn abs sttl,CPT,RVU2026A,2026
61516,Crnec treph exc cyst sttl,CPT,RVU2026A,2026
61517,Implt brn intrcv chemotx agt,CPT,RVU2026A,2026
61518,Removal of brain lesion,CPT,RVU2026A,2026
61519,Remove brain lining lesion,CPT,RVU2026A,2026
61520,Removal of brain lesion,CPT,RVU2026A,2026
61521,Removal of brain lesion,CPT,RVU2026A,2026
61522,Removal of brain abscess,CPT,RVU2026A,2026
61524,Removal of brain lesion,CPT,RVU2026A,2026
61526,Removal of brain lesion,CPT,RVU2026A,2026
61530,Removal of brain lesion,CPT,RVU2026A,2026
61531,Implant brain electrodes,CPT,RVU2026A,2026
61533,Implant brain electrodes,CPT,RVU2026A,2026
61534,Removal of brain lesion,CPT,RVU2026A,2026
61535,Remove brain electrodes,CPT,RVU2026A,2026
61536,Removal of brain lesion,CPT,RVU2026A,2026
61537,Removal of brain tissue,CPT,RVU2026A,2026
61538,Removal of brain tissue,CPT,RVU2026A,2026
61539,Removal of brain tissue,CPT,RVU2026A,2026
61540,Removal of brain tissue,CPT,RVU2026A,2026
61541,Incision of brain tissue,CPT,RVU2026A,2026
61543,Removal of brain tissue,CPT,RVU2026A,2026
61544,Remove & treat brain lesion,CPT,RVU2026A,2026
61545,Excision of brain tumor,CPT,RVU2026A,2026
61546,Removal of pituitary gland,CPT,RVU2026A,2026
61548,Removal of pituitary gland,CPT,RVU2026A,2026
61550,Release of skull seams,CPT,RVU2026A,2026
61552,Release of skull seams,CPT,RVU2026A,2026
61556,Incise skull/sutures,CPT,RVU2026A,2026
61557,Incise skull/sutures,CPT,RVU2026A,2026
61558,Excision of skull/sutures,CPT,RVU2026A,2026
61559,Excision of skull/sutures,CPT,RVU2026A,2026
61563,Excision of skull tumor,CPT,RVU2026A,2026
61564,Excision of skull tumor,CPT,RVU2026A,2026
61566,Removal of brain tissue,CPT,RVU2026A,2026
61567,Incision of brain tissue,CPT,RVU2026A,2026
61570,Remove foreign body brain,CPT,RVU2026A,2026
61571,Incise skull for brain wound,CPT,RVU2026A,2026
61575,Skull base/brainstem surgery,CPT,RVU2026A,2026
61576,Skull base/brainstem surgery,CPT,RVU2026A,2026
61580,Craniofacial approach skull,CPT,RVU2026A,2026
61581,Craniofacial approach skull,CPT,RVU2026A,2026
61582,Craniofacial approach skull,CPT,RVU2026A,2026
61583,Craniofacial approach skull,CPT,RVU2026A,2026
61584,Orbitocranial approach/skull,CPT,RVU2026A,2026
61585,Orbitocranial approach/skull,CPT,RVU2026A,2026
61586,Resect nasopharynx skull,CPT,RVU2026A,2026
61590,Infratemporal approach/skull,CPT,RVU2026A,2026
61591,Infratemporal approach/skull,CPT,RVU2026A,2026
61592,Orbitocranial approach/skull,CPT,RVU2026A,2026
61595,Transtemporal approach/skull,CPT,RVU2026A,2026
61596,Transcochlear approach/skull,CPT,RVU2026A,2026
61597,Transcondylar approach/skull,CPT,RVU2026A,2026
61598,Transpetrosal approach/skull,CPT,RVU2026A,2026
61600,Resect/excise cranial lesion,CPT,RVU2026A,2026
61601,Resect/excise cranial lesion,CPT,RVU2026A,2026
61605,Resect/excise cranial lesion,CPT,RVU2026A,2026
61606,Resect/excise cranial lesion,CPT,RVU2026A,2026
61607,Resect/excise cranial lesion,CPT,RVU2026A,2026
61608,Resect/excise cranial lesion,CPT,RVU2026A,2026
61611,Transect artery sinus,CPT,RVU2026A,2026
61613,Remove aneurysm sinus,CPT,RVU2026A,2026
61615,Resect/excise lesion skull,CPT,RVU2026A,2026
61616,Resect/excise lesion skull,CPT,RVU2026A,2026
61618,Repair dura,CPT,RVU2026A,2026
61619,Repair dura,CPT,RVU2026A,2026
61623,Evasc temp balo artl occ h/n,CPT,RVU2026A,2026
61624,Tcat perm occls/embolj cns,CPT,RVU2026A,2026
61626,Tcat perm occls/embol noncns,CPT,RVU2026A,2026
61630,Balo angioplasty icr perq,CPT,RVU2026A,2026
61635,Intracran angioplsty w/stent,CPT,RVU2026A,2026
61640,Dilate ic vasospasm init,CPT,RVU2026A,2026
61641,Dilat ic vspsm ea vsl sm ter,CPT,RVU2026A,2026
61642,Dilat ic vspsm ea diff ter,CPT,RVU2026A,2026
61645,Perq art m-thrombect &/nfs,CPT,RVU2026A,2026
61650,Evasc prlng admn rx agnt 1st,CPT,RVU2026A,2026
61651,Evasc prlng admn rx agnt add,CPT,RVU2026A,2026
61680,Intracranial vessel surgery,CPT,RVU2026A,2026
61682,Intracranial vessel surgery,CPT,RVU2026A,2026
61684,Intracranial vessel surgery,CPT,RVU2026A,2026
61686,Intracranial vessel surgery,CPT,RVU2026A,2026
61690,Intracranial vessel surgery,CPT,RVU2026A,2026
61692,Intracranial vessel surgery,CPT,RVU2026A,2026
61697,Brain aneurysm repr complx,CPT,RVU2026A,2026
61698,Brain aneurysm repr complx,CPT,RVU2026A,2026
61700,Brain aneurysm repr simple,CPT,RVU2026A,2026
61702,Inner skull vessel surgery,CPT,RVU2026A,2026
61703,Clamp neck artery,CPT,RVU2026A,2026
61705,Revise circulation to head,CPT,RVU2026A,2026
61708,Revise circulation to head,CPT,RVU2026A,2026
61710,Revise circulation to head,CPT,RVU2026A,2026
61711,Fusion of skull arteries,CPT,RVU2026A,2026
61715,Mrgfus strtctc ablt trgt icr,CPT,RVU2026A,2026
61720,Incise skull/brain surgery,CPT,RVU2026A,2026
61735,Incise skull/brain surgery,CPT,RVU2026A,2026
61736,Litt icr 1 traj 1 smpl les,CPT,RVU2026A,2026
61737,Litt icr mlt trj mlt/cplx ls,CPT,RVU2026A,2026
61750,Incise skull/brain biopsy,CPT,RVU2026A,2026
61751,Brain biopsy w/ct/mr guide,CPT,RVU2026A,2026
61760,Implant brain electrodes,CPT,RVU2026A,2026
61770,Incise skull for treatment,CPT,RVU2026A,2026
61781,Scan proc cranial intra,CPT,RVU2026A,2026
61782,Scan proc cranial extra,CPT,RVU2026A,2026
61783,Scan proc spinal,CPT,RVU2026A,2026
61790,Treat trigeminal nerve,CPT,RVU2026A,2026
61791,Treat trigeminal tract,CPT,RVU2026A,2026
61796,Srs cranial lesion simple,CPT,RVU2026A,2026
61797,Srs cran les simple addl,CPT,RVU2026A,2026
61798,Srs cranial lesion complex,CPT,RVU2026A,2026
61799,Srs cran les complex addl,CPT,RVU2026A,2026
61800,Apply srs headframe add-on,CPT,RVU2026A,2026
61850,Implant neuroelectrodes,CPT,RVU2026A,2026
61860,Implant neuroelectrodes,CPT,RVU2026A,2026
61863,Implant neuroelectrode,CPT,RVU2026A,2026
61864,Implant neuroelectrde addl,CPT,RVU2026A,2026
61867,Implant neuroelectrode,CPT,RVU2026A,2026
61868,Implant neuroelectrde addl,CPT,RVU2026A,2026
61880,Revise/remove neuroelectrode,CPT,RVU2026A,2026
61885,Insrt/redo neurostim 1 array,CPT,RVU2026A,2026
61886,Implant neurostim arrays,CPT,RVU2026A,2026
61888,Revise/remove neuroreceiver,CPT,RVU2026A,2026
61889,Ins sk-mnt crnl nstm pg/rcvr,CPT,RVU2026A,2026
61891,Rev/rplcmt sk-mnt crnl nstm,CPT,RVU2026A,2026
61892,Rmv sk-mnt crnl nstm pg/rcvr,CPT,RVU2026A,2026
62000,Treat skull fracture,CPT,RVU2026A,2026
62005,Treat skull fracture,CPT,RVU2026A,2026
62010,Treatment of head injury,CPT,RVU2026A,2026
62100,Repair brain fluid leakage,CPT,RVU2026A,2026
62115,Reduction of skull defect,CPT,RVU2026A,2026
62117,Reduction of skull defect,CPT,RVU2026A,2026
62120,Repair skull cavity lesion,CPT,RVU2026A,2026
62121,Incise skull repair,CPT,RVU2026A,2026
62140,Crnop skull defect<5 cm diam,CPT,RVU2026A,2026
62141,Crnop skull defect>5 cm diam,CPT,RVU2026A,2026
62142,Rmvl b1 flp/prostc plate skl,CPT,RVU2026A,2026
62143,Rpl b1 flp/prostc plate skl,CPT,RVU2026A,2026
62145,Repair of skull & brain,CPT,RVU2026A,2026
62146,Crnop w/autograft<5 cm diam,CPT,RVU2026A,2026
62147,Crnop w/autograft>5 cm diam,CPT,RVU2026A,2026
62148,Retr bone flap to fix skull,CPT,RVU2026A,2026
62160,Neuroendoscopy add-on,CPT,RVU2026A,2026
62161,Dissect brain w/scope,CPT,RVU2026A,2026
62162,Remove colloid cyst w/scope,CPT,RVU2026A,2026
62164,Remove brain tumor w/scope,CPT,RVU2026A,2026
62165,Remove pituit tumor w/scope,CPT,RVU2026A,2026
62180,Establish brain cavity shunt,CPT,RVU2026A,2026
62190,Establish brain cavity shunt,CPT,RVU2026A,2026
62192,Establish brain cavity shunt,CPT,RVU2026A,2026
62194,Replace/irrigate catheter,CPT,RVU2026A,2026
62200,Establish brain cavity shunt,CPT,RVU2026A,2026
62201,Brain cavity shunt w/scope,CPT,RVU2026A,2026
62220,Establish brain cavity shunt,CPT,RVU2026A,2026
62223,Establish brain cavity shunt,CPT,RVU2026A,2026
62225,Replace/irrigate catheter,CPT,RVU2026A,2026
62230,Replace/revise brain shunt,CPT,RVU2026A,2026
62252,Csf shunt reprogram,CPT,RVU2026A,2026
62256,Remove brain cavity shunt,CPT,RVU2026A,2026
62258,Replace brain cavity shunt,CPT,RVU2026A,2026
62263,Epidural lysis mult sessions,CPT,RVU2026A,2026
62264,Epidural lysis on single day,CPT,RVU2026A,2026
62267,Interdiscal perq aspir dx,CPT,RVU2026A,2026
62268,Drain spinal cord cyst,CPT,RVU2026A,2026
62269,Needle biopsy spinal cord,CPT,RVU2026A,2026
62270,Dx lmbr spi pnxr,CPT,RVU2026A,2026
62272,Ther spi pnxr drg csf,CPT,RVU2026A,2026
62273,Inject epidural patch,CPT,RVU2026A,2026
62280,Treat spinal cord lesion,CPT,RVU2026A,2026
62281,Treat spinal cord lesion,CPT,RVU2026A,2026
62282,Treat spinal canal lesion,CPT,RVU2026A,2026
62284,Injection for myelogram,CPT,RVU2026A,2026
62287,Dcmprn pq nuc pul 1/mlt lmbr,CPT,RVU2026A,2026
62290,Njx px discography lumbar,CPT,RVU2026A,2026
62291,Njx px discography crv/thrc,CPT,RVU2026A,2026
62292,Njx chemonucleolysis lmbr,CPT,RVU2026A,2026
62294,Injection into spinal artery,CPT,RVU2026A,2026
62302,Myelography lumbar injection,CPT,RVU2026A,2026
62303,Myelography lumbar injection,CPT,RVU2026A,2026
62304,Myelography lumbar injection,CPT,RVU2026A,2026
62305,Myelography lumbar injection,CPT,RVU2026A,2026
62320,Njx interlaminar crv/thrc,CPT,RVU2026A,2026
62321,Njx interlaminar crv/thrc,CPT,RVU2026A,2026
62322,Njx interlaminar lmbr/sac,CPT,RVU2026A,2026
62323,Njx interlaminar lmbr/sac,CPT,RVU2026A,2026
62324,Njx interlaminar crv/thrc,CPT,RVU2026A,2026
62325,Njx interlaminar crv/thrc,CPT,RVU2026A,2026
62326,Njx interlaminar lmbr/sac,CPT,RVU2026A,2026
62327,Njx interlaminar lmbr/sac,CPT,RVU2026A,2026
62328,Dx lmbr spi pnxr w/fluor/ct,CPT,RVU2026A,2026
62329,Ther spi pnxr csf fluor/ct,CPT,RVU2026A,2026
62330,Dcmprn prq rmv lig flv 1lmbr,CPT,RVU2026A,2026
62331,Dcmprn prq rmv lig flv addl,CPT,RVU2026A,2026
62350,Implant spinal canal cath,CPT,RVU2026A,2026
62351,Implant spinal canal cath,CPT,RVU2026A,2026
62355,Remove spinal canal catheter,CPT,RVU2026A,2026
62360,Insert spine infusion device,CPT,RVU2026A,2026
62361,Implant spine infusion pump,CPT,RVU2026A,2026
62362,Implant spine infusion pump,CPT,RVU2026A,2026
62365,Remove spine infusion device,CPT,RVU2026A,2026
62367,Analyze spine infus pump,CPT,RVU2026A,2026
62368,Analyze sp inf pump w/reprog,CPT,RVU2026A,2026
62369,Anal sp inf pmp w/reprg&fill,CPT,RVU2026A,2026
62370,Anl sp inf pmp w/mdreprg&fil,CPT,RVU2026A,2026
62380,Ndsc dcmprn 1 ntrspc lumbar,CPT,RVU2026A,2026
63001,Remove spine lamina 1/2 crvl,CPT,RVU2026A,2026
63003,Remove spine lamina 1/2 thrc,CPT,RVU2026A,2026
63005,Remove spine lamina 1/2 lmbr,CPT,RVU2026A,2026
63011,Remove spine lamina 1/2 scrl,CPT,RVU2026A,2026
63012,Remove lamina/facets lumbar,CPT,RVU2026A,2026
63015,Remove spine lamina >2 crvcl,CPT,RVU2026A,2026
63016,Remove spine lamina >2 thrc,CPT,RVU2026A,2026
63017,Remove spine lamina >2 lmbr,CPT,RVU2026A,2026
63020,Lamot dcmprn nrv rt 1 cerv,CPT,RVU2026A,2026
63030,Lamot dcmprn nrv rt 1 lmbr,CPT,RVU2026A,2026
63032,Lamot rpr anulr dfct 1 lmbr,CPT,RVU2026A,2026
63035,Lamot dcmprn nrv rt ea addl,CPT,RVU2026A,2026
63040,Laminotomy single cervical,CPT,RVU2026A,2026
63042,Laminotomy single lumbar,CPT,RVU2026A,2026
63043,Laminotomy addl cervical,CPT,RVU2026A,2026
63044,Laminotomy addl lumbar,CPT,RVU2026A,2026
63045,Lam facetec & foramot crv,CPT,RVU2026A,2026
63046,Lam facetec & foramot thrc,CPT,RVU2026A,2026
63047,Lam facetec & foramot lumbar,CPT,RVU2026A,2026
63048,Lam facetec &foramot ea addl,CPT,RVU2026A,2026
63050,Cervical laminoplsty 2/> seg,CPT,RVU2026A,2026
63051,C-laminoplasty w/graft/plate,CPT,RVU2026A,2026
63052,Lam facetc/frmt arthrd lum 1,CPT,RVU2026A,2026
63053,Lam factc/frmt arthrd lum ea,CPT,RVU2026A,2026
63055,Decompress spinal cord thrc,CPT,RVU2026A,2026
63056,Decompress spinal cord lmbr,CPT,RVU2026A,2026
63057,Decompress spine cord add-on,CPT,RVU2026A,2026
63064,Decompress spinal cord thrc,CPT,RVU2026A,2026
63066,Decompress spine cord add-on,CPT,RVU2026A,2026
63075,Neck spine disk surgery,CPT,RVU2026A,2026
63076,Neck spine disk surgery,CPT,RVU2026A,2026
63077,Spine disk surgery thorax,CPT,RVU2026A,2026
63078,Spine disk surgery thorax,CPT,RVU2026A,2026
63081,Remove vert body dcmprn crvl,CPT,RVU2026A,2026
63082,Remove vertebral body add-on,CPT,RVU2026A,2026
63085,Remove vert body dcmprn thrc,CPT,RVU2026A,2026
63086,Remove vertebral body add-on,CPT,RVU2026A,2026
63087,Remov vertbr dcmprn thrclmbr,CPT,RVU2026A,2026
63088,Remove vertebral body add-on,CPT,RVU2026A,2026
63090,Remove vert body dcmprn lmbr,CPT,RVU2026A,2026
63091,Remove vertebral body add-on,CPT,RVU2026A,2026
63101,Remove vert body dcmprn thrc,CPT,RVU2026A,2026
63102,Remove vert body dcmprn lmbr,CPT,RVU2026A,2026
63103,Remove vertebral body add-on,CPT,RVU2026A,2026
63170,Incise spinal cord tract(s),CPT,RVU2026A,2026
63172,Drainage of spinal cyst,CPT,RVU2026A,2026
63173,Drainage of spinal cyst,CPT,RVU2026A,2026
63185,Incise spine nrv half segmnt,CPT,RVU2026A,2026
63190,Incise spine nrv >2 segmnts,CPT,RVU2026A,2026
63191,Incise spine accessory nerve,CPT,RVU2026A,2026
63197,Lam w/cordotomy 1stg thrc,CPT,RVU2026A,2026
63200,Release spinal cord lumbar,CPT,RVU2026A,2026
63250,Revise spinal cord vsls crvl,CPT,RVU2026A,2026
63251,Revise spinal cord vsls thrc,CPT,RVU2026A,2026
63252,Revise spine cord vsl thrlmb,CPT,RVU2026A,2026
63265,Excise intraspinl lesion crv,CPT,RVU2026A,2026
63266,Excise intrspinl lesion thrc,CPT,RVU2026A,2026
63267,Excise intrspinl lesion lmbr,CPT,RVU2026A,2026
63268,Excise intrspinl lesion scrl,CPT,RVU2026A,2026
63270,Excise intrspinl lesion crvl,CPT,RVU2026A,2026
63271,Excise intrspinl lesion thrc,CPT,RVU2026A,2026
63272,Excise intrspinl lesion lmbr,CPT,RVU2026A,2026
63273,Excise intrspinl lesion scrl,CPT,RVU2026A,2026
63275,Bx/exc xdrl spine lesn crvl,CPT,RVU2026A,2026
63276,Bx/exc xdrl spine lesn thrc,CPT,RVU2026A,2026
63277,Bx/exc xdrl spine lesn lmbr,CPT,RVU2026A,2026
63278,Bx/exc xdrl spine lesn scrl,CPT,RVU2026A,2026
63280,Bx/exc idrl spine lesn crvl,CPT,RVU2026A,2026
63281,Bx/exc idrl spine lesn thrc,CPT,RVU2026A,2026
63282,Bx/exc idrl spine lesn lmbr,CPT,RVU2026A,2026
63283,Bx/exc idrl spine lesn scrl,CPT,RVU2026A,2026
63285,Bx/exc idrl imed lesn cervl,CPT,RVU2026A,2026
63286,Bx/exc idrl imed lesn thrc,CPT,RVU2026A,2026
63287,Bx/exc idrl imed lesn thrlmb,CPT,RVU2026A,2026
63290,Bx/exc xdrl/idrl lsn any lvl,CPT,RVU2026A,2026
63295,Repair laminectomy defect,CPT,RVU2026A,2026
63300,Remove vert xdrl body crvcl,CPT,RVU2026A,2026
63301,Remove vert xdrl body thrc,CPT,RVU2026A,2026
63302,Remove vert xdrl body thrlmb,CPT,RVU2026A,2026
63303,Remov vert xdrl bdy lmbr/sac,CPT,RVU2026A,2026
63304,Remove vert idrl body crvcl,CPT,RVU2026A,2026
63305,Remove vert idrl body thrc,CPT,RVU2026A,2026
63306,Remov vert idrl bdy thrclmbr,CPT,RVU2026A,2026
63307,Remov vert idrl bdy lmbr/sac,CPT,RVU2026A,2026
63308,Remove vertebral body add-on,CPT,RVU2026A,2026
63600,Remove spinal cord lesion,CPT,RVU2026A,2026
63610,Stimulation of spinal cord,CPT,RVU2026A,2026
63620,Srs spinal lesion,CPT,RVU2026A,2026
63621,Srs spinal lesion addl,CPT,RVU2026A,2026
63650,Implant neuroelectrodes,CPT,RVU2026A,2026
63655,Implant neuroelectrodes,CPT,RVU2026A,2026
63661,Remove spine eltrd perq aray,CPT,RVU2026A,2026
63662,Remove spine eltrd plate,CPT,RVU2026A,2026
63663,Revise spine eltrd perq aray,CPT,RVU2026A,2026
63664,Revise spine eltrd plate,CPT,RVU2026A,2026
63685,Ins/rplc spi npg/rcvr pocket,CPT,RVU2026A,2026
63688,Rev/rmv imp sp npg/r dtch cn,CPT,RVU2026A,2026
63700,Repair of spinal herniation,CPT,RVU2026A,2026
63702,Repair of spinal herniation,CPT,RVU2026A,2026
63704,Repair of spinal herniation,CPT,RVU2026A,2026
63706,Repair of spinal herniation,CPT,RVU2026A,2026
63707,Repair spinal fluid leakage,CPT,RVU2026A,2026
63709,Repair spinal fluid leakage,CPT,RVU2026A,2026
63710,Graft repair of spine defect,CPT,RVU2026A,2026
63740,Install spinal shunt,CPT,RVU2026A,2026
63741,Install spinal shunt,CPT,RVU2026A,2026
63744,Revision of spinal shunt,CPT,RVU2026A,2026
63746,Removal of spinal shunt,CPT,RVU2026A,2026
64400,Njx aa&/strd trigeminal nrv,CPT,RVU2026A,2026
64405,Njx aa&/strd gr ocpl nrv,CPT,RVU2026A,2026
64408,Njx aa&/strd vagus nrv,CPT,RVU2026A,2026
64415,Njx aa&/strd brch plxs img,CPT,RVU2026A,2026
64416,Njx aa&/strd brch pl nfs img,CPT,RVU2026A,2026
64417,Njx aa&/strd ax nerve img,CPT,RVU2026A,2026
64418,Njx aa&/strd sprscap nrv,CPT,RVU2026A,2026
64420,Njx aa&/strd ntrcost nrv 1,CPT,RVU2026A,2026
64421,Njx aa&/strd ntrcost nrv ea,CPT,RVU2026A,2026
64425,Njx aa&/strd ii ih nerves,CPT,RVU2026A,2026
64430,Njx aa&/strd pudendal nerve,CPT,RVU2026A,2026
64435,Njx aa&/strd paracrv nrv,CPT,RVU2026A,2026
64445,Njx aa&/strd sciatic nrv img,CPT,RVU2026A,2026
64446,Njx aa&/strd sc nrv nfs img,CPT,RVU2026A,2026
64447,Njx aa&/strd femoral nrv img,CPT,RVU2026A,2026
64448,Njx aa&/strd fem nrv nfs img,CPT,RVU2026A,2026
64449,Njx aa&/strd lmbr plex nfs,CPT,RVU2026A,2026
64450,Njx aa&/strd other pn/branch,CPT,RVU2026A,2026
64451,Njx aa&/strd nrv nrvtg si jt,CPT,RVU2026A,2026
64454,Njx aa&/strd gnclr nrv brnch,CPT,RVU2026A,2026
64455,Njx aa&/strd pltr com dg nrv,CPT,RVU2026A,2026
64461,Pvb thoracic single inj site,CPT,RVU2026A,2026
64462,Pvb thoracic 2nd+ inj site,CPT,RVU2026A,2026
64463,Pvb thoracic cont infusion,CPT,RVU2026A,2026
64466,Thrc fascial pln blk uni njx,CPT,RVU2026A,2026
64467,Thrc fascial pln blk uni nfs,CPT,RVU2026A,2026
64468,Thrc fascial pln blk bi njx,CPT,RVU2026A,2026
64469,Thrc fascial pln blk bi nfs,CPT,RVU2026A,2026
64473,Lwr xtr fscl pln blk uni njx,CPT,RVU2026A,2026
64474,Lwr xtr fscl pln blk uni nfs,CPT,RVU2026A,2026
64479,Njx aa&/strd tfrm epi c/t 1,CPT,RVU2026A,2026
64480,Njx aa&/strd tfrm epi c/t ea,CPT,RVU2026A,2026
64483,Njx aa&/strd tfrm epi l/s 1,CPT,RVU2026A,2026
64484,Njx aa&/strd tfrm epi l/s ea,CPT,RVU2026A,2026
64486,Tap block unil by injection,CPT,RVU2026A,2026
64487,Tap block uni by infusion,CPT,RVU2026A,2026
64488,Tap block bi injection,CPT,RVU2026A,2026
64489,Tap block bi by infusion,CPT,RVU2026A,2026
64490,Inj paravert f jnt c/t 1 lev,CPT,RVU2026A,2026
64491,Inj paravert f jnt c/t 2 lev,CPT,RVU2026A,2026
64492,Inj paravert f jnt c/t 3 lev,CPT,RVU2026A,2026
64493,Inj paravert f jnt l/s 1 lev,CPT,RVU2026A,2026
64494,Inj paravert f jnt l/s 2 lev,CPT,RVU2026A,2026
64495,Inj paravert f jnt l/s 3 lev,CPT,RVU2026A,2026
64505,N block spenopalatine gangl,CPT,RVU2026A,2026
64510,N block stellate ganglion,CPT,RVU2026A,2026
64517,N block inj hypogas plxs,CPT,RVU2026A,2026
64520,N block lumbar/thoracic,CPT,RVU2026A,2026
64530,N block inj celiac pelus,CPT,RVU2026A,2026
64553,Implant neuroelectrodes,CPT,RVU2026A,2026
64555,Implant neuroelectrodes,CPT,RVU2026A,2026
64561,Implant neuroelectrodes,CPT,RVU2026A,2026
64566,Neuroeltrd stim post tibial,CPT,RVU2026A,2026
64567,Perq elec nrv field stimj cn,CPT,RVU2026A,2026
64568,Opn impltj crnl nrv nea&pg,CPT,RVU2026A,2026
64569,Revise/repl vagus n eltrd,CPT,RVU2026A,2026
64570,Remove vagus n eltrd,CPT,RVU2026A,2026
64575,Opn impltj nea perph nerve,CPT,RVU2026A,2026
64580,Opn impltj nea neuromuscular,CPT,RVU2026A,2026
64581,Opn impltj nea sacral nerve,CPT,RVU2026A,2026
64582,Opn mpltj hpglsl nstm ary pg,CPT,RVU2026A,2026
64583,Rev/rplct hpglsl nstm ary pg,CPT,RVU2026A,2026
64584,Rmvl hpglsl nstim ary pg,CPT,RVU2026A,2026
64585,Rev/rmv perph nstim eltrd ra,CPT,RVU2026A,2026
64590,Ins/rpl prph sac/gstr npg/r,CPT,RVU2026A,2026
64595,Rev/rmv prph sac/gstr npg/r,CPT,RVU2026A,2026
64596,Ins/rplcmt prq eltrd ra pn 1,CPT,RVU2026A,2026
64597,Ins/rplcm prq eltrd ra pn ea,CPT,RVU2026A,2026
64598,Revj/rmvl nea pn w/int nstim,CPT,RVU2026A,2026
64600,Injection treatment of nerve,CPT,RVU2026A,2026
64605,Injection treatment of nerve,CPT,RVU2026A,2026
64610,Injection treatment of nerve,CPT,RVU2026A,2026
64611,Chemodenerv saliv glands,CPT,RVU2026A,2026
64612,Destroy nerve face muscle,CPT,RVU2026A,2026
64615,Chemodenerv musc migraine,CPT,RVU2026A,2026
64616,Chemodenerv musc neck dyston,CPT,RVU2026A,2026
64617,Chemodener muscle larynx emg,CPT,RVU2026A,2026
64620,Injection treatment of nerve,CPT,RVU2026A,2026
64624,Dstrj nulyt agt gnclr nrv,CPT,RVU2026A,2026
64625,Rf abltj nrv nrvtg si jt,CPT,RVU2026A,2026
64628,Trml dstrj ios bvn 1st 2 l/s,CPT,RVU2026A,2026
64629,Trml dstrj ios bvn ea addl,CPT,RVU2026A,2026
64630,Injection treatment of nerve,CPT,RVU2026A,2026
64632,N block inj common digit,CPT,RVU2026A,2026
64633,Destroy cerv/thor facet jnt,CPT,RVU2026A,2026
64634,Destroy c/th facet jnt addl,CPT,RVU2026A,2026
64635,Destroy lumb/sac facet jnt,CPT,RVU2026A,2026
64636,Destroy l/s facet jnt addl,CPT,RVU2026A,2026
64640,Injection treatment of nerve,CPT,RVU2026A,2026
64642,Chemodenerv 1 extremity 1-4,CPT,RVU2026A,2026
64643,Chemodenerv 1 extrem 1-4 ea,CPT,RVU2026A,2026
64644,Chemodenerv 1 extrem 5/> mus,CPT,RVU2026A,2026
64645,Chemodenerv 1 extrem 5/> ea,CPT,RVU2026A,2026
64646,Chemodenerv trunk musc 1-5,CPT,RVU2026A,2026
64647,Chemodenerv trunk musc 6/>,CPT,RVU2026A,2026
64650,Chemodenerv eccrine glands,CPT,RVU2026A,2026
64653,Chemodenerv eccrine glands,CPT,RVU2026A,2026
64654,1st opn implt bat modulj sys,CPT,RVU2026A,2026
64655,Revj/rplcmt bat mod sys lead,CPT,RVU2026A,2026
64656,Revj/rplcmt bat mod sys pg,CPT,RVU2026A,2026
64657,Rmvl bat modulj sys tot sys,CPT,RVU2026A,2026
64658,Rmvl bat modul sys lead only,CPT,RVU2026A,2026
64659,Rmvl bat modulj sys pg only,CPT,RVU2026A,2026
64680,Injection treatment of nerve,CPT,RVU2026A,2026
64681,Injection treatment of nerve,CPT,RVU2026A,2026
64702,Revise finger/toe nerve,CPT,RVU2026A,2026
64704,Revise hand/foot nerve,CPT,RVU2026A,2026
64708,Revise arm/leg nerve,CPT,RVU2026A,2026
64712,Revision of sciatic nerve,CPT,RVU2026A,2026
64713,Revision of arm nerve(s),CPT,RVU2026A,2026
64714,Revise low back nerve(s),CPT,RVU2026A,2026
64716,Revision of cranial nerve,CPT,RVU2026A,2026
64718,Revise ulnar nerve at elbow,CPT,RVU2026A,2026
64719,Revise ulnar nerve at wrist,CPT,RVU2026A,2026
64721,Carpal tunnel surgery,CPT,RVU2026A,2026
64722,Decompression unspec nerve,CPT,RVU2026A,2026
64726,Dcmprn plantar digital nerve,CPT,RVU2026A,2026
64727,Internal neurolysis,CPT,RVU2026A,2026
64728,Dcmprn median nrv carpl tunl,CPT,RVU2026A,2026
64732,Incision of brow nerve,CPT,RVU2026A,2026
64734,Incision of cheek nerve,CPT,RVU2026A,2026
64736,Incision of chin nerve,CPT,RVU2026A,2026
64738,Incision of jaw nerve,CPT,RVU2026A,2026
64740,Incision of tongue nerve,CPT,RVU2026A,2026
64742,Incision of facial nerve,CPT,RVU2026A,2026
64744,Incise nerve back of head,CPT,RVU2026A,2026
64746,Incise diaphragm nerve,CPT,RVU2026A,2026
64755,Incision of stomach nerves,CPT,RVU2026A,2026
64760,Incision of vagus nerve,CPT,RVU2026A,2026
64763,Incise hip/thigh nerve,CPT,RVU2026A,2026
64766,Incise hip/thigh nerve,CPT,RVU2026A,2026
64771,Sever cranial nerve,CPT,RVU2026A,2026
64772,Incision of spinal nerve,CPT,RVU2026A,2026
64774,Remove skin nerve lesion,CPT,RVU2026A,2026
64776,Remove digit nerve lesion,CPT,RVU2026A,2026
64778,Digit nerve surgery add-on,CPT,RVU2026A,2026
64782,Remove limb nerve lesion,CPT,RVU2026A,2026
64783,Limb nerve surgery add-on,CPT,RVU2026A,2026
64784,Remove nerve lesion,CPT,RVU2026A,2026
64786,Remove sciatic nerve lesion,CPT,RVU2026A,2026
64787,Implant nerve end,CPT,RVU2026A,2026
64788,Remove skin nerve lesion,CPT,RVU2026A,2026
64790,Removal of nerve lesion,CPT,RVU2026A,2026
64792,Removal of nerve lesion,CPT,RVU2026A,2026
64795,Biopsy of nerve,CPT,RVU2026A,2026
64802,Sympathectomy cervical,CPT,RVU2026A,2026
64804,Sympathectomy cervicothorac,CPT,RVU2026A,2026
64809,Sympathectomy thoracolumbar,CPT,RVU2026A,2026
64818,Sympathectomy lumbar,CPT,RVU2026A,2026
64820,Sympathectomy digital artery,CPT,RVU2026A,2026
64821,Sympathectomy radial artery,CPT,RVU2026A,2026
64822,Sympathectomy ulnar artery,CPT,RVU2026A,2026
64823,Sympathectomy supfc palmar,CPT,RVU2026A,2026
64831,Repair of digit nerve,CPT,RVU2026A,2026
64832,Repair nerve add-on,CPT,RVU2026A,2026
64834,Repair of hand or foot nerve,CPT,RVU2026A,2026
64835,Repair of hand or foot nerve,CPT,RVU2026A,2026
64836,Repair of hand or foot nerve,CPT,RVU2026A,2026
64837,Repair nerve add-on,CPT,RVU2026A,2026
64840,Repair of leg nerve,CPT,RVU2026A,2026
64856,Repair/transpose nerve,CPT,RVU2026A,2026
64857,Repair arm/leg nerve,CPT,RVU2026A,2026
64858,Repair sciatic nerve,CPT,RVU2026A,2026
64859,Nerve surgery,CPT,RVU2026A,2026
64861,Repair of arm nerves,CPT,RVU2026A,2026
64862,Repair of low back nerves,CPT,RVU2026A,2026
64864,Repair of facial nerve,CPT,RVU2026A,2026
64865,Repair of facial nerve,CPT,RVU2026A,2026
64866,Fusion of facial/other nerve,CPT,RVU2026A,2026
64868,Fusion of facial/other nerve,CPT,RVU2026A,2026
64872,Subsequent repair of nerve,CPT,RVU2026A,2026
64874,Repair & revise nerve add-on,CPT,RVU2026A,2026
64876,Repair nerve/shorten bone,CPT,RVU2026A,2026
64885,Nerve graft head/neck <4 cm,CPT,RVU2026A,2026
64886,Nerve graft head/neck >4 cm,CPT,RVU2026A,2026
64890,Nrv grf 1strnd hnd/foot <4cm,CPT,RVU2026A,2026
64891,Nrv grf 1strnd hnd/foot >4cm,CPT,RVU2026A,2026
64892,Nrv grf 1strnd arm/leg <4cm,CPT,RVU2026A,2026
64893,Nrv grf 1strnd arm/leg >4 cm,CPT,RVU2026A,2026
64895,Nrv grf mltst hnd/foot <4 cm,CPT,RVU2026A,2026
64896,Nrv grf mltst hnd/foot >4 cm,CPT,RVU2026A,2026
64897,Nrv grf mltst arm/leg <4 cm,CPT,RVU2026A,2026
64898,Nrv grf mltst arm/leg >4 cm,CPT,RVU2026A,2026
64901,Nerve graft add-on,CPT,RVU2026A,2026
64902,Nerve graft add-on,CPT,RVU2026A,2026
64905,Nerve pedicle transfer,CPT,RVU2026A,2026
64907,Nerve pedicle transfer,CPT,RVU2026A,2026
64910,Nerve repair w/allograft,CPT,RVU2026A,2026
64911,Neurorraphy w/vein autograft,CPT,RVU2026A,2026
64912,Nrv rpr w/nrv algrft 1st,CPT,RVU2026A,2026
64913,Nrv rpr w/nrv algrft ea addl,CPT,RVU2026A,2026
64999,Unlisted px nervous system,CPT,RVU2026A,2026
65091,Revise eye,CPT,RVU2026A,2026
65093,Revise eye with implant,CPT,RVU2026A,2026
65101,Removal of eye,CPT,RVU2026A,2026
65103,Remove eye/insert implant,CPT,RVU2026A,2026
65105,Remove eye/attach implant,CPT,RVU2026A,2026
65110,Removal of eye,CPT,RVU2026A,2026
65112,Remove eye/revise socket,CPT,RVU2026A,2026
65114,Remove eye/revise socket,CPT,RVU2026A,2026
65125,Revise ocular implant,CPT,RVU2026A,2026
65130,Insert ocular implant,CPT,RVU2026A,2026
65135,Insert ocular implant,CPT,RVU2026A,2026
65140,Attach ocular implant,CPT,RVU2026A,2026
65150,Revise ocular implant,CPT,RVU2026A,2026
65155,Reinsert ocular implant,CPT,RVU2026A,2026
65175,Removal of ocular implant,CPT,RVU2026A,2026
65205,Remove foreign body from eye,CPT,RVU2026A,2026
65210,Remove foreign body from eye,CPT,RVU2026A,2026
65220,Remove foreign body from eye,CPT,RVU2026A,2026
65222,Remove foreign body from eye,CPT,RVU2026A,2026
65235,Remove foreign body from eye,CPT,RVU2026A,2026
65260,Remove foreign body from eye,CPT,RVU2026A,2026
65265,Remove foreign body from eye,CPT,RVU2026A,2026
65270,Repair of eye wound,CPT,RVU2026A,2026
65272,Repair of eye wound,CPT,RVU2026A,2026
65273,Repair of eye wound,CPT,RVU2026A,2026
65275,Repair of eye wound,CPT,RVU2026A,2026
65280,Repair of eye wound,CPT,RVU2026A,2026
65285,Repair of eye wound,CPT,RVU2026A,2026
65286,Repair of eye wound,CPT,RVU2026A,2026
65290,Repair of eye socket wound,CPT,RVU2026A,2026
65400,Removal of eye lesion,CPT,RVU2026A,2026
65410,Biopsy of cornea,CPT,RVU2026A,2026
65420,Removal of eye lesion,CPT,RVU2026A,2026
65426,Removal of eye lesion,CPT,RVU2026A,2026
65430,Corneal smear,CPT,RVU2026A,2026
65435,Curette/treat cornea,CPT,RVU2026A,2026
65436,Curette/treat cornea,CPT,RVU2026A,2026
65450,Treatment of corneal lesion,CPT,RVU2026A,2026
65600,Revision of cornea,CPT,RVU2026A,2026
65710,Corneal transplant,CPT,RVU2026A,2026
65730,Corneal transplant,CPT,RVU2026A,2026
65750,Corneal transplant,CPT,RVU2026A,2026
65755,Corneal transplant,CPT,RVU2026A,2026
65756,Corneal trnspl endothelial,CPT,RVU2026A,2026
65757,Prep corneal endo allograft,CPT,RVU2026A,2026
65760,Keratomileusis,CPT,RVU2026A,2026
65765,Keratophakia,CPT,RVU2026A,2026
65767,Epikeratoplasty,CPT,RVU2026A,2026
65770,Keratoprosthesis,CPT,RVU2026A,2026
65771,Radial keratotomy,CPT,RVU2026A,2026
65772,Correction of astigmatism,CPT,RVU2026A,2026
65775,Correction of astigmatism,CPT,RVU2026A,2026
65778,Cover eye w/membrane,CPT,RVU2026A,2026
65779,Cover eye w/membrane suture,CPT,RVU2026A,2026
65780,Ocular reconst transplant,CPT,RVU2026A,2026
65781,Ocular reconst transplant,CPT,RVU2026A,2026
65782,Ocular reconst transplant,CPT,RVU2026A,2026
65785,Impltj ntrstrml crnl rng seg,CPT,RVU2026A,2026
65800,Drainage of eye,CPT,RVU2026A,2026
65810,Drainage of eye,CPT,RVU2026A,2026
65815,Drainage of eye,CPT,RVU2026A,2026
65820,Goniotomy,CPT,RVU2026A,2026
65850,Trabeculotomy ab externo,CPT,RVU2026A,2026
65855,Trabeculoplasty laser surg,CPT,RVU2026A,2026
65860,Severing ads ant sgm laser,CPT,RVU2026A,2026
65865,Incise inner eye adhesions,CPT,RVU2026A,2026
65870,Incise inner eye adhesions,CPT,RVU2026A,2026
65875,Incise inner eye adhesions,CPT,RVU2026A,2026
65880,Incise inner eye adhesions,CPT,RVU2026A,2026
65900,Remove eye lesion,CPT,RVU2026A,2026
65920,Remove implant of eye,CPT,RVU2026A,2026
65930,Remove blood clot from eye,CPT,RVU2026A,2026
66020,Injection treatment of eye,CPT,RVU2026A,2026
66030,Injection treatment of eye,CPT,RVU2026A,2026
66130,Remove eye lesion,CPT,RVU2026A,2026
66150,Glaucoma surgery,CPT,RVU2026A,2026
66155,Glaucoma surgery,CPT,RVU2026A,2026
66160,Glaucoma surgery,CPT,RVU2026A,2026
66170,Glaucoma surgery,CPT,RVU2026A,2026
66172,Incision of eye,CPT,RVU2026A,2026
66174,Trluml dil aq o/f can w/o st,CPT,RVU2026A,2026
66175,Trluml dil aq o/f can w/st,CPT,RVU2026A,2026
66179,Aqueous shunt eye w/o graft,CPT,RVU2026A,2026
66180,Aqueous shunt eye w/graft,CPT,RVU2026A,2026
66183,Insert ant drainage device,CPT,RVU2026A,2026
66184,Revision of aqueous shunt,CPT,RVU2026A,2026
66185,Revise aqueous shunt eye,CPT,RVU2026A,2026
66225,Repair/graft eye lesion,CPT,RVU2026A,2026
66250,Follow-up surgery of eye,CPT,RVU2026A,2026
66500,Incision of iris,CPT,RVU2026A,2026
66505,Incision of iris,CPT,RVU2026A,2026
66600,Remove iris and lesion,CPT,RVU2026A,2026
66605,Removal of iris,CPT,RVU2026A,2026
66625,Removal of iris,CPT,RVU2026A,2026
66630,Removal of iris,CPT,RVU2026A,2026
66635,Removal of iris,CPT,RVU2026A,2026
66680,Repair iris & ciliary body,CPT,RVU2026A,2026
66682,Repair iris & ciliary body,CPT,RVU2026A,2026
66683,Implantation iris prosthesis,CPT,RVU2026A,2026
66700,Destruction ciliary body,CPT,RVU2026A,2026
66710,Ciliary transsleral therapy,CPT,RVU2026A,2026
66711,Ecp ciliary body destruction,CPT,RVU2026A,2026
66720,Destruction ciliary body,CPT,RVU2026A,2026
66740,Destruction ciliary body,CPT,RVU2026A,2026
66761,Revision of iris,CPT,RVU2026A,2026
66762,Revision of iris,CPT,RVU2026A,2026
66770,Removal of inner eye lesion,CPT,RVU2026A,2026
66820,Incision secondary cataract,CPT,RVU2026A,2026
66821,After cataract laser surgery,CPT,RVU2026A,2026
66825,Reposition intraocular lens,CPT,RVU2026A,2026
66830,Removal of lens lesion,CPT,RVU2026A,2026
66840,Removal of lens material,CPT,RVU2026A,2026
66850,Removal of lens material,CPT,RVU2026A,2026
66852,Removal of lens material,CPT,RVU2026A,2026
66920,Extraction of lens,CPT,RVU2026A,2026
66930,Extraction of lens,CPT,RVU2026A,2026
66940,Extraction of lens,CPT,RVU2026A,2026
66982,Xcapsl ctrc rmvl cplx wo ecp,CPT,RVU2026A,2026
66983,Cataract surg w/iol 1 stage,CPT,RVU2026A,2026
66984,Xcapsl ctrc rmvl w/o ecp,CPT,RVU2026A,2026
66985,Insert lens prosthesis,CPT,RVU2026A,2026
66986,Exchange lens prosthesis,CPT,RVU2026A,2026
66987,Xcapsl ctrc rmvl cplx w/ecp,CPT,RVU2026A,2026
66988,Xcapsl ctrc rmvl w/ecp,CPT,RVU2026A,2026
66989,Xcpsl ctrc rmvl cplx insj 1+,CPT,RVU2026A,2026
66990,Ophthalmic endoscope add-on,CPT,RVU2026A,2026
66991,Xcapsl ctrc rmvl insj 1+,CPT,RVU2026A,2026
66999,Unlisted px ant segment eye,CPT,RVU2026A,2026
67005,Partial removal of eye fluid,CPT,RVU2026A,2026
67010,Partial removal of eye fluid,CPT,RVU2026A,2026
67015,Release of eye fluid,CPT,RVU2026A,2026
67025,Replace eye fluid,CPT,RVU2026A,2026
67027,Implant eye drug system,CPT,RVU2026A,2026
67028,Injection eye drug,CPT,RVU2026A,2026
67030,Incise inner eye strands,CPT,RVU2026A,2026
67031,Laser surgery eye strands,CPT,RVU2026A,2026
67036,Removal of inner eye fluid,CPT,RVU2026A,2026
67039,Laser treatment of retina,CPT,RVU2026A,2026
67040,Laser treatment of retina,CPT,RVU2026A,2026
67041,Vit for macular pucker,CPT,RVU2026A,2026
67042,Vit for macular hole,CPT,RVU2026A,2026
67043,Vit for membrane dissect,CPT,RVU2026A,2026
67101,Repair detached retina crtx,CPT,RVU2026A,2026
67105,Repair detached retina pc,CPT,RVU2026A,2026
67107,Repair detached retina,CPT,RVU2026A,2026
67108,Repair detached retina,CPT,RVU2026A,2026
67110,Repair detached retina,CPT,RVU2026A,2026
67113,Repair retinal detach cplx,CPT,RVU2026A,2026
67115,Release encircling material,CPT,RVU2026A,2026
67120,Remove eye implant material,CPT,RVU2026A,2026
67121,Remove eye implant material,CPT,RVU2026A,2026
67141,Proph rta dtchmnt crtx dthrm,CPT,RVU2026A,2026
67145,Proph rta dtchmnt pc,CPT,RVU2026A,2026
67208,Treatment of retinal lesion,CPT,RVU2026A,2026
67210,Treatment of retinal lesion,CPT,RVU2026A,2026
67218,Treatment of retinal lesion,CPT,RVU2026A,2026
67220,Treatment of choroid lesion,CPT,RVU2026A,2026
67221,Ocular photodynamic ther,CPT,RVU2026A,2026
67225,Eye photodynamic ther add-on,CPT,RVU2026A,2026
67227,Dstrj extensive retinopathy,CPT,RVU2026A,2026
67228,Treatment x10sv retinopathy,CPT,RVU2026A,2026
67229,Tr retinal les preterm inf,CPT,RVU2026A,2026
67250,Reinforce eye wall,CPT,RVU2026A,2026
67255,Reinforce/graft eye wall,CPT,RVU2026A,2026
67299,Unlisted px posterior segmnt,CPT,RVU2026A,2026
67311,Revise eye muscle,CPT,RVU2026A,2026
67312,Revise two eye muscles,CPT,RVU2026A,2026
67314,Revise eye muscle,CPT,RVU2026A,2026
67316,Revise two eye muscles,CPT,RVU2026A,2026
67318,Revise eye muscle(s),CPT,RVU2026A,2026
67320,Revise eye muscle(s) add-on,CPT,RVU2026A,2026
67331,Eye surgery follow-up add-on,CPT,RVU2026A,2026
67332,Rerevise eye muscles add-on,CPT,RVU2026A,2026
67334,Revise eye muscle w/suture,CPT,RVU2026A,2026
67335,Eye suture during surgery,CPT,RVU2026A,2026
67340,Revise eye muscle add-on,CPT,RVU2026A,2026
67343,Release eye tissue,CPT,RVU2026A,2026
67345,Destroy nerve of eye muscle,CPT,RVU2026A,2026
67346,Biopsy eye muscle,CPT,RVU2026A,2026
67399,Unlisted px extraocular musc,CPT,RVU2026A,2026
67400,Explore/biopsy eye socket,CPT,RVU2026A,2026
67405,Explore/drain eye socket,CPT,RVU2026A,2026
67412,Explore/treat eye socket,CPT,RVU2026A,2026
67413,Explore/treat eye socket,CPT,RVU2026A,2026
67414,Explr/decompress eye socket,CPT,RVU2026A,2026
67415,Aspiration orbital contents,CPT,RVU2026A,2026
67420,Explore/treat eye socket,CPT,RVU2026A,2026
67430,Explore/treat eye socket,CPT,RVU2026A,2026
67440,Explore/drain eye socket,CPT,RVU2026A,2026
67445,Explr/decompress eye socket,CPT,RVU2026A,2026
67450,Explore/biopsy eye socket,CPT,RVU2026A,2026
67500,Inject/treat eye socket,CPT,RVU2026A,2026
67505,Inject/treat eye socket,CPT,RVU2026A,2026
67515,Inject/treat eye socket,CPT,RVU2026A,2026
67516,Sprchoroidal spc njx rx agt,CPT,RVU2026A,2026
67550,Insert eye socket implant,CPT,RVU2026A,2026
67560,Revise eye socket implant,CPT,RVU2026A,2026
67570,Decompress optic nerve,CPT,RVU2026A,2026
67599,Unlisted procedure orbit,CPT,RVU2026A,2026
67700,Blepharotomy drg absc eyelid,CPT,RVU2026A,2026
67710,Severing tarsorrhaphy,CPT,RVU2026A,2026
67715,Canthotomy,CPT,RVU2026A,2026
67800,Remove eyelid lesion,CPT,RVU2026A,2026
67801,Remove eyelid lesions,CPT,RVU2026A,2026
67805,Remove eyelid lesions,CPT,RVU2026A,2026
67808,Remove eyelid lesion(s),CPT,RVU2026A,2026
67810,Incal bx eyelid skn lid mrgn,CPT,RVU2026A,2026
67820,Revise eyelashes,CPT,RVU2026A,2026
67825,Revise eyelashes,CPT,RVU2026A,2026
67830,Revise eyelashes,CPT,RVU2026A,2026
67835,Revise eyelashes,CPT,RVU2026A,2026
67840,Remove eyelid lesion,CPT,RVU2026A,2026
67850,Dstrj lesion lid margin <1cm,CPT,RVU2026A,2026
67875,Closure of eyelid by suture,CPT,RVU2026A,2026
67880,Revision of eyelid,CPT,RVU2026A,2026
67882,Revision of eyelid,CPT,RVU2026A,2026
67900,Repair brow defect,CPT,RVU2026A,2026
67901,Repair eyelid defect,CPT,RVU2026A,2026
67902,Repair eyelid defect,CPT,RVU2026A,2026
67903,Repair eyelid defect,CPT,RVU2026A,2026
67904,Repair eyelid defect,CPT,RVU2026A,2026
67906,Repair eyelid defect,CPT,RVU2026A,2026
67908,Repair eyelid defect,CPT,RVU2026A,2026
67909,Revise eyelid defect,CPT,RVU2026A,2026
67911,Revise eyelid defect,CPT,RVU2026A,2026
67912,Correction eyelid w/implant,CPT,RVU2026A,2026
67914,Repair eyelid defect,CPT,RVU2026A,2026
67915,Repair eyelid defect,CPT,RVU2026A,2026
67916,Repair eyelid defect,CPT,RVU2026A,2026
67917,Repair eyelid defect,CPT,RVU2026A,2026
67921,Repair eyelid defect,CPT,RVU2026A,2026
67922,Repair eyelid defect,CPT,RVU2026A,2026
67923,Repair eyelid defect,CPT,RVU2026A,2026
67924,Repair eyelid defect,CPT,RVU2026A,2026
67930,Repair eyelid wound,CPT,RVU2026A,2026
67935,Repair eyelid wound,CPT,RVU2026A,2026
67938,Remove eyelid foreign body,CPT,RVU2026A,2026
67950,Revision of eyelid,CPT,RVU2026A,2026
67961,Revision of eyelid,CPT,RVU2026A,2026
67966,Revision of eyelid,CPT,RVU2026A,2026
67971,Reconstruction of eyelid,CPT,RVU2026A,2026
67973,Reconstruction of eyelid,CPT,RVU2026A,2026
67974,Reconstruction of eyelid,CPT,RVU2026A,2026
67975,Reconstruction of eyelid,CPT,RVU2026A,2026
67999,Unlisted procedure eyelids,CPT,RVU2026A,2026
68020,Incise/drain eyelid lining,CPT,RVU2026A,2026
68040,Treatment of eyelid lesions,CPT,RVU2026A,2026
68100,Biopsy conjunctiva,CPT,RVU2026A,2026
68110,Exc les conjunctiva <1 cm,CPT,RVU2026A,2026
68115,Exc les conjunctiva >1 cm,CPT,RVU2026A,2026
68130,Exc les conjunctiva adj scl,CPT,RVU2026A,2026
68135,Destruction les conjunctiva,CPT,RVU2026A,2026
68200,Treat eyelid by injection,CPT,RVU2026A,2026
68320,Revise/graft eyelid lining,CPT,RVU2026A,2026
68325,Revise/graft eyelid lining,CPT,RVU2026A,2026
68326,Revise/graft eyelid lining,CPT,RVU2026A,2026
68328,Revise/graft eyelid lining,CPT,RVU2026A,2026
68330,Revise eyelid lining,CPT,RVU2026A,2026
68335,Revise/graft eyelid lining,CPT,RVU2026A,2026
68340,Separate eyelid adhesions,CPT,RVU2026A,2026
68360,Revise eyelid lining,CPT,RVU2026A,2026
68362,Revise eyelid lining,CPT,RVU2026A,2026
68371,Harvest eye tissue alograft,CPT,RVU2026A,2026
68399,Unlisted px conjunctiva,CPT,RVU2026A,2026
68400,I&d lacrimal gland,CPT,RVU2026A,2026
68420,I&d lacrimal sac,CPT,RVU2026A,2026
68440,Snip inc lacrimal punctum,CPT,RVU2026A,2026
68500,Removal of tear gland,CPT,RVU2026A,2026
68505,Partial removal tear gland,CPT,RVU2026A,2026
68510,Biopsy of tear gland,CPT,RVU2026A,2026
68520,Removal of tear sac,CPT,RVU2026A,2026
68525,Biopsy of tear sac,CPT,RVU2026A,2026
68530,Clearance of tear duct,CPT,RVU2026A,2026
68540,Remove tear gland lesion,CPT,RVU2026A,2026
68550,Remove tear gland lesion,CPT,RVU2026A,2026
68700,Repair tear ducts,CPT,RVU2026A,2026
68705,Revise tear duct opening,CPT,RVU2026A,2026
68720,Create tear sac drain,CPT,RVU2026A,2026
68745,Create tear duct drain,CPT,RVU2026A,2026
68750,Create tear duct drain,CPT,RVU2026A,2026
68760,Close tear duct opening,CPT,RVU2026A,2026
68761,Close tear duct opening,CPT,RVU2026A,2026
68770,Close tear system fistula,CPT,RVU2026A,2026
68801,Dilate tear duct opening,CPT,RVU2026A,2026
68810,Probe nasolacrimal duct,CPT,RVU2026A,2026
68811,Probe nasolacrimal duct,CPT,RVU2026A,2026
68815,Probe nasolacrimal duct,CPT,RVU2026A,2026
68816,Probe nl duct w/balloon,CPT,RVU2026A,2026
68840,Explore/irrigate tear ducts,CPT,RVU2026A,2026
68841,Insj rx elut implt lac canal,CPT,RVU2026A,2026
68850,Injection for tear sac x-ray,CPT,RVU2026A,2026
68899,Unlisted px lacrimal system,CPT,RVU2026A,2026
69000,Drg xtrnl ear absc/hem smpl,CPT,RVU2026A,2026
69005,Drg xtrnl ear absc/hem comp,CPT,RVU2026A,2026
69020,Drg xtrnl aud canal abscess,CPT,RVU2026A,2026
69090,Ear piercing,CPT,RVU2026A,2026
69100,Biopsy of external ear,CPT,RVU2026A,2026
69105,Biopsy of external ear canal,CPT,RVU2026A,2026
69110,Remove external ear partial,CPT,RVU2026A,2026
69120,Removal of external ear,CPT,RVU2026A,2026
69140,Remove ear canal lesion(s),CPT,RVU2026A,2026
69145,Remove ear canal lesion(s),CPT,RVU2026A,2026
69150,Extensive ear canal surgery,CPT,RVU2026A,2026
69155,Extensive ear/neck surgery,CPT,RVU2026A,2026
69200,Clear outer ear canal,CPT,RVU2026A,2026
69205,Clear outer ear canal,CPT,RVU2026A,2026
69209,Remove impacted ear wax uni,CPT,RVU2026A,2026
69210,Remove impacted ear wax uni,CPT,RVU2026A,2026
69220,Clean out mastoid cavity,CPT,RVU2026A,2026
69222,Clean out mastoid cavity,CPT,RVU2026A,2026
69300,Revise external ear,CPT,RVU2026A,2026
69310,Rebuild outer ear canal,CPT,RVU2026A,2026
69320,Rebuild outer ear canal,CPT,RVU2026A,2026
69399,Unlisted px external ear,CPT,RVU2026A,2026
69420,Incision of eardrum,CPT,RVU2026A,2026
69421,Incision of eardrum,CPT,RVU2026A,2026
69424,Remove ventilating tube,CPT,RVU2026A,2026
69433,Create eardrum opening,CPT,RVU2026A,2026
69436,Create eardrum opening,CPT,RVU2026A,2026
69440,Exploration of middle ear,CPT,RVU2026A,2026
69450,Eardrum revision,CPT,RVU2026A,2026
69501,Mastoidectomy,CPT,RVU2026A,2026
69502,Mastoidectomy,CPT,RVU2026A,2026
69505,Remove mastoid structures,CPT,RVU2026A,2026
69511,Extensive mastoid surgery,CPT,RVU2026A,2026
69530,Extensive mastoid surgery,CPT,RVU2026A,2026
69535,Remove part of temporal bone,CPT,RVU2026A,2026
69540,Excision aural polyp,CPT,RVU2026A,2026
69550,Exc aurl glomus tum trnscanl,CPT,RVU2026A,2026
69552,Exc aurl glomus tum trnsmstd,CPT,RVU2026A,2026
69554,Exc aurl glomus tum extended,CPT,RVU2026A,2026
69601,Revj mstdc rsltg compl mstdc,CPT,RVU2026A,2026
69602,Rev mstdc rslt mod rad mstdc,CPT,RVU2026A,2026
69603,Revj mstdc rsltg rad mstdc,CPT,RVU2026A,2026
69604,Revj mstdc rsltg tympanplsty,CPT,RVU2026A,2026
69610,Tympanic membrane repair,CPT,RVU2026A,2026
69620,Myringoplasty,CPT,RVU2026A,2026
69631,Repair eardrum structures,CPT,RVU2026A,2026
69632,Rebuild eardrum structures,CPT,RVU2026A,2026
69633,Rebuild eardrum structures,CPT,RVU2026A,2026
69635,Repair eardrum structures,CPT,RVU2026A,2026
69636,Rebuild eardrum structures,CPT,RVU2026A,2026
69637,Rebuild eardrum structures,CPT,RVU2026A,2026
69641,Revise middle ear & mastoid,CPT,RVU2026A,2026
69642,Revise middle ear & mastoid,CPT,RVU2026A,2026
69643,Revise middle ear & mastoid,CPT,RVU2026A,2026
69644,Revise middle ear & mastoid,CPT,RVU2026A,2026
69645,Revise middle ear & mastoid,CPT,RVU2026A,2026
69646,Revise middle ear & mastoid,CPT,RVU2026A,2026
69650,Stapes mobilization,CPT,RVU2026A,2026
69660,Revise middle ear bone,CPT,RVU2026A,2026
69661,Revise middle ear bone,CPT,RVU2026A,2026
69662,Revise middle ear bone,CPT,RVU2026A,2026
69666,Repair middle ear structures,CPT,RVU2026A,2026
69667,Repair middle ear structures,CPT,RVU2026A,2026
69670,Remove mastoid air cells,CPT,RVU2026A,2026
69676,Remove middle ear nerve,CPT,RVU2026A,2026
69700,Close mastoid fistula,CPT,RVU2026A,2026
69705,Nps surg dilat eust tube uni,CPT,RVU2026A,2026
69706,Nps surg dilat eust tube bi,CPT,RVU2026A,2026
69710,Implant/replace hearing aid,CPT,RVU2026A,2026
69711,Remove/repair hearing aid,CPT,RVU2026A,2026
69714,Impl oi implt skull perq esp,CPT,RVU2026A,2026
69716,Impl oi implt sk tc esp<100,CPT,RVU2026A,2026
69717,Rplcmt oi implt skl prq esp,CPT,RVU2026A,2026
69719,Rplcm oi implt sk tc esp<100,CPT,RVU2026A,2026
69720,Release facial nerve,CPT,RVU2026A,2026
69725,Release facial nerve,CPT,RVU2026A,2026
69726,Rmv ntr oi implt skl prq esp,CPT,RVU2026A,2026
69727,Rmv ntr oi imp sk tc esp<100,CPT,RVU2026A,2026
69728,Rmv ntr oi imp sk tc>=100,CPT,RVU2026A,2026
69729,Impl oi implt sk tc esp>=100,CPT,RVU2026A,2026
69730,Rplc oi implt sk tc esp>=100,CPT,RVU2026A,2026
69740,Repair facial nerve,CPT,RVU2026A,2026
69745,Repair facial nerve,CPT,RVU2026A,2026
69799,Unlisted px middle ear,CPT,RVU2026A,2026
69801,Incise inner ear,CPT,RVU2026A,2026
69805,Explore inner ear,CPT,RVU2026A,2026
69806,Explore inner ear,CPT,RVU2026A,2026
69905,Remove inner ear,CPT,RVU2026A,2026
69910,Remove inner ear & mastoid,CPT,RVU2026A,2026
69915,Incise inner ear nerve,CPT,RVU2026A,2026
69930,Implant cochlear device,CPT,RVU2026A,2026
69949,Unlisted px inner ear,CPT,RVU2026A,2026
69950,Incise inner ear nerve,CPT,RVU2026A,2026
69955,Release facial nerve,CPT,RVU2026A,2026
69960,Release inner ear canal,CPT,RVU2026A,2026
69970,Remove inner ear lesion,CPT,RVU2026A,2026
69979,Unlisted px temporal bone,CPT,RVU2026A,2026
69990,Microsurgery add-on,CPT,RVU2026A,2026
70010,Contrast x-ray of brain,CPT,RVU2026A,2026
70015,Contrast x-ray of brain,CPT,RVU2026A,2026
70030,X-ray eye for foreign body,CPT,RVU2026A,2026
70100,X-ray exam of jaw <4views,CPT,RVU2026A,2026
7010F,Pt info into recall system,Other,RVU2026A,2026
70110,X-ray exam of jaw 4/> views,CPT,RVU2026A,2026
70120,X-ray exam of mastoids,CPT,RVU2026A,2026
70130,X-ray exam of mastoids,CPT,RVU2026A,2026
70134,X-ray exam of middle ear,CPT,RVU2026A,2026
70140,X-ray exam of facial bones,CPT,RVU2026A,2026
70150,X-ray exam of facial bones,CPT,RVU2026A,2026
70160,X-ray exam of nasal bones,CPT,RVU2026A,2026
70170,X-ray exam of tear duct,CPT,RVU2026A,2026
70190,X-ray exam of eye sockets,CPT,RVU2026A,2026
70200,X-ray exam of eye sockets,CPT,RVU2026A,2026
7020F,Mammo assess cat in dbase,Other,RVU2026A,2026
70210,X-ray exam of sinuses,CPT,RVU2026A,2026
70220,X-ray exam of sinuses,CPT,RVU2026A,2026
70240,X-ray exam pituitary saddle,CPT,RVU2026A,2026
70250,X-ray exam of skull,CPT,RVU2026A,2026
7025F,Pt infosys alarm 4 nxt mammo,Other,RVU2026A,2026
70260,X-ray exam of skull,CPT,RVU2026A,2026
70300,X-ray exam of teeth,CPT,RVU2026A,2026
70310,X-ray exam of teeth,CPT,RVU2026A,2026
70320,Full mouth x-ray of teeth,CPT,RVU2026A,2026
70328,X-ray exam of jaw joint,CPT,RVU2026A,2026
70330,X-ray exam of jaw joints,CPT,RVU2026A,2026
70332,X-ray exam of jaw joint,CPT,RVU2026A,2026
70336,Magnetic image jaw joint,CPT,RVU2026A,2026
70350,X-ray head for orthodontia,CPT,RVU2026A,2026
70355,Panoramic x-ray of jaws,CPT,RVU2026A,2026
70360,X-ray exam of neck,CPT,RVU2026A,2026
70370,Throat x-ray & fluoroscopy,CPT,RVU2026A,2026
70371,Speech evaluation complex,CPT,RVU2026A,2026
70380,X-ray exam of salivary gland,CPT,RVU2026A,2026
70390,X-ray exam of salivary duct,CPT,RVU2026A,2026
70450,Ct head/brain w/o dye,CPT,RVU2026A,2026
70460,Ct head/brain w/dye,CPT,RVU2026A,2026
70470,Ct head/brain w/o & w/dye,CPT,RVU2026A,2026
70471,Cta h&n c+ w/noncontrast img,CPT,RVU2026A,2026
70472,Ct cere prfu alys c+w/ct/cta,CPT,RVU2026A,2026
70473,Ct cere prfu aly c+wo ct/cta,CPT,RVU2026A,2026
70480,Ct orbit/ear/fossa w/o dye,CPT,RVU2026A,2026
70481,Ct orbit/ear/fossa w/dye,CPT,RVU2026A,2026
70482,Ct orbit/ear/fossa w/o&w/dye,CPT,RVU2026A,2026
70486,Ct maxillofacial w/o dye,CPT,RVU2026A,2026
70487,Ct maxillofacial w/dye,CPT,RVU2026A,2026
70488,Ct maxillofacial w/o & w/dye,CPT,RVU2026A,2026
70490,Ct soft tissue neck w/o dye,CPT,RVU2026A,2026
70491,Ct soft tissue neck w/dye,CPT,RVU2026A,2026
70492,Ct sft tsue nck w/o & w/dye,CPT,RVU2026A,2026
70496,Ct angiography head,CPT,RVU2026A,2026
70498,Ct angiography neck,CPT,RVU2026A,2026
70540,Mri orbit/face/neck w/o dye,CPT,RVU2026A,2026
70542,Mri orbit/face/neck w/dye,CPT,RVU2026A,2026
70543,Mri orbt/fac/nck w/o &w/dye,CPT,RVU2026A,2026
70544,Mr angiography head w/o dye,CPT,RVU2026A,2026
70545,Mr angiography head w/dye,CPT,RVU2026A,2026
70546,Mr angiograph head w/o&w/dye,CPT,RVU2026A,2026
70547,Mr angiography neck w/o dye,CPT,RVU2026A,2026
70548,Mr angiography neck w/dye,CPT,RVU2026A,2026
70549,Mr angiograph neck w/o&w/dye,CPT,RVU2026A,2026
70551,Mri brain stem w/o dye,CPT,RVU2026A,2026
70552,Mri brain stem w/dye,CPT,RVU2026A,2026
70553,Mri brain stem w/o & w/dye,CPT,RVU2026A,2026
70554,Fmri brain by tech,CPT,RVU2026A,2026
70555,Fmri brain by phys/psych,CPT,RVU2026A,2026
70557,Mri brain w/o dye,CPT,RVU2026A,2026
70558,Mri brain w/dye,CPT,RVU2026A,2026
70559,Mri brain w/o & w/dye,CPT,RVU2026A,2026
71045,X-ray exam chest 1 view,CPT,RVU2026A,2026
71046,X-ray exam chest 2 views,CPT,RVU2026A,2026
71047,X-ray exam chest 3 views,CPT,RVU2026A,2026
71048,X-ray exam chest 4+ views,CPT,RVU2026A,2026
71100,X-ray exam ribs uni 2 views,CPT,RVU2026A,2026
71101,X-ray exam unilat ribs/chest,CPT,RVU2026A,2026
71110,X-ray exam ribs bil 3 views,CPT,RVU2026A,2026
71111,X-ray exam ribs/chest4/> vws,CPT,RVU2026A,2026
71120,X-ray exam breastbone 2/>vws,CPT,RVU2026A,2026
71130,X-ray strenoclavic jt 3/>vws,CPT,RVU2026A,2026
71250,Ct thorax dx c-,CPT,RVU2026A,2026
71260,Ct thorax dx c+,CPT,RVU2026A,2026
71270,Ct thorax dx c-/c+,CPT,RVU2026A,2026
71271,Ct thorax lung cancer scr c-,CPT,RVU2026A,2026
71275,Ct angiography chest,CPT,RVU2026A,2026
71550,Mri chest w/o dye,CPT,RVU2026A,2026
71551,Mri chest w/dye,CPT,RVU2026A,2026
71552,Mri chest w/o & w/dye,CPT,RVU2026A,2026
71555,Mri angio chest w or w/o dye,CPT,RVU2026A,2026
72020,X-ray exam of spine 1 view,CPT,RVU2026A,2026
72040,X-ray exam neck spine 2-3 vw,CPT,RVU2026A,2026
72050,X-ray exam neck spine 4/5vws,CPT,RVU2026A,2026
72052,X-ray exam neck spine 6/>vws,CPT,RVU2026A,2026
72070,X-ray exam thorac spine 2vws,CPT,RVU2026A,2026
72072,X-ray exam thorac spine 3vws,CPT,RVU2026A,2026
72074,X-ray exam thorac spine4/>vw,CPT,RVU2026A,2026
72080,X-ray exam thoracolmb 2/> vw,CPT,RVU2026A,2026
72081,X-ray exam entire spi 1 vw,CPT,RVU2026A,2026
72082,X-ray exam entire spi 2/3 vw,CPT,RVU2026A,2026
72083,X-ray exam entire spi 4/5 vw,CPT,RVU2026A,2026
72084,X-ray exam entire spi 6/> vw,CPT,RVU2026A,2026
72100,X-ray exam l-s spine 2/3 vws,CPT,RVU2026A,2026
72110,X-ray exam l-2 spine 4/>vws,CPT,RVU2026A,2026
72114,X-ray exam l-s spine bending,CPT,RVU2026A,2026
72120,X-ray bend only l-s spine,CPT,RVU2026A,2026
72125,Ct neck spine w/o dye,CPT,RVU2026A,2026
72126,Ct neck spine w/dye,CPT,RVU2026A,2026
72127,Ct neck spine w/o & w/dye,CPT,RVU2026A,2026
72128,Ct chest spine w/o dye,CPT,RVU2026A,2026
72129,Ct chest spine w/dye,CPT,RVU2026A,2026
72130,Ct chest spine w/o & w/dye,CPT,RVU2026A,2026
72131,Ct lumbar spine w/o dye,CPT,RVU2026A,2026
72132,Ct lumbar spine w/dye,CPT,RVU2026A,2026
72133,Ct lumbar spine w/o & w/dye,CPT,RVU2026A,2026
72141,Mri neck spine w/o dye,CPT,RVU2026A,2026
72142,Mri neck spine w/dye,CPT,RVU2026A,2026
72146,Mri chest spine w/o dye,CPT,RVU2026A,2026
72147,Mri chest spine w/dye,CPT,RVU2026A,2026
72148,Mri lumbar spine w/o dye,CPT,RVU2026A,2026
72149,Mri lumbar spine w/dye,CPT,RVU2026A,2026
72156,Mri neck spine w/o & w/dye,CPT,RVU2026A,2026
72157,Mri chest spine w/o & w/dye,CPT,RVU2026A,2026
72158,Mri lumbar spine w/o & w/dye,CPT,RVU2026A,2026
72159,Mr angio spine w/o&w/dye,CPT,RVU2026A,2026
72170,X-ray exam of pelvis,CPT,RVU2026A,2026
72190,X-ray exam of pelvis,CPT,RVU2026A,2026
72191,Ct angiograph pelv w/o&w/dye,CPT,RVU2026A,2026
72192,Ct pelvis w/o dye,CPT,RVU2026A,2026
72193,Ct pelvis w/dye,CPT,RVU2026A,2026
72194,Ct pelvis w/o & w/dye,CPT,RVU2026A,2026
72195,Mri pelvis w/o dye,CPT,RVU2026A,2026
72196,Mri pelvis w/dye,CPT,RVU2026A,2026
72197,Mri pelvis w/o & w/dye,CPT,RVU2026A,2026
72198,Mr angio pelvis w/o & w/dye,CPT,RVU2026A,2026
72200,X-ray exam si joints,CPT,RVU2026A,2026
72202,X-ray exam si joints 3/> vws,CPT,RVU2026A,2026
72220,X-ray exam sacrum tailbone,CPT,RVU2026A,2026
72240,Myelography neck spine,CPT,RVU2026A,2026
72255,Myelography thoracic spine,CPT,RVU2026A,2026
72265,Myelography l-s spine,CPT,RVU2026A,2026
72270,Myelogphy 2/> spine regions,CPT,RVU2026A,2026
72285,Discography cerv/thor spine,CPT,RVU2026A,2026
72295,X-ray of lower spine disk,CPT,RVU2026A,2026
73000,X-ray exam of collar bone,CPT,RVU2026A,2026
73010,X-ray exam of shoulder blade,CPT,RVU2026A,2026
73020,X-ray exam of shoulder,CPT,RVU2026A,2026
73030,X-ray exam of shoulder,CPT,RVU2026A,2026
73040,Contrast x-ray of shoulder,CPT,RVU2026A,2026
73050,X-ray exam of shoulders,CPT,RVU2026A,2026
73060,X-ray exam of humerus,CPT,RVU2026A,2026
73070,X-ray exam of elbow,CPT,RVU2026A,2026
73080,X-ray exam of elbow,CPT,RVU2026A,2026
73085,Contrast x-ray of elbow,CPT,RVU2026A,2026
73090,X-ray exam of forearm,CPT,RVU2026A,2026
73092,X-ray exam of arm infant,CPT,RVU2026A,2026
73100,X-ray exam of wrist,CPT,RVU2026A,2026
73110,X-ray exam of wrist,CPT,RVU2026A,2026
73115,Contrast x-ray of wrist,CPT,RVU2026A,2026
73120,X-ray exam of hand,CPT,RVU2026A,2026
73130,X-ray exam of hand,CPT,RVU2026A,2026
73140,X-ray exam of finger(s),CPT,RVU2026A,2026
73200,Ct upper extremity w/o dye,CPT,RVU2026A,2026
73201,Ct upper extremity w/dye,CPT,RVU2026A,2026
73202,Ct uppr extremity w/o&w/dye,CPT,RVU2026A,2026
73206,Ct angio upr extrm w/o&w/dye,CPT,RVU2026A,2026
73218,Mri upper extremity w/o dye,CPT,RVU2026A,2026
73219,Mri upper extremity w/dye,CPT,RVU2026A,2026
73220,Mri uppr extremity w/o&w/dye,CPT,RVU2026A,2026
73221,Mri joint upr extrem w/o dye,CPT,RVU2026A,2026
73222,Mri joint upr extrem w/dye,CPT,RVU2026A,2026
73223,Mri joint upr extr w/o&w/dye,CPT,RVU2026A,2026
73225,Mr angio upr extr w/o&w/dye,CPT,RVU2026A,2026
73501,X-ray exam hip uni 1 view,CPT,RVU2026A,2026
73502,X-ray exam hip uni 2-3 views,CPT,RVU2026A,2026
73503,X-ray exam hip uni 4/> views,CPT,RVU2026A,2026
73521,X-ray exam hips bi 2 views,CPT,RVU2026A,2026
73522,X-ray exam hips bi 3-4 views,CPT,RVU2026A,2026
73523,X-ray exam hips bi 5/> views,CPT,RVU2026A,2026
73525,Contrast x-ray of hip,CPT,RVU2026A,2026
73551,X-ray exam of femur 1,CPT,RVU2026A,2026
73552,X-ray exam of femur 2/>,CPT,RVU2026A,2026
73560,X-ray exam of knee 1 or 2,CPT,RVU2026A,2026
73562,X-ray exam of knee 3,CPT,RVU2026A,2026
73564,X-ray exam knee 4 or more,CPT,RVU2026A,2026
73565,X-ray exam of knees,CPT,RVU2026A,2026
73580,Contrast x-ray of knee joint,CPT,RVU2026A,2026
73590,X-ray exam of lower leg,CPT,RVU2026A,2026
73592,X-ray exam of leg infant,CPT,RVU2026A,2026
73600,X-ray exam of ankle,CPT,RVU2026A,2026
73610,X-ray exam of ankle,CPT,RVU2026A,2026
73615,Contrast x-ray of ankle,CPT,RVU2026A,2026
73620,X-ray exam of foot,CPT,RVU2026A,2026
73630,X-ray exam of foot,CPT,RVU2026A,2026
73650,X-ray exam of heel,CPT,RVU2026A,2026
73660,X-ray exam of toe(s),CPT,RVU2026A,2026
73700,Ct lower extremity w/o dye,CPT,RVU2026A,2026
73701,Ct lower extremity w/dye,CPT,RVU2026A,2026
73702,Ct lwr extremity w/o&w/dye,CPT,RVU2026A,2026
73706,Ct angio lwr extr w/o&w/dye,CPT,RVU2026A,2026
73718,Mri lower extremity w/o dye,CPT,RVU2026A,2026
73719,Mri lower extremity w/dye,CPT,RVU2026A,2026
73720,Mri lwr extremity w/o&w/dye,CPT,RVU2026A,2026
73721,Mri jnt of lwr extre w/o dye,CPT,RVU2026A,2026
73722,Mri joint of lwr extr w/dye,CPT,RVU2026A,2026
73723,Mri joint lwr extr w/o&w/dye,CPT,RVU2026A,2026
73725,Mr ang lwr ext w or w/o dye,CPT,RVU2026A,2026
74018,Radex abdomen 1 view,CPT,RVU2026A,2026
74019,Radex abdomen 2 views,CPT,RVU2026A,2026
74021,Radex abdomen 3+ views,CPT,RVU2026A,2026
74022,Radex compl aqt abd series,CPT,RVU2026A,2026
74150,Ct abdomen w/o contrast,CPT,RVU2026A,2026
74160,Ct abdomen w/contrast,CPT,RVU2026A,2026
74170,Ct abd wo cntrst flwd cntrst,CPT,RVU2026A,2026
74174,Cta abd&plvs w/contrast,CPT,RVU2026A,2026
74175,Cta abdomen w/contrast,CPT,RVU2026A,2026
74176,Ct abd & pelvis w/o contrast,CPT,RVU2026A,2026
74177,Ct abd & pelvis w/contrast,CPT,RVU2026A,2026
74178,Ct abd&plv wo cntr flwd cntr,CPT,RVU2026A,2026
74181,Mri abdomen w/o contrast,CPT,RVU2026A,2026
74182,Mri abdomen w/contrast,CPT,RVU2026A,2026
74183,Mri abd w/o cntr flwd cntr,CPT,RVU2026A,2026
74185,Mra abd w or w/o cntrst,CPT,RVU2026A,2026
74190,Peritoneogram rs&i,CPT,RVU2026A,2026
74210,X-ray xm phrnx&/crv esoph c+,CPT,RVU2026A,2026
74220,X-ray xm esophagus 1cntrst,CPT,RVU2026A,2026
74221,X-ray xm esophagus 2cntrst,CPT,RVU2026A,2026
74230,X-ray xm swlng funcj c+,CPT,RVU2026A,2026
74235,Remove esophagus obstruction,CPT,RVU2026A,2026
74240,X-ray xm upr gi trc 1cntrst,CPT,RVU2026A,2026
74246,X-ray xm upr gi trc 2cntrst,CPT,RVU2026A,2026
74248,X-ray sm int f-thru std,CPT,RVU2026A,2026
74250,X-ray xm sm int 1cntrst std,CPT,RVU2026A,2026
74251,X-ray xm sm int 2cntrst std,CPT,RVU2026A,2026
74261,Ct colonography dx,CPT,RVU2026A,2026
74262,Ct colonography dx w/dye,CPT,RVU2026A,2026
74263,Ct colonography screening,CPT,RVU2026A,2026
74270,X-ray xm colon 1cntrst std,CPT,RVU2026A,2026
74280,X-ray xm colon 2cntrst std,CPT,RVU2026A,2026
74283,Ther nma rdctj intus/obstrcj,CPT,RVU2026A,2026
74290,Contrast x-ray gallbladder,CPT,RVU2026A,2026
74300,X-ray bile ducts/pancreas,CPT,RVU2026A,2026
74301,X-rays at surgery add-on,CPT,RVU2026A,2026
74328,X-ray bile duct endoscopy,CPT,RVU2026A,2026
74329,X-ray for pancreas endoscopy,CPT,RVU2026A,2026
74330,X-ray bile/panc endoscopy,CPT,RVU2026A,2026
74340,X-ray guide for gi tube,CPT,RVU2026A,2026
74355,X-ray guide intestinal tube,CPT,RVU2026A,2026
74360,X-ray guide gi dilation,CPT,RVU2026A,2026
74363,X-ray bile duct dilation,CPT,RVU2026A,2026
74400,Urography iv +-kub tomog,CPT,RVU2026A,2026
74410,Urography nfs drip&/bolus,CPT,RVU2026A,2026
74415,Urography nfs drip&/bls w/nf,CPT,RVU2026A,2026
74420,Urography rtrgr +-kub,CPT,RVU2026A,2026
74425,Urography antegrade rs&i,CPT,RVU2026A,2026
74430,Contrast x-ray bladder,CPT,RVU2026A,2026
74440,X-ray male genital tract,CPT,RVU2026A,2026
74445,X-ray exam of penis,CPT,RVU2026A,2026
74450,X-ray urethra/bladder,CPT,RVU2026A,2026
74455,X-ray urethra/bladder,CPT,RVU2026A,2026
74470,X-ray exam of kidney lesion,CPT,RVU2026A,2026
74485,Dilation urtr/urt rs&i,CPT,RVU2026A,2026
74712,Mri fetal sngl/1st gestation,CPT,RVU2026A,2026
74713,Mri fetal ea addl gestation,CPT,RVU2026A,2026
74740,X-ray female genital tract,CPT,RVU2026A,2026
74742,X-ray fallopian tube,CPT,RVU2026A,2026
74775,X-ray exam of perineum,CPT,RVU2026A,2026
75557,Cardiac mri for morph,CPT,RVU2026A,2026
75559,Cardiac mri w/stress img,CPT,RVU2026A,2026
75561,Cardiac mri for morph w/dye,CPT,RVU2026A,2026
75563,Card mri w/stress img & dye,CPT,RVU2026A,2026
75565,Card mri veloc flow mapping,CPT,RVU2026A,2026
75571,Ct hrt w/o dye w/ca test,CPT,RVU2026A,2026
75572,Ct hrt w/3d image,CPT,RVU2026A,2026
75573,Ct hrt c+ strux cgen hrt ds,CPT,RVU2026A,2026
75574,Ct angio hrt w/3d image,CPT,RVU2026A,2026
75577,Quan&char c athrosclrtc plaq,CPT,RVU2026A,2026
75580,N-invas est c ffr sw aly cta,CPT,RVU2026A,2026
75600,Contrast exam thoracic aorta,CPT,RVU2026A,2026
75605,Contrast exam thoracic aorta,CPT,RVU2026A,2026
75625,Contrast exam abdominl aorta,CPT,RVU2026A,2026
75630,X-ray aorta leg arteries,CPT,RVU2026A,2026
75635,Ct angio abdominal arteries,CPT,RVU2026A,2026
75705,Artery x-rays spine,CPT,RVU2026A,2026
75710,Artery x-rays arm/leg,CPT,RVU2026A,2026
75716,Artery x-rays arms/legs,CPT,RVU2026A,2026
75726,Artery x-rays abdomen,CPT,RVU2026A,2026
75731,Artery x-rays adrenal gland,CPT,RVU2026A,2026
75733,Artery x-rays adrenals,CPT,RVU2026A,2026
75736,Artery x-rays pelvis,CPT,RVU2026A,2026
75741,Artery x-rays lung,CPT,RVU2026A,2026
75743,Artery x-rays lungs,CPT,RVU2026A,2026
75746,Artery x-rays lung,CPT,RVU2026A,2026
75756,Artery x-rays chest,CPT,RVU2026A,2026
75774,Artery x-ray each vessel,CPT,RVU2026A,2026
75801,Lymph vessel x-ray arm/leg,CPT,RVU2026A,2026
75803,Lymph vessel x-ray arms/legs,CPT,RVU2026A,2026
75805,Lymph vessel x-ray trunk,CPT,RVU2026A,2026
75807,Lymph vessel x-ray trunk,CPT,RVU2026A,2026
75809,Nonvascular shunt x-ray,CPT,RVU2026A,2026
75810,Vein x-ray spleen/liver,CPT,RVU2026A,2026
75820,Vein x-ray arm/leg,CPT,RVU2026A,2026
75822,Vein x-ray arms/legs,CPT,RVU2026A,2026
75825,Vein x-ray trunk,CPT,RVU2026A,2026
75827,Vein x-ray chest,CPT,RVU2026A,2026
75831,Vein x-ray kidney,CPT,RVU2026A,2026
75833,Vein x-ray kidneys,CPT,RVU2026A,2026
75840,Vein x-ray adrenal gland,CPT,RVU2026A,2026
75860,Vein x-ray neck,CPT,RVU2026A,2026
75870,Vein x-ray skull,CPT,RVU2026A,2026
75872,Vein x-ray skull epidural,CPT,RVU2026A,2026
75880,Vein x-ray eye socket,CPT,RVU2026A,2026
75885,Vein x-ray liver w/hemodynam,CPT,RVU2026A,2026
75887,Vein x-ray liver w/o hemodyn,CPT,RVU2026A,2026
75889,Vein x-ray liver w/hemodynam,CPT,RVU2026A,2026
75891,Vein x-ray liver,CPT,RVU2026A,2026
75893,Venous sampling by catheter,CPT,RVU2026A,2026
75894,X-rays transcath therapy,CPT,RVU2026A,2026
75898,Follow-up angiography,CPT,RVU2026A,2026
75901,Remove cva device obstruct,CPT,RVU2026A,2026
75902,Remove cva lumen obstruct,CPT,RVU2026A,2026
75970,Vascular biopsy,CPT,RVU2026A,2026
75984,Xray control catheter change,CPT,RVU2026A,2026
75989,Abscess drainage under x-ray,CPT,RVU2026A,2026
76000,Fluoroscopy <1 hr phys/qhp,CPT,RVU2026A,2026
76010,X-ray nose to rectum,CPT,RVU2026A,2026
76014,Mr sfty implt&/fb asmt stf 1,CPT,RVU2026A,2026
76015,Mr sfty mplt&/fb asmt stf ea,CPT,RVU2026A,2026
76016,Mr safety deter phys/qhp,CPT,RVU2026A,2026
76017,Mr sfty med physics xm cstmz,CPT,RVU2026A,2026
76018,Mr safety implant elec prepj,CPT,RVU2026A,2026
76019,Mr safety implt pos&/immoblj,CPT,RVU2026A,2026
76080,X-ray exam of fistula,CPT,RVU2026A,2026
76098,X-ray exam surgical specimen,CPT,RVU2026A,2026
76100,X-ray exam of body section,CPT,RVU2026A,2026
76120,Cine/video x-rays,CPT,RVU2026A,2026
76125,Cine/video x-rays add-on,CPT,RVU2026A,2026
76140,X-ray consultation,CPT,RVU2026A,2026
76145,Med physic dos eval rad exps,CPT,RVU2026A,2026
76376,3d render w/intrp postproces,CPT,RVU2026A,2026
76377,3d render w/intrp postproces,CPT,RVU2026A,2026
76380,Cat scan follow-up study,CPT,RVU2026A,2026
76390,Mr spectroscopy,CPT,RVU2026A,2026
76391,Mr elastography,CPT,RVU2026A,2026
76496,Unlisted fluoroscopic px,CPT,RVU2026A,2026
76497,Unlisted ct procedure,CPT,RVU2026A,2026
76498,Unlisted mr procedure,CPT,RVU2026A,2026
76499,Unlisted dx radiographic px,CPT,RVU2026A,2026
76506,Echo exam of head,CPT,RVU2026A,2026
76510,Oph us dx b-scan&quan a-scan,CPT,RVU2026A,2026
76511,Oph us dx quan a-scan only,CPT,RVU2026A,2026
76512,Oph us dx b-scan,CPT,RVU2026A,2026
76513,Oph us dx ant sgm us uni/bi,CPT,RVU2026A,2026
76514,Echo exam of eye thickness,CPT,RVU2026A,2026
76516,Echo exam of eye,CPT,RVU2026A,2026
76519,Echo exam of eye,CPT,RVU2026A,2026
76529,Echo exam of eye,CPT,RVU2026A,2026
76536,Us exam of head and neck,CPT,RVU2026A,2026
76604,Us exam chest,CPT,RVU2026A,2026
76641,Ultrasound breast complete,CPT,RVU2026A,2026
76642,Ultrasound breast limited,CPT,RVU2026A,2026
76700,Us exam abdom complete,CPT,RVU2026A,2026
76705,Echo exam of abdomen,CPT,RVU2026A,2026
76706,Us abdl aorta screen aaa,CPT,RVU2026A,2026
76770,Us exam abdo back wall comp,CPT,RVU2026A,2026
76775,Us exam abdo back wall lim,CPT,RVU2026A,2026
76776,Us exam k transpl w/doppler,CPT,RVU2026A,2026
76800,Us exam spinal canal,CPT,RVU2026A,2026
76801,Ob us < 14 wks single fetus,CPT,RVU2026A,2026
76802,Ob us < 14 wks addl fetus,CPT,RVU2026A,2026
76805,Ob us >/= 14 wks sngl fetus,CPT,RVU2026A,2026
76810,Ob us >/= 14 wks addl fetus,CPT,RVU2026A,2026
76811,Ob us detailed sngl fetus,CPT,RVU2026A,2026
76812,Ob us detailed addl fetus,CPT,RVU2026A,2026
76813,Ob us nuchal meas 1 gest,CPT,RVU2026A,2026
76814,Ob us nuchal meas add-on,CPT,RVU2026A,2026
76815,Ob us limited fetus(s),CPT,RVU2026A,2026
76816,Ob us follow-up per fetus,CPT,RVU2026A,2026
76817,Transvaginal us obstetric,CPT,RVU2026A,2026
76818,Fetal biophys profile w/nst,CPT,RVU2026A,2026
76819,Fetal biophys profil w/o nst,CPT,RVU2026A,2026
76820,Umbilical artery echo,CPT,RVU2026A,2026
76821,Middle cerebral artery echo,CPT,RVU2026A,2026
76825,Echo exam of fetal heart,CPT,RVU2026A,2026
76826,Echo exam of fetal heart,CPT,RVU2026A,2026
76827,Echo exam of fetal heart,CPT,RVU2026A,2026
76828,Echo exam of fetal heart,CPT,RVU2026A,2026
76830,Transvaginal us non-ob,CPT,RVU2026A,2026
76831,Echo exam uterus,CPT,RVU2026A,2026
76856,Us exam pelvic complete,CPT,RVU2026A,2026
76857,Us exam pelvic limited,CPT,RVU2026A,2026
76870,Us exam scrotum,CPT,RVU2026A,2026
76872,Us transrectal,CPT,RVU2026A,2026
76873,Echograp trans r pros study,CPT,RVU2026A,2026
76881,Us compl joint r-t w/img,CPT,RVU2026A,2026
76882,Us lmtd jt/fcl evl nvasc xtr,CPT,RVU2026A,2026
76883,Us nrv&acc strux 1xtr compre,CPT,RVU2026A,2026
76885,Us exam infant hips dynamic,CPT,RVU2026A,2026
76886,Us exam infant hips static,CPT,RVU2026A,2026
76932,Echo guide for heart biopsy,CPT,RVU2026A,2026
76936,Echo guide for artery repair,CPT,RVU2026A,2026
76937,Us guide vascular access,CPT,RVU2026A,2026
76940,Us guide tissue ablation,CPT,RVU2026A,2026
76941,Echo guide for transfusion,CPT,RVU2026A,2026
76942,Echo guide for biopsy,CPT,RVU2026A,2026
76945,Echo guide villus sampling,CPT,RVU2026A,2026
76946,Echo guide for amniocentesis,CPT,RVU2026A,2026
76948,Echo guide ova aspiration,CPT,RVU2026A,2026
76965,Echo guidance radiotherapy,CPT,RVU2026A,2026
76975,Gi endoscopic ultrasound,CPT,RVU2026A,2026
76977,Us bone density measure,CPT,RVU2026A,2026
76978,Us trgt dyn mbubb 1st les,CPT,RVU2026A,2026
76979,Us trgt dyn mbubb ea addl,CPT,RVU2026A,2026
76981,Use parenchyma,CPT,RVU2026A,2026
76982,Use 1st target lesion,CPT,RVU2026A,2026
76983,Use ea addl target lesion,CPT,RVU2026A,2026
76984,Dx intraop thoracic aorta us,CPT,RVU2026A,2026
76987,Dx intraop epicar car us chd,CPT,RVU2026A,2026
76988,Dx ntrop epcr us chd img acq,CPT,RVU2026A,2026
76989,Dx intraop epcar us chd i&r,CPT,RVU2026A,2026
76998,Us guide intraop,CPT,RVU2026A,2026
76999,Echo examination procedure,CPT,RVU2026A,2026
77001,Fluoroguide for vein device,CPT,RVU2026A,2026
77002,Needle localization by xray,CPT,RVU2026A,2026
77003,Fluoroguide for spine inject,CPT,RVU2026A,2026
77011,Ct scan for localization,CPT,RVU2026A,2026
77012,Ct scan for needle biopsy,CPT,RVU2026A,2026
77013,Ct guide for tissue ablation,CPT,RVU2026A,2026
77021,Mri guidance ndl plmt rs&i,CPT,RVU2026A,2026
77022,Mri gdn parnchyma tiss abltj,CPT,RVU2026A,2026
77046,Mri breast c- unilateral,CPT,RVU2026A,2026
77047,Mri breast c- bilateral,CPT,RVU2026A,2026
77048,Mri breast c-+ w/cad uni,CPT,RVU2026A,2026
77049,Mri breast c-+ w/cad bi,CPT,RVU2026A,2026
77053,X-ray of mammary duct,CPT,RVU2026A,2026
77054,X-ray of mammary ducts,CPT,RVU2026A,2026
77061,Breast tomosynthesis uni,CPT,RVU2026A,2026
77062,Breast tomosynthesis bi,CPT,RVU2026A,2026
77063,Breast tomosynthesis bi,CPT,RVU2026A,2026
77065,Dx mammo incl cad uni,CPT,RVU2026A,2026
77066,Dx mammo incl cad bi,CPT,RVU2026A,2026
77067,Scr mammo bi incl cad,CPT,RVU2026A,2026
77071,Mnl appl strs jt radiography,CPT,RVU2026A,2026
77072,Bone age studies,CPT,RVU2026A,2026
77073,Bone length studies,CPT,RVU2026A,2026
77074,Radex osseous survey lmtd,CPT,RVU2026A,2026
77075,Radex osseous survey compl,CPT,RVU2026A,2026
77076,Radex osseous survey infant,CPT,RVU2026A,2026
77077,Joint survey single view,CPT,RVU2026A,2026
77078,Ct bone density axial,CPT,RVU2026A,2026
77080,Dxa bone density axial,CPT,RVU2026A,2026
77081,Dxa bone density appendiculr,CPT,RVU2026A,2026
77084,Mri bone marrow blood supply,CPT,RVU2026A,2026
77085,Dxa bone density axl vrt fx,CPT,RVU2026A,2026
77086,Vrt fracture assmt via dxa,CPT,RVU2026A,2026
77089,Tbs dxa cal w/i&r fx risk,CPT,RVU2026A,2026
77090,Tbs techl prep&transmis data,CPT,RVU2026A,2026
77091,Tbs techl calculation only,CPT,RVU2026A,2026
77092,Tbs i&r fx rsk qhp,CPT,RVU2026A,2026
77261,Ther radiology tx plng smpl,CPT,RVU2026A,2026
77262,Ther radiology tx plng intrm,CPT,RVU2026A,2026
77263,Ther radiology tx plng cplx,CPT,RVU2026A,2026
77280,Ther rad simulaj field smpl,CPT,RVU2026A,2026
77285,Ther rad simulaj field intrm,CPT,RVU2026A,2026
77290,Ther rad simulaj field cplx,CPT,RVU2026A,2026
77293,Respirator motion mgmt simul,CPT,RVU2026A,2026
77295,3-d radiotherapy plan,CPT,RVU2026A,2026
77299,Unlisted px ther rad tx plng,CPT,RVU2026A,2026
77300,Radiation therapy dose plan,CPT,RVU2026A,2026
77301,Radiotherapy dose plan imrt,CPT,RVU2026A,2026
77306,Telethx isodose plan simple,CPT,RVU2026A,2026
77307,Telethx isodose plan cplx,CPT,RVU2026A,2026
77316,Brachytx isodose plan simple,CPT,RVU2026A,2026
77317,Brachytx isodose intermed,CPT,RVU2026A,2026
77318,Brachytx isodose complex,CPT,RVU2026A,2026
77321,Special teletx port plan,CPT,RVU2026A,2026
77331,Special radiation dosimetry,CPT,RVU2026A,2026
77332,Radiation treatment aid(s),CPT,RVU2026A,2026
77333,Radiation treatment aid(s),CPT,RVU2026A,2026
77334,Radiation treatment aid(s),CPT,RVU2026A,2026
77336,Radiation physics consult,CPT,RVU2026A,2026
77338,Design mlc device for imrt,CPT,RVU2026A,2026
77370,Radiation physics consult,CPT,RVU2026A,2026
77371,Srs multisource,CPT,RVU2026A,2026
77372,Srs linear based,CPT,RVU2026A,2026
77373,Strtctc bdy rad ther tx dlvr,CPT,RVU2026A,2026
77387,Guidance for radj tx dlvr,CPT,RVU2026A,2026
77399,Unlisted px med radj physics,CPT,RVU2026A,2026
77402,Radiation tx delivery lvl 1,CPT,RVU2026A,2026
77407,Radiation tx delivery lvl 2,CPT,RVU2026A,2026
77412,Radiation tx delivery lvl 3,CPT,RVU2026A,2026
77417,Ther radiology port image(s),CPT,RVU2026A,2026
77423,Neutron beam tx complex,CPT,RVU2026A,2026
77424,Io rad tx delivery by x-ray,CPT,RVU2026A,2026
77425,Io rad tx deliver by elctrns,CPT,RVU2026A,2026
77427,Radiation tx management x5,CPT,RVU2026A,2026
77431,Radiation therapy management,CPT,RVU2026A,2026
77432,Stereotactic radiation trmt,CPT,RVU2026A,2026
77435,Sbrt management,CPT,RVU2026A,2026
77436,Surf radj ther tx planning,CPT,RVU2026A,2026
77437,Surf radj ther supfc<=150kv,CPT,RVU2026A,2026
77438,Surf rad thr orthvlt>150-500,CPT,RVU2026A,2026
77439,Surf rad thr img gdn us plmt,CPT,RVU2026A,2026
77469,Io radiation tx management,CPT,RVU2026A,2026
77470,Special radiation treatment,CPT,RVU2026A,2026
77499,Unlisted px ther rad tx mgmt,CPT,RVU2026A,2026
77520,Proton trmt simple w/o comp,CPT,RVU2026A,2026
77522,Proton trmt simple w/comp,CPT,RVU2026A,2026
77523,Proton trmt intermediate,CPT,RVU2026A,2026
77525,Proton treatment complex,CPT,RVU2026A,2026
77600,Hyperthermia ext gen supfc,CPT,RVU2026A,2026
77605,Hyperthermia ext gen deep,CPT,RVU2026A,2026
77610,Hyperthermia ntrstl prb 5/<,CPT,RVU2026A,2026
77615,Hyperthermia ntrstl prb>5,CPT,RVU2026A,2026
77620,Hyperthermia gen intrcv prb,CPT,RVU2026A,2026
77750,Infuse radioactive materials,CPT,RVU2026A,2026
77761,Apply intrcav radiat simple,CPT,RVU2026A,2026
77762,Apply intrcav radiat interm,CPT,RVU2026A,2026
77763,Apply intrcav radiat compl,CPT,RVU2026A,2026
77767,Hdr rdncl skn surf brachytx,CPT,RVU2026A,2026
77768,Hdr rdncl skn surf brachytx,CPT,RVU2026A,2026
77770,Hdr rdncl ntrstl/icav brchtx,CPT,RVU2026A,2026
77771,Hdr rdncl ntrstl/icav brchtx,CPT,RVU2026A,2026
77772,Hdr rdncl ntrstl/icav brchtx,CPT,RVU2026A,2026
77778,Apply interstit radiat compl,CPT,RVU2026A,2026
77789,Apply surf ldr radionuclide,CPT,RVU2026A,2026
77790,Radiation handling,CPT,RVU2026A,2026
77799,Unlisted px clin brachytx,CPT,RVU2026A,2026
78012,Thyroid uptake measurement,CPT,RVU2026A,2026
78013,Thyroid imaging w/blood flow,CPT,RVU2026A,2026
78014,Thyroid imaging w/blood flow,CPT,RVU2026A,2026
78015,Thyroid met imaging,CPT,RVU2026A,2026
78016,Thyroid met imaging/studies,CPT,RVU2026A,2026
78018,Thyroid met imaging body,CPT,RVU2026A,2026
78020,Thyroid met uptake,CPT,RVU2026A,2026
78070,Parathyroid planar imaging,CPT,RVU2026A,2026
78071,Parathyrd planar w/wo subtrj,CPT,RVU2026A,2026
78072,Parathyrd planar w/spect&ct,CPT,RVU2026A,2026
78075,Adrenal cortex & medulla img,CPT,RVU2026A,2026
78099,Unlisted endocrine px dx nuc,CPT,RVU2026A,2026
78102,Bone marrow imaging ltd,CPT,RVU2026A,2026
78103,Bone marrow imaging mult,CPT,RVU2026A,2026
78104,Bone marrow imaging body,CPT,RVU2026A,2026
78110,Plasma volume single,CPT,RVU2026A,2026
78111,Plasma volume multiple,CPT,RVU2026A,2026
78120,Red cell mass single,CPT,RVU2026A,2026
78121,Red cell mass multiple,CPT,RVU2026A,2026
78122,Whl bld volume determination,CPT,RVU2026A,2026
78130,Red cell survival study,CPT,RVU2026A,2026
78140,Red cell sequestration,CPT,RVU2026A,2026
78185,Spleen imaging,CPT,RVU2026A,2026
78191,Platelet survival study,CPT,RVU2026A,2026
78195,Lymph system imaging,CPT,RVU2026A,2026
78199,Unlstd hematop ret/endo lymp,CPT,RVU2026A,2026
78201,Liver imaging static only,CPT,RVU2026A,2026
78202,Liver imaging with vasc flow,CPT,RVU2026A,2026
78215,Lvr&spleen img static only,CPT,RVU2026A,2026
78216,Lvr&spleen img w/vasc flow,CPT,RVU2026A,2026
78226,Hepatobiliary system imaging,CPT,RVU2026A,2026
78227,Hepatobil syst image w/drug,CPT,RVU2026A,2026
78230,Salivary gland imaging,CPT,RVU2026A,2026
78231,Salivary glnd img serial img,CPT,RVU2026A,2026
78232,Salivary gland function std,CPT,RVU2026A,2026
78258,Esophageal motility,CPT,RVU2026A,2026
78261,Gastric mucosa imaging,CPT,RVU2026A,2026
78262,Gastroesophageal reflux std,CPT,RVU2026A,2026
78264,Gastric emptying img study,CPT,RVU2026A,2026
78265,Gstr emptg img sm bwl trnst,CPT,RVU2026A,2026
78266,Gstr empt img sm bwl&colon,CPT,RVU2026A,2026
78267,Urea breath tst c-14 acquisj,CPT,RVU2026A,2026
78268,Urea breath test c-14 alys,CPT,RVU2026A,2026
78278,Acute gi blood loss imaging,CPT,RVU2026A,2026
78282,Gi protein loss,CPT,RVU2026A,2026
78290,Intestine imaging,CPT,RVU2026A,2026
78291,Pertl-ven shunt patency test,CPT,RVU2026A,2026
78299,Unlisted gi px dx nuc med,CPT,RVU2026A,2026
78300,Bone imaging limited area,CPT,RVU2026A,2026
78305,Bone imaging multiple areas,CPT,RVU2026A,2026
78306,Bone imaging whole body,CPT,RVU2026A,2026
78315,Bone imaging 3 phase,CPT,RVU2026A,2026
78350,Bone mineral single photon,CPT,RVU2026A,2026
78351,Bone mineral dual photon,CPT,RVU2026A,2026
78399,Unlisted muscskel px dx nuc,CPT,RVU2026A,2026
78414,Non-imaging heart function,CPT,RVU2026A,2026
78428,Cardiac shunt imaging,CPT,RVU2026A,2026
78429,Myocrd img pet 1 std w/ct,CPT,RVU2026A,2026
78430,Myocrd img pet rst/strs w/ct,CPT,RVU2026A,2026
78431,Myocrd img pet rst&strs ct,CPT,RVU2026A,2026
78432,Myocrd img pet 2rtracer,CPT,RVU2026A,2026
78433,Myocrd img pet 2rtracer ct,CPT,RVU2026A,2026
78434,Aqmbf pet rest & rx stress,CPT,RVU2026A,2026
78445,Vascular flow imaging,CPT,RVU2026A,2026
78451,Ht muscle image spect sing,CPT,RVU2026A,2026
78452,Ht muscle image spect mult,CPT,RVU2026A,2026
78453,Ht muscle image planar sing,CPT,RVU2026A,2026
78454,Ht musc image planar mult,CPT,RVU2026A,2026
78456,Acute venous thrombus image,CPT,RVU2026A,2026
78457,Venous thrombosis imaging,CPT,RVU2026A,2026
78458,Ven thrombosis images bilat,CPT,RVU2026A,2026
78459,Myocrd img pet single study,CPT,RVU2026A,2026
78466,Heart infarct image,CPT,RVU2026A,2026
78468,Heart infarct image (ef),CPT,RVU2026A,2026
78469,Heart infarct image (3d),CPT,RVU2026A,2026
78472,Gated heart planar single,CPT,RVU2026A,2026
78473,Gated heart multiple,CPT,RVU2026A,2026
78481,Heart first pass single,CPT,RVU2026A,2026
78483,Heart first pass multiple,CPT,RVU2026A,2026
78491,Myocrd img pet 1std rst/strs,CPT,RVU2026A,2026
78492,Myocrd img pet mlt rst&strs,CPT,RVU2026A,2026
78494,Heart image spect,CPT,RVU2026A,2026
78496,Heart first pass add-on,CPT,RVU2026A,2026
78499,Unlisted cv px dx nuc med,CPT,RVU2026A,2026
78579,Lung ventilation imaging,CPT,RVU2026A,2026
78580,Lung perfusion imaging,CPT,RVU2026A,2026
78582,Lung ventilat&perfus imaging,CPT,RVU2026A,2026
78597,Lung perfusion differential,CPT,RVU2026A,2026
78598,Lung perf&ventilat diferentl,CPT,RVU2026A,2026
78599,Unlisted resp px dx nuc med,CPT,RVU2026A,2026
78600,Brain image < 4 views,CPT,RVU2026A,2026
78601,Brain image w/flow < 4 views,CPT,RVU2026A,2026
78605,Brain image 4+ views,CPT,RVU2026A,2026
78606,Brain image w/flow 4 + views,CPT,RVU2026A,2026
78608,Brain imaging (pet),CPT,RVU2026A,2026
78609,Brain imaging (pet),CPT,RVU2026A,2026
78610,Brain flow imaging only,CPT,RVU2026A,2026
78630,Cerebrospinal fluid scan,CPT,RVU2026A,2026
78635,Csf ventriculography,CPT,RVU2026A,2026
78645,Csf shunt evaluation,CPT,RVU2026A,2026
78650,Csf leakage imaging,CPT,RVU2026A,2026
78660,Nuclear exam of tear flow,CPT,RVU2026A,2026
78699,Unlisted nrvs sys px dx nuc,CPT,RVU2026A,2026
78700,Kidney imaging morphol,CPT,RVU2026A,2026
78701,Kidney imaging with flow,CPT,RVU2026A,2026
78707,K flow/funct image w/o drug,CPT,RVU2026A,2026
78708,K flow/funct image w/drug,CPT,RVU2026A,2026
78709,K flow/funct image multiple,CPT,RVU2026A,2026
78725,Kidney function study,CPT,RVU2026A,2026
78730,Urinary bladder retention,CPT,RVU2026A,2026
78740,Ureteral reflux study,CPT,RVU2026A,2026
78761,Testicular imaging w/flow,CPT,RVU2026A,2026
78799,Unlisted gu px dx nuc med,CPT,RVU2026A,2026
78800,Rp loclzj tum 1 area 1 d img,CPT,RVU2026A,2026
78801,Rp loclzj tum 2+area 1+d img,CPT,RVU2026A,2026
78802,Rp loclzj tum whbdy 1 d img,CPT,RVU2026A,2026
78803,Rp loclzj tum spect 1 area,CPT,RVU2026A,2026
78804,Rp loclzj tum whbdy 2+d img,CPT,RVU2026A,2026
78808,Iv inj ra drug dx study,CPT,RVU2026A,2026
78811,Pet image ltd area,CPT,RVU2026A,2026
78812,Pet image skull-thigh,CPT,RVU2026A,2026
78813,Pet image full body,CPT,RVU2026A,2026
78814,Pet image w/ct lmtd,CPT,RVU2026A,2026
78815,Pet image w/ct skull-thigh,CPT,RVU2026A,2026
78816,Pet image w/ct full body,CPT,RVU2026A,2026
78830,Rp loclzj tum spect w/ct 1,CPT,RVU2026A,2026
78831,Rp loclzj tum spect 2 areas,CPT,RVU2026A,2026
78832,Rp loclzj tum spect w/ct 2,CPT,RVU2026A,2026
78835,Rp quan meas single area,CPT,RVU2026A,2026
78999,Unlisted misc px dx nuc med,CPT,RVU2026A,2026
79005,Nuclear rx oral admin,CPT,RVU2026A,2026
79101,Nuclear rx iv admin,CPT,RVU2026A,2026
79200,Nuclear rx intracav admin,CPT,RVU2026A,2026
79300,Nuclr rx interstit colloid,CPT,RVU2026A,2026
79403,Hematopoietic nuclear tx,CPT,RVU2026A,2026
79440,Nuclear rx intra-articular,CPT,RVU2026A,2026
79445,Nuclear rx intra-arterial,CPT,RVU2026A,2026
79999,Rp therapy unlisted px,CPT,RVU2026A,2026
80047,Basic metablc pnl ionized ca,CPT,RVU2026A,2026
80048,Basic metabolic pnl total ca,CPT,RVU2026A,2026
80050,General health panel,CPT,RVU2026A,2026
80051,Electrolyte panel,CPT,RVU2026A,2026
80053,Comprehen metabolic panel,CPT,RVU2026A,2026
80055,Obstetric panel,CPT,RVU2026A,2026
80061,Lipid panel,CPT,RVU2026A,2026
80069,Renal function panel,CPT,RVU2026A,2026
80074,Acute hepatitis panel,CPT,RVU2026A,2026
80076,Hepatic function panel,CPT,RVU2026A,2026
80081,Obstetric panel inc hiv tstg,CPT,RVU2026A,2026
80143,Drug assay acetaminophen,CPT,RVU2026A,2026
80145,Drug assay adalimumab,CPT,RVU2026A,2026
80150,Assay of amikacin,CPT,RVU2026A,2026
80151,Drug assay amiodarone,CPT,RVU2026A,2026
80155,Drug assay caffeine,CPT,RVU2026A,2026
80156,Assay carbamazepine total,CPT,RVU2026A,2026
80157,Assay carbamazepine free,CPT,RVU2026A,2026
80158,Drug assay cyclosporine,CPT,RVU2026A,2026
80159,Drug assay clozapine,CPT,RVU2026A,2026
80161,"Asy carbamazepin 10,11-epxid",CPT,RVU2026A,2026
80162,Assay of digoxin total,CPT,RVU2026A,2026
80163,Assay of digoxin free,CPT,RVU2026A,2026
80164,Assay dipropylacetic acd tot,CPT,RVU2026A,2026
80165,Dipropylacetic acid free,CPT,RVU2026A,2026
80167,Drug assay felbamate,CPT,RVU2026A,2026
80168,Assay of ethosuximide,CPT,RVU2026A,2026
80169,Drug assay everolimus,CPT,RVU2026A,2026
80170,Assay of gentamicin,CPT,RVU2026A,2026
80171,Drug screen quant gabapentin,CPT,RVU2026A,2026
80173,Assay of haloperidol,CPT,RVU2026A,2026
80175,Drug screen quan lamotrigine,CPT,RVU2026A,2026
80176,Assay of lidocaine,CPT,RVU2026A,2026
80177,Drug scrn quan levetiracetam,CPT,RVU2026A,2026
80178,Assay of lithium,CPT,RVU2026A,2026
80179,Drug assay salicylate,CPT,RVU2026A,2026
80180,Drug scrn quan mycophenolate,CPT,RVU2026A,2026
80181,Drug assay flecainide,CPT,RVU2026A,2026
80183,Drug scrn quant oxcarbazepin,CPT,RVU2026A,2026
80184,Assay of phenobarbital,CPT,RVU2026A,2026
80185,Assay of phenytoin total,CPT,RVU2026A,2026
80186,Assay of phenytoin free,CPT,RVU2026A,2026
80187,Drug assay posaconazole,CPT,RVU2026A,2026
80188,Assay of primidone,CPT,RVU2026A,2026
80189,Drug assay itraconazole,CPT,RVU2026A,2026
80190,Assay of procainamide,CPT,RVU2026A,2026
80192,Assay of procainamide,CPT,RVU2026A,2026
80193,Drug assay leflunomide,CPT,RVU2026A,2026
80194,Assay of quinidine,CPT,RVU2026A,2026
80195,Assay of sirolimus,CPT,RVU2026A,2026
80197,Assay of tacrolimus,CPT,RVU2026A,2026
80198,Assay of theophylline,CPT,RVU2026A,2026
80199,Drug screen quant tiagabine,CPT,RVU2026A,2026
80200,Assay of tobramycin,CPT,RVU2026A,2026
80201,Assay of topiramate,CPT,RVU2026A,2026
80202,Assay of vancomycin,CPT,RVU2026A,2026
80203,Drug screen quant zonisamide,CPT,RVU2026A,2026
80204,Drug assay methotrexate,CPT,RVU2026A,2026
80210,Drug assay rufinamide,CPT,RVU2026A,2026
80220,Drug asy hydroxychloroquine,CPT,RVU2026A,2026
80230,Drug assay infliximab,CPT,RVU2026A,2026
80235,Drug assay lacosamide,CPT,RVU2026A,2026
80280,Drug assay vedolizumab,CPT,RVU2026A,2026
80285,Drug assay voriconazole,CPT,RVU2026A,2026
80299,Quantitative assay drug,CPT,RVU2026A,2026
80305,Drug test prsmv dir opt obs,CPT,RVU2026A,2026
80306,Drug test prsmv instrmnt,CPT,RVU2026A,2026
80307,Drug test prsmv chem anlyzr,CPT,RVU2026A,2026
80320,Drug screen quantalcohols,CPT,RVU2026A,2026
80321,Alcohols biomarkers 1or 2,CPT,RVU2026A,2026
80322,Alcohols biomarkers 3/more,CPT,RVU2026A,2026
80323,Alkaloids nos,CPT,RVU2026A,2026
80324,Drug screen amphetamines 1/2,CPT,RVU2026A,2026
80325,Amphetamines 3or 4,CPT,RVU2026A,2026
80326,Amphetamines 5 or more,CPT,RVU2026A,2026
80327,Anabolic steroid 1 or 2,CPT,RVU2026A,2026
80328,Anabolic steroid 3 or more,CPT,RVU2026A,2026
80329,Analgesics non-opioid 1 or 2,CPT,RVU2026A,2026
80330,Analgesics non-opioid 3-5,CPT,RVU2026A,2026
80331,Analgesics non-opioid 6/more,CPT,RVU2026A,2026
80332,Antidepressants class 1 or 2,CPT,RVU2026A,2026
80333,Antidepressants class 3-5,CPT,RVU2026A,2026
80334,Antidepressants class 6/more,CPT,RVU2026A,2026
80335,Antidepressant tricyclic 1/2,CPT,RVU2026A,2026
80336,Antidepressant tricyclic 3-5,CPT,RVU2026A,2026
80337,Tricyclic & cyclicals 6/more,CPT,RVU2026A,2026
80338,Antidepressant not specified,CPT,RVU2026A,2026
80339,Antiepileptics nos 1-3,CPT,RVU2026A,2026
80340,Antiepileptics nos 4-6,CPT,RVU2026A,2026
80341,Antiepileptics nos 7/more,CPT,RVU2026A,2026
80342,Antipsychotics nos 1-3,CPT,RVU2026A,2026
80343,Antipsychotics nos 4-6,CPT,RVU2026A,2026
80344,Antipsychotics nos 7/more,CPT,RVU2026A,2026
80345,Drug screening barbiturates,CPT,RVU2026A,2026
80346,Benzodiazepines1-12,CPT,RVU2026A,2026
80347,Benzodiazepines 13 or more,CPT,RVU2026A,2026
80348,Drug screening buprenorphine,CPT,RVU2026A,2026
80349,Cannabinoids natural,CPT,RVU2026A,2026
80350,Cannabinoids synthetic 1-3,CPT,RVU2026A,2026
80351,Cannabinoids synthetic 4-6,CPT,RVU2026A,2026
80352,Cannabinoid synthetic 7/more,CPT,RVU2026A,2026
80353,Drug screening cocaine,CPT,RVU2026A,2026
80354,Drug screening fentanyl,CPT,RVU2026A,2026
80355,Gabapentin non-blood,CPT,RVU2026A,2026
80356,Heroin metabolite,CPT,RVU2026A,2026
80357,Ketamine and norketamine,CPT,RVU2026A,2026
80358,Drug screening methadone,CPT,RVU2026A,2026
80359,Methylenedioxyamphetamines,CPT,RVU2026A,2026
80360,Methylphenidate,CPT,RVU2026A,2026
80361,Opiates 1 or more,CPT,RVU2026A,2026
80362,Opioids & opiate analogs 1/2,CPT,RVU2026A,2026
80363,Opioids & opiate analogs 3/4,CPT,RVU2026A,2026
80364,Opioid &opiate analog 5/more,CPT,RVU2026A,2026
80365,Drug screening oxycodone,CPT,RVU2026A,2026
80366,Drug screening pregabalin,CPT,RVU2026A,2026
80367,Drug screening propoxyphene,CPT,RVU2026A,2026
80368,Sedative hypnotics,CPT,RVU2026A,2026
80369,Skeletal muscle relaxant 1/2,CPT,RVU2026A,2026
80370,Skel musc relaxant 3 or more,CPT,RVU2026A,2026
80371,Stimulants synthetic,CPT,RVU2026A,2026
80372,Drug screening tapentadol,CPT,RVU2026A,2026
80373,Drug screening tramadol,CPT,RVU2026A,2026
80374,Stereoisomer analysis,CPT,RVU2026A,2026
80375,Drug/substance nos 1-3,CPT,RVU2026A,2026
80376,Drug/substance nos 4-6,CPT,RVU2026A,2026
80377,Drug/substance nos 7/more,CPT,RVU2026A,2026
80400,Acth stimulation panel,CPT,RVU2026A,2026
80402,Acth stimulation panel,CPT,RVU2026A,2026
80406,Acth stimulation panel,CPT,RVU2026A,2026
80408,Aldosterone suppression eval,CPT,RVU2026A,2026
80410,Calcitonin stimul panel,CPT,RVU2026A,2026
80412,Crh stimulation panel,CPT,RVU2026A,2026
80414,Testosterone response panel,CPT,RVU2026A,2026
80415,Tot estradiol response panel,CPT,RVU2026A,2026
80416,Renin stimulation panel,CPT,RVU2026A,2026
80417,Renin stimulation panel,CPT,RVU2026A,2026
80418,Pituitary evaluation panel,CPT,RVU2026A,2026
80420,Dexamethasone panel,CPT,RVU2026A,2026
80422,Glucagon tolerance panel,CPT,RVU2026A,2026
80424,Glucagon tolerance panel,CPT,RVU2026A,2026
80426,Gonadotropin hormone panel,CPT,RVU2026A,2026
80428,Growth hormone panel,CPT,RVU2026A,2026
80430,Growth hormone panel,CPT,RVU2026A,2026
80432,Insulin suppression panel,CPT,RVU2026A,2026
80434,Insulin tolerance panel,CPT,RVU2026A,2026
80435,Insulin tolerance panel,CPT,RVU2026A,2026
80436,Metyrapone panel,CPT,RVU2026A,2026
80438,Trh stimulation panel,CPT,RVU2026A,2026
80439,Trh stimulation panel,CPT,RVU2026A,2026
80503,Path clin consltj sf 5-20,CPT,RVU2026A,2026
80504,Path clin consltj mod 21-40,CPT,RVU2026A,2026
80505,Path clin consltj high 41-60,CPT,RVU2026A,2026
80506,Path clin consltj prolng svc,CPT,RVU2026A,2026
81000,Urinalysis nonauto w/scope,CPT,RVU2026A,2026
81001,Urinalysis auto w/scope,CPT,RVU2026A,2026
81002,Urinalysis nonauto w/o scope,CPT,RVU2026A,2026
81003,Urinalysis auto w/o scope,CPT,RVU2026A,2026
81005,Urinalysis,CPT,RVU2026A,2026
81007,Urine screen for bacteria,CPT,RVU2026A,2026
81015,Microscopic exam of urine,CPT,RVU2026A,2026
81020,Urinalysis glass test,CPT,RVU2026A,2026
81025,Urine pregnancy test,CPT,RVU2026A,2026
81050,Urinalysis volume measure,CPT,RVU2026A,2026
81099,Unlisted urinalysis px,CPT,RVU2026A,2026
81105,Hpa-1 genotyping,CPT,RVU2026A,2026
81106,Hpa-2 genotyping,CPT,RVU2026A,2026
81107,Hpa-3 genotyping,CPT,RVU2026A,2026
81108,Hpa-4 genotyping,CPT,RVU2026A,2026
81109,Hpa-5 genotyping,CPT,RVU2026A,2026
81110,Hpa-6 genotyping,CPT,RVU2026A,2026
81111,Hpa-9 genotyping,CPT,RVU2026A,2026
81112,Hpa-15 genotyping,CPT,RVU2026A,2026
81120,Idh1 common variants,CPT,RVU2026A,2026
81121,Idh2 common variants,CPT,RVU2026A,2026
81161,Dmd dup/delet analysis,CPT,RVU2026A,2026
81162,Brca1&2 gen full seq dup/del,CPT,RVU2026A,2026
81163,Brca1&2 gene full seq alys,CPT,RVU2026A,2026
81164,Brca1&2 gen ful dup/del alys,CPT,RVU2026A,2026
81165,Brca1 gene full seq alys,CPT,RVU2026A,2026
81166,Brca1 gene full dup/del alys,CPT,RVU2026A,2026
81167,Brca2 gene full dup/del alys,CPT,RVU2026A,2026
81168,Ccnd1/igh translocation alys,CPT,RVU2026A,2026
81170,Abl1 gene,CPT,RVU2026A,2026
81171,Aff2 gen aly detc abnl allel,CPT,RVU2026A,2026
81172,Aff2 gen alys charac alleles,CPT,RVU2026A,2026
81173,Ar gene full gene sequence,CPT,RVU2026A,2026
81174,Ar gene known famil variant,CPT,RVU2026A,2026
81175,Asxl1 full gene sequence,CPT,RVU2026A,2026
81176,Asxl1 gene target seq alys,CPT,RVU2026A,2026
81177,Atn1 gene detc abnor alleles,CPT,RVU2026A,2026
81178,Atxn1 gene detc abnor allele,CPT,RVU2026A,2026
81179,Atxn2 gene detc abnor allele,CPT,RVU2026A,2026
81180,Atxn3 gene detc abnor allele,CPT,RVU2026A,2026
81181,Atxn7 gene detc abnor allele,CPT,RVU2026A,2026
81182,Atxn8os gen detc abnor allel,CPT,RVU2026A,2026
81183,Atxn10 gene detc abnor allel,CPT,RVU2026A,2026
81184,Cacna1a gen detc abnor allel,CPT,RVU2026A,2026
81185,Cacna1a gene full gene seq,CPT,RVU2026A,2026
81186,Cacna1a gen known famil vrnt,CPT,RVU2026A,2026
81187,Cnbp gene detc abnor allele,CPT,RVU2026A,2026
81188,Cstb gene detc abnor allele,CPT,RVU2026A,2026
81189,Cstb gene full gene sequence,CPT,RVU2026A,2026
81190,Cstb gene known famil vrnt,CPT,RVU2026A,2026
81191,Ntrk1 translocation analysis,CPT,RVU2026A,2026
81192,Ntrk2 translocation analysis,CPT,RVU2026A,2026
81193,Ntrk3 translocation analysis,CPT,RVU2026A,2026
81194,Ntrk translocation analysis,CPT,RVU2026A,2026
81195,Cytog genom-wid alys hem mal,CPT,RVU2026A,2026
81200,Aspa gene,CPT,RVU2026A,2026
81201,Apc gene full sequence,CPT,RVU2026A,2026
81202,Apc gene known fam variants,CPT,RVU2026A,2026
81203,Apc gene dup/delet variants,CPT,RVU2026A,2026
81204,Ar gene charac alleles,CPT,RVU2026A,2026
81205,Bckdhb gene,CPT,RVU2026A,2026
81206,Bcr/abl1 gene major bp,CPT,RVU2026A,2026
81207,Bcr/abl1 gene minor bp,CPT,RVU2026A,2026
81208,Bcr/abl1 gene other bp,CPT,RVU2026A,2026
81209,Blm gene,CPT,RVU2026A,2026
81210,Braf gene,CPT,RVU2026A,2026
81212,Brca1&2 185&5385&6174 vrnt,CPT,RVU2026A,2026
81215,Brca1 gene known famil vrnt,CPT,RVU2026A,2026
81216,Brca2 gene full seq alys,CPT,RVU2026A,2026
81217,Brca2 gene known famil vrnt,CPT,RVU2026A,2026
81218,Cebpa gene full sequence,CPT,RVU2026A,2026
81219,Calr gene com variants,CPT,RVU2026A,2026
81220,Cftr gene com variants,CPT,RVU2026A,2026
81221,Cftr gene known fam variants,CPT,RVU2026A,2026
81222,Cftr gene dup/delet variants,CPT,RVU2026A,2026
81223,Cftr gene full sequence,CPT,RVU2026A,2026
81224,Cftr gene intron poly t,CPT,RVU2026A,2026
81225,Cyp2c19 gene com variants,CPT,RVU2026A,2026
81226,Cyp2d6 gene com variants,CPT,RVU2026A,2026
81227,Cyp2c9 gene com variants,CPT,RVU2026A,2026
81228,Cytog alys chrml abnr cgh,CPT,RVU2026A,2026
81229,Cytog alys chrml abnr snpcgh,CPT,RVU2026A,2026
81230,Cyp3a4 gene common variants,CPT,RVU2026A,2026
81231,Cyp3a5 gene common variants,CPT,RVU2026A,2026
81232,Dpyd gene common variants,CPT,RVU2026A,2026
81233,Btk gene common variants,CPT,RVU2026A,2026
81234,Dmpk gene detc abnor allele,CPT,RVU2026A,2026
81235,Egfr gene com variants,CPT,RVU2026A,2026
81236,Ezh2 gene full gene sequence,CPT,RVU2026A,2026
81237,Ezh2 gene common variants,CPT,RVU2026A,2026
81238,F9 full gene sequence,CPT,RVU2026A,2026
81239,Dmpk gene charac alleles,CPT,RVU2026A,2026
81240,F2 gene,CPT,RVU2026A,2026
81241,F5 gene,CPT,RVU2026A,2026
81242,Fancc gene,CPT,RVU2026A,2026
81243,Fmr1 gen aly detc abnl allel,CPT,RVU2026A,2026
81244,Fmr1 gen alys charac alleles,CPT,RVU2026A,2026
81245,Flt3 gene,CPT,RVU2026A,2026
81246,Flt3 gene analysis,CPT,RVU2026A,2026
81247,G6pd gene alys cmn variant,CPT,RVU2026A,2026
81248,G6pd known familial variant,CPT,RVU2026A,2026
81249,G6pd full gene sequence,CPT,RVU2026A,2026
81250,G6pc gene,CPT,RVU2026A,2026
81251,Gba gene,CPT,RVU2026A,2026
81252,Gjb2 gene full sequence,CPT,RVU2026A,2026
81253,Gjb2 gene known fam variants,CPT,RVU2026A,2026
81254,Gjb6 gene com variants,CPT,RVU2026A,2026
81255,Hexa gene,CPT,RVU2026A,2026
81256,Hfe gene,CPT,RVU2026A,2026
81257,Hba1/hba2 gene,CPT,RVU2026A,2026
81258,Hba1/hba2 gene fam vrnt,CPT,RVU2026A,2026
81259,Hba1/hba2 full gene sequence,CPT,RVU2026A,2026
81260,Ikbkap gene,CPT,RVU2026A,2026
81261,Igh gene rearrange amp meth,CPT,RVU2026A,2026
81262,Igh gene rearrang dir probe,CPT,RVU2026A,2026
81263,Igh vari regional mutation,CPT,RVU2026A,2026
81264,Igk rearrangeabn clonal pop,CPT,RVU2026A,2026
81265,Str markers specimen anal,CPT,RVU2026A,2026
81266,Str markers spec anal addl,CPT,RVU2026A,2026
81267,Chimerism anal no cell selec,CPT,RVU2026A,2026
81268,Chimerism anal w/cell select,CPT,RVU2026A,2026
81269,Hba1/hba2 gene dup/del vrnts,CPT,RVU2026A,2026
81270,Jak2 gene,CPT,RVU2026A,2026
81271,Htt gene detc abnor alleles,CPT,RVU2026A,2026
81272,Kit gene targeted seq analys,CPT,RVU2026A,2026
81273,Kit gene analys d816 variant,CPT,RVU2026A,2026
81274,Htt gene charac alleles,CPT,RVU2026A,2026
81275,Kras gene variants exon 2,CPT,RVU2026A,2026
81276,Kras gene addl variants,CPT,RVU2026A,2026
81277,Cytogenomic neo microra alys,CPT,RVU2026A,2026
81278,Igh@/bcl2 translocation alys,CPT,RVU2026A,2026
81279,Jak2 gene trgt sequence alys,CPT,RVU2026A,2026
81283,Ifnl3 gene,CPT,RVU2026A,2026
81284,Fxn gene detc abnor alleles,CPT,RVU2026A,2026
81285,Fxn gene charac alleles,CPT,RVU2026A,2026
81286,Fxn gene full gene sequence,CPT,RVU2026A,2026
81287,Mgmt gene prmtr mthyltn alys,CPT,RVU2026A,2026
81288,Mlh1 gene,CPT,RVU2026A,2026
81289,Fxn gene known famil variant,CPT,RVU2026A,2026
81290,Mcoln1 gene,CPT,RVU2026A,2026
81291,Mthfr gene,CPT,RVU2026A,2026
81292,Mlh1 gene full seq,CPT,RVU2026A,2026
81293,Mlh1 gene known variants,CPT,RVU2026A,2026
81294,Mlh1 gene dup/delete variant,CPT,RVU2026A,2026
81295,Msh2 gene full seq,CPT,RVU2026A,2026
81296,Msh2 gene known variants,CPT,RVU2026A,2026
81297,Msh2 gene dup/delete variant,CPT,RVU2026A,2026
81298,Msh6 gene full seq,CPT,RVU2026A,2026
81299,Msh6 gene known variants,CPT,RVU2026A,2026
81300,Msh6 gene dup/delete variant,CPT,RVU2026A,2026
81301,Microsatellite instability,CPT,RVU2026A,2026
81302,Mecp2 gene full seq,CPT,RVU2026A,2026
81303,Mecp2 gene known variant,CPT,RVU2026A,2026
81304,Mecp2 gene dup/delet variant,CPT,RVU2026A,2026
81305,Myd88 gene p.leu265pro vrnt,CPT,RVU2026A,2026
81306,Nudt15 gene common variants,CPT,RVU2026A,2026
81307,Palb2 gene full gene seq,CPT,RVU2026A,2026
81308,Palb2 gene known famil vrnt,CPT,RVU2026A,2026
81309,Pik3ca gene trgt seq alys,CPT,RVU2026A,2026
81310,Npm1 gene,CPT,RVU2026A,2026
81311,Nras gene variants exon 2&3,CPT,RVU2026A,2026
81312,Pabpn1 gene detc abnor allel,CPT,RVU2026A,2026
81313,Pca3/klk3 antigen,CPT,RVU2026A,2026
81314,Pdgfra gene,CPT,RVU2026A,2026
81315,Pml/raralpha com breakpoints,CPT,RVU2026A,2026
81316,Pml/raralpha 1 breakpoint,CPT,RVU2026A,2026
81317,Pms2 gene full seq analysis,CPT,RVU2026A,2026
81318,Pms2 known familial variants,CPT,RVU2026A,2026
81319,Pms2 gene dup/delet variants,CPT,RVU2026A,2026
81320,Plcg2 gene common variants,CPT,RVU2026A,2026
81321,Pten gene full sequence,CPT,RVU2026A,2026
81322,Pten gene known fam variant,CPT,RVU2026A,2026
81323,Pten gene dup/delet variant,CPT,RVU2026A,2026
81324,Pmp22 gene dup/delet,CPT,RVU2026A,2026
81325,Pmp22 gene full sequence,CPT,RVU2026A,2026
81326,Pmp22 gene known fam variant,CPT,RVU2026A,2026
81327,Sept9 gen prmtr mthyltn alys,CPT,RVU2026A,2026
81328,Slco1b1 gene com variants,CPT,RVU2026A,2026
81329,Smn1 gene dos/deletion alys,CPT,RVU2026A,2026
81330,Smpd1 gene common variants,CPT,RVU2026A,2026
81331,Snrpn/ube3a gene,CPT,RVU2026A,2026
81332,Serpina1 gene,CPT,RVU2026A,2026
81333,Tgfbi gene common variants,CPT,RVU2026A,2026
81334,Runx1 gene targeted seq alys,CPT,RVU2026A,2026
81335,Tpmt gene com variants,CPT,RVU2026A,2026
81336,Smn1 gene full gene sequence,CPT,RVU2026A,2026
81337,Smn1 gen nown famil seq vrnt,CPT,RVU2026A,2026
81338,Mpl gene common variants,CPT,RVU2026A,2026
81339,Mpl gene seq alys exon 10,CPT,RVU2026A,2026
81340,Trb@ gene rearrange amplify,CPT,RVU2026A,2026
81341,Trb@ gene rearrange dirprobe,CPT,RVU2026A,2026
81342,Trg gene rearrangement anal,CPT,RVU2026A,2026
81343,Ppp2r2b gen detc abnor allel,CPT,RVU2026A,2026
81344,Tbp gene detc abnor alleles,CPT,RVU2026A,2026
81345,Tert gene targeted seq alys,CPT,RVU2026A,2026
81346,Tyms gene com variants,CPT,RVU2026A,2026
81347,Sf3b1 gene common variants,CPT,RVU2026A,2026
81348,Srsf2 gene common variants,CPT,RVU2026A,2026
81349,Cytog alys chrml abnr lw-ps,CPT,RVU2026A,2026
81350,Ugt1a1 gene common variants,CPT,RVU2026A,2026
81351,Tp53 gene full gene sequence,CPT,RVU2026A,2026
81352,Tp53 gene trgt sequence alys,CPT,RVU2026A,2026
81353,Tp53 gene known famil vrnt,CPT,RVU2026A,2026
81354,Cytog alys chrml abnor ogm,CPT,RVU2026A,2026
81355,Vkorc1 gene,CPT,RVU2026A,2026
81357,U2af1 gene common variants,CPT,RVU2026A,2026
81360,Zrsr2 gene common variants,CPT,RVU2026A,2026
81361,Hbb gene com variants,CPT,RVU2026A,2026
81362,Hbb gene known fam variant,CPT,RVU2026A,2026
81363,Hbb gene dup/del variants,CPT,RVU2026A,2026
81364,Hbb full gene sequence,CPT,RVU2026A,2026
81370,Hla i & ii typing lr,CPT,RVU2026A,2026
81371,Hla i & ii type verify lr,CPT,RVU2026A,2026
81372,Hla i typing complete lr,CPT,RVU2026A,2026
81373,Hla i typing 1 locus lr,CPT,RVU2026A,2026
81374,Hla i typing 1 antigen lr,CPT,RVU2026A,2026
81375,Hla ii typing ag equiv lr,CPT,RVU2026A,2026
81376,Hla ii typing 1 locus lr,CPT,RVU2026A,2026
81377,Hla ii type 1 ag equiv lr,CPT,RVU2026A,2026
81378,Hla i & ii typing hr,CPT,RVU2026A,2026
81379,Hla i typing complete hr,CPT,RVU2026A,2026
81380,Hla i typing 1 locus hr,CPT,RVU2026A,2026
81381,Hla i typing 1 allele hr,CPT,RVU2026A,2026
81382,Hla ii typing 1 loc hr,CPT,RVU2026A,2026
81383,Hla ii typing 1 allele hr,CPT,RVU2026A,2026
81400,Mopath procedure level 1,CPT,RVU2026A,2026
81401,Mopath procedure level 2,CPT,RVU2026A,2026
81402,Mopath procedure level 3,CPT,RVU2026A,2026
81403,Mopath procedure level 4,CPT,RVU2026A,2026
81404,Mopath procedure level 5,CPT,RVU2026A,2026
81405,Mopath procedure level 6,CPT,RVU2026A,2026
81406,Mopath procedure level 7,CPT,RVU2026A,2026
81407,Mopath procedure level 8,CPT,RVU2026A,2026
81408,Mopath procedure level 9,CPT,RVU2026A,2026
81410,Aortic dysfunction/dilation,CPT,RVU2026A,2026
81411,Aortic dysfunction/dilation,CPT,RVU2026A,2026
81412,Ashkenazi jewish assoc dis,CPT,RVU2026A,2026
81413,Car ion chnnlpath inc 10 gns,CPT,RVU2026A,2026
81414,Car ion chnnlpath inc 2 gns,CPT,RVU2026A,2026
81415,Exome sequence analysis,CPT,RVU2026A,2026
81416,Exome sequence analysis,CPT,RVU2026A,2026
81417,Exome re-evaluation,CPT,RVU2026A,2026
81418,Rx metab gen seq alys pnl 6,CPT,RVU2026A,2026
81419,Epilepsy gen seq alys panel,CPT,RVU2026A,2026
81420,Fetal chrmoml aneuploidy,CPT,RVU2026A,2026
81422,Fetal chrmoml microdeltj,CPT,RVU2026A,2026
81425,Genome sequence analysis,CPT,RVU2026A,2026
81426,Genome sequence analysis,CPT,RVU2026A,2026
81427,Genome re-evaluation,CPT,RVU2026A,2026
81430,Hearing loss sequence analys,CPT,RVU2026A,2026
81431,Hearing loss dup/del analys,CPT,RVU2026A,2026
81432,Hrdtry brst ca-rlatd do 5+,CPT,RVU2026A,2026
81434,Hered rta do gen seq 15,CPT,RVU2026A,2026
81435,Hered colon ca-rlatd do 5+,CPT,RVU2026A,2026
81437,Hered neuroend tum-rlt do 5+,CPT,RVU2026A,2026
81439,Hrdtry cardmypy gene panel,CPT,RVU2026A,2026
81440,Mitochondrial gene,CPT,RVU2026A,2026
81441,Ibmfs seq alys pnl 30 genes,CPT,RVU2026A,2026
81442,Noonan spectrum disorders,CPT,RVU2026A,2026
81443,Genetic tstg severe inh cond,CPT,RVU2026A,2026
81445,So neo gsap 5-50dna/dna&rna,CPT,RVU2026A,2026
81448,Hrdtry perph neurphy panel,CPT,RVU2026A,2026
81449,So neo gsap 5-50 rna alys,CPT,RVU2026A,2026
81450,Hl neo gsap 5-50dna/dna&rna,CPT,RVU2026A,2026
81451,Hl neo gsap 5-50 rna alys,CPT,RVU2026A,2026
81455,So/hl 51/>gsap dna/dna&rna,CPT,RVU2026A,2026
81456,So/hl 51/>gsap rna alys,CPT,RVU2026A,2026
81457,So neo gsap dna mcrstl ins,CPT,RVU2026A,2026
81458,So gsap dna cpy nmbr&mcrstl,CPT,RVU2026A,2026
81459,So neo gsap dna/dna&rna,CPT,RVU2026A,2026
81460,Whole mitochondrial genome,CPT,RVU2026A,2026
81462,So gsap cll fr dna/dna&rna,CPT,RVU2026A,2026
81463,So gsap cl fr cpy nmbr&mcrst,CPT,RVU2026A,2026
81464,So gsap cll fr mcrstl ins,CPT,RVU2026A,2026
81465,Whole mitochondrial genome,CPT,RVU2026A,2026
81470,X-linked intellectual dblt,CPT,RVU2026A,2026
81471,X-linked intellectual dblt,CPT,RVU2026A,2026
81479,Unlisted molecular pathology,CPT,RVU2026A,2026
81490,Autoimmune ra alys 12 bmrk,CPT,RVU2026A,2026
81493,Cor artery disease mrna,CPT,RVU2026A,2026
81500,Onco (ovar) two proteins,CPT,RVU2026A,2026
81503,Onco (ovar) five proteins,CPT,RVU2026A,2026
81504,Oncology tissue of origin,CPT,RVU2026A,2026
81506,Endo assay seven anal,CPT,RVU2026A,2026
81507,Fetal aneuploidy trisom risk,CPT,RVU2026A,2026
81508,Ftl cgen abnor two proteins,CPT,RVU2026A,2026
81509,Ftl cgen abnor 3 proteins,CPT,RVU2026A,2026
81510,Ftl cgen abnor three anal,CPT,RVU2026A,2026
81511,Ftl cgen abnor four anal,CPT,RVU2026A,2026
81512,Ftl cgen abnor five anal,CPT,RVU2026A,2026
81513,Nfct ds bv rna vag flu alg,CPT,RVU2026A,2026
81514,Nfct ds bv&vaginitis dna alg,CPT,RVU2026A,2026
81515,Nfct ds bv&vaginitis dna alg,CPT,RVU2026A,2026
81517,Liver ds alys 3 bmrk srm alg,CPT,RVU2026A,2026
81518,Onc brst mrna 11 genes,CPT,RVU2026A,2026
81519,Oncology breast mrna,CPT,RVU2026A,2026
81520,Onc breast mrna 58 genes,CPT,RVU2026A,2026
81521,Onc breast mrna 70 genes,CPT,RVU2026A,2026
81522,Onc breast mrna 12 genes,CPT,RVU2026A,2026
81523,Onc brst mrna 70 cnt 31 gene,CPT,RVU2026A,2026
81524,"Onc cns tum dna mthyl 10,000",CPT,RVU2026A,2026
81525,Oncology colon mrna,CPT,RVU2026A,2026
81528,Oncology colorectal scr,CPT,RVU2026A,2026
81529,Onc cutan mlnma mrna 31 gene,CPT,RVU2026A,2026
81535,Oncology gynecologic,CPT,RVU2026A,2026
81536,Oncology gynecologic,CPT,RVU2026A,2026
81538,Oncology lung,CPT,RVU2026A,2026
81539,Oncology prostate prob score,CPT,RVU2026A,2026
81540,Oncology tum unknown origin,CPT,RVU2026A,2026
81541,Onc prostate mrna 46 genes,CPT,RVU2026A,2026
81542,Onc prostate mrna 22 cnt gen,CPT,RVU2026A,2026
81546,"Onc thyr mrna 10,196 gen alg",CPT,RVU2026A,2026
81551,Onc prostate 3 genes,CPT,RVU2026A,2026
81552,Onc uveal mlnma mrna 15 gene,CPT,RVU2026A,2026
81554,Pulm ds ipf mrna 190 gen alg,CPT,RVU2026A,2026
81558,Trnspl rej kdn mrna qpcr 139,CPT,RVU2026A,2026
81560,Trnsplj pd lvr&bwl cd154+cll,CPT,RVU2026A,2026
81595,Cardiology hrt trnspl mrna,CPT,RVU2026A,2026
81596,Nfct ds chrnc hcv 6 assays,CPT,RVU2026A,2026
81599,Unlisted maaa,CPT,RVU2026A,2026
82009,Ketone bodys qual,CPT,RVU2026A,2026
82010,Ketone bodys quan,CPT,RVU2026A,2026
82013,Acetylcholinesterase assay,CPT,RVU2026A,2026
82016,Acylcarnitines qual,CPT,RVU2026A,2026
82017,Acylcarnitines quant,CPT,RVU2026A,2026
82024,Assay of acth,CPT,RVU2026A,2026
82030,Assay of adp & amp,CPT,RVU2026A,2026
82040,Assay of serum albumin,CPT,RVU2026A,2026
82042,Other source albumin quan ea,CPT,RVU2026A,2026
82043,Ur albumin quantitative,CPT,RVU2026A,2026
82044,Ur albumin semiquantitative,CPT,RVU2026A,2026
82045,Albumin ischemia modified,CPT,RVU2026A,2026
82075,Assay of breath ethanol,CPT,RVU2026A,2026
82077,Assay spec xcp ur&breath ia,CPT,RVU2026A,2026
82085,Assay of aldolase,CPT,RVU2026A,2026
82088,Assay of aldosterone,CPT,RVU2026A,2026
82103,Alpha-1-antitrypsin total,CPT,RVU2026A,2026
82104,Alpha-1-antitrypsin pheno,CPT,RVU2026A,2026
82105,Alpha-fetoprotein serum,CPT,RVU2026A,2026
82106,Alpha-fetoprotein amniotic,CPT,RVU2026A,2026
82107,Alpha-fetoprotein l3,CPT,RVU2026A,2026
82108,Assay of aluminum,CPT,RVU2026A,2026
82120,Amines vaginal fluid qual,CPT,RVU2026A,2026
82127,Amino acid single qual,CPT,RVU2026A,2026
82128,Amino acids mult qual,CPT,RVU2026A,2026
82131,Amino acids single quant,CPT,RVU2026A,2026
82135,Assay aminolevulinic acid,CPT,RVU2026A,2026
82136,Amino acids quant 2-5,CPT,RVU2026A,2026
82139,Amino acids quan 6 or more,CPT,RVU2026A,2026
82140,Assay of ammonia,CPT,RVU2026A,2026
82143,Amniotic fluid scan,CPT,RVU2026A,2026
82150,Assay of amylase,CPT,RVU2026A,2026
82154,Androstanediol glucuronide,CPT,RVU2026A,2026
82157,Assay of androstenedione,CPT,RVU2026A,2026
82160,Assay of androsterone,CPT,RVU2026A,2026
82163,Assay of angiotensin ii,CPT,RVU2026A,2026
82164,Angiotensin i enzyme test,CPT,RVU2026A,2026
82166,Assay anti-mullerian horm,CPT,RVU2026A,2026
82172,Assay of apolipoprotein,CPT,RVU2026A,2026
82175,Assay of arsenic,CPT,RVU2026A,2026
82180,Assay of ascorbic acid,CPT,RVU2026A,2026
82190,Atomic absorption,CPT,RVU2026A,2026
82232,Assay of beta-2 protein,CPT,RVU2026A,2026
82233,Beta-amyloid 1-40 (abeta 40),CPT,RVU2026A,2026
82234,Beta-amyloid 1-42 (abeta 42),CPT,RVU2026A,2026
82239,Bile acids total,CPT,RVU2026A,2026
82240,Bile acids cholylglycine,CPT,RVU2026A,2026
82247,Bilirubin total,CPT,RVU2026A,2026
82248,Bilirubin direct,CPT,RVU2026A,2026
82252,Fecal bilirubin test,CPT,RVU2026A,2026
82261,Assay of biotinidase,CPT,RVU2026A,2026
82270,Occult blood feces,CPT,RVU2026A,2026
82271,Occult blood other sources,CPT,RVU2026A,2026
82272,Occult bld feces 1-3 tests,CPT,RVU2026A,2026
82274,Assay test for blood fecal,CPT,RVU2026A,2026
82286,Assay of bradykinin,CPT,RVU2026A,2026
82300,Assay of cadmium,CPT,RVU2026A,2026
82306,Vitamin d 25 hydroxy,CPT,RVU2026A,2026
82308,Assay of calcitonin,CPT,RVU2026A,2026
82310,Assay of calcium,CPT,RVU2026A,2026
82330,Assay of calcium,CPT,RVU2026A,2026
82331,Calcium infusion test,CPT,RVU2026A,2026
82340,Assay of calcium in urine,CPT,RVU2026A,2026
82355,Calculus analysis qual,CPT,RVU2026A,2026
82360,Calculus assay quant,CPT,RVU2026A,2026
82365,Calculus spectroscopy,CPT,RVU2026A,2026
82370,X-ray assay calculus,CPT,RVU2026A,2026
82373,Assay c-d transfer measure,CPT,RVU2026A,2026
82374,Assay blood carbon dioxide,CPT,RVU2026A,2026
82375,Assay carboxyhb quant,CPT,RVU2026A,2026
82376,Assay carboxyhb qual,CPT,RVU2026A,2026
82378,Carcinoembryonic antigen,CPT,RVU2026A,2026
82379,Assay of carnitine,CPT,RVU2026A,2026
82380,Assay of carotene,CPT,RVU2026A,2026
82382,Assay urine catecholamines,CPT,RVU2026A,2026
82383,Assay blood catecholamines,CPT,RVU2026A,2026
82384,Assay three catecholamines,CPT,RVU2026A,2026
82387,Assay of cathepsin-d,CPT,RVU2026A,2026
82390,Assay of ceruloplasmin,CPT,RVU2026A,2026
82397,Chemiluminescent assay,CPT,RVU2026A,2026
82415,Assay of chloramphenicol,CPT,RVU2026A,2026
82435,Assay of blood chloride,CPT,RVU2026A,2026
82436,Assay of urine chloride,CPT,RVU2026A,2026
82438,Assay other fluid chlorides,CPT,RVU2026A,2026
82441,Test for chlorohydrocarbons,CPT,RVU2026A,2026
82465,Assay bld/serum cholesterol,CPT,RVU2026A,2026
82480,Assay serum cholinesterase,CPT,RVU2026A,2026
82482,Assay rbc cholinesterase,CPT,RVU2026A,2026
82485,Assay chondroitin sulfate,CPT,RVU2026A,2026
82495,Assay of chromium,CPT,RVU2026A,2026
82507,Assay of citrate,CPT,RVU2026A,2026
82523,Collagen crosslinks,CPT,RVU2026A,2026
82525,Assay of copper,CPT,RVU2026A,2026
82528,Assay of corticosterone,CPT,RVU2026A,2026
82530,Cortisol free,CPT,RVU2026A,2026
82533,Total cortisol,CPT,RVU2026A,2026
82540,Assay of creatine,CPT,RVU2026A,2026
82542,Col chromotography qual/quan,CPT,RVU2026A,2026
82550,Assay of ck (cpk),CPT,RVU2026A,2026
82552,Assay of cpk in blood,CPT,RVU2026A,2026
82553,Creatine mb fraction,CPT,RVU2026A,2026
82554,Creatine isoforms,CPT,RVU2026A,2026
82565,Assay of creatinine,CPT,RVU2026A,2026
82570,Assay of urine creatinine,CPT,RVU2026A,2026
82575,Creatinine clearance test,CPT,RVU2026A,2026
82585,Assay of cryofibrinogen,CPT,RVU2026A,2026
82595,Assay of cryoglobulin,CPT,RVU2026A,2026
82600,Assay of cyanide,CPT,RVU2026A,2026
82607,Vitamin b-12,CPT,RVU2026A,2026
82608,B-12 binding capacity,CPT,RVU2026A,2026
82610,Cystatin c,CPT,RVU2026A,2026
82615,Test for urine cystines,CPT,RVU2026A,2026
82626,Dehydroepiandrosterone,CPT,RVU2026A,2026
82627,Dehydroepiandrosterone,CPT,RVU2026A,2026
82633,Desoxycorticosterone,CPT,RVU2026A,2026
82634,Deoxycortisol,CPT,RVU2026A,2026
82638,Assay of dibucaine number,CPT,RVU2026A,2026
82642,Dihydrotestosterone,CPT,RVU2026A,2026
82652,Vit d 1 25-dihydroxy,CPT,RVU2026A,2026
82653,El-1 fecal quantitative,CPT,RVU2026A,2026
82656,El-1 fecal qual/semiq,CPT,RVU2026A,2026
82657,Enzyme cell activity,CPT,RVU2026A,2026
82658,Enzyme cell activity ra,CPT,RVU2026A,2026
82664,Electrophoretic test,CPT,RVU2026A,2026
82668,Assay of erythropoietin,CPT,RVU2026A,2026
82670,Assay of total estradiol,CPT,RVU2026A,2026
82671,Assay of estrogens,CPT,RVU2026A,2026
82672,Assay of estrogen,CPT,RVU2026A,2026
82677,Assay of estriol,CPT,RVU2026A,2026
82679,Assay of estrone,CPT,RVU2026A,2026
82681,Assay dir meas fr estradiol,CPT,RVU2026A,2026
82693,Assay of ethylene glycol,CPT,RVU2026A,2026
82696,Assay of etiocholanolone,CPT,RVU2026A,2026
82705,Fats/lipids feces qual,CPT,RVU2026A,2026
82710,Fats/lipids feces quant,CPT,RVU2026A,2026
82715,Assay of fecal fat,CPT,RVU2026A,2026
82725,Assay of blood fatty acids,CPT,RVU2026A,2026
82726,Long chain fatty acids,CPT,RVU2026A,2026
82728,Assay of ferritin,CPT,RVU2026A,2026
82731,Assay of fetal fibronectin,CPT,RVU2026A,2026
82735,Assay of fluoride,CPT,RVU2026A,2026
82746,Assay of folic acid serum,CPT,RVU2026A,2026
82747,Assay of folic acid rbc,CPT,RVU2026A,2026
82757,Assay of semen fructose,CPT,RVU2026A,2026
82759,Assay of rbc galactokinase,CPT,RVU2026A,2026
82760,Assay of galactose,CPT,RVU2026A,2026
82775,Assay galactose transferase,CPT,RVU2026A,2026
82776,Galactose transferase test,CPT,RVU2026A,2026
82777,Galectin-3,CPT,RVU2026A,2026
82784,Assay iga/igd/igg/igm each,CPT,RVU2026A,2026
82785,Assay of ige,CPT,RVU2026A,2026
82787,Igg 1 2 3 or 4 each,CPT,RVU2026A,2026
82800,Blood ph,CPT,RVU2026A,2026
82803,Blood gases any combination,CPT,RVU2026A,2026
82805,Blood gases w/o2 saturation,CPT,RVU2026A,2026
82810,Blood gases o2 sat only,CPT,RVU2026A,2026
82820,Hemoglobin-oxygen affinity,CPT,RVU2026A,2026
82930,Gastric analy w/ph ea spec,CPT,RVU2026A,2026
82938,Gastrin test,CPT,RVU2026A,2026
82941,Assay of gastrin,CPT,RVU2026A,2026
82943,Assay of glucagon,CPT,RVU2026A,2026
82945,Glucose other fluid,CPT,RVU2026A,2026
82946,Glucagon tolerance test,CPT,RVU2026A,2026
82947,Assay glucose blood quant,CPT,RVU2026A,2026
82948,Reagent strip/blood glucose,CPT,RVU2026A,2026
82950,Glucose test,CPT,RVU2026A,2026
82951,Glucose tolerance test (gtt),CPT,RVU2026A,2026
82952,Gtt-added samples,CPT,RVU2026A,2026
82955,Assay of g6pd enzyme,CPT,RVU2026A,2026
82960,Test for g6pd enzyme,CPT,RVU2026A,2026
82962,Glucose blood test,CPT,RVU2026A,2026
82963,Assay of glucosidase,CPT,RVU2026A,2026
82965,Assay of gdh enzyme,CPT,RVU2026A,2026
82977,Assay of ggt,CPT,RVU2026A,2026
82978,Assay of glutathione,CPT,RVU2026A,2026
82979,Assay rbc glutathione,CPT,RVU2026A,2026
82985,Assay of glycated protein,CPT,RVU2026A,2026
83001,Assay of gonadotropin (fsh),CPT,RVU2026A,2026
83002,Assay of gonadotropin (lh),CPT,RVU2026A,2026
83003,Assay growth hormone (hgh),CPT,RVU2026A,2026
83006,Growth stimulation gene 2,CPT,RVU2026A,2026
83009,H pylori (c-13) blood,CPT,RVU2026A,2026
83010,Assay of haptoglobin quant,CPT,RVU2026A,2026
83012,Assay of haptoglobins,CPT,RVU2026A,2026
83013,H pylori (c-13) breath,CPT,RVU2026A,2026
83014,H pylori drug admin,CPT,RVU2026A,2026
83015,Heavy metal qual any number,CPT,RVU2026A,2026
83018,Heavy metal quan each nes,CPT,RVU2026A,2026
83020,Hemoglobin electrophoresis,CPT,RVU2026A,2026
83021,Hemoglobin chromotography,CPT,RVU2026A,2026
83026,Hemoglobin copper sulfate,CPT,RVU2026A,2026
83030,Hemoglobin f fetal chemical,CPT,RVU2026A,2026
83033,Hemoglobin ftl f assay qual,CPT,RVU2026A,2026
83036,Hemoglobin glycosylated a1c,CPT,RVU2026A,2026
83037,Hb glycosylated a1c home dev,CPT,RVU2026A,2026
83045,Hgb methemoglobin qual,CPT,RVU2026A,2026
83050,Hgb methemoglobin quan,CPT,RVU2026A,2026
83051,Hemoglobin plasma,CPT,RVU2026A,2026
83060,Hgb sulfhemoglobin quan,CPT,RVU2026A,2026
83065,Hemoglobin thermolabile,CPT,RVU2026A,2026
83068,Hemoglobin unstable screen,CPT,RVU2026A,2026
83069,Hemoglobin urine,CPT,RVU2026A,2026
83070,Assay of hemosiderin qual,CPT,RVU2026A,2026
83080,Assay of b hexosaminidase ea,CPT,RVU2026A,2026
83088,Assay of histamine,CPT,RVU2026A,2026
83090,Assay of homocysteine,CPT,RVU2026A,2026
83150,Assay of homovanillic acid,CPT,RVU2026A,2026
83491,Asy hydroxycorticosteroids17,CPT,RVU2026A,2026
83497,Assay of 5-hiaa,CPT,RVU2026A,2026
83498,Asy hydroxyprogesterone 17-d,CPT,RVU2026A,2026
83500,Assay free hydroxyproline,CPT,RVU2026A,2026
83505,Assay total hydroxyproline,CPT,RVU2026A,2026
83516,Immunoassay nonantibody,CPT,RVU2026A,2026
83518,Immunoassay dipstick,CPT,RVU2026A,2026
83519,Ria nonantibody,CPT,RVU2026A,2026
83520,Immunoassay quant nos nonab,CPT,RVU2026A,2026
83521,Ig light chains free each,CPT,RVU2026A,2026
83525,Assay of insulin,CPT,RVU2026A,2026
83527,Assay of insulin,CPT,RVU2026A,2026
83528,Assay of intrinsic factor,CPT,RVU2026A,2026
83529,Asay of interleukin-6 (il-6),CPT,RVU2026A,2026
83540,Assay of iron,CPT,RVU2026A,2026
83550,Iron binding test,CPT,RVU2026A,2026
83570,Assay of idh enzyme,CPT,RVU2026A,2026
83582,Assay of ketogenic steroids,CPT,RVU2026A,2026
83586,Assay 17- ketosteroids,CPT,RVU2026A,2026
83593,Fractionation ketosteroids,CPT,RVU2026A,2026
83605,Assay of lactic acid,CPT,RVU2026A,2026
83615,Lactate (ld) (ldh) enzyme,CPT,RVU2026A,2026
83625,Assay of ldh enzymes,CPT,RVU2026A,2026
83630,Lactoferrin fecal (qual),CPT,RVU2026A,2026
83631,Lactoferrin fecal (quant),CPT,RVU2026A,2026
83632,Placental lactogen,CPT,RVU2026A,2026
83633,Test urine for lactose,CPT,RVU2026A,2026
83655,Assay of lead,CPT,RVU2026A,2026
83661,L/s ratio fetal lung,CPT,RVU2026A,2026
83662,Foam stability fetal lung,CPT,RVU2026A,2026
83663,Fluoro polarize fetal lung,CPT,RVU2026A,2026
83664,Lamellar bdy fetal lung,CPT,RVU2026A,2026
83670,Assay of lap enzyme,CPT,RVU2026A,2026
83690,Assay of lipase,CPT,RVU2026A,2026
83695,Assay of lipoprotein(a),CPT,RVU2026A,2026
83698,Assay lipoprotein pla2,CPT,RVU2026A,2026
83700,Lipopro bld electrophoretic,CPT,RVU2026A,2026
83701,Lipoprotein bld hr fraction,CPT,RVU2026A,2026
83704,Lipoprotein bld quan part,CPT,RVU2026A,2026
83718,Assay of lipoprotein,CPT,RVU2026A,2026
83719,Assay of blood lipoprotein,CPT,RVU2026A,2026
83721,Assay of blood lipoprotein,CPT,RVU2026A,2026
83722,Lipoprtn dir meas sd ldl chl,CPT,RVU2026A,2026
83727,Assay of lrh hormone,CPT,RVU2026A,2026
83735,Assay of magnesium,CPT,RVU2026A,2026
83775,Assay malate dehydrogenase,CPT,RVU2026A,2026
83785,Assay of manganese,CPT,RVU2026A,2026
83789,Mass spectrometry qual/quan,CPT,RVU2026A,2026
83825,Assay of mercury,CPT,RVU2026A,2026
83835,Assay of metanephrines,CPT,RVU2026A,2026
83857,Assay of methemalbumin,CPT,RVU2026A,2026
83861,Microfluid analy tears,CPT,RVU2026A,2026
83864,Mucopolysaccharides,CPT,RVU2026A,2026
83872,Assay synovial fluid mucin,CPT,RVU2026A,2026
83873,Assay of csf protein,CPT,RVU2026A,2026
83874,Assay of myoglobin,CPT,RVU2026A,2026
83876,Assay myeloperoxidase,CPT,RVU2026A,2026
83880,Assay of natriuretic peptide,CPT,RVU2026A,2026
83883,Assay nephelometry not spec,CPT,RVU2026A,2026
83884,Assay neurflmnt light chain,CPT,RVU2026A,2026
83885,Assay of nickel,CPT,RVU2026A,2026
83915,Assay of nucleotidase,CPT,RVU2026A,2026
83916,Oligoclonal bands,CPT,RVU2026A,2026
83918,Organic acids total quant,CPT,RVU2026A,2026
83919,Organic acids qual each,CPT,RVU2026A,2026
83921,Organic acid single quant,CPT,RVU2026A,2026
83930,Assay of blood osmolality,CPT,RVU2026A,2026
83935,Assay of urine osmolality,CPT,RVU2026A,2026
83937,Assay of osteocalcin,CPT,RVU2026A,2026
83945,Assay of oxalate,CPT,RVU2026A,2026
83950,Oncoprotein her-2/neu,CPT,RVU2026A,2026
83951,Oncoprotein dcp,CPT,RVU2026A,2026
83970,Assay of parathormone,CPT,RVU2026A,2026
83986,Assay ph body fluid nos,CPT,RVU2026A,2026
83987,Exhaled breath condensate,CPT,RVU2026A,2026
83992,Assay for phencyclidine,CPT,RVU2026A,2026
83993,Assay for calprotectin fecal,CPT,RVU2026A,2026
84030,Assay of blood pku,CPT,RVU2026A,2026
84035,Assay of phenylketones,CPT,RVU2026A,2026
84060,Assay acid phosphatase,CPT,RVU2026A,2026
84066,Assay prostate phosphatase,CPT,RVU2026A,2026
84075,Assay alkaline phosphatase,CPT,RVU2026A,2026
84078,Assay alkaline phosphatase,CPT,RVU2026A,2026
84080,Assay alkaline phosphatases,CPT,RVU2026A,2026
84081,Assay phosphatidylglycerol,CPT,RVU2026A,2026
84085,Assay of rbc pg6d enzyme,CPT,RVU2026A,2026
84087,Assay phosphohexose enzymes,CPT,RVU2026A,2026
84100,Assay of phosphorus,CPT,RVU2026A,2026
84105,Assay of urine phosphorus,CPT,RVU2026A,2026
84106,Test for porphobilinogen,CPT,RVU2026A,2026
84110,Assay of porphobilinogen,CPT,RVU2026A,2026
84112,Eval amniotic fluid protein,CPT,RVU2026A,2026
84119,Test urine for porphyrins,CPT,RVU2026A,2026
84120,Assay of urine porphyrins,CPT,RVU2026A,2026
84126,Assay of feces porphyrins,CPT,RVU2026A,2026
84132,Assay of serum potassium,CPT,RVU2026A,2026
84133,Assay of urine potassium,CPT,RVU2026A,2026
84134,Assay of prealbumin,CPT,RVU2026A,2026
84135,Assay of pregnanediol,CPT,RVU2026A,2026
84138,Assay of pregnanetriol,CPT,RVU2026A,2026
84140,Assay of pregnenolone,CPT,RVU2026A,2026
84143,Assay of 17-hydroxypregneno,CPT,RVU2026A,2026
84144,Assay of progesterone,CPT,RVU2026A,2026
84145,Procalcitonin (pct),CPT,RVU2026A,2026
84146,Assay of prolactin,CPT,RVU2026A,2026
84150,Assay of prostaglandin,CPT,RVU2026A,2026
84152,Assay of psa complexed,CPT,RVU2026A,2026
84153,Assay of psa total,CPT,RVU2026A,2026
84154,Assay of psa free,CPT,RVU2026A,2026
84155,Assay of protein serum,CPT,RVU2026A,2026
84156,Assay of protein urine,CPT,RVU2026A,2026
84157,Assay of protein other,CPT,RVU2026A,2026
84160,Assay of protein any source,CPT,RVU2026A,2026
84163,Pappa serum,CPT,RVU2026A,2026
84165,Protein e-phoresis serum,CPT,RVU2026A,2026
84166,Protein e-phoresis/urine/csf,CPT,RVU2026A,2026
84181,Western blot test,CPT,RVU2026A,2026
84182,Protein western blot test,CPT,RVU2026A,2026
84202,Assay rbc protoporphyrin,CPT,RVU2026A,2026
84203,Test rbc protoporphyrin,CPT,RVU2026A,2026
84206,Assay of proinsulin,CPT,RVU2026A,2026
84207,Assay of vitamin b-6,CPT,RVU2026A,2026
84210,Assay of pyruvate,CPT,RVU2026A,2026
84220,Assay of pyruvate kinase,CPT,RVU2026A,2026
84228,Assay of quinine,CPT,RVU2026A,2026
84233,Assay of estrogen,CPT,RVU2026A,2026
84234,Assay of progesterone,CPT,RVU2026A,2026
84235,Assay of endocrine hormone,CPT,RVU2026A,2026
84238,Assay nonendocrine receptor,CPT,RVU2026A,2026
84244,Assay of renin,CPT,RVU2026A,2026
84252,Assay of vitamin b-2,CPT,RVU2026A,2026
84255,Assay of selenium,CPT,RVU2026A,2026
84260,Assay of serotonin,CPT,RVU2026A,2026
84270,Assay of sex hormone globul,CPT,RVU2026A,2026
84275,Assay of sialic acid,CPT,RVU2026A,2026
84285,Assay of silica,CPT,RVU2026A,2026
84295,Assay of serum sodium,CPT,RVU2026A,2026
84300,Assay of urine sodium,CPT,RVU2026A,2026
84302,Assay of sweat sodium,CPT,RVU2026A,2026
84305,Assay of somatomedin,CPT,RVU2026A,2026
84307,Assay of somatostatin,CPT,RVU2026A,2026
84311,Spectrophotometry,CPT,RVU2026A,2026
84315,Body fluid specific gravity,CPT,RVU2026A,2026
84375,Chromatogram assay sugars,CPT,RVU2026A,2026
84376,Sugars single qual,CPT,RVU2026A,2026
84377,Sugars multiple qual,CPT,RVU2026A,2026
84378,Sugars single quant,CPT,RVU2026A,2026
84379,Sugars multiple quant,CPT,RVU2026A,2026
84392,Assay of urine sulfate,CPT,RVU2026A,2026
84393,Tau phosphorylated ea,CPT,RVU2026A,2026
84394,Total tau,CPT,RVU2026A,2026
84402,Assay of free testosterone,CPT,RVU2026A,2026
84403,Assay of total testosterone,CPT,RVU2026A,2026
84410,Testosterone bioavailable,CPT,RVU2026A,2026
84425,Assay of vitamin b-1,CPT,RVU2026A,2026
84430,Assay of thiocyanate,CPT,RVU2026A,2026
84431,Thromboxane urine,CPT,RVU2026A,2026
84432,Assay of thyroglobulin,CPT,RVU2026A,2026
84433,Asy thiopurin s-mthyltrnsfrs,CPT,RVU2026A,2026
84436,Assay of total thyroxine,CPT,RVU2026A,2026
84437,Assay of neonatal thyroxine,CPT,RVU2026A,2026
84439,Assay of free thyroxine,CPT,RVU2026A,2026
84442,Assay of thyroid activity,CPT,RVU2026A,2026
84443,Assay thyroid stim hormone,CPT,RVU2026A,2026
84445,Assay of tsi globulin,CPT,RVU2026A,2026
84446,Assay of vitamin e,CPT,RVU2026A,2026
84449,Assay of transcortin,CPT,RVU2026A,2026
84450,Transferase (ast) (sgot),CPT,RVU2026A,2026
84460,Alanine amino (alt) (sgpt),CPT,RVU2026A,2026
84466,Assay of transferrin,CPT,RVU2026A,2026
84478,Assay of triglycerides,CPT,RVU2026A,2026
84479,Assay of thyroid (t3 or t4),CPT,RVU2026A,2026
84480,Assay triiodothyronine (t3),CPT,RVU2026A,2026
84481,Free assay (ft-3),CPT,RVU2026A,2026
84482,T3 reverse,CPT,RVU2026A,2026
84484,Assay of troponin quant,CPT,RVU2026A,2026
84485,Assay duodenal fluid trypsin,CPT,RVU2026A,2026
84488,Test feces for trypsin,CPT,RVU2026A,2026
84490,Assay of feces for trypsin,CPT,RVU2026A,2026
84510,Assay of tyrosine,CPT,RVU2026A,2026
84512,Assay of troponin qual,CPT,RVU2026A,2026
84520,Assay of urea nitrogen,CPT,RVU2026A,2026
84525,Urea nitrogen semi-quant,CPT,RVU2026A,2026
84540,Assay of urine/urea-n,CPT,RVU2026A,2026
84545,Urea-n clearance test,CPT,RVU2026A,2026
84550,Assay of blood/uric acid,CPT,RVU2026A,2026
84560,Assay of urine/uric acid,CPT,RVU2026A,2026
84577,Assay of feces/urobilinogen,CPT,RVU2026A,2026
84578,Test urine urobilinogen,CPT,RVU2026A,2026
84580,Assay of urine urobilinogen,CPT,RVU2026A,2026
84583,Assay of urine urobilinogen,CPT,RVU2026A,2026
84585,Assay of urine vma,CPT,RVU2026A,2026
84586,Assay of vip,CPT,RVU2026A,2026
84588,Assay of vasopressin,CPT,RVU2026A,2026
84590,Assay of vitamin a,CPT,RVU2026A,2026
84591,Assay of nos vitamin,CPT,RVU2026A,2026
84597,Assay of vitamin k,CPT,RVU2026A,2026
84600,Assay of volatiles,CPT,RVU2026A,2026
84620,Xylose tolerance test,CPT,RVU2026A,2026
84630,Assay of zinc,CPT,RVU2026A,2026
84681,Assay of c-peptide,CPT,RVU2026A,2026
84702,Chorionic gonadotropin test,CPT,RVU2026A,2026
84703,Chorionic gonadotropin assay,CPT,RVU2026A,2026
84704,Hcg free betachain test,CPT,RVU2026A,2026
84830,Ovulation tests,CPT,RVU2026A,2026
84999,Unlisted chemistry procedure,CPT,RVU2026A,2026
85002,Bleeding time test,CPT,RVU2026A,2026
85004,Automated diff wbc count,CPT,RVU2026A,2026
85007,Bl smear w/diff wbc count,CPT,RVU2026A,2026
85008,Bl smear w/o diff wbc count,CPT,RVU2026A,2026
85009,Manual diff wbc count b-coat,CPT,RVU2026A,2026
85013,Spun microhematocrit,CPT,RVU2026A,2026
85014,Hematocrit,CPT,RVU2026A,2026
85018,Hemoglobin,CPT,RVU2026A,2026
85025,Complete cbc w/auto diff wbc,CPT,RVU2026A,2026
85027,Complete cbc automated,CPT,RVU2026A,2026
85032,Manual cell count each,CPT,RVU2026A,2026
85041,Automated rbc count,CPT,RVU2026A,2026
85044,Manual reticulocyte count,CPT,RVU2026A,2026
85045,Automated reticulocyte count,CPT,RVU2026A,2026
85046,Reticyte/hgb concentrate,CPT,RVU2026A,2026
85048,Automated leukocyte count,CPT,RVU2026A,2026
85049,Automated platelet count,CPT,RVU2026A,2026
85055,Reticulated platelet assay,CPT,RVU2026A,2026
85060,Blood smear interpretation,CPT,RVU2026A,2026
85097,Bone marrow interpretation,CPT,RVU2026A,2026
85130,Chromogenic substrate assay,CPT,RVU2026A,2026
85170,Blood clot retraction,CPT,RVU2026A,2026
85175,Blood clot lysis time,CPT,RVU2026A,2026
85210,Clot factor ii prothrom spec,CPT,RVU2026A,2026
85220,Blooc clot factor v test,CPT,RVU2026A,2026
85230,Clot factor vii proconvertin,CPT,RVU2026A,2026
85240,Clot factor viii ahg 1 stage,CPT,RVU2026A,2026
85244,Clot factor viii reltd antgn,CPT,RVU2026A,2026
85245,Clot factor viii vw ristoctn,CPT,RVU2026A,2026
85246,Clot factor viii vw antigen,CPT,RVU2026A,2026
85247,Clot factor viii multimetric,CPT,RVU2026A,2026
85250,Clot factor ix ptc/chrstmas,CPT,RVU2026A,2026
85260,Clot factor x stuart-power,CPT,RVU2026A,2026
85270,Clot factor xi pta,CPT,RVU2026A,2026
85280,Clot factor xii hageman,CPT,RVU2026A,2026
85290,Clot factor xiii fibrin stab,CPT,RVU2026A,2026
85291,Clot factor xiii fibrin scrn,CPT,RVU2026A,2026
85292,Clot factor fletcher fact,CPT,RVU2026A,2026
85293,Clot factor wght kininogen,CPT,RVU2026A,2026
85300,Antithrombin iii activity,CPT,RVU2026A,2026
85301,Antithrombin iii antigen,CPT,RVU2026A,2026
85302,Clot inhibit prot c antigen,CPT,RVU2026A,2026
85303,Clot inhibit prot c activity,CPT,RVU2026A,2026
85305,Clot inhibit prot s total,CPT,RVU2026A,2026
85306,Clot inhibit prot s free,CPT,RVU2026A,2026
85307,Assay activated protein c,CPT,RVU2026A,2026
85335,Factor inhibitor test,CPT,RVU2026A,2026
85337,Thrombomodulin,CPT,RVU2026A,2026
85345,Coagulation time lee & white,CPT,RVU2026A,2026
85347,Coagulation time activated,CPT,RVU2026A,2026
85348,Coagulation time otr method,CPT,RVU2026A,2026
85360,Euglobulin lysis,CPT,RVU2026A,2026
85362,Fibrin degradation products,CPT,RVU2026A,2026
85366,Fibrinogen test,CPT,RVU2026A,2026
85370,Fibrinogen test,CPT,RVU2026A,2026
85378,Fibrin degrade semiquant,CPT,RVU2026A,2026
85379,Fibrin degradation quant,CPT,RVU2026A,2026
85380,Fibrin degradj d-dimer,CPT,RVU2026A,2026
85384,Fibrinogen activity,CPT,RVU2026A,2026
85385,Fibrinogen antigen,CPT,RVU2026A,2026
85390,Fibrinolysins screen i&r,CPT,RVU2026A,2026
85396,Clotting assay whole blood,CPT,RVU2026A,2026
85397,Clotting funct activity,CPT,RVU2026A,2026
85400,Fibrinolytic plasmin,CPT,RVU2026A,2026
85410,Fibrinolytic antiplasmin,CPT,RVU2026A,2026
85415,Fibrinolytic plasminogen,CPT,RVU2026A,2026
85420,Fibrinolytic plasminogen,CPT,RVU2026A,2026
85421,Fibrinolytic plasminogen,CPT,RVU2026A,2026
85441,Heinz bodies direct,CPT,RVU2026A,2026
85445,Heinz bodies induced,CPT,RVU2026A,2026
85460,Hemoglobin fetal,CPT,RVU2026A,2026
85461,Hemoglobin fetal,CPT,RVU2026A,2026
85475,Hemolysin acid,CPT,RVU2026A,2026
85520,Heparin assay,CPT,RVU2026A,2026
85525,Heparin neutralization,CPT,RVU2026A,2026
85530,Heparin-protamine tolerance,CPT,RVU2026A,2026
85536,Iron stain peripheral blood,CPT,RVU2026A,2026
85540,Wbc alkaline phosphatase,CPT,RVU2026A,2026
85547,Rbc mechanical fragility,CPT,RVU2026A,2026
85549,Muramidase,CPT,RVU2026A,2026
85555,Rbc osmotic fragility,CPT,RVU2026A,2026
85557,Rbc osmotic fragility,CPT,RVU2026A,2026
85576,Blood platelet aggregation,CPT,RVU2026A,2026
85597,Phospholipid pltlt neutraliz,CPT,RVU2026A,2026
85598,Hexagnal phosph pltlt neutrl,CPT,RVU2026A,2026
85610,Prothrombin time,CPT,RVU2026A,2026
85611,Prothrombin test,CPT,RVU2026A,2026
85612,Viper venom prothrombin time,CPT,RVU2026A,2026
85613,Russell viper venom diluted,CPT,RVU2026A,2026
85635,Reptilase test,CPT,RVU2026A,2026
85651,Rbc sed rate nonautomated,CPT,RVU2026A,2026
85652,Rbc sed rate automated,CPT,RVU2026A,2026
85660,Rbc sickle cell test,CPT,RVU2026A,2026
85670,Thrombin time plasma,CPT,RVU2026A,2026
85675,Thrombin time titer,CPT,RVU2026A,2026
85705,Thromboplastin inhibition,CPT,RVU2026A,2026
85730,Thromboplastin time partial,CPT,RVU2026A,2026
85732,Thromboplastin time partial,CPT,RVU2026A,2026
85810,Blood viscosity examination,CPT,RVU2026A,2026
85999,Unlisted hematology&coagj px,CPT,RVU2026A,2026
86000,Agglutinins febrile antigen,CPT,RVU2026A,2026
86001,Allergen specific igg,CPT,RVU2026A,2026
86003,Allg spec ige crude xtrc ea,CPT,RVU2026A,2026
86005,Allg spec ige multiallg scr,CPT,RVU2026A,2026
86008,Allg spec ige recomb ea,CPT,RVU2026A,2026
86015,Actin antibody each,CPT,RVU2026A,2026
86021,Wbc antibody identification,CPT,RVU2026A,2026
86022,Platelet antibodies,CPT,RVU2026A,2026
86023,Immunoglobulin assay,CPT,RVU2026A,2026
86036,Anca screen each antibody,CPT,RVU2026A,2026
86037,Anca titer each antibody,CPT,RVU2026A,2026
86038,Antinuclear antibodies,CPT,RVU2026A,2026
86039,Antinuclear antibodies (ana),CPT,RVU2026A,2026
86041,Acetylcholn rcptr bndng antb,CPT,RVU2026A,2026
86042,Acetylcholn rcptr blckg antb,CPT,RVU2026A,2026
86043,Acetylcholn rcptr modlg antb,CPT,RVU2026A,2026
86051,Aquaporin-4 antb elisa,CPT,RVU2026A,2026
86052,Aquaporin-4 antb cba each,CPT,RVU2026A,2026
86053,Aqaprn-4 antb flo cytmtry ea,CPT,RVU2026A,2026
86060,Antistreptolysin o titer,CPT,RVU2026A,2026
86063,Antistreptolysin o screen,CPT,RVU2026A,2026
86077,Phys blood bank serv xmatch,CPT,RVU2026A,2026
86078,Phys blood bank serv reactj,CPT,RVU2026A,2026
86079,Phys blood bank serv authrj,CPT,RVU2026A,2026
86140,C-reactive protein,CPT,RVU2026A,2026
86141,C-reactive protein hs,CPT,RVU2026A,2026
86146,Beta-2 glycoprotein antibody,CPT,RVU2026A,2026
86147,Cardiolipin antibody ea ig,CPT,RVU2026A,2026
86148,Anti-phospholipid antibody,CPT,RVU2026A,2026
86152,Cell enumeration & id,CPT,RVU2026A,2026
86153,Cell enumeration phys interp,CPT,RVU2026A,2026
86155,Chemotaxis assay,CPT,RVU2026A,2026
86156,Cold agglutinin screen,CPT,RVU2026A,2026
86157,Cold agglutinin titer,CPT,RVU2026A,2026
86160,Complement antigen,CPT,RVU2026A,2026
86161,Complement/function activity,CPT,RVU2026A,2026
86162,Complement total (ch50),CPT,RVU2026A,2026
86171,Complement fixation each,CPT,RVU2026A,2026
86200,Ccp antibody,CPT,RVU2026A,2026
86215,Deoxyribonuclease antibody,CPT,RVU2026A,2026
86225,Dna antibody native,CPT,RVU2026A,2026
86226,Dna antibody single strand,CPT,RVU2026A,2026
86231,Ema each ig class,CPT,RVU2026A,2026
86235,Nuclear antigen antibody,CPT,RVU2026A,2026
86255,Fluorescent antibody screen,CPT,RVU2026A,2026
86256,Fluorescent antibody titer,CPT,RVU2026A,2026
86258,Dgp antibody each ig class,CPT,RVU2026A,2026
86277,Growth hormone antibody,CPT,RVU2026A,2026
86280,Hemagglutination inhibition,CPT,RVU2026A,2026
86294,Immunoassay tumor qual,CPT,RVU2026A,2026
86300,Immunoassay tumor ca 15-3,CPT,RVU2026A,2026
86301,Immunoassay tumor ca 19-9,CPT,RVU2026A,2026
86304,Immunoassay tumor ca 125,CPT,RVU2026A,2026
86305,Human epididymis protein 4,CPT,RVU2026A,2026
86308,Heterophile antibody screen,CPT,RVU2026A,2026
86309,Heterophile antibody titer,CPT,RVU2026A,2026
86310,Heterophile antibody absrbj,CPT,RVU2026A,2026
86316,Immunoassay tumor other,CPT,RVU2026A,2026
86317,Immunoassay infectious agent,CPT,RVU2026A,2026
86318,Ia infectious agent antibody,CPT,RVU2026A,2026
86320,Serum immunoelectrophoresis,CPT,RVU2026A,2026
86325,Other immunoelectrophoresis,CPT,RVU2026A,2026
86328,Ia nfct ab sarscov2 covid19,CPT,RVU2026A,2026
86329,Immunodiffusion nes,CPT,RVU2026A,2026
86331,Immunodiffusion ouchterlony,CPT,RVU2026A,2026
86332,Immune complex assay,CPT,RVU2026A,2026
86334,Immunofix e-phoresis serum,CPT,RVU2026A,2026
86335,Immunfix e-phorsis/urine/csf,CPT,RVU2026A,2026
86336,Inhibin a,CPT,RVU2026A,2026
86337,Insulin antibodies,CPT,RVU2026A,2026
86340,Intrinsic factor antibody,CPT,RVU2026A,2026
86341,Islet cell antibody,CPT,RVU2026A,2026
86343,Leukocyte histamine release,CPT,RVU2026A,2026
86344,Leukocyte phagocytosis,CPT,RVU2026A,2026
86352,Cell function assay w/stim,CPT,RVU2026A,2026
86353,Lymphocyte transformation,CPT,RVU2026A,2026
86355,B cells total count,CPT,RVU2026A,2026
86356,Mononuclear cell antigen,CPT,RVU2026A,2026
86357,Nk cells total count,CPT,RVU2026A,2026
86359,T cells total count,CPT,RVU2026A,2026
86360,T cell absolute count/ratio,CPT,RVU2026A,2026
86361,T cell absolute count,CPT,RVU2026A,2026
86362,Mog-igg1 antb cba each,CPT,RVU2026A,2026
86363,Mog-igg1 antb flo cytmtry ea,CPT,RVU2026A,2026
86364,Tiss trnsgltmnase ea ig clas,CPT,RVU2026A,2026
86366,Muscle-specific kinase antb,CPT,RVU2026A,2026
86367,Stem cells total count,CPT,RVU2026A,2026
86376,Microsomal antibody each,CPT,RVU2026A,2026
86381,Mitochondrial antibody each,CPT,RVU2026A,2026
86382,Neutralization test viral,CPT,RVU2026A,2026
86384,Nitroblue tetrazolium dye,CPT,RVU2026A,2026
86386,Nuclear matrix protein 22,CPT,RVU2026A,2026
86403,Particle agglut antbdy scrn,CPT,RVU2026A,2026
86406,Particle agglut antbdy titr,CPT,RVU2026A,2026
86408,Neutrlzg antb sarscov2 scr,CPT,RVU2026A,2026
86409,Neutrlzg antb sarscov2 titer,CPT,RVU2026A,2026
86413,Sars-cov-2 antb quantitative,CPT,RVU2026A,2026
86430,Rheumatoid factor test qual,CPT,RVU2026A,2026
86431,Rheumatoid factor quant,CPT,RVU2026A,2026
86480,Tb test cell immun measure,CPT,RVU2026A,2026
86481,Tb ag response t-cell susp,CPT,RVU2026A,2026
86485,Skin test candida,CPT,RVU2026A,2026
86486,Skin test unlisted antign ea,CPT,RVU2026A,2026
86510,Histoplasmosis skin test,CPT,RVU2026A,2026
86580,Tb intradermal test,CPT,RVU2026A,2026
86581,Strptcs pneum antb serot ia,CPT,RVU2026A,2026
86590,Streptokinase antibody,CPT,RVU2026A,2026
86592,Syphilis test non-trep qual,CPT,RVU2026A,2026
86593,Syphilis test non-trep quant,CPT,RVU2026A,2026
86596,Voltage-gtd ca chnl antb ea,CPT,RVU2026A,2026
86602,Antinomyces antibody,CPT,RVU2026A,2026
86603,Adenovirus antibody,CPT,RVU2026A,2026
86606,Aspergillus antibody,CPT,RVU2026A,2026
86609,Bacterium antibody,CPT,RVU2026A,2026
86611,Bartonella antibody,CPT,RVU2026A,2026
86612,Blastomyces antibody,CPT,RVU2026A,2026
86615,Bordetella antibody,CPT,RVU2026A,2026
86617,Lyme disease antibody,CPT,RVU2026A,2026
86618,Lyme disease antibody,CPT,RVU2026A,2026
86619,Borrelia antibody,CPT,RVU2026A,2026
86622,Brucella antibody,CPT,RVU2026A,2026
86625,Campylobacter antibody,CPT,RVU2026A,2026
86628,Candida antibody,CPT,RVU2026A,2026
86631,Chlamydia antibody,CPT,RVU2026A,2026
86632,Chlamydia igm antibody,CPT,RVU2026A,2026
86635,Coccidioides antibody,CPT,RVU2026A,2026
86638,Q fever antibody,CPT,RVU2026A,2026
86641,Cryptococcus antibody,CPT,RVU2026A,2026
86644,Cmv antibody,CPT,RVU2026A,2026
86645,Cmv antibody igm,CPT,RVU2026A,2026
86648,Diphtheria antibody,CPT,RVU2026A,2026
86651,Encephalitis californ antbdy,CPT,RVU2026A,2026
86652,Encephaltis east eqne anbdy,CPT,RVU2026A,2026
86653,Encephaltis st louis antbody,CPT,RVU2026A,2026
86654,Encephaltis west eqne antbdy,CPT,RVU2026A,2026
86658,Enterovirus antibody,CPT,RVU2026A,2026
86663,Epstein-barr antibody,CPT,RVU2026A,2026
86664,Epstein-barr nuclear antigen,CPT,RVU2026A,2026
86665,Epstein-barr capsid vca,CPT,RVU2026A,2026
86666,Ehrlichia antibody,CPT,RVU2026A,2026
86668,Francisella tularensis,CPT,RVU2026A,2026
86671,Fungus nes antibody,CPT,RVU2026A,2026
86674,Giardia lamblia antibody,CPT,RVU2026A,2026
86677,Helicobacter pylori antibody,CPT,RVU2026A,2026
86682,Helminth antibody,CPT,RVU2026A,2026
86684,Hemophilus influenza antibdy,CPT,RVU2026A,2026
86687,Htlv-i antibody,CPT,RVU2026A,2026
86688,Htlv-ii antibody,CPT,RVU2026A,2026
86689,Htlv/hiv confirmj antibody,CPT,RVU2026A,2026
86692,Hepatitis delta agent antbdy,CPT,RVU2026A,2026
86694,Herpes simplex nes antbdy,CPT,RVU2026A,2026
86695,Herpes simplex type 1 test,CPT,RVU2026A,2026
86696,Herpes simplex type 2 test,CPT,RVU2026A,2026
86698,Histoplasma antibody,CPT,RVU2026A,2026
86701,Hiv-1antibody,CPT,RVU2026A,2026
86702,Hiv-2 antibody,CPT,RVU2026A,2026
86703,Hiv-1/hiv-2 1 result antbdy,CPT,RVU2026A,2026
86704,Hep b core antibody total,CPT,RVU2026A,2026
86705,Hep b core antibody igm,CPT,RVU2026A,2026
86706,Hep b surface antibody,CPT,RVU2026A,2026
86707,Hepatitis be antibody,CPT,RVU2026A,2026
86708,Hepatitis a antibody,CPT,RVU2026A,2026
86709,Hepatitis a igm antibody,CPT,RVU2026A,2026
86710,Influenza virus antibody,CPT,RVU2026A,2026
86711,John cunningham antibody,CPT,RVU2026A,2026
86713,Legionella antibody,CPT,RVU2026A,2026
86717,Leishmania antibody,CPT,RVU2026A,2026
86720,Leptospira antibody,CPT,RVU2026A,2026
86723,Listeria monocytogenes,CPT,RVU2026A,2026
86727,Lymph choriomeningitis ab,CPT,RVU2026A,2026
86732,Mucormycosis antibody,CPT,RVU2026A,2026
86735,Mumps antibody,CPT,RVU2026A,2026
86738,Mycoplasma antibody,CPT,RVU2026A,2026
86741,Neisseria meningitidis,CPT,RVU2026A,2026
86744,Nocardia antibody,CPT,RVU2026A,2026
86747,Parvovirus antibody,CPT,RVU2026A,2026
86750,Malaria antibody,CPT,RVU2026A,2026
86753,Protozoa antibody nos,CPT,RVU2026A,2026
86756,Respiratory virus antibody,CPT,RVU2026A,2026
86757,Rickettsia antibody,CPT,RVU2026A,2026
86759,Rotavirus antibody,CPT,RVU2026A,2026
86762,Rubella antibody,CPT,RVU2026A,2026
86765,Rubeola antibody,CPT,RVU2026A,2026
86768,Salmonella antibody,CPT,RVU2026A,2026
86769,Sars-cov-2 covid-19 antibody,CPT,RVU2026A,2026
86771,Shigella antibody,CPT,RVU2026A,2026
86774,Tetanus antibody,CPT,RVU2026A,2026
86777,Toxoplasma antibody,CPT,RVU2026A,2026
86778,Toxoplasma antibody igm,CPT,RVU2026A,2026
86780,Treponema pallidum,CPT,RVU2026A,2026
86784,Trichinella antibody,CPT,RVU2026A,2026
86787,Varicella-zoster antibody,CPT,RVU2026A,2026
86788,West nile virus ab igm,CPT,RVU2026A,2026
86789,West nile virus antibody,CPT,RVU2026A,2026
86790,Virus antibody nos,CPT,RVU2026A,2026
86793,Yersinia antibody,CPT,RVU2026A,2026
86794,Zika virus igm antibody,CPT,RVU2026A,2026
86800,Thyroglobulin antibody,CPT,RVU2026A,2026
86803,Hepatitis c ab test,CPT,RVU2026A,2026
86804,Hep c ab test confirm,CPT,RVU2026A,2026
86805,Lymphocytotoxicity assay,CPT,RVU2026A,2026
86806,Lymphocytotoxicity assay,CPT,RVU2026A,2026
86807,Cytotoxic antibody screening,CPT,RVU2026A,2026
86808,Cytotoxic antibody screening,CPT,RVU2026A,2026
86812,Hla typing a b or c,CPT,RVU2026A,2026
86813,Hla typing a b or c,CPT,RVU2026A,2026
86816,Hla typing dr/dq,CPT,RVU2026A,2026
86817,Hla typing dr/dq,CPT,RVU2026A,2026
86821,Lymphocyte culture mixed,CPT,RVU2026A,2026
86825,Hla x-math non-cytotoxic,CPT,RVU2026A,2026
86826,Hla x-match noncytotoxc addl,CPT,RVU2026A,2026
86828,Hla class i&ii antibody qual,CPT,RVU2026A,2026
86829,Hla class i/ii antibody qual,CPT,RVU2026A,2026
86830,Hla class i phenotype qual,CPT,RVU2026A,2026
86831,Hla class ii phenotype qual,CPT,RVU2026A,2026
86832,Hla class i high defin qual,CPT,RVU2026A,2026
86833,Hla class ii high defin qual,CPT,RVU2026A,2026
86834,Hla class i semiquant panel,CPT,RVU2026A,2026
86835,Hla class ii semiquant panel,CPT,RVU2026A,2026
86849,Immunology procedure,CPT,RVU2026A,2026
86850,Rbc antibody screen,CPT,RVU2026A,2026
86860,Rbc antibody elution,CPT,RVU2026A,2026
86870,Rbc antibody identification,CPT,RVU2026A,2026
86880,Coombs test direct,CPT,RVU2026A,2026
86885,Coombs test indirect qual,CPT,RVU2026A,2026
86886,Coombs test indirect titer,CPT,RVU2026A,2026
86890,Autologous blood process,CPT,RVU2026A,2026
86891,Autologous blood op salvage,CPT,RVU2026A,2026
86900,Blood typing serologic abo,CPT,RVU2026A,2026
86901,Blood typing serologic rh(d),CPT,RVU2026A,2026
86902,Blood type antigen donor ea,CPT,RVU2026A,2026
86904,Blood typing patient serum,CPT,RVU2026A,2026
86905,Blood typing rbc antigens,CPT,RVU2026A,2026
86906,Bld typing serologic rh phnt,CPT,RVU2026A,2026
86910,Blood typing paternity test,CPT,RVU2026A,2026
86911,Blood typing antigen system,CPT,RVU2026A,2026
86920,Compatibility test spin,CPT,RVU2026A,2026
86921,Compatibility test incubate,CPT,RVU2026A,2026
86922,Compatibility test antiglob,CPT,RVU2026A,2026
86923,Compatibility test electric,CPT,RVU2026A,2026
86927,Plasma fresh frozen,CPT,RVU2026A,2026
86930,Frozen blood prep,CPT,RVU2026A,2026
86931,Frozen blood thaw,CPT,RVU2026A,2026
86932,Frozen blood freeze/thaw,CPT,RVU2026A,2026
86940,Hemolysins/agglutinins auto,CPT,RVU2026A,2026
86941,Hemolysins/agglutinins,CPT,RVU2026A,2026
86945,Blood product/irradiation,CPT,RVU2026A,2026
86950,Leukacyte transfusion,CPT,RVU2026A,2026
86960,Vol reduction of blood/prod,CPT,RVU2026A,2026
86965,Pooling blood platelets,CPT,RVU2026A,2026
86970,Rbc pretx incubatj w/chemicl,CPT,RVU2026A,2026
86971,Rbc pretx incubatj w/enzymes,CPT,RVU2026A,2026
86972,Rbc pretx incubatj w/density,CPT,RVU2026A,2026
86975,Rbc serum pretx incubj drugs,CPT,RVU2026A,2026
86976,Rbc serum pretx id dilution,CPT,RVU2026A,2026
86977,Rbc serum pretx incubj/inhib,CPT,RVU2026A,2026
86978,Rbc pretreatment serum,CPT,RVU2026A,2026
86985,Split blood or products,CPT,RVU2026A,2026
86999,Unlisted transfusion med px,CPT,RVU2026A,2026
87003,Small animal inoculation,CPT,RVU2026A,2026
87015,Specimen infect agnt concntj,CPT,RVU2026A,2026
87040,Blood culture for bacteria,CPT,RVU2026A,2026
87045,Feces culture aerobic bact,CPT,RVU2026A,2026
87046,Stool cultr aerobic bact ea,CPT,RVU2026A,2026
87070,Culture othr specimn aerobic,CPT,RVU2026A,2026
87071,Culture aerobic quant other,CPT,RVU2026A,2026
87073,Culture bacteria anaerobic,CPT,RVU2026A,2026
87075,Cultr bacteria except blood,CPT,RVU2026A,2026
87076,Culture anaerobe ident each,CPT,RVU2026A,2026
87077,Culture aerobic identify,CPT,RVU2026A,2026
87081,Culture screen only,CPT,RVU2026A,2026
87084,Culture of specimen by kit,CPT,RVU2026A,2026
87086,Urine culture/colony count,CPT,RVU2026A,2026
87088,Urine bacteria culture,CPT,RVU2026A,2026
87101,Skin fungi culture,CPT,RVU2026A,2026
87102,Fungus isolation culture,CPT,RVU2026A,2026
87103,Blood fungus culture,CPT,RVU2026A,2026
87106,Fungi identification yeast,CPT,RVU2026A,2026
87107,Fungi identification mold,CPT,RVU2026A,2026
87109,Mycoplasma,CPT,RVU2026A,2026
87110,Chlamydia culture,CPT,RVU2026A,2026
87116,Mycobacteria culture,CPT,RVU2026A,2026
87118,Mycobacteric identification,CPT,RVU2026A,2026
87140,Culture type immunofluoresc,CPT,RVU2026A,2026
87143,Culture typing glc/hplc,CPT,RVU2026A,2026
87147,Culture type immunologic,CPT,RVU2026A,2026
87149,Dna/rna direct probe,CPT,RVU2026A,2026
87150,Dna/rna amplified probe,CPT,RVU2026A,2026
87152,Culture type pulse field gel,CPT,RVU2026A,2026
87153,Dna/rna sequencing,CPT,RVU2026A,2026
87154,Cul typ id bld pthgn 6+ trgt,CPT,RVU2026A,2026
87158,Culture typing added method,CPT,RVU2026A,2026
87164,Dark field exam spec collj,CPT,RVU2026A,2026
87166,Dark field exam w/o collj,CPT,RVU2026A,2026
87168,Macroscopic exam arthropod,CPT,RVU2026A,2026
87169,Macroscopic exam parasite,CPT,RVU2026A,2026
87172,Pinworm exam,CPT,RVU2026A,2026
87176,Tissue homogenization cultr,CPT,RVU2026A,2026
87177,Ova and parasites smears,CPT,RVU2026A,2026
87181,Sc std agar dilution per agt,CPT,RVU2026A,2026
87182,Sc std carbapenemase nzm det,CPT,RVU2026A,2026
87183,Sc std carbapenem resist gen,CPT,RVU2026A,2026
87184,Sc std disk method per plate,CPT,RVU2026A,2026
87185,Sc std enzyme detcj per nzm,CPT,RVU2026A,2026
87186,Sc std microdil/agar dil,CPT,RVU2026A,2026
87187,Sc std microdil/agar mlc,CPT,RVU2026A,2026
87188,Sc std macrobroth dil meth,CPT,RVU2026A,2026
87190,Sc std myobacteria prop meth,CPT,RVU2026A,2026
87197,Serum bactericidal titer,CPT,RVU2026A,2026
87205,Smear gram stain,CPT,RVU2026A,2026
87206,Smear fluorescent/acid stai,CPT,RVU2026A,2026
87207,Smear special stain,CPT,RVU2026A,2026
87209,Smear complex stain,CPT,RVU2026A,2026
87210,Smear wet mount saline/ink,CPT,RVU2026A,2026
87220,Tissue exam for fungi,CPT,RVU2026A,2026
87230,Toxin/antitoxin asy tiss cul,CPT,RVU2026A,2026
87250,Virus inoculate eggs/animal,CPT,RVU2026A,2026
87252,Virus inoculation tissue,CPT,RVU2026A,2026
87253,Virus inoculate tissue addl,CPT,RVU2026A,2026
87254,Virus inoculation shell via,CPT,RVU2026A,2026
87255,Genet virus isolate hsv,CPT,RVU2026A,2026
87260,Adenovirus ag if,CPT,RVU2026A,2026
87265,Pertussis ag if,CPT,RVU2026A,2026
87267,Enterovirus antibody dfa,CPT,RVU2026A,2026
87269,Giardia ag if,CPT,RVU2026A,2026
87270,Chlamydia trachomatis ag if,CPT,RVU2026A,2026
87271,Cytomegalovirus dfa,CPT,RVU2026A,2026
87272,Cryptosporidium ag if,CPT,RVU2026A,2026
87273,Herpes simplex 2 ag if,CPT,RVU2026A,2026
87274,Herpes simplex 1 ag if,CPT,RVU2026A,2026
87275,Influenza b ag if,CPT,RVU2026A,2026
87276,Influenza a ag if,CPT,RVU2026A,2026
87278,Legion pneumophilia ag if,CPT,RVU2026A,2026
87279,Parainfluenza ag if,CPT,RVU2026A,2026
87280,Respiratory syncytial ag if,CPT,RVU2026A,2026
87281,Pneumocystis carinii ag if,CPT,RVU2026A,2026
87283,Rubeola ag if,CPT,RVU2026A,2026
87285,Treponema pallidum ag if,CPT,RVU2026A,2026
87290,Varicella zoster ag if,CPT,RVU2026A,2026
87299,Antibody detection nos if,CPT,RVU2026A,2026
87300,Ag detection polyval if,CPT,RVU2026A,2026
87301,Adenovirus ag ia,CPT,RVU2026A,2026
87305,Aspergillus ag ia,CPT,RVU2026A,2026
87320,Chlmyd trach ag ia,CPT,RVU2026A,2026
87324,Clostridium ag ia,CPT,RVU2026A,2026
87327,Cryptococcus neoform ag ia,CPT,RVU2026A,2026
87328,Cryptosporidium ag ia,CPT,RVU2026A,2026
87329,Giardia ag ia,CPT,RVU2026A,2026
87332,Cytomegalovirus ag ia,CPT,RVU2026A,2026
87335,E coli 0157 ag ia,CPT,RVU2026A,2026
87336,Entamoeb hist dispr ag ia,CPT,RVU2026A,2026
87337,Entamoeb hist group ag ia,CPT,RVU2026A,2026
87338,Hpylori stool ag ia,CPT,RVU2026A,2026
87339,H pylori ag ia,CPT,RVU2026A,2026
87340,Hepatitis b surface ag ia,CPT,RVU2026A,2026
87341,Hep b surface ag neutrlzj ia,CPT,RVU2026A,2026
87350,Hepatitis be ag ia,CPT,RVU2026A,2026
87380,Hepatitis delta agent ag ia,CPT,RVU2026A,2026
87385,Histoplasma capsul ag ia,CPT,RVU2026A,2026
87389,Hiv-1 ag w/hiv-1&-2 ab ag ia,CPT,RVU2026A,2026
87390,Hiv-1 ag ia,CPT,RVU2026A,2026
87391,Hiv-2 ag ia,CPT,RVU2026A,2026
87400,Influenza a/b each ag ia,CPT,RVU2026A,2026
87420,Resp syncytial virus ag ia,CPT,RVU2026A,2026
87425,Rotavirus ag ia,CPT,RVU2026A,2026
87426,Sarscov coronavirus ag ia,CPT,RVU2026A,2026
87427,Shiga-like toxin ag ia,CPT,RVU2026A,2026
87428,Sarscov & inf vir a&b ag ia,CPT,RVU2026A,2026
87430,Strep a ag ia,CPT,RVU2026A,2026
87449,Nos each organism ag ia,CPT,RVU2026A,2026
87451,Polyvalent mult org ea ag ia,CPT,RVU2026A,2026
87467,Hepatitis b surface ag quan,CPT,RVU2026A,2026
87468,Anaplsma phgcytophlm amp prb,CPT,RVU2026A,2026
87469,Babesia microti amp prb,CPT,RVU2026A,2026
87471,Bartonella dna amp probe,CPT,RVU2026A,2026
87472,Bartonella dna quant,CPT,RVU2026A,2026
87475,Lyme dis dna dir probe,CPT,RVU2026A,2026
87476,Lyme dis dna amp probe,CPT,RVU2026A,2026
87478,Borrelia miyamotoi amp prb,CPT,RVU2026A,2026
87480,Candida dna dir probe,CPT,RVU2026A,2026
87481,Candida dna amp probe,CPT,RVU2026A,2026
87482,Candida dna quant,CPT,RVU2026A,2026
87483,Cns dna amp probe type 12-25,CPT,RVU2026A,2026
87484,Ehrlicha chaffeensis amp prb,CPT,RVU2026A,2026
87485,Chlmyd pneum dna dir probe,CPT,RVU2026A,2026
87486,Chlmyd pneum dna amp probe,CPT,RVU2026A,2026
87487,Chlmyd pneum dna quant,CPT,RVU2026A,2026
87490,Chlmyd trach dna dir probe,CPT,RVU2026A,2026
87491,Chlmyd trach dna amp probe,CPT,RVU2026A,2026
87492,Chlmyd trach dna quant,CPT,RVU2026A,2026
87493,C diff amplified probe,CPT,RVU2026A,2026
87494,Chlmy trch&neisra gonor mult,CPT,RVU2026A,2026
87495,Cytomeg dna dir probe,CPT,RVU2026A,2026
87496,Cytomeg dna amp probe,CPT,RVU2026A,2026
87497,Cytomeg dna quant,CPT,RVU2026A,2026
87498,Enterovirus probe&revrs trns,CPT,RVU2026A,2026
87500,Vanomycin dna amp probe,CPT,RVU2026A,2026
87501,Influenza dna amp prob 1+,CPT,RVU2026A,2026
87502,Influenza dna amp probe,CPT,RVU2026A,2026
87503,Influenza dna amp prob addl,CPT,RVU2026A,2026
87505,Nfct agent detection gi,CPT,RVU2026A,2026
87506,Iadna-dna/rna probe tq 6-11,CPT,RVU2026A,2026
87507,Iadna-dna/rna probe tq 12-25,CPT,RVU2026A,2026
87510,Gardner vag dna dir probe,CPT,RVU2026A,2026
87511,Gardner vag dna amp probe,CPT,RVU2026A,2026
87512,Gardner vag dna quant,CPT,RVU2026A,2026
87513,H pylri clrthmcn rst amp prb,CPT,RVU2026A,2026
87516,Hepatitis b dna amp probe,CPT,RVU2026A,2026
87517,Hepatitis b dna quant,CPT,RVU2026A,2026
87520,Hepatitis c rna dir probe,CPT,RVU2026A,2026
87521,Hepatitis c probe&rvrs trnsc,CPT,RVU2026A,2026
87522,Hepatitis c revrs trnscrpj,CPT,RVU2026A,2026
87523,Hepatitis d quantification,CPT,RVU2026A,2026
87525,Hepatitis g dna dir probe,CPT,RVU2026A,2026
87526,Hepatitis g dna amp probe,CPT,RVU2026A,2026
87527,Hepatitis g dna quant,CPT,RVU2026A,2026
87528,Hsv dna dir probe,CPT,RVU2026A,2026
87529,Hsv dna amp probe,CPT,RVU2026A,2026
87530,Hsv dna quant,CPT,RVU2026A,2026
87531,Hhv-6 dna dir probe,CPT,RVU2026A,2026
87532,Hhv-6 dna amp probe,CPT,RVU2026A,2026
87533,Hhv-6 dna quant,CPT,RVU2026A,2026
87534,Hiv-1 dna dir probe,CPT,RVU2026A,2026
87535,Hiv-1 probe&reverse trnscrpj,CPT,RVU2026A,2026
87536,Hiv-1 quant&revrse trnscrpj,CPT,RVU2026A,2026
87537,Hiv-2 dna dir probe,CPT,RVU2026A,2026
87538,Hiv-2 probe&revrse trnscripj,CPT,RVU2026A,2026
87539,Hiv-2 quant&revrse trnscripj,CPT,RVU2026A,2026
87540,Legion pneumo dna dir prob,CPT,RVU2026A,2026
87541,Legion pneumo dna amp prob,CPT,RVU2026A,2026
87542,Legion pneumo dna quant,CPT,RVU2026A,2026
87550,Mycobacteria dna dir probe,CPT,RVU2026A,2026
87551,Mycobacteria dna amp probe,CPT,RVU2026A,2026
87552,Mycobacteria dna quant,CPT,RVU2026A,2026
87555,M.tuberculo dna dir probe,CPT,RVU2026A,2026
87556,M.tuberculo dna amp probe,CPT,RVU2026A,2026
87557,M.tuberculo dna quant,CPT,RVU2026A,2026
87560,M.avium-intra dna dir prob,CPT,RVU2026A,2026
87561,M.avium-intra dna amp prob,CPT,RVU2026A,2026
87562,M.avium-intra dna quant,CPT,RVU2026A,2026
87563,M. genitalium amp probe,CPT,RVU2026A,2026
87564,Mtb rifampin rst amp prb tq,CPT,RVU2026A,2026
87580,M.pneumon dna dir probe,CPT,RVU2026A,2026
87581,M.pneumon dna amp probe,CPT,RVU2026A,2026
87582,M.pneumon dna quant,CPT,RVU2026A,2026
87590,N.gonorrhoeae dna dir prob,CPT,RVU2026A,2026
87591,N.gonorrhoeae dna amp prob,CPT,RVU2026A,2026
87592,N.gonorrhoeae dna quant,CPT,RVU2026A,2026
87593,Orthopoxvirus amp prb each,CPT,RVU2026A,2026
87594,Pneumcysts jirovecii amp prb,CPT,RVU2026A,2026
87623,Hpv low-risk types,CPT,RVU2026A,2026
87624,Hpv hi-risk typ pooled rslt,CPT,RVU2026A,2026
87625,Hpv types 16 & 18 only,CPT,RVU2026A,2026
87626,Hpv sep hi-rsk typ&pool rslt,CPT,RVU2026A,2026
87627,Jt spc pthgn&rx rsist gen26+,CPT,RVU2026A,2026
87631,Resp virus 3-5 targets,CPT,RVU2026A,2026
87632,Resp virus 6-11 targets,CPT,RVU2026A,2026
87633,Resp virus 12-25 targets,CPT,RVU2026A,2026
87634,Rsv dna/rna amp probe,CPT,RVU2026A,2026
87635,Sars-cov-2 covid-19 amp prb,CPT,RVU2026A,2026
87636,Sarscov2 & inf a&b amp prb,CPT,RVU2026A,2026
87637,Sarscov2&inf a&b&rsv amp prb,CPT,RVU2026A,2026
87640,Staph a dna amp probe,CPT,RVU2026A,2026
87641,Mr-staph dna amp probe,CPT,RVU2026A,2026
87650,Strep a dna dir probe,CPT,RVU2026A,2026
87651,Strep a dna amp probe,CPT,RVU2026A,2026
87652,Strep a dna quant,CPT,RVU2026A,2026
87653,Strep b dna amp probe,CPT,RVU2026A,2026
87660,Trichomonas vagin dir probe,CPT,RVU2026A,2026
87661,Trichomonas vaginalis amplif,CPT,RVU2026A,2026
87662,Zika virus dna/rna amp probe,CPT,RVU2026A,2026
87797,Detect agent nos dna dir,CPT,RVU2026A,2026
87798,Detect agent nos dna amp,CPT,RVU2026A,2026
87799,Detect agent nos dna quant,CPT,RVU2026A,2026
87800,Detect agnt mult dna direc,CPT,RVU2026A,2026
87801,Detect agnt mult dna ampli,CPT,RVU2026A,2026
87802,Strep b assay w/optic,CPT,RVU2026A,2026
87803,Clostridium toxin a w/optic,CPT,RVU2026A,2026
87804,Influenza assay w/optic,CPT,RVU2026A,2026
87806,Hiv ag w/hiv1&2 antb w/optic,CPT,RVU2026A,2026
87807,Rsv assay w/optic,CPT,RVU2026A,2026
87808,Trichomonas assay w/optic,CPT,RVU2026A,2026
87809,Adenovirus assay w/optic,CPT,RVU2026A,2026
87810,Chlmyd trach assay w/optic,CPT,RVU2026A,2026
87811,Sars-cov-2 covid19 w/optic,CPT,RVU2026A,2026
87812,Sarscov2&inf typ a&b w/optic,CPT,RVU2026A,2026
87850,N. gonorrhoeae assay w/optic,CPT,RVU2026A,2026
87880,Strep a assay w/optic,CPT,RVU2026A,2026
87899,Agent nos assay w/optic,CPT,RVU2026A,2026
87900,Phenotype infect agent drug,CPT,RVU2026A,2026
87901,Nfct agt gntyp alys hiv1 rev,CPT,RVU2026A,2026
87902,Nfct agt gntyp alys hep c,CPT,RVU2026A,2026
87903,Phenotype dna hiv w/culture,CPT,RVU2026A,2026
87904,Phenotype dna hiv w/clt add,CPT,RVU2026A,2026
87905,Ia nzmtc actv oth/thn virus,CPT,RVU2026A,2026
87906,Nfct agt gntyp alys hiv1,CPT,RVU2026A,2026
87910,Nfct agt gntyp alys cmv,CPT,RVU2026A,2026
87912,Nfct agt gntyp alys hep b,CPT,RVU2026A,2026
87913,Nfct agt gntyp alys sarscov2,CPT,RVU2026A,2026
87999,Unlisted microbiology px,CPT,RVU2026A,2026
88000,Autopsy (necropsy) gross,CPT,RVU2026A,2026
88005,Autopsy (necropsy) gross,CPT,RVU2026A,2026
88007,Autopsy (necropsy) gross,CPT,RVU2026A,2026
88012,Autopsy (necropsy) gross,CPT,RVU2026A,2026
88014,Autopsy (necropsy) gross,CPT,RVU2026A,2026
88016,Autopsy (necropsy) gross,CPT,RVU2026A,2026
88020,Autopsy (necropsy) complete,CPT,RVU2026A,2026
88025,Autopsy (necropsy) complete,CPT,RVU2026A,2026
88027,Autopsy (necropsy) complete,CPT,RVU2026A,2026
88028,Autopsy (necropsy) complete,CPT,RVU2026A,2026
88029,Autopsy (necropsy) complete,CPT,RVU2026A,2026
88036,Limited autopsy,CPT,RVU2026A,2026
88037,Limited autopsy,CPT,RVU2026A,2026
88040,Forensic autopsy (necropsy),CPT,RVU2026A,2026
88045,Coroners autopsy (necropsy),CPT,RVU2026A,2026
88099,Unlisted necropsy (autopsy),CPT,RVU2026A,2026
88104,Cytopath fl nongyn smears,CPT,RVU2026A,2026
88106,Cytopath fl nongyn filter,CPT,RVU2026A,2026
88108,Cytopath concentrate tech,CPT,RVU2026A,2026
88112,Cytopath cell enhance tech,CPT,RVU2026A,2026
88120,Cytp urne 3-5 probes ea spec,CPT,RVU2026A,2026
88121,Cytp urine 3-5 probes cmptr,CPT,RVU2026A,2026
88125,Forensic cytopathology,CPT,RVU2026A,2026
88130,Sex chromatin identification,CPT,RVU2026A,2026
88140,Sex chromatin identification,CPT,RVU2026A,2026
88141,Cytopath c/v interpret,CPT,RVU2026A,2026
88142,Cytopath c/v thin layer,CPT,RVU2026A,2026
88143,Cytopath c/v thin layer redo,CPT,RVU2026A,2026
88147,Cytopath c/v automated,CPT,RVU2026A,2026
88148,Cytopath c/v auto rescreen,CPT,RVU2026A,2026
88150,Cytopath c/v manual,CPT,RVU2026A,2026
88152,Cytopath c/v auto redo,CPT,RVU2026A,2026
88153,Cytopath c/v redo,CPT,RVU2026A,2026
88155,Cytopath c/v index add-on,CPT,RVU2026A,2026
88160,Cytopath smear other source,CPT,RVU2026A,2026
88161,Cytopath smear other source,CPT,RVU2026A,2026
88162,Cytopath smear other source,CPT,RVU2026A,2026
88164,Cytopath tbs c/v manual,CPT,RVU2026A,2026
88165,Cytopath tbs c/v redo,CPT,RVU2026A,2026
88166,Cytopath tbs c/v auto redo,CPT,RVU2026A,2026
88167,Cytopath tbs c/v select,CPT,RVU2026A,2026
88172,Cytp dx eval fna 1st ea site,CPT,RVU2026A,2026
88173,Cytopath eval fna report,CPT,RVU2026A,2026
88174,Cytopath c/v auto in fluid,CPT,RVU2026A,2026
88175,Cytopath c/v auto fluid redo,CPT,RVU2026A,2026
88177,Cytp fna eval ea addl,CPT,RVU2026A,2026
88182,Cell marker study,CPT,RVU2026A,2026
88184,Flowcytometry/ tc 1 marker,CPT,RVU2026A,2026
88185,Flowcytometry/tc add-on,CPT,RVU2026A,2026
88187,Flowcytometry/read 2-8,CPT,RVU2026A,2026
88188,Flowcytometry/read 9-15,CPT,RVU2026A,2026
88189,Flowcytometry/read 16 & >,CPT,RVU2026A,2026
88199,Unlisted cytopathology px,CPT,RVU2026A,2026
88230,Tissue culture lymphocyte,CPT,RVU2026A,2026
88233,Tissue culture skin/biopsy,CPT,RVU2026A,2026
88235,Tissue culture placenta,CPT,RVU2026A,2026
88237,Tissue culture bone marrow,CPT,RVU2026A,2026
88239,Tissue culture tumor,CPT,RVU2026A,2026
88240,Cell cryopreserve/storage,CPT,RVU2026A,2026
88241,Frozen cell preparation,CPT,RVU2026A,2026
88245,Chromosome analysis 20-25,CPT,RVU2026A,2026
88248,Chromosome analysis 50-100,CPT,RVU2026A,2026
88249,Chromosome analysis 100,CPT,RVU2026A,2026
88261,Chromosome analysis 5,CPT,RVU2026A,2026
88262,Chromosome analysis 15-20,CPT,RVU2026A,2026
88263,Chromosome analysis 45,CPT,RVU2026A,2026
88264,Chromosome analysis 20-25,CPT,RVU2026A,2026
88267,Chromosome analys placenta,CPT,RVU2026A,2026
88269,Chromosome analys amniotic,CPT,RVU2026A,2026
88271,Cytogenetics dna probe,CPT,RVU2026A,2026
88272,Cytogenetics 3-5,CPT,RVU2026A,2026
88273,Cytogenetics 10-30,CPT,RVU2026A,2026
88274,Cytogenetics 25-99,CPT,RVU2026A,2026
88275,Cytogenetics 100-300,CPT,RVU2026A,2026
88280,Chromosome karyotype study,CPT,RVU2026A,2026
88283,Chromosome banding study,CPT,RVU2026A,2026
88285,Chromosome count additional,CPT,RVU2026A,2026
88289,Chromosome study additional,CPT,RVU2026A,2026
88291,Cyto/molecular report,CPT,RVU2026A,2026
88299,Unlisted cytogenetic study,CPT,RVU2026A,2026
88300,Surgical path gross,CPT,RVU2026A,2026
88302,Tissue exam by pathologist,CPT,RVU2026A,2026
88304,Tissue exam by pathologist,CPT,RVU2026A,2026
88305,Tissue exam by pathologist,CPT,RVU2026A,2026
88307,Tissue exam by pathologist,CPT,RVU2026A,2026
88309,Tissue exam by pathologist,CPT,RVU2026A,2026
88311,Decalcify tissue,CPT,RVU2026A,2026
88312,Special stains group 1,CPT,RVU2026A,2026
88313,Special stains group 2,CPT,RVU2026A,2026
88314,Histochemical stains add-on,CPT,RVU2026A,2026
88319,Enzyme histochemistry,CPT,RVU2026A,2026
88321,Consltj&reprt sld prep elswr,CPT,RVU2026A,2026
88323,Consltj&reprt matrl prep sld,CPT,RVU2026A,2026
88325,Consltj compre rvw rec reprt,CPT,RVU2026A,2026
88329,Path consltj drg surg,CPT,RVU2026A,2026
88331,Path consltj surg 1 blk 1spc,CPT,RVU2026A,2026
88332,Path consltj surg ea add blk,CPT,RVU2026A,2026
88333,Path consltj surg cyto xm 1,CPT,RVU2026A,2026
88334,Path consltj surg cyto xm ea,CPT,RVU2026A,2026
88341,Imhchem/imcytchm ea add antb,CPT,RVU2026A,2026
88342,Imhchem/imcytchm 1st antb,CPT,RVU2026A,2026
88344,Imhchem/imcytchm ea mlt antb,CPT,RVU2026A,2026
88346,Imfluor 1st 1antb stain px,CPT,RVU2026A,2026
88348,Electron microscopy dx,CPT,RVU2026A,2026
88350,Imfluor ea addl 1antb stn px,CPT,RVU2026A,2026
88355,M/phmtrc alys skeletal musc,CPT,RVU2026A,2026
88356,Analysis nerve,CPT,RVU2026A,2026
88358,Analysis tumor,CPT,RVU2026A,2026
88360,Tumor immunohistochem/manual,CPT,RVU2026A,2026
88361,Tumor immunohistochem/comput,CPT,RVU2026A,2026
88362,Nerve teasing preparations,CPT,RVU2026A,2026
88363,Xm archive tissue molec anal,CPT,RVU2026A,2026
88364,Insitu hybridization (fish),CPT,RVU2026A,2026
88365,Insitu hybridization (fish),CPT,RVU2026A,2026
88366,Insitu hybridization (fish),CPT,RVU2026A,2026
88367,Insitu hybridization auto,CPT,RVU2026A,2026
88368,Insitu hybridization manual,CPT,RVU2026A,2026
88369,M/phmtrc alysishquant/semiq,CPT,RVU2026A,2026
88371,Protein western blot tissue,CPT,RVU2026A,2026
88372,Protein analysis w/probe,CPT,RVU2026A,2026
88373,M/phmtrc alys ishquant/semiq,CPT,RVU2026A,2026
88374,M/phmtrc alys ishquant/semiq,CPT,RVU2026A,2026
88375,Optical endomicroscpy interp,CPT,RVU2026A,2026
88377,M/phmtrc alys ishquant/semiq,CPT,RVU2026A,2026
88380,Microdissection laser,CPT,RVU2026A,2026
88381,Microdissection manual,CPT,RVU2026A,2026
88387,Macroscopic xm dsj&prep tiss,CPT,RVU2026A,2026
88399,Unlisted surgical path px,CPT,RVU2026A,2026
88720,Bilirubin total transcut,CPT,RVU2026A,2026
88738,Hgb quant transcutaneous,CPT,RVU2026A,2026
88740,Transcutaneous carboxyhb,CPT,RVU2026A,2026
88741,Transcutaneous methb,CPT,RVU2026A,2026
88749,Unlisted in vivo lab service,CPT,RVU2026A,2026
89049,Chct for mal hyperthermia,CPT,RVU2026A,2026
89050,Body fluid cell count,CPT,RVU2026A,2026
89051,Body fluid cell count,CPT,RVU2026A,2026
89055,Leukocyte assessment fecal,CPT,RVU2026A,2026
89060,Exam synovial fluid crystals,CPT,RVU2026A,2026
89125,Specimen fat stain,CPT,RVU2026A,2026
89160,Exam feces for meat fibers,CPT,RVU2026A,2026
89190,Nasal smear for eosinophils,CPT,RVU2026A,2026
89220,Sputum specimen collection,CPT,RVU2026A,2026
89230,Collect sweat for test,CPT,RVU2026A,2026
89240,Unlisted misc path test,CPT,RVU2026A,2026
89250,Cultr oocyte/embryo <4 days,CPT,RVU2026A,2026
89251,Cultr oocyte/embryo <4 days,CPT,RVU2026A,2026
89253,Embryo hatching,CPT,RVU2026A,2026
89254,Oocyte identification,CPT,RVU2026A,2026
89255,Prepare embryo for transfer,CPT,RVU2026A,2026
89257,Sperm identification,CPT,RVU2026A,2026
89258,Cryopreservation embryo(s),CPT,RVU2026A,2026
89259,Cryopreservation sperm,CPT,RVU2026A,2026
89260,Sperm isolation simple,CPT,RVU2026A,2026
89261,Sperm isolation complex,CPT,RVU2026A,2026
89264,Identify sperm tissue,CPT,RVU2026A,2026
89268,Insemination of oocytes,CPT,RVU2026A,2026
89272,Extended culture of oocytes,CPT,RVU2026A,2026
89280,Assist oocyte fertilization,CPT,RVU2026A,2026
89281,Assist oocyte fertilization,CPT,RVU2026A,2026
89290,Biopsy oocyte polar body <=5,CPT,RVU2026A,2026
89291,Biopsy oocyte polar body,CPT,RVU2026A,2026
89300,Semen analysis w/huhner,CPT,RVU2026A,2026
89310,Semen analysis w/count,CPT,RVU2026A,2026
89320,Semen anal vol/count/mot,CPT,RVU2026A,2026
89321,Semen anal sperm detection,CPT,RVU2026A,2026
89322,Semen anal strict criteria,CPT,RVU2026A,2026
89325,Sperm antibody test,CPT,RVU2026A,2026
89329,Sperm evaluation test,CPT,RVU2026A,2026
89330,Evaluation cervical mucus,CPT,RVU2026A,2026
89331,Retrograde ejaculation anal,CPT,RVU2026A,2026
89335,Cryopreserve testicular tiss,CPT,RVU2026A,2026
89337,Cryopreservation oocyte(s),CPT,RVU2026A,2026
89342,Storage/year embryo(s),CPT,RVU2026A,2026
89343,Storage/year sperm/semen,CPT,RVU2026A,2026
89344,Storage/year reprod tissue,CPT,RVU2026A,2026
89346,Storage/year oocyte(s),CPT,RVU2026A,2026
89352,Thawing cryopresrved embryo,CPT,RVU2026A,2026
89353,Thawing cryopresrved sperm,CPT,RVU2026A,2026
89354,Thaw cryoprsvrd reprod tiss,CPT,RVU2026A,2026
89356,Thawing cryopresrved oocyte,CPT,RVU2026A,2026
89398,Unlisted reprod med lab proc,CPT,RVU2026A,2026
9001F,Aortic aneurysm<5cm diam ct,Other,RVU2026A,2026
9002F,Aortic aneurysm 5-5.4cm diam,Other,RVU2026A,2026
9003F,Aortic anrysm5.5-5.9cm diam,Other,RVU2026A,2026
9004F,Aortic anrysm 6/> cm diam,Other,RVU2026A,2026
9005F,Asympt carot/vrtbrbas sten,Other,RVU2026A,2026
9006F,Sympt sten-tia/strk<120days,Other,RVU2026A,2026
9007F,Other carot sten 120 days/>,Other,RVU2026A,2026
90281,Human ig im,CPT,RVU2026A,2026
90283,Human ig iv,CPT,RVU2026A,2026
90284,Human ig sc,CPT,RVU2026A,2026
90287,Botulinum antitoxin,CPT,RVU2026A,2026
90288,Botulism ig iv,CPT,RVU2026A,2026
90291,Cmv ig iv,CPT,RVU2026A,2026
90296,Diphtheria antitoxin,CPT,RVU2026A,2026
90371,Hep b ig im,CPT,RVU2026A,2026
90375,Rabies ig im/sc,CPT,RVU2026A,2026
90376,Rabies ig heat treated,CPT,RVU2026A,2026
90377,Rabies ig ht&sol human im/sc,CPT,RVU2026A,2026
90378,Rsv mab im 50mg,CPT,RVU2026A,2026
90380,Rsv monoc antb seasn .5ml im,CPT,RVU2026A,2026
90381,Rsv monoc antb seasn 1 ml im,CPT,RVU2026A,2026
90382,Rsv monoc antb seasn .7ml im,CPT,RVU2026A,2026
90384,Rh ig full-dose im,CPT,RVU2026A,2026
90385,Rh ig minidose im,CPT,RVU2026A,2026
90386,Rh ig iv,CPT,RVU2026A,2026
90389,Tetanus ig im,CPT,RVU2026A,2026
90393,Vaccina ig im,CPT,RVU2026A,2026
90396,Varicella-zoster ig im,CPT,RVU2026A,2026
90399,Unlisted immune globulin,CPT,RVU2026A,2026
90460,Im admin 1st/only component,CPT,RVU2026A,2026
90461,Im admin each addl component,CPT,RVU2026A,2026
90471,Immunization admin,CPT,RVU2026A,2026
90472,Immunization admin each add,CPT,RVU2026A,2026
90473,Immune admin oral/nasal,CPT,RVU2026A,2026
90474,Immune admin oral/nasal addl,CPT,RVU2026A,2026
90476,Adenovirus vaccine type 4,CPT,RVU2026A,2026
90477,Adenovirus vaccine type 7,CPT,RVU2026A,2026
90480,Admn sarscov2 vac 1/only cmp,CPT,RVU2026A,2026
90481,Admn sarscov2 vac ea add cmp,CPT,RVU2026A,2026
90482,Imm cnsl not admn sm 3<10,CPT,RVU2026A,2026
90483,Imm cnsl not admn sm>10<20,CPT,RVU2026A,2026
90484,Imm cnsl not admn sm>20,CPT,RVU2026A,2026
90581,Anthrax vaccine sc or im,CPT,RVU2026A,2026
90584,Dengue vacc quad 2 dose subq,CPT,RVU2026A,2026
90585,Bcg vaccine percut,CPT,RVU2026A,2026
90586,Bcg vaccine intravesical,CPT,RVU2026A,2026
90587,Dengue vacc quad 3 dose subq,CPT,RVU2026A,2026
90589,Chikungunya vaccine live im,CPT,RVU2026A,2026
90593,Chikungunya vacc recomb im,CPT,RVU2026A,2026
90611,Smallpox&monkeypox vac 0.5ml,CPT,RVU2026A,2026
90612,Inf&sarscov2 vacc 31.7/.32im,CPT,RVU2026A,2026
90613,Inf&sarscov2 vacc 40/0.4 im,CPT,RVU2026A,2026
90619,Menacwy-tt vaccine im,CPT,RVU2026A,2026
90620,Menb-4c vaccine im,CPT,RVU2026A,2026
90621,Menb-fhbp vacc 2/3 dose im,CPT,RVU2026A,2026
90622,Vaccinia vrs vac 0.3 ml perq,CPT,RVU2026A,2026
90623,Menacwy-tt menb-fhbp vacc im,CPT,RVU2026A,2026
90624,Menb-4c&menacwy vacc im,CPT,RVU2026A,2026
90625,Cholera vaccine live oral,CPT,RVU2026A,2026
90626,Tic-brn enceph vac 0.25ml im,CPT,RVU2026A,2026
90627,Tic-brn enceph vac 0.5ml im,CPT,RVU2026A,2026
90631,H5 vaccine pandemic im use,CPT,RVU2026A,2026
90632,Hepa vaccine adult im,CPT,RVU2026A,2026
90633,Hepa vacc ped/adol 2 dose im,CPT,RVU2026A,2026
90634,Hepa vacc ped/adol 3 dose,CPT,RVU2026A,2026
90635,H5n1 vacc drv cll cul adj im,CPT,RVU2026A,2026
90636,Hep a/hep b vacc adult im,CPT,RVU2026A,2026
90637,Vacc qirv mrna 30mcg/.5ml im,CPT,RVU2026A,2026
90638,Vacc qirv mrna 60mcg/.5ml im,CPT,RVU2026A,2026
90644,Hib-mency vacc 6wk-18m0 im,CPT,RVU2026A,2026
90647,Hib prp-omp vacc 3 dose im,CPT,RVU2026A,2026
90648,Hib prp-t vaccine 4 dose im,CPT,RVU2026A,2026
90649,4vhpv vaccine 3 dose im,CPT,RVU2026A,2026
90650,2vhpv vaccine 3 dose im,CPT,RVU2026A,2026
90651,9vhpv vaccine 2/3 dose im,CPT,RVU2026A,2026
90653,Iiv adjuvant vaccine im,CPT,RVU2026A,2026
90655,Iiv3 vacc no prsv 0.25 ml im,CPT,RVU2026A,2026
90656,Iiv3 vacc no prsv 0.5 ml im,CPT,RVU2026A,2026
90657,Iiv3 vaccine splt 0.25 ml im,CPT,RVU2026A,2026
90658,Iiv3 vaccine splt 0.5 ml im,CPT,RVU2026A,2026
90660,Laiv3 vaccine intranasal,CPT,RVU2026A,2026
90661,Cciiv3 vac abx fr 0.5 ml im,CPT,RVU2026A,2026
90662,Iiv no prsv increased ag im,CPT,RVU2026A,2026
90664,Laiv vacc pandemic intranasl,CPT,RVU2026A,2026
90666,Flu vac pandem prsrv free im,CPT,RVU2026A,2026
90667,Iiv vacc pandemic adjuvt im,CPT,RVU2026A,2026
90668,Iiv vaccine pandemic im,CPT,RVU2026A,2026
90670,Pcv13 vaccine im,CPT,RVU2026A,2026
90671,Pcv15 vaccine im,CPT,RVU2026A,2026
90672,Laiv4 vaccine intranasal,CPT,RVU2026A,2026
90673,Riv3 vaccine no preserv im,CPT,RVU2026A,2026
90674,Cciiv4 vac no prsv 0.5 ml im,CPT,RVU2026A,2026
90675,Rabies vaccine im,CPT,RVU2026A,2026
90676,Rabies vaccine id,CPT,RVU2026A,2026
90677,Pcv20 vaccine im,CPT,RVU2026A,2026
90678,Rsv vacc pref bivalent im,CPT,RVU2026A,2026
90679,Rsv vacc pref recomb adjt im,CPT,RVU2026A,2026
90680,Rv5 vacc 3 dose live oral,CPT,RVU2026A,2026
90681,Rv1 vacc 2 dose live oral,CPT,RVU2026A,2026
90682,Riv4 vacc recombinant dna im,CPT,RVU2026A,2026
90683,Rsv vacc mrna lipid nano im,CPT,RVU2026A,2026
90684,Pcv21 vaccine im,CPT,RVU2026A,2026
90685,Iiv4 vacc no prsv 0.25 ml im,CPT,RVU2026A,2026
90686,Iiv4 vacc no prsv 0.5 ml im,CPT,RVU2026A,2026
90687,Iiv4 vaccine splt 0.25 ml im,CPT,RVU2026A,2026
90688,Iiv4 vaccine splt 0.5 ml im,CPT,RVU2026A,2026
90689,Vacc iiv4 no prsrv 0.25ml im,CPT,RVU2026A,2026
90690,Typhoid vaccine oral,CPT,RVU2026A,2026
90691,Typhoid vaccine im,CPT,RVU2026A,2026
90694,Vacc aiiv4 no prsrv 0.5ml im,CPT,RVU2026A,2026
90695,H5n8 vacc drv cll cul adj im,CPT,RVU2026A,2026
90696,Dtap-ipv vaccine 4-6 yrs im,CPT,RVU2026A,2026
90697,Dtap-ipv-hib-hepb vaccine im,CPT,RVU2026A,2026
90698,Dtap-ipv/hib vaccine im,CPT,RVU2026A,2026
90700,Dtap vaccine < 7 yrs im,CPT,RVU2026A,2026
90702,Dt vaccine under 7 yrs im,CPT,RVU2026A,2026
90707,Mmr vaccine sc,CPT,RVU2026A,2026
90710,Mmrv vaccine sc,CPT,RVU2026A,2026
90713,Poliovirus ipv sc/im,CPT,RVU2026A,2026
90714,Td vacc no presv 7 yrs+ im,CPT,RVU2026A,2026
90715,Tdap vaccine 7 yrs/> im,CPT,RVU2026A,2026
90716,Var vaccine live subq,CPT,RVU2026A,2026
90717,Yellow fever vaccine subq,CPT,RVU2026A,2026
90723,Dtap-hep b-ipv vaccine im,CPT,RVU2026A,2026
90732,Ppsv23 vacc 2 yrs+ subq/im,CPT,RVU2026A,2026
90733,Mpsv4 vaccine subq,CPT,RVU2026A,2026
90734,Menacwyd/menacwycrm vacc im,CPT,RVU2026A,2026
90736,Hzv vaccine live subq,CPT,RVU2026A,2026
90738,Inactivated je vacc im,CPT,RVU2026A,2026
90739,Hepb vacc 2/4 dose adult im,CPT,RVU2026A,2026
90740,Hepb vacc 3 dose immunsup im,CPT,RVU2026A,2026
90743,Hepb vacc 2 dose adolesc im,CPT,RVU2026A,2026
90744,Hepb vacc 3 dose ped/adol im,CPT,RVU2026A,2026
90746,Hepb vaccine 3 dose adult im,CPT,RVU2026A,2026
90747,Hepb vacc 4 dose immunsup im,CPT,RVU2026A,2026
90748,Hib-hepb vaccine im,CPT,RVU2026A,2026
90749,Unlisted vaccine/toxoid,CPT,RVU2026A,2026
90750,Hzv vacc recombinant im,CPT,RVU2026A,2026
90756,Cciiv4 vacc abx free im,CPT,RVU2026A,2026
90758,Zaire ebolavirus vac live im,CPT,RVU2026A,2026
90759,Hep b vac 3ag 10mcg 3 dos im,CPT,RVU2026A,2026
90785,Psytx complex interactive,CPT,RVU2026A,2026
90791,Psych diagnostic evaluation,CPT,RVU2026A,2026
90792,Psych diag eval w/med srvcs,CPT,RVU2026A,2026
90832,Psytx w pt 30 minutes,CPT,RVU2026A,2026
90833,Psytx w pt w e/m 30 min,CPT,RVU2026A,2026
90834,Psytx w pt 45 minutes,CPT,RVU2026A,2026
90836,Psytx w pt w e/m 45 min,CPT,RVU2026A,2026
90837,Psytx w pt 60 minutes,CPT,RVU2026A,2026
90838,Psytx w pt w e/m 60 min,CPT,RVU2026A,2026
90839,Psytx crisis initial 60 min,CPT,RVU2026A,2026
90840,Psytx crisis ea addl 30 min,CPT,RVU2026A,2026
90845,Psychoanalysis,CPT,RVU2026A,2026
90846,Family psytx w/o pt 50 min,CPT,RVU2026A,2026
90847,Family psytx w/pt 50 min,CPT,RVU2026A,2026
90849,Multiple family group psytx,CPT,RVU2026A,2026
90853,Group psychotherapy,CPT,RVU2026A,2026
90863,Pharmacologic mgmt w/psytx,CPT,RVU2026A,2026
90865,Narcosynthesis,CPT,RVU2026A,2026
90867,Tcranial magn stim tx plan,CPT,RVU2026A,2026
90868,Tcranial magn stim tx deli,CPT,RVU2026A,2026
90869,Tcran magn stim redetemine,CPT,RVU2026A,2026
90870,Electroconvulsive therapy,CPT,RVU2026A,2026
90875,Psychophysiological therapy,CPT,RVU2026A,2026
90876,Psychophysiological therapy,CPT,RVU2026A,2026
90880,Hypnotherapy,CPT,RVU2026A,2026
90882,Envrn ivntj med mgmt psyc pt,CPT,RVU2026A,2026
90885,Psy evaluation of records,CPT,RVU2026A,2026
90887,Interpj/explnaj rslt psyc xm,CPT,RVU2026A,2026
90889,Preparation of report,CPT,RVU2026A,2026
90899,Unlisted psyc svc/therapy,CPT,RVU2026A,2026
90901,Biofeedback train any meth,CPT,RVU2026A,2026
90912,Bfb training 1st 15 min,CPT,RVU2026A,2026
90913,Bfb training ea addl 15 min,CPT,RVU2026A,2026
90935,Hemodialysis one evaluation,CPT,RVU2026A,2026
90937,Hemodialysis repeated eval,CPT,RVU2026A,2026
90940,Hemodialysis access study,CPT,RVU2026A,2026
90945,Dialysis one evaluation,CPT,RVU2026A,2026
90947,Dialysis repeated eval,CPT,RVU2026A,2026
90951,Esrd serv 4 visits p mo <2yr,CPT,RVU2026A,2026
90952,Esrd serv 2-3 vsts p mo <2yr,CPT,RVU2026A,2026
90953,Esrd serv 1 visit p mo <2yrs,CPT,RVU2026A,2026
90954,Esrd serv 4 vsts p mo 2-11,CPT,RVU2026A,2026
90955,Esrd srv 2-3 vsts p mo 2-11,CPT,RVU2026A,2026
90956,Esrd srv 1 visit p mo 2-11,CPT,RVU2026A,2026
90957,Esrd srv 4 vsts p mo 12-19,CPT,RVU2026A,2026
90958,Esrd srv 2-3 vsts p mo 12-19,CPT,RVU2026A,2026
90959,Esrd serv 1 vst p mo 12-19,CPT,RVU2026A,2026
90960,Esrd srv 4 visits p mo 20+,CPT,RVU2026A,2026
90961,Esrd srv 2-3 vsts p mo 20+,CPT,RVU2026A,2026
90962,Esrd serv 1 visit p mo 20+,CPT,RVU2026A,2026
90963,Esrd home pt serv p mo <2yrs,CPT,RVU2026A,2026
90964,Esrd home pt serv p mo 2-11,CPT,RVU2026A,2026
90965,Esrd home pt serv p mo 12-19,CPT,RVU2026A,2026
90966,Esrd home pt serv p mo 20+,CPT,RVU2026A,2026
90967,Esrd svc pr day pt <2,CPT,RVU2026A,2026
90968,Esrd svc pr day pt 2-11,CPT,RVU2026A,2026
90969,Esrd svc pr day pt 12-19,CPT,RVU2026A,2026
90970,Esrd svc pr day pt 20+,CPT,RVU2026A,2026
90989,Dialysis training complete,CPT,RVU2026A,2026
90993,Dialysis training incompl,CPT,RVU2026A,2026
90997,Hemoperfusion,CPT,RVU2026A,2026
90999,Unlisted dialysis procedure,CPT,RVU2026A,2026
91010,Esophagus motility study,CPT,RVU2026A,2026
91013,Esophgl motil w/stim/perfus,CPT,RVU2026A,2026
91020,Gastric motility studies,CPT,RVU2026A,2026
91022,Duodenal motility study,CPT,RVU2026A,2026
91030,Acid perfusion of esophagus,CPT,RVU2026A,2026
91034,Gastroesophageal reflux test,CPT,RVU2026A,2026
91035,G-esoph reflx tst w/electrod,CPT,RVU2026A,2026
91037,Esoph imped function test,CPT,RVU2026A,2026
91038,Esoph imped funct test > 1hr,CPT,RVU2026A,2026
91040,Esoph balloon distension tst,CPT,RVU2026A,2026
91065,Breath hydrogen/methane test,CPT,RVU2026A,2026
91110,Gi trc img intral esoph-ile,CPT,RVU2026A,2026
91111,Gi trc img intral esophagus,CPT,RVU2026A,2026
91112,Gi wireless capsule measure,CPT,RVU2026A,2026
91113,Gi trc img intral colon i&r,CPT,RVU2026A,2026
91117,Colon motility 6 hr study,CPT,RVU2026A,2026
91124,Rct snsatn tone&cmplianc std,CPT,RVU2026A,2026
91125,Anrct mano rct snsatn&balo,CPT,RVU2026A,2026
91132,Electrogastrography,CPT,RVU2026A,2026
91133,Electrogastrography w/test,CPT,RVU2026A,2026
91200,Liver elastography,CPT,RVU2026A,2026
91299,Unlisted dx gi procedure,CPT,RVU2026A,2026
91304,Sarscov2 vac 5mcg/0.5ml im,CPT,RVU2026A,2026
91318,Sarscov2 vac 3mcg trs-suc im,CPT,RVU2026A,2026
91319,Sarscv2 vac 10mcg trs-suc im,CPT,RVU2026A,2026
91320,Sarscv2 vac 30mcg trs-suc im,CPT,RVU2026A,2026
91321,Sarscov2 vac 25 mcg/.25ml im,CPT,RVU2026A,2026
91322,Sarscov2 vac 50 mcg/0.5ml im,CPT,RVU2026A,2026
91323,Sarscov2 vac 10 mcg/0.2ml im,CPT,RVU2026A,2026
92002,Intrm oph exam new patient,CPT,RVU2026A,2026
92004,Compre oph exam new pt 1/>,CPT,RVU2026A,2026
92012,Intrm oph exam est patient,CPT,RVU2026A,2026
92014,Compre oph exam est pt 1/>,CPT,RVU2026A,2026
92015,Determine refractive state,CPT,RVU2026A,2026
92018,Compl oph exam general anes,CPT,RVU2026A,2026
92019,Lmtd oph exam general anes,CPT,RVU2026A,2026
92020,Gonioscopy,CPT,RVU2026A,2026
92025,Cptrized corneal topography,CPT,RVU2026A,2026
92060,Sensorimotor examination,CPT,RVU2026A,2026
92065,Orthop traing pfrmd phys/qhp,CPT,RVU2026A,2026
92066,Orthop traing supvj phys/qhp,CPT,RVU2026A,2026
92071,Contact lens fitting for tx,CPT,RVU2026A,2026
92072,Fitg c-lens keratoconus 1st,CPT,RVU2026A,2026
92081,Limited visual field xm,CPT,RVU2026A,2026
92082,Intermediate visual field xm,CPT,RVU2026A,2026
92083,Extended visual field xm,CPT,RVU2026A,2026
92100,Serial tonometry,CPT,RVU2026A,2026
92132,Cptrzd oph dx img ant sgm,CPT,RVU2026A,2026
92133,Cptrzd oph dx img pst sgm on,CPT,RVU2026A,2026
92134,Cptrz oph dx img pst sgm rta,CPT,RVU2026A,2026
92136,Ophthalmic biometry,CPT,RVU2026A,2026
92137,Cptrz oph img pst sg rta oct,CPT,RVU2026A,2026
92145,Corneal hysteresis deter,CPT,RVU2026A,2026
92201,Opscpy extnd rta draw uni/bi,CPT,RVU2026A,2026
92202,Opscpy extnd on/mac draw,CPT,RVU2026A,2026
92227,Img rta detcj/mntr ds staff,CPT,RVU2026A,2026
92228,Img rta detc/mntr ds phy/qhp,CPT,RVU2026A,2026
92229,Img rta detc/mntr ds poc aly,CPT,RVU2026A,2026
92230,Fluorescein angioscopy i&r,CPT,RVU2026A,2026
92235,Fluorescein angrph mltiframe,CPT,RVU2026A,2026
92240,Icg angiography i&r uni/bi,CPT,RVU2026A,2026
92242,Fluorescein&icg angiography,CPT,RVU2026A,2026
92250,Fundus photography w/i&r,CPT,RVU2026A,2026
92260,Ophthalmodynamometry,CPT,RVU2026A,2026
92265,Ndl oculoelectromyography 1+,CPT,RVU2026A,2026
92270,Electro-oculography w/i&r,CPT,RVU2026A,2026
92273,Full field erg w/i&r,CPT,RVU2026A,2026
92274,Multifocal erg w/i&r,CPT,RVU2026A,2026
92283,Extnd color vision xm,CPT,RVU2026A,2026
92284,Dx dark adaptation exam i&r,CPT,RVU2026A,2026
92285,External ocular photography,CPT,RVU2026A,2026
92286,Ant sgm img i&r speclr mic,CPT,RVU2026A,2026
92287,Ant sgm img ir flrscn angrph,CPT,RVU2026A,2026
92288,Scr dark adaptation meas i&r,CPT,RVU2026A,2026
92310,Contact lens fitting ou,CPT,RVU2026A,2026
92311,Contact lens fitg aphakia 1,CPT,RVU2026A,2026
92312,Contact lens fitg aphakia ou,CPT,RVU2026A,2026
92313,C-lens fitg corneosclrl lens,CPT,RVU2026A,2026
92314,C-lens fitg tech ou,CPT,RVU2026A,2026
92315,C-lens fitg tech aphakia 1,CPT,RVU2026A,2026
92316,C-lens fitg tech aphakia ou,CPT,RVU2026A,2026
92317,C-lens fitg tech corneosclrl,CPT,RVU2026A,2026
92325,Modification of contact lens,CPT,RVU2026A,2026
92326,Replacement of contact lens,CPT,RVU2026A,2026
92340,Fit spectacles monofocal,CPT,RVU2026A,2026
92341,Fit spectacles bifocal,CPT,RVU2026A,2026
92342,Fit spectacles multifocal,CPT,RVU2026A,2026
92352,Fit aphakia spectcl monofocl,CPT,RVU2026A,2026
92353,Fit aphakia spectcl multifoc,CPT,RVU2026A,2026
92354,Fitg spect low vis 1system,CPT,RVU2026A,2026
92355,Fitg spect lw vis cmpnd lens,CPT,RVU2026A,2026
92358,Aphakia prosth service temp,CPT,RVU2026A,2026
92370,Rpr&refitg spect xcp aphakia,CPT,RVU2026A,2026
92371,Rpr&refit spct prsth aphakia,CPT,RVU2026A,2026
92499,Unlisted oph svc/procedure,CPT,RVU2026A,2026
92502,Ear and throat examination,CPT,RVU2026A,2026
92504,Ear microscopy examination,CPT,RVU2026A,2026
92507,Tx sp lang voice comm indiv,CPT,RVU2026A,2026
92508,Tx sp lang voice comm group,CPT,RVU2026A,2026
92511,Nasopharyngoscopy,CPT,RVU2026A,2026
92512,Nasal function studies,CPT,RVU2026A,2026
92516,Facial nerve function test,CPT,RVU2026A,2026
92517,Vemp test i&r cervical,CPT,RVU2026A,2026
92518,Vemp test i&r ocular,CPT,RVU2026A,2026
92519,Vemp tst i&r cervical&ocular,CPT,RVU2026A,2026
92520,Laryngeal function studies,CPT,RVU2026A,2026
92521,Evaluation of speech fluency,CPT,RVU2026A,2026
92522,Evaluate speech production,CPT,RVU2026A,2026
92523,Speech sound lang comprehen,CPT,RVU2026A,2026
92524,Behavral qualit analys voice,CPT,RVU2026A,2026
92526,Oral function therapy,CPT,RVU2026A,2026
92531,Spontaneous nystagmus study,CPT,RVU2026A,2026
92532,Positional nystagmus test,CPT,RVU2026A,2026
92533,Caloric vestibular test,CPT,RVU2026A,2026
92534,Optokinetic nystagmus test,CPT,RVU2026A,2026
92537,Caloric vstblr test w/rec,CPT,RVU2026A,2026
92538,Caloric vstblr test w/rec,CPT,RVU2026A,2026
92540,Basic vestibular evaluation,CPT,RVU2026A,2026
92541,Spontaneous nystagmus test,CPT,RVU2026A,2026
92542,Positional nystagmus test,CPT,RVU2026A,2026
92544,Optokinetic nystagmus test,CPT,RVU2026A,2026
92545,Oscillating tracking test,CPT,RVU2026A,2026
92546,Sinusoidal rotational test,CPT,RVU2026A,2026
92547,Supplemental electrical test,CPT,RVU2026A,2026
92548,Cdp-sot 6 cond w/i&r,CPT,RVU2026A,2026
92549,Cdp-sot 6 cond w/i&r mct&adt,CPT,RVU2026A,2026
92550,Tympanometry & reflex thresh,CPT,RVU2026A,2026
92551,Pure tone hearing test air,CPT,RVU2026A,2026
92552,Pure tone audiometry air,CPT,RVU2026A,2026
92553,Audiometry air & bone,CPT,RVU2026A,2026
92555,Speech threshold audiometry,CPT,RVU2026A,2026
92556,Speech audiometry complete,CPT,RVU2026A,2026
92557,Comprehensive hearing test,CPT,RVU2026A,2026
92558,Evoked auditory test qual,CPT,RVU2026A,2026
92562,Loudness balance test,CPT,RVU2026A,2026
92563,Tone decay hearing test,CPT,RVU2026A,2026
92565,Stenger test pure tone,CPT,RVU2026A,2026
92567,Tympanometry,CPT,RVU2026A,2026
92568,Acoustic refl threshold tst,CPT,RVU2026A,2026
92570,Acoustic immitance testing,CPT,RVU2026A,2026
92571,Filtered speech test,CPT,RVU2026A,2026
92572,Staggered spondaic word test,CPT,RVU2026A,2026
92575,Sensorineural acuity lvl tst,CPT,RVU2026A,2026
92576,Synthetic sentence id test,CPT,RVU2026A,2026
92577,Stenger test speech,CPT,RVU2026A,2026
92579,Visual audiometry (vra),CPT,RVU2026A,2026
92582,Conditioning play audiometry,CPT,RVU2026A,2026
92583,Select picture audiometry,CPT,RVU2026A,2026
92584,Electrocochleography,CPT,RVU2026A,2026
92587,Evoked auditory test limited,CPT,RVU2026A,2026
92588,Evoked auditory tst complete,CPT,RVU2026A,2026
92596,Ear protector evaluation,CPT,RVU2026A,2026
92597,Oral speech device eval,CPT,RVU2026A,2026
92601,Cochlear implt f/up exam <7,CPT,RVU2026A,2026
92602,Reprogram cochlear implt <7,CPT,RVU2026A,2026
92603,Cochlear implt f/up exam 7/>,CPT,RVU2026A,2026
92604,Reprogram cochlear implt 7/>,CPT,RVU2026A,2026
92605,Ex for nonspeech device rx,CPT,RVU2026A,2026
92606,Non-speech device service,CPT,RVU2026A,2026
92607,Ex for speech device rx 1hr,CPT,RVU2026A,2026
92608,Ex for speech device rx addl,CPT,RVU2026A,2026
92609,Use of speech device service,CPT,RVU2026A,2026
92610,Evaluate swallowing function,CPT,RVU2026A,2026
92611,Motion fluoroscopy/swallow,CPT,RVU2026A,2026
92612,Endoscopy swallow (fees) vid,CPT,RVU2026A,2026
92613,Endoscopy swallow (fees) i&r,CPT,RVU2026A,2026
92614,Laryngoscopic sensory vid,CPT,RVU2026A,2026
92615,Laryngoscopic sensory i&r,CPT,RVU2026A,2026
92616,Fees w/laryngeal sense test,CPT,RVU2026A,2026
92617,Fees w/laryngeal sense i&r,CPT,RVU2026A,2026
92618,Ex for nonspeech dev rx add,CPT,RVU2026A,2026
92620,Auditory function 60 min,CPT,RVU2026A,2026
92621,Auditory function + 15 min,CPT,RVU2026A,2026
92622,Dx aly aud oi snd prcsr 1st,CPT,RVU2026A,2026
92623,Dx aly aud oi snd prcsr each,CPT,RVU2026A,2026
92625,Tinnitus assessment,CPT,RVU2026A,2026
92626,Eval aud funcj 1st hour,CPT,RVU2026A,2026
92627,Eval aud funcj ea addl 15,CPT,RVU2026A,2026
92628,Eval hearing aid cand 1st 30,CPT,RVU2026A,2026
92629,Eval hearing aid cand ea add,CPT,RVU2026A,2026
92630,Aud rehab pre-ling hear loss,CPT,RVU2026A,2026
92631,Hearing aid slctn svc 1st 30,CPT,RVU2026A,2026
92632,Hearing aid slctn svc ea add,CPT,RVU2026A,2026
92633,Aud rehab postling hear loss,CPT,RVU2026A,2026
92634,Hearing aid fitg svc 1st 60,CPT,RVU2026A,2026
92635,Hearing aid fitg svc ea addl,CPT,RVU2026A,2026
92636,Hearing aid post-fitg f-up 1,CPT,RVU2026A,2026
92637,Hearing aid pst-fitg f-up ea,CPT,RVU2026A,2026
92638,Bhvl verif of amplification,CPT,RVU2026A,2026
92639,Hearing aid meas verif,CPT,RVU2026A,2026
92640,Aud brainstem implt programg,CPT,RVU2026A,2026
92641,Hearing dev verif eacous aly,CPT,RVU2026A,2026
92642,Hearing asstv dev fitg svc,CPT,RVU2026A,2026
92650,Aep scr auditory potential,CPT,RVU2026A,2026
92651,Aep hearing status deter i&r,CPT,RVU2026A,2026
92652,Aep thrshld est mlt freq i&r,CPT,RVU2026A,2026
92653,Aep neurodiagnostic i&r,CPT,RVU2026A,2026
92700,Unlisted orl service/px,CPT,RVU2026A,2026
92920,Prq trluml c angiop 1art&/br,CPT,RVU2026A,2026
92924,Prq trluml c athrc 1 art&/br,CPT,RVU2026A,2026
92928,Prq tcat plmt ntrac st 1 les,CPT,RVU2026A,2026
92930,Prq tcat plmt ntrac st 2+les,CPT,RVU2026A,2026
92933,Prq trlml c athrc st angiop1,CPT,RVU2026A,2026
92937,Prq trluml revsc cab grf 1,CPT,RVU2026A,2026
92941,Prq trlml revsc tot occl ami,CPT,RVU2026A,2026
92943,Prq trluml revsc ch occ ant,CPT,RVU2026A,2026
92945,Prq trl rvs ch occ ant&rtrgr,CPT,RVU2026A,2026
92950,Heart/lung resuscitation cpr,CPT,RVU2026A,2026
92953,Temporary external pacing,CPT,RVU2026A,2026
92960,Cardioversion electric ext,CPT,RVU2026A,2026
92961,Cardioversion electric int,CPT,RVU2026A,2026
92970,Cardioassist internal,CPT,RVU2026A,2026
92971,Cardioassist external,CPT,RVU2026A,2026
92972,Perq trluml coronry lithotrp,CPT,RVU2026A,2026
92973,Prq trluml c mchn asp thrmbc,CPT,RVU2026A,2026
92974,Cath place cardio brachytx,CPT,RVU2026A,2026
92978,Endoluminl ivus oct c 1st,CPT,RVU2026A,2026
92979,Endoluminl ivus oct c ea,CPT,RVU2026A,2026
92986,Revision of aortic valve,CPT,RVU2026A,2026
92987,Revision of mitral valve,CPT,RVU2026A,2026
92990,Revision of pulmonary valve,CPT,RVU2026A,2026
92997,Pul art balloon repr percut,CPT,RVU2026A,2026
92998,Pul art balloon repr percut,CPT,RVU2026A,2026
93000,Electrocardiogram complete,CPT,RVU2026A,2026
93005,Electrocardiogram tracing,CPT,RVU2026A,2026
93010,Electrocardiogram report,CPT,RVU2026A,2026
93015,Cv stress test supvj i&r,CPT,RVU2026A,2026
93016,Cv stress test supvj only,CPT,RVU2026A,2026
93017,Cv stress test tracing only,CPT,RVU2026A,2026
93018,Cv stress test i&r only,CPT,RVU2026A,2026
93024,Ergonovine provocation test,CPT,RVU2026A,2026
93025,Microvolt t-wave assess,CPT,RVU2026A,2026
93040,Rhythm ecg with report,CPT,RVU2026A,2026
93041,Rhythm ecg tracing,CPT,RVU2026A,2026
93042,Rhythm ecg report,CPT,RVU2026A,2026
93050,Art pressure waveform analys,CPT,RVU2026A,2026
93145,Interrog crtd sins bat ip wo,CPT,RVU2026A,2026
93146,Interrog crtd sins bat ip w/,CPT,RVU2026A,2026
93150,Therapy activation ipnss,CPT,RVU2026A,2026
93151,Interrog&prgrmg ipnss,CPT,RVU2026A,2026
93152,Interrog&prgrmg ipnss polysm,CPT,RVU2026A,2026
93153,Interrog w/o prgrmg ipnss,CPT,RVU2026A,2026
93224,Xtrnl ecg rec up to 48 hrs,CPT,RVU2026A,2026
93225,Xtrnl ecg rec<48 hrs rec,CPT,RVU2026A,2026
93226,Xtrnl ecg rec<48 hr scan a/r,CPT,RVU2026A,2026
93227,Xtrnl ecg rec<48 hr r&i,CPT,RVU2026A,2026
93228,Remote 30 day ecg rev/report,CPT,RVU2026A,2026
93229,Remote 30 day ecg tech supp,CPT,RVU2026A,2026
93241,Xtrnl ecg rec>48hr<7d,CPT,RVU2026A,2026
93242,Ext ecg>48hr<7d recording,CPT,RVU2026A,2026
93243,Ext ecg>48hr<7d scan a/r,CPT,RVU2026A,2026
93244,Ext ecg>48hr<7d rev&interpj,CPT,RVU2026A,2026
93245,Ext ecg>7d<15d rec scan a/r,CPT,RVU2026A,2026
93246,Ext ecg>7d<15d recording,CPT,RVU2026A,2026
93247,Ext ecg>7d<15d scan a/r,CPT,RVU2026A,2026
93248,Ext ecg>7d<15d rev&interpj,CPT,RVU2026A,2026
93260,Prgrmg dev eval impltbl sys,CPT,RVU2026A,2026
93261,Interrogate subq defib,CPT,RVU2026A,2026
93264,Rem mntr wrls p-art prs snr,CPT,RVU2026A,2026
93268,Ecg record/review,CPT,RVU2026A,2026
93270,Remote 30 day ecg rev/report,CPT,RVU2026A,2026
93271,Ecg/monitoring and analysis,CPT,RVU2026A,2026
93272,Ecg/review interpret only,CPT,RVU2026A,2026
93278,Ecg/signal-averaged,CPT,RVU2026A,2026
93279,Prgrmg dev eval pm/ldls pm,CPT,RVU2026A,2026
93280,Pm device progr eval dual,CPT,RVU2026A,2026
93281,Pm device progr eval multi,CPT,RVU2026A,2026
93282,Prgrmg eval implantable dfb,CPT,RVU2026A,2026
93283,Prgrmg eval implantable dfb,CPT,RVU2026A,2026
93284,Prgrmg eval implantable dfb,CPT,RVU2026A,2026
93285,Prgrmg dev eval scrms ip,CPT,RVU2026A,2026
93286,Peri-px eval pm/ldls pm ip,CPT,RVU2026A,2026
93287,Peri-px device eval & prgr,CPT,RVU2026A,2026
93288,Interrog evl pm/ldls pm ip,CPT,RVU2026A,2026
93289,Interrog device eval heart,CPT,RVU2026A,2026
93290,Interrog dev eval icpms ip,CPT,RVU2026A,2026
93291,Interrog dev eval scrms ip,CPT,RVU2026A,2026
93292,Wcd device interrogate,CPT,RVU2026A,2026
93293,Pm phone r-strip device eval,CPT,RVU2026A,2026
93294,Rem interrog evl pm/ldls pm,CPT,RVU2026A,2026
93295,Dev interrog remote 1/2/mlt,CPT,RVU2026A,2026
93296,Rem interrog evl pm/ids,CPT,RVU2026A,2026
93297,Rem interrog dev eval icpms,CPT,RVU2026A,2026
93298,Rem interrog dev eval scrms,CPT,RVU2026A,2026
93303,Echo transthoracic,CPT,RVU2026A,2026
93304,Echo transthoracic,CPT,RVU2026A,2026
93306,Tte w/doppler complete,CPT,RVU2026A,2026
93307,Tte w/o doppler complete,CPT,RVU2026A,2026
93308,Tte f-up or lmtd,CPT,RVU2026A,2026
93312,Echo transesophageal,CPT,RVU2026A,2026
93313,Echo transesophageal,CPT,RVU2026A,2026
93314,Echo transesophageal,CPT,RVU2026A,2026
93315,Echo transesophageal,CPT,RVU2026A,2026
93316,Echo transesophageal,CPT,RVU2026A,2026
93317,Echo transesophageal,CPT,RVU2026A,2026
93318,Echo transesophageal intraop,CPT,RVU2026A,2026
93319,3d echo img cgen car anomal,CPT,RVU2026A,2026
93320,Doppler echo complete,CPT,RVU2026A,2026
93321,Doppler echo f-up/lmtd std,CPT,RVU2026A,2026
93325,Doppler echo color flow mapg,CPT,RVU2026A,2026
93350,Stress tte only,CPT,RVU2026A,2026
93351,Stress tte complete,CPT,RVU2026A,2026
93352,Admin ecg contrast agent,CPT,RVU2026A,2026
93355,Echo transesophageal (tee),CPT,RVU2026A,2026
93356,Myocrd strain img spckl trck,CPT,RVU2026A,2026
93451,Right heart cath,CPT,RVU2026A,2026
93452,Left hrt cath w/ventrclgrphy,CPT,RVU2026A,2026
93453,R&l hrt cath w/ventriclgrphy,CPT,RVU2026A,2026
93454,Coronary artery angio s&i,CPT,RVU2026A,2026
93455,Coronary art/grft angio s&i,CPT,RVU2026A,2026
93456,R hrt coronary artery angio,CPT,RVU2026A,2026
93457,R hrt art/grft angio,CPT,RVU2026A,2026
93458,L hrt artery/ventricle angio,CPT,RVU2026A,2026
93459,L hrt art/grft angio,CPT,RVU2026A,2026
93460,R&l hrt art/ventricle angio,CPT,RVU2026A,2026
93461,R&l hrt art/ventricle angio,CPT,RVU2026A,2026
93462,L hrt cath trnsptl puncture,CPT,RVU2026A,2026
93463,Drug admin & hemodynmic meas,CPT,RVU2026A,2026
93464,Exercise w/hemodynamic meas,CPT,RVU2026A,2026
93503,Insert/place heart catheter,CPT,RVU2026A,2026
93505,Endomyocardial biopsy,CPT,RVU2026A,2026
93563,Njx cgen car cth slctv c ang,CPT,RVU2026A,2026
93564,Njx cgen car cath slctv opac,CPT,RVU2026A,2026
93565,Njx car cth slctv lv/la ang,CPT,RVU2026A,2026
93566,Njx car cth slctv rv/ra ang,CPT,RVU2026A,2026
93567,Njx car cth sprvlv aortgrphy,CPT,RVU2026A,2026
93568,Njx car cth nslc p-art angrp,CPT,RVU2026A,2026
93569,Njx cth slct p-art angrp uni,CPT,RVU2026A,2026
93571,Iv dop vel&/press c flo 1st,CPT,RVU2026A,2026
93572,Iv dop vel&/press c flo ea,CPT,RVU2026A,2026
93573,Njx cath slct p-art angrp bi,CPT,RVU2026A,2026
93574,Njx cath slct pulm vn angrph,CPT,RVU2026A,2026
93575,Njx cath slct p angrph mapca,CPT,RVU2026A,2026
93580,Transcath closure of asd,CPT,RVU2026A,2026
93581,Transcath closure of vsd,CPT,RVU2026A,2026
93582,Perq transcath closure pda,CPT,RVU2026A,2026
93583,Perq transcath septal reduxn,CPT,RVU2026A,2026
93584,Vngrph chd anom/persist svc,CPT,RVU2026A,2026
93585,Vngrph chd azygs/hemiazygs,CPT,RVU2026A,2026
93586,Vngrph chd coronary sinus,CPT,RVU2026A,2026
93587,Vngrph chd vnvn cltrl at/abv,CPT,RVU2026A,2026
93588,Vngrph chd vnvn cltrl below,CPT,RVU2026A,2026
93590,Perq transcath cls mitral,CPT,RVU2026A,2026
93591,Perq transcath cls aortic,CPT,RVU2026A,2026
93592,Perq transcath closure each,CPT,RVU2026A,2026
93593,R hrt cath chd nml nt cnj,CPT,RVU2026A,2026
93594,R hrt cath chd abnl nt cnj,CPT,RVU2026A,2026
93595,L hrt cath chd nm/abn nt cnj,CPT,RVU2026A,2026
93596,R&l hrt cath chd nml nt cnj,CPT,RVU2026A,2026
93597,R&l hrt cath chd abnl nt cnj,CPT,RVU2026A,2026
93598,Car outp meas drg cath chd,CPT,RVU2026A,2026
93600,Bundle of his recording,CPT,RVU2026A,2026
93602,Intra-atrial recording,CPT,RVU2026A,2026
93603,Right ventricular recording,CPT,RVU2026A,2026
93609,Intra-vntr mapg tchycar site,CPT,RVU2026A,2026
93610,Intra-atrial pacing,CPT,RVU2026A,2026
93612,Intraventricular pacing,CPT,RVU2026A,2026
93613,Intracardiac ephys 3d mapg,CPT,RVU2026A,2026
93615,Esophageal recording,CPT,RVU2026A,2026
93616,Esophageal recording w/pacg,CPT,RVU2026A,2026
93618,Indctj arrhythmia elec pacg,CPT,RVU2026A,2026
93619,Comprehensive ep evaluation,CPT,RVU2026A,2026
93620,Comp ep evl r at ven pac&rec,CPT,RVU2026A,2026
93621,Comp ep evl l pac&rec c sins,CPT,RVU2026A,2026
93622,Comp ep eval l ventr pac&rec,CPT,RVU2026A,2026
93623,Prgrmd stimj&pacg iv rx nfs,CPT,RVU2026A,2026
93624,Ep f-up study pacg&rec,CPT,RVU2026A,2026
93631,Ntraop epicar&endcar pac&map,CPT,RVU2026A,2026
93640,Ep eval 1/2chmbr pacg cvdfb,CPT,RVU2026A,2026
93641,Ep evl 1/2chmb pac cvdfb tst,CPT,RVU2026A,2026
93642,Ep evl 1/2chmb trnsvns cvdfb,CPT,RVU2026A,2026
93644,Ep eval subq impl dfb,CPT,RVU2026A,2026
93650,Icar cath abltj av node func,CPT,RVU2026A,2026
93653,Compre ep eval tx svt,CPT,RVU2026A,2026
93654,Compre ep eval tx vt,CPT,RVU2026A,2026
93655,Icar cath abltj dscrt arrhyt,CPT,RVU2026A,2026
93656,Compre ep eval abltj atr fib,CPT,RVU2026A,2026
93657,Tx l/r atrial fib addl,CPT,RVU2026A,2026
93660,Tilt table evaluation,CPT,RVU2026A,2026
93662,Intracardiac ecg (ice),CPT,RVU2026A,2026
93668,Peripheral vascular rehab,CPT,RVU2026A,2026
93701,Bioimpedance cv analysis,CPT,RVU2026A,2026
93702,Bis xtracell fluid analysis,CPT,RVU2026A,2026
93724,Elec alys antitchycar pm sys,CPT,RVU2026A,2026
93740,Temperature gradient studies,CPT,RVU2026A,2026
93745,Set-up cardiovert-defibrill,CPT,RVU2026A,2026
93750,Interrogation vad in person,CPT,RVU2026A,2026
93770,Determination venous press,CPT,RVU2026A,2026
93784,Ambl bp mntr w/software,CPT,RVU2026A,2026
93786,Ambl bp mntr w/sw rec only,CPT,RVU2026A,2026
93788,Ambl bp mntr w/sw a/r,CPT,RVU2026A,2026
93790,Ambl bp mntr w/sw i&r,CPT,RVU2026A,2026
93792,Pt/caregiver traing home inr,CPT,RVU2026A,2026
93793,Anticoag mgmt pt warfarin,CPT,RVU2026A,2026
93797,Phys/qhp op car rhab wo ecg,CPT,RVU2026A,2026
93798,Phys/qhp op car rhab w/ecg,CPT,RVU2026A,2026
93799,Unlisted cv svc/procedure,CPT,RVU2026A,2026
93880,Extracranial bilat study,CPT,RVU2026A,2026
93882,Extracranial uni/ltd study,CPT,RVU2026A,2026
93886,Intracranial complete study,CPT,RVU2026A,2026
93888,Intracranial limited study,CPT,RVU2026A,2026
93892,Tcd emboli detect w/o inj,CPT,RVU2026A,2026
93893,Tcd std icr art ven-art shnt,CPT,RVU2026A,2026
93895,Carotid intima atheroma eval,CPT,RVU2026A,2026
93896,Vsrctv std tcd icr art compl,CPT,RVU2026A,2026
93897,Emboli detcj wo iv mbubb njx,CPT,RVU2026A,2026
93898,Ven-artl shunt det mbubb njx,CPT,RVU2026A,2026
93922,Upr/l xtremity art 2 levels,CPT,RVU2026A,2026
93923,Upr/lxtr art stdy 3+ lvls,CPT,RVU2026A,2026
93924,Lwr xtr vasc stdy bilat,CPT,RVU2026A,2026
93925,Lower extremity study,CPT,RVU2026A,2026
93926,Lower extremity study,CPT,RVU2026A,2026
93930,Upper extremity study,CPT,RVU2026A,2026
93931,Upper extremity study,CPT,RVU2026A,2026
93970,Extremity study,CPT,RVU2026A,2026
93971,Extremity study,CPT,RVU2026A,2026
93975,Vascular study,CPT,RVU2026A,2026
93976,Vascular study,CPT,RVU2026A,2026
93978,Vascular study,CPT,RVU2026A,2026
93979,Vascular study,CPT,RVU2026A,2026
93980,Penile vascular study,CPT,RVU2026A,2026
93981,Penile vascular study,CPT,RVU2026A,2026
93985,Dup-scan hemo compl bi std,CPT,RVU2026A,2026
93986,Dup-scan hemo compl uni std,CPT,RVU2026A,2026
93990,Doppler flow testing,CPT,RVU2026A,2026
93998,Unlistd noninvas vasc dx std,CPT,RVU2026A,2026
94002,Vent mgmt inpat init day,CPT,RVU2026A,2026
94003,Vent mgmt inpat subq day,CPT,RVU2026A,2026
94004,Vent mgmt nf per day,CPT,RVU2026A,2026
94005,Home vent mgmt supervision,CPT,RVU2026A,2026
94010,Breathing capacity test,CPT,RVU2026A,2026
94011,Spirometry up to 2 yrs old,CPT,RVU2026A,2026
94012,Spirmtry w/brnchdil inf-2 yr,CPT,RVU2026A,2026
94013,Meas lung vol thru 2 yrs,CPT,RVU2026A,2026
94014,Patient recorded spirometry,CPT,RVU2026A,2026
94015,Patient recorded spirometry,CPT,RVU2026A,2026
94016,Review patient spirometry,CPT,RVU2026A,2026
94060,Evaluation of wheezing,CPT,RVU2026A,2026
94070,Evaluation of wheezing,CPT,RVU2026A,2026
94150,Vital capacity test,CPT,RVU2026A,2026
94200,Lung function test (mbc/mvv),CPT,RVU2026A,2026
94375,Respiratory flow volume loop,CPT,RVU2026A,2026
94450,Breathing response hypoxia,CPT,RVU2026A,2026
94452,Hast w/i&r phys/qhp,CPT,RVU2026A,2026
94453,Hast w/suppl oxygen titrj,CPT,RVU2026A,2026
94610,Intrapulm surfactant admn,CPT,RVU2026A,2026
94617,Exercise tst brncspsm w/ecg,CPT,RVU2026A,2026
94618,Pulmonary stress testing,CPT,RVU2026A,2026
94619,Exercise tst brncspsm wo ecg,CPT,RVU2026A,2026
94621,Cardiopulm exercise testing,CPT,RVU2026A,2026
94625,Phy/qhp op pulm rhb w/o mntr,CPT,RVU2026A,2026
94626,Phy/qhp op pulm rhb w/mntr,CPT,RVU2026A,2026
94640,Airway inhalation treatment,CPT,RVU2026A,2026
94642,Aerosol inhalation treatment,CPT,RVU2026A,2026
94644,Cont inhlj tx 1st hour,CPT,RVU2026A,2026
94645,Cont inhlj tx each addl hour,CPT,RVU2026A,2026
94660,Cpap initiation&mgmt,CPT,RVU2026A,2026
94664,Demo&/eval pt use inhaler,CPT,RVU2026A,2026
94667,Mnpj chest wall 1st,CPT,RVU2026A,2026
94668,Mnpj chest wall sbsq,CPT,RVU2026A,2026
94669,Mechanical chest wall oscill,CPT,RVU2026A,2026
94680,O2 uptk rst&xers dir simple,CPT,RVU2026A,2026
94681,O2 uptk co2 outp % o2 xtrc,CPT,RVU2026A,2026
94690,O2 uptk rest indirect,CPT,RVU2026A,2026
94726,Plethysmography lung volumes,CPT,RVU2026A,2026
94727,Gas dil/wshot deter lng vol,CPT,RVU2026A,2026
94728,Airwy resist by oscillometry,CPT,RVU2026A,2026
94729,Diffusing capacity,CPT,RVU2026A,2026
94760,N-invas ear/pls oximetry 1,CPT,RVU2026A,2026
94761,N-invas ear/pls oximetry mlt,CPT,RVU2026A,2026
94762,N-invas ear/pls oximtry cont,CPT,RVU2026A,2026
94772,Circadian respir pattern rec,CPT,RVU2026A,2026
94774,Ped home apnea mntr evnt rec,CPT,RVU2026A,2026
94775,Ped home apnea mntr att only,CPT,RVU2026A,2026
94776,Ped home apnea mntr dl&alys,CPT,RVU2026A,2026
94777,Ped home apnea mntr rvw i&r,CPT,RVU2026A,2026
94780,Cars/bd tst inft-12mo 60 min,CPT,RVU2026A,2026
94781,Cars/bd tst inft-12mo +30min,CPT,RVU2026A,2026
94799,Unlisted pulmonary svc/px,CPT,RVU2026A,2026
95004,Perq tests w/alrgnc xtrcs,CPT,RVU2026A,2026
95012,Nitric oxide exp gas deter,CPT,RVU2026A,2026
95017,All tstg perq&iq w/venoms,CPT,RVU2026A,2026
95018,All tstg perq&iq drugs/biol,CPT,RVU2026A,2026
95024,Iq tests w/allergenic xtrcs,CPT,RVU2026A,2026
95027,Iq tsts seql&incrl airborne,CPT,RVU2026A,2026
95028,Iq tsts allergy delayed rxn,CPT,RVU2026A,2026
95044,Patch/application tests,CPT,RVU2026A,2026
95052,Photo patch tests,CPT,RVU2026A,2026
95056,Photo tests,CPT,RVU2026A,2026
95060,Oph mucous membrane tests,CPT,RVU2026A,2026
95065,Dir nsl mucous membrane test,CPT,RVU2026A,2026
95070,Inhlj brncl challenge tstg,CPT,RVU2026A,2026
95076,Ingest challenge ini 120 min,CPT,RVU2026A,2026
95079,Ingest challenge addl 60 min,CPT,RVU2026A,2026
95115,Immunotherapy one injection,CPT,RVU2026A,2026
95117,Immunotherapy injections,CPT,RVU2026A,2026
95120,Immunotherapy one injection,CPT,RVU2026A,2026
95125,Immunotherapy 2/> injections,CPT,RVU2026A,2026
95130,Immntx 1 sting insect,CPT,RVU2026A,2026
95131,Immntx 2 sting insects,CPT,RVU2026A,2026
95132,Immntx 3 sting insects,CPT,RVU2026A,2026
95133,Immntx 4 sting insects,CPT,RVU2026A,2026
95134,Immntx 5 sting insects,CPT,RVU2026A,2026
95144,Antigen therapy services,CPT,RVU2026A,2026
95145,Antigen therapy services,CPT,RVU2026A,2026
95146,Antigen therapy services,CPT,RVU2026A,2026
95147,Antigen therapy services,CPT,RVU2026A,2026
95148,Antigen therapy services,CPT,RVU2026A,2026
95149,Antigen therapy services,CPT,RVU2026A,2026
95165,Antigen therapy services,CPT,RVU2026A,2026
95170,Antigen therapy services,CPT,RVU2026A,2026
95180,Rapid desensitization,CPT,RVU2026A,2026
95199,Unlisted all/immlg svc/px,CPT,RVU2026A,2026
95249,Cont gluc mntr pt prov eqp,CPT,RVU2026A,2026
95250,Cont gluc mntr phys/qhp eqp,CPT,RVU2026A,2026
95251,Cont gluc mntr analysis i&r,CPT,RVU2026A,2026
95700,Eeg cont rec w/vid eeg tech,CPT,RVU2026A,2026
95705,Eeg w/o vid 2-12 hr unmntr,CPT,RVU2026A,2026
95706,Eeg wo vid 2-12hr intmt mntr,CPT,RVU2026A,2026
95707,Eeg w/o vid 2-12hr cont mntr,CPT,RVU2026A,2026
95708,Eeg wo vid ea 12-26hr unmntr,CPT,RVU2026A,2026
95709,Eeg w/o vid ea 12-26hr intmt,CPT,RVU2026A,2026
95710,Eeg w/o vid ea 12-26hr cont,CPT,RVU2026A,2026
95711,Veeg 2-12 hr unmonitored,CPT,RVU2026A,2026
95712,Veeg 2-12 hr intmt mntr,CPT,RVU2026A,2026
95713,Veeg 2-12 hr cont mntr,CPT,RVU2026A,2026
95714,Veeg ea 12-26 hr unmntr,CPT,RVU2026A,2026
95715,Veeg ea 12-26hr intmt mntr,CPT,RVU2026A,2026
95716,Veeg ea 12-26hr cont mntr,CPT,RVU2026A,2026
95717,Eeg phys/qhp 2-12 hr w/o vid,CPT,RVU2026A,2026
95718,Eeg phys/qhp 2-12 hr w/veeg,CPT,RVU2026A,2026
95719,Eeg phys/qhp ea incr w/o vid,CPT,RVU2026A,2026
95720,Eeg phy/qhp ea incr w/veeg,CPT,RVU2026A,2026
95721,Eeg phy/qhp>36<60 hr w/o vid,CPT,RVU2026A,2026
95722,Eeg phy/qhp>36<60 hr w/veeg,CPT,RVU2026A,2026
95723,Eeg phy/qhp>60<84 hr w/o vid,CPT,RVU2026A,2026
95724,Eeg phy/qhp>60<84 hr w/veeg,CPT,RVU2026A,2026
95725,Eeg phy/qhp>84 hr w/o vid,CPT,RVU2026A,2026
95726,Eeg phy/qhp>84 hr w/veeg,CPT,RVU2026A,2026
95782,Polysom <6 yrs 4/> paramtrs,CPT,RVU2026A,2026
95783,Polysom <6 yrs cpap/bilvl,CPT,RVU2026A,2026
95800,Slp stdy unattended,CPT,RVU2026A,2026
95801,Slp stdy unatnd w/anal,CPT,RVU2026A,2026
95803,Actigraphy testing,CPT,RVU2026A,2026
95805,Multiple sleep latency test,CPT,RVU2026A,2026
95806,Sleep study unatt&resp efft,CPT,RVU2026A,2026
95807,Sleep study attended,CPT,RVU2026A,2026
95808,Polysom any age 1-3> param,CPT,RVU2026A,2026
95810,Polysom 6/> yrs 4/> param,CPT,RVU2026A,2026
95811,Polysom 6/>yrs cpap 4/> parm,CPT,RVU2026A,2026
95812,Eeg 41-60 minutes,CPT,RVU2026A,2026
95813,Eeg extnd mntr 61-119 min,CPT,RVU2026A,2026
95816,Eeg awake and drowsy,CPT,RVU2026A,2026
95819,Eeg awake and asleep,CPT,RVU2026A,2026
95822,Eeg coma or sleep only,CPT,RVU2026A,2026
95824,Eeg cerebral death only,CPT,RVU2026A,2026
95829,Surgery electrocorticogram,CPT,RVU2026A,2026
95830,Insert electrodes for eeg,CPT,RVU2026A,2026
95836,Ecog impltd brn npgt <30 d,CPT,RVU2026A,2026
95851,Range of motion measurements,CPT,RVU2026A,2026
95852,Range of motion measurements,CPT,RVU2026A,2026
95857,Cholinesterase challenge,CPT,RVU2026A,2026
95860,Needle emg 1 extremity,CPT,RVU2026A,2026
95861,Needle emg 2 extremities,CPT,RVU2026A,2026
95863,Needle emg 3 extremities,CPT,RVU2026A,2026
95864,Needle emg 4 extremities,CPT,RVU2026A,2026
95865,Needle emg larynx,CPT,RVU2026A,2026
95866,Needle emg hemidiaphragm,CPT,RVU2026A,2026
95867,Ndl emg cranial nrv musc uni,CPT,RVU2026A,2026
95868,Ndl emg cranial nrv musc bi,CPT,RVU2026A,2026
95869,Ndl emg thrc paraspinal musc,CPT,RVU2026A,2026
95870,Ndl emg lmtd std musc 1 xtr,CPT,RVU2026A,2026
95872,Ndl emg single fiber eltrd,CPT,RVU2026A,2026
95873,Guide nerv destr elec stim,CPT,RVU2026A,2026
95874,Guide nerv destr needle emg,CPT,RVU2026A,2026
95875,Limb exercise test,CPT,RVU2026A,2026
95885,Musc tst done w/nerv tst lim,CPT,RVU2026A,2026
95886,Musc test done w/n test comp,CPT,RVU2026A,2026
95887,Musc tst done w/n tst nonext,CPT,RVU2026A,2026
95905,Motor &/ sens nrve cndj test,CPT,RVU2026A,2026
95907,Nvr cndj tst 1-2 studies,CPT,RVU2026A,2026
95908,Nrv cndj tst 3-4 studies,CPT,RVU2026A,2026
95909,Nrv cndj tst 5-6 studies,CPT,RVU2026A,2026
95910,Nrv cndj test 7-8 studies,CPT,RVU2026A,2026
95911,Nrv cndj test 9-10 studies,CPT,RVU2026A,2026
95912,Nrv cndj test 11-12 studies,CPT,RVU2026A,2026
95913,Nrv cndj test 13/> studies,CPT,RVU2026A,2026
95919,Quan puplmtry phy/qhp uni/bi,CPT,RVU2026A,2026
95921,Autonomic nrv parasym inervj,CPT,RVU2026A,2026
95922,Autonomic nrv adrenrg inervj,CPT,RVU2026A,2026
95923,Autonomic nrv syst funj test,CPT,RVU2026A,2026
95924,Ans parasymp & symp w/tilt,CPT,RVU2026A,2026
95925,Somatosensory testing,CPT,RVU2026A,2026
95926,Somatosensory testing,CPT,RVU2026A,2026
95927,Somatosensory testing,CPT,RVU2026A,2026
95928,C motor evoked uppr limbs,CPT,RVU2026A,2026
95929,C motor evoked lwr limbs,CPT,RVU2026A,2026
95930,Visual ep test cns w/i&r,CPT,RVU2026A,2026
95933,Blink reflex test,CPT,RVU2026A,2026
95937,Neuromuscular junction test,CPT,RVU2026A,2026
95938,Somatosensory testing,CPT,RVU2026A,2026
95939,C motor evoked upr&lwr limbs,CPT,RVU2026A,2026
95940,Ionm in operatng room 15 min,CPT,RVU2026A,2026
95941,Ionm remote/>1 pt or per hr,CPT,RVU2026A,2026
95954,Eeg monitoring/giving drugs,CPT,RVU2026A,2026
95955,Eeg during surgery,CPT,RVU2026A,2026
95957,Eeg digital analysis,CPT,RVU2026A,2026
95958,Eeg monitoring/function test,CPT,RVU2026A,2026
95961,Electrode stimulation brain,CPT,RVU2026A,2026
95962,Electrode stim brain add-on,CPT,RVU2026A,2026
95965,Meg spontaneous,CPT,RVU2026A,2026
95966,Meg evoked single,CPT,RVU2026A,2026
95967,Meg evoked each addl,CPT,RVU2026A,2026
95970,Alys npgt w/o prgrmg,CPT,RVU2026A,2026
95971,Alys smpl sp/pn npgt w/prgrm,CPT,RVU2026A,2026
95972,Alys cplx sp/pn npgt w/prgrm,CPT,RVU2026A,2026
95976,Alys smpl cn npgt prgrmg,CPT,RVU2026A,2026
95977,Alys cplx cn npgt prgrmg,CPT,RVU2026A,2026
95980,Io anal gast n-stim init,CPT,RVU2026A,2026
95981,Io anal gast n-stim subsq,CPT,RVU2026A,2026
95982,Io ga n-stim subsq w/reprog,CPT,RVU2026A,2026
95983,Alys brn npgt prgrmg 15 min,CPT,RVU2026A,2026
95984,Alys brn npgt prgrmg addl 15,CPT,RVU2026A,2026
95990,Spin/brain pump refil & main,CPT,RVU2026A,2026
95991,Spin/brain pump refil & main,CPT,RVU2026A,2026
95992,Canalith repositioning proc,CPT,RVU2026A,2026
95999,Unlisted neurological dx px,CPT,RVU2026A,2026
96000,Motion analysis video/3d,CPT,RVU2026A,2026
96001,Motion test w/ft press meas,CPT,RVU2026A,2026
96002,Dynamic surface emg,CPT,RVU2026A,2026
96004,Phys review of motion tests,CPT,RVU2026A,2026
96020,Functional brain mapping,CPT,RVU2026A,2026
96041,Genetic counseling svc ea 30,CPT,RVU2026A,2026
96105,Assessment of aphasia,CPT,RVU2026A,2026
96110,Developmental screen w/score,CPT,RVU2026A,2026
96112,Devel tst phys/qhp 1st hr,CPT,RVU2026A,2026
96113,Devel tst phys/qhp ea addl,CPT,RVU2026A,2026
96116,Nubhvl xm phys/qhp 1st hr,CPT,RVU2026A,2026
96121,Nubhvl xm phy/qhp ea addl hr,CPT,RVU2026A,2026
96125,Cognitive test by hc pro,CPT,RVU2026A,2026
96127,Brief emotional/behav assmt,CPT,RVU2026A,2026
96130,Psycl tst eval phys/qhp 1st,CPT,RVU2026A,2026
96131,Psycl tst eval phys/qhp ea,CPT,RVU2026A,2026
96132,Nrpsyc tst eval phys/qhp 1st,CPT,RVU2026A,2026
96133,Nrpsyc tst eval phys/qhp ea,CPT,RVU2026A,2026
96136,Psycl/nrpsyc tst phy/qhp 1st,CPT,RVU2026A,2026
96137,Psycl/nrpsyc tst phy/qhp ea,CPT,RVU2026A,2026
96138,Psycl/nrpsyc tech 1st,CPT,RVU2026A,2026
96139,Psycl/nrpsyc tst tech ea,CPT,RVU2026A,2026
96146,Psycl/nrpsyc tst auto result,CPT,RVU2026A,2026
96156,Hlth bhv assmt/reassessment,CPT,RVU2026A,2026
96158,Hlth bhv ivntj indiv 1st 30,CPT,RVU2026A,2026
96159,Hlth bhv ivntj indiv ea addl,CPT,RVU2026A,2026
96160,Pt-focused hlth risk assmt,CPT,RVU2026A,2026
96161,Caregiver health risk assmt,CPT,RVU2026A,2026
96164,Hlth bhv ivntj grp 1st 30,CPT,RVU2026A,2026
96165,Hlth bhv ivntj grp ea addl,CPT,RVU2026A,2026
96167,Hlth bhv ivntj fam 1st 30,CPT,RVU2026A,2026
96168,Hlth bhv ivntj fam ea addl,CPT,RVU2026A,2026
96170,Hlth bhv ivntj fam wo pt 1st,CPT,RVU2026A,2026
96171,Hlth bhv ivntj fam w/o pt ea,CPT,RVU2026A,2026
96202,Mlt fam grp bhv train 1st 60,CPT,RVU2026A,2026
96203,Mlt fam grp bhv train ea add,CPT,RVU2026A,2026
96360,Hydration iv infusion init,CPT,RVU2026A,2026
96361,Hydrate iv infusion add-on,CPT,RVU2026A,2026
96365,Ther/proph/diag iv inf init,CPT,RVU2026A,2026
96366,Ther/proph/diag iv inf addon,CPT,RVU2026A,2026
96367,Tx/proph/dg addl seq iv inf,CPT,RVU2026A,2026
96368,Ther/diag concurrent inf,CPT,RVU2026A,2026
96369,Sc ther infusion up to 1 hr,CPT,RVU2026A,2026
96370,Sc ther infusion addl hr,CPT,RVU2026A,2026
96371,Sc ther infusion reset pump,CPT,RVU2026A,2026
96372,Ther/proph/diag inj sc/im,CPT,RVU2026A,2026
96373,Ther/proph/diag inj ia,CPT,RVU2026A,2026
96374,Ther/proph/diag inj iv push,CPT,RVU2026A,2026
96375,Tx/pro/dx inj new drug addon,CPT,RVU2026A,2026
96376,Tx/pro/dx inj same drug adon,CPT,RVU2026A,2026
96377,Applicaton on-body injector,CPT,RVU2026A,2026
96379,Unl ther/prop/diag inj/inf,CPT,RVU2026A,2026
96380,Admn rsv monoc antb im cnsl,CPT,RVU2026A,2026
96381,Admn rsv monoc antb im njx,CPT,RVU2026A,2026
96401,Chemo anti-neopl sq/im,CPT,RVU2026A,2026
96402,Chemo hormon antineopl sq/im,CPT,RVU2026A,2026
96405,Chemo intralesional up to 7,CPT,RVU2026A,2026
96406,Chemo intralesional over 7,CPT,RVU2026A,2026
96409,Chemo iv push sngl drug,CPT,RVU2026A,2026
96411,Chemo iv push addl drug,CPT,RVU2026A,2026
96413,Chemo iv infusion 1 hr,CPT,RVU2026A,2026
96415,Chemo iv infusion addl hr,CPT,RVU2026A,2026
96416,Chemo prolong infuse w/pump,CPT,RVU2026A,2026
96417,Chemo iv infus each addl seq,CPT,RVU2026A,2026
96420,Chemo ia push tecnique,CPT,RVU2026A,2026
96422,Chemo ia infusion up to 1 hr,CPT,RVU2026A,2026
96423,Chemo ia infuse each addl hr,CPT,RVU2026A,2026
96425,Chemotherapy infusion method,CPT,RVU2026A,2026
96440,Chmotx admn plrl cav thrcnts,CPT,RVU2026A,2026
96446,Chemotx admn pertl cav impl,CPT,RVU2026A,2026
96450,Chemotherapy into cns,CPT,RVU2026A,2026
96521,Refill/maint portable pump,CPT,RVU2026A,2026
96522,Refill/maint pump/resvr syst,CPT,RVU2026A,2026
96523,Irrig drug delivery device,CPT,RVU2026A,2026
96542,Chemotherapy injection,CPT,RVU2026A,2026
96547,Intraop hipec px 1st 60 min,CPT,RVU2026A,2026
96548,Ntraop hipec px ea add 30min,CPT,RVU2026A,2026
96549,Unlisted chemotherapy px,CPT,RVU2026A,2026
96567,Pdt dstr prmlg les skn,CPT,RVU2026A,2026
96570,Photodynmc tx 30 min add-on,CPT,RVU2026A,2026
96571,Photodynamic tx addl 15 min,CPT,RVU2026A,2026
96573,Pdt dstr prmlg les phys/qhp,CPT,RVU2026A,2026
96574,Dbrdmt prmlg les w/pdt,CPT,RVU2026A,2026
96900,Actinotherapy uv light,CPT,RVU2026A,2026
96902,Mcrscp xm hair pluck/clipped,CPT,RVU2026A,2026
96904,Whole body photography,CPT,RVU2026A,2026
96910,Photchmtx tar&uvb/ptrltm&uvb,CPT,RVU2026A,2026
96912,Photochemotherapy puva,CPT,RVU2026A,2026
96913,Photochemotx sev dermatoses,CPT,RVU2026A,2026
96920,Excimer lsr psriasis<250sqcm,CPT,RVU2026A,2026
96921,Excimer lsr psriasis 250-500,CPT,RVU2026A,2026
96922,Excimer lsr psriasis>500sqcm,CPT,RVU2026A,2026
96931,Rcm img acquisj&i&r 1st les,CPT,RVU2026A,2026
96932,Rcm img acquisj only 1st les,CPT,RVU2026A,2026
96933,Rcm i&r only 1st lesion,CPT,RVU2026A,2026
96934,Rcm img acquisj&i&r ea addl,CPT,RVU2026A,2026
96935,Rcm img acquisj only ea addl,CPT,RVU2026A,2026
96936,Rcm i&r only ea addl lesion,CPT,RVU2026A,2026
96999,Unlisted spec derm svc/px,CPT,RVU2026A,2026
97007,Mchnl sclp cool meas fitg,CPT,RVU2026A,2026
97008,Mchnl sclp cool prep plmt,CPT,RVU2026A,2026
97009,Mchnl sclp cool after chemo,CPT,RVU2026A,2026
97010,Hot or cold packs therapy,CPT,RVU2026A,2026
97012,Mechanical traction therapy,CPT,RVU2026A,2026
97014,Electric stimulation therapy,CPT,RVU2026A,2026
97016,Vasopneumatic device therapy,CPT,RVU2026A,2026
97018,Paraffin bath therapy,CPT,RVU2026A,2026
97022,Whirlpool therapy,CPT,RVU2026A,2026
97024,Diathermy eg microwave,CPT,RVU2026A,2026
97026,Infrared therapy,CPT,RVU2026A,2026
97028,Ultraviolet therapy,CPT,RVU2026A,2026
97032,Appl modality 1+estim ea 15,CPT,RVU2026A,2026
97033,App mdlty 1+iontphrsis ea 15,CPT,RVU2026A,2026
97034,App mdlty 1+cntrst bth ea 15,CPT,RVU2026A,2026
97035,App mdlty 1+ultrasound ea 15,CPT,RVU2026A,2026
97036,App mdlty 1+hubbrd tnk ea 15,CPT,RVU2026A,2026
97037,Appl modality 1+lllt po pain,CPT,RVU2026A,2026
97039,Unlisted modality,CPT,RVU2026A,2026
97110,Therapeutic exercises,CPT,RVU2026A,2026
97112,Neuromuscular reeducation,CPT,RVU2026A,2026
97113,Aquatic therapy/exercises,CPT,RVU2026A,2026
97116,Gait training therapy,CPT,RVU2026A,2026
97124,Massage therapy,CPT,RVU2026A,2026
97129,Ther ivntj 1st 15 min,CPT,RVU2026A,2026
97130,Ther ivntj ea addl 15 min,CPT,RVU2026A,2026
97139,Unlisted therapeutic px,CPT,RVU2026A,2026
97140,Manual therapy 1/> regions,CPT,RVU2026A,2026
97150,Group therapeutic procedures,CPT,RVU2026A,2026
97151,Bhv id assmt by phys/qhp,CPT,RVU2026A,2026
97152,Bhv id suprt assmt by 1 tech,CPT,RVU2026A,2026
97153,Adaptive behavior tx by tech,CPT,RVU2026A,2026
97154,Grp adapt bhv tx by tech,CPT,RVU2026A,2026
97155,Adapt behavior tx phys/qhp,CPT,RVU2026A,2026
97156,Fam adapt bhv tx gdn phy/qhp,CPT,RVU2026A,2026
97157,Mult fam adapt bhv tx gdn,CPT,RVU2026A,2026
97158,Grp adapt bhv tx by phy/qhp,CPT,RVU2026A,2026
97161,Pt eval low complex 20 min,CPT,RVU2026A,2026
97162,Pt eval mod complex 30 min,CPT,RVU2026A,2026
97163,Pt eval high complex 45 min,CPT,RVU2026A,2026
97164,Pt re-eval est plan care,CPT,RVU2026A,2026
97165,Ot eval low complex 30 min,CPT,RVU2026A,2026
97166,Ot eval mod complex 45 min,CPT,RVU2026A,2026
97167,Ot eval high complex 60 min,CPT,RVU2026A,2026
97168,Ot re-eval est plan care,CPT,RVU2026A,2026
97169,Athletic trn eval low cmplx,CPT,RVU2026A,2026
97170,Athletic trn eval mod cmplx,CPT,RVU2026A,2026
97171,Athletic trn eval high cmplx,CPT,RVU2026A,2026
97172,Athletic trn re-eval plan cr,CPT,RVU2026A,2026
97530,Therapeutic activities,CPT,RVU2026A,2026
97533,Sensory integration,CPT,RVU2026A,2026
97535,Self care mngment training,CPT,RVU2026A,2026
97537,Community/work reintegration,CPT,RVU2026A,2026
97542,Wheelchair mngment training,CPT,RVU2026A,2026
97545,Work hardening,CPT,RVU2026A,2026
97546,Work hardening add-on,CPT,RVU2026A,2026
97550,Caregiver traing 1st 30 min,CPT,RVU2026A,2026
97551,Caregiver traing ea addl 15,CPT,RVU2026A,2026
97552,Group caregiver training,CPT,RVU2026A,2026
97597,Dbrdmt opn wnd 1st 20 cm/<,CPT,RVU2026A,2026
97598,Dbrdmt opn wnd addl 20cm/<,CPT,RVU2026A,2026
97602,Wound(s) care non-selective,CPT,RVU2026A,2026
97605,Neg prs wnd ther dme<=50sqcm,CPT,RVU2026A,2026
97606,Neg prs wnd ther dme>50 sqcm,CPT,RVU2026A,2026
97607,Neg prs wnd thr ndme<=50sqcm,CPT,RVU2026A,2026
97608,Neg prs wnd ther ndme>50sqcm,CPT,RVU2026A,2026
97610,Low frequency non-thermal us,CPT,RVU2026A,2026
97750,Physical performance test,CPT,RVU2026A,2026
97755,Assistive technology assess,CPT,RVU2026A,2026
97760,Orthotic mgmt&traing 1st enc,CPT,RVU2026A,2026
97761,Prosthetic traing 1st enc,CPT,RVU2026A,2026
97763,Orthc/prostc mgmt sbsq enc,CPT,RVU2026A,2026
97799,Unlisted physcl med/rehab px,CPT,RVU2026A,2026
97802,Medical nutrition indiv in,CPT,RVU2026A,2026
97803,Med nutrition indiv subseq,CPT,RVU2026A,2026
97804,Medical nutrition group,CPT,RVU2026A,2026
97810,Acup 1/> wo estim 1st 15 min,CPT,RVU2026A,2026
97811,Acup 1/> w/o estim ea add 15,CPT,RVU2026A,2026
97813,Acup 1/> w/estim 1st 15 min,CPT,RVU2026A,2026
97814,Acup 1/> w/estim ea addl 15,CPT,RVU2026A,2026
98000,Synch audio-video new sf 15,CPT,RVU2026A,2026
98001,Synch audio-video new low 30,CPT,RVU2026A,2026
98002,Synch audio-video new mod 45,CPT,RVU2026A,2026
98003,Synch audio-video new hi 60,CPT,RVU2026A,2026
98004,Synch audio-video est sf 10,CPT,RVU2026A,2026
98005,Synch audio-video est low 20,CPT,RVU2026A,2026
98006,Synch audio-video est mod 30,CPT,RVU2026A,2026
98007,Synch audio-video est hi 40,CPT,RVU2026A,2026
98008,Synch audio-only new sf 15,CPT,RVU2026A,2026
98009,Synch audio-only new low 30,CPT,RVU2026A,2026
98010,Synch audio-only new mod 45,CPT,RVU2026A,2026
98011,Synch audio-only new high 60,CPT,RVU2026A,2026
98012,Synch audio-only est sf 10,CPT,RVU2026A,2026
98013,Synch audio-only est low 20,CPT,RVU2026A,2026
98014,Synch audio-only est mod 30,CPT,RVU2026A,2026
98015,Synch audio-only est high 40,CPT,RVU2026A,2026
98016,Brief comunicaj tech-bsd svc,CPT,RVU2026A,2026
98925,Osteopath manj 1-2 regions,CPT,RVU2026A,2026
98926,Osteopath manj 3-4 regions,CPT,RVU2026A,2026
98927,Osteopath manj 5-6 regions,CPT,RVU2026A,2026
98928,Osteopath manj 7-8 regions,CPT,RVU2026A,2026
98929,Osteopath manj 9-10 regions,CPT,RVU2026A,2026
98940,Chiropract manj 1-2 regions,CPT,RVU2026A,2026
98941,Chiropract manj 3-4 regions,CPT,RVU2026A,2026
98942,Chiropractic manj 5 regions,CPT,RVU2026A,2026
98943,Chiropract manj xtrspinl 1/>,CPT,RVU2026A,2026
98960,Edu&trn pt self-mgmt nqhp 1,CPT,RVU2026A,2026
98961,Edu&trn pt slf-mgmt nqhp 2-4,CPT,RVU2026A,2026
98962,Edu&trn pt slf-mgmt nqhp 5-8,CPT,RVU2026A,2026
98966,Ph1 assmt&mgmt nqhp 5-10,CPT,RVU2026A,2026
98967,Ph1 assmt&mgmt nqhp 11-20,CPT,RVU2026A,2026
98968,Ph1 assmt&mgmt nqhp 21-30,CPT,RVU2026A,2026
98970,Nqhp ol dig assmt&mgmt 5-10,CPT,RVU2026A,2026
98971,Nqhp ol dig assmt&mgmt 11-20,CPT,RVU2026A,2026
98972,Nqhp ol dig assmt&mgmt 21+,CPT,RVU2026A,2026
98975,Rtm 1st set-up&pt educaj eqp,CPT,RVU2026A,2026
98976,Rtm dev sply resp sys 16-30d,CPT,RVU2026A,2026
98977,Rtm dev sply mscskl 16-30 d,CPT,RVU2026A,2026
98978,Rtm dev sply cbt 16-30 d,CPT,RVU2026A,2026
98979,Rtm tx mgmt 1st 10 min,CPT,RVU2026A,2026
98980,Rtm tx mgmt 1st 20 min,CPT,RVU2026A,2026
98981,Rtm tx mgmt ea addl 20 min,CPT,RVU2026A,2026
98984,Rtm dev sply resp sys 2-15 d,CPT,RVU2026A,2026
98985,Rtm dev sply mscsk sys 2-15d,CPT,RVU2026A,2026
98986,Rtm dev sply cbt 2-15 d,CPT,RVU2026A,2026
99000,Specimen handling office-lab,CPT,RVU2026A,2026
99001,Specimen handling pt-lab,CPT,RVU2026A,2026
99002,Device handling phys/qhp,CPT,RVU2026A,2026
99024,Postop follow-up visit,CPT,RVU2026A,2026
99026,In-hospital on call service,CPT,RVU2026A,2026
99027,Out-of-hosp on call service,CPT,RVU2026A,2026
99050,Medical services after hrs,CPT,RVU2026A,2026
99051,Med serv eve/wkend/holiday,CPT,RVU2026A,2026
99053,Med serv 10pm-8am 24 hr fac,CPT,RVU2026A,2026
99056,Med service out of office,CPT,RVU2026A,2026
99058,Office emergency care,CPT,RVU2026A,2026
99060,Out of office emerg med serv,CPT,RVU2026A,2026
99070,Special supplies phys/qhp,CPT,RVU2026A,2026
99071,Patient education materials,CPT,RVU2026A,2026
99072,Addl supl matrl&staf tm phe,CPT,RVU2026A,2026
99075,Medical testimony,CPT,RVU2026A,2026
99078,Group health education,CPT,RVU2026A,2026
99080,Special reports or forms,CPT,RVU2026A,2026
99082,Unusual physician travel,CPT,RVU2026A,2026
99091,Collj & interpj data ea 30 d,CPT,RVU2026A,2026
99100,Anes pt exteme age<1 yr&>70,CPT,RVU2026A,2026
99116,Anes comp tot bdy hypthrm,CPT,RVU2026A,2026
99135,Anes comp ctrld hypotension,CPT,RVU2026A,2026
99140,Anes comp emergency cond,CPT,RVU2026A,2026
99151,Mod sed same phys/qhp <5 yrs,CPT,RVU2026A,2026
99152,Mod sed same phys/qhp 5/>yrs,CPT,RVU2026A,2026
99153,Mod sed same phys/qhp ea,CPT,RVU2026A,2026
99155,Mod sed oth phys/qhp <5 yrs,CPT,RVU2026A,2026
99156,Mod sed oth phys/qhp 5/>yrs,CPT,RVU2026A,2026
99157,Mod sed other phys/qhp ea,CPT,RVU2026A,2026
99170,Anogenital exam child w imag,CPT,RVU2026A,2026
99172,Ocular function screen,CPT,RVU2026A,2026
99173,Visual acuity screen,CPT,RVU2026A,2026
99174,Ocular instrumnt screen bil,CPT,RVU2026A,2026
99175,Induction of vomiting,CPT,RVU2026A,2026
99177,Ocular instrumnt screen bil,CPT,RVU2026A,2026
99183,Hyperbaric oxygen therapy,CPT,RVU2026A,2026
99184,Hypothermia ill neonate,CPT,RVU2026A,2026
99188,App topical fluoride varnish,CPT,RVU2026A,2026
99190,Special pump services,CPT,RVU2026A,2026
99191,Special pump services,CPT,RVU2026A,2026
99192,Special pump services,CPT,RVU2026A,2026
99195,Phlebotomy,CPT,RVU2026A,2026
99199,Unlisted special svc px/rprt,CPT,RVU2026A,2026
99202,Office o/p new sf 15 min,CPT,RVU2026A,2026
99203,Office o/p new low 30 min,CPT,RVU2026A,2026
99204,Office o/p new mod 45 min,CPT,RVU2026A,2026
99205,Office o/p new hi 60 min,CPT,RVU2026A,2026
99211,Off/op est may x req phy/qhp,CPT,RVU2026A,2026
99212,Office o/p est sf 10 min,CPT,RVU2026A,2026
99213,Office o/p est low 20 min,CPT,RVU2026A,2026
99214,Office o/p est mod 30 min,CPT,RVU2026A,2026
99215,Office o/p est hi 40 min,CPT,RVU2026A,2026
99221,1st hosp ip/obs sf/low 40,CPT,RVU2026A,2026
99222,1st hosp ip/obs moderate 55,CPT,RVU2026A,2026
99223,1st hosp ip/obs high 75,CPT,RVU2026A,2026
99231,Sbsq hosp ip/obs sf/low 25,CPT,RVU2026A,2026
99232,Sbsq hosp ip/obs moderate 35,CPT,RVU2026A,2026
99233,Sbsq hosp ip/obs high 50,CPT,RVU2026A,2026
99234,Hosp ip/obs sm dt sf/low 45,CPT,RVU2026A,2026
99235,Hosp ip/obs same date mod 70,CPT,RVU2026A,2026
99236,Hosp ip/obs same date hi 85,CPT,RVU2026A,2026
99238,Hosp ip/obs dschrg mgmt 30/<,CPT,RVU2026A,2026
99239,Hosp ip/obs dschrg mgmt >30,CPT,RVU2026A,2026
99242,Off/op consltj new/est sf 20,CPT,RVU2026A,2026
99243,Off/op cnsltj new/est low 30,CPT,RVU2026A,2026
99244,Off/op cnsltj new/est mod 40,CPT,RVU2026A,2026
99245,Off/op consltj new/est hi 55,CPT,RVU2026A,2026
99252,Ip/obs consltj new/est sf 35,CPT,RVU2026A,2026
99253,Ip/obs cnsltj new/est low 45,CPT,RVU2026A,2026
99254,Ip/obs cnsltj new/est mod 60,CPT,RVU2026A,2026
99255,Ip/obs consltj new/est hi 80,CPT,RVU2026A,2026
99281,Emr dpt vst mayx req phy/qhp,CPT,RVU2026A,2026
99282,Emergency dept visit sf mdm,CPT,RVU2026A,2026
99283,Emergency dept visit low mdm,CPT,RVU2026A,2026
99284,Emergency dept visit mod mdm,CPT,RVU2026A,2026
99285,Emergency dept visit hi mdm,CPT,RVU2026A,2026
99288,Direct advanced life support,CPT,RVU2026A,2026
99291,Critical care first hour,CPT,RVU2026A,2026
99292,Critical care addl 30 min,CPT,RVU2026A,2026
99304,1st nf care sf/low mdm 25,CPT,RVU2026A,2026
99305,1st nf care moderate mdm 35,CPT,RVU2026A,2026
99306,1st nf care high mdm 50,CPT,RVU2026A,2026
99307,Sbsq nf care sf mdm 10,CPT,RVU2026A,2026
99308,Sbsq nf care low mdm 20,CPT,RVU2026A,2026
99309,Sbsq nf care moderate mdm 30,CPT,RVU2026A,2026
99310,Sbsq nf care high mdm 45,CPT,RVU2026A,2026
99315,Nf dschrg mgmt 30 min/less,CPT,RVU2026A,2026
99316,Nf dschrg mgmt 30 min+,CPT,RVU2026A,2026
99341,Home/res vst new sf mdm 15,CPT,RVU2026A,2026
99342,Home/res vst new low mdm 30,CPT,RVU2026A,2026
99344,Home/res vst new mod mdm 60,CPT,RVU2026A,2026
99345,Home/res vst new high mdm 75,CPT,RVU2026A,2026
99347,Home/res vst est sf mdm 20,CPT,RVU2026A,2026
99348,Home/res vst est low mdm 30,CPT,RVU2026A,2026
99349,Home/res vst est mod mdm 40,CPT,RVU2026A,2026
99350,Home/res vst est high mdm 60,CPT,RVU2026A,2026
99358,Prolong service w/o contact,CPT,RVU2026A,2026
99359,Prolong serv w/o contact add,CPT,RVU2026A,2026
99360,Physician standby services,CPT,RVU2026A,2026
99366,Team conf w/pat by hc prof,CPT,RVU2026A,2026
99367,Team conf w/o pat by phys,CPT,RVU2026A,2026
99368,Team conf w/o pat by hc pro,CPT,RVU2026A,2026
99374,Home health care supervision,CPT,RVU2026A,2026
99375,Home health care supervision,CPT,RVU2026A,2026
99377,Hospice care supervision,CPT,RVU2026A,2026
99378,Hospice care supervision,CPT,RVU2026A,2026
99379,Nursing fac care supervision,CPT,RVU2026A,2026
99380,Nursing fac care supervision,CPT,RVU2026A,2026
99381,Init pm e/m new pat infant,CPT,RVU2026A,2026
99382,Init pm e/m new pat 1-4 yrs,CPT,RVU2026A,2026
99383,Prev visit new age 5-11,CPT,RVU2026A,2026
99384,Prev visit new age 12-17,CPT,RVU2026A,2026
99385,Prev visit new age 18-39,CPT,RVU2026A,2026
99386,Prev visit new age 40-64,CPT,RVU2026A,2026
99387,Init pm e/m new pat 65+ yrs,CPT,RVU2026A,2026
99391,Per pm reeval est pat infant,CPT,RVU2026A,2026
99392,Prev visit est age 1-4,CPT,RVU2026A,2026
99393,Prev visit est age 5-11,CPT,RVU2026A,2026
99394,Prev visit est age 12-17,CPT,RVU2026A,2026
99395,Prev visit est age 18-39,CPT,RVU2026A,2026
99396,Prev visit est age 40-64,CPT,RVU2026A,2026
99397,Per pm reeval est pat 65+ yr,CPT,RVU2026A,2026
99401,Prev med cnsl indiv apprx 15,CPT,RVU2026A,2026
99402,Prev med cnsl indiv apprx 30,CPT,RVU2026A,2026
99403,Prev med cnsl indiv apprx 45,CPT,RVU2026A,2026
99404,Prev med cnsl indiv apprx 60,CPT,RVU2026A,2026
99406,Behav chng smoking 3-10 min,CPT,RVU2026A,2026
99407,Behav chng smoking > 10 min,CPT,RVU2026A,2026
99408,Audit/dast 15-30 min,CPT,RVU2026A,2026
99409,Audit/dast over 30 min,CPT,RVU2026A,2026
99411,Preventive counseling group,CPT,RVU2026A,2026
99412,Preventive counseling group,CPT,RVU2026A,2026
99415,Prolng clin staff svc 1st hr,CPT,RVU2026A,2026
99416,Prolng clin staff svc ea add,CPT,RVU2026A,2026
99417,Prolng op e/m each 15 min,CPT,RVU2026A,2026
99418,Prolng ip/obs e/m ea 15 min,CPT,RVU2026A,2026
99421,Ol dig e/m svc 5-10 min,CPT,RVU2026A,2026
99422,Ol dig e/m svc 11-20 min,CPT,RVU2026A,2026
99423,Ol dig e/m svc 21+ min,CPT,RVU2026A,2026
99424,Prin care mgmt phys 1st 30,CPT,RVU2026A,2026
99425,Prin care mgmt phys ea addl,CPT,RVU2026A,2026
99426,Prin care mgmt staff 1st 30,CPT,RVU2026A,2026
99427,Prin care mgmt staff ea addl,CPT,RVU2026A,2026
99429,Unlisted preventive service,CPT,RVU2026A,2026
99437,Chrnc care mgmt phys ea addl,CPT,RVU2026A,2026
99439,Chrnc care mgmt staf ea addl,CPT,RVU2026A,2026
99445,Rem mntr physiol param 2-15,CPT,RVU2026A,2026
99446,Ntrprof ph1/ntrnet/ehr 5-10,CPT,RVU2026A,2026
99447,Ntrprof ph1/ntrnet/ehr 11-20,CPT,RVU2026A,2026
99448,Ntrprof ph1/ntrnet/ehr 21-30,CPT,RVU2026A,2026
99449,Ntrprof ph1/ntrnet/ehr 31/>,CPT,RVU2026A,2026
99450,Basic life disability exam,CPT,RVU2026A,2026
99451,Ntrprof ph1/ntrnet/ehr 5/>,CPT,RVU2026A,2026
99452,Ntrprof ph1/ntrnet/ehr rfrl,CPT,RVU2026A,2026
99453,Rem mntr physiol param setup,CPT,RVU2026A,2026
99454,Rem mntr physiol param 16-30,CPT,RVU2026A,2026
99455,Work related disability exam,CPT,RVU2026A,2026
99456,Disability examination,CPT,RVU2026A,2026
99457,Rpm tx mgmt 1st 20 min,CPT,RVU2026A,2026
99458,Rpm tx mgmt ea addl 20 min,CPT,RVU2026A,2026
99459,Pelvic examination,CPT,RVU2026A,2026
99460,Init nb em per day hosp,CPT,RVU2026A,2026
99461,Init nb em per day non-fac,CPT,RVU2026A,2026
99462,Sbsq nb em per day hosp,CPT,RVU2026A,2026
99463,Same day nb discharge,CPT,RVU2026A,2026
99464,Attendance at delivery,CPT,RVU2026A,2026
99465,Nb resuscitation,CPT,RVU2026A,2026
99466,Ped crit care transport,CPT,RVU2026A,2026
99467,Ped crit care transport addl,CPT,RVU2026A,2026
99468,Neonate crit care initial,CPT,RVU2026A,2026
99469,Neonate crit care subsq,CPT,RVU2026A,2026
99470,Rpm tx mgmt 1st 10 min,CPT,RVU2026A,2026
99471,Ped critical care initial,CPT,RVU2026A,2026
99472,Ped critical care subsq,CPT,RVU2026A,2026
99473,Self-meas bp pt educaj/train,CPT,RVU2026A,2026
99474,Self-meas bp 2 readg bid 30d,CPT,RVU2026A,2026
99475,Ped crit care age 2-5 init,CPT,RVU2026A,2026
99476,Ped crit care age 2-5 subsq,CPT,RVU2026A,2026
99477,Init day hosp neonate care,CPT,RVU2026A,2026
99478,"Sbsq ic vlbw inf<1,500 gm",CPT,RVU2026A,2026
99479,"Sbsq ic lbw inf 1,500-2,500",CPT,RVU2026A,2026
99480,"Sbsq ic inf pbw 2,501-5,000",CPT,RVU2026A,2026
99483,Assmt & care pln pt cog imp,CPT,RVU2026A,2026
99484,Care mgmt svc bhvl hlth cond,CPT,RVU2026A,2026
99485,Suprv interfacilty transport,CPT,RVU2026A,2026
99486,Suprv interfac trnsport addl,CPT,RVU2026A,2026
99487,Cplx chrnc care 1st 60 min,CPT,RVU2026A,2026
99489,Cplx chrnc care ea addl 30,CPT,RVU2026A,2026
99490,Chrnc care mgmt staff 1st 20,CPT,RVU2026A,2026
99491,Chrnc care mgmt phys 1st 30,CPT,RVU2026A,2026
99492,1st psyc collab care mgmt,CPT,RVU2026A,2026
99493,Sbsq psyc collab care mgmt,CPT,RVU2026A,2026
99494,1st/sbsq psyc collab care,CPT,RVU2026A,2026
99495,Transj care mgmt mod f2f 14d,CPT,RVU2026A,2026
99496,Transj care mgmt high f2f 7d,CPT,RVU2026A,2026
99497,Advncd care plan 30 min,CPT,RVU2026A,2026
99498,Advncd care plan addl 30 min,CPT,RVU2026A,2026
99499,Unlisted e&m service,CPT,RVU2026A,2026
99500,Home visit prenatal,CPT,RVU2026A,2026
99501,Home visit postnatal,CPT,RVU2026A,2026
99502,Home visit nb care,CPT,RVU2026A,2026
99503,Home visit resp therapy,CPT,RVU2026A,2026
99504,Home visit mech ventilator,CPT,RVU2026A,2026
99505,Home visit stoma care,CPT,RVU2026A,2026
99506,Home visit im injection,CPT,RVU2026A,2026
99507,Home visit cath maintain,CPT,RVU2026A,2026
99509,Home visit day life activity,CPT,RVU2026A,2026
99510,Home visit sing/m/fam couns,CPT,RVU2026A,2026
99511,Home visit fecal/enema mgmt,CPT,RVU2026A,2026
99512,Home visit for hemodialysis,CPT,RVU2026A,2026
99600,Unlisted home visit svc/px,CPT,RVU2026A,2026
99601,Home nfs visit <2 hrs,CPT,RVU2026A,2026
99602,Home nfs visit each addl hr,CPT,RVU2026A,2026
99605,Mtms by pharm np 15 min,CPT,RVU2026A,2026
99606,Mtms by pharm est 15 min,CPT,RVU2026A,2026
99607,Mtms by pharm addl 15 min,CPT,RVU2026A,2026
A0021,"Ambulance service, outside state per mile, transport (medicaid only)",HCPCS_Level_II,HCPC2026_JAN,2026
A0080,"Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest",HCPCS_Level_II,HCPC2026_JAN,2026
A0090,"Non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest",HCPCS_Level_II,HCPC2026_JAN,2026
A0100,Non-emergency transportation; taxi,HCPCS_Level_II,HCPC2026_JAN,2026
A0110,"Non-emergency transportation and bus, intra or inter state carrier",HCPCS_Level_II,HCPC2026_JAN,2026
A0120,"Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems",HCPCS_Level_II,HCPC2026_JAN,2026
A0130,Non-emergency transportation: wheelchair van,HCPCS_Level_II,HCPC2026_JAN,2026
A0140,Non-emergency transportation and air travel (private or commercial) intra or inter state,HCPCS_Level_II,HCPC2026_JAN,2026
A0160,Non-emergency transportation: per mile - case worker or social worker,HCPCS_Level_II,HCPC2026_JAN,2026
A0170,"Transportation ancillary: parking fees, tolls, other",HCPCS_Level_II,HCPC2026_JAN,2026
A0180,Non-emergency transportation: ancillary: lodging-recipient,HCPCS_Level_II,HCPC2026_JAN,2026
A0190,Non-emergency transportation: ancillary: meals-recipient,HCPCS_Level_II,HCPC2026_JAN,2026
A0200,Non-emergency transportation: ancillary: lodging escort,HCPCS_Level_II,HCPC2026_JAN,2026
A0210,Non-emergency transportation: ancillary: meals-escort,HCPCS_Level_II,HCPC2026_JAN,2026
A0225,"Ambulance service, neonatal transport, base rate, emergency transport, one way",HCPCS_Level_II,HCPC2026_JAN,2026
A0380,Bls mileage (per mile),HCPCS_Level_II,HCPC2026_JAN,2026
A0382,Bls routine disposable supplies,HCPCS_Level_II,HCPC2026_JAN,2026
A0384,Bls specialized service disposable supplies; defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances),HCPCS_Level_II,HCPC2026_JAN,2026
A0390,Als mileage (per mile),HCPCS_Level_II,HCPC2026_JAN,2026
A0392,Als specialized service disposable supplies; defibrillation (to be used only in jurisdictions where defibrillation cannot be performed in bls ambulances),HCPCS_Level_II,HCPC2026_JAN,2026
A0394,Als specialized service disposable supplies; iv drug therapy,HCPCS_Level_II,HCPC2026_JAN,2026
A0396,Als specialized service disposable supplies; esophageal intubation,HCPCS_Level_II,HCPC2026_JAN,2026
A0398,Als routine disposable supplies,HCPCS_Level_II,HCPC2026_JAN,2026
A0420,"Ambulance waiting time (als or bls), one half (1/2) hour increments",HCPCS_Level_II,HCPC2026_JAN,2026
A0422,"Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation",HCPCS_Level_II,HCPC2026_JAN,2026
A0424,"Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)",HCPCS_Level_II,HCPC2026_JAN,2026
A0425,"Ground mileage, per statute mile",HCPCS_Level_II,HCPC2026_JAN,2026
A0426,"Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)",HCPCS_Level_II,HCPC2026_JAN,2026
A0427,"Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)",HCPCS_Level_II,HCPC2026_JAN,2026
A0428,"Ambulance service, basic life support, non-emergency transport, (bls)",HCPCS_Level_II,HCPC2026_JAN,2026
A0429,"Ambulance service, basic life support, emergency transport (bls-emergency)",HCPCS_Level_II,HCPC2026_JAN,2026
A0430,"Ambulance service, conventional air services, transport, one way (fixed wing)",HCPCS_Level_II,HCPC2026_JAN,2026
A0431,"Ambulance service, conventional air services, transport, one way (rotary wing)",HCPCS_Level_II,HCPC2026_JAN,2026
A0432,"Paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers",HCPCS_Level_II,HCPC2026_JAN,2026
A0433,"Advanced life support, level 2 (als 2)",HCPCS_Level_II,HCPC2026_JAN,2026
A0434,Specialty care transport (sct),HCPCS_Level_II,HCPC2026_JAN,2026
A0435,"Fixed wing air mileage, per statute mile",HCPCS_Level_II,HCPC2026_JAN,2026
A0436,"Rotary wing air mileage, per statute mile",HCPCS_Level_II,HCPC2026_JAN,2026
A0888,"Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)",HCPCS_Level_II,HCPC2026_JAN,2026
A0998,"Ambulance response and treatment, no transport",HCPCS_Level_II,HCPC2026_JAN,2026
A0999,Unlisted ambulance service,HCPCS_Level_II,HCPC2026_JAN,2026
A1,Dressing for one wound,HCPCS_Level_II,HCPC2026_JAN,2026
A2,Dressing for two wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A2001,"Innovamatrix ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2002,"Mirragen advanced wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2004,"Xcellistem, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A2005,"Microlyte matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2006,"Novosorb synpath dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2007,"Restrata, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2008,"Theragenesis, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2009,"Symphony, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2010,"Apis, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2011,"Supra sdrm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2012,"Suprathel, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2013,"Innovamatrix fs, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2014,"Omeza collagen matrix, per 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A2015,"Phoenix wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2016,"Permeaderm b, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2017,"Permeaderm glove, each",HCPCS_Level_II,HCPC2026_JAN,2026
A2018,"Permeaderm c, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2019,"Kerecis omega3 marigen shield, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2020,Ac5 advanced wound system (ac5),HCPCS_Level_II,HCPC2026_JAN,2026
A2021,"Neomatrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2022,"Innovaburn or innovamatrix xl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2023,"Innovamatrix pd, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A2024,"Resolve matrix or xenopatch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2025,"Miro3d, per cubic centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2026,"Restrata minimatrix, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A2027,"Matriderm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2028,"Micromatrix flex, per mg",HCPCS_Level_II,HCPC2026_JAN,2026
A2029,"Mirotract wound matrix sheet, per cubic centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2030,"Miro3d fibers, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
A2031,"Mirodry wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2032,"Myriad matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2033,"Myriad morcells, 4 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
A2034,"Foundation drs solo, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2035,"Corplex p or theracor p or allacor p, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
A2036,"Cohealyx collagen dermal matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2037,"G4derm plus, per milliliter",HCPCS_Level_II,HCPC2026_JAN,2026
A2038,"Marigen pacto, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A2039,"Innovamatrix fd, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A3,Dressing for three wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A4,Dressing for four wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A4100,"Non-sheet form skin substitute, fda cleared as a device, not otherwise specified (list in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
A4206,"Syringe with needle, sterile, 1 cc or less, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4207,"Syringe with needle, sterile 2 cc, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4208,"Syringe with needle, sterile 3 cc, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4209,"Syringe with needle, sterile 5 cc or greater, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4210,"Needle-free injection device, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4211,Supplies for self-administered injections,HCPCS_Level_II,HCPC2026_JAN,2026
A4212,Non-coring needle or stylet with or without catheter,HCPCS_Level_II,HCPC2026_JAN,2026
A4213,"Syringe, sterile, 20 cc or greater, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4215,"Needle, sterile, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4216,"Sterile water, saline and/or dextrose, diluent/flush, 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4217,"Sterile water/saline, 500 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4218,"Sterile saline or water, metered dose dispenser, 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4220,Refill kit for implantable infusion pump,HCPCS_Level_II,HCPC2026_JAN,2026
A4221,"Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs  separately)",HCPCS_Level_II,HCPC2026_JAN,2026
A4222,"Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)",HCPCS_Level_II,HCPC2026_JAN,2026
A4223,"Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)",HCPCS_Level_II,HCPC2026_JAN,2026
A4224,"Supplies for maintenance of insulin infusion catheter, per week",HCPCS_Level_II,HCPC2026_JAN,2026
A4225,"Supplies for external insulin infusion pump, syringe type cartridge, sterile, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4226,"Supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week",HCPCS_Level_II,HCPC2026_JAN,2026
A4230,"Infusion set for external insulin pump, non needle cannula type",HCPCS_Level_II,HCPC2026_JAN,2026
A4231,"Infusion set for external insulin pump, needle type",HCPCS_Level_II,HCPC2026_JAN,2026
A4232,"Syringe with needle for external insulin pump, sterile, 3 cc",HCPCS_Level_II,HCPC2026_JAN,2026
A4233,"Replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4234,"Replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4235,"Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4236,"Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4238,"Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service",HCPCS_Level_II,HCPC2026_JAN,2026
A4239,"Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service",HCPCS_Level_II,HCPC2026_JAN,2026
A4244,"Alcohol or peroxide, per pint",HCPCS_Level_II,HCPC2026_JAN,2026
A4245,"Alcohol wipes, per box",HCPCS_Level_II,HCPC2026_JAN,2026
A4246,"Betadine or phisohex solution, per pint",HCPCS_Level_II,HCPC2026_JAN,2026
A4247,"Betadine or iodine swabs/wipes, per box",HCPCS_Level_II,HCPC2026_JAN,2026
A4248,"Chlorhexidine containing antiseptic, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4250,Urine test or reagent strips or tablets (100 tablets or strips),HCPCS_Level_II,HCPC2026_JAN,2026
A4252,"Blood ketone test or reagent strip, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4253,"Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips",HCPCS_Level_II,HCPC2026_JAN,2026
A4255,"Platforms for home blood glucose monitor, 50 per box",HCPCS_Level_II,HCPC2026_JAN,2026
A4256,"Normal, low and high calibrator solution / chips",HCPCS_Level_II,HCPC2026_JAN,2026
A4257,"Replacement lens shield cartridge for use with laser skin piercing device, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4258,"Spring-powered device for lancet, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4259,"Lancets, per box of 100",HCPCS_Level_II,HCPC2026_JAN,2026
A4261,Cervical cap for contraceptive use,HCPCS_Level_II,HCPC2026_JAN,2026
A4262,"Temporary, absorbable lacrimal duct implant, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4263,"Permanent, long term, non-dissolvable lacrimal duct implant, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4264,Permanent implantable contraceptive intratubal occlusion device(s) and delivery system,HCPCS_Level_II,HCPC2026_JAN,2026
A4265,"Paraffin, per pound",HCPCS_Level_II,HCPC2026_JAN,2026
A4266,Diaphragm for contraceptive use,HCPCS_Level_II,HCPC2026_JAN,2026
A4267,"Contraceptive supply, condom, male, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4268,"Contraceptive supply, condom, female, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4269,"Contraceptive supply, spermicide (e.g., foam, gel), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4270,"Disposable endoscope sheath, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4271,"Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per 50 tests",HCPCS_Level_II,HCPC2026_JAN,2026
A4280,"Adhesive skin support attachment for use with external breast prosthesis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4281,"Tubing for breast pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4282,"Adapter for breast pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4283,"Cap for breast pump bottle, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4284,"Breast shield and splash protector for use with breast pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4285,"Polycarbonate bottle for use with breast pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4286,"Locking ring for breast pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4287,"Disposable collection and storage bag for breast milk, any size, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4288,"Valve for breast pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4290,"Sacral nerve stimulation test lead, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4295,"Intermittent urinary catheter; straight tip, hydrophilic coating, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4296,"Intermittent urinary catheter; coude (curved) tip, hydrophilic coating, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4297,"Intermittent urinary catheter; hydrophilic coating, with insertion supplies",HCPCS_Level_II,HCPC2026_JAN,2026
A4300,"Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access",HCPCS_Level_II,HCPC2026_JAN,2026
A4301,"Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
A4305,"Disposable drug delivery system, flow rate of 50 ml or greater per hour",HCPCS_Level_II,HCPC2026_JAN,2026
A4306,"Disposable drug delivery system, flow rate of less than 50 ml per hour",HCPCS_Level_II,HCPC2026_JAN,2026
A4310,Insertion tray without drainage bag and without catheter (accessories only),HCPCS_Level_II,HCPC2026_JAN,2026
A4311,"Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
A4312,"Insertion tray without drainage bag with indwelling catheter, foley type, two-way, all silicone",HCPCS_Level_II,HCPC2026_JAN,2026
A4313,"Insertion tray without drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation",HCPCS_Level_II,HCPC2026_JAN,2026
A4314,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
A4315,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone",HCPCS_Level_II,HCPC2026_JAN,2026
A4316,"Insertion tray with drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation",HCPCS_Level_II,HCPC2026_JAN,2026
A4320,"Irrigation tray with bulb or piston syringe, any purpose",HCPCS_Level_II,HCPC2026_JAN,2026
A4321,Therapeutic agent for urinary catheter irrigation,HCPCS_Level_II,HCPC2026_JAN,2026
A4322,"Irrigation syringe, bulb or piston, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4326,"Male external catheter with integral collection chamber, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4327,"Female external urinary collection device; meatal cup, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4328,"Female external urinary collection device; pouch, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4330,"Perianal fecal collection pouch with adhesive, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4331,"Extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4332,"Lubricant, individual sterile packet, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4333,"Urinary catheter anchoring device, adhesive skin attachment, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4334,"Urinary catheter anchoring device, leg strap, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4335,Incontinence supply; miscellaneous,HCPCS_Level_II,HCPC2026_JAN,2026
A4336,"Incontinence supply, urethral insert, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4337,"Incontinence supply, rectal insert, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4338,"Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4340,"Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4341,"Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4342,"Accessories for patient inserted indwelling intraurethral drainage device with valve, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4344,"Indwelling catheter, foley type, two-way, all silicone or polyurethane, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4346,"Indwelling catheter; foley type, three way for continuous irrigation, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4349,"Male external catheter, with or without adhesive, disposable, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4351,"Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4352,"Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, or silicone elastomeric, etc.), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4353,"Intermittent urinary catheter, with insertion supplies",HCPCS_Level_II,HCPC2026_JAN,2026
A4354,Insertion tray with drainage bag but without catheter,HCPCS_Level_II,HCPC2026_JAN,2026
A4355,"Irrigation tubing set for continuous bladder irrigation through a three-way indwelling foley catheter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4356,"External urethral clamp or compression device (not to be used for catheter clamp), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4357,"Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4358,"Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4360,"Disposable external urethral clamp or compression device, with pad and/or pouch, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4361,"Ostomy faceplate, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4362,"Skin barrier; solid, 4 x 4 or equivalent; each",HCPCS_Level_II,HCPC2026_JAN,2026
A4363,"Ostomy clamp, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4364,"Adhesive, liquid or equal, any type, per oz",HCPCS_Level_II,HCPC2026_JAN,2026
A4366,"Ostomy vent, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4367,"Ostomy belt, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4368,"Ostomy filter, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4369,"Ostomy skin barrier, liquid (spray, brush, etc.), per oz",HCPCS_Level_II,HCPC2026_JAN,2026
A4371,"Ostomy skin barrier, powder, per oz",HCPCS_Level_II,HCPC2026_JAN,2026
A4372,"Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4373,"Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4375,"Ostomy pouch, drainable, with faceplate attached, plastic, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4376,"Ostomy pouch, drainable, with faceplate attached, rubber, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4377,"Ostomy pouch, drainable, for use on faceplate, plastic, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4378,"Ostomy pouch, drainable, for use on faceplate, rubber, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4379,"Ostomy pouch, urinary, with faceplate attached, plastic, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4380,"Ostomy pouch, urinary, with faceplate attached, rubber, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4381,"Ostomy pouch, urinary, for use on faceplate, plastic, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4382,"Ostomy pouch, urinary, for use on faceplate, heavy plastic, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4383,"Ostomy pouch, urinary, for use on faceplate, rubber, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4384,"Ostomy faceplate equivalent, silicone ring, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4385,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4387,"Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4388,"Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4389,"Ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4390,"Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4391,"Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4392,"Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4393,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4394,"Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A4395,"Ostomy deodorant for use in ostomy pouch, solid, per tablet",HCPCS_Level_II,HCPC2026_JAN,2026
A4396,Ostomy belt with peristomal hernia support,HCPCS_Level_II,HCPC2026_JAN,2026
A4397,"Irrigation supply; sleeve, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4398,"Ostomy irrigation supply; bag, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4399,"Ostomy irrigation supply; cone/catheter, with or without brush",HCPCS_Level_II,HCPC2026_JAN,2026
A4400,Ostomy irrigation set,HCPCS_Level_II,HCPC2026_JAN,2026
A4402,"Lubricant, per ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A4404,"Ostomy ring, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4405,"Ostomy skin barrier, non-pectin based, paste, per ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A4406,"Ostomy skin barrier, pectin-based, paste, per ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A4407,"Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4408,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, with built-in convexity, larger than 4 x 4 inches, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4409,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4410,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4411,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4412,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4413,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), with filter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4414,"Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4415,"Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, larger than 4 x 4 inches, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4416,"Ostomy pouch, closed, with barrier attached, with filter (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4417,"Ostomy pouch, closed, with barrier attached, with built-in convexity, with filter (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4418,"Ostomy pouch, closed; without barrier attached, with filter (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4419,"Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4420,"Ostomy pouch, closed; for use on barrier with locking flange (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4421,Ostomy supply; miscellaneous,HCPCS_Level_II,HCPC2026_JAN,2026
A4422,"Ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to thicken liquid stomal output, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4423,"Ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4424,"Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4425,"Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4426,"Ostomy pouch, drainable; for use on barrier with locking flange (2 piece system), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4427,"Ostomy pouch, drainable; for use on barrier with locking flange, with filter (2 piece system), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4428,"Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4429,"Ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4430,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4431,"Ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4432,"Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4433,"Ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4434,"Ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type tap with valve (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4435,"Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4436,"Irrigation supply; sleeve, reusable, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A4437,"Irrigation supply; sleeve, disposable, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A4438,"Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4450,"Tape, non-waterproof, per 18 square inches",HCPCS_Level_II,HCPC2026_JAN,2026
A4452,"Tape, waterproof, per 18 square inches",HCPCS_Level_II,HCPC2026_JAN,2026
A4453,"Rectal catheter with or without balloon, for use with any type transanal irrigation system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4455,"Adhesive remover or solvent (for tape, cement or other adhesive), per ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A4456,"Adhesive remover, wipes, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4457,"Enema tube, with or without adapter, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4458,"Enema bag with tubing, reusable",HCPCS_Level_II,HCPC2026_JAN,2026
A4459,"Manual transanal irrigation system, includes water reservoir, pump, tubing, and accessories, without catheter, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A4461,"Surgical dressing holder, non-reusable, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4463,"Surgical dressing holder, reusable, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4465,Non-elastic binder for extremity,HCPCS_Level_II,HCPC2026_JAN,2026
A4466,"Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4467,"Belt, strap, sleeve, garment, or covering, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A4468,"Exsufflation belt, includes all supplies and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A4470,Gravlee jet washer,HCPCS_Level_II,HCPC2026_JAN,2026
A4480,Vabra aspirator,HCPCS_Level_II,HCPC2026_JAN,2026
A4481,"Tracheostoma filter, any type, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4483,"Moisture exchanger, disposable, for use with invasive mechanical ventilation",HCPCS_Level_II,HCPC2026_JAN,2026
A4490,"Surgical stockings above knee length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4495,"Surgical stockings thigh length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4500,"Surgical stockings below knee length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4510,"Surgical stockings full length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4520,"Incontinence garment, any type, (e.g., brief, diaper), each",HCPCS_Level_II,HCPC2026_JAN,2026
A4540,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm",HCPCS_Level_II,HCPC2026_JAN,2026
A4541,Monthly supplies for use of device coded at e0733,HCPCS_Level_II,HCPC2026_JAN,2026
A4542,Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist,HCPCS_Level_II,HCPC2026_JAN,2026
A4543,"Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A4544,Electrode for external lower extremity nerve stimulator for restless legs syndrome,HCPCS_Level_II,HCPC2026_JAN,2026
A4545,"Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month",HCPCS_Level_II,HCPC2026_JAN,2026
A4550,Surgical trays,HCPCS_Level_II,HCPC2026_JAN,2026
A4553,"Non-disposable underpads, all sizes",HCPCS_Level_II,HCPC2026_JAN,2026
A4554,"Disposable underpads, all sizes",HCPCS_Level_II,HCPC2026_JAN,2026
A4555,"Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
A4556,"Electrodes, (e.g., apnea monitor), per pair",HCPCS_Level_II,HCPC2026_JAN,2026
A4557,"Lead wires, (e.g., apnea monitor), per pair",HCPCS_Level_II,HCPC2026_JAN,2026
A4558,"Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz",HCPCS_Level_II,HCPC2026_JAN,2026
A4559,"Coupling gel or paste, for use with ultrasound device, per oz",HCPCS_Level_II,HCPC2026_JAN,2026
A4560,"Neuromuscular electrical stimulator (nmes), disposable, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
A4561,"Pessary, reusable, rubber, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A4562,"Pessary, reusable, non rubber, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A4563,"Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each",HCPCS_Level_II,HCPC2026_JAN,2026
A4564,"Pessary, disposable, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A4565,Slings,HCPCS_Level_II,HCPC2026_JAN,2026
A4566,"Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
A4570,Splint,HCPCS_Level_II,HCPC2026_JAN,2026
A4575,"Topical hyperbaric oxygen chamber, disposable",HCPCS_Level_II,HCPC2026_JAN,2026
A4580,"Cast supplies (e.g., plaster)",HCPCS_Level_II,HCPC2026_JAN,2026
A4590,"Special casting material (e.g., fiberglass)",HCPCS_Level_II,HCPC2026_JAN,2026
A4593,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, controller",HCPCS_Level_II,HCPC2026_JAN,2026
A4594,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each",HCPCS_Level_II,HCPC2026_JAN,2026
A4595,"Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)",HCPCS_Level_II,HCPC2026_JAN,2026
A4596,"Cranial electrotherapy stimulation (ces) system supplies and accessories, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A4600,"Sleeve for intermittent limb compression device, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4601,"Lithium ion battery, rechargeable, for non-prosthetic use, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4602,"Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4604,Tubing with integrated heating element for use with positive airway pressure device,HCPCS_Level_II,HCPC2026_JAN,2026
A4605,"Tracheal suction catheter, closed system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4606,"Oxygen probe for use with oximeter device, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
A4608,"Transtracheal oxygen catheter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4611,"Battery, heavy duty; replacement for patient owned ventilator",HCPCS_Level_II,HCPC2026_JAN,2026
A4612,Battery cables; replacement for patient-owned ventilator,HCPCS_Level_II,HCPC2026_JAN,2026
A4613,Battery charger; replacement for patient-owned ventilator,HCPCS_Level_II,HCPC2026_JAN,2026
A4614,"Peak expiratory flow rate meter, hand held",HCPCS_Level_II,HCPC2026_JAN,2026
A4615,"Cannula, nasal",HCPCS_Level_II,HCPC2026_JAN,2026
A4616,"Tubing (oxygen), per foot",HCPCS_Level_II,HCPC2026_JAN,2026
A4617,Mouth piece,HCPCS_Level_II,HCPC2026_JAN,2026
A4618,Breathing circuits,HCPCS_Level_II,HCPC2026_JAN,2026
A4619,Face tent,HCPCS_Level_II,HCPC2026_JAN,2026
A4620,Variable concentration mask,HCPCS_Level_II,HCPC2026_JAN,2026
A4623,"Tracheostomy, inner cannula",HCPCS_Level_II,HCPC2026_JAN,2026
A4624,"Tracheal suction catheter, any type other than closed system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4625,Tracheostomy care kit for new tracheostomy,HCPCS_Level_II,HCPC2026_JAN,2026
A4626,"Tracheostomy cleaning brush, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4627,"Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler",HCPCS_Level_II,HCPC2026_JAN,2026
A4628,"Oral and/or oropharyngeal suction catheter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4629,Tracheostomy care kit for established tracheostomy,HCPCS_Level_II,HCPC2026_JAN,2026
A4630,"Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient",HCPCS_Level_II,HCPC2026_JAN,2026
A4633,"Replacement bulb/lamp for ultraviolet light therapy system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4634,"Replacement bulb for therapeutic light box, tabletop model",HCPCS_Level_II,HCPC2026_JAN,2026
A4635,"Underarm pad, crutch, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4636,"Replacement, handgrip, cane, crutch, or walker, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4637,"Replacement, tip, cane, crutch, walker, each.",HCPCS_Level_II,HCPC2026_JAN,2026
A4638,"Replacement battery for patient-owned ear pulse generator, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4639,"Replacement pad for infrared heating pad system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4640,Replacement pad for use with medically necessary alternating pressure pad owned by patient,HCPCS_Level_II,HCPC2026_JAN,2026
A4641,"Radiopharmaceutical, diagnostic, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A4642,"Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A4648,"Tissue marker, implantable, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4649,Surgical supply; miscellaneous,HCPCS_Level_II,HCPC2026_JAN,2026
A4650,"Implantable radiation dosimeter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4651,"Calibrated microcapillary tube, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4652,Microcapillary tube sealant,HCPCS_Level_II,HCPC2026_JAN,2026
A4653,"Peritoneal dialysis catheter anchoring device, belt, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4657,"Syringe, with or without needle, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4660,Sphygmomanometer/blood pressure apparatus with cuff and stethoscope,HCPCS_Level_II,HCPC2026_JAN,2026
A4663,Blood pressure cuff only,HCPCS_Level_II,HCPC2026_JAN,2026
A4670,Automatic blood pressure monitor,HCPCS_Level_II,HCPC2026_JAN,2026
A4671,"Disposable cycler set used with cycler dialysis machine, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4672,"Drainage extension line, sterile, for dialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4673,"Extension line with easy lock connectors, used with dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4674,"Chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per 8 oz",HCPCS_Level_II,HCPC2026_JAN,2026
A4680,"Activated carbon filter for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4690,"Dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4706,"Bicarbonate concentrate, solution, for hemodialysis, per gallon",HCPCS_Level_II,HCPC2026_JAN,2026
A4707,"Bicarbonate concentrate, powder, for hemodialysis, per packet",HCPCS_Level_II,HCPC2026_JAN,2026
A4708,"Acetate concentrate solution, for hemodialysis, per gallon",HCPCS_Level_II,HCPC2026_JAN,2026
A4709,"Acid concentrate, solution, for hemodialysis, per gallon",HCPCS_Level_II,HCPC2026_JAN,2026
A4714,"Treated water (deionized, distilled, or reverse osmosis) for peritoneal dialysis, per gallon",HCPCS_Level_II,HCPC2026_JAN,2026
A4719,"""y set"" tubing for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4720,"Dialysate solution, any concentration of dextrose, fluid volume greater than 249 cc, but less than or equal to 999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4721,"Dialysate solution, any concentration of dextrose, fluid volume greater than 999 cc but less than or equal to 1999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4722,"Dialysate solution, any concentration of dextrose, fluid volume greater than 1999 cc but less than or equal to 2999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4723,"Dialysate solution, any concentration of dextrose, fluid volume greater than 2999 cc but less than or equal to 3999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4724,"Dialysate solution, any concentration of dextrose, fluid volume greater than 3999 cc but less than or equal to 4999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4725,"Dialysate solution, any concentration of dextrose, fluid volume greater than 4999 cc but less than or equal to 5999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4726,"Dialysate solution, any concentration of dextrose, fluid volume greater than 5999 cc, for peritoneal dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
A4728,"Dialysate solution, non-dextrose containing, 500 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4730,"Fistula cannulation set for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4736,"Topical anesthetic, for dialysis, per gram",HCPCS_Level_II,HCPC2026_JAN,2026
A4737,"Injectable anesthetic, for dialysis, per 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4740,"Shunt accessory, for hemodialysis, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4750,"Blood tubing, arterial or venous, for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4755,"Blood tubing, arterial and venous combined, for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4760,"Dialysate solution test kit, for peritoneal dialysis, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4765,"Dialysate concentrate, powder, additive for peritoneal dialysis, per packet",HCPCS_Level_II,HCPC2026_JAN,2026
A4766,"Dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A4770,"Blood collection tube, vacuum, for dialysis, per 50",HCPCS_Level_II,HCPC2026_JAN,2026
A4771,"Serum clotting time tube, for dialysis, per 50",HCPCS_Level_II,HCPC2026_JAN,2026
A4772,"Blood glucose test strips, for dialysis, per 50",HCPCS_Level_II,HCPC2026_JAN,2026
A4773,"Occult blood test strips, for dialysis, per 50",HCPCS_Level_II,HCPC2026_JAN,2026
A4774,"Ammonia test strips, for dialysis, per 50",HCPCS_Level_II,HCPC2026_JAN,2026
A4802,"Protamine sulfate, for hemodialysis, per 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A4860,"Disposable catheter tips for peritoneal dialysis, per 10",HCPCS_Level_II,HCPC2026_JAN,2026
A4870,Plumbing and/or electrical work for home hemodialysis equipment,HCPCS_Level_II,HCPC2026_JAN,2026
A4890,"Contracts, repair and maintenance, for hemodialysis equipment",HCPCS_Level_II,HCPC2026_JAN,2026
A4911,"Drain bag/bottle, for dialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4913,"Miscellaneous dialysis supplies, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A4918,"Venous pressure clamp, for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4927,"Gloves, non-sterile, per 100",HCPCS_Level_II,HCPC2026_JAN,2026
A4928,"Surgical mask, per 20",HCPCS_Level_II,HCPC2026_JAN,2026
A4929,"Tourniquet for dialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4930,"Gloves, sterile, per pair",HCPCS_Level_II,HCPC2026_JAN,2026
A4931,"Oral thermometer, reusable, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A4932,"Rectal thermometer, reusable, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5,Dressing for five wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A5051,"Ostomy pouch, closed; with barrier attached (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5052,"Ostomy pouch, closed; without barrier attached (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5053,"Ostomy pouch, closed; for use on faceplate, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5054,"Ostomy pouch, closed; for use on barrier with flange (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5055,Stoma cap,HCPCS_Level_II,HCPC2026_JAN,2026
A5056,"Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5057,"Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5061,"Ostomy pouch, drainable; with barrier attached, (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5062,"Ostomy pouch, drainable; without barrier attached (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5063,"Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5071,"Ostomy pouch, urinary; with barrier attached (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5072,"Ostomy pouch, urinary; without barrier attached (1 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5073,"Ostomy pouch, urinary; for use on barrier with flange (2 piece), each",HCPCS_Level_II,HCPC2026_JAN,2026
A5081,"Stoma plug or seal, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A5082,Continent device; catheter for continent stoma,HCPCS_Level_II,HCPC2026_JAN,2026
A5083,"Continent device, stoma absorptive cover for continent stoma",HCPCS_Level_II,HCPC2026_JAN,2026
A5093,Ostomy accessory; convex insert,HCPCS_Level_II,HCPC2026_JAN,2026
A5102,"Bedside drainage bottle with or without tubing, rigid or expandable, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5105,"Urinary suspensory with leg bag, with or without tube, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5112,"Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5113,"Leg strap; latex, replacement only, per set",HCPCS_Level_II,HCPC2026_JAN,2026
A5114,"Leg strap; foam or fabric, replacement only, per set",HCPCS_Level_II,HCPC2026_JAN,2026
A5120,"Skin barrier, wipes or swabs, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5121,"Skin barrier; solid, 6 x 6 or equivalent, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5122,"Skin barrier; solid, 8 x 8 or equivalent, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5126,Adhesive or non-adhesive; disk or foam pad,HCPCS_Level_II,HCPC2026_JAN,2026
A5131,"Appliance cleaner, incontinence and ostomy appliances, per 16 oz.",HCPCS_Level_II,HCPC2026_JAN,2026
A5200,"Percutaneous catheter/tube anchoring device, adhesive skin attachment",HCPCS_Level_II,HCPC2026_JAN,2026
A5500,"For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5501,"For diabetics only, fitting (including follow-up), custom preparation and supply of shoe molded from cast(s) of patient's foot (custom molded shoe), per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5503,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5504,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with wedge(s), per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5505,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5506,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5507,"For diabetics only, not otherwise specified modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5508,"For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5510,"For diabetics only, direct formed, compression molded to patient's foot without external heat source, multiple-density insert(s) prefabricated, per shoe",HCPCS_Level_II,HCPC2026_JAN,2026
A5512,"For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5513,"For diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each",HCPCS_Level_II,HCPC2026_JAN,2026
A5514,"For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6,Dressing for six wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A6000,Non-contact wound warming wound cover for use with the non-contact wound warming device and warming card,HCPCS_Level_II,HCPC2026_JAN,2026
A6010,"Collagen based wound filler, dry form, sterile, per gram of collagen",HCPCS_Level_II,HCPC2026_JAN,2026
A6011,"Collagen based wound filler, gel/paste, per gram of collagen",HCPCS_Level_II,HCPC2026_JAN,2026
A6021,"Collagen dressing, sterile, size 16 sq. in. or less, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6022,"Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each",HCPCS_Level_II,HCPC2026_JAN,2026
A6023,"Collagen dressing, sterile, size more than 48 sq. in., each",HCPCS_Level_II,HCPC2026_JAN,2026
A6024,"Collagen dressing wound filler, sterile, per 6 inches",HCPCS_Level_II,HCPC2026_JAN,2026
A6025,"Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each",HCPCS_Level_II,HCPC2026_JAN,2026
A6154,"Wound pouch, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6196,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6197,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6198,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6199,"Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches",HCPCS_Level_II,HCPC2026_JAN,2026
A6203,"Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6204,"Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6205,"Composite dressing, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6206,"Contact layer, sterile, 16 sq. in. or less, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6207,"Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6208,"Contact layer, sterile, more than 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6209,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6210,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6211,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6212,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6213,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6214,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6215,"Foam dressing, wound filler, sterile, per gram",HCPCS_Level_II,HCPC2026_JAN,2026
A6216,"Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6217,"Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6218,"Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6219,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6220,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6221,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6222,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6223,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6224,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6228,"Gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6229,"Gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6230,"Gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6231,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6232,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6233,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6234,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6235,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6236,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6237,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6238,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6239,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6240,"Hydrocolloid dressing, wound filler, paste, sterile, per ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A6241,"Hydrocolloid dressing, wound filler, dry form, sterile, per gram",HCPCS_Level_II,HCPC2026_JAN,2026
A6242,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6243,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6244,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6245,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6246,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6247,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6248,"Hydrogel dressing, wound filler, gel, per fluid ounce",HCPCS_Level_II,HCPC2026_JAN,2026
A6250,"Skin sealants, protectants, moisturizers, ointments, any type, any size",HCPCS_Level_II,HCPC2026_JAN,2026
A6251,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6252,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6253,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6254,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6255,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6256,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6257,"Transparent film, sterile, 16 sq. in. or less, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6258,"Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6259,"Transparent film, sterile, more than 48 sq. in., each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6260,"Wound cleansers, any type, any size",HCPCS_Level_II,HCPC2026_JAN,2026
A6261,"Wound filler, gel/paste, per fluid ounce, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A6262,"Wound filler, dry form, per gram, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A6266,"Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6402,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6403,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6404,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6407,"Packing strips, non-impregnated, sterile, up to 2 inches in width, per linear yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6410,"Eye pad, sterile, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6411,"Eye pad, non-sterile, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6412,"Eye patch, occlusive, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6413,"Adhesive bandage, first-aid type, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6441,"Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6442,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width less than three inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6443,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6444,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to 5 inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6445,"Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6446,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6447,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6448,"Light compression bandage, elastic, knitted/woven, width less than three inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6449,"Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6450,"Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6451,"Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6452,"High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6453,"Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6454,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6455,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6456,"Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6457,"Tubular dressing with or without elastic, any width, per linear yard",HCPCS_Level_II,HCPC2026_JAN,2026
A6460,"Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6461,"Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing",HCPCS_Level_II,HCPC2026_JAN,2026
A6501,"Compression burn garment, bodysuit (head to foot), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6502,"Compression burn garment, chin strap, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6503,"Compression burn garment, facial hood, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6504,"Compression burn garment, glove to wrist, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6505,"Compression burn garment, glove to elbow, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6506,"Compression burn garment, glove to axilla, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6507,"Compression burn garment, foot to knee length, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6508,"Compression burn garment, foot to thigh length, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6509,"Compression burn garment, upper trunk to waist including arm openings (vest), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6510,"Compression burn garment, trunk, including arms down to leg openings (leotard), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6511,"Compression burn garment, lower trunk including leg openings (panty), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6512,"Compression burn garment, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A6513,"Compression burn mask, face and/or neck, plastic or equal, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
A6515,"Gradient compression wrap with adjustable straps, full leg, each, custom",HCPCS_Level_II,HCPC2026_JAN,2026
A6516,"Gradient compression wrap with adjustable straps, foot, each, custom",HCPCS_Level_II,HCPC2026_JAN,2026
A6517,"Gradient compression wrap with adjustable straps, below knee, each, custom",HCPCS_Level_II,HCPC2026_JAN,2026
A6518,"Gradient compression wrap with adjustable straps, arm, each, custom",HCPCS_Level_II,HCPC2026_JAN,2026
A6519,"Gradient compression garment, not otherwise specified, for nighttime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6520,"Gradient compression garment, glove, padded, for nighttime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6521,"Gradient compression garment, glove, padded, for nighttime use, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6522,"Gradient compression garment, arm, padded, for nighttime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6523,"Gradient compression garment, arm, padded, for nighttime use, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6524,"Gradient compression garment, lower leg and foot, padded, for nighttime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6525,"Gradient compression garment, lower leg and foot, padded, for nighttime use, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6526,"Gradient compression garment, full leg and foot, padded, for nighttime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6527,"Gradient compression garment, full leg and foot, padded, for nighttime use, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6528,"Gradient compression garment, bra, for nighttime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6529,"Gradient compression garment, bra, for nighttime use, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6530,"Gradient compression stocking, below knee, 18-30 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6531,"Gradient compression stocking, below knee, 30-40 mmhg, used as a surgical dressing, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6532,"Gradient compression stocking, below knee, 40-50 mmhg, used as a surgical dressing, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6533,"Gradient compression stocking, thigh length, 18-30 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6534,"Gradient compression stocking, thigh length, 30-40 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6535,"Gradient compression stocking, thigh length, 40 mmhg or greater, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6536,"Gradient compression stocking, full length/chap style, 18-30 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6537,"Gradient compression stocking, full length/chap style, 30-40 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6538,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6539,"Gradient compression stocking, waist length, 18-30 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6540,"Gradient compression stocking, waist length, 30-40 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6541,"Gradient compression stocking, waist length, 40 mmhg or greater, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6544,"Gradient compression stocking, garter belt",HCPCS_Level_II,HCPC2026_JAN,2026
A6545,"Gradient compression wrap, non-elastic, below knee, 30-50 mmhg, used as a surgical dressing, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6549,"Gradient compression garment, not otherwise specified, for daytime use, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6550,"Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A6552,"Gradient compression stocking, below knee, 30-40 mmhg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6553,"Gradient compression stocking, below knee, 30-40 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6554,"Gradient compression stocking, below knee, 40 mmhg or greater, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6555,"Gradient compression stocking, below knee, 40 mmhg or greater, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6556,"Gradient compression stocking, thigh length, 18-30 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6557,"Gradient compression stocking, thigh length, 30-40 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6558,"Gradient compression stocking, thigh length, 40 mmhg or greater, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6559,"Gradient compression stocking, full length/chap style, 18-30 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6560,"Gradient compression stocking, full length/chap style, 30-40 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6561,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6562,"Gradient compression stocking, waist length, 18-30 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6563,"Gradient compression stocking, waist length, 30-40 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6564,"Gradient compression stocking, waist length, 40 mmhg or greater, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6565,"Gradient compression gauntlet, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6566,"Gradient compression garment, neck/head, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6567,"Gradient compression garment, neck/head, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6568,"Gradient compression garment, torso and shoulder, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6569,"Gradient compression garment, torso/shoulder, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6570,"Gradient compression garment, genital region, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6571,"Gradient compression garment, genital region, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6572,"Gradient compression garment, toe caps, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6573,"Gradient compression garment, toe caps, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6574,"Gradient compression arm sleeve and glove combination, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6575,"Gradient  compression arm sleeve and glove combination, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6576,"Gradient  compression arm sleeve, custom, medium weight, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6577,"Gradient  compression arm sleeve, custom, heavy weight, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6578,"Gradient  compression arm sleeve, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6579,"Gradient compression glove, custom, medium weight, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6580,"Gradient  compression glove, custom, heavy weight, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6581,"Gradient compression glove, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6582,"Gradient compression gauntlet, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6583,"Gradient compression wrap with adjustable straps, below knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6584,"Gradient compression wrap with adjustable straps, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A6585,"Gradient compression wrap with adjustable straps, above knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6586,"Gradient compression wrap with adjustable straps, full leg, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6587,"Gradient compression wrap with adjustable straps, foot, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6588,"Gradient compression wrap with adjustable straps, arm, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6589,"Gradient pressure wrap with adjustable straps, bra, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6590,"External urinary catheters; disposable, with wicking material, for use with suction pump, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A6591,"External urinary catheter; non-disposable, for use with suction pump, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A6593,"Accessory for gradient compression garment or wrap with adjustable straps, not-otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A6594,"Gradient compression bandaging supply, bandage liner, lower extremity, any size or length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6595,"Gradient compression bandaging supply, bandage liner, upper extremity, any size or length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6596,"Gradient compression bandaging supply, conforming gauze, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6597,"Gradient compression bandage roll, elastic long stretch, linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6598,"Gradient compression bandage roll, elastic medium stretch, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6599,"Gradient compression bandage roll, inelastic short stretch, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6600,"Gradient compression bandaging supply, high density foam sheet, per 250 square centimeters, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6601,"Gradient compression bandaging supply, high density foam pad, any size or shape, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6602,"Gradient compression bandaging supply, high density foam roll for bandage, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6603,"Gradient compression bandaging supply, low density channel foam sheet, per 250 square centimeters, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6604,"Gradient compression bandaging supply, low density flat foam sheet, per 250 square centimeters, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6605,"Gradient compression bandaging supply, padded foam, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6606,"Gradient compression bandaging supply, padded textile, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6607,"Gradient compression bandaging supply, tubular protective absorption layer, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6608,"Gradient compression bandaging supply, tubular protective absorption padded layer, per linear yard, any width, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6609,"Gradient compression bandaging supply, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A6610,"Gradient compression stocking, below knee, 18-30 mmhg, custom, each",HCPCS_Level_II,HCPC2026_JAN,2026
A6611,"Gradient compression wrap with adjustable straps, above knee, each, custom",HCPCS_Level_II,HCPC2026_JAN,2026
A7,Dressing for seven wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A7000,"Canister, disposable, used with suction pump, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7001,"Canister, non-disposable, used with suction pump, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7002,"Tubing, used with suction pump, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7003,"Administration set, with small volume nonfiltered pneumatic nebulizer, disposable",HCPCS_Level_II,HCPC2026_JAN,2026
A7004,"Small volume nonfiltered pneumatic nebulizer, disposable",HCPCS_Level_II,HCPC2026_JAN,2026
A7005,"Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable",HCPCS_Level_II,HCPC2026_JAN,2026
A7006,"Administration set, with small volume filtered pneumatic nebulizer",HCPCS_Level_II,HCPC2026_JAN,2026
A7007,"Large volume nebulizer, disposable, unfilled, used with aerosol compressor",HCPCS_Level_II,HCPC2026_JAN,2026
A7008,"Large volume nebulizer, disposable, prefilled, used with aerosol compressor",HCPCS_Level_II,HCPC2026_JAN,2026
A7009,"Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer",HCPCS_Level_II,HCPC2026_JAN,2026
A7010,"Corrugated tubing, disposable, used with large volume nebulizer, 100 feet",HCPCS_Level_II,HCPC2026_JAN,2026
A7011,"Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feet",HCPCS_Level_II,HCPC2026_JAN,2026
A7012,"Water collection device, used with large volume nebulizer",HCPCS_Level_II,HCPC2026_JAN,2026
A7013,"Filter, disposable, used with aerosol compressor or ultrasonic generator",HCPCS_Level_II,HCPC2026_JAN,2026
A7014,"Filter, nondisposable, used with aerosol compressor or ultrasonic generator",HCPCS_Level_II,HCPC2026_JAN,2026
A7015,"Aerosol mask, used with dme nebulizer",HCPCS_Level_II,HCPC2026_JAN,2026
A7016,"Dome and mouthpiece, used with small volume ultrasonic nebulizer",HCPCS_Level_II,HCPC2026_JAN,2026
A7017,"Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen",HCPCS_Level_II,HCPC2026_JAN,2026
A7018,"Water, distilled, used with large volume nebulizer, 1000 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A7020,"Interface for cough stimulating device, includes all components, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
A7021,"Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter)",HCPCS_Level_II,HCPC2026_JAN,2026
A7023,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical",HCPCS_Level_II,HCPC2026_JAN,2026
A7025,"High frequency chest wall oscillation system vest, replacement for use with patient owned equipment, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7026,"High frequency chest wall oscillation system hose, replacement for use with patient owned equipment, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7027,"Combination oral/nasal mask, used with continuous positive airway pressure device, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7028,"Oral cushion for combination oral/nasal mask, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7029,"Nasal pillows for combination oral/nasal mask, replacement only, pair",HCPCS_Level_II,HCPC2026_JAN,2026
A7030,"Full face mask used with positive airway pressure device, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7031,"Face mask interface, replacement for full face mask, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7032,"Cushion for use on nasal mask interface, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7033,"Pillow for use on nasal cannula type interface, replacement only, pair",HCPCS_Level_II,HCPC2026_JAN,2026
A7034,"Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap",HCPCS_Level_II,HCPC2026_JAN,2026
A7035,Headgear used with positive airway pressure device,HCPCS_Level_II,HCPC2026_JAN,2026
A7036,Chinstrap used with positive airway pressure device,HCPCS_Level_II,HCPC2026_JAN,2026
A7037,Tubing used with positive airway pressure device,HCPCS_Level_II,HCPC2026_JAN,2026
A7038,"Filter, disposable, used with positive airway pressure device",HCPCS_Level_II,HCPC2026_JAN,2026
A7039,"Filter, non disposable, used with positive airway pressure device",HCPCS_Level_II,HCPC2026_JAN,2026
A7040,One way chest drain valve,HCPCS_Level_II,HCPC2026_JAN,2026
A7041,Water seal drainage container and tubing for use with implanted chest tube,HCPCS_Level_II,HCPC2026_JAN,2026
A7042,"Implanted pleural catheter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7043,Vacuum drainage bottle and tubing for use with implanted catheter,HCPCS_Level_II,HCPC2026_JAN,2026
A7044,"Oral interface used with positive airway pressure device, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7045,"Exhalation port with or without swivel used with accessories for positive airway devices, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
A7046,"Water chamber for humidifier, used with positive airway pressure device, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7047,"Oral interface used with respiratory suction pump, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7048,"Vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7049,Expiratory positive airway pressure intranasal resistance valve,HCPCS_Level_II,HCPC2026_JAN,2026
A7501,"Tracheostoma valve, including diaphragm, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7502,"Replacement diaphragm/faceplate for tracheostoma valve, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7503,"Filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7504,"Filter for use in a tracheostoma heat and moisture exchange system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7505,"Housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7506,"Adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each",HCPCS_Level_II,HCPC2026_JAN,2026
A7507,"Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7508,"Housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7509,"Filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7520,"Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7521,"Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7522,"Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and reusable), each",HCPCS_Level_II,HCPC2026_JAN,2026
A7523,"Tracheostomy shower protector, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7524,"Tracheostoma stent/stud/button, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7525,"Tracheostomy mask, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7526,"Tracheostomy tube collar/holder, each",HCPCS_Level_II,HCPC2026_JAN,2026
A7527,"Tracheostomy/laryngectomy tube plug/stop, each",HCPCS_Level_II,HCPC2026_JAN,2026
A8,Dressing for eight wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A8000,"Helmet, protective, soft, prefabricated, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A8001,"Helmet, protective, hard, prefabricated, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A8002,"Helmet, protective, soft, custom fabricated, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A8003,"Helmet, protective, hard, custom fabricated, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A8004,"Soft interface for helmet, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
A9,Dressing for nine or more wounds,HCPCS_Level_II,HCPC2026_JAN,2026
A9150,Non-prescription drugs,HCPCS_Level_II,HCPC2026_JAN,2026
A9152,"Single vitamin/mineral/trace element, oral, per dose, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A9153,"Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A9154,"Artificial saliva, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9155,"Artificial saliva, 30 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9156,"Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9180,"Pediculosis (lice infestation) treatment, topical, for administration by patient/caretaker",HCPCS_Level_II,HCPC2026_JAN,2026
A9268,"Programmer for transient, orally ingested capsule",HCPCS_Level_II,HCPC2026_JAN,2026
A9269,"Programable, transient, orally ingested capsule, for use with external programmer, per month",HCPCS_Level_II,HCPC2026_JAN,2026
A9270,Non-covered item or service,HCPCS_Level_II,HCPC2026_JAN,2026
A9272,"Wound suction, disposable, includes dressing, all accessories and components, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A9273,"Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type",HCPCS_Level_II,HCPC2026_JAN,2026
A9274,"External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A9275,"Home glucose disposable monitor, includes test strips",HCPCS_Level_II,HCPC2026_JAN,2026
A9276,"Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply",HCPCS_Level_II,HCPC2026_JAN,2026
A9277,"Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system",HCPCS_Level_II,HCPC2026_JAN,2026
A9278,"Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system",HCPCS_Level_II,HCPC2026_JAN,2026
A9279,"Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A9280,"Alert or alarm device, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A9281,"Reaching/grabbing device, any type, any length, each",HCPCS_Level_II,HCPC2026_JAN,2026
A9282,"Wig, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A9283,"Foot pressure off loading/supportive device, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A9284,"Spirometer, non-electronic, includes all accessories",HCPCS_Level_II,HCPC2026_JAN,2026
A9285,Inversion/eversion correction device,HCPCS_Level_II,HCPC2026_JAN,2026
A9286,"Hygienic item or device, disposable or non-disposable, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
A9291,"Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment",HCPCS_Level_II,HCPC2026_JAN,2026
A9292,"Prescription digital visual therapy, software-only, fda cleared, per course of treatment",HCPCS_Level_II,HCPC2026_JAN,2026
A9293,"Fertility cycle (contraception & conception) tracking software application, fda cleared, per month, includes accessories (e.g., thermometer)",HCPCS_Level_II,HCPC2026_JAN,2026
A9300,Exercise equipment,HCPCS_Level_II,HCPC2026_JAN,2026
A9500,"Technetium tc-99m sestamibi, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9501,"Technetium tc-99m teboroxime, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9502,"Technetium tc-99m tetrofosmin, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9503,"Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9504,"Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9505,"Thallium tl-201 thallous chloride, diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9506,"Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible",HCPCS_Level_II,HCPC2026_JAN,2026
A9507,"Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9508,"Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9509,"Iodine i-123 sodium iodide, diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9510,"Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9512,"Technetium tc-99m pertechnetate, diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9513,"Lutetium lu 177, dotatate, therapeutic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9515,"Choline c-11, diagnostic, per study dose up to 20 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9516,"Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9517,"Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9520,"Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9521,"Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9524,"Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9526,"Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9527,"Iodine i-125, sodium iodide solution, therapeutic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9528,"Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9529,"Iodine i-131 sodium iodide solution, diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9530,"Iodine i-131 sodium iodide solution, therapeutic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9531,"Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)",HCPCS_Level_II,HCPC2026_JAN,2026
A9532,"Iodine i-125 serum albumin, diagnostic, per 5 microcuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9536,"Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9537,"Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9538,"Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9539,"Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9540,"Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9541,"Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9542,"Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9543,"Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9544,"Iodine i-131 tositumomab, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9545,"Iodine i-131 tositumomab, therapeutic, per treatment dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9546,"Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9547,"Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9548,"Indium in-111 pentetate, diagnostic, per 0.5 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9550,"Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9551,"Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9552,"Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9553,"Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9554,"Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9555,"Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9556,"Gallium ga-67 citrate, diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9557,"Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9558,"Xenon xe-133 gas, diagnostic, per 10 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9559,"Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9560,"Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9561,"Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9562,"Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9563,"Sodium phosphate p-32, therapeutic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9564,"Chromic phosphate p-32 suspension, therapeutic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9566,"Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9567,"Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9568,"Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9569,"Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9570,"Indium in-111 labeled autologous white blood cells, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9571,"Indium in-111 labeled autologous platelets, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9572,"Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9573,"Injection, gadopiclenol, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9575,"Injection, gadoterate meglumine, 0.1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9576,"Injection, gadoteridol, (prohance multipack), per ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9577,"Injection, gadobenate dimeglumine (multihance), per ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9578,"Injection, gadobenate dimeglumine (multihance multipack), per ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9579,"Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9580,"Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9581,"Injection, gadoxetate disodium, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9582,"Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9583,"Injection, gadofosveset trisodium, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9584,"Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9585,"Injection, gadobutrol, 0.1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
A9586,"Florbetapir f18, diagnostic, per study dose, up to 10 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9587,"Gallium ga-68, dotatate, diagnostic, 0.1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9588,"Fluciclovine f-18, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9589,"Instillation, hexaminolevulinate hydrochloride, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A9590,"Iodine i-131, iobenguane, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9591,"Fluoroestradiol f 18, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9592,"Copper cu-64, dotatate, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9593,"Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9594,"Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9595,"Piflufolastat f-18, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9596,"Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9597,"Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A9598,"Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A9599,"Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
A9600,"Strontium sr-89 chloride, therapeutic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9601,"Flortaucipir f 18 injection, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9602,"Fluorodopa f-18, diagnostic, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9603,"Injection, pafolacianine, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A9604,"Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
A9606,"Radium ra-223 dichloride, therapeutic, per microcurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9607,"Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9608,"Flotufolastat f 18, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9609,Fludeoxyglucose f18 up to 15 millicuries,HCPCS_Level_II,HCPC2026_JAN,2026
A9610,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9611,"Flurpiridaz f 18, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9612,"Injection, fluorescein, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A9615,"Injection, pegulicianine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
A9616,"Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9697,"Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
A9698,"Non-radioactive contrast imaging material, not otherwise classified, per study",HCPCS_Level_II,HCPC2026_JAN,2026
A9699,"Radiopharmaceutical, therapeutic, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
A9700,"Supply of injectable contrast material for use in echocardiography, per study",HCPCS_Level_II,HCPC2026_JAN,2026
A9800,"Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
A9900,"Miscellaneous dme supply, accessory, and/or service component of another hcpcs code",HCPCS_Level_II,HCPC2026_JAN,2026
A9901,"Dme delivery, set up, and/or dispensing service component of another hcpcs code",HCPCS_Level_II,HCPC2026_JAN,2026
A9999,"Miscellaneous dme supply or accessory, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
AA,Anesthesia services performed personally by anesthesiologist,HCPCS_Level_II,HCPC2026_JAN,2026
AB,"Audiology service furnished personally by an audiologist without a physician/npp order for non-acute hearing assessment unrelated to disequilibrium, or hearing aids, or examinations for the purpose of prescribing, fitting, or changing hearing aids; service may be performed once every 12 months, per beneficiary",HCPCS_Level_II,HCPC2026_JAN,2026
AD,Medical supervision by a physician: more than four concurrent anesthesia procedures,HCPCS_Level_II,HCPC2026_JAN,2026
AE,Registered dietician,HCPCS_Level_II,HCPC2026_JAN,2026
AF,Specialty physician,HCPCS_Level_II,HCPC2026_JAN,2026
AG,Primary physician,HCPCS_Level_II,HCPC2026_JAN,2026
AH,Clinical psychologist,HCPCS_Level_II,HCPC2026_JAN,2026
AI,Principal physician of record,HCPCS_Level_II,HCPC2026_JAN,2026
AJ,Clinical social worker,HCPCS_Level_II,HCPC2026_JAN,2026
AK,Non participating physician,HCPCS_Level_II,HCPC2026_JAN,2026
AM,"Physician, team member service",HCPCS_Level_II,HCPC2026_JAN,2026
AO,Alternate payment method declined by provider of service,HCPCS_Level_II,HCPC2026_JAN,2026
AP,Determination of refractive state was not performed in the course of diagnostic ophthalmological examination,HCPCS_Level_II,HCPC2026_JAN,2026
AQ,Physician providing a service in an unlisted health professional shortage area (hpsa),HCPCS_Level_II,HCPC2026_JAN,2026
AR,Physician provider services in a physician scarcity area,HCPCS_Level_II,HCPC2026_JAN,2026
AS,"Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery",HCPCS_Level_II,HCPC2026_JAN,2026
AT,"Acute treatment (this modifier should be used when reporting service 98940, 98941, 98942)",HCPCS_Level_II,HCPC2026_JAN,2026
AU,"Item furnished in conjunction with a urological, ostomy, or tracheostomy supply",HCPCS_Level_II,HCPC2026_JAN,2026
AV,"Item furnished in conjunction with a prosthetic device, prosthetic or orthotic",HCPCS_Level_II,HCPC2026_JAN,2026
AW,Item furnished in conjunction with a surgical dressing,HCPCS_Level_II,HCPC2026_JAN,2026
AX,Item furnished in conjunction with dialysis services,HCPCS_Level_II,HCPC2026_JAN,2026
AY,Item or service furnished to an esrd patient that is not for the treatment of esrd,HCPCS_Level_II,HCPC2026_JAN,2026
AZ,Physician providing a service in a dental health professional shortage area for the purpose of an electronic health record incentive payment,HCPCS_Level_II,HCPC2026_JAN,2026
B4034,"Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",HCPCS_Level_II,HCPC2026_JAN,2026
B4035,"Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",HCPCS_Level_II,HCPC2026_JAN,2026
B4036,"Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",HCPCS_Level_II,HCPC2026_JAN,2026
B4081,Nasogastric tubing with stylet,HCPCS_Level_II,HCPC2026_JAN,2026
B4082,Nasogastric tubing without stylet,HCPCS_Level_II,HCPC2026_JAN,2026
B4083,Stomach tube - levine type,HCPCS_Level_II,HCPC2026_JAN,2026
B4087,"Gastrostomy/jejunostomy tube, standard, any material, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
B4088,"Gastrostomy/jejunostomy tube, low-profile, any material, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
B4100,"Food thickener, administered orally, per ounce",HCPCS_Level_II,HCPC2026_JAN,2026
B4102,"Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4103,"Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4104,"Additive for enteral formula (e.g., fiber)",HCPCS_Level_II,HCPC2026_JAN,2026
B4105,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each",HCPCS_Level_II,HCPC2026_JAN,2026
B4148,"Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape",HCPCS_Level_II,HCPC2026_JAN,2026
B4149,"Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4150,"Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4152,"Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4153,"Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4154,"Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4155,"Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4157,"Enteral formula, nutritionally complete, for special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4158,"Enteral formula, for pediatrics, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4159,"Enteral formula, for pediatrics, nutritionally complete soy based with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4160,"Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4161,"Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4162,"Enteral formula, for pediatrics, special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
B4164,"Parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml = 1 unit) - home mix",HCPCS_Level_II,HCPC2026_JAN,2026
B4168,"Parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix",HCPCS_Level_II,HCPC2026_JAN,2026
B4172,"Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) - home mix",HCPCS_Level_II,HCPC2026_JAN,2026
B4176,"Parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) - home mix",HCPCS_Level_II,HCPC2026_JAN,2026
B4178,"Parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit) - home mix",HCPCS_Level_II,HCPC2026_JAN,2026
B4180,"Parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500 ml = 1 unit) - home mix",HCPCS_Level_II,HCPC2026_JAN,2026
B4185,"Parenteral nutrition solution, not otherwise specified, 10 grams lipids",HCPCS_Level_II,HCPC2026_JAN,2026
B4187,"Omegaven, 10 grams lipids",HCPCS_Level_II,HCPC2026_JAN,2026
B4189,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix",HCPCS_Level_II,HCPC2026_JAN,2026
B4193,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix",HCPCS_Level_II,HCPC2026_JAN,2026
B4197,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix",HCPCS_Level_II,HCPC2026_JAN,2026
B4199,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix",HCPCS_Level_II,HCPC2026_JAN,2026
B4216,"Parenteral nutrition; additives (vitamins, trace elements, heparin, electrolytes), home mix, per day",HCPCS_Level_II,HCPC2026_JAN,2026
B4220,"Parenteral nutrition supply kit; premix, per day",HCPCS_Level_II,HCPC2026_JAN,2026
B4222,"Parenteral nutrition supply kit; home mix, per day",HCPCS_Level_II,HCPC2026_JAN,2026
B4224,"Parenteral nutrition administration kit, per day",HCPCS_Level_II,HCPC2026_JAN,2026
B5000,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, renal-aminosyn-rf, nephramine, renamine-premix",HCPCS_Level_II,HCPC2026_JAN,2026
B5100,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, hepatic, hepatamine-premix",HCPCS_Level_II,HCPC2026_JAN,2026
B5200,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, stress-branch chain amino acids-freamine-hbc-premix",HCPCS_Level_II,HCPC2026_JAN,2026
B9000,Enteral nutrition infusion pump - without alarm,HCPCS_Level_II,HCPC2026_JAN,2026
B9002,"Enteral nutrition infusion pump, any type",HCPCS_Level_II,HCPC2026_JAN,2026
B9004,"Parenteral nutrition infusion pump, portable",HCPCS_Level_II,HCPC2026_JAN,2026
B9006,"Parenteral nutrition infusion pump, stationary",HCPCS_Level_II,HCPC2026_JAN,2026
B9998,Noc for enteral supplies,HCPCS_Level_II,HCPC2026_JAN,2026
B9999,Noc for parenteral supplies,HCPCS_Level_II,HCPC2026_JAN,2026
BA,Item furnished in conjunction with parenteral enteral nutrition (pen) services,HCPCS_Level_II,HCPC2026_JAN,2026
BL,Special acquisition of blood and blood products,HCPCS_Level_II,HCPC2026_JAN,2026
BO,"Orally administered nutrition, not by feeding tube",HCPCS_Level_II,HCPC2026_JAN,2026
BP,The beneficiary has been informed of the purchase and rental options and has elected to purchase the item,HCPCS_Level_II,HCPC2026_JAN,2026
BR,The beneficiary has been informed of the purchase and rental options and has elected to rent the item,HCPCS_Level_II,HCPC2026_JAN,2026
BU,The beneficiary has been informed of the purchase and rental options and after 30 days has not informed the supplier of his/her decision,HCPCS_Level_II,HCPC2026_JAN,2026
C1052,"Hemostatic agent, gastrointestinal, topical",HCPCS_Level_II,HCPC2026_JAN,2026
C1062,"Intravertebral body fracture augmentation with implant (e.g., metal, polymer)",HCPCS_Level_II,HCPC2026_JAN,2026
C1300,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval",HCPCS_Level_II,HCPC2026_JAN,2026
C1600,"Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1601,"Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1602,"Orthopedic/device/drug matrix/absorbable bone void filler, antimicrobial-eluting (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1603,"Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter)",HCPCS_Level_II,HCPC2026_JAN,2026
C1604,"Graft, transmural transvenous arterial bypass (implantable), with all delivery system components",HCPCS_Level_II,HCPC2026_JAN,2026
C1605,"Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation",HCPCS_Level_II,HCPC2026_JAN,2026
C1606,"Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper gastrointestinal endoscope",HCPCS_Level_II,HCPC2026_JAN,2026
C1607,"Neurostimulator, integrated (implantable), rechargeable with all implantable and external components including charging system",HCPCS_Level_II,HCPC2026_JAN,2026
C1608,"Prosthesis, total, dual mobility, first carpometacarpal joint (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1713,Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1714,"Catheter, transluminal atherectomy, directional",HCPCS_Level_II,HCPC2026_JAN,2026
C1715,Brachytherapy needle,HCPCS_Level_II,HCPC2026_JAN,2026
C1716,"Brachytherapy source, non-stranded, gold-198, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C1717,"Brachytherapy source, non-stranded, high dose rate iridium-192, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C1719,"Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C1721,"Cardioverter-defibrillator, dual chamber (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1722,"Cardioverter-defibrillator, single chamber (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1724,"Catheter, transluminal atherectomy, rotational",HCPCS_Level_II,HCPC2026_JAN,2026
C1725,"Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)",HCPCS_Level_II,HCPC2026_JAN,2026
C1726,"Catheter, balloon dilatation, non-vascular",HCPCS_Level_II,HCPC2026_JAN,2026
C1727,"Catheter, balloon tissue dissector, non-vascular (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1728,"Catheter, brachytherapy seed administration",HCPCS_Level_II,HCPC2026_JAN,2026
C1729,"Catheter, drainage",HCPCS_Level_II,HCPC2026_JAN,2026
C1730,"Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)",HCPCS_Level_II,HCPC2026_JAN,2026
C1731,"Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)",HCPCS_Level_II,HCPC2026_JAN,2026
C1732,"Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping",HCPCS_Level_II,HCPC2026_JAN,2026
C1733,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip",HCPCS_Level_II,HCPC2026_JAN,2026
C1734,Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1735,"Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system components",HCPCS_Level_II,HCPC2026_JAN,2026
C1736,"Catheter(s), intravascular for renal denervation, ultrasound, including all single use system components",HCPCS_Level_II,HCPC2026_JAN,2026
C1737,"Joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1738,"Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy device",HCPCS_Level_II,HCPC2026_JAN,2026
C1739,"Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C1740,"Leadless electrode, transmitter, battery (all implantable), for sequential left ventricular pacing",HCPCS_Level_II,HCPC2026_JAN,2026
C1741,"Anchor/screw for bone fixation, absorbable, metallic (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1742,"Pressure monitoring system, compartmental intramuscular (implantable), continuous, including all components (e.g., introducer, sensor), excludes mobile (wireless) software application",HCPCS_Level_II,HCPC2026_JAN,2026
C1747,"Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1748,"Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1749,"Endoscope, retrograde imaging/illumination colonoscope device (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1750,"Catheter, hemodialysis/peritoneal, long-term",HCPCS_Level_II,HCPC2026_JAN,2026
C1751,"Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
C1752,"Catheter, hemodialysis/peritoneal, short-term",HCPCS_Level_II,HCPC2026_JAN,2026
C1753,"Catheter, intravascular ultrasound",HCPCS_Level_II,HCPC2026_JAN,2026
C1754,"Catheter, intradiscal",HCPCS_Level_II,HCPC2026_JAN,2026
C1755,"Catheter, intraspinal",HCPCS_Level_II,HCPC2026_JAN,2026
C1756,"Catheter, pacing, transesophageal",HCPCS_Level_II,HCPC2026_JAN,2026
C1757,"Catheter, thrombectomy/embolectomy",HCPCS_Level_II,HCPC2026_JAN,2026
C1758,"Catheter, ureteral",HCPCS_Level_II,HCPC2026_JAN,2026
C1759,"Catheter, intracardiac echocardiography",HCPCS_Level_II,HCPC2026_JAN,2026
C1760,"Closure device, vascular (implantable/insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1761,"Catheter, transluminal intravascular lithotripsy, coronary",HCPCS_Level_II,HCPC2026_JAN,2026
C1762,"Connective tissue, human (includes fascia lata)",HCPCS_Level_II,HCPC2026_JAN,2026
C1763,"Connective tissue, non-human (includes synthetic)",HCPCS_Level_II,HCPC2026_JAN,2026
C1764,"Event recorder, cardiac (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1765,Adhesion barrier,HCPCS_Level_II,HCPC2026_JAN,2026
C1766,"Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away",HCPCS_Level_II,HCPC2026_JAN,2026
C1767,"Generator, neurostimulator (implantable), non-rechargeable",HCPCS_Level_II,HCPC2026_JAN,2026
C1768,"Graft, vascular",HCPCS_Level_II,HCPC2026_JAN,2026
C1769,Guide wire,HCPCS_Level_II,HCPC2026_JAN,2026
C1770,"Imaging coil, magnetic resonance (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1771,"Repair device, urinary, incontinence, with sling graft",HCPCS_Level_II,HCPC2026_JAN,2026
C1772,"Infusion pump, programmable (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1773,"Retrieval device, insertable (used to retrieve fractured medical devices)",HCPCS_Level_II,HCPC2026_JAN,2026
C1776,Joint device (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1777,"Lead, cardioverter-defibrillator, endocardial single coil (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1778,"Lead, neurostimulator (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1779,"Lead, pacemaker, transvenous vdd single pass",HCPCS_Level_II,HCPC2026_JAN,2026
C1780,"Lens, intraocular (new technology)",HCPCS_Level_II,HCPC2026_JAN,2026
C1781,Mesh (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1782,Morcellator,HCPCS_Level_II,HCPC2026_JAN,2026
C1783,"Ocular implant, aqueous drainage assist device",HCPCS_Level_II,HCPC2026_JAN,2026
C1784,"Ocular device, intraoperative, detached retina",HCPCS_Level_II,HCPC2026_JAN,2026
C1785,"Pacemaker, dual chamber, rate-responsive (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1786,"Pacemaker, single chamber, rate-responsive (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1787,"Patient programmer, neurostimulator",HCPCS_Level_II,HCPC2026_JAN,2026
C1788,"Port, indwelling (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1789,"Prosthesis, breast (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1813,"Prosthesis, penile, inflatable",HCPCS_Level_II,HCPC2026_JAN,2026
C1814,"Retinal tamponade device, silicone oil",HCPCS_Level_II,HCPC2026_JAN,2026
C1815,"Prosthesis, urinary sphincter (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1816,"Receiver and/or transmitter, neurostimulator (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1817,"Septal defect implant system, intracardiac",HCPCS_Level_II,HCPC2026_JAN,2026
C1818,Integrated keratoprosthesis,HCPCS_Level_II,HCPC2026_JAN,2026
C1819,Surgical tissue localization and excision device (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1820,"Generator, neurostimulator (implantable), with rechargeable battery and charging system",HCPCS_Level_II,HCPC2026_JAN,2026
C1821,Interspinous process distraction device (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1822,"Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system",HCPCS_Level_II,HCPC2026_JAN,2026
C1823,"Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads",HCPCS_Level_II,HCPC2026_JAN,2026
C1824,"Generator, cardiac contractility modulation (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1825,"Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C1826,"Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system",HCPCS_Level_II,HCPC2026_JAN,2026
C1827,"Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller",HCPCS_Level_II,HCPC2026_JAN,2026
C1830,Powered bone marrow biopsy needle,HCPCS_Level_II,HCPC2026_JAN,2026
C1831,"Interbody cage, anterior, lateral or posterior, personalized (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1832,"Autograft suspension, including cell processing and application, and all system components",HCPCS_Level_II,HCPC2026_JAN,2026
C1833,"Monitor, cardiac, including intracardiac lead and all system components (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1834,"Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software application",HCPCS_Level_II,HCPC2026_JAN,2026
C1839,Iris prosthesis,HCPCS_Level_II,HCPC2026_JAN,2026
C1840,"Lens, intraocular (telescopic)",HCPCS_Level_II,HCPC2026_JAN,2026
C1841,"Retinal prosthesis, includes all internal and external components",HCPCS_Level_II,HCPC2026_JAN,2026
C1842,"Retinal prosthesis, includes all internal and external components; add-on to c1841",HCPCS_Level_II,HCPC2026_JAN,2026
C1849,"Skin substitute, synthetic, resorbable, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C1874,"Stent, coated/covered, with delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C1875,"Stent, coated/covered, without delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C1876,"Stent, non-coated/non-covered, with delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C1877,"Stent, non-coated/non-covered, without delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C1878,"Material for vocal cord medialization, synthetic (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1880,Vena cava filter,HCPCS_Level_II,HCPC2026_JAN,2026
C1881,Dialysis access system (implantable),HCPCS_Level_II,HCPC2026_JAN,2026
C1882,"Cardioverter-defibrillator, other than single or dual chamber (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1883,"Adapter/extension, pacing lead or neurostimulator lead (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1884,Embolization protective system,HCPCS_Level_II,HCPC2026_JAN,2026
C1885,"Catheter, transluminal angioplasty, laser",HCPCS_Level_II,HCPC2026_JAN,2026
C1886,"Catheter, extravascular tissue ablation, any modality (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1887,"Catheter, guiding (may include infusion/perfusion capability)",HCPCS_Level_II,HCPC2026_JAN,2026
C1888,"Catheter, ablation, non-cardiac, endovascular (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1889,"Implantable/insertable device, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
C1890,No implantable/insertable device used with device-intensive procedures,HCPCS_Level_II,HCPC2026_JAN,2026
C1891,"Infusion pump, non-programmable, permanent (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1892,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away",HCPCS_Level_II,HCPC2026_JAN,2026
C1893,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away",HCPCS_Level_II,HCPC2026_JAN,2026
C1894,"Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser",HCPCS_Level_II,HCPC2026_JAN,2026
C1895,"Lead, cardioverter-defibrillator, endocardial dual coil (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1896,"Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1897,"Lead, neurostimulator test kit (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1898,"Lead, pacemaker, other than transvenous vdd single pass",HCPCS_Level_II,HCPC2026_JAN,2026
C1899,"Lead, pacemaker/cardioverter-defibrillator combination (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C1900,"Lead, left ventricular coronary venous system",HCPCS_Level_II,HCPC2026_JAN,2026
C1982,"Catheter, pressure-generating, (e.g., one-way valve, intermittently occlusive)",HCPCS_Level_II,HCPC2026_JAN,2026
C2596,"Probe, image-guided, robotic, waterjet ablation",HCPCS_Level_II,HCPC2026_JAN,2026
C2613,Lung biopsy plug with delivery system,HCPCS_Level_II,HCPC2026_JAN,2026
C2614,"Probe, percutaneous lumbar discectomy",HCPCS_Level_II,HCPC2026_JAN,2026
C2615,"Sealant, pulmonary, liquid",HCPCS_Level_II,HCPC2026_JAN,2026
C2616,"Brachytherapy source, non-stranded, yttrium-90, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2617,"Stent, non-coronary, temporary, without delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C2618,"Probe/needle, cryoablation",HCPCS_Level_II,HCPC2026_JAN,2026
C2619,"Pacemaker, dual chamber, non rate-responsive (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C2620,"Pacemaker, single chamber, non rate-responsive (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C2621,"Pacemaker, other than single or dual chamber (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C2622,"Prosthesis, penile, non-inflatable",HCPCS_Level_II,HCPC2026_JAN,2026
C2623,"Catheter, transluminal angioplasty, drug-coated, non-laser",HCPCS_Level_II,HCPC2026_JAN,2026
C2624,"Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components",HCPCS_Level_II,HCPC2026_JAN,2026
C2625,"Stent, non-coronary, temporary, with delivery system",HCPCS_Level_II,HCPC2026_JAN,2026
C2626,"Infusion pump, non-programmable, temporary (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C2627,"Catheter, suprapubic/cystoscopic",HCPCS_Level_II,HCPC2026_JAN,2026
C2628,"Catheter, occlusion",HCPCS_Level_II,HCPC2026_JAN,2026
C2629,"Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser",HCPCS_Level_II,HCPC2026_JAN,2026
C2630,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip",HCPCS_Level_II,HCPC2026_JAN,2026
C2631,"Repair device, urinary, incontinence, without sling graft",HCPCS_Level_II,HCPC2026_JAN,2026
C2634,"Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2635,"Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2636,"Brachytherapy linear source, non-stranded, palladium-103, per 1 mm",HCPCS_Level_II,HCPC2026_JAN,2026
C2637,"Brachytherapy source, non-stranded, ytterbium-169, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2638,"Brachytherapy source, stranded, iodine-125, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2639,"Brachytherapy source, non-stranded, iodine-125, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2640,"Brachytherapy source, stranded, palladium-103, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2641,"Brachytherapy source, non-stranded, palladium-103, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2642,"Brachytherapy source, stranded, cesium-131, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2643,"Brachytherapy source, non-stranded, cesium-131, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2644,"Brachytherapy source, cesium-131 chloride solution, per millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
C2645,"Brachytherapy planar source, palladium-103, per square millimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C2698,"Brachytherapy source, stranded, not otherwise specified, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C2699,"Brachytherapy source, non-stranded, not otherwise specified, per source",HCPCS_Level_II,HCPC2026_JAN,2026
C5271,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area",HCPCS_Level_II,HCPC2026_JAN,2026
C5272,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C5273,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children",HCPCS_Level_II,HCPC2026_JAN,2026
C5274,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C5275,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area",HCPCS_Level_II,HCPC2026_JAN,2026
C5276,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C5277,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children",HCPCS_Level_II,HCPC2026_JAN,2026
C5278,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C7500,"Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (e.g., subfacial) drug-delivery device(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C7501,"Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)",HCPCS_Level_II,HCPC2026_JAN,2026
C7502,"Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)",HCPCS_Level_II,HCPC2026_JAN,2026
C7503,"Open biopsy or excision of deep cervical node(s) with intraoperative identification (e.g., mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7504,"Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C7505,"Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C7506,"Arthrodesis, interphalangeal joints, with or without internal fixation",HCPCS_Level_II,HCPC2026_JAN,2026
C7507,"Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C7508,"Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C7509,"Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7510,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7511,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7512,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7513,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7514,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7515,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7516,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7517,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7518,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7519,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7520,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7521,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7522,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7523,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7524,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7525,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7526,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7527,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7528,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7529,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7530,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7531,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7532,"Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7533,"Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy",HCPCS_Level_II,HCPC2026_JAN,2026
C7534,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7535,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7537,"Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)",HCPCS_Level_II,HCPC2026_JAN,2026
C7538,"Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)",HCPCS_Level_II,HCPC2026_JAN,2026
C7539,"Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)",HCPCS_Level_II,HCPC2026_JAN,2026
C7540,"Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)",HCPCS_Level_II,HCPC2026_JAN,2026
C7541,"Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C7542,"Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C7543,"Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C7544,"Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C7545,"Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7546,"Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7547,"Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7548,"Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7549,"Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7550,"Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with fluorescent imaging agent",HCPCS_Level_II,HCPC2026_JAN,2026
C7551,"Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle",HCPCS_Level_II,HCPC2026_JAN,2026
C7552,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel",HCPCS_Level_II,HCPC2026_JAN,2026
C7553,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7554,Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent,HCPCS_Level_II,HCPC2026_JAN,2026
C7555,"Thyroidectomy, total or complete with parathyroid autotransplantation",HCPCS_Level_II,HCPC2026_JAN,2026
C7556,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7557,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention",HCPCS_Level_II,HCPC2026_JAN,2026
C7558,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C7560,Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s),HCPCS_Level_II,HCPC2026_JAN,2026
C7562,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention",HCPCS_Level_II,HCPC2026_JAN,2026
C7563,"Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the  angioplasty within the same artery, initial artery and all additional arteries",HCPCS_Level_II,HCPC2026_JAN,2026
C7564,"Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance with intravascular ultrasound (noncoronary vessel(s)) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation",HCPCS_Level_II,HCPC2026_JAN,2026
C7565,"Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (i.e., open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s) less than 3 cm, reducible with removal of total or near total non-infected mesh or other prosthesis at the time of initial or recurrent anterior abdominal hernia repair or parastomal hernia repair",HCPCS_Level_II,HCPC2026_JAN,2026
C7566,"Arthrodesis, interphalangeal joints, with or without internal fixation, with autografts (includes obtaining grafts)",HCPCS_Level_II,HCPC2026_JAN,2026
C7567,"Bronchoscopy, rigid or flexible, including fluoroscopic guidance when performed, with transbronchial needle aspiration biopsy(s), trachea, main stem and/or lobar bronchus(i), with computer-assisted image-guided naviagation",HCPCS_Level_II,HCPC2026_JAN,2026
C7568,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress",HCPCS_Level_II,HCPC2026_JAN,2026
C7569,"Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C7570,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C7571,"Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with percutaneous transluminal coronary lithotripsy",HCPCS_Level_II,HCPC2026_JAN,2026
C7900,"Service for diagnosis, evaluation, or treatment of a mental health  or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service",HCPCS_Level_II,HCPC2026_JAN,2026
C7901,"Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service",HCPCS_Level_II,HCPC2026_JAN,2026
C7902,"Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)",HCPCS_Level_II,HCPC2026_JAN,2026
C7903,"Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service",HCPCS_Level_II,HCPC2026_JAN,2026
C8000,"Support device, extravascular, for arteriovenous fistula (implantable)",HCPCS_Level_II,HCPC2026_JAN,2026
C8001,"3d anatomical segmentation imaging for preoperative planning, data preparation and transmission, obtained from previous diagnostic computed tomographic or magnetic resonance examination of the same anatomy",HCPCS_Level_II,HCPC2026_JAN,2026
C8002,"Preparation of skin cell suspension autograft, automated, including all enzymatic processing and device components (do not report with manual suspension preparation)",HCPCS_Level_II,HCPC2026_JAN,2026
C8003,"Implantation of medial knee extraarticular implantable shock absorber spanning the knee joint from distal femur to proximal tibia, open, includes measurements, positioning and adjustments, with imaging guidance (e.g., fluoroscopy)",HCPCS_Level_II,HCPC2026_JAN,2026
C8004,"Simulation angiogram with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the angiogram, for subsequent therapeutic radioembolization of tumors",HCPCS_Level_II,HCPC2026_JAN,2026
C8005,"Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or ultrasound guidance, when performed, with computed tomography acquisition(s) and 3d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) of lung(s) and all mediastinal and/or hilar lymph node stations or structures, and therapeutic intervention(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C8006,"Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiological supervision and interpretation, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C8900,"Magnetic resonance angiography with contrast, abdomen",HCPCS_Level_II,HCPC2026_JAN,2026
C8901,"Magnetic resonance angiography without contrast, abdomen",HCPCS_Level_II,HCPC2026_JAN,2026
C8902,"Magnetic resonance angiography without contrast followed by with contrast, abdomen",HCPCS_Level_II,HCPC2026_JAN,2026
C8903,"Magnetic resonance imaging with contrast, breast; unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C8904,"Magnetic resonance imaging without contrast, breast; unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C8905,"Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C8906,"Magnetic resonance imaging with contrast, breast; bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C8907,"Magnetic resonance imaging without contrast, breast; bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C8908,"Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C8909,"Magnetic resonance angiography with contrast, chest (excluding myocardium)",HCPCS_Level_II,HCPC2026_JAN,2026
C8910,"Magnetic resonance angiography without contrast, chest (excluding myocardium)",HCPCS_Level_II,HCPC2026_JAN,2026
C8911,"Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)",HCPCS_Level_II,HCPC2026_JAN,2026
C8912,"Magnetic resonance angiography with contrast, lower extremity",HCPCS_Level_II,HCPC2026_JAN,2026
C8913,"Magnetic resonance angiography without contrast, lower extremity",HCPCS_Level_II,HCPC2026_JAN,2026
C8914,"Magnetic resonance angiography without contrast followed by with contrast, lower extremity",HCPCS_Level_II,HCPC2026_JAN,2026
C8918,"Magnetic resonance angiography with contrast, pelvis",HCPCS_Level_II,HCPC2026_JAN,2026
C8919,"Magnetic resonance angiography without contrast, pelvis",HCPCS_Level_II,HCPC2026_JAN,2026
C8920,"Magnetic resonance angiography without contrast followed by with contrast, pelvis",HCPCS_Level_II,HCPC2026_JAN,2026
C8921,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete",HCPCS_Level_II,HCPC2026_JAN,2026
C8922,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study",HCPCS_Level_II,HCPC2026_JAN,2026
C8923,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography",HCPCS_Level_II,HCPC2026_JAN,2026
C8924,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study",HCPCS_Level_II,HCPC2026_JAN,2026
C8925,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C8926,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C8927,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis",HCPCS_Level_II,HCPC2026_JAN,2026
C8928,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C8929,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography",HCPCS_Level_II,HCPC2026_JAN,2026
C8930,"Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
C8931,"Magnetic resonance angiography with contrast, spinal canal and contents",HCPCS_Level_II,HCPC2026_JAN,2026
C8932,"Magnetic resonance angiography without contrast, spinal canal and contents",HCPCS_Level_II,HCPC2026_JAN,2026
C8933,"Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents",HCPCS_Level_II,HCPC2026_JAN,2026
C8934,"Magnetic resonance angiography with contrast, upper extremity",HCPCS_Level_II,HCPC2026_JAN,2026
C8935,"Magnetic resonance angiography without contrast, upper extremity",HCPCS_Level_II,HCPC2026_JAN,2026
C8936,"Magnetic resonance angiography without contrast followed by with contrast, upper extremity",HCPCS_Level_II,HCPC2026_JAN,2026
C8937,"Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C8957,"Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump",HCPCS_Level_II,HCPC2026_JAN,2026
C9014,"Injection, cerliponase alfa, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9015,"Injection, c-1 esterase inhibitor (human), haegarda, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
C9016,"Injection, triptorelin extended release, 3.75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9021,"Injection, obinutuzumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9022,"Injection, elosulfase alfa, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9023,"Injection, testosterone undecanoate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9024,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine",HCPCS_Level_II,HCPC2026_JAN,2026
C9025,"Injection, ramucirumab, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9026,"Injection, vedolizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9027,"Injection, pembrolizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9028,"Injection, inotuzumab ozogamicin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9029,"Injection, guselkumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9030,"Injection, copanlisib, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9031,"Lutetium lu 177, dotatate, therapeutic, 1 mci",HCPCS_Level_II,HCPC2026_JAN,2026
C9032,"Injection, voretigene neparvovec-rzyl, 1 billion vector genome",HCPCS_Level_II,HCPC2026_JAN,2026
C9033,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9034,"Injection, dexamethasone 9%, intraocular, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
C9035,"Injection, aripiprazole lauroxil (aristada initio), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9036,"Injection, patisiran, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9037,"Injection, risperidone (perseris), 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9038,"Injection, mogamulizumab-kpkc, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9039,"Injection, plazomicin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9040,"Injection, fremanezumab-vfrm, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9041,"Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9042,"Injection, bendamustine hcl (belrapzo), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9043,"Injection, levoleucovorin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9044,"Injection, cemiplimab-rwlc, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9045,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9046,"Cocaine hydrochloride nasal solution (goprelto), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9047,"Injection, caplacizumab-yhdp, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9048,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9049,"Injection, tagraxofusp-erzs, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
C9050,"Injection, emapalumab-lzsg, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9051,"Injection, omadacycline, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9052,"Injection, ravulizumab-cwvz, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9053,"Injection,  crizanlizumab-tmca, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9054,"Injection, lefamulin (xenleta), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9055,"Injection, brexanolone, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9056,"Injection, givosiran, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9057,"Injection, cetirizine hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9058,"Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9059,"Injection, meloxicam, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9060,"Fluoroestradiol f18, diagnostic, 1 mci",HCPCS_Level_II,HCPC2026_JAN,2026
C9061,"Injection, teprotumumab-trbw, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9062,"Injection, daratumumab 10 mg and hyaluronidase-fihj",HCPCS_Level_II,HCPC2026_JAN,2026
C9063,"Injection, eptinezumab-jjmr, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9064,"Mitomycin pyelocalyceal instillation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9065,"Injection, romidepsin, non-lyophilized (e.g. liquid), 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9066,"Injection, sacituzumab govitecan-hziy, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9067,"Gallium ga-68, dotatoc, diagnostic, 0.01 mci",HCPCS_Level_II,HCPC2026_JAN,2026
C9068,"Copper cu-64, dotatate, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
C9069,"Injection, belantamab mafodontin-blmf, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9070,"Injection, tafasitamab-cxix, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9071,"Injection, viltolarsen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9072,"Injection, immune globulin (asceniv), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9073,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9074,"Injection, lumasiran, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9075,"Injection, casimersen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9076,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9077,"Injection, cabotegravir and rilpivirine, 2mg/3mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9078,"Injection, trilaciclib, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9079,"Injection, evinacumab-dgnb, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9080,"Injection, melphalan flufenamide hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9081,"Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9082,"Injection, dostarlimab-gxly, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9083,"Injection, amivantamab-vmjw, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9084,"Injection, loncastuximab tesirine-lpyl, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9085,"Injection, avalglucosidase alfa-ngpt, 4 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9086,"Injection, anifrolumab-fnia, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9087,"Injection, cyclophosphamide, (auromedics), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9088,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9089,"Bupivacaine, collagen-matrix implant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9090,"Injection, plasminogen, human-tvmh, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9091,"Injection, sirolimus protein-bound particles, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9092,"Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9093,"Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9094,"Inj, sutimlimab-jome, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9095,"Inj, tebentafusp-tebn, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
C9096,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
C9097,"Inj, faricimab-svoa, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9098,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9101,"Injection, oliceridine, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9113,"Injection, pantoprazole sodium, per vial",HCPCS_Level_II,HCPC2026_JAN,2026
C9121,"Injection, argatroban, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9122,"Mometasone furoate sinus implant, 10 micrograms (sinuva)",HCPCS_Level_II,HCPC2026_JAN,2026
C9132,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity",HCPCS_Level_II,HCPC2026_JAN,2026
C9133,"Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9134,"Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9135,"Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9136,"Injection, factor viii, fc fusion protein, (recombinant), per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9137,"Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9138,"Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9139,"Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9140,"Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9141,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9142,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9143,"Cocaine hydrochloride nasal solution (numbrino), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9144,"Injection, bupivacaine (posimir), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9145,"Injection, aprepitant, (aponvie), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9146,"Injection, mirvetuximab soravtansine-gynx, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9147,"Injection, tremelimumab-actl, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9148,"Injection, teclistamab-cqyv, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9149,"Injection, teplizumab-mzwv, 5 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
C9150,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9151,"Injection, pegcetacoplan, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9152,"Injection, aripiprazole, (abilify asimtufii), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9153,"Injection, amisulpride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9154,"Injection, buprenorphine extended-release (brixadi), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9155,"Injection, epcoritamab-bysp, 0.16 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9156,"Flotufolastat f 18, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
C9157,"Injection, tofersen, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9158,"Injection, risperidone, (uzedy), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9159,"Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activity",HCPCS_Level_II,HCPC2026_JAN,2026
C9160,"Injection, daxibotulinumtoxina-lanm, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
C9161,"Injection, aflibercept hd, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9162,"Injection, avacincaptad pegol, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9163,"Injection, talquetamab-tgvs, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9164,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)",HCPCS_Level_II,HCPC2026_JAN,2026
C9165,"Injection, elranatamab-bcmm, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9166,"Injection, secukinumab, intravenous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9167,"Injection, adamts13, recombinant-krhn, 10 iu",HCPCS_Level_II,HCPC2026_JAN,2026
C9168,"Injection, mirikizumab-mrkz, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9169,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
C9170,"Injection, tarlatamab-dlle, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9171,"Injection, pegulicianine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9172,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9173,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
C9174,"Injection, datopotamab deruxtecan-dlnk, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9175,"Injection, treosulfan, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9176,"Tc-99m from domestically produced non-heu mo-99, [minimum 50 percent], full cost recovery add-on, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9248,"Injection, clevidipine butyrate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9250,"Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml",HCPCS_Level_II,HCPC2026_JAN,2026
C9254,"Injection, lacosamide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9257,"Injection, bevacizumab, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9275,"Injection, hexaminolevulinate hydrochloride, 100 mg, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9285,"Lidocaine 70 mg/tetracaine 70 mg, per patch",HCPCS_Level_II,HCPC2026_JAN,2026
C9290,"Injection, bupivacaine liposome, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9293,"Injection, glucarpidase, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
C9300,"Injection, indigotindisulfonate sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9301,"Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9302,"Injection, zanidatamab-hrii, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9303,"Injection, zolbetuximab-clzb, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9304,"Injection, marstacimab-hncq, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9305,"Injection, nipocalimab-aahu, 3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9306,"Injection, telisotuzumab vedotin-tllv, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9307,"Injection, linvoseltamab-gcpt, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9308,"Injection, carboplatin (avyxa), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9349,"Puraply, and puraply antimicrobial, any type, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C9352,"Microporous collagen implantable tube (neuragen nerve guide), per centimeter length",HCPCS_Level_II,HCPC2026_JAN,2026
C9353,"Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length",HCPCS_Level_II,HCPC2026_JAN,2026
C9354,"Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C9355,"Collagen nerve cuff (neuromatrix), per 0.5 centimeter length",HCPCS_Level_II,HCPC2026_JAN,2026
C9356,"Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C9358,"Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters",HCPCS_Level_II,HCPC2026_JAN,2026
C9359,"Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
C9360,"Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters",HCPCS_Level_II,HCPC2026_JAN,2026
C9361,"Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length",HCPCS_Level_II,HCPC2026_JAN,2026
C9362,"Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
C9363,"Skin substitute, integra meshed bilayer wound matrix, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C9364,"Porcine implant, permacol, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
C9399,Unclassified drugs or biologicals,HCPCS_Level_II,HCPC2026_JAN,2026
C9407,"Iodine i-131 iobenguane, diagnostic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
C9408,"Iodine i-131 iobenguane, therapeutic, 1 millicurie",HCPCS_Level_II,HCPC2026_JAN,2026
C9441,"Injection, ferric carboxymaltose, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9442,"Injection, belinostat, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9443,"Injection, dalbavancin, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9444,"Injection, oritavancin, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9445,"Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
C9446,"Injection, tedizolid phosphate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9447,"Injection, phenylephrine and ketorolac, 4 ml vial",HCPCS_Level_II,HCPC2026_JAN,2026
C9448,"Netupitant 300 mg and palonosetron 0.5 mg, oral",HCPCS_Level_II,HCPC2026_JAN,2026
C9449,"Injection, blinatumomab, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
C9450,"Injection, fluocinolone acetonide intravitreal implant, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9451,"Injection, peramivir, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9452,"Injection, ceftolozane 50 mg and tazobactam 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9453,"Injection, nivolumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9454,"Injection, pasireotide long acting, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9455,"Injection, siltuximab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9456,"Injection, isavuconazonium sulfate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9457,"Injection, sulfur hexafluoride lipid microsphere, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
C9458,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
C9459,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
C9460,"Injection, cangrelor, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9461,"Choline c 11, diagnostic, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9462,"Injection, delafloxacin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9463,"Injection, aprepitant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9464,"Injection, rolapitant, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9465,"Hyaluronan or derivative, durolane, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
C9466,"Injection, benralizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9467,"Injection, rituximab and hyaluronidase, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9468,"Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
C9469,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9470,"Injection, aripiprazole lauroxil, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9471,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9472,"Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)",HCPCS_Level_II,HCPC2026_JAN,2026
C9473,"Injection, mepolizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9474,"Injection, irinotecan liposome, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9475,"Injection, necitumumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9476,"Injection, daratumumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9477,"Injection, elotuzumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9478,"Injection, sebelipase alfa, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9479,"Instillation, ciprofloxacin otic suspension, 6 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9480,"Injection, trabectedin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9481,"Injection, reslizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9482,"Injection, sotalol hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9483,"Injection, atezolizumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9484,"Injection, eteplirsen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9485,"Injection, olaratumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9486,"Injection, granisetron extended release, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9487,"Ustekinumab, for intravenous injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9488,"Injection, conivaptan hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9489,"Injection, nusinersen, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9490,"Injection, bezlotoxumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9491,"Injection, avelumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9492,"Injection, durvalumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9493,"Injection, edaravone, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9494,"Injection, ocrelizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9497,"Loxapine, inhalation powder, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
C9507,"Plasma, high titer covid-19 convalescent, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
C9600,"Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch",HCPCS_Level_II,HCPC2026_JAN,2026
C9601,"Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C9602,"Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch",HCPCS_Level_II,HCPC2026_JAN,2026
C9603,"Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C9604,"Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel",HCPCS_Level_II,HCPC2026_JAN,2026
C9605,"Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C9606,"Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel",HCPCS_Level_II,HCPC2026_JAN,2026
C9607,"Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel",HCPCS_Level_II,HCPC2026_JAN,2026
C9608,"Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C9610,"Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable)",HCPCS_Level_II,HCPC2026_JAN,2026
C9724,Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
C9725,Placement of endorectal intracavitary applicator for high intensity brachytherapy,HCPCS_Level_II,HCPC2026_JAN,2026
C9726,"Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure",HCPCS_Level_II,HCPC2026_JAN,2026
C9727,Insertion of implants into the soft palate; minimum of three implants,HCPCS_Level_II,HCPC2026_JAN,2026
C9728,"Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple",HCPCS_Level_II,HCPC2026_JAN,2026
C9733,Non-ophthalmic fluorescent vascular angiography,HCPCS_Level_II,HCPC2026_JAN,2026
C9734,"Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C9735,"Anoscopy; with directed submucosal injection(s), any substance",HCPCS_Level_II,HCPC2026_JAN,2026
C9737,"Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)",HCPCS_Level_II,HCPC2026_JAN,2026
C9738,Adjunctive blue light cystoscopy with fluorescent imaging agent  (list separately in addition to code for primary procedure),HCPCS_Level_II,HCPC2026_JAN,2026
C9739,"Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants",HCPCS_Level_II,HCPC2026_JAN,2026
C9740,"Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants",HCPCS_Level_II,HCPC2026_JAN,2026
C9741,"Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report",HCPCS_Level_II,HCPC2026_JAN,2026
C9742,"Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9743,Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies),HCPCS_Level_II,HCPC2026_JAN,2026
C9744,"Ultrasound, abdominal, with contrast",HCPCS_Level_II,HCPC2026_JAN,2026
C9745,"Nasal endoscopy, surgical; balloon dilation of eustachian tube",HCPCS_Level_II,HCPC2026_JAN,2026
C9746,"Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9747,"Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C9748,Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy,HCPCS_Level_II,HCPC2026_JAN,2026
C9749,Repair of nasal vestibular lateral wall stenosis with implant(s),HCPCS_Level_II,HCPC2026_JAN,2026
C9750,Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode),HCPCS_Level_II,HCPC2026_JAN,2026
C9751,"Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including  fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)",HCPCS_Level_II,HCPC2026_JAN,2026
C9752,"Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum",HCPCS_Level_II,HCPC2026_JAN,2026
C9753,"Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C9754,"Creation of arteriovenous fistula,  percutaneous; direct, any site, including  all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)",HCPCS_Level_II,HCPC2026_JAN,2026
C9755,"Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9756,Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure),HCPCS_Level_II,HCPC2026_JAN,2026
C9757,"Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect  measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar",HCPCS_Level_II,HCPC2026_JAN,2026
C9758,"Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study",HCPCS_Level_II,HCPC2026_JAN,2026
C9759,"Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9760,"Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study",HCPCS_Level_II,HCPC2026_JAN,2026
C9761,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter)",HCPCS_Level_II,HCPC2026_JAN,2026
C9762,"Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging",HCPCS_Level_II,HCPC2026_JAN,2026
C9763,"Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging",HCPCS_Level_II,HCPC2026_JAN,2026
C9764,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9765,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9766,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9767,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9768,Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure),HCPCS_Level_II,HCPC2026_JAN,2026
C9769,"Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts",HCPCS_Level_II,HCPC2026_JAN,2026
C9770,"Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent",HCPCS_Level_II,HCPC2026_JAN,2026
C9771,"Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
C9772,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9773,"Revascularization, endovascular, open or percutaneous,  tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty  within the same vessel(s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9774,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9775,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9776,"Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
C9777,"Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy",HCPCS_Level_II,HCPC2026_JAN,2026
C9778,"Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)",HCPCS_Level_II,HCPC2026_JAN,2026
C9779,"Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9780,"Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C9781,"Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9782,"Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study",HCPCS_Level_II,HCPC2026_JAN,2026
C9783,"Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study",HCPCS_Level_II,HCPC2026_JAN,2026
C9784,"Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components",HCPCS_Level_II,HCPC2026_JAN,2026
C9785,"Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components",HCPCS_Level_II,HCPC2026_JAN,2026
C9786,"Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
C9787,Gastric electrophysiology mapping with simultaneous patient symptom profiling,HCPCS_Level_II,HCPC2026_JAN,2026
C9788,"Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination",HCPCS_Level_II,HCPC2026_JAN,2026
C9789,"Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed",HCPCS_Level_II,HCPC2026_JAN,2026
C9790,"Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance",HCPCS_Level_II,HCPC2026_JAN,2026
C9791,"Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent",HCPCS_Level_II,HCPC2026_JAN,2026
C9792,"Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)",HCPCS_Level_II,HCPC2026_JAN,2026
C9793,"3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report",HCPCS_Level_II,HCPC2026_JAN,2026
C9794,"Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)",HCPCS_Level_II,HCPC2026_JAN,2026
C9795,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions",HCPCS_Level_II,HCPC2026_JAN,2026
C9796,"Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis])",HCPCS_Level_II,HCPC2026_JAN,2026
C9797,"Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction",HCPCS_Level_II,HCPC2026_JAN,2026
C9800,"Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and supplies",HCPCS_Level_II,HCPC2026_JAN,2026
C9803,"Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",HCPCS_Level_II,HCPC2026_JAN,2026
C9804,"Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9806,"Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9807,"Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve stimulation system), including electrode and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9808,"Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice cryosphere, cryoice cryo2), including probe and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9809,"Cryoablation needle (e.g., iovera system), including needle/tip and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9810,"Water circulating motorized cold therapy device (e.g., iceman) including all system components (e.g. pads, console, disposable parts), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9811,"Electronic ambulatory infusion pump (e.g. sapphire pump), including all pump components, including disposable components , non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9812,"Echogenic nerve block needles (e.g. sonoplex, sonoblock, sonotap), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9813,"Perforated continuous infusion catheter set (e.g. infiltralong), including all components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9814,"Continuous anesthesia echogenic conduction catheter set (e.g. sonolong), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9815,"Linear peristaltic pain management infusion pump (e.g. cadd-solis ambulatory infusion pump), and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9816,"Rotary peristaltic infusion pump (e.g., reusable ambit pump) including all disposable system components, reusable non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9817,"Electronic cryo-pneumatic compression, pain management system (e.g. game ready grpro 2.1 system), including control unit, anatomically correct wrap(s), and other system component(s), non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)",HCPCS_Level_II,HCPC2026_JAN,2026
C9898,Radiolabeled product provided during a hospital inpatient stay,HCPCS_Level_II,HCPC2026_JAN,2026
C9899,"Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage",HCPCS_Level_II,HCPC2026_JAN,2026
C9901,"Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components",HCPCS_Level_II,HCPC2026_JAN,2026
CA,Procedure payable only in the inpatient setting when performed emergently on an outpatient who expires prior to admission,HCPCS_Level_II,HCPC2026_JAN,2026
CB,"Service ordered by a renal dialysis facility (rdf) physician as part of the esrd beneficiary's dialysis benefit, is not part of the composite rate, and is separately reimbursable",HCPCS_Level_II,HCPC2026_JAN,2026
CC,Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed),HCPCS_Level_II,HCPC2026_JAN,2026
CD,Amcc test has been ordered by an esrd facility or mcp physician that is part of the composite rate and is not separately billable,HCPCS_Level_II,HCPC2026_JAN,2026
CE,Amcc test has been ordered by an esrd facility or mcp physician that is a composite rate test but is beyond the normal frequency covered under the rate and is separately reimbursable based on medical necessity,HCPCS_Level_II,HCPC2026_JAN,2026
CF,Amcc test has been ordered by an esrd facility or mcp physician that is not part of the composite rate and is separately billable,HCPCS_Level_II,HCPC2026_JAN,2026
CG,Policy criteria applied,HCPCS_Level_II,HCPC2026_JAN,2026
CH,"0 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CI,"At least 1 percent but less than 20 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CJ,"At least 20 percent but less than 40 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CK,"At least 40 percent but less than 60 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CL,"At least 60 percent but less than 80 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CM,"At least 80 percent but less than 100 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CN,"100 percent impaired, limited or restricted",HCPCS_Level_II,HCPC2026_JAN,2026
CO,Outpatient occupational therapy services furnished in whole or in part by an occupational therapy assistant,HCPCS_Level_II,HCPC2026_JAN,2026
CP,"Adjunctive service related to a procedure assigned to a comprehensive ambulatory payment classification (c-apc) procedure, but reported on a different claim",HCPCS_Level_II,HCPC2026_JAN,2026
CQ,Outpatient physical therapy services furnished in whole or in part by a physical therapist assistant,HCPCS_Level_II,HCPC2026_JAN,2026
CR,Catastrophe/disaster related,HCPCS_Level_II,HCPC2026_JAN,2026
CS,Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency,HCPCS_Level_II,HCPC2026_JAN,2026
CT,Computed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standard,HCPCS_Level_II,HCPC2026_JAN,2026
D0120,Periodic oral evaluation,HCPCS_Level_II,RVU2026A,2026
D0140,Limit oral eval problm focus,HCPCS_Level_II,RVU2026A,2026
D0145,"Oral evaluation, pt < 3yrs",HCPCS_Level_II,RVU2026A,2026
D0150,Comprehensve oral evaluation,HCPCS_Level_II,RVU2026A,2026
D0160,Extensv oral eval prob focus,HCPCS_Level_II,RVU2026A,2026
D0170,"Re-eval,est pt,problem focus",HCPCS_Level_II,RVU2026A,2026
D0171,Re-eval post-op visit,HCPCS_Level_II,RVU2026A,2026
D0180,Comp periodontal evaluation,HCPCS_Level_II,RVU2026A,2026
D0190,Screening of a patient,HCPCS_Level_II,RVU2026A,2026
D0191,Assessment of a patient,HCPCS_Level_II,RVU2026A,2026
D0210,Intraor comprehensive series,HCPCS_Level_II,RVU2026A,2026
D0220,Intraoral periapical first,HCPCS_Level_II,RVU2026A,2026
D0230,Intraoral periapical ea add,HCPCS_Level_II,RVU2026A,2026
D0240,Intraoral occlusal film,HCPCS_Level_II,RVU2026A,2026
D0250,Extraoral 2d project image,HCPCS_Level_II,RVU2026A,2026
D0251,Extraoral posterior image,HCPCS_Level_II,RVU2026A,2026
D0270,Dental bitewing single image,HCPCS_Level_II,RVU2026A,2026
D0272,Dental bitewings two images,HCPCS_Level_II,RVU2026A,2026
D0273,Bitewings - three images,HCPCS_Level_II,RVU2026A,2026
D0274,Bitewings four images,HCPCS_Level_II,RVU2026A,2026
D0277,Vert bitewings 7 to 8 images,HCPCS_Level_II,RVU2026A,2026
D0310,Dental saliography,HCPCS_Level_II,RVU2026A,2026
D0320,Dental tmj arthrogram incl i,HCPCS_Level_II,RVU2026A,2026
D0321,Other tmj images by report,HCPCS_Level_II,RVU2026A,2026
D0322,Dental tomographic survey,HCPCS_Level_II,RVU2026A,2026
D0330,Panoramic image,HCPCS_Level_II,RVU2026A,2026
D0340,2d cephalometric image,HCPCS_Level_II,RVU2026A,2026
D0350,Oral/facial photo images,HCPCS_Level_II,RVU2026A,2026
D0364,Cone beam ct capt & interp,HCPCS_Level_II,RVU2026A,2026
D0365,Cone beam ct interprete man,HCPCS_Level_II,RVU2026A,2026
D0366,Cone beam ct interprete max,HCPCS_Level_II,RVU2026A,2026
D0367,Cone beam ct interp both jaw,HCPCS_Level_II,RVU2026A,2026
D0368,Cone beam ct interprete tmj,HCPCS_Level_II,RVU2026A,2026
D0369,Max mri capture & interprete,HCPCS_Level_II,RVU2026A,2026
D0370,Max ultrasound capt & interp,HCPCS_Level_II,RVU2026A,2026
D0371,Sialoendoscopy capt & interp,HCPCS_Level_II,RVU2026A,2026
D0372,Tomo comp series images,HCPCS_Level_II,RVU2026A,2026
D0373,Tomo bitewing image,HCPCS_Level_II,RVU2026A,2026
D0374,Tomo periapical image,HCPCS_Level_II,RVU2026A,2026
D0380,Cone beam ct capture limited,HCPCS_Level_II,RVU2026A,2026
D0381,Cone beam ct capt mandible,HCPCS_Level_II,RVU2026A,2026
D0382,Cone beam ct capt maxilla,HCPCS_Level_II,RVU2026A,2026
D0383,Cone beam ct both jaws,HCPCS_Level_II,RVU2026A,2026
D0384,Cone beam ct capture tmj,HCPCS_Level_II,RVU2026A,2026
D0385,Max mri image capture,HCPCS_Level_II,RVU2026A,2026
D0386,Max ultrasound image capture,HCPCS_Level_II,RVU2026A,2026
D0387,Comp image capture only,HCPCS_Level_II,RVU2026A,2026
D0388,Bitewing image capture only,HCPCS_Level_II,RVU2026A,2026
D0389,Periopic image capture only,HCPCS_Level_II,RVU2026A,2026
D0391,Imterprete diagnostic image,HCPCS_Level_II,RVU2026A,2026
D0393,Trtmnt simulation 3d image,HCPCS_Level_II,RVU2026A,2026
D0394,Digital sub 2 or more images,HCPCS_Level_II,RVU2026A,2026
D0395,Fusion 2 or more 3d images,HCPCS_Level_II,RVU2026A,2026
D0396,3d print of 3d surface scan,HCPCS_Level_II,RVU2026A,2026
D0411,Hba1c in office testing,HCPCS_Level_II,RVU2026A,2026
D0412,Blood glucose level test,HCPCS_Level_II,RVU2026A,2026
D0414,Lab process microbial spec,HCPCS_Level_II,RVU2026A,2026
D0415,Collection of microorganisms,HCPCS_Level_II,RVU2026A,2026
D0416,Viral culture,HCPCS_Level_II,RVU2026A,2026
D0417,Collect & prep saliva sample,HCPCS_Level_II,RVU2026A,2026
D0418,Analysis of saliva sample,HCPCS_Level_II,RVU2026A,2026
D0419,Assess of salivary flow,HCPCS_Level_II,RVU2026A,2026
D0422,Collect & prep genetic samp,HCPCS_Level_II,RVU2026A,2026
D0423,Genetic test spec analysis,HCPCS_Level_II,RVU2026A,2026
D0425,Caries susceptibility test,HCPCS_Level_II,RVU2026A,2026
D0426,"Coll, analys of saliva",HCPCS_Level_II,RVU2026A,2026
D0431,Diag tst detect mucos abnorm,HCPCS_Level_II,RVU2026A,2026
D0460,Pulp vitality test,HCPCS_Level_II,RVU2026A,2026
D0461,Testing for cracked tooth,HCPCS_Level_II,RVU2026A,2026
D0470,Diagnostic casts,HCPCS_Level_II,RVU2026A,2026
D0472,"Gross exam, prep & report",HCPCS_Level_II,RVU2026A,2026
D0473,"Micro exam, prep & report",HCPCS_Level_II,RVU2026A,2026
D0474,Micro w exam of surg margins,HCPCS_Level_II,RVU2026A,2026
D0475,Decalcification procedure,HCPCS_Level_II,RVU2026A,2026
D0476,Spec stains for microorganis,HCPCS_Level_II,RVU2026A,2026
D0477,Spec stains not for microorg,HCPCS_Level_II,RVU2026A,2026
D0478,Immunohistochemical stains,HCPCS_Level_II,RVU2026A,2026
D0479,Tissue in-situ hybridization,HCPCS_Level_II,RVU2026A,2026
D0480,Cytopath smear prep & report,HCPCS_Level_II,RVU2026A,2026
D0481,Electron microscopy,HCPCS_Level_II,RVU2026A,2026
D0482,Direct immunofluorescence,HCPCS_Level_II,RVU2026A,2026
D0483,Indirect immunofluorescence,HCPCS_Level_II,RVU2026A,2026
D0484,Consult slides prep elsewher,HCPCS_Level_II,RVU2026A,2026
D0485,Consult inc prep of slides,HCPCS_Level_II,RVU2026A,2026
D0486,Access of transep cytol samp,HCPCS_Level_II,RVU2026A,2026
D0502,Other oral pathology procedu,HCPCS_Level_II,RVU2026A,2026
D0600,Non-ionizing diag proc,HCPCS_Level_II,RVU2026A,2026
D0601,Caries risk assess low risk,HCPCS_Level_II,RVU2026A,2026
D0602,Caries risk assess mod risk,HCPCS_Level_II,RVU2026A,2026
D0603,Caries risk assess high risk,HCPCS_Level_II,RVU2026A,2026
D0604,Antigen test pub hlth pathog,HCPCS_Level_II,RVU2026A,2026
D0605,Antibody test pub hlth path,HCPCS_Level_II,RVU2026A,2026
D0606,Molecular test pub hlth path,HCPCS_Level_II,RVU2026A,2026
D0701,Pano radio image,HCPCS_Level_II,RVU2026A,2026
D0702,2d cephal radio image,HCPCS_Level_II,RVU2026A,2026
D0703,2d oral/facial photo image,HCPCS_Level_II,RVU2026A,2026
D0705,Extra oral post radio image,HCPCS_Level_II,RVU2026A,2026
D0706,Intraoral occlus radio image,HCPCS_Level_II,RVU2026A,2026
D0707,Intraoral periap radio image,HCPCS_Level_II,RVU2026A,2026
D0708,Intraoral bite radio image,HCPCS_Level_II,RVU2026A,2026
D0709,Intraoral comp image capture,HCPCS_Level_II,RVU2026A,2026
D0801,3d intraoral scan direct,HCPCS_Level_II,RVU2026A,2026
D0802,3d dental scan indirect,HCPCS_Level_II,RVU2026A,2026
D0803,3d facial scan direct,HCPCS_Level_II,RVU2026A,2026
D0804,3d facial scan indirect,HCPCS_Level_II,RVU2026A,2026
D0999,Unspecified diagnostic proce,HCPCS_Level_II,RVU2026A,2026
D1110,Dental prophylaxis adult,HCPCS_Level_II,RVU2026A,2026
D1120,Dental prophylaxis child,HCPCS_Level_II,RVU2026A,2026
D1206,Topical fluoride varnish,HCPCS_Level_II,RVU2026A,2026
D1208,Topical app fluorid ex vrnsh,HCPCS_Level_II,RVU2026A,2026
D1301,Immunization counseling,HCPCS_Level_II,RVU2026A,2026
D1310,Nutri counsel-control caries,HCPCS_Level_II,RVU2026A,2026
D1320,Tobacco counseling,HCPCS_Level_II,RVU2026A,2026
D1321,Couns for high risk sub use,HCPCS_Level_II,RVU2026A,2026
D1330,Oral hygiene instructions,HCPCS_Level_II,RVU2026A,2026
D1351,Dental sealant per tooth,HCPCS_Level_II,RVU2026A,2026
D1353,Sealant repair per tooth,HCPCS_Level_II,RVU2026A,2026
D1354,Int caries med app per tooth,HCPCS_Level_II,RVU2026A,2026
D1355,Caries med app per tooth,HCPCS_Level_II,RVU2026A,2026
D1510,Space maintainer fxd unilat,HCPCS_Level_II,RVU2026A,2026
D1516,"Fixed bilat space maint, max",HCPCS_Level_II,RVU2026A,2026
D1517,"Fixed bilat space maint, man",HCPCS_Level_II,RVU2026A,2026
D1520,Remove unilat space maintain,HCPCS_Level_II,RVU2026A,2026
D1526,"Remove bilat space main, max",HCPCS_Level_II,RVU2026A,2026
D1527,"Remove bilat space main, man",HCPCS_Level_II,RVU2026A,2026
D1551,Recement space maint - max,HCPCS_Level_II,RVU2026A,2026
D1552,Recement space maint - man,HCPCS_Level_II,RVU2026A,2026
D1553,Recement unilat space maint,HCPCS_Level_II,RVU2026A,2026
D1556,Rem fixed unilat space maint,HCPCS_Level_II,RVU2026A,2026
D1557,Remove fixed bilat maint max,HCPCS_Level_II,RVU2026A,2026
D1558,Remove fixed bilat man,HCPCS_Level_II,RVU2026A,2026
D1575,"Dist space maint, fixed unil",HCPCS_Level_II,RVU2026A,2026
D1701,Pfizer vacc admin 1st dose,HCPCS_Level_II,RVU2026A,2026
D1702,Pfizer vacc admin 2nd dose,HCPCS_Level_II,RVU2026A,2026
D1703,Moderna vacc admin 1st dose,HCPCS_Level_II,RVU2026A,2026
D1704,Moderna vacc admin 2nd dose,HCPCS_Level_II,RVU2026A,2026
D1708,Pfizer vacc admin 3rd dose,HCPCS_Level_II,RVU2026A,2026
D1709,Pfizer vaccine admin booster,HCPCS_Level_II,RVU2026A,2026
D1710,Moderna vacc admin 3rd dose,HCPCS_Level_II,RVU2026A,2026
D1711,Moderna vacc admin booster,HCPCS_Level_II,RVU2026A,2026
D1713,Pfizer vacc adm ped 1st dose,HCPCS_Level_II,RVU2026A,2026
D1714,Pfizer vacc adm ped 2nd dose,HCPCS_Level_II,RVU2026A,2026
D1720,Influenza vacc admin,HCPCS_Level_II,RVU2026A,2026
D1781,Vac admin human pap dose 1,HCPCS_Level_II,RVU2026A,2026
D1782,Vac admin human pap dose 2,HCPCS_Level_II,RVU2026A,2026
D1783,Vac admin human pap dose 3,HCPCS_Level_II,RVU2026A,2026
D1999,Unspecified preventive proc,HCPCS_Level_II,RVU2026A,2026
D2140,Amalgam one surface permanen,HCPCS_Level_II,RVU2026A,2026
D2150,Amalgam two surfaces permane,HCPCS_Level_II,RVU2026A,2026
D2160,Amalgam three surfaces perma,HCPCS_Level_II,RVU2026A,2026
D2161,Amalgam 4 or > surfaces perm,HCPCS_Level_II,RVU2026A,2026
D2330,Resin one surface-anterior,HCPCS_Level_II,RVU2026A,2026
D2331,Resin two surfaces-anterior,HCPCS_Level_II,RVU2026A,2026
D2332,Resin three surfaces-anterio,HCPCS_Level_II,RVU2026A,2026
D2335,Resin 4/> surf or w incis an,HCPCS_Level_II,RVU2026A,2026
D2390,Ant resin-based cmpst crown,HCPCS_Level_II,RVU2026A,2026
D2391,Post 1 srfc resinbased cmpst,HCPCS_Level_II,RVU2026A,2026
D2392,Post 2 srfc resinbased cmpst,HCPCS_Level_II,RVU2026A,2026
D2393,Post 3 srfc resinbased cmpst,HCPCS_Level_II,RVU2026A,2026
D2394,Post >=4srfc resinbase cmpst,HCPCS_Level_II,RVU2026A,2026
D2410,Dental gold foil one surface,HCPCS_Level_II,RVU2026A,2026
D2420,Dental gold foil two surface,HCPCS_Level_II,RVU2026A,2026
D2430,Dental gold foil three surfa,HCPCS_Level_II,RVU2026A,2026
D2510,Dental inlay metalic 1 surf,HCPCS_Level_II,RVU2026A,2026
D2520,Dental inlay metallic 2 surf,HCPCS_Level_II,RVU2026A,2026
D2530,Dental inlay metl 3/more sur,HCPCS_Level_II,RVU2026A,2026
D2542,Dental onlay metallic 2 surf,HCPCS_Level_II,RVU2026A,2026
D2543,Dental onlay metallic 3 surf,HCPCS_Level_II,RVU2026A,2026
D2544,Dental onlay metl 4/more sur,HCPCS_Level_II,RVU2026A,2026
D2610,Inlay porcelain/ceramic 1 su,HCPCS_Level_II,RVU2026A,2026
D2620,Inlay porcelain/ceramic 2 su,HCPCS_Level_II,RVU2026A,2026
D2630,Dental onlay porc 3/more sur,HCPCS_Level_II,RVU2026A,2026
D2642,Dental onlay porcelin 2 surf,HCPCS_Level_II,RVU2026A,2026
D2643,Dental onlay porcelin 3 surf,HCPCS_Level_II,RVU2026A,2026
D2644,Dental onlay porc 4/more sur,HCPCS_Level_II,RVU2026A,2026
D2650,Inlay composite/resin one su,HCPCS_Level_II,RVU2026A,2026
D2651,Inlay composite/resin two su,HCPCS_Level_II,RVU2026A,2026
D2652,Dental inlay resin 3/mre sur,HCPCS_Level_II,RVU2026A,2026
D2662,Dental onlay resin 2 surface,HCPCS_Level_II,RVU2026A,2026
D2663,Dental onlay resin 3 surface,HCPCS_Level_II,RVU2026A,2026
D2664,Dental onlay resin 4/mre sur,HCPCS_Level_II,RVU2026A,2026
D2710,Crown resin-based indirect,HCPCS_Level_II,RVU2026A,2026
D2712,Crown 3/4 resin-based compos,HCPCS_Level_II,RVU2026A,2026
D2720,Crown resin w/ high noble me,HCPCS_Level_II,RVU2026A,2026
D2721,Crown resin w/ base metal,HCPCS_Level_II,RVU2026A,2026
D2722,Crown resin w/ noble metal,HCPCS_Level_II,RVU2026A,2026
D2740,Crown porcelain/ceramic,HCPCS_Level_II,RVU2026A,2026
D2750,Crown porcelain w/ h noble m,HCPCS_Level_II,RVU2026A,2026
D2751,Crown porcelain fused base m,HCPCS_Level_II,RVU2026A,2026
D2752,Crown porcelain w/ noble met,HCPCS_Level_II,RVU2026A,2026
D2753,Crown porc fused to titanium,HCPCS_Level_II,RVU2026A,2026
D2780,Crown 3/4 cast hi noble met,HCPCS_Level_II,RVU2026A,2026
D2781,Crown 3/4 cast base metal,HCPCS_Level_II,RVU2026A,2026
D2782,Crown 3/4 cast noble metal,HCPCS_Level_II,RVU2026A,2026
D2783,Crown 3/4 porcelain/ceramic,HCPCS_Level_II,RVU2026A,2026
D2790,Crown full cast high noble m,HCPCS_Level_II,RVU2026A,2026
D2791,Crown full cast base metal,HCPCS_Level_II,RVU2026A,2026
D2792,Crown full cast noble metal,HCPCS_Level_II,RVU2026A,2026
D2794,Crown-titanium,HCPCS_Level_II,RVU2026A,2026
D2799,Interim crown,HCPCS_Level_II,RVU2026A,2026
D2910,Recement inlay onlay or part,HCPCS_Level_II,RVU2026A,2026
D2915,Recement cast or prefab post,HCPCS_Level_II,RVU2026A,2026
D2920,Re-cement or re-bond crown,HCPCS_Level_II,RVU2026A,2026
D2921,Reattach tooth fragment,HCPCS_Level_II,RVU2026A,2026
D2928,Prefab porc/cer crown perm,HCPCS_Level_II,RVU2026A,2026
D2929,Prefab porc/ceram crown pri,HCPCS_Level_II,RVU2026A,2026
D2930,Prefab stnlss steel crwn pri,HCPCS_Level_II,RVU2026A,2026
D2931,Prefab stnlss steel crown pe,HCPCS_Level_II,RVU2026A,2026
D2932,Prefabricated resin crown,HCPCS_Level_II,RVU2026A,2026
D2933,Prefab stainless steel crown,HCPCS_Level_II,RVU2026A,2026
D2934,Prefab steel crown primary,HCPCS_Level_II,RVU2026A,2026
D2940,Place direct restoration,HCPCS_Level_II,RVU2026A,2026
D2949,Restorative foundation,HCPCS_Level_II,RVU2026A,2026
D2950,Core build-up incl any pins,HCPCS_Level_II,RVU2026A,2026
D2951,Tooth pin retention,HCPCS_Level_II,RVU2026A,2026
D2952,Post and core cast + crown,HCPCS_Level_II,RVU2026A,2026
D2953,Each addtnl cast post,HCPCS_Level_II,RVU2026A,2026
D2954,Prefab post/core + crown,HCPCS_Level_II,RVU2026A,2026
D2955,Post removal,HCPCS_Level_II,RVU2026A,2026
D2956,Indirect rest remov,HCPCS_Level_II,RVU2026A,2026
D2957,Each addtnl prefab post,HCPCS_Level_II,RVU2026A,2026
D2960,Labial veneer resin direct,HCPCS_Level_II,RVU2026A,2026
D2961,Labial veneer resin indirect,HCPCS_Level_II,RVU2026A,2026
D2962,Labial veneer porc indirect,HCPCS_Level_II,RVU2026A,2026
D2971,Add proc construct new crown,HCPCS_Level_II,RVU2026A,2026
D2975,Coping,HCPCS_Level_II,RVU2026A,2026
D2976,Band stabilization per tooth,HCPCS_Level_II,RVU2026A,2026
D2980,Crown repair,HCPCS_Level_II,RVU2026A,2026
D2981,Inlay repair,HCPCS_Level_II,RVU2026A,2026
D2982,Onlay repair,HCPCS_Level_II,RVU2026A,2026
D2983,Veneer repair,HCPCS_Level_II,RVU2026A,2026
D2989,Excavate tooth non-restorabl,HCPCS_Level_II,RVU2026A,2026
D2990,Resin infiltration of lesion,HCPCS_Level_II,RVU2026A,2026
D2991,App of hydroxyapatite,HCPCS_Level_II,RVU2026A,2026
D2999,Dental unspec restorative pr,HCPCS_Level_II,RVU2026A,2026
D3110,Pulp cap direct,HCPCS_Level_II,RVU2026A,2026
D3120,Pulp cap indirect,HCPCS_Level_II,RVU2026A,2026
D3220,Therapeutic pulpotomy,HCPCS_Level_II,RVU2026A,2026
D3221,Gross pulpal debridement,HCPCS_Level_II,RVU2026A,2026
D3222,Part pulp for apexogenesis,HCPCS_Level_II,RVU2026A,2026
D3230,Pulpal therapy anterior prim,HCPCS_Level_II,RVU2026A,2026
D3240,Pulpal therapy posterior pri,HCPCS_Level_II,RVU2026A,2026
D3310,"End thxpy, anterior tooth",HCPCS_Level_II,RVU2026A,2026
D3320,"End thxpy, premolar tooth",HCPCS_Level_II,RVU2026A,2026
D3330,"End thxpy, molar tooth",HCPCS_Level_II,RVU2026A,2026
D3331,Non-surg tx root canal obs,HCPCS_Level_II,RVU2026A,2026
D3332,Incomplete endodontic tx,HCPCS_Level_II,RVU2026A,2026
D3333,Internal root repair,HCPCS_Level_II,RVU2026A,2026
D3346,Retreat root canal anterior,HCPCS_Level_II,RVU2026A,2026
D3347,Retreat root canal premolar,HCPCS_Level_II,RVU2026A,2026
D3348,Retreat root canal molar,HCPCS_Level_II,RVU2026A,2026
D3351,Apexification/recalc initial,HCPCS_Level_II,RVU2026A,2026
D3352,Apexification/recalc interim,HCPCS_Level_II,RVU2026A,2026
D3353,Apexification/recalc final,HCPCS_Level_II,RVU2026A,2026
D3355,Pulpal regeneration initial,HCPCS_Level_II,RVU2026A,2026
D3356,Pulpal regeneration interim,HCPCS_Level_II,RVU2026A,2026
D3357,Pulpal regeneration complete,HCPCS_Level_II,RVU2026A,2026
D3410,Apicoectomy - anterior,HCPCS_Level_II,RVU2026A,2026
D3421,Root surgery premolar,HCPCS_Level_II,RVU2026A,2026
D3425,Root surgery molar,HCPCS_Level_II,RVU2026A,2026
D3426,Root surgery ea add root,HCPCS_Level_II,RVU2026A,2026
D3428,Bone graft peri per tooth,HCPCS_Level_II,RVU2026A,2026
D3429,Bone graft peri each addl,HCPCS_Level_II,RVU2026A,2026
D3430,Retrograde filling,HCPCS_Level_II,RVU2026A,2026
D3431,Biological materials,HCPCS_Level_II,RVU2026A,2026
D3432,Guided tissue regeneration,HCPCS_Level_II,RVU2026A,2026
D3450,Root amputation,HCPCS_Level_II,RVU2026A,2026
D3460,Endodontic endosseous implan,HCPCS_Level_II,RVU2026A,2026
D3470,Intentional replantation,HCPCS_Level_II,RVU2026A,2026
D3471,Surg rep root res anterior,HCPCS_Level_II,RVU2026A,2026
D3472,Surg rep root res premolar,HCPCS_Level_II,RVU2026A,2026
D3473,Surg rep root res molar,HCPCS_Level_II,RVU2026A,2026
D3501,Surg exp root surf anterior,HCPCS_Level_II,RVU2026A,2026
D3502,Surg exp root surf premolar,HCPCS_Level_II,RVU2026A,2026
D3503,Surg exp root surf molar,HCPCS_Level_II,RVU2026A,2026
D3910,Isolation- tooth w rubb dam,HCPCS_Level_II,RVU2026A,2026
D3911,Intraorifice barrier,HCPCS_Level_II,RVU2026A,2026
D3920,Tooth splitting,HCPCS_Level_II,RVU2026A,2026
D3921,Decor or submerg erupt tooth,HCPCS_Level_II,RVU2026A,2026
D3950,Canal prep/fitting of dowel,HCPCS_Level_II,RVU2026A,2026
D3999,Endodontic procedure,HCPCS_Level_II,RVU2026A,2026
D4210,Gingivectomy/plasty 4 or mor,HCPCS_Level_II,RVU2026A,2026
D4211,Gingivectomy/plasty 1 to 3,HCPCS_Level_II,RVU2026A,2026
D4212,Gingivectomy/plasty rest,HCPCS_Level_II,RVU2026A,2026
D4230,Ana crown exp 4 or> per quad,HCPCS_Level_II,RVU2026A,2026
D4231,Ana crown exp 1-3 per quad,HCPCS_Level_II,RVU2026A,2026
D4240,Gingival flap proc w/ planin,HCPCS_Level_II,RVU2026A,2026
D4241,Gngvl flap w rootplan 1-3 th,HCPCS_Level_II,RVU2026A,2026
D4245,Apically positioned flap,HCPCS_Level_II,RVU2026A,2026
D4249,Crown lengthen hard tissue,HCPCS_Level_II,RVU2026A,2026
D4260,Osseous surgery 4 or more,HCPCS_Level_II,RVU2026A,2026
D4261,Osseous surg 1 to 3 teeth,HCPCS_Level_II,RVU2026A,2026
D4263,Bone replce graft first site,HCPCS_Level_II,RVU2026A,2026
D4264,Bone replce graft each add,HCPCS_Level_II,RVU2026A,2026
D4265,Bio mtrls to aid soft/os reg,HCPCS_Level_II,RVU2026A,2026
D4266,Guided tiss regen resorble,HCPCS_Level_II,RVU2026A,2026
D4267,Guided tiss regen nonresorb,HCPCS_Level_II,RVU2026A,2026
D4268,Surgical revision procedure,HCPCS_Level_II,RVU2026A,2026
D4270,Pedicle soft tissue graft pr,HCPCS_Level_II,RVU2026A,2026
D4273,Auto tissue graft 1st tooth,HCPCS_Level_II,RVU2026A,2026
D4274,Mesial/distal wedge proc,HCPCS_Level_II,RVU2026A,2026
D4275,Non-auto graft 1st tooth,HCPCS_Level_II,RVU2026A,2026
D4276,Con tissue w pedicle graft,HCPCS_Level_II,RVU2026A,2026
D4277,Soft tissue graft firsttooth,HCPCS_Level_II,RVU2026A,2026
D4278,Soft tissue graft addl tooth,HCPCS_Level_II,RVU2026A,2026
D4283,Auto tissue graft addl tooth,HCPCS_Level_II,RVU2026A,2026
D4285,Non-auto graft addl tooth,HCPCS_Level_II,RVU2026A,2026
D4286,Remove non-resorb barrier,HCPCS_Level_II,RVU2026A,2026
D4322,Splint intra-coronal,HCPCS_Level_II,RVU2026A,2026
D4323,Splint extra-coronal,HCPCS_Level_II,RVU2026A,2026
D4341,Periodontal scaling & root,HCPCS_Level_II,RVU2026A,2026
D4342,Periodontal scaling 1-3teeth,HCPCS_Level_II,RVU2026A,2026
D4346,Scaling gingiv inflammation,HCPCS_Level_II,RVU2026A,2026
D4355,Full mouth debridement,HCPCS_Level_II,RVU2026A,2026
D4381,Localized delivery antimicro,HCPCS_Level_II,RVU2026A,2026
D4910,Periodontal maint procedures,HCPCS_Level_II,RVU2026A,2026
D4920,Unscheduled dressing change,HCPCS_Level_II,RVU2026A,2026
D4921,Gingival irrigation per quad,HCPCS_Level_II,RVU2026A,2026
D4999,Unspecified periodontal proc,HCPCS_Level_II,RVU2026A,2026
D5110,Dentures complete maxillary,HCPCS_Level_II,RVU2026A,2026
D5120,Dentures complete mandible,HCPCS_Level_II,RVU2026A,2026
D5130,Dentures immediat maxillary,HCPCS_Level_II,RVU2026A,2026
D5140,Dentures immediat mandible,HCPCS_Level_II,RVU2026A,2026
D5211,Dentures maxill part resin,HCPCS_Level_II,RVU2026A,2026
D5212,Dentures mand part resin,HCPCS_Level_II,RVU2026A,2026
D5213,Dentures maxill part metal,HCPCS_Level_II,RVU2026A,2026
D5214,Dentures mandibl part metal,HCPCS_Level_II,RVU2026A,2026
D5221,Immed max part denture resin,HCPCS_Level_II,RVU2026A,2026
D5222,Immed man part denture resin,HCPCS_Level_II,RVU2026A,2026
D5223,Immed max part dent metal,HCPCS_Level_II,RVU2026A,2026
D5224,Immed mand part dent metal,HCPCS_Level_II,RVU2026A,2026
D5225,Maxillary part denture flex,HCPCS_Level_II,RVU2026A,2026
D5226,Mandibular part denture flex,HCPCS_Level_II,RVU2026A,2026
D5227,Immed max part denture,HCPCS_Level_II,RVU2026A,2026
D5228,Immed mand part denture,HCPCS_Level_II,RVU2026A,2026
D5282,"Remove unil part denture,max",HCPCS_Level_II,RVU2026A,2026
D5283,"Remove unil part denture,man",HCPCS_Level_II,RVU2026A,2026
D5284,Rem unilat dent flex base,HCPCS_Level_II,RVU2026A,2026
D5286,Rem unilat dent 1 pc resin,HCPCS_Level_II,RVU2026A,2026
D5410,Dentures adjust cmplt maxil,HCPCS_Level_II,RVU2026A,2026
D5411,Dentures adjust cmplt mand,HCPCS_Level_II,RVU2026A,2026
D5421,Dentures adjust part maxill,HCPCS_Level_II,RVU2026A,2026
D5422,Dentures adjust part mandbl,HCPCS_Level_II,RVU2026A,2026
D5511,Rep broke comp dent base man,HCPCS_Level_II,RVU2026A,2026
D5512,Rep broke comp dent base max,HCPCS_Level_II,RVU2026A,2026
D5520,Replace denture teeth complt,HCPCS_Level_II,RVU2026A,2026
D5611,Rep resin part dent base man,HCPCS_Level_II,RVU2026A,2026
D5612,Rep resin part dent base max,HCPCS_Level_II,RVU2026A,2026
D5621,Rep cast part frame man,HCPCS_Level_II,RVU2026A,2026
D5622,Rep cast part frame max,HCPCS_Level_II,RVU2026A,2026
D5630,Rep partial denture clasp,HCPCS_Level_II,RVU2026A,2026
D5640,Replace part denture teeth,HCPCS_Level_II,RVU2026A,2026
D5650,Add tooth to partial denture,HCPCS_Level_II,RVU2026A,2026
D5660,Add clasp to partial denture,HCPCS_Level_II,RVU2026A,2026
D5670,Replc tth&acrlc on mtl frmwk,HCPCS_Level_II,RVU2026A,2026
D5671,Replc tth&acrlc mandibular,HCPCS_Level_II,RVU2026A,2026
D5710,Dentures rebase cmplt maxil,HCPCS_Level_II,RVU2026A,2026
D5711,Dentures rebase cmplt mand,HCPCS_Level_II,RVU2026A,2026
D5720,Dentures rebase part maxill,HCPCS_Level_II,RVU2026A,2026
D5721,Dentures rebase part mandbl,HCPCS_Level_II,RVU2026A,2026
D5725,Rebase hybrid prosthesis,HCPCS_Level_II,RVU2026A,2026
D5730,Denture reln cmplt max dir,HCPCS_Level_II,RVU2026A,2026
D5731,Denture reln cmplt mand dir,HCPCS_Level_II,RVU2026A,2026
D5740,Denture reln part max dir,HCPCS_Level_II,RVU2026A,2026
D5741,Denture reln part mand dir,HCPCS_Level_II,RVU2026A,2026
D5750,Denture reln cmplt max indir,HCPCS_Level_II,RVU2026A,2026
D5751,Denture reln cmplt mand ind,HCPCS_Level_II,RVU2026A,2026
D5760,Denture reln part max indir,HCPCS_Level_II,RVU2026A,2026
D5761,Denture reln part mand indir,HCPCS_Level_II,RVU2026A,2026
D5765,Liner compl/partial rem dent,HCPCS_Level_II,RVU2026A,2026
D5810,Denture interm cmplt maxill,HCPCS_Level_II,RVU2026A,2026
D5811,Denture interm cmplt mandbl,HCPCS_Level_II,RVU2026A,2026
D5820,Denture interm part maxill,HCPCS_Level_II,RVU2026A,2026
D5821,Denture interm part mandbl,HCPCS_Level_II,RVU2026A,2026
D5850,Denture tiss conditn maxill,HCPCS_Level_II,RVU2026A,2026
D5851,Denture tiss condtin mandbl,HCPCS_Level_II,RVU2026A,2026
D5862,Precision attachment,HCPCS_Level_II,RVU2026A,2026
D5863,Overdenture complete max,HCPCS_Level_II,RVU2026A,2026
D5864,Overdenture partial max,HCPCS_Level_II,RVU2026A,2026
D5865,Overdenture complete mandib,HCPCS_Level_II,RVU2026A,2026
D5866,Overdenture partial mandib,HCPCS_Level_II,RVU2026A,2026
D5867,Replacement of precision att,HCPCS_Level_II,RVU2026A,2026
D5875,Prosthesis modification,HCPCS_Level_II,RVU2026A,2026
D5876,Add metal sub to acrylc dent,HCPCS_Level_II,RVU2026A,2026
D5877,Dup of complt dent-maxill,HCPCS_Level_II,RVU2026A,2026
D5878,Dup of complt dent-mandib,HCPCS_Level_II,RVU2026A,2026
D5899,Removable prosthodontic proc,HCPCS_Level_II,RVU2026A,2026
D5909,Max guid prothes w/ flange,HCPCS_Level_II,RVU2026A,2026
D5911,Facial moulage sectional,HCPCS_Level_II,RVU2026A,2026
D5912,Facial moulage complete,HCPCS_Level_II,RVU2026A,2026
D5913,Nasal prosthesis,HCPCS_Level_II,RVU2026A,2026
D5914,Auricular prosthesis,HCPCS_Level_II,RVU2026A,2026
D5915,Orbital prosthesis,HCPCS_Level_II,RVU2026A,2026
D5916,Ocular prosthesis,HCPCS_Level_II,RVU2026A,2026
D5919,Facial prosthesis,HCPCS_Level_II,RVU2026A,2026
D5922,Nasal septal prosthesis,HCPCS_Level_II,RVU2026A,2026
D5923,Ocular prosthesis interim,HCPCS_Level_II,RVU2026A,2026
D5924,Cranial prosthesis,HCPCS_Level_II,RVU2026A,2026
D5925,Facial augmentation implant,HCPCS_Level_II,RVU2026A,2026
D5926,Replacement nasal prosthesis,HCPCS_Level_II,RVU2026A,2026
D5927,Auricular replacement,HCPCS_Level_II,RVU2026A,2026
D5928,Orbital replacement,HCPCS_Level_II,RVU2026A,2026
D5929,Facial replacement,HCPCS_Level_II,RVU2026A,2026
D5930,Max guid prothes w/o flange,HCPCS_Level_II,RVU2026A,2026
D5931,Surgical obturator,HCPCS_Level_II,RVU2026A,2026
D5932,Postsurgical obturator,HCPCS_Level_II,RVU2026A,2026
D5933,Refitting of obturator,HCPCS_Level_II,RVU2026A,2026
D5934,Mandibular flange prosthesis,HCPCS_Level_II,RVU2026A,2026
D5935,Mandibular denture prosth,HCPCS_Level_II,RVU2026A,2026
D5936,Temp obturator prosthesis,HCPCS_Level_II,RVU2026A,2026
D5937,Trismus appliance,HCPCS_Level_II,RVU2026A,2026
D5938,Resct proth max comp remov,HCPCS_Level_II,RVU2026A,2026
D5939,Resct proth mand comp remov,HCPCS_Level_II,RVU2026A,2026
D5940,Resct proth max part remov,HCPCS_Level_II,RVU2026A,2026
D5941,Resct proth mand part remov,HCPCS_Level_II,RVU2026A,2026
D5942,Proth max implt sup remv,HCPCS_Level_II,RVU2026A,2026
D5943,Proth mandib implt sup remv,HCPCS_Level_II,RVU2026A,2026
D5944,Max implt sup remv part,HCPCS_Level_II,RVU2026A,2026
D5945,Mand implt sup remv part,HCPCS_Level_II,RVU2026A,2026
D5946,Max implt sup fix,HCPCS_Level_II,RVU2026A,2026
D5947,Mand implt sup fix,HCPCS_Level_II,RVU2026A,2026
D5948,Max implt sup fix part,HCPCS_Level_II,RVU2026A,2026
D5949,Mand implt sup fix part,HCPCS_Level_II,RVU2026A,2026
D5951,Feeding aid,HCPCS_Level_II,RVU2026A,2026
D5952,Pediatric speech aid,HCPCS_Level_II,RVU2026A,2026
D5953,Adult speech aid,HCPCS_Level_II,RVU2026A,2026
D5954,Superimposed prosthesis,HCPCS_Level_II,RVU2026A,2026
D5955,Palatal lift prosthesis,HCPCS_Level_II,RVU2026A,2026
D5958,Intraoral con def inter plt,HCPCS_Level_II,RVU2026A,2026
D5959,Intraoral con def mod palat,HCPCS_Level_II,RVU2026A,2026
D5960,Modify speech aid prosthesis,HCPCS_Level_II,RVU2026A,2026
D5982,Surgical stent,HCPCS_Level_II,RVU2026A,2026
D5983,Radiation applicator,HCPCS_Level_II,RVU2026A,2026
D5984,Radiation shield,HCPCS_Level_II,RVU2026A,2026
D5985,Radiation cone locator,HCPCS_Level_II,RVU2026A,2026
D5986,Fluoride applicator,HCPCS_Level_II,RVU2026A,2026
D5987,Commissure splint,HCPCS_Level_II,RVU2026A,2026
D5988,Surgical splint,HCPCS_Level_II,RVU2026A,2026
D5991,Vesiculobullous disease carr,HCPCS_Level_II,RVU2026A,2026
D5992,Adjust max prost appliance,HCPCS_Level_II,RVU2026A,2026
D5993,Main/clean max prosthesis,HCPCS_Level_II,RVU2026A,2026
D5995,"Peri medicament w/seal, max",HCPCS_Level_II,RVU2026A,2026
D5996,"Peri medicament w/seal, mand",HCPCS_Level_II,RVU2026A,2026
D5999,Maxillofacial prosthesis,HCPCS_Level_II,RVU2026A,2026
D6010,Odontics endosteal implant,HCPCS_Level_II,RVU2026A,2026
D6011,Second stage implant surgery,HCPCS_Level_II,RVU2026A,2026
D6012,Endosteal implant,HCPCS_Level_II,RVU2026A,2026
D6013,Surgical place mini implant,HCPCS_Level_II,RVU2026A,2026
D6040,Odontics eposteal implant,HCPCS_Level_II,RVU2026A,2026
D6049,Scale implt peri-implt inflm,HCPCS_Level_II,RVU2026A,2026
D6050,Odontics transosteal implnt,HCPCS_Level_II,RVU2026A,2026
D6051,Interim implant abutment,HCPCS_Level_II,RVU2026A,2026
D6055,Implant connecting bar,HCPCS_Level_II,RVU2026A,2026
D6056,Prefabricated abutment,HCPCS_Level_II,RVU2026A,2026
D6057,Custom abutment,HCPCS_Level_II,RVU2026A,2026
D6058,Abutment supported crown,HCPCS_Level_II,RVU2026A,2026
D6059,Abutment supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6060,Abutment supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6061,Abutment supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6062,Abutment supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6063,Abutment supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6064,Abutment supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6065,Implant supported crown,HCPCS_Level_II,RVU2026A,2026
D6066,Implant supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6067,Implant supported mtl crown,HCPCS_Level_II,RVU2026A,2026
D6068,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6069,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6070,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6071,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6072,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6073,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6074,Abutment supported retainer,HCPCS_Level_II,RVU2026A,2026
D6075,Implant supported retainer,HCPCS_Level_II,RVU2026A,2026
D6076,Implant supported retainer,HCPCS_Level_II,RVU2026A,2026
D6077,Implant supported retainer,HCPCS_Level_II,RVU2026A,2026
D6080,Implant maintenance,HCPCS_Level_II,RVU2026A,2026
D6081,"Scale & debride, single imp",HCPCS_Level_II,RVU2026A,2026
D6082,Imp crown porc to base alloy,HCPCS_Level_II,RVU2026A,2026
D6083,Imp crown porc to noble allo,HCPCS_Level_II,RVU2026A,2026
D6084,Imp crown porc to titanium,HCPCS_Level_II,RVU2026A,2026
D6085,Interim implant crown,HCPCS_Level_II,RVU2026A,2026
D6086,Imp crown base alloys,HCPCS_Level_II,RVU2026A,2026
D6087,Implant crown noble alloys,HCPCS_Level_II,RVU2026A,2026
D6088,Imp crown titanium alloys,HCPCS_Level_II,RVU2026A,2026
D6089,Access/retorq implant screw,HCPCS_Level_II,RVU2026A,2026
D6090,Repair implant,HCPCS_Level_II,RVU2026A,2026
D6091,Repl semi/precision attach,HCPCS_Level_II,RVU2026A,2026
D6092,Recement supp crown,HCPCS_Level_II,RVU2026A,2026
D6093,Recement supp part denture,HCPCS_Level_II,RVU2026A,2026
D6094,Abut support crown titanium,HCPCS_Level_II,RVU2026A,2026
D6096,Remove broken imp ret screw,HCPCS_Level_II,RVU2026A,2026
D6097,Abut crown porc to titanium,HCPCS_Level_II,RVU2026A,2026
D6098,Imp retain porc to base allo,HCPCS_Level_II,RVU2026A,2026
D6099,Imp retainer for fpd,HCPCS_Level_II,RVU2026A,2026
D6100,Surg removal of implant body,HCPCS_Level_II,RVU2026A,2026
D6101,Debridement of a periimplant,HCPCS_Level_II,RVU2026A,2026
D6102,Debridement & contouring,HCPCS_Level_II,RVU2026A,2026
D6103,Bone graft repair perimplant,HCPCS_Level_II,RVU2026A,2026
D6104,Bone graft time of implant,HCPCS_Level_II,RVU2026A,2026
D6105,Remove implant body,HCPCS_Level_II,RVU2026A,2026
D6106,Tissue regen resorbable,HCPCS_Level_II,RVU2026A,2026
D6107,Tissue regen non-resorbable,HCPCS_Level_II,RVU2026A,2026
D6110,Implnt/abut remov dent max,HCPCS_Level_II,RVU2026A,2026
D6111,Implnt/abut remov dent mand,HCPCS_Level_II,RVU2026A,2026
D6112,Imp/abut rem dent part max,HCPCS_Level_II,RVU2026A,2026
D6113,Imp/abut rem dent part mand,HCPCS_Level_II,RVU2026A,2026
D6114,Implnt/abut fixed dent max,HCPCS_Level_II,RVU2026A,2026
D6115,Implnt/abut fixed dent mand,HCPCS_Level_II,RVU2026A,2026
D6116,Imp/abut fixed dent part max,HCPCS_Level_II,RVU2026A,2026
D6117,Imp/abut fixed dent part man,HCPCS_Level_II,RVU2026A,2026
D6118,Imp/abut int fixed dent man,HCPCS_Level_II,RVU2026A,2026
D6119,Int/abut int fixed dent max,HCPCS_Level_II,RVU2026A,2026
D6120,Imp retain porc to titanium,HCPCS_Level_II,RVU2026A,2026
D6121,Retain metal fpd base alloys,HCPCS_Level_II,RVU2026A,2026
D6122,Retain metal fpd noble alloy,HCPCS_Level_II,RVU2026A,2026
D6123,Retain metal fpd titanium,HCPCS_Level_II,RVU2026A,2026
D6180,Implnt maint proced,HCPCS_Level_II,RVU2026A,2026
D6190,Radio/surgical implant index,HCPCS_Level_II,RVU2026A,2026
D6191,Semi precision abutment,HCPCS_Level_II,RVU2026A,2026
D6192,Semi precision attachment,HCPCS_Level_II,RVU2026A,2026
D6193,Replace implnt screw,HCPCS_Level_II,RVU2026A,2026
D6194,Abut support retainer titani,HCPCS_Level_II,RVU2026A,2026
D6195,Abut retain porc to titanium,HCPCS_Level_II,RVU2026A,2026
D6196,Remv of ind rest on implt,HCPCS_Level_II,RVU2026A,2026
D6197,Replace material prosthesis,HCPCS_Level_II,RVU2026A,2026
D6198,Remove interim implant,HCPCS_Level_II,RVU2026A,2026
D6199,Implant procedure,HCPCS_Level_II,RVU2026A,2026
D6205,Pontic-indirect resin based,HCPCS_Level_II,RVU2026A,2026
D6210,Prosthodont high noble metal,HCPCS_Level_II,RVU2026A,2026
D6211,Bridge base metal cast,HCPCS_Level_II,RVU2026A,2026
D6212,Bridge noble metal cast,HCPCS_Level_II,RVU2026A,2026
D6214,Pontic titanium,HCPCS_Level_II,RVU2026A,2026
D6240,Bridge porcelain high noble,HCPCS_Level_II,RVU2026A,2026
D6241,Bridge porcelain base metal,HCPCS_Level_II,RVU2026A,2026
D6242,Bridge porcelain nobel metal,HCPCS_Level_II,RVU2026A,2026
D6243,Pontic porcelain to titanium,HCPCS_Level_II,RVU2026A,2026
D6245,Bridge porcelain/ceramic,HCPCS_Level_II,RVU2026A,2026
D6250,Bridge resin w/high noble,HCPCS_Level_II,RVU2026A,2026
D6251,Bridge resin base metal,HCPCS_Level_II,RVU2026A,2026
D6252,Bridge resin w/noble metal,HCPCS_Level_II,RVU2026A,2026
D6253,Interim pontic,HCPCS_Level_II,RVU2026A,2026
D6280,Implt maint procd remv implt,HCPCS_Level_II,RVU2026A,2026
D6545,Dental retainr cast metl,HCPCS_Level_II,RVU2026A,2026
D6548,Porcelain/ceramic retainer,HCPCS_Level_II,RVU2026A,2026
D6549,Resin retainer,HCPCS_Level_II,RVU2026A,2026
D6600,Porcelain/ceramic inlay 2srf,HCPCS_Level_II,RVU2026A,2026
D6601,Porc/ceram inlay >= 3 surfac,HCPCS_Level_II,RVU2026A,2026
D6602,Cst hgh nble mtl inlay 2 srf,HCPCS_Level_II,RVU2026A,2026
D6603,Cst hgh nble mtl inlay >=3sr,HCPCS_Level_II,RVU2026A,2026
D6604,Cst bse mtl inlay 2 surfaces,HCPCS_Level_II,RVU2026A,2026
D6605,Cst bse mtl inlay >= 3 surfa,HCPCS_Level_II,RVU2026A,2026
D6606,Cast noble metal inlay 2 sur,HCPCS_Level_II,RVU2026A,2026
D6607,Cst noble mtl inlay >=3 surf,HCPCS_Level_II,RVU2026A,2026
D6608,Onlay porc/crmc 2 surfaces,HCPCS_Level_II,RVU2026A,2026
D6609,Onlay porc/crmc >=3 surfaces,HCPCS_Level_II,RVU2026A,2026
D6610,Onlay cst hgh nbl mtl 2 srfc,HCPCS_Level_II,RVU2026A,2026
D6611,Onlay cst hgh nbl mtl >=3srf,HCPCS_Level_II,RVU2026A,2026
D6612,Onlay cst base mtl 2 surface,HCPCS_Level_II,RVU2026A,2026
D6613,Onlay cst base mtl >=3 surfa,HCPCS_Level_II,RVU2026A,2026
D6614,Onlay cst nbl mtl 2 surfaces,HCPCS_Level_II,RVU2026A,2026
D6615,Onlay cst nbl mtl >=3 surfac,HCPCS_Level_II,RVU2026A,2026
D6624,Inlay titanium,HCPCS_Level_II,RVU2026A,2026
D6634,Onlay titanium,HCPCS_Level_II,RVU2026A,2026
D6710,Crown-indirect resin based,HCPCS_Level_II,RVU2026A,2026
D6720,Retain crown resin w hi nble,HCPCS_Level_II,RVU2026A,2026
D6721,Crown resin w/base metal,HCPCS_Level_II,RVU2026A,2026
D6722,Crown resin w/noble metal,HCPCS_Level_II,RVU2026A,2026
D6740,Crown porcelain/ceramic,HCPCS_Level_II,RVU2026A,2026
D6750,Crown porcelain high noble,HCPCS_Level_II,RVU2026A,2026
D6751,Crown porcelain base metal,HCPCS_Level_II,RVU2026A,2026
D6752,Crown porcelain noble metal,HCPCS_Level_II,RVU2026A,2026
D6753,Retain crown porc to titaniu,HCPCS_Level_II,RVU2026A,2026
D6780,Crown 3/4 high noble metal,HCPCS_Level_II,RVU2026A,2026
D6781,Crown 3/4 cast based metal,HCPCS_Level_II,RVU2026A,2026
D6782,Crown 3/4 cast noble metal,HCPCS_Level_II,RVU2026A,2026
D6783,Crown 3/4 porcelain/ceramic,HCPCS_Level_II,RVU2026A,2026
D6784,Retainer crown 3/4 titanium,HCPCS_Level_II,RVU2026A,2026
D6790,Crown full high noble metal,HCPCS_Level_II,RVU2026A,2026
D6791,Crown full base metal cast,HCPCS_Level_II,RVU2026A,2026
D6792,Crown full noble metal cast,HCPCS_Level_II,RVU2026A,2026
D6793,Interim retainer crown,HCPCS_Level_II,RVU2026A,2026
D6794,Crown titanium,HCPCS_Level_II,RVU2026A,2026
D6920,Dental connector bar,HCPCS_Level_II,RVU2026A,2026
D6930,Recement/bond part denture,HCPCS_Level_II,RVU2026A,2026
D6940,Stress breaker,HCPCS_Level_II,RVU2026A,2026
D6950,Precision attachment,HCPCS_Level_II,RVU2026A,2026
D6980,Fixed partial repair,HCPCS_Level_II,RVU2026A,2026
D6985,Pediatric partial denture fx,HCPCS_Level_II,RVU2026A,2026
D6999,Fixed prosthodontic proc,HCPCS_Level_II,RVU2026A,2026
D7111,Extraction coronal remnants,HCPCS_Level_II,RVU2026A,2026
D7140,Extraction erupted tooth/exr,HCPCS_Level_II,RVU2026A,2026
D7210,Rem imp tooth w mucoper flp,HCPCS_Level_II,RVU2026A,2026
D7220,Impact tooth remov soft tiss,HCPCS_Level_II,RVU2026A,2026
D7230,Impact tooth remov part bony,HCPCS_Level_II,RVU2026A,2026
D7240,Impact tooth remov comp bony,HCPCS_Level_II,RVU2026A,2026
D7241,Impact tooth rem bony w/comp,HCPCS_Level_II,RVU2026A,2026
D7250,Tooth root removal,HCPCS_Level_II,RVU2026A,2026
D7251,Coronectomy,HCPCS_Level_II,RVU2026A,2026
D7252,Part extract for implant,HCPCS_Level_II,RVU2026A,2026
D7259,Nerve dissection,HCPCS_Level_II,RVU2026A,2026
D7260,Oral antral fistula closure,HCPCS_Level_II,RVU2026A,2026
D7261,Primary closure sinus perf,HCPCS_Level_II,RVU2026A,2026
D7270,Tooth reimplantation,HCPCS_Level_II,RVU2026A,2026
D7272,Tooth transplantation,HCPCS_Level_II,RVU2026A,2026
D7280,Exposure of unerupted tooth,HCPCS_Level_II,RVU2026A,2026
D7282,Mobilize erupted/malpos toot,HCPCS_Level_II,RVU2026A,2026
D7283,Place device impacted tooth,HCPCS_Level_II,RVU2026A,2026
D7284,Exc biopsy of saliv glands,HCPCS_Level_II,RVU2026A,2026
D7285,Biopsy of oral tissue hard,HCPCS_Level_II,RVU2026A,2026
D7286,Biopsy of oral tissue soft,HCPCS_Level_II,RVU2026A,2026
D7287,Exfoliative cytolog collect,HCPCS_Level_II,RVU2026A,2026
D7288,Brush biopsy,HCPCS_Level_II,RVU2026A,2026
D7290,Repositioning of teeth,HCPCS_Level_II,RVU2026A,2026
D7291,Transseptal fiberotomy,HCPCS_Level_II,RVU2026A,2026
D7292,Screw retained plate,HCPCS_Level_II,RVU2026A,2026
D7293,Temp anchorage dev w flap,HCPCS_Level_II,RVU2026A,2026
D7294,Temp anchorage dev w/o flap,HCPCS_Level_II,RVU2026A,2026
D7295,"Bone harvest,auto graft proc",HCPCS_Level_II,RVU2026A,2026
D7296,"Corticotomy, 1-3 teeth",HCPCS_Level_II,RVU2026A,2026
D7297,"Corticotomy, 4 or more teeth",HCPCS_Level_II,RVU2026A,2026
D7298,Remove screw retained plate,HCPCS_Level_II,RVU2026A,2026
D7299,Rem anchorage device w/flap,HCPCS_Level_II,RVU2026A,2026
D7300,Rem anchorage dev w/o flap,HCPCS_Level_II,RVU2026A,2026
D7310,Alveoplasty w/ extraction,HCPCS_Level_II,RVU2026A,2026
D7311,Alveoloplasty w/extract 1-3,HCPCS_Level_II,RVU2026A,2026
D7320,Alveoplasty w/o extraction,HCPCS_Level_II,RVU2026A,2026
D7321,Alveoloplasty not w/extracts,HCPCS_Level_II,RVU2026A,2026
D7340,Vestibuloplasty ridge extens,HCPCS_Level_II,RVU2026A,2026
D7350,Vestibuloplasty exten graft,HCPCS_Level_II,RVU2026A,2026
D7410,Rad exc lesion up to 1.25 cm,HCPCS_Level_II,RVU2026A,2026
D7411,Excision benign lesion>1.25c,HCPCS_Level_II,RVU2026A,2026
D7412,Excision benign lesion compl,HCPCS_Level_II,RVU2026A,2026
D7413,Excision malig lesion<=1.25c,HCPCS_Level_II,RVU2026A,2026
D7414,Excision malig lesion>1.25cm,HCPCS_Level_II,RVU2026A,2026
D7415,Excision malig les complicat,HCPCS_Level_II,RVU2026A,2026
D7440,Malig tumor exc to 1.25 cm,HCPCS_Level_II,RVU2026A,2026
D7441,Malig tumor > 1.25 cm,HCPCS_Level_II,RVU2026A,2026
D7450,Rem odontogen cyst to 1.25cm,HCPCS_Level_II,RVU2026A,2026
D7451,Rem odontogen cyst > 1.25 cm,HCPCS_Level_II,RVU2026A,2026
D7460,Rem nonodonto cyst to 1.25cm,HCPCS_Level_II,RVU2026A,2026
D7461,Rem nonodonto cyst > 1.25 cm,HCPCS_Level_II,RVU2026A,2026
D7465,Lesion destruction,HCPCS_Level_II,RVU2026A,2026
D7471,Rem exostosis any site,HCPCS_Level_II,RVU2026A,2026
D7472,Removal of torus palatinus,HCPCS_Level_II,RVU2026A,2026
D7473,Remove torus mandibularis,HCPCS_Level_II,RVU2026A,2026
D7485,Surg reduct osseoustuberosit,HCPCS_Level_II,RVU2026A,2026
D7490,Maxilla or mandible resectio,HCPCS_Level_II,RVU2026A,2026
D7509,Marsupialization odon cyst,HCPCS_Level_II,RVU2026A,2026
D7510,I&d absc intraoral soft tiss,HCPCS_Level_II,RVU2026A,2026
D7511,Incision/drain abscess intra,HCPCS_Level_II,RVU2026A,2026
D7520,I&d abscess extraoral,HCPCS_Level_II,RVU2026A,2026
D7521,Incision/drain abscess extra,HCPCS_Level_II,RVU2026A,2026
D7530,Removal fb skin/areolar tiss,HCPCS_Level_II,RVU2026A,2026
D7540,Removal of fb reaction,HCPCS_Level_II,RVU2026A,2026
D7550,Removal of sloughed off bone,HCPCS_Level_II,RVU2026A,2026
D7560,Maxillary sinusotomy,HCPCS_Level_II,RVU2026A,2026
D7610,Maxilla open reduct simple,HCPCS_Level_II,RVU2026A,2026
D7620,Clsd reduct simpl maxilla fx,HCPCS_Level_II,RVU2026A,2026
D7630,Open red simpl mandible fx,HCPCS_Level_II,RVU2026A,2026
D7640,Clsd red simpl mandible fx,HCPCS_Level_II,RVU2026A,2026
D7650,Open red simp malar/zygom fx,HCPCS_Level_II,RVU2026A,2026
D7660,Clsd red simp malar/zygom fx,HCPCS_Level_II,RVU2026A,2026
D7670,Closd rductn splint alveolus,HCPCS_Level_II,RVU2026A,2026
D7671,Alveolus open reduction,HCPCS_Level_II,RVU2026A,2026
D7680,Reduct simple facial bone fx,HCPCS_Level_II,RVU2026A,2026
D7710,Maxilla open reduct compound,HCPCS_Level_II,RVU2026A,2026
D7720,Clsd reduct compd maxilla fx,HCPCS_Level_II,RVU2026A,2026
D7730,Open reduct compd mandble fx,HCPCS_Level_II,RVU2026A,2026
D7740,Clsd reduct compd mandble fx,HCPCS_Level_II,RVU2026A,2026
D7750,Open red comp malar/zygma fx,HCPCS_Level_II,RVU2026A,2026
D7760,Clsd red comp malar/zygma fx,HCPCS_Level_II,RVU2026A,2026
D7770,Open reduc compd alveolus fx,HCPCS_Level_II,RVU2026A,2026
D7771,Alveolus clsd reduc stblz te,HCPCS_Level_II,RVU2026A,2026
D7780,Reduct compnd facial bone fx,HCPCS_Level_II,RVU2026A,2026
D7810,Tmj open reduct-dislocation,HCPCS_Level_II,RVU2026A,2026
D7820,Closed tmp manipulation,HCPCS_Level_II,RVU2026A,2026
D7830,Tmj manipulation under anest,HCPCS_Level_II,RVU2026A,2026
D7840,Removal of tmj condyle,HCPCS_Level_II,RVU2026A,2026
D7850,Tmj meniscectomy,HCPCS_Level_II,RVU2026A,2026
D7852,Tmj repair of joint disc,HCPCS_Level_II,RVU2026A,2026
D7854,Tmj excisn of joint membrane,HCPCS_Level_II,RVU2026A,2026
D7856,Tmj cutting of a muscle,HCPCS_Level_II,RVU2026A,2026
D7858,Tmj reconstruction,HCPCS_Level_II,RVU2026A,2026
D7860,Tmj cutting into joint,HCPCS_Level_II,RVU2026A,2026
D7865,Tmj reshaping components,HCPCS_Level_II,RVU2026A,2026
D7870,Tmj aspiration joint fluid,HCPCS_Level_II,RVU2026A,2026
D7871,Lysis + lavage w catheters,HCPCS_Level_II,RVU2026A,2026
D7872,Tmj diagnostic arthroscopy,HCPCS_Level_II,RVU2026A,2026
D7873,Tmj arthroscopy lysis adhesn,HCPCS_Level_II,RVU2026A,2026
D7874,Tmj arthroscopy disc reposit,HCPCS_Level_II,RVU2026A,2026
D7875,Tmj arthroscopy synovectomy,HCPCS_Level_II,RVU2026A,2026
D7876,Tmj arthroscopy discectomy,HCPCS_Level_II,RVU2026A,2026
D7877,Tmj arthroscopy debridement,HCPCS_Level_II,RVU2026A,2026
D7880,Occlusal orthotic appliance,HCPCS_Level_II,RVU2026A,2026
D7881,Occ orthotic device adjust,HCPCS_Level_II,RVU2026A,2026
D7899,Tmj unspecified therapy,HCPCS_Level_II,RVU2026A,2026
D7910,Dent sutur recent wnd to 5cm,HCPCS_Level_II,RVU2026A,2026
D7911,Dental suture wound to 5 cm,HCPCS_Level_II,RVU2026A,2026
D7912,Suture complicate wnd > 5 cm,HCPCS_Level_II,RVU2026A,2026
D7920,Dental skin graft,HCPCS_Level_II,RVU2026A,2026
D7921,Collect & appl blood product,HCPCS_Level_II,RVU2026A,2026
D7922,Place intra-socket bio dress,HCPCS_Level_II,RVU2026A,2026
D7939,Indexing for osteotomy,HCPCS_Level_II,RVU2026A,2026
D7940,Reshaping bone orthognathic,HCPCS_Level_II,RVU2026A,2026
D7941,Bone cutting ramus closed,HCPCS_Level_II,RVU2026A,2026
D7943,Cutting ramus open w/graft,HCPCS_Level_II,RVU2026A,2026
D7944,Bone cutting segmented,HCPCS_Level_II,RVU2026A,2026
D7945,Bone cutting body mandible,HCPCS_Level_II,RVU2026A,2026
D7946,Reconstruction maxilla total,HCPCS_Level_II,RVU2026A,2026
D7947,Reconstruct maxilla segment,HCPCS_Level_II,RVU2026A,2026
D7948,Reconstruct midface no graft,HCPCS_Level_II,RVU2026A,2026
D7949,Reconstruct midface w/graft,HCPCS_Level_II,RVU2026A,2026
D7950,Mandible graft,HCPCS_Level_II,RVU2026A,2026
D7951,Sinus aug w bone or bone sub,HCPCS_Level_II,RVU2026A,2026
D7952,Sinus augmentation vertical,HCPCS_Level_II,RVU2026A,2026
D7953,Bone replacement graft,HCPCS_Level_II,RVU2026A,2026
D7955,Repair maxillofacial defects,HCPCS_Level_II,RVU2026A,2026
D7956,Tiss regen edent resorb,HCPCS_Level_II,RVU2026A,2026
D7957,Tiss regen edent nonresorb,HCPCS_Level_II,RVU2026A,2026
D7961,Buccal/labial frenectomy,HCPCS_Level_II,RVU2026A,2026
D7962,Lingual frenectomy,HCPCS_Level_II,RVU2026A,2026
D7963,Frenuloplasty,HCPCS_Level_II,RVU2026A,2026
D7970,Excision hyperplastic tissue,HCPCS_Level_II,RVU2026A,2026
D7971,Excision pericoronal gingiva,HCPCS_Level_II,RVU2026A,2026
D7972,Surg redct fibrous tuberosit,HCPCS_Level_II,RVU2026A,2026
D7979,Non-surgical sialolithotomy,HCPCS_Level_II,RVU2026A,2026
D7980,Surgical sialolithotomy,HCPCS_Level_II,RVU2026A,2026
D7981,Excision of salivary gland,HCPCS_Level_II,RVU2026A,2026
D7982,Sialodochoplasty,HCPCS_Level_II,RVU2026A,2026
D7983,Closure of salivary fistula,HCPCS_Level_II,RVU2026A,2026
D7990,Emergency tracheotomy,HCPCS_Level_II,RVU2026A,2026
D7991,Dental coronoidectomy,HCPCS_Level_II,RVU2026A,2026
D7993,Surg place craniofacial impl,HCPCS_Level_II,RVU2026A,2026
D7994,Surg place zygomatic impl,HCPCS_Level_II,RVU2026A,2026
D7995,Synthetic graft facial bones,HCPCS_Level_II,RVU2026A,2026
D7996,Implant mandible for augment,HCPCS_Level_II,RVU2026A,2026
D7997,Appliance removal,HCPCS_Level_II,RVU2026A,2026
D7998,Intraoral place of fix dev,HCPCS_Level_II,RVU2026A,2026
D7999,Oral surgery procedure,HCPCS_Level_II,RVU2026A,2026
D8010,Limited dental tx primary,HCPCS_Level_II,RVU2026A,2026
D8020,Limited dental tx transition,HCPCS_Level_II,RVU2026A,2026
D8030,Limited dental tx adolescent,HCPCS_Level_II,RVU2026A,2026
D8040,Limited dental tx adult,HCPCS_Level_II,RVU2026A,2026
D8070,Compre dental tx transition,HCPCS_Level_II,RVU2026A,2026
D8080,Compre dental tx adolescent,HCPCS_Level_II,RVU2026A,2026
D8090,Compre dental tx adult,HCPCS_Level_II,RVU2026A,2026
D8091,Compre ortho treat w surg,HCPCS_Level_II,RVU2026A,2026
D8210,Orthodontic rem appliance tx,HCPCS_Level_II,RVU2026A,2026
D8220,Fixed appliance therapy habt,HCPCS_Level_II,RVU2026A,2026
D8660,Preorthodontic tx visit,HCPCS_Level_II,RVU2026A,2026
D8670,Periodic orthodontc tx visit,HCPCS_Level_II,RVU2026A,2026
D8671,Periodic orth treat w surg,HCPCS_Level_II,RVU2026A,2026
D8680,Orthodontic retention,HCPCS_Level_II,RVU2026A,2026
D8681,Removable retainer adjust,HCPCS_Level_II,RVU2026A,2026
D8695,Remove fixed ortho appliance,HCPCS_Level_II,RVU2026A,2026
D8696,Rep of ortho appliance max,HCPCS_Level_II,RVU2026A,2026
D8697,Rep of ortho appliance man,HCPCS_Level_II,RVU2026A,2026
D8698,Recement fixed retainer max,HCPCS_Level_II,RVU2026A,2026
D8699,Recement fixed retainer man,HCPCS_Level_II,RVU2026A,2026
D8701,Repair fixed retainer max,HCPCS_Level_II,RVU2026A,2026
D8702,Repair of fixed retainer man,HCPCS_Level_II,RVU2026A,2026
D8703,Replace broken retainer max,HCPCS_Level_II,RVU2026A,2026
D8704,Replace broken retainer man,HCPCS_Level_II,RVU2026A,2026
D8999,Orthodontic procedure,HCPCS_Level_II,RVU2026A,2026
D9110,Palliative tx dental pain,HCPCS_Level_II,RVU2026A,2026
D9120,Fix partial denture section,HCPCS_Level_II,RVU2026A,2026
D9128,Photobio therpy-first 15 min,HCPCS_Level_II,RVU2026A,2026
D9129,Photobio therpy-sub 15 mins,HCPCS_Level_II,RVU2026A,2026
D9130,Temporomandibular joint dysf,HCPCS_Level_II,RVU2026A,2026
D9210,Dent anesthesia w/o surgery,HCPCS_Level_II,RVU2026A,2026
D9211,Regional block anesthesia,HCPCS_Level_II,RVU2026A,2026
D9212,Trigeminal block anesthesia,HCPCS_Level_II,RVU2026A,2026
D9215,Local anesthesia,HCPCS_Level_II,RVU2026A,2026
D9219,Eval mod/deep sed/gen anest,HCPCS_Level_II,RVU2026A,2026
D9222,"Deep anest, 1st 15 min",HCPCS_Level_II,RVU2026A,2026
D9223,General anesth ea addl 15 mi,HCPCS_Level_II,RVU2026A,2026
D9224,Gen anes adv air-15 min,HCPCS_Level_II,RVU2026A,2026
D9225,Gen anes adv air-sub 15 min,HCPCS_Level_II,RVU2026A,2026
D9230,Analgesia,HCPCS_Level_II,RVU2026A,2026
D9239,"Iv mod sedation, 1st 15 min",HCPCS_Level_II,RVU2026A,2026
D9243,Iv sedation ea addl 15m,HCPCS_Level_II,RVU2026A,2026
D9244,Office min sed drug enteral,HCPCS_Level_II,RVU2026A,2026
D9245,Admin mod sedation-enteral,HCPCS_Level_II,RVU2026A,2026
D9246,Mod sedation noniv-15 min,HCPCS_Level_II,RVU2026A,2026
D9247,Mod sedation noniv-sub15min,HCPCS_Level_II,RVU2026A,2026
D9310,Dental consultation,HCPCS_Level_II,RVU2026A,2026
D9311,Consult w/med hlth care prof,HCPCS_Level_II,RVU2026A,2026
D9410,Dental house call,HCPCS_Level_II,RVU2026A,2026
D9420,Hospital/asc call,HCPCS_Level_II,RVU2026A,2026
D9430,Office visit during hours,HCPCS_Level_II,RVU2026A,2026
D9440,Office visit after hours,HCPCS_Level_II,RVU2026A,2026
D9450,Case presentation tx plan,HCPCS_Level_II,RVU2026A,2026
D9610,Dent therapeutic drug inject,HCPCS_Level_II,RVU2026A,2026
D9612,Thera par drugs 2 or > admin,HCPCS_Level_II,RVU2026A,2026
D9613,Infiltration thera drug,HCPCS_Level_II,RVU2026A,2026
D9630,Drugs/meds disp for home use,HCPCS_Level_II,RVU2026A,2026
D9910,Dent appl desensitizing med,HCPCS_Level_II,RVU2026A,2026
D9911,Appl desensitizing resin,HCPCS_Level_II,RVU2026A,2026
D9912,Pre-visit patient screening,HCPCS_Level_II,RVU2026A,2026
D9913,Admin of neuromod,HCPCS_Level_II,RVU2026A,2026
D9914,Admin of dermal fill,HCPCS_Level_II,RVU2026A,2026
D9920,Behavior management,HCPCS_Level_II,RVU2026A,2026
D9930,Treatment of complications,HCPCS_Level_II,RVU2026A,2026
D9932,Clean & inspect rem dent max,HCPCS_Level_II,RVU2026A,2026
D9933,Clean & inspect rem dent man,HCPCS_Level_II,RVU2026A,2026
D9934,Clean rem part denture max,HCPCS_Level_II,RVU2026A,2026
D9935,Clean rem part denture mand,HCPCS_Level_II,RVU2026A,2026
D9936,Clean occ guard,HCPCS_Level_II,RVU2026A,2026
D9938,Fab removable appliance,HCPCS_Level_II,RVU2026A,2026
D9939,Placemnt removable appliance,HCPCS_Level_II,RVU2026A,2026
D9941,Fabrication athletic guard,HCPCS_Level_II,RVU2026A,2026
D9942,Repair/reline occlusal guard,HCPCS_Level_II,RVU2026A,2026
D9943,Occlusal guard adjustment,HCPCS_Level_II,RVU2026A,2026
D9944,"Occ guard, hard, full arch",HCPCS_Level_II,RVU2026A,2026
D9945,"Occ guard, soft, full arch",HCPCS_Level_II,RVU2026A,2026
D9946,"Occ guard, hard, part arch",HCPCS_Level_II,RVU2026A,2026
D9947,Sleep apnea appliance,HCPCS_Level_II,RVU2026A,2026
D9948,Adjust sleep apnea appliance,HCPCS_Level_II,RVU2026A,2026
D9949,Repair sleep apnea appliance,HCPCS_Level_II,RVU2026A,2026
D9950,Occlusion analysis,HCPCS_Level_II,RVU2026A,2026
D9951,Limited occlusal adjustment,HCPCS_Level_II,RVU2026A,2026
D9952,Complete occlusal adjustment,HCPCS_Level_II,RVU2026A,2026
D9953,Reline sleep apnea appliance,HCPCS_Level_II,RVU2026A,2026
D9954,Fab/del oral appliance thxpy,HCPCS_Level_II,RVU2026A,2026
D9955,Oral app thxpy titration vis,HCPCS_Level_II,RVU2026A,2026
D9956,Admin home sleep apnea test,HCPCS_Level_II,RVU2026A,2026
D9957,Screening sleep disorders,HCPCS_Level_II,RVU2026A,2026
D9959,Unspec sleep ap proc,HCPCS_Level_II,RVU2026A,2026
D9961,Dup/copy patient's records,HCPCS_Level_II,RVU2026A,2026
D9970,Enamel microabrasion,HCPCS_Level_II,RVU2026A,2026
D9971,Odontoplasty per tooth,HCPCS_Level_II,RVU2026A,2026
D9972,Extrnl bleaching per arch,HCPCS_Level_II,RVU2026A,2026
D9973,Extrnl bleaching per tooth,HCPCS_Level_II,RVU2026A,2026
D9974,Intrnl bleaching per tooth,HCPCS_Level_II,RVU2026A,2026
D9975,External bleaching home app,HCPCS_Level_II,RVU2026A,2026
D9985,Sales tax,HCPCS_Level_II,RVU2026A,2026
D9986,Missed appointment,HCPCS_Level_II,RVU2026A,2026
D9987,Cancelled appointment,HCPCS_Level_II,RVU2026A,2026
D9990,Trans or sign language svcs,HCPCS_Level_II,RVU2026A,2026
D9991,"Case mgmt, appt barriers",HCPCS_Level_II,RVU2026A,2026
D9992,"Case mgmt, care coordination",HCPCS_Level_II,RVU2026A,2026
D9993,"Case mgmt, interviewing",HCPCS_Level_II,RVU2026A,2026
D9994,"Case mgmt, pt education",HCPCS_Level_II,RVU2026A,2026
D9995,Teledentistry real-time,HCPCS_Level_II,RVU2026A,2026
D9996,Teledentistry dent review,HCPCS_Level_II,RVU2026A,2026
D9997,Dent case mgmt special needs,HCPCS_Level_II,RVU2026A,2026
D9999,Adjunctive procedure,HCPCS_Level_II,RVU2026A,2026
DA,Oral health assessment by a licensed health professional other than a dentist,HCPCS_Level_II,HCPC2026_JAN,2026
E0100,"Cane, includes canes of all materials, adjustable or fixed, with tip",HCPCS_Level_II,HCPC2026_JAN,2026
E0105,"Cane, quad or three prong, includes canes of all materials, adjustable or fixed, with tips",HCPCS_Level_II,HCPC2026_JAN,2026
E0110,"Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips",HCPCS_Level_II,HCPC2026_JAN,2026
E0111,"Crutch forearm, includes crutches of various materials, adjustable or fixed, each, with tip and handgrips",HCPCS_Level_II,HCPC2026_JAN,2026
E0112,"Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips",HCPCS_Level_II,HCPC2026_JAN,2026
E0113,"Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip",HCPCS_Level_II,HCPC2026_JAN,2026
E0114,"Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips",HCPCS_Level_II,HCPC2026_JAN,2026
E0116,"Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0117,"Crutch, underarm, articulating, spring assisted, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0118,"Crutch substitute, lower leg platform, with or without wheels, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0130,"Walker, rigid (pickup), adjustable or fixed height",HCPCS_Level_II,HCPC2026_JAN,2026
E0135,"Walker, folding (pickup), adjustable or fixed height",HCPCS_Level_II,HCPC2026_JAN,2026
E0140,"Walker, with trunk support, adjustable or fixed height, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0141,"Walker, rigid, wheeled, adjustable or fixed height",HCPCS_Level_II,HCPC2026_JAN,2026
E0143,"Walker, folding, wheeled, adjustable or fixed height",HCPCS_Level_II,HCPC2026_JAN,2026
E0144,"Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat",HCPCS_Level_II,HCPC2026_JAN,2026
E0147,"Walker, heavy duty, multiple braking system, variable wheel resistance",HCPCS_Level_II,HCPC2026_JAN,2026
E0148,"Walker, heavy duty, without wheels, rigid or folding, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0149,"Walker, heavy duty, wheeled, rigid or folding, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0150,"Combination wheeled walker with seat and transport chair, folding, adjustable or fixed height",HCPCS_Level_II,HCPC2026_JAN,2026
E0152,"Walker, battery powered, wheeled, folding, adjustable or fixed height",HCPCS_Level_II,HCPC2026_JAN,2026
E0153,"Platform attachment, forearm crutch, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0154,"Platform attachment, walker, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0155,"Wheel attachment, rigid pick-up walker, per pair",HCPCS_Level_II,HCPC2026_JAN,2026
E0156,"Seat attachment, walker",HCPCS_Level_II,HCPC2026_JAN,2026
E0157,"Crutch attachment, walker, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0158,"Leg extensions for walker, per set of four (4)",HCPCS_Level_II,HCPC2026_JAN,2026
E0159,"Brake attachment for wheeled walker, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0160,"Sitz type bath or equipment, portable, used with or without commode",HCPCS_Level_II,HCPC2026_JAN,2026
E0161,"Sitz type bath or equipment, portable, used with or without commode, with faucet attachment/s",HCPCS_Level_II,HCPC2026_JAN,2026
E0162,Sitz bath chair,HCPCS_Level_II,HCPC2026_JAN,2026
E0163,"Commode chair, mobile or stationary, with fixed arms",HCPCS_Level_II,HCPC2026_JAN,2026
E0165,"Commode chair, mobile or stationary, with detachable arms",HCPCS_Level_II,HCPC2026_JAN,2026
E0167,"Pail or pan for use with commode chair, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E0168,"Commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0170,"Commode chair with integrated seat lift mechanism, electric, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0171,"Commode chair with integrated seat lift mechanism, non-electric, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0172,"Seat lift mechanism placed over or on top of toilet, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0175,"Foot rest, for use with commode chair, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0181,"Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty",HCPCS_Level_II,HCPC2026_JAN,2026
E0182,"Pump for alternating pressure pad, for replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E0183,"Powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty",HCPCS_Level_II,HCPC2026_JAN,2026
E0184,Dry pressure mattress,HCPCS_Level_II,HCPC2026_JAN,2026
E0185,"Gel or gel-like pressure pad for mattress, standard mattress length and width",HCPCS_Level_II,HCPC2026_JAN,2026
E0186,Air pressure mattress,HCPCS_Level_II,HCPC2026_JAN,2026
E0187,Water pressure mattress,HCPCS_Level_II,HCPC2026_JAN,2026
E0188,Synthetic sheepskin pad,HCPCS_Level_II,HCPC2026_JAN,2026
E0189,"Lambswool sheepskin pad, any size",HCPCS_Level_II,HCPC2026_JAN,2026
E0190,"Positioning cushion/pillow/wedge, any shape or size, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0191,"Heel or elbow protector, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0193,Powered air flotation bed (low air loss therapy),HCPCS_Level_II,HCPC2026_JAN,2026
E0194,Air fluidized bed,HCPCS_Level_II,HCPC2026_JAN,2026
E0196,Gel pressure mattress,HCPCS_Level_II,HCPC2026_JAN,2026
E0197,"Air pressure pad for mattress, standard mattress length and width",HCPCS_Level_II,HCPC2026_JAN,2026
E0198,"Water pressure pad for mattress, standard mattress length and width",HCPCS_Level_II,HCPC2026_JAN,2026
E0199,"Dry pressure pad for mattress, standard mattress length and width",HCPCS_Level_II,HCPC2026_JAN,2026
E0200,"Heat lamp, without stand (table model), includes bulb, or infrared element",HCPCS_Level_II,HCPC2026_JAN,2026
E0201,"Penile contracture device, manual, greater than 3 lbs traction force",HCPCS_Level_II,HCPC2026_JAN,2026
E0202,Phototherapy (bilirubin) light with photometer,HCPCS_Level_II,HCPC2026_JAN,2026
E0203,"Therapeutic lightbox, minimum 10,000 lux, table top model",HCPCS_Level_II,HCPC2026_JAN,2026
E0205,"Heat lamp, with stand, includes bulb, or infrared element",HCPCS_Level_II,HCPC2026_JAN,2026
E0210,"Electric heat pad, standard",HCPCS_Level_II,HCPC2026_JAN,2026
E0215,"Electric heat pad, moist",HCPCS_Level_II,HCPC2026_JAN,2026
E0217,Water circulating heat pad with pump,HCPCS_Level_II,HCPC2026_JAN,2026
E0218,"Fluid circulating cold pad with pump, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0221,Infrared heating pad system,HCPCS_Level_II,HCPC2026_JAN,2026
E0225,"Hydrocollator unit, includes pads",HCPCS_Level_II,HCPC2026_JAN,2026
E0231,"Non-contact wound warming device (temperature control unit, ac adapter and power cord) for use with warming card and wound cover",HCPCS_Level_II,HCPC2026_JAN,2026
E0232,Warming card for use with the non contact wound warming device and non contact wound warming wound cover,HCPCS_Level_II,HCPC2026_JAN,2026
E0235,"Paraffin bath unit, portable (see medical supply code a4265 for paraffin)",HCPCS_Level_II,HCPC2026_JAN,2026
E0236,Pump for water circulating pad,HCPCS_Level_II,HCPC2026_JAN,2026
E0239,"Hydrocollator unit, portable",HCPCS_Level_II,HCPC2026_JAN,2026
E0240,"Bath/shower chair, with or without wheels, any size",HCPCS_Level_II,HCPC2026_JAN,2026
E0241,"Bath tub wall rail, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0242,"Bath tub rail, floor base",HCPCS_Level_II,HCPC2026_JAN,2026
E0243,"Toilet rail, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0244,Raised toilet seat,HCPCS_Level_II,HCPC2026_JAN,2026
E0245,Tub stool or bench,HCPCS_Level_II,HCPC2026_JAN,2026
E0246,Transfer tub rail attachment,HCPCS_Level_II,HCPC2026_JAN,2026
E0247,Transfer bench for tub or toilet with or without commode opening,HCPCS_Level_II,HCPC2026_JAN,2026
E0248,"Transfer bench, heavy duty, for tub or toilet with or without commode opening",HCPCS_Level_II,HCPC2026_JAN,2026
E0249,"Pad for water circulating heat unit, for replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E0250,"Hospital bed, fixed height, with any type side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0251,"Hospital bed, fixed height, with any type side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0255,"Hospital bed, variable height, hi-lo, with any type side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0256,"Hospital bed, variable height, hi-lo, with any type side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0260,"Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0261,"Hospital bed, semi-electric (head and foot adjustment), with any type side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0265,"Hospital bed, total electric (head, foot and height adjustments), with any type side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0266,"Hospital bed, total electric (head, foot and height adjustments), with any type side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0270,"Hospital bed, institutional type includes: oscillating, circulating and stryker frame, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0271,"Mattress, innerspring",HCPCS_Level_II,HCPC2026_JAN,2026
E0272,"Mattress, foam rubber",HCPCS_Level_II,HCPC2026_JAN,2026
E0273,Bed board,HCPCS_Level_II,HCPC2026_JAN,2026
E0274,Over-bed table,HCPCS_Level_II,HCPC2026_JAN,2026
E0275,"Bed pan, standard, metal or plastic",HCPCS_Level_II,HCPC2026_JAN,2026
E0276,"Bed pan, fracture, metal or plastic",HCPCS_Level_II,HCPC2026_JAN,2026
E0277,Powered pressure-reducing air mattress,HCPCS_Level_II,HCPC2026_JAN,2026
E0280,"Bed cradle, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0290,"Hospital bed, fixed height, without side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0291,"Hospital bed, fixed height, without side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0292,"Hospital bed, variable height, hi-lo, without side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0293,"Hospital bed, variable height, hi-lo, without side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0294,"Hospital bed, semi-electric (head and foot adjustment), without side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0295,"Hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0296,"Hospital bed, total electric (head, foot and height adjustments), without side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0297,"Hospital bed, total electric (head, foot and height adjustments), without side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0300,"Pediatric crib, hospital grade, fully enclosed, with or without top enclosure",HCPCS_Level_II,HCPC2026_JAN,2026
E0301,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0302,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, without mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0303,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0304,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, with mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0305,"Bed side rails, half length",HCPCS_Level_II,HCPC2026_JAN,2026
E0310,"Bed side rails, full length",HCPCS_Level_II,HCPC2026_JAN,2026
E0315,"Bed accessory: board, table, or support device, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0316,"Safety enclosure frame/canopy for use with hospital bed, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0325,"Urinal; male, jug-type, any material",HCPCS_Level_II,HCPC2026_JAN,2026
E0326,"Urinal; female, jug-type, any material",HCPCS_Level_II,HCPC2026_JAN,2026
E0328,"Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0329,"Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress",HCPCS_Level_II,HCPC2026_JAN,2026
E0350,Control unit for electronic bowel irrigation/evacuation system,HCPCS_Level_II,HCPC2026_JAN,2026
E0352,"Disposable pack (water reservoir bag, speculum, valving mechanism and collection bag/box) for use with the electronic bowel irrigation/evacuation system",HCPCS_Level_II,HCPC2026_JAN,2026
E0370,Air pressure elevator for heel,HCPCS_Level_II,HCPC2026_JAN,2026
E0371,"Nonpowered advanced pressure reducing overlay for mattress, standard mattress length and width",HCPCS_Level_II,HCPC2026_JAN,2026
E0372,"Powered air overlay for mattress, standard mattress length and width",HCPCS_Level_II,HCPC2026_JAN,2026
E0373,Nonpowered advanced pressure reducing mattress,HCPCS_Level_II,HCPC2026_JAN,2026
E0424,"Stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0425,"Stationary compressed gas system, purchase; includes regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0430,"Portable gaseous oxygen system, purchase; includes regulator, flowmeter, humidifier, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0431,"Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0433,"Portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge",HCPCS_Level_II,HCPC2026_JAN,2026
E0434,"Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0435,"Portable liquid oxygen system, purchase; includes portable container, supply reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and refill adaptor",HCPCS_Level_II,HCPC2026_JAN,2026
E0439,"Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0440,"Stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
E0441,"Stationary oxygen contents, gaseous, 1 month's supply = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
E0442,"Stationary oxygen contents, liquid, 1 month's supply = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
E0443,"Portable oxygen contents, gaseous, 1 month's supply = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
E0444,"Portable oxygen contents, liquid, 1 month's supply = 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
E0445,Oximeter device for measuring blood oxygen levels non-invasively,HCPCS_Level_II,HCPC2026_JAN,2026
E0446,"Topical oxygen delivery system, not otherwise specified, includes all supplies and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0447,"Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)",HCPCS_Level_II,HCPC2026_JAN,2026
E0450,"Volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)",HCPCS_Level_II,HCPC2026_JAN,2026
E0455,"Oxygen tent, excluding croup or pediatric tents",HCPCS_Level_II,HCPC2026_JAN,2026
E0457,Chest shell (cuirass),HCPCS_Level_II,HCPC2026_JAN,2026
E0459,Chest wrap,HCPCS_Level_II,HCPC2026_JAN,2026
E0460,Negative pressure ventilator; portable or stationary,HCPCS_Level_II,HCPC2026_JAN,2026
E0461,"Volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)",HCPCS_Level_II,HCPC2026_JAN,2026
E0462,Rocking bed with or without side rails,HCPCS_Level_II,HCPC2026_JAN,2026
E0463,"Pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)",HCPCS_Level_II,HCPC2026_JAN,2026
E0464,"Pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask)",HCPCS_Level_II,HCPC2026_JAN,2026
E0465,"Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)",HCPCS_Level_II,HCPC2026_JAN,2026
E0466,"Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)",HCPCS_Level_II,HCPC2026_JAN,2026
E0467,"Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions",HCPCS_Level_II,HCPC2026_JAN,2026
E0468,"Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions",HCPCS_Level_II,HCPC2026_JAN,2026
E0469,"Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device",HCPCS_Level_II,HCPC2026_JAN,2026
E0470,"Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)",HCPCS_Level_II,HCPC2026_JAN,2026
E0471,"Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)",HCPCS_Level_II,HCPC2026_JAN,2026
E0472,"Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)",HCPCS_Level_II,HCPC2026_JAN,2026
E0480,"Percussor, electric or pneumatic, home model",HCPCS_Level_II,HCPC2026_JAN,2026
E0481,Intrapulmonary percussive ventilation system and related accessories,HCPCS_Level_II,HCPC2026_JAN,2026
E0482,"Cough stimulating device, alternating positive and negative airway pressure",HCPCS_Level_II,HCPC2026_JAN,2026
E0483,"High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0484,"Oscillatory positive expiratory pressure device, non-electric, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0485,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
E0486,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
E0487,"Spirometer, electronic, includes all accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0490,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote",HCPCS_Level_II,HCPC2026_JAN,2026
E0491,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply",HCPCS_Level_II,HCPC2026_JAN,2026
E0492,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application",HCPCS_Level_II,HCPC2026_JAN,2026
E0493,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply",HCPCS_Level_II,HCPC2026_JAN,2026
E0500,"Ippb machine, all types, with built-in nebulization; manual or automatic valves; internal or external power source",HCPCS_Level_II,HCPC2026_JAN,2026
E0530,"Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0550,"Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery",HCPCS_Level_II,HCPC2026_JAN,2026
E0555,"Humidifier, durable, glass or autoclavable plastic bottle type, for use with regulator or flowmeter",HCPCS_Level_II,HCPC2026_JAN,2026
E0560,"Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery",HCPCS_Level_II,HCPC2026_JAN,2026
E0561,"Humidifier, non-heated, used with positive airway pressure device",HCPCS_Level_II,HCPC2026_JAN,2026
E0562,"Humidifier, heated, used with positive airway pressure device",HCPCS_Level_II,HCPC2026_JAN,2026
E0565,"Compressor, air power source for equipment which is not self-contained or cylinder driven",HCPCS_Level_II,HCPC2026_JAN,2026
E0570,"Nebulizer, with compressor",HCPCS_Level_II,HCPC2026_JAN,2026
E0572,"Aerosol compressor, adjustable pressure, light duty for intermittent use",HCPCS_Level_II,HCPC2026_JAN,2026
E0574,Ultrasonic/electronic aerosol generator with small volume nebulizer,HCPCS_Level_II,HCPC2026_JAN,2026
E0575,"Nebulizer, ultrasonic, large volume",HCPCS_Level_II,HCPC2026_JAN,2026
E0580,"Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter",HCPCS_Level_II,HCPC2026_JAN,2026
E0585,"Nebulizer, with compressor and heater",HCPCS_Level_II,HCPC2026_JAN,2026
E0600,"Respiratory suction pump, home model, portable or stationary, electric",HCPCS_Level_II,HCPC2026_JAN,2026
E0601,Continuous positive airway pressure (cpap) device,HCPCS_Level_II,HCPC2026_JAN,2026
E0602,"Breast pump, manual, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0603,"Breast pump, electric (ac and/or dc), any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0604,"Breast pump, hospital grade, electric (ac and / or dc), any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0605,"Vaporizer, room type",HCPCS_Level_II,HCPC2026_JAN,2026
E0606,Postural drainage board,HCPCS_Level_II,HCPC2026_JAN,2026
E0607,Home blood glucose monitor,HCPCS_Level_II,HCPC2026_JAN,2026
E0610,"Pacemaker monitor, self-contained, (checks battery depletion, includes audible and visible check systems)",HCPCS_Level_II,HCPC2026_JAN,2026
E0615,"Pacemaker monitor, self contained, checks battery depletion and other pacemaker components, includes digital/visible check systems",HCPCS_Level_II,HCPC2026_JAN,2026
E0616,"Implantable cardiac event recorder with memory, activator and programmer",HCPCS_Level_II,HCPC2026_JAN,2026
E0617,External defibrillator with integrated electrocardiogram analysis,HCPCS_Level_II,HCPC2026_JAN,2026
E0618,"Apnea monitor, without recording feature",HCPCS_Level_II,HCPC2026_JAN,2026
E0619,"Apnea monitor, with recording feature",HCPCS_Level_II,HCPC2026_JAN,2026
E0620,"Skin piercing device for collection of capillary blood, laser, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0621,"Sling or seat, patient lift, canvas or nylon",HCPCS_Level_II,HCPC2026_JAN,2026
E0625,"Patient lift, bathroom or toilet, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
E0627,"Seat lift mechanism, electric, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0628,Separate seat lift mechanism for use with patient owned furniture-electric,HCPCS_Level_II,HCPC2026_JAN,2026
E0629,"Seat lift mechanism, non-electric, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0630,"Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)",HCPCS_Level_II,HCPC2026_JAN,2026
E0635,"Patient lift, electric with seat or sling",HCPCS_Level_II,HCPC2026_JAN,2026
E0636,"Multipositional patient support system, with integrated lift, patient accessible controls",HCPCS_Level_II,HCPC2026_JAN,2026
E0637,"Combination sit to stand frame/table system, any size including pediatric, with seat lift feature, with or without wheels",HCPCS_Level_II,HCPC2026_JAN,2026
E0638,"Standing frame/table system, one position (e.g., upright, supine or prone stander), any size including pediatric, with or without wheels",HCPCS_Level_II,HCPC2026_JAN,2026
E0639,"Patient lift, moveable from room to room with disassembly and reassembly, includes all components/accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0640,"Patient lift, fixed system, includes all components/accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0641,"Standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels",HCPCS_Level_II,HCPC2026_JAN,2026
E0642,"Standing frame/table system, mobile (dynamic stander), any size including pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
E0650,"Pneumatic compressor, non-segmental home model",HCPCS_Level_II,HCPC2026_JAN,2026
E0651,"Pneumatic compressor, segmental home model without calibrated gradient pressure",HCPCS_Level_II,HCPC2026_JAN,2026
E0652,"Pneumatic compressor, segmental home model with calibrated gradient pressure",HCPCS_Level_II,HCPC2026_JAN,2026
E0655,"Non-segmental pneumatic appliance for use with pneumatic compressor, half arm",HCPCS_Level_II,HCPC2026_JAN,2026
E0656,"Segmental pneumatic appliance for use with pneumatic compressor, trunk",HCPCS_Level_II,HCPC2026_JAN,2026
E0657,"Segmental pneumatic appliance for use with pneumatic compressor, chest",HCPCS_Level_II,HCPC2026_JAN,2026
E0658,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest",HCPCS_Level_II,HCPC2026_JAN,2026
E0659,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest",HCPCS_Level_II,HCPC2026_JAN,2026
E0660,"Non-segmental pneumatic appliance for use with pneumatic compressor, full leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0665,"Non-segmental pneumatic appliance for use with pneumatic compressor, full arm",HCPCS_Level_II,HCPC2026_JAN,2026
E0666,"Non-segmental pneumatic appliance for use with pneumatic compressor, half leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0667,"Segmental pneumatic appliance for use with pneumatic compressor, full leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0668,"Segmental pneumatic appliance for use with pneumatic compressor, full arm",HCPCS_Level_II,HCPC2026_JAN,2026
E0669,"Segmental pneumatic appliance for use with pneumatic compressor, half leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0670,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk",HCPCS_Level_II,HCPC2026_JAN,2026
E0671,"Segmental gradient pressure pneumatic appliance, full leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0672,"Segmental gradient pressure pneumatic appliance, full arm",HCPCS_Level_II,HCPC2026_JAN,2026
E0673,"Segmental gradient pressure pneumatic appliance, half leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0675,"Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)",HCPCS_Level_II,HCPC2026_JAN,2026
E0676,"Intermittent limb compression device (includes all accessories), not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
E0677,"Non-pneumatic sequential compression garment, trunk",HCPCS_Level_II,HCPC2026_JAN,2026
E0678,"Non-pneumatic sequential compression garment, full leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0679,"Non-pneumatic sequential compression garment, half leg",HCPCS_Level_II,HCPC2026_JAN,2026
E0680,Non-pneumatic compression controller with sequential calibrated gradient pressure,HCPCS_Level_II,HCPC2026_JAN,2026
E0681,Non-pneumatic compression controller without calibrated gradient pressure,HCPCS_Level_II,HCPC2026_JAN,2026
E0682,"Non-pneumatic sequential compression garment, full arm",HCPCS_Level_II,HCPC2026_JAN,2026
E0683,"Non-pneumatic, non-sequential, peristaltic wave compression pump",HCPCS_Level_II,HCPC2026_JAN,2026
E0691,"Ultraviolet light therapy system, includes bulbs/lamps, timer and eye protection; treatment area 2 square feet or less",HCPCS_Level_II,HCPC2026_JAN,2026
E0692,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 4 foot panel",HCPCS_Level_II,HCPC2026_JAN,2026
E0693,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 6 foot panel",HCPCS_Level_II,HCPC2026_JAN,2026
E0694,"Ultraviolet multidirectional light therapy system in 6 foot cabinet, includes bulbs/lamps, timer and eye protection",HCPCS_Level_II,HCPC2026_JAN,2026
E0700,"Safety equipment, device or accessory, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0705,"Transfer device, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0710,"Restraints, any type (body, chest, wrist or ankle)",HCPCS_Level_II,HCPC2026_JAN,2026
E0711,"Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion",HCPCS_Level_II,HCPC2026_JAN,2026
E0715,Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises,HCPCS_Level_II,HCPC2026_JAN,2026
E0716,Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises,HCPCS_Level_II,HCPC2026_JAN,2026
E0720,"Transcutaneous electrical nerve stimulation (tens) device, two lead, localized stimulation",HCPCS_Level_II,HCPC2026_JAN,2026
E0721,Transcutaneous electrical nerve stimulator for nerves in the auricular region,HCPCS_Level_II,HCPC2026_JAN,2026
E0730,"Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation",HCPCS_Level_II,HCPC2026_JAN,2026
E0731,Form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient's skin by layers of fabric),HCPCS_Level_II,HCPC2026_JAN,2026
E0732,"Cranial electrotherapy stimulation (ces) system, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0733,Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve,HCPCS_Level_II,HCPC2026_JAN,2026
E0734,External upper limb tremor stimulator of the peripheral nerves of the wrist,HCPCS_Level_II,HCPC2026_JAN,2026
E0735,Non-invasive vagus nerve stimulator,HCPCS_Level_II,HCPC2026_JAN,2026
E0736,Transcutaneous tibial nerve stimulator,HCPCS_Level_II,HCPC2026_JAN,2026
E0737,"Transcutaneous tibial nerve stimulator, controlled by phone application",HCPCS_Level_II,HCPC2026_JAN,2026
E0738,"Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0739,"Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors",HCPCS_Level_II,HCPC2026_JAN,2026
E0740,"Non-implanted pelvic floor electrical stimulator, complete system",HCPCS_Level_II,HCPC2026_JAN,2026
E0743,"External lower extremity nerve stimulator for restless legs syndrome, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0744,Neuromuscular stimulator for scoliosis,HCPCS_Level_II,HCPC2026_JAN,2026
E0745,"Neuromuscular stimulator, electronic shock unit",HCPCS_Level_II,HCPC2026_JAN,2026
E0746,"Electromyography (emg), biofeedback device",HCPCS_Level_II,HCPC2026_JAN,2026
E0747,"Osteogenesis stimulator, electrical, non-invasive, other than spinal applications",HCPCS_Level_II,HCPC2026_JAN,2026
E0748,"Osteogenesis stimulator, electrical, non-invasive, spinal applications",HCPCS_Level_II,HCPC2026_JAN,2026
E0749,"Osteogenesis stimulator, electrical, surgically implanted",HCPCS_Level_II,HCPC2026_JAN,2026
E0755,Electronic salivary reflex stimulator (intra-oral/non-invasive),HCPCS_Level_II,HCPC2026_JAN,2026
E0760,"Osteogenesis stimulator, low intensity ultrasound, non-invasive",HCPCS_Level_II,HCPC2026_JAN,2026
E0761,"Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device",HCPCS_Level_II,HCPC2026_JAN,2026
E0762,"Transcutaneous electrical joint stimulation device system, includes all accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0764,"Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program",HCPCS_Level_II,HCPC2026_JAN,2026
E0765,"Fda approved nerve stimulator, for treatment of nausea and vomiting",HCPCS_Level_II,HCPC2026_JAN,2026
E0766,"Electrical stimulation device used for cancer treatment, includes all accessories, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0767,"Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E0769,"Electrical stimulation or electromagnetic wound treatment device, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
E0770,"Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
E0776,Iv pole,HCPCS_Level_II,HCPC2026_JAN,2026
E0779,"Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater",HCPCS_Level_II,HCPC2026_JAN,2026
E0780,"Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours",HCPCS_Level_II,HCPC2026_JAN,2026
E0781,"Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient",HCPCS_Level_II,HCPC2026_JAN,2026
E0782,"Infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
E0783,"Infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
E0784,"External ambulatory infusion pump, insulin",HCPCS_Level_II,HCPC2026_JAN,2026
E0785,"Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
E0786,"Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)",HCPCS_Level_II,HCPC2026_JAN,2026
E0787,"External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing",HCPCS_Level_II,HCPC2026_JAN,2026
E0791,"Parenteral infusion pump, stationary, single or multi-channel",HCPCS_Level_II,HCPC2026_JAN,2026
E0830,"Ambulatory traction device, all types, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0840,"Traction frame, attached to headboard, cervical traction",HCPCS_Level_II,HCPC2026_JAN,2026
E0849,"Traction equipment, cervical, free-standing stand/frame, pneumatic, applying traction force to other than mandible",HCPCS_Level_II,HCPC2026_JAN,2026
E0850,"Traction stand, free standing, cervical traction",HCPCS_Level_II,HCPC2026_JAN,2026
E0855,Cervical traction equipment not requiring additional stand or frame,HCPCS_Level_II,HCPC2026_JAN,2026
E0856,"Cervical traction device, with inflatable air bladder(s)",HCPCS_Level_II,HCPC2026_JAN,2026
E0860,"Traction equipment, overdoor, cervical",HCPCS_Level_II,HCPC2026_JAN,2026
E0870,"Traction frame, attached to footboard, extremity traction, (e.g., buck's)",HCPCS_Level_II,HCPC2026_JAN,2026
E0880,"Traction stand, free standing, extremity traction",HCPCS_Level_II,HCPC2026_JAN,2026
E0890,"Traction frame, attached to footboard, pelvic traction",HCPCS_Level_II,HCPC2026_JAN,2026
E0900,"Traction stand, free standing, pelvic traction, (e.g., buck's)",HCPCS_Level_II,HCPC2026_JAN,2026
E0910,"Trapeze bars, a/k/a patient helper, attached to bed, with grab bar",HCPCS_Level_II,HCPC2026_JAN,2026
E0911,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar",HCPCS_Level_II,HCPC2026_JAN,2026
E0912,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar",HCPCS_Level_II,HCPC2026_JAN,2026
E0920,"Fracture frame, attached to bed, includes weights",HCPCS_Level_II,HCPC2026_JAN,2026
E0930,"Fracture frame, free standing, includes weights",HCPCS_Level_II,HCPC2026_JAN,2026
E0935,Continuous passive motion exercise device for use on knee only,HCPCS_Level_II,HCPC2026_JAN,2026
E0936,Continuous passive motion exercise device for use other than knee,HCPCS_Level_II,HCPC2026_JAN,2026
E0940,"Trapeze bar, free standing, complete with grab bar",HCPCS_Level_II,HCPC2026_JAN,2026
E0941,"Gravity assisted traction device, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E0942,Cervical head harness/halter,HCPCS_Level_II,HCPC2026_JAN,2026
E0944,Pelvic belt/harness/boot,HCPCS_Level_II,HCPC2026_JAN,2026
E0945,Extremity belt/harness,HCPCS_Level_II,HCPC2026_JAN,2026
E0946,"Fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster)",HCPCS_Level_II,HCPC2026_JAN,2026
E0947,"Fracture frame, attachments for complex pelvic traction",HCPCS_Level_II,HCPC2026_JAN,2026
E0948,"Fracture frame, attachments for complex cervical traction",HCPCS_Level_II,HCPC2026_JAN,2026
E0950,"Wheelchair accessory, tray, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0951,"Heel loop/holder, any type, with or without ankle strap, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0952,"Toe loop/holder, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0953,"Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0954,"Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot",HCPCS_Level_II,HCPC2026_JAN,2026
E0955,"Wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0956,"Wheelchair accessory, lateral trunk or hip support, any type, including fixed mounting hardware, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0957,"Wheelchair accessory, medial thigh support, any type, including fixed mounting hardware, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0958,"Manual wheelchair accessory, one-arm drive attachment, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0959,"Manual wheelchair accessory, adapter for amputee, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0960,"Wheelchair accessory, shoulder harness/straps or chest strap, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E0961,"Manual wheelchair accessory, wheel lock brake extension (handle), each",HCPCS_Level_II,HCPC2026_JAN,2026
E0966,"Manual wheelchair accessory, headrest extension, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0967,"Manual wheelchair accessory, hand rim with projections, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0968,"Commode seat, wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
E0969,"Narrowing device, wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
E0970,"No. 2 footplates, except for elevating leg rest",HCPCS_Level_II,HCPC2026_JAN,2026
E0971,"Manual wheelchair accessory, anti-tipping device, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0973,"Wheelchair accessory, adjustable height, detachable armrest, complete assembly, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0974,"Manual wheelchair accessory, anti-rollback device, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0978,"Wheelchair accessory, positioning belt/safety belt/pelvic strap, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0980,"Safety vest, wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
E0981,"Wheelchair accessory, seat upholstery, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0982,"Wheelchair accessory, back upholstery, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0983,"Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, joystick control",HCPCS_Level_II,HCPC2026_JAN,2026
E0984,"Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, tiller control",HCPCS_Level_II,HCPC2026_JAN,2026
E0985,"Wheelchair accessory, seat lift mechanism",HCPCS_Level_II,HCPC2026_JAN,2026
E0986,"Manual wheelchair accessory, power assist system",HCPCS_Level_II,HCPC2026_JAN,2026
E0988,"Manual wheelchair accessory, lever-activated, wheel drive, pair",HCPCS_Level_II,HCPC2026_JAN,2026
E0990,"Wheelchair accessory, elevating leg rest, complete assembly, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0992,"Manual wheelchair accessory, solid seat insert",HCPCS_Level_II,HCPC2026_JAN,2026
E0994,"Arm rest, each",HCPCS_Level_II,HCPC2026_JAN,2026
E0995,"Wheelchair accessory, calf rest/pad, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1,"Upper left, eyelid",HCPCS_Level_II,HCPC2026_JAN,2026
E1002,"Wheelchair accessory, power seating system, tilt only",HCPCS_Level_II,HCPC2026_JAN,2026
E1003,"Wheelchair accessory, power seating system, recline only, without shear reduction",HCPCS_Level_II,HCPC2026_JAN,2026
E1004,"Wheelchair accessory, power seating system, recline only, with mechanical shear reduction",HCPCS_Level_II,HCPC2026_JAN,2026
E1005,"Wheelchair accessory, power seating system, recline only, with power shear reduction",HCPCS_Level_II,HCPC2026_JAN,2026
E1006,"Wheelchair accessory, power seating system, combination tilt and recline, without shear reduction",HCPCS_Level_II,HCPC2026_JAN,2026
E1007,"Wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction",HCPCS_Level_II,HCPC2026_JAN,2026
E1008,"Wheelchair accessory, power seating system, combination tilt and recline, with power shear reduction",HCPCS_Level_II,HCPC2026_JAN,2026
E1009,"Wheelchair accessory, addition to power seating system, mechanically linked leg elevation system, including pushrod and leg rest, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1010,"Wheelchair accessory, addition to power seating system, power leg elevation system, including leg rest, pair",HCPCS_Level_II,HCPC2026_JAN,2026
E1011,"Modification to pediatric size wheelchair, width adjustment package (not to be dispensed with initial chair)",HCPCS_Level_II,HCPC2026_JAN,2026
E1012,"Wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1014,"Reclining back, addition to pediatric size wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
E1015,"Shock absorber for manual wheelchair, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1016,"Shock absorber for power wheelchair, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1017,"Heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1018,"Heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1020,"Residual limb support system for wheelchair, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E1022,"Wheelchair transportation securement system, any type includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1023,"Wheelchair transit securement system, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1028,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware, other",HCPCS_Level_II,HCPC2026_JAN,2026
E1029,"Wheelchair accessory, ventilator tray, fixed",HCPCS_Level_II,HCPC2026_JAN,2026
E1030,"Wheelchair accessory, ventilator tray, gimbaled",HCPCS_Level_II,HCPC2026_JAN,2026
E1031,"Rollabout chair, any and all types with casters 5"" or greater",HCPCS_Level_II,HCPC2026_JAN,2026
E1032,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware used with joystick or other drive control interface",HCPCS_Level_II,HCPC2026_JAN,2026
E1033,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for headrest, cushioned, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E1034,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for lateral trunk or hip support, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E1035,"Multi-positional patient transfer system, with integrated seat, operated by care giver, patient weight capacity up to and including 300 lbs",HCPCS_Level_II,HCPC2026_JAN,2026
E1036,"Multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs",HCPCS_Level_II,HCPC2026_JAN,2026
E1037,"Transport chair, pediatric size",HCPCS_Level_II,HCPC2026_JAN,2026
E1038,"Transport chair, adult size, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
E1039,"Transport chair, adult size, heavy duty, patient weight capacity greater than 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
E1050,"Fully-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1060,"Fully-reclining wheelchair, detachable arms, desk or full length, swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1070,"Fully-reclining wheelchair, detachable arms (desk or full length) swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1083,"Hemi-wheelchair, fixed full length arms, swing away detachable elevating leg rest",HCPCS_Level_II,HCPC2026_JAN,2026
E1084,"Hemi-wheelchair, detachable arms desk or full length arms, swing away detachable elevating leg rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1085,"Hemi-wheelchair, fixed full length arms, swing away detachable foot rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1086,"Hemi-wheelchair detachable arms desk or full length, swing away detachable footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1087,"High strength lightweight wheelchair, fixed full length arms, swing away detachable elevating leg rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1088,"High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable elevating leg rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1089,"High strength lightweight wheelchair, fixed length arms, swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1090,"High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable foot rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1092,"Wide heavy duty wheel chair, detachable arms (desk or full length), swing away detachable elevating leg rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1093,"Wide heavy duty wheelchair, detachable arms desk or full length arms, swing away detachable footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1100,"Semi-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests",HCPCS_Level_II,HCPC2026_JAN,2026
E1110,"Semi-reclining wheelchair, detachable arms (desk or full length) elevating leg rest",HCPCS_Level_II,HCPC2026_JAN,2026
E1130,"Standard wheelchair, fixed full length arms, fixed or swing away detachable footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1140,"Wheelchair, detachable arms, desk or full length, swing away detachable footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1150,"Wheelchair, detachable arms, desk or full length swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1160,"Wheelchair, fixed full length arms, swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1161,"Manual adult size wheelchair, includes tilt in space",HCPCS_Level_II,HCPC2026_JAN,2026
E1170,"Amputee wheelchair, fixed full length arms, swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1171,"Amputee wheelchair, fixed full length arms, without footrests or legrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1172,"Amputee wheelchair, detachable arms (desk or full length) without footrests or legrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1180,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1190,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1195,"Heavy duty wheelchair, fixed full length arms, swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1200,"Amputee wheelchair, fixed full length arms, swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1220,"Wheelchair; specially sized or constructed, (indicate brand name, model number, if any) and justification",HCPCS_Level_II,HCPC2026_JAN,2026
E1221,"Wheelchair with fixed arm, footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1222,"Wheelchair with fixed arm, elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1223,"Wheelchair with detachable arms, footrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1224,"Wheelchair with detachable arms, elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1225,"Wheelchair accessory, manual semi-reclining back, (recline greater than 15 degrees, but less than 80 degrees), each",HCPCS_Level_II,HCPC2026_JAN,2026
E1226,"Wheelchair accessory, manual fully reclining back, (recline greater than 80 degrees), each",HCPCS_Level_II,HCPC2026_JAN,2026
E1227,Special height arms for wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
E1228,Special back height for wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
E1229,"Wheelchair, pediatric size, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
E1230,Power operated vehicle (three or four wheel nonhighway) specify brand name and model number,HCPCS_Level_II,HCPC2026_JAN,2026
E1231,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1232,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1233,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1234,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1235,"Wheelchair, pediatric size, rigid, adjustable, with seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1236,"Wheelchair, pediatric size, folding, adjustable, with seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1237,"Wheelchair, pediatric size, rigid, adjustable, without seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1238,"Wheelchair, pediatric size, folding, adjustable, without seating system",HCPCS_Level_II,HCPC2026_JAN,2026
E1239,"Power wheelchair, pediatric size, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
E1240,"Lightweight wheelchair, detachable arms, (desk or full length) swing away detachable, elevating legrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1250,"Lightweight wheelchair, fixed full length arms, swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1260,"Lightweight wheelchair, detachable arms (desk or full length) swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1270,"Lightweight wheelchair, fixed full length arms, swing away detachable elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1280,"Heavy duty wheelchair, detachable arms (desk or full length) elevating legrests",HCPCS_Level_II,HCPC2026_JAN,2026
E1285,"Heavy duty wheelchair, fixed full length arms, swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1290,"Heavy duty wheelchair, detachable arms (desk or full length) swing away detachable footrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1295,"Heavy duty wheelchair, fixed full length arms, elevating legrest",HCPCS_Level_II,HCPC2026_JAN,2026
E1296,Special wheelchair seat height from floor,HCPCS_Level_II,HCPC2026_JAN,2026
E1297,"Special wheelchair seat depth, by upholstery",HCPCS_Level_II,HCPC2026_JAN,2026
E1298,"Special wheelchair seat depth and/or width, by construction",HCPCS_Level_II,HCPC2026_JAN,2026
E1300,"Whirlpool, portable (overtub type)",HCPCS_Level_II,HCPC2026_JAN,2026
E1301,"Whirlpool tub, walk-in, portable",HCPCS_Level_II,HCPC2026_JAN,2026
E1310,"Whirlpool, non-portable (built-in type)",HCPCS_Level_II,HCPC2026_JAN,2026
E1352,"Oxygen accessory, flow regulator capable of positive inspiratory pressure",HCPCS_Level_II,HCPC2026_JAN,2026
E1353,Regulator,HCPCS_Level_II,HCPC2026_JAN,2026
E1354,"Oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1355,Stand/rack,HCPCS_Level_II,HCPC2026_JAN,2026
E1356,"Oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1357,"Oxygen accessory, battery charger for portable concentrator, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1358,"Oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1372,Immersion external heater for nebulizer,HCPCS_Level_II,HCPC2026_JAN,2026
E1390,"Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate",HCPCS_Level_II,HCPC2026_JAN,2026
E1391,"Oxygen concentrator, dual delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1392,"Portable oxygen concentrator, rental",HCPCS_Level_II,HCPC2026_JAN,2026
E1399,"Durable medical equipment, miscellaneous",HCPCS_Level_II,HCPC2026_JAN,2026
E1405,Oxygen and water vapor enriching system with heated delivery,HCPCS_Level_II,HCPC2026_JAN,2026
E1406,Oxygen and water vapor enriching system without heated delivery,HCPCS_Level_II,HCPC2026_JAN,2026
E1500,"Centrifuge, for dialysis",HCPCS_Level_II,HCPC2026_JAN,2026
E1510,"Kidney, dialysate delivery syst kidney machine, pump recirculating, air removal syst, flowrate meter, power off, heater and temperature control with alarm, i.v. poles, pressure gauge, concentrate container",HCPCS_Level_II,HCPC2026_JAN,2026
E1520,Heparin infusion pump for hemodialysis,HCPCS_Level_II,HCPC2026_JAN,2026
E1530,"Air bubble detector for hemodialysis, each, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
E1540,"Pressure alarm for hemodialysis, each, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
E1550,"Bath conductivity meter for hemodialysis, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1560,"Blood leak detector for hemodialysis, each, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
E1570,"Adjustable chair, for esrd patients",HCPCS_Level_II,HCPC2026_JAN,2026
E1575,"Transducer protectors/fluid barriers, for hemodialysis, any size, per 10",HCPCS_Level_II,HCPC2026_JAN,2026
E1580,Unipuncture control system for hemodialysis,HCPCS_Level_II,HCPC2026_JAN,2026
E1590,Hemodialysis machine,HCPCS_Level_II,HCPC2026_JAN,2026
E1592,Automatic intermittent peritoneal dialysis system,HCPCS_Level_II,HCPC2026_JAN,2026
E1594,Cycler dialysis machine for peritoneal dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
E1600,Delivery and/or installation charges for hemodialysis equipment,HCPCS_Level_II,HCPC2026_JAN,2026
E1610,"Reverse osmosis water purification system, for hemodialysis",HCPCS_Level_II,HCPC2026_JAN,2026
E1615,"Deionizer water purification system, for hemodialysis",HCPCS_Level_II,HCPC2026_JAN,2026
E1620,"Blood pump for hemodialysis, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
E1625,"Water softening system, for hemodialysis",HCPCS_Level_II,HCPC2026_JAN,2026
E1629,Tablo hemodialysis system for the billable dialysis service,HCPCS_Level_II,HCPC2026_JAN,2026
E1630,Reciprocating peritoneal dialysis system,HCPCS_Level_II,HCPC2026_JAN,2026
E1632,"Wearable artificial kidney, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1634,"Peritoneal dialysis clamps, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1635,Compact (portable) travel hemodialyzer system,HCPCS_Level_II,HCPC2026_JAN,2026
E1636,"Sorbent cartridges, for hemodialysis, per 10",HCPCS_Level_II,HCPC2026_JAN,2026
E1637,"Hemostats, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1639,"Scale, each",HCPCS_Level_II,HCPC2026_JAN,2026
E1699,"Dialysis equipment, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
E1700,Jaw motion rehabilitation system,HCPCS_Level_II,HCPC2026_JAN,2026
E1701,"Replacement cushions for jaw motion rehabilitation system, pkg. of 6",HCPCS_Level_II,HCPC2026_JAN,2026
E1702,"Replacement measuring scales for jaw motion rehabilitation system, pkg. of 200",HCPCS_Level_II,HCPC2026_JAN,2026
E1800,"Dynamic adjustable elbow extension and flexion device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1801,"Static progressive stretch/patient actualized serial stretch elbow device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1802,"Dynamic adjustable forearm pronation/supination device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1803,"Dynamic adjustable elbow extension only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1804,"Dynamic adjustable elbow flexion only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1805,"Dynamic adjustable wrist extension and flexion device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1806,"Static progressive stretch wrist device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1807,"Dynamic adjustable wrist extension only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1808,"Dynamic adjustable wrist flexion only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1810,"Dynamic adjustable knee extension and flexion device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1811,"Static progressive stretch/patient actualized serial stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1812,"Dynamic knee, extension/flexion device with active resistance control",HCPCS_Level_II,HCPC2026_JAN,2026
E1813,"Dynamic adjustable knee extension only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1814,"Dynamic adjustable knee flexion only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1815,"Dynamic adjustable ankle extension and flexion device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1816,"Static progressive stretch/patient actualized serial stretch ankle device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1818,"Static progressive stretch/patient actualized serial stretch forearm pronation / supination device, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1820,"Replacement soft interface material, dynamic adjustable extension/flexion device",HCPCS_Level_II,HCPC2026_JAN,2026
E1821,Replacement soft interface material/cuffs for bi-directional static progressive stretch device,HCPCS_Level_II,HCPC2026_JAN,2026
E1822,"Dynamic adjustable ankle extension only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1823,"Dynamic adjustable ankle flexion only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1825,"Dynamic adjustable finger extension and flexion device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1826,"Dynamic adjustable finger extension only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1827,"Dynamic adjustable finger flexion only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1828,"Dynamic adjustable toe extension only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1829,"Dynamic adjustable toe flexion only device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1830,"Dynamic adjustable toe extension and flexion device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1831,"Static progressive stretch toe device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1832,"Static progressive stretch finger device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1840,"Dynamic adjustable shoulder flexion / abduction / rotation device, includes soft interface material",HCPCS_Level_II,HCPC2026_JAN,2026
E1841,"Static progressive stretch/patient actualized serial stretch shoulder device, with or without range of motion adjustment, includes all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E1902,"Communication board, non-electronic augmentative or alternative communication device",HCPCS_Level_II,HCPC2026_JAN,2026
E1905,"Virtual reality cognitive behavioral therapy device (cbt), including pre-programmed therapy software",HCPCS_Level_II,HCPC2026_JAN,2026
E2,"Lower left, eyelid",HCPCS_Level_II,HCPC2026_JAN,2026
E2000,"Gastric suction pump, home model, portable or stationary, electric",HCPCS_Level_II,HCPC2026_JAN,2026
E2001,"Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system",HCPCS_Level_II,HCPC2026_JAN,2026
E2100,Blood glucose monitor with integrated voice synthesizer,HCPCS_Level_II,HCPC2026_JAN,2026
E2101,Blood glucose monitor with integrated lancing/blood sample,HCPCS_Level_II,HCPC2026_JAN,2026
E2102,"Adjunctive, non-implanted continuous glucose monitor or receiver",HCPCS_Level_II,HCPC2026_JAN,2026
E2103,"Non-adjunctive, non-implanted continuous glucose monitor or receiver",HCPCS_Level_II,HCPC2026_JAN,2026
E2104,Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge,HCPCS_Level_II,HCPC2026_JAN,2026
E2120,Pulse generator system for tympanic treatment of inner ear endolymphatic fluid,HCPCS_Level_II,HCPC2026_JAN,2026
E2201,"Manual wheelchair accessory, nonstandard seat frame, width greater than or equal to 20 inches and less than 24 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2202,"Manual wheelchair accessory, nonstandard seat frame width, 24-27 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2203,"Manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2204,"Manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2205,"Manual wheelchair accessory, handrim without projections (includes ergonomic or contoured), any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2206,"Manual wheelchair accessory, wheel lock assembly, complete, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2207,"Wheelchair accessory, crutch and cane holder, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2208,"Wheelchair accessory, cylinder tank carrier, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2209,"Accessory, arm trough, with or without hand support, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2210,"Wheelchair accessory, bearings, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2211,"Manual wheelchair accessory, pneumatic propulsion tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2212,"Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2213,"Manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2214,"Manual wheelchair accessory, pneumatic caster tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2215,"Manual wheelchair accessory, tube for pneumatic caster tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2216,"Manual wheelchair accessory, foam filled propulsion tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2217,"Manual wheelchair accessory, foam filled caster tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2218,"Manual wheelchair accessory, foam propulsion tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2219,"Manual wheelchair accessory, foam caster tire, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2220,"Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2221,"Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2222,"Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2224,"Manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2225,"Manual wheelchair accessory, caster wheel excludes tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2226,"Manual wheelchair accessory, caster fork, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2227,"Manual wheelchair accessory, gear reduction drive wheel, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2228,"Manual wheelchair accessory, wheel braking system and lock, complete, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2230,"Manual wheelchair accessory, manual standing system",HCPCS_Level_II,HCPC2026_JAN,2026
E2231,"Manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2291,"Back, planar, for pediatric size wheelchair including fixed attaching hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2292,"Seat, planar, for pediatric size wheelchair including fixed attaching hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2293,"Back, contoured, for pediatric size wheelchair including fixed attaching hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2294,"Seat, contoured, for pediatric size wheelchair including fixed attaching hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2295,"Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features",HCPCS_Level_II,HCPC2026_JAN,2026
E2298,"Complex rehabilitative power wheelchair accessory, power seat elevation system, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E2300,"Wheelchair accessory, power seat elevation system, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E2301,"Wheelchair accessory, power standing system, any type",HCPCS_Level_II,HCPC2026_JAN,2026
E2310,"Power wheelchair accessory, electronic connection between wheelchair controller and one power seating system motor, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2311,"Power wheelchair accessory, electronic connection between wheelchair controller and two or more power seating system motors, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2312,"Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2313,"Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2321,"Power wheelchair accessory, hand control interface, remote joystick, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2322,"Power wheelchair accessory, hand control interface, multiple mechanical switches, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2323,"Power wheelchair accessory, specialty joystick handle for hand control interface, prefabricated",HCPCS_Level_II,HCPC2026_JAN,2026
E2324,"Power wheelchair accessory, chin cup for chin control interface",HCPCS_Level_II,HCPC2026_JAN,2026
E2325,"Power wheelchair accessory, sip and puff interface, nonproportional, including all related electronics, mechanical stop switch, and manual swingaway mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2326,"Power wheelchair accessory, breath tube kit for sip and puff interface",HCPCS_Level_II,HCPC2026_JAN,2026
E2327,"Power wheelchair accessory, head control interface, mechanical, proportional, including all related electronics, mechanical direction change switch, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2328,"Power wheelchair accessory, head control or extremity control interface, electronic, proportional, including all related electronics and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2329,"Power wheelchair accessory, head control interface, contact switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2330,"Power wheelchair accessory, head control interface, proximity switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2331,"Power wheelchair accessory, attendant control, proportional, including all related electronics and fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2340,"Power wheelchair accessory, nonstandard seat frame width, 20-23 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2341,"Power wheelchair accessory, nonstandard seat frame width, 24-27 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2342,"Power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2343,"Power wheelchair accessory, nonstandard seat frame depth, 22-25 inches",HCPCS_Level_II,HCPC2026_JAN,2026
E2351,"Power wheelchair accessory, electronic interface to operate speech generating device using power wheelchair control interface",HCPCS_Level_II,HCPC2026_JAN,2026
E2358,"Power wheelchair accessory, group 34 non-sealed lead acid battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2359,"Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",HCPCS_Level_II,HCPC2026_JAN,2026
E2360,"Power wheelchair accessory, 22nf non-sealed lead acid battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2361,"Power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel cell, absorbed glassmat)",HCPCS_Level_II,HCPC2026_JAN,2026
E2362,"Power wheelchair accessory, group 24 non-sealed lead acid battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2363,"Power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",HCPCS_Level_II,HCPC2026_JAN,2026
E2364,"Power wheelchair accessory, u-1 non-sealed lead acid battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2365,"Power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",HCPCS_Level_II,HCPC2026_JAN,2026
E2366,"Power wheelchair accessory, battery charger, single mode, for use with only one battery type, sealed or non-sealed, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2367,"Power wheelchair accessory, battery charger, dual mode, for use with either battery type, sealed or non-sealed, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2368,"Power wheelchair component, drive wheel motor, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2369,"Power wheelchair component, drive wheel gear box, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2370,"Power wheelchair component, integrated drive wheel motor and gear box combination, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2371,"Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each",HCPCS_Level_II,HCPC2026_JAN,2026
E2372,"Power wheelchair accessory, group 27 non-sealed lead acid battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2373,"Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2374,"Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2375,"Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2376,"Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2377,"Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue",HCPCS_Level_II,HCPC2026_JAN,2026
E2378,"Power wheelchair component, actuator, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
E2381,"Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2382,"Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2383,"Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2384,"Power wheelchair accessory, pneumatic caster tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2385,"Power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2386,"Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2387,"Power wheelchair accessory, foam filled caster tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2388,"Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2389,"Power wheelchair accessory, foam caster tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2390,"Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2391,"Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2392,"Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2394,"Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2395,"Power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2396,"Power wheelchair accessory, caster fork, any size, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2397,"Power wheelchair accessory, lithium-based battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2398,"Wheelchair accessory, dynamic positioning hardware for back",HCPCS_Level_II,HCPC2026_JAN,2026
E2402,"Negative pressure wound therapy electrical pump, stationary or portable",HCPCS_Level_II,HCPC2026_JAN,2026
E2500,"Speech generating device, digitized speech, using pre-recorded messages, less than or equal to 8 minutes recording time",HCPCS_Level_II,HCPC2026_JAN,2026
E2502,"Speech generating device, digitized speech, using pre-recorded messages, greater than 8 minutes but less than or equal to 20 minutes recording time",HCPCS_Level_II,HCPC2026_JAN,2026
E2504,"Speech generating device, digitized speech, using pre-recorded messages, greater than 20 minutes but less than or equal to 40 minutes recording time",HCPCS_Level_II,HCPC2026_JAN,2026
E2506,"Speech generating device, digitized speech, using pre-recorded messages, greater than 40 minutes recording time",HCPCS_Level_II,HCPC2026_JAN,2026
E2508,"Speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device",HCPCS_Level_II,HCPC2026_JAN,2026
E2510,"Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access",HCPCS_Level_II,HCPC2026_JAN,2026
E2511,"Speech generating software program, for personal computer or personal digital assistant",HCPCS_Level_II,HCPC2026_JAN,2026
E2512,"Accessory for speech generating device, mounting system",HCPCS_Level_II,HCPC2026_JAN,2026
E2513,"Accessory for speech generating device, electromyographic sensor",HCPCS_Level_II,HCPC2026_JAN,2026
E2599,"Accessory for speech generating device, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
E2601,"General use wheelchair seat cushion, width less than 22 inches, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2602,"General use wheelchair seat cushion, width 22 inches or greater, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2603,"Skin protection wheelchair seat cushion, width less than 22 inches, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2604,"Skin protection wheelchair seat cushion, width 22 inches or greater, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2605,"Positioning wheelchair seat cushion, width less than 22 inches, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2606,"Positioning wheelchair seat cushion, width 22 inches or greater, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2607,"Skin protection and positioning wheelchair seat cushion, width less than 22 inches, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2608,"Skin protection and positioning wheelchair seat cushion, width 22 inches or greater, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2609,"Custom fabricated wheelchair seat cushion, any size",HCPCS_Level_II,HCPC2026_JAN,2026
E2610,"Wheelchair seat cushion, powered",HCPCS_Level_II,HCPC2026_JAN,2026
E2611,"General use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2612,"General use wheelchair back cushion, width 22 inches or greater, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2613,"Positioning wheelchair back cushion, posterior, width less than 22 inches, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2614,"Positioning wheelchair back cushion, posterior, width 22 inches or greater, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2615,"Positioning wheelchair back cushion, posterior-lateral, width less than 22 inches, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2616,"Positioning wheelchair back cushion, posterior-lateral, width 22 inches or greater, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2617,"Custom fabricated wheelchair back cushion, any size, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2619,"Replacement cover for wheelchair seat cushion or back cushion, each",HCPCS_Level_II,HCPC2026_JAN,2026
E2620,"Positioning wheelchair back cushion, planar back with lateral supports, width less than 22 inches, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2621,"Positioning wheelchair back cushion, planar back with lateral supports, width 22 inches or greater, any height, including any type mounting hardware",HCPCS_Level_II,HCPC2026_JAN,2026
E2622,"Skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2623,"Skin protection wheelchair seat cushion, adjustable, width 22 inches or greater, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2624,"Skin protection and positioning wheelchair seat cushion, adjustable, width less than 22 inches, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2625,"Skin protection and positioning wheelchair seat cushion, adjustable, width 22 inches or greater, any depth",HCPCS_Level_II,HCPC2026_JAN,2026
E2626,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable",HCPCS_Level_II,HCPC2026_JAN,2026
E2627,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type",HCPCS_Level_II,HCPC2026_JAN,2026
E2628,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining",HCPCS_Level_II,HCPC2026_JAN,2026
E2629,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)",HCPCS_Level_II,HCPC2026_JAN,2026
E2630,"Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support",HCPCS_Level_II,HCPC2026_JAN,2026
E2631,"Wheelchair accessory, addition to mobile arm support, elevating proximal arm",HCPCS_Level_II,HCPC2026_JAN,2026
E2632,"Wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control",HCPCS_Level_II,HCPC2026_JAN,2026
E2633,"Wheelchair accessory, addition to mobile arm support, supinator",HCPCS_Level_II,HCPC2026_JAN,2026
E3,"Upper right, eyelid",HCPCS_Level_II,HCPC2026_JAN,2026
E3000,"Speech volume modulation system, any type, including all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
E3200,"Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only",HCPCS_Level_II,HCPC2026_JAN,2026
E4,"Lower right, eyelid",HCPCS_Level_II,HCPC2026_JAN,2026
E8000,"Gait trainer, pediatric size, posterior support, includes all accessories and components",HCPCS_Level_II,HCPC2026_JAN,2026
E8001,"Gait trainer, pediatric size, upright support, includes all accessories and components",HCPCS_Level_II,HCPC2026_JAN,2026
E8002,"Gait trainer, pediatric size, anterior support, includes all accessories and components",HCPCS_Level_II,HCPC2026_JAN,2026
EA,Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
EB,Erythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
EC,Erythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
ED,Hematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle,HCPCS_Level_II,HCPC2026_JAN,2026
EE,Hematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycle,HCPCS_Level_II,HCPC2026_JAN,2026
EJ,"Subsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab",HCPCS_Level_II,HCPC2026_JAN,2026
EM,Emergency reserve supply (for esrd benefit only),HCPCS_Level_II,HCPC2026_JAN,2026
EP,Service provided as part of medicaid early periodic screening diagnosis and treatment (epsdt) program,HCPCS_Level_II,HCPC2026_JAN,2026
ER,"Items and services furnished by a provider-based, off-campus emergency department",HCPCS_Level_II,HCPC2026_JAN,2026
ET,Emergency services,HCPCS_Level_II,HCPC2026_JAN,2026
EX,Expatriate beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
EY,No physician or other licensed health care provider order for this item or service,HCPCS_Level_II,HCPC2026_JAN,2026
F1,"Left hand, second digit",HCPCS_Level_II,HCPC2026_JAN,2026
F2,"Left hand, third digit",HCPCS_Level_II,HCPC2026_JAN,2026
F3,"Left hand, fourth digit",HCPCS_Level_II,HCPC2026_JAN,2026
F4,"Left hand, fifth digit",HCPCS_Level_II,HCPC2026_JAN,2026
F5,"Right hand, thumb",HCPCS_Level_II,HCPC2026_JAN,2026
F6,"Right hand, second digit",HCPCS_Level_II,HCPC2026_JAN,2026
F7,"Right hand, third digit",HCPCS_Level_II,HCPC2026_JAN,2026
F8,"Right hand, fourth digit",HCPCS_Level_II,HCPC2026_JAN,2026
F9,"Right hand, fifth digit",HCPCS_Level_II,HCPC2026_JAN,2026
FA,"Left hand, thumb",HCPCS_Level_II,HCPC2026_JAN,2026
FB,"Item provided without cost to provider, supplier or practitioner, or full credit received for replaced device (examples, but not limited to, covered under warranty, replaced due to defect, free samples)",HCPCS_Level_II,HCPC2026_JAN,2026
FC,Partial credit received for replaced device,HCPCS_Level_II,HCPC2026_JAN,2026
FP,Service provided as part of family planning program,HCPCS_Level_II,HCPC2026_JAN,2026
FQ,The service was furnished using audio-only communication technology,HCPCS_Level_II,HCPC2026_JAN,2026
FR,"The supervising practitioner was present through two-way, audio/video communication technology",HCPCS_Level_II,HCPC2026_JAN,2026
FS,Split (or shared) evaluation and management visit,HCPCS_Level_II,HCPC2026_JAN,2026
FT,"Unrelated evaluation and management (e/m) visit on the same day as another e/m visit or during a global procedure (preoperative, postoperative period, or on the same day as the procedure, as applicable). (report when an e/m visit is furnished within the global period but is unrelated, or when one or more additional e/m visits furnished on the same day are unrelated)",HCPCS_Level_II,HCPC2026_JAN,2026
FX,X-ray taken using film,HCPCS_Level_II,HCPC2026_JAN,2026
FY,X-ray taken using computed radiography technology/cassette-based imaging,HCPCS_Level_II,HCPC2026_JAN,2026
G0,"Telehealth services for diagnosis, evaluation, or treatment, of symptoms of an acute stroke",HCPCS_Level_II,HCPC2026_JAN,2026
G0008,Administration of influenza virus vaccine,HCPCS_Level_II,HCPC2026_JAN,2026
G0009,Administration of pneumococcal vaccine,HCPCS_Level_II,HCPC2026_JAN,2026
G0010,Administration of hepatitis b vaccine,HCPCS_Level_II,HCPC2026_JAN,2026
G0011,"Individual counseling for pre-exposure prophylaxis (prep) by physician or qualified health care professional (qhp) to prevent human immunodeficiency virus (hiv), includes hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence, 15-30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0012,"Injection of pre-exposure prophylaxis (prep) drug for hiv prevention, under skin or into muscle",HCPCS_Level_II,HCPC2026_JAN,2026
G0013,"Individual counseling for pre-exposure prophylaxis (prep) by clinical staff to prevent human immunodeficiency virus (hiv), includes: hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence",HCPCS_Level_II,HCPC2026_JAN,2026
G0017,"Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); first 60 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0018,"Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); each additional 30 minutes (list separately in addition to code for primary service)",HCPCS_Level_II,HCPC2026_JAN,2026
G0019,"Community health integration services performed by certified or trained auxiliary personnel, including a community health worker, under the direction of a physician or other practitioner; 60 minutes per calendar month, in the following activities to address social determinants of health (sdoh) need(s) that are significantly limiting the ability to diagnose or treat problem(s) addressed in an initiating visit: person-centered assessment, performed to better understand the individualized context of the intersection between the sdoh need(s) and the problem(s) addressed in the initiating visit. ++ conducting a person-centered assessment to understand patient's life story, strengths, needs, goals, preferences and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal-setting and establishing an action plan. ++ providing tailored support to the patient as needed to accomplish the practitioner's treatment plan. practitioner, home-, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; and from home- and community-based service providers, social service providers, and caregiver (if applicable). ++ communication with practitioners, home- and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) to address the sdoh need(s). health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, and preferences, in the context of the sdoh need(s), and educating the patient on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services addressing the sdoh need(s), in ways that are more likely to promote personalized and effective diagnosis or treatment. health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care and helping secure appointments with them. facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals. facilitating and providing social and emotional support to help the patient cope with the problem(s) addressed in the initiating visit, the sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals. leveraging lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals",HCPCS_Level_II,HCPC2026_JAN,2026
G0022,"Community health integration services, each additional 30 minutes per calendar month (list separately in addition to g0019)",HCPCS_Level_II,HCPC2026_JAN,2026
G0023,"Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month, in the following activities:  person-centered assessment, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered assessment to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the practitioner's treatment plan.  identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services.  practitioner, home, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; home- and community-based service providers; and caregiver (if applicable). ++ communication with practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s).  health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making.  building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition.  health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care,  and helping secure appointments with them. ++ providing the patient with information/resources to consider participation in clinical trials or clinical research as applicable.  facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals.  facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals.  leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals",HCPCS_Level_II,HCPC2026_JAN,2026
G0024,"Principal illness navigation services, additional 30 minutes per calendar month (list separately in addition to g0023)",HCPCS_Level_II,HCPC2026_JAN,2026
G0027,Semen analysis; presence and/or motility of sperm excluding huhner,HCPCS_Level_II,HCPC2026_JAN,2026
G0028,"Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G0029,Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G0030,"Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user",HCPCS_Level_II,HCPC2026_JAN,2026
G0031,Palliative care services given to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G0032,"Two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics",HCPCS_Level_II,HCPC2026_JAN,2026
G0033,"Two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines",HCPCS_Level_II,HCPC2026_JAN,2026
G0034,Patients receiving palliative care during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G0035,Patient has any emergency department encounter during the performance period with place of service indicator 23,HCPCS_Level_II,HCPC2026_JAN,2026
G0036,Patient or care partner decline assessment,HCPCS_Level_II,HCPC2026_JAN,2026
G0037,"On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available",HCPCS_Level_II,HCPC2026_JAN,2026
G0038,Clinician determines patient does not require referral,HCPCS_Level_II,HCPC2026_JAN,2026
G0039,"Patient not referred, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G0040,Patient already receiving physical/occupational/speech/recreational therapy during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G0041,Patient and/or care partner decline referral,HCPCS_Level_II,HCPC2026_JAN,2026
G0042,"Referral to physical, occupational, speech, or recreational therapy",HCPCS_Level_II,HCPC2026_JAN,2026
G0043,Patients with mechanical prosthetic heart valve,HCPCS_Level_II,HCPC2026_JAN,2026
G0044,Patients with moderate or severe mitral stenosis,HCPCS_Level_II,HCPC2026_JAN,2026
G0045,Clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention,HCPCS_Level_II,HCPC2026_JAN,2026
G0046,Clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention,HCPCS_Level_II,HCPC2026_JAN,2026
G0047,Pediatric patient with minor blunt head trauma and pecarn prediction criteria are not assessed,HCPCS_Level_II,HCPC2026_JAN,2026
G0048,Patients who receive palliative care services any time during the intake period through the end of the measurement year,HCPCS_Level_II,HCPC2026_JAN,2026
G0049,With maintenance hemodialysis (in-center and home hd) for the complete reporting month,HCPCS_Level_II,HCPC2026_JAN,2026
G0050,Patients with a catheter that have limited life expectancy,HCPCS_Level_II,HCPC2026_JAN,2026
G0051,Patients under hospice care in the current reporting month,HCPCS_Level_II,HCPC2026_JAN,2026
G0052,Patients on peritoneal dialysis for any portion of the reporting month,HCPCS_Level_II,HCPC2026_JAN,2026
G0053,Advancing rheumatology patient care mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0054,Coordinating stroke care to promote prevention and cultivate positive outcomes mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0055,Advancing care for heart disease mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0056,Optimizing chronic disease management mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0057,Proposed adopting best practices and promoting patient safety within emergency medicine mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0058,Improving care for lower extremity joint repair mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0059,Patient safety and support of positive experiences with anesthesia mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
G0060,Allergy/immunology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0061,Anesthesiology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0062,Audiology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0063,Cardiology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0064,Certified nurse midwife mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0065,Chiropractic medicine mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0066,Clinical social work mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0067,Dentistry mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G0068,"Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0069,"Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0070,"Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0071,"Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only",HCPCS_Level_II,HCPC2026_JAN,2026
G0076,"Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0077,"Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0078,"Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0079,"Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0080,"Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0081,"Brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0082,"Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0083,"Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0084,"Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0085,"Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0086,"Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0087,"Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)",HCPCS_Level_II,HCPC2026_JAN,2026
G0088,"Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0089,"Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0090,"Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0101,Cervical or vaginal cancer screening; pelvic and clinical breast examination,HCPCS_Level_II,HCPC2026_JAN,2026
G0102,Prostate cancer screening; digital rectal examination,HCPCS_Level_II,HCPC2026_JAN,2026
G0103,Prostate cancer screening; prostate specific antigen test (psa),HCPCS_Level_II,HCPC2026_JAN,2026
G0104,Colorectal cancer screening; flexible sigmoidoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G0105,Colorectal cancer screening; colonoscopy on individual at high risk,HCPCS_Level_II,HCPC2026_JAN,2026
G0106,"Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enema",HCPCS_Level_II,HCPC2026_JAN,2026
G0108,"Diabetes outpatient self-management training services, individual, per 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0109,"Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0117,Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist,HCPCS_Level_II,HCPC2026_JAN,2026
G0118,Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist,HCPCS_Level_II,HCPC2026_JAN,2026
G0120,"Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.",HCPCS_Level_II,HCPC2026_JAN,2026
G0121,Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk,HCPCS_Level_II,HCPC2026_JAN,2026
G0122,Colorectal cancer screening; barium enema,HCPCS_Level_II,HCPC2026_JAN,2026
G0123,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
G0124,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician",HCPCS_Level_II,HCPC2026_JAN,2026
G0127,"Trimming of dystrophic nails, any number",HCPCS_Level_II,HCPC2026_JAN,2026
G0128,"Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0129,"Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization or intensive outpatient treatment program, per session (45 minutes or more)",HCPCS_Level_II,HCPC2026_JAN,2026
G0130,"Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)",HCPCS_Level_II,HCPC2026_JAN,2026
G0136,"Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months",HCPCS_Level_II,HCPC2026_JAN,2026
G0137,"Intensive outpatient services; weekly bundle, minimum of 9 services over a 7 contiguous day period, which can include individual and group therapy with physicians or psychologists (or other mental health professionals to the extent authorized under state law); occupational therapy requiring the skills of a qualified occupational therapist; services of social workers, trained psychiatric nurses, and other staff trained to work with psychiatric patients; individualized activity therapies that are not primarily recreational or diversionary; family counseling (the primary purpose of which is treatment of the individual's condition); patient training and education (to the extent that training and educational activities are closely and clearly related to individual's care and treatment); diagnostic services; and such other items and services (excluding meals and transportation) that are reasonable and necessary for the diagnosis or active treatment of the individual's condition, reasonably expected to improve or maintain the individual's condition and functional level and to prevent relapse or hospitalization, and furnished pursuant to such guidelines relating to frequency and duration of services in accordance with a physician certification and plan of treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G0138,"Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga",HCPCS_Level_II,HCPC2026_JAN,2026
G0140,"Principal illness navigation - peer support by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a certified peer specialist; 60 minutes per calendar month, in the following activities:  person-centered interview, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors, and including unmet sdoh needs (that are not billed separately). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the person-centered goals in the practitioner's treatment plan. identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services. practitioner, home, and community-based care communication. ++ assist the patient in communicating with their practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s). health education. helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition. developing and proposing strategies to help meet person-centered treatment goals and supporting the patient in using chosen strategies to reach person-centered treatment goals. facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet person-centered diagnosis and treatment goals. leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals",HCPCS_Level_II,HCPC2026_JAN,2026
G0141,"Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician",HCPCS_Level_II,HCPC2026_JAN,2026
G0143,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
G0144,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
G0145,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
G0146,"Principal illness navigation - peer support, additional 30 minutes per calendar month (list separately in addition to g0140)",HCPCS_Level_II,HCPC2026_JAN,2026
G0147,"Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
G0148,"Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening",HCPCS_Level_II,HCPC2026_JAN,2026
G0151,"Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0152,"Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0153,"Services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0154,"Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0155,"Services of clinical social worker in home health or hospice settings, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0156,"Services of home health/hospice aide in home health or hospice settings, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0157,"Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0158,"Services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0159,"Services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0160,"Services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0161,"Services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0162,Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting),HCPCS_Level_II,HCPC2026_JAN,2026
G0163,"Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)",HCPCS_Level_II,HCPC2026_JAN,2026
G0164,"Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0166,"External counterpulsation, per treatment session",HCPCS_Level_II,HCPC2026_JAN,2026
G0168,Wound closure utilizing tissue adhesive(s) only,HCPCS_Level_II,HCPC2026_JAN,2026
G0173,"Linear accelerator based stereotactic radiosurgery, complete course of therapy in one session",HCPCS_Level_II,HCPC2026_JAN,2026
G0175,Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present,HCPCS_Level_II,HCPC2026_JAN,2026
G0176,"Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)",HCPCS_Level_II,HCPC2026_JAN,2026
G0177,Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more),HCPCS_Level_II,HCPC2026_JAN,2026
G0179,"Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care",HCPCS_Level_II,HCPC2026_JAN,2026
G0180,"Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care",HCPCS_Level_II,HCPC2026_JAN,2026
G0181,Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans,HCPCS_Level_II,HCPC2026_JAN,2026
G0182,"Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more",HCPCS_Level_II,HCPC2026_JAN,2026
G0183,"Quantitative software measurements of cardiac volume, cardiac chambers volumes and left ventricular wall mass derived from ct scan(s) data of the chest/heart (with or without contrast)",HCPCS_Level_II,HCPC2026_JAN,2026
G0186,"Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)",HCPCS_Level_II,HCPC2026_JAN,2026
G0202,"Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed",HCPCS_Level_II,HCPC2026_JAN,2026
G0204,"Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
G0206,"Diagnostic mammography, including computer-aided detection (cad) when performed; unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
G0219,Pet imaging whole body; melanoma for non-covered indications,HCPCS_Level_II,HCPC2026_JAN,2026
G0235,"Pet imaging, any site, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G0237,"Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)",HCPCS_Level_II,HCPC2026_JAN,2026
G0238,"Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)",HCPCS_Level_II,HCPC2026_JAN,2026
G0239,"Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)",HCPCS_Level_II,HCPC2026_JAN,2026
G0245,"Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education",HCPCS_Level_II,HCPC2026_JAN,2026
G0246,"Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education",HCPCS_Level_II,HCPC2026_JAN,2026
G0247,"Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails",HCPCS_Level_II,HCPC2026_JAN,2026
G0248,"Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results",HCPCS_Level_II,HCPC2026_JAN,2026
G0249,"Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests",HCPCS_Level_II,HCPC2026_JAN,2026
G0250,"Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests",HCPCS_Level_II,HCPC2026_JAN,2026
G0251,"Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G0252,"Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0255,"Current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve",HCPCS_Level_II,HCPC2026_JAN,2026
G0257,Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility,HCPCS_Level_II,HCPC2026_JAN,2026
G0259,Injection procedure for sacroiliac joint; arthrography,HCPCS_Level_II,HCPC2026_JAN,2026
G0260,"Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography",HCPCS_Level_II,HCPC2026_JAN,2026
G0268,Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing,HCPCS_Level_II,HCPC2026_JAN,2026
G0269,"Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)",HCPCS_Level_II,HCPC2026_JAN,2026
G0270,"Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0271,"Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0276,"Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial",HCPCS_Level_II,HCPC2026_JAN,2026
G0277,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval",HCPCS_Level_II,HCPC2026_JAN,2026
G0278,"Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
G0279,"Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)",HCPCS_Level_II,HCPC2026_JAN,2026
G0281,"Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care",HCPCS_Level_II,HCPC2026_JAN,2026
G0282,"Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281",HCPCS_Level_II,HCPC2026_JAN,2026
G0283,"Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care",HCPCS_Level_II,HCPC2026_JAN,2026
G0288,"Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery",HCPCS_Level_II,HCPC2026_JAN,2026
G0289,"Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee",HCPCS_Level_II,HCPC2026_JAN,2026
G0293,"Noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day",HCPCS_Level_II,HCPC2026_JAN,2026
G0294,"Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day",HCPCS_Level_II,HCPC2026_JAN,2026
G0295,"Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses",HCPCS_Level_II,HCPC2026_JAN,2026
G0296,Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making),HCPCS_Level_II,HCPC2026_JAN,2026
G0297,Low dose ct scan (ldct) for lung cancer screening,HCPCS_Level_II,HCPC2026_JAN,2026
G0299,"Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0300,"Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0302,"Pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services",HCPCS_Level_II,HCPC2026_JAN,2026
G0303,"Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services",HCPCS_Level_II,HCPC2026_JAN,2026
G0304,"Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services",HCPCS_Level_II,HCPC2026_JAN,2026
G0305,"Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services",HCPCS_Level_II,HCPC2026_JAN,2026
G0306,"Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count",HCPCS_Level_II,HCPC2026_JAN,2026
G0307,"Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)",HCPCS_Level_II,HCPC2026_JAN,2026
G0308,"Creation of subcutaneous pocket with insertion of 180 day implantable interstitial glucose sensor, including system activation and patient training",HCPCS_Level_II,HCPC2026_JAN,2026
G0309,"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activation",HCPCS_Level_II,HCPC2026_JAN,2026
G0310,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0311,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service,  16-30 mins time (this code is used for medicaid billing purposes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0312,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0313,"Immunization counseling by a physician or other qualified health care professional when  the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0314,"Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)",HCPCS_Level_II,HCPC2026_JAN,2026
G0315,"Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)",HCPCS_Level_II,HCPC2026_JAN,2026
G0316,"Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0317,"Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0318,"Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)",HCPCS_Level_II,HCPC2026_JAN,2026
G0320,Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system,HCPCS_Level_II,HCPC2026_JAN,2026
G0321,Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system,HCPCS_Level_II,HCPC2026_JAN,2026
G0322,"The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)",HCPCS_Level_II,HCPC2026_JAN,2026
G0323,"Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist, clinical social worker, mental health counselor, or marriage and family therapist time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)",HCPCS_Level_II,HCPC2026_JAN,2026
G0327,Colorectal cancer screening; blood-based biomarker,HCPCS_Level_II,HCPC2026_JAN,2026
G0328,"Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous",HCPCS_Level_II,HCPC2026_JAN,2026
G0329,"Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care",HCPCS_Level_II,HCPC2026_JAN,2026
G0330,"Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room",HCPCS_Level_II,HCPC2026_JAN,2026
G0333,Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
G0337,"Hospice evaluation and counseling services, pre-election",HCPCS_Level_II,HCPC2026_JAN,2026
G0339,"Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G0340,"Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G0341,"Percutaneous islet cell transplant, includes portal vein catheterization and infusion",HCPCS_Level_II,HCPC2026_JAN,2026
G0342,"Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion",HCPCS_Level_II,HCPC2026_JAN,2026
G0343,"Laparotomy for islet cell transplant, includes portal vein catheterization and infusion",HCPCS_Level_II,HCPC2026_JAN,2026
G0364,Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service,HCPCS_Level_II,HCPC2026_JAN,2026
G0365,"Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)",HCPCS_Level_II,HCPC2026_JAN,2026
G0372,Physician service required to establish and document the need for a power mobility device,HCPCS_Level_II,HCPC2026_JAN,2026
G0378,"Hospital observation service, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
G0379,Direct admission of patient for hospital observation care,HCPCS_Level_II,HCPC2026_JAN,2026
G0380,"Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0381,"Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0382,"Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0383,"Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0384,"Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0389,Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screening,HCPCS_Level_II,HCPC2026_JAN,2026
G0390,Trauma response team associated with hospital critical care service,HCPCS_Level_II,HCPC2026_JAN,2026
G0396,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0397,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0398,"Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation",HCPCS_Level_II,HCPC2026_JAN,2026
G0399,"Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation",HCPCS_Level_II,HCPC2026_JAN,2026
G0400,"Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels",HCPCS_Level_II,HCPC2026_JAN,2026
G0402,"Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment",HCPCS_Level_II,HCPC2026_JAN,2026
G0403,"Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
G0404,"Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination",HCPCS_Level_II,HCPC2026_JAN,2026
G0405,"Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination",HCPCS_Level_II,HCPC2026_JAN,2026
G0406,"Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0407,"Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0408,"Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0409,"Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)",HCPCS_Level_II,HCPC2026_JAN,2026
G0410,"Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0411,"Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0412,"Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
G0413,"Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)",HCPCS_Level_II,HCPC2026_JAN,2026
G0414,"Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)",HCPCS_Level_II,HCPC2026_JAN,2026
G0415,"Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)",HCPCS_Level_II,HCPC2026_JAN,2026
G0416,"Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method",HCPCS_Level_II,HCPC2026_JAN,2026
G0417,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, 21-40 specimens",HCPCS_Level_II,HCPC2026_JAN,2026
G0418,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, 41-60 specimens",HCPCS_Level_II,HCPC2026_JAN,2026
G0419,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, >60 specimens",HCPCS_Level_II,HCPC2026_JAN,2026
G0420,"Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour",HCPCS_Level_II,HCPC2026_JAN,2026
G0421,"Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour",HCPCS_Level_II,HCPC2026_JAN,2026
G0422,"Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session",HCPCS_Level_II,HCPC2026_JAN,2026
G0423,"Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session",HCPCS_Level_II,HCPC2026_JAN,2026
G0424,"Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per day",HCPCS_Level_II,HCPC2026_JAN,2026
G0425,"Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0426,"Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0427,"Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0428,"Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)",HCPCS_Level_II,HCPC2026_JAN,2026
G0429,"Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)",HCPCS_Level_II,HCPC2026_JAN,2026
G0431,"Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G0432,"Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening",HCPCS_Level_II,HCPC2026_JAN,2026
G0433,"Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening",HCPCS_Level_II,HCPC2026_JAN,2026
G0434,"Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G0435,"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening",HCPCS_Level_II,HCPC2026_JAN,2026
G0436,"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0437,"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0438,"Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit",HCPCS_Level_II,HCPC2026_JAN,2026
G0439,"Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit",HCPCS_Level_II,HCPC2026_JAN,2026
G0442,"Annual alcohol misuse screening, 5 to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0443,"Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0444,"Annual depression screening, 5 to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0445,"High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0446,"Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0447,"Face-to-face behavioral counseling for obesity, 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0448,"Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing",HCPCS_Level_II,HCPC2026_JAN,2026
G0451,"Development testing, with interpretation and report, per standardized instrument form",HCPCS_Level_II,HCPC2026_JAN,2026
G0452,Molecular pathology procedure; physician interpretation and report,HCPCS_Level_II,HCPC2026_JAN,2026
G0453,"Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
G0454,"Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist",HCPCS_Level_II,HCPC2026_JAN,2026
G0455,"Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen",HCPCS_Level_II,HCPC2026_JAN,2026
G0456,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters",HCPCS_Level_II,HCPC2026_JAN,2026
G0457,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters",HCPCS_Level_II,HCPC2026_JAN,2026
G0458,"Low dose rate (ldr) prostate brachytherapy services, composite rate",HCPCS_Level_II,HCPC2026_JAN,2026
G0459,"Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy",HCPCS_Level_II,HCPC2026_JAN,2026
G0460,"Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G0461,"Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stain",HCPCS_Level_II,HCPC2026_JAN,2026
G0462,"Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
G0463,Hospital outpatient clinic visit for assessment and management of a patient,HCPCS_Level_II,HCPC2026_JAN,2026
G0464,"Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)",HCPCS_Level_II,HCPC2026_JAN,2026
G0465,"Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0466,"Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit",HCPCS_Level_II,HCPC2026_JAN,2026
G0467,"Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit",HCPCS_Level_II,HCPC2026_JAN,2026
G0468,"Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv",HCPCS_Level_II,HCPC2026_JAN,2026
G0469,"Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit",HCPCS_Level_II,HCPC2026_JAN,2026
G0470,"Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit",HCPCS_Level_II,HCPC2026_JAN,2026
G0471,Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha),HCPCS_Level_II,HCPC2026_JAN,2026
G0472,"Hepatitis c antibody screening, for individual at high risk and other covered indication(s)",HCPCS_Level_II,HCPC2026_JAN,2026
G0473,"Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0475,"Hiv antigen/antibody, combination assay, screening",HCPCS_Level_II,HCPC2026_JAN,2026
G0476,"Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test",HCPCS_Level_II,HCPC2026_JAN,2026
G0477,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service",HCPCS_Level_II,HCPC2026_JAN,2026
G0478,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of service",HCPCS_Level_II,HCPC2026_JAN,2026
G0479,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service",HCPCS_Level_II,HCPC2026_JAN,2026
G0480,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed",HCPCS_Level_II,HCPC2026_JAN,2026
G0481,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed",HCPCS_Level_II,HCPC2026_JAN,2026
G0482,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed",HCPCS_Level_II,HCPC2026_JAN,2026
G0483,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed",HCPCS_Level_II,HCPC2026_JAN,2026
G0490,Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies;  (services limited to rn or lpn only),HCPCS_Level_II,HCPC2026_JAN,2026
G0491,Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd,HCPCS_Level_II,HCPC2026_JAN,2026
G0492,Dialysis procedure with single evaluation by a physician or other qualified health care professional  for acute kidney injury without esrd,HCPCS_Level_II,HCPC2026_JAN,2026
G0493,"Skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)",HCPCS_Level_II,HCPC2026_JAN,2026
G0494,"Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)",HCPCS_Level_II,HCPC2026_JAN,2026
G0495,"Skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0496,"Skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0498,"Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion",HCPCS_Level_II,HCPC2026_JAN,2026
G0499,"Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result",HCPCS_Level_II,HCPC2026_JAN,2026
G0500,"Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G0501,"Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management  visit (list separately in addition to primary service)",HCPCS_Level_II,HCPC2026_JAN,2026
G0502,"Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan;  review by the psychiatric consultant with modifications of the plan if recommended;  entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies",HCPCS_Level_II,HCPC2026_JAN,2026
G0503,"Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements:  tracking patient follow-up and progress using the registry, with appropriate documentation;  participation in weekly caseload consultation with the psychiatric consultant;  ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers;  additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant;  provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies;  monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G0504,"Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure);  (use g0504 in conjunction with g0502, g0503)",HCPCS_Level_II,HCPC2026_JAN,2026
G0505,"Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest home",HCPCS_Level_II,HCPC2026_JAN,2026
G0506,Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service),HCPCS_Level_II,HCPC2026_JAN,2026
G0507,"Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team",HCPCS_Level_II,HCPC2026_JAN,2026
G0508,"Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0509,"Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth",HCPCS_Level_II,HCPC2026_JAN,2026
G0511,"Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G0512,"Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G0513,"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)",HCPCS_Level_II,HCPC2026_JAN,2026
G0514,"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)",HCPCS_Level_II,HCPC2026_JAN,2026
G0515,"Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0516,"Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)",HCPCS_Level_II,HCPC2026_JAN,2026
G0517,"Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)",HCPCS_Level_II,HCPC2026_JAN,2026
G0518,"Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)",HCPCS_Level_II,HCPC2026_JAN,2026
G0519,"Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0520,"Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0521,"Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0522,"Management of a new patient with dementia, low complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0523,"Management of a new patient with dementia, moderate to high complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0524,"Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0525,"Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0526,"Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0527,"Management of established patient with dementia, low complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0528,"Management of established patient with dementia, moderate to high complexity, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0529,"In-home respite care, 4-hour unit, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0530,"Adult day center, 8-hour unit, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0531,"Facility-based respite, 24-hour unit, for use in cmmi model",HCPCS_Level_II,HCPC2026_JAN,2026
G0532,"Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0533,"Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G0534,"Coordinated care and/or referral services, such as to adequate and accessible community resources to address unmet health-related social needs, including harm reduction interventions and recovery support services a patient needs and wishes to pursue, which significantly limit the ability to diagnose or treat an opioid use disorder; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0535,"Patient navigational services, provided directly or by referral; including helping the patient to navigate health systems and identify care providers and supportive services, to build patient self-advocacy and communication skills with care providers, and to promote patient-driven action plans and goals; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0536,"Peer recovery support services, provided directly or by referral; including leveraging knowledge of the condition or lived experience to provide support, mentorship, or inspiration to meet oud treatment and recovery goals; conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes; developing and proposing strategies to help meet person-centered treatment goals; assisting the patient in locating or navigating recovery support services; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0537,"Administration of a standardized, evidence-based atherosclerotic cardiovascular disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12 months",HCPCS_Level_II,HCPC2026_JAN,2026
G0538,Atherosclerotic cardiovascular disease (ascvd) risk management services; clinical staff time; per calendar month,HCPCS_Level_II,HCPC2026_JAN,2026
G0539,"Caregiver training in behavior management/modification for caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; initial 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0540,"Caregiver training in behavior management/modification for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; each additional 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0541,"Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; initial 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0542,"Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; each additional 15 minutes (list separately in addition to code for primary service) (use g0542 in conjunction with g0541)",HCPCS_Level_II,HCPC2026_JAN,2026
G0543,"Group caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face with multiple sets of caregivers",HCPCS_Level_II,HCPC2026_JAN,2026
G0544,"Post discharge telephonic follow-up contacts performed in conjunction with a discharge from the emergency department for behavioral health or other crisis encounter, 4 calls per calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G0545,"Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge)",HCPCS_Level_II,HCPC2026_JAN,2026
G0546,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty   whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 5-10 minutes of medical consultative discussion and review",HCPCS_Level_II,HCPC2026_JAN,2026
G0547,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 11-20 minutes of medical consultative discussion and review",HCPCS_Level_II,HCPC2026_JAN,2026
G0548,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 21-30 minutes of medical consultative discussion and review",HCPCS_Level_II,HCPC2026_JAN,2026
G0549,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 31 or more minutes of medical consultative discussion and review",HCPCS_Level_II,HCPC2026_JAN,2026
G0550,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a written report to the patient's treating/requesting practitioner, 5 minutes or more of medical consultative time",HCPCS_Level_II,HCPC2026_JAN,2026
G0551,"Interprofessional telephone/internet/electronic health record referral service(s) provided by a treating/requesting practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, 30 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G0552,"Supply of digital mental health treatment device and initial education and onboarding, per course of treatment that augments a behavioral therapy plan",HCPCS_Level_II,HCPC2026_JAN,2026
G0553,"First 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing information related to the use of the dmht device, including patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G0554,"Each additional 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing data generated from the dmht device from patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G0555,"Provision of replacement patient electronics system (e.g., system pillow, handheld reader) for home pulmonary artery pressure monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
G0556,"Advanced primary care management services for a patient with one chronic condition [expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline], or fewer, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan with typical care plan elements when clinically relevant; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology",HCPCS_Level_II,HCPC2026_JAN,2026
G0557,"Advanced primary care management services for a patient with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology",HCPCS_Level_II,HCPC2026_JAN,2026
G0558,"Advanced primary care management services for a patient that is a qualified medicare beneficiary with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate:   consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology",HCPCS_Level_II,HCPC2026_JAN,2026
G0559,"Post-operative follow-up visit complexity inherent to evaluation and management services addressing surgical procedure(s), provided by a physician or qualified health care professional who is not the practitioner who performed the procedure (or in the same group practice) and is of the same or of a different specialty than the practitioner who performed the procedure, within the 90-day global period of the procedure(s), once per 90-day global period, when there has not been a formal transfer of care and requires the following required elements, when possible and applicable:    reading available surgical note to understand the relative success of the procedure, the anatomy that was affected, and potential complications that could have arisen due to the unique circumstances of the patient's operation.    research the procedure to determine expected post-operative course and potential complications (in the case of doing a post-op for a procedure outside the specialty).    evaluate and physically examine the patient to determine whether the post-operative course is progressing appropriately.    communicate with the practitioner who performed the procedure if any questions or concerns arise. (list separately in addition to office/outpatient evaluation and management visit, new or established)",HCPCS_Level_II,HCPC2026_JAN,2026
G0560,"Safety planning interventions, each 20 minutes personally performed by the billing practitioner, including assisting the patient in the identification of the following personalized elements of a safety plan: recognizing warning signs of an impending suicidal or substance use-related crisis; employing internal coping strategies; utilizing social contacts and social settings as a means of distraction from suicidal thoughts or risky substance use; utilizing family members, significant others, caregivers, and/or friends to help resolve the crisis; contacting mental health or substance use disorder professionals or agencies; and making the environment safe",HCPCS_Level_II,HCPC2026_JAN,2026
G0561,"Tympanostomy with local or topical anesthesia and insertion of a ventilating tube when performed with tympanostomy tube delivery device, unilateral (list separately in addition to 69433) (do not use in conjunction with 0583t)",HCPCS_Level_II,HCPC2026_JAN,2026
G0562,"Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)",HCPCS_Level_II,HCPC2026_JAN,2026
G0563,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions",HCPCS_Level_II,HCPC2026_JAN,2026
G0564,"Creation of subcutaneous pocket with insertion of 365 day implantable interstitial glucose sensor, including system activation and patient training",HCPCS_Level_II,HCPC2026_JAN,2026
G0565,"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activation",HCPCS_Level_II,HCPC2026_JAN,2026
G0566,"3d radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination of the same anatomy",HCPCS_Level_II,HCPC2026_JAN,2026
G0567,"Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique",HCPCS_Level_II,HCPC2026_JAN,2026
G0568,"Initial psychiatric collaborative care management, in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional, initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan, review by the psychiatric consultant with modifications of the plan if recommended, entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant, and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies (list separately in addition to the advanced primary care management code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0569,"Subsequent psychiatric collaborative care management, in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment (list separately in addition to advanced primary care management code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0570,"Care management services for behavioral health conditions, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales, behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes, facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation, and continuity of care with a designated member of the care team (list separately in addition to advanced primary care management code)",HCPCS_Level_II,HCPC2026_JAN,2026
G0571,Intraoperative nerve(s) cryoablation for post-surgical pain relief (list separately in addition to code for primary service),HCPCS_Level_II,HCPC2026_JAN,2026
G0659,"Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes",HCPCS_Level_II,HCPC2026_JAN,2026
G0660,Team remote e/m new pt 10mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0661,Team remote e/m new pt 20mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0662,Team remote e/m new pt 30 mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0663,Team remote e/m new pt 45mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0664,Team remote e/m new pt 60mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0665,Team remote e/m est. pt 10mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0666,Team remote e/m est. pt 15mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0667,Team remote e/m est. pt 25mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0668,Team remote e/m est. pt 40mins,HCPCS_Level_II,HCPC2026_JAN,2026
G0908,Most recent hemoglobin (hgb) level > 12.0 g/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G0909,"Hemoglobin level measurement not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G0910,Most recent hemoglobin level <= 12.0 g/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G0913,Improvement in visual function achieved within 90 days following cataract surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G0914,Patient care survey was not completed by patient,HCPCS_Level_II,HCPC2026_JAN,2026
G0915,Improvement in visual function not achieved within 90 days following cataract surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G0916,Satisfaction with care achieved within 90 days following cataract surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G0917,Patient care survey was not completed by patient,HCPCS_Level_II,HCPC2026_JAN,2026
G0918,Satisfaction with care not achieved within 90 days following cataract surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G0919,Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visit,HCPCS_Level_II,HCPC2026_JAN,2026
G0920,"Type, anatomic location, and activity all documented",HCPCS_Level_II,HCPC2026_JAN,2026
G0921,"Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)",HCPCS_Level_II,HCPC2026_JAN,2026
G0922,"No documentation of disease type, anatomic location, and activity, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G1,Most recent urr reading of less than 60,HCPCS_Level_II,HCPC2026_JAN,2026
G1000,"Clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1001,"Clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1002,"Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1003,"Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1004,"Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1005,"Clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1006,"Clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1007,"Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1008,"Clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1009,"Clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1010,"Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1011,"Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1012,"Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1013,"Clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1014,"Clinical decision support mechanism inveniqa semantic answers in medicine, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1015,"Clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1016,"Clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1017,"Clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1018,"Clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1019,"Clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1020,"Clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1021,"Clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1022,"Clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1023,"Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1024,"Clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria program",HCPCS_Level_II,HCPC2026_JAN,2026
G1025,Patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month,HCPCS_Level_II,HCPC2026_JAN,2026
G1026,The number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month,HCPCS_Level_II,HCPC2026_JAN,2026
G1027,The number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months,HCPCS_Level_II,HCPC2026_JAN,2026
G1028,Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G2,Most recent urr reading of 60 to 64.9,HCPCS_Level_II,HCPC2026_JAN,2026
G2000,"Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session",HCPCS_Level_II,HCPC2026_JAN,2026
G2001,"Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2002,"Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2003,"Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2004,"Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2005,"Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2006,"Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2007,"Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2008,"Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2009,"Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2010,"Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment",HCPCS_Level_II,HCPC2026_JAN,2026
G2011,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G2012,"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion",HCPCS_Level_II,HCPC2026_JAN,2026
G2013,"Extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2014,"Limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2015,"Comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2020,Services for high intensity clinical services associated with the initial engagement and outreach of beneficiaries assigned to the sip component of the pcf model (do not bill with chronic care management codes),HCPCS_Level_II,HCPC2026_JAN,2026
G2021,Health care practitioners rendering treatment in place (tip),HCPCS_Level_II,HCPC2026_JAN,2026
G2022,"A model participant (ambulance supplier/provider), the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place)",HCPCS_Level_II,HCPC2026_JAN,2026
G2023,"Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",HCPCS_Level_II,HCPC2026_JAN,2026
G2024,"Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a  snf or by a laboratory on behalf of a hha, any specimen source",HCPCS_Level_II,HCPC2026_JAN,2026
G2025,Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only,HCPCS_Level_II,HCPC2026_JAN,2026
G2058,"Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).",HCPCS_Level_II,HCPC2026_JAN,2026
G2061,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G2062,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G2063,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G2064,"Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician  or other qualified health care professional  time per calendar month with the following elements: one complex chronic condition lasting  at least 3 months,  which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities",HCPCS_Level_II,HCPC2026_JAN,2026
G2065,"Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbidities",HCPCS_Level_II,HCPC2026_JAN,2026
G2066,"Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results",HCPCS_Level_II,HCPC2026_JAN,2026
G2067,"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2068,"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2069,"Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2070,"Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2071,"Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2072,"Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2073,"Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2074,"Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2075,"Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)",HCPCS_Level_II,HCPC2026_JAN,2026
G2076,"Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based assessment, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, physical activity and/or nutrition needs and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code",HCPCS_Level_II,HCPC2026_JAN,2026
G2077,"Periodic assessment; assessing periodically by an otp practitioner and includes a  review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code",HCPCS_Level_II,HCPC2026_JAN,2026
G2078,Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G2079,Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G2080,"Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G2081,"Patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2082,"Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation",HCPCS_Level_II,HCPC2026_JAN,2026
G2083,"Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of  greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation",HCPCS_Level_II,HCPC2026_JAN,2026
G2086,"Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G2087,"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
G2088,"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
G2089,Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%,HCPCS_Level_II,HCPC2026_JAN,2026
G2090,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2091,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2092,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken,HCPCS_Level_II,HCPC2026_JAN,2026
G2093,"Documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G2094,"Documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G2095,"Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G2096,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G2097,"Episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti)",HCPCS_Level_II,HCPC2026_JAN,2026
G2098,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2099,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2100,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2101,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2102,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
G2103,Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
G2104,Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
G2105,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2106,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2107,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2108,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2109,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2110,"Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2112,"Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months",HCPCS_Level_II,HCPC2026_JAN,2026
G2113,"Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity",HCPCS_Level_II,HCPC2026_JAN,2026
G2114,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2115,Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2116,Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2117,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2118,Patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2119,"Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performed",HCPCS_Level_II,HCPC2026_JAN,2026
G2120,"Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performed",HCPCS_Level_II,HCPC2026_JAN,2026
G2121,"Depression, anxiety, apathy, and psychosis assessed",HCPCS_Level_II,HCPC2026_JAN,2026
G2122,"Depression, anxiety, apathy, and psychosis not assessed",HCPCS_Level_II,HCPC2026_JAN,2026
G2123,"Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2124,Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medication,HCPCS_Level_II,HCPC2026_JAN,2026
G2125,Patients 81 years of age and older with at least one claim/encounter for frailty during the six months prior to the measurement period through  december 31 of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2126,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2127,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2128,"Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)",HCPCS_Level_II,HCPC2026_JAN,2026
G2129,"Procedure-related bp's not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy",HCPCS_Level_II,HCPC2026_JAN,2026
G2130,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2131,Patients 81 years and older with a diagnosis of frailty,HCPCS_Level_II,HCPC2026_JAN,2026
G2132,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2133,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2134,Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2135,"Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2136,Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G2137,Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points,HCPCS_Level_II,HCPC2026_JAN,2026
G2138,Back pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G2139,Back pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points,HCPCS_Level_II,HCPC2026_JAN,2026
G2140,Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G2141,Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points,HCPCS_Level_II,HCPC2026_JAN,2026
G2142,Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G2143,Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of less than 30 points,HCPCS_Level_II,HCPC2026_JAN,2026
G2144,Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6-20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6-20 weeks) postoperatively demonstrated an improvement of 30 points or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G2145,Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points,HCPCS_Level_II,HCPC2026_JAN,2026
G2146,Leg pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G2147,Leg pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points,HCPCS_Level_II,HCPC2026_JAN,2026
G2148,Multimodal pain management was used,HCPCS_Level_II,HCPC2026_JAN,2026
G2149,"Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))",HCPCS_Level_II,HCPC2026_JAN,2026
G2150,Multimodal pain management was not used,HCPCS_Level_II,HCPC2026_JAN,2026
G2151,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
G2152,Residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),HCPCS_Level_II,HCPC2026_JAN,2026
G2153,In hospice or using hospice services during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2154,Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2155,"Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2156,"Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)",HCPCS_Level_II,HCPC2026_JAN,2026
G2157,"Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2158,Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2159,"Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G2160,Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2161,Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2162,Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2163,Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2164,Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2165,Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G2166,"Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reason",HCPCS_Level_II,HCPC2026_JAN,2026
G2167,Residual score for the neck impairment successfully calculated and the score was less than zero (< 0),HCPCS_Level_II,HCPC2026_JAN,2026
G2168,"Services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G2169,"Services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G2170,"Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
G2171,"Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performed",HCPCS_Level_II,HCPC2026_JAN,2026
G2172,All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project,HCPCS_Level_II,HCPC2026_JAN,2026
G2173,"Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)",HCPCS_Level_II,HCPC2026_JAN,2026
G2174,Uri episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date,HCPCS_Level_II,HCPC2026_JAN,2026
G2175,"Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)",HCPCS_Level_II,HCPC2026_JAN,2026
G2176,"Outpatient, ed, or observation visits that result in an inpatient admission",HCPCS_Level_II,HCPC2026_JAN,2026
G2177,Acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date,HCPCS_Level_II,HCPC2026_JAN,2026
G2178,"Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation",HCPCS_Level_II,HCPC2026_JAN,2026
G2179,Clinician documented that patient had medical reason for not performing lower extremity neurological exam,HCPCS_Level_II,HCPC2026_JAN,2026
G2180,Clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee,HCPCS_Level_II,HCPC2026_JAN,2026
G2181,Bmi not documented due to medical reason or patient refusal of height or weight measurement,HCPCS_Level_II,HCPC2026_JAN,2026
G2182,Patient receiving first-time biologic and/or immune response modifier therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G2183,Documentation patient unable to communicate and informant not available,HCPCS_Level_II,HCPC2026_JAN,2026
G2184,Patient does not have a caregiver,HCPCS_Level_II,HCPC2026_JAN,2026
G2185,Documentation caregiver is trained and certified in dementia care,HCPCS_Level_II,HCPC2026_JAN,2026
G2186,Patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed,HCPCS_Level_II,HCPC2026_JAN,2026
G2187,Patients with clinical indications for imaging of the head: head trauma,HCPCS_Level_II,HCPC2026_JAN,2026
G2188,Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age,HCPCS_Level_II,HCPC2026_JAN,2026
G2189,Patients with clinical indications for imaging of the head: abnormal neurologic exam,HCPCS_Level_II,HCPC2026_JAN,2026
G2190,Patients with clinical indications for imaging of the head: headache radiating to the neck,HCPCS_Level_II,HCPC2026_JAN,2026
G2191,Patients with clinical indications for imaging of the head: positional headaches,HCPCS_Level_II,HCPC2026_JAN,2026
G2192,Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age,HCPCS_Level_II,HCPC2026_JAN,2026
G2193,Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age),HCPCS_Level_II,HCPC2026_JAN,2026
G2194,Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior,HCPCS_Level_II,HCPC2026_JAN,2026
G2195,Patients with clinical indications for imaging of the head: occipital headache in children,HCPCS_Level_II,HCPC2026_JAN,2026
G2196,Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method,HCPCS_Level_II,HCPC2026_JAN,2026
G2197,Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user,HCPCS_Level_II,HCPC2026_JAN,2026
G2198,"Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G2199,Patient not screened for unhealthy alcohol use using a systematic screening method,HCPCS_Level_II,HCPC2026_JAN,2026
G2200,Patient identified as an unhealthy alcohol user received brief counseling,HCPCS_Level_II,HCPC2026_JAN,2026
G2201,"Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G2202,Patient did not receive brief counseling if identified as an unhealthy alcohol user,HCPCS_Level_II,HCPC2026_JAN,2026
G2203,"Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G2204,Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
G2205,Patients with pregnancy during adjuvant treatment course,HCPCS_Level_II,HCPC2026_JAN,2026
G2206,Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G2207,"Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)",HCPCS_Level_II,HCPC2026_JAN,2026
G2208,Patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G2209,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G2210,"Residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G2211,"Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition.  (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)",HCPCS_Level_II,HCPC2026_JAN,2026
G2212,"Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)",HCPCS_Level_II,HCPC2026_JAN,2026
G2213,"Initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
G2214,"Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional",HCPCS_Level_II,HCPC2026_JAN,2026
G2215,Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G2216,Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G2250,"Remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment",HCPCS_Level_II,HCPC2026_JAN,2026
G2251,"Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion",HCPCS_Level_II,HCPC2026_JAN,2026
G2252,"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion",HCPCS_Level_II,HCPC2026_JAN,2026
G3,Most recent urr reading of 65 to 69.9,HCPCS_Level_II,HCPC2026_JAN,2026
G3001,"Administration and supply of tositumomab, 450 mg",HCPCS_Level_II,HCPC2026_JAN,2026
G3002,"Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)",HCPCS_Level_II,HCPC2026_JAN,2026
G3003,"Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)",HCPCS_Level_II,HCPC2026_JAN,2026
G4,Most recent urr reading of 70 to 74.9,HCPCS_Level_II,HCPC2026_JAN,2026
G4000,Dermatology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4001,Diagnostic radiology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4002,Electrophysiology cardiac specialist mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4003,Emergency medicine mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4004,Endocrinology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4005,Family medicine mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4006,Gastro-enterology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4007,General surgery mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4008,Geriatrics mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4009,Hospitalists mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4010,Infectious disease mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4011,Internal medicine mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4012,Interventional radiology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4013,Mental/behavioral and psychiatry mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4014,Nephrology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4015,Neurology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4016,Neurosurgical mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4017,Nutrition/dietician mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4018,Obstetrics/gynecology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4019,Oncology/hematology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4020,Ophthalmology/optometry mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4021,Orthopedic surgery mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4022,Otolaryngology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4023,Pathology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4024,Pediatrics mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4025,Physical medicine mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4026,Physical therapy/occupational therapy mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4027,Plastic surgery mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4028,Podiatry mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4029,Preventive medicine mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4030,Pulmonology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4031,Radiation oncology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4032,Rheumatology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4033,Skilled nursing facility mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4034,Speech language pathology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4035,Thoracic surgery mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4036,Urgent care mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4037,Urology mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G4038,Vascular surgery mips specialty set,HCPCS_Level_II,HCPC2026_JAN,2026
G5,Most recent urr reading of 75 or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G6,Esrd patient for whom less than six dialysis sessions have been provided in a month,HCPCS_Level_II,HCPC2026_JAN,2026
G6001,Ultrasonic guidance for placement of radiation therapy fields,HCPCS_Level_II,HCPC2026_JAN,2026
G6002,Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G6003,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6004,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6005,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6006,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater",HCPCS_Level_II,HCPC2026_JAN,2026
G6007,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6008,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6009,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6010,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater",HCPCS_Level_II,HCPC2026_JAN,2026
G6011,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6012,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6013,"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev",HCPCS_Level_II,HCPC2026_JAN,2026
G6014,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater",HCPCS_Level_II,HCPC2026_JAN,2026
G6015,"Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session",HCPCS_Level_II,HCPC2026_JAN,2026
G6016,"Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session",HCPCS_Level_II,HCPC2026_JAN,2026
G6017,"Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G6018,"Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)",HCPCS_Level_II,HCPC2026_JAN,2026
G6019,"Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique",HCPCS_Level_II,HCPC2026_JAN,2026
G6020,Colonoscopy through stoma; with transendoscopic stent placement (includes predilation),HCPCS_Level_II,HCPC2026_JAN,2026
G6021,"Unlisted procedure, intestine",HCPCS_Level_II,HCPC2026_JAN,2026
G6022,"Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique",HCPCS_Level_II,HCPC2026_JAN,2026
G6023,"Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)",HCPCS_Level_II,HCPC2026_JAN,2026
G6024,"Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare technique",HCPCS_Level_II,HCPC2026_JAN,2026
G6025,"Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)",HCPCS_Level_II,HCPC2026_JAN,2026
G6027,"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performed",HCPCS_Level_II,HCPC2026_JAN,2026
G6028,"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)",HCPCS_Level_II,HCPC2026_JAN,2026
G6030,Amitriptyline,HCPCS_Level_II,HCPC2026_JAN,2026
G6031,Benzodiazepines,HCPCS_Level_II,HCPC2026_JAN,2026
G6032,Desipramine,HCPCS_Level_II,HCPC2026_JAN,2026
G6034,Doxepin,HCPCS_Level_II,HCPC2026_JAN,2026
G6035,Gold,HCPCS_Level_II,HCPC2026_JAN,2026
G6036,Assay of imipramine,HCPCS_Level_II,HCPC2026_JAN,2026
G6037,Nortriptyline,HCPCS_Level_II,HCPC2026_JAN,2026
G6038,Salicylate,HCPCS_Level_II,HCPC2026_JAN,2026
G6039,Acetaminophen,HCPCS_Level_II,HCPC2026_JAN,2026
G6040,Alcohol (ethanol); any specimen except breath,HCPCS_Level_II,HCPC2026_JAN,2026
G6041,"Alkaloids, urine, quantitative",HCPCS_Level_II,HCPC2026_JAN,2026
G6042,Amphetamine or methamphetamine,HCPCS_Level_II,HCPC2026_JAN,2026
G6043,"Barbiturates, not elsewhere specified",HCPCS_Level_II,HCPC2026_JAN,2026
G6044,Cocaine or metabolite,HCPCS_Level_II,HCPC2026_JAN,2026
G6045,Dihydrocodeinone,HCPCS_Level_II,HCPC2026_JAN,2026
G6046,Dihydromorphinone,HCPCS_Level_II,HCPC2026_JAN,2026
G6047,Dihydrotestosterone,HCPCS_Level_II,HCPC2026_JAN,2026
G6048,Dimethadione,HCPCS_Level_II,HCPC2026_JAN,2026
G6049,Epiandrosterone,HCPCS_Level_II,HCPC2026_JAN,2026
G6050,Ethchlorvynol,HCPCS_Level_II,HCPC2026_JAN,2026
G6051,Flurazepam,HCPCS_Level_II,HCPC2026_JAN,2026
G6052,Meprobamate,HCPCS_Level_II,HCPC2026_JAN,2026
G6053,Methadone,HCPCS_Level_II,HCPC2026_JAN,2026
G6054,Methsuximide,HCPCS_Level_II,HCPC2026_JAN,2026
G6055,Nicotine,HCPCS_Level_II,HCPC2026_JAN,2026
G6056,"Opiate(s), drug and metabolites, each procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G6057,Phenothiazine,HCPCS_Level_II,HCPC2026_JAN,2026
G6058,"Drug confirmation, each procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G7,Pregnancy resulted from rape or incest or pregnancy certified by physician as life threatening,HCPCS_Level_II,HCPC2026_JAN,2026
G8,"Monitored anesthesia care (mac) for deep complex, complicated, or markedly invasive surgical procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G8126,Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week)  acute treatment phase,HCPCS_Level_II,HCPC2026_JAN,2026
G8127,Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase,HCPCS_Level_II,HCPC2026_JAN,2026
G8128,Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure,HCPCS_Level_II,HCPC2026_JAN,2026
G8395,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function,HCPCS_Level_II,HCPC2026_JAN,2026
G8396,Left ventricular ejection fraction (lvef) not performed or documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8397,"Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy",HCPCS_Level_II,HCPC2026_JAN,2026
G8398,Dilated macular or fundus exam not performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8399,Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8400,"Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8401,Clinician documented that patient was not an eligible candidate for screening,HCPCS_Level_II,HCPC2026_JAN,2026
G8404,Lower extremity neurological exam performed and documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8405,Lower extremity neurological exam not performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8406,Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure,HCPCS_Level_II,HCPC2026_JAN,2026
G8410,Footwear evaluation performed and documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8415,Footwear evaluation was not performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8416,Clinician documented that patient was not an eligible candidate for footwear evaluation measure,HCPCS_Level_II,HCPC2026_JAN,2026
G8417,Bmi is documented above normal parameters and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8418,Bmi is documented below normal parameters and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8419,"Bmi documented outside normal parameters, no follow-up plan documented, no reason given",HCPCS_Level_II,HCPC2026_JAN,2026
G8420,Bmi is documented within normal parameters and no follow-up plan is required,HCPCS_Level_II,HCPC2026_JAN,2026
G8421,Bmi not documented and no reason is given,HCPCS_Level_II,HCPC2026_JAN,2026
G8422,"Bmi not documented, documentation the patient is not eligible for bmi calculation",HCPCS_Level_II,HCPC2026_JAN,2026
G8427,"Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications",HCPCS_Level_II,HCPC2026_JAN,2026
G8428,"Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8430,"Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an acute health crisis where time is of the essence and delay of treatment would jeopardize the patient's health status)",HCPCS_Level_II,HCPC2026_JAN,2026
G8431,Screening for depression is documented as being positive and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8432,"Depression screening not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8433,"Screening for depression not completed, documented patient or medical reason",HCPCS_Level_II,HCPC2026_JAN,2026
G8442,"Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G8450,Beta-blocker therapy prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8451,"Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8452,Beta-blocker therapy not prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8458,"Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)",HCPCS_Level_II,HCPC2026_JAN,2026
G8460,Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c,HCPCS_Level_II,HCPC2026_JAN,2026
G8461,Patient receiving antiviral treatment for hepatitis c during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G8464,Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determined,HCPCS_Level_II,HCPC2026_JAN,2026
G8465,High or very high risk of recurrence of prostate cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G8473,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8474,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8475,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8476,Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg,HCPCS_Level_II,HCPC2026_JAN,2026
G8477,Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg,HCPCS_Level_II,HCPC2026_JAN,2026
G8478,"Blood pressure measurement not performed or documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8482,Influenza immunization administered or previously received,HCPCS_Level_II,HCPC2026_JAN,2026
G8483,"Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8484,"Influenza immunization was not administered, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8485,I intend to report the diabetes mellitus (dm) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8486,I intend to report the preventive care measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8487,I intend to report the chronic kidney disease (ckd) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8489,I intend to report the coronary artery disease (cad) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8490,I intend to report the rheumatoid arthritis (ra) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8491,I intend to report the hiv/aids measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8492,I intend to report the perioperative care measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8493,I intend to report the back pain measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8494,All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8495,All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8496,All quality actions for the applicable measures in the preventive care measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8497,All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8498,All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8499,All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8500,All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8501,All quality actions for the applicable measures in the perioperative care measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8502,All quality actions for the applicable measures in the back pain measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8506,Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G8509,"Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8510,"Screening for depression is documented as negative, a follow-up plan is not required",HCPCS_Level_II,HCPC2026_JAN,2026
G8511,"Screening for depression documented as positive, follow-up plan not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8530,Autogenous av fistula received,HCPCS_Level_II,HCPC2026_JAN,2026
G8531,Clinician documented that patient was not an eligible candidate for autogenous av fistula,HCPCS_Level_II,HCPC2026_JAN,2026
G8532,"Clinician documented that patient received vascular access other than autogenous av fistula, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8535,"Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter related to one of the following reasons: (1) patient refuses to participate in the screening and has reasonable decisional capacity for self-protection, or (2) patient is in an urgent or emergent situation where time is of the essence and to delay treatment to perform the screening would jeopardize the patient's health status",HCPCS_Level_II,HCPC2026_JAN,2026
G8536,"No documentation of an elder maltreatment screen, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8539,Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment,HCPCS_Level_II,HCPC2026_JAN,2026
G8540,"Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G8541,"Functional outcome assessment using a standardized tool not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8542,"Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required",HCPCS_Level_II,HCPC2026_JAN,2026
G8543,"Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented within two days of assessment, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8544,I intend to report the coronary artery bypass graft (cabg) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8545,I intend to report the hepatitis c measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8547,I intend to report the ischemic vascular disease (ivd) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8548,I intend to report the heart failure (hf) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8549,All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8551,All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8552,All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8559,Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
G8560,Patient has a history of active drainage from the ear within the previous 90 days,HCPCS_Level_II,HCPC2026_JAN,2026
G8561,Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure,HCPCS_Level_II,HCPC2026_JAN,2026
G8562,Patient does not have a history of active drainage from the ear within the previous 90 days,HCPCS_Level_II,HCPC2026_JAN,2026
G8563,"Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8564,"Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)",HCPCS_Level_II,HCPC2026_JAN,2026
G8565,Verification and documentation of sudden or rapidly progressive hearing loss,HCPCS_Level_II,HCPC2026_JAN,2026
G8566,"Patient is not eligible for the ""referral for otologic evaluation for sudden or rapidly progressive hearing loss"" measure",HCPCS_Level_II,HCPC2026_JAN,2026
G8567,Patient does not have verification and documentation of sudden or rapidly progressive hearing loss,HCPCS_Level_II,HCPC2026_JAN,2026
G8568,"Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8569,Prolonged postoperative intubation (> 24 hrs) required,HCPCS_Level_II,HCPC2026_JAN,2026
G8570,Prolonged postoperative intubation (> 24 hrs) not required,HCPCS_Level_II,HCPC2026_JAN,2026
G8571,Development of deep sternal wound infection/mediastinitis within 30 days postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G8572,No deep sternal wound infection/mediastinitis,HCPCS_Level_II,HCPC2026_JAN,2026
G8573,Stroke following isolated cabg surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G8574,No stroke following isolated cabg surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G8575,Developed postoperative renal failure or required dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
G8576,No postoperative renal failure/dialysis not required,HCPCS_Level_II,HCPC2026_JAN,2026
G8577,"Re-exploration required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason",HCPCS_Level_II,HCPC2026_JAN,2026
G8578,"Re-exploration not required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason",HCPCS_Level_II,HCPC2026_JAN,2026
G8579,Antiplatelet medication at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8580,Antiplatelet medication contraindicated,HCPCS_Level_II,HCPC2026_JAN,2026
G8581,No antiplatelet medication at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8582,Beta-blocker at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8583,Beta-blocker contraindicated,HCPCS_Level_II,HCPC2026_JAN,2026
G8584,No beta-blocker at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8585,Anti-lipid treatment at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8586,Anti-lipid treatment contraindicated,HCPCS_Level_II,HCPC2026_JAN,2026
G8587,No anti-lipid treatment at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8593,"Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)",HCPCS_Level_II,HCPC2026_JAN,2026
G8594,"Lipid profile not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8595,Most recent ldl-c < 100 mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G8597,Most recent ldl-c >= 100 mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G8598,Aspirin or another antiplatelet therapy used,HCPCS_Level_II,HCPC2026_JAN,2026
G8599,"Aspirin or another antiplatelet therapy not used, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8600,Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time last known well,HCPCS_Level_II,HCPC2026_JAN,2026
G8601,"Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for stroke, patient admitted for elective carotid intervention)",HCPCS_Level_II,HCPC2026_JAN,2026
G8602,"Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8627,"Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)",HCPCS_Level_II,HCPC2026_JAN,2026
G8628,"Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)",HCPCS_Level_II,HCPC2026_JAN,2026
G8629,"Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)",HCPCS_Level_II,HCPC2026_JAN,2026
G8630,"Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as ordered",HCPCS_Level_II,HCPC2026_JAN,2026
G8631,"Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)",HCPCS_Level_II,HCPC2026_JAN,2026
G8632,"Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8633,Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8634,Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosis,HCPCS_Level_II,HCPC2026_JAN,2026
G8635,"Pharmacologic therapy for osteoporosis was not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8645,I intend to report the asthma measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8646,All quality actions for the applicable measures in the asthma measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8647,Residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8648,Residual score for the knee impairment successfully calculated and the score was less than zero (< 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8649,"Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8650,"Residual score for the knee impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8651,Residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8652,Residual score for the hip impairment successfully calculated and the score was less than zero (< 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8653,"Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8654,"Residual score for the hip impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8655,"Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0)",HCPCS_Level_II,HCPC2026_JAN,2026
G8656,"Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (< 0)",HCPCS_Level_II,HCPC2026_JAN,2026
G8657,"Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8658,"Residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8659,Residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8660,Residual score for the low back impairment successfully calculated and the score was less than zero (< 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8661,"Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8662,"Residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8663,Residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8664,Residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0),HCPCS_Level_II,HCPC2026_JAN,2026
G8665,"Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8666,"Residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8667,"Residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)",HCPCS_Level_II,HCPC2026_JAN,2026
G8668,"Residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (< 0)",HCPCS_Level_II,HCPC2026_JAN,2026
G8669,"Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8670,"Residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8671,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)",HCPCS_Level_II,HCPC2026_JAN,2026
G8672,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0)",HCPCS_Level_II,HCPC2026_JAN,2026
G8673,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate",HCPCS_Level_II,HCPC2026_JAN,2026
G8674,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8682,Lvf testing documented as being performed prior to discharge or in the previous 12 months,HCPCS_Level_II,HCPC2026_JAN,2026
G8683,Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reason,HCPCS_Level_II,HCPC2026_JAN,2026
G8685,"Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8694,Current or prior left ventricular ejection fraction (lvef) < = 40% or documentation of moderate or severe lvsd,HCPCS_Level_II,HCPC2026_JAN,2026
G8696,Antithrombotic therapy prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8697,"Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))",HCPCS_Level_II,HCPC2026_JAN,2026
G8698,"Antithrombotic therapy was not prescribed at discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8699,"Rehabilitation services (occupational, physical or speech) ordered at or prior to discharge",HCPCS_Level_II,HCPC2026_JAN,2026
G8700,"Rehabilitation services (occupational, physical or speech) not indicated at or prior to discharge",HCPCS_Level_II,HCPC2026_JAN,2026
G8701,"Rehabilitation services were not ordered, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G8702,Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G8703,Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G8704,12-lead electrocardiogram (ecg) performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8705,Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg),HCPCS_Level_II,HCPC2026_JAN,2026
G8706,Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg),HCPCS_Level_II,HCPC2026_JAN,2026
G8707,"12-lead electrocardiogram (ecg) not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8708,Patient not prescribed antibiotic,HCPCS_Level_II,HCPC2026_JAN,2026
G8709,"Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)",HCPCS_Level_II,HCPC2026_JAN,2026
G8710,Patient prescribed antibiotic,HCPCS_Level_II,HCPC2026_JAN,2026
G8711,Prescribed antibiotic on or within 3 days after the episode date,HCPCS_Level_II,HCPC2026_JAN,2026
G8712,Antibiotic not prescribed or dispensed,HCPCS_Level_II,HCPC2026_JAN,2026
G8713,Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v]),HCPCS_Level_II,HCPC2026_JAN,2026
G8714,Hemodialysis treatment performed exactly three times per week for > 90 days,HCPCS_Level_II,HCPC2026_JAN,2026
G8717,"Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8718,Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v]),HCPCS_Level_II,HCPC2026_JAN,2026
G8720,Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v]),HCPCS_Level_II,HCPC2026_JAN,2026
G8721,"Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report",HCPCS_Level_II,HCPC2026_JAN,2026
G8722,"Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)",HCPCS_Level_II,HCPC2026_JAN,2026
G8723,Specimen site is other than anatomic location of primary tumor,HCPCS_Level_II,HCPC2026_JAN,2026
G8724,"Pt category, pn category and histologic grade were not documented in the pathology report, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8725,"Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)",HCPCS_Level_II,HCPC2026_JAN,2026
G8726,"Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8728,"Fasting lipid profile not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8730,Pain assessment documented as positive using a standardized tool and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8731,"Pain assessment using a standardized tool is documented as negative, no follow-up plan required",HCPCS_Level_II,HCPC2026_JAN,2026
G8732,"No documentation of pain assessment, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8733,Elder maltreatment screen documented as positive and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8734,"Elder maltreatment screen documented as negative, follow-up is not required",HCPCS_Level_II,HCPC2026_JAN,2026
G8735,"Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8736,Most current ldl-c <100mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G8737,Most current ldl-c >=100mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G8738,Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic function,HCPCS_Level_II,HCPC2026_JAN,2026
G8739,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function,HCPCS_Level_II,HCPC2026_JAN,2026
G8740,"Left ventricular ejection fraction (lvef) not performed or assessed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8749,"Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)",HCPCS_Level_II,HCPC2026_JAN,2026
G8751,"Smoking status and exposure to second hand smoke in the home not assessed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8752,Most recent systolic blood pressure < 140 mmhg,HCPCS_Level_II,HCPC2026_JAN,2026
G8753,Most recent systolic blood pressure >= 140 mmhg,HCPCS_Level_II,HCPC2026_JAN,2026
G8754,Most recent diastolic blood pressure < 90 mmhg,HCPCS_Level_II,HCPC2026_JAN,2026
G8755,Most recent diastolic blood pressure >= 90 mmhg,HCPCS_Level_II,HCPC2026_JAN,2026
G8756,"No documentation of blood pressure measurement, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8757,All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8758,All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8759,All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8761,All quality actions for the applicable measures in the dementia measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8762,All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8763,All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8764,All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8765,All quality actions for the applicable measures in the cataract measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8767,"Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)",HCPCS_Level_II,HCPC2026_JAN,2026
G8768,"Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8769,"Lipid profile not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8770,Urine protein test result documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
G8771,Documentation of diagnosis of chronic kidney disease,HCPCS_Level_II,HCPC2026_JAN,2026
G8772,"Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8773,"Urine protein test was not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8774,Serum creatinine test result documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
G8775,"Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8776,"Serum creatinine test not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8777,Diabetes screening test performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8778,"Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8779,"Diabetes screening test not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8780,Counseling for diet and physical activity performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8781,"Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8782,"Counseling for diet and physical activity not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8783,"Normal blood pressure reading documented, follow-up not required",HCPCS_Level_II,HCPC2026_JAN,2026
G8784,"Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)",HCPCS_Level_II,HCPC2026_JAN,2026
G8785,"Blood pressure reading not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8797,Specimen site other than anatomic location of esophagus,HCPCS_Level_II,HCPC2026_JAN,2026
G8798,Specimen site other than anatomic location of prostate,HCPCS_Level_II,HCPC2026_JAN,2026
G8806,Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8807,"Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has a documented intrauterine pregnancy [iup])",HCPCS_Level_II,HCPC2026_JAN,2026
G8808,"Trans-abdominal or trans-vaginal ultrasound not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8809,Rh-immunoglobulin (rhogam) ordered,HCPCS_Level_II,HCPC2026_JAN,2026
G8810,"Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)",HCPCS_Level_II,HCPC2026_JAN,2026
G8811,"Documentation rh-immunoglobulin (rhogam) was not ordered, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8815,"Documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)",HCPCS_Level_II,HCPC2026_JAN,2026
G8816,Statin medication prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8817,"Statin therapy not prescribed at discharge, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8818,Patient discharge to home no later than post-operative day #7,HCPCS_Level_II,HCPC2026_JAN,2026
G8825,Patient not discharged to home by post-operative day #7,HCPCS_Level_II,HCPC2026_JAN,2026
G8826,Patient discharged to home no later than post-operative day #2 following evar,HCPCS_Level_II,HCPC2026_JAN,2026
G8833,Patient not discharged to home by post-operative day #2 following evar,HCPCS_Level_II,HCPC2026_JAN,2026
G8834,Patient discharged to home no later than post-operative day #2 following cea,HCPCS_Level_II,HCPC2026_JAN,2026
G8838,Patient not discharged to home by post-operative day #2 following cea,HCPCS_Level_II,HCPC2026_JAN,2026
G8839,"Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness",HCPCS_Level_II,HCPC2026_JAN,2026
G8840,"Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)",HCPCS_Level_II,HCPC2026_JAN,2026
G8841,"Sleep apnea symptoms not assessed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8842,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea",HCPCS_Level_II,HCPC2026_JAN,2026
G8843,"Documentation of reason(s) for not measuring an apnea hypopnea index (ahi), a respiratory disturbance index (rdi), or a respiratory event index (rei) within 2 months after initial evaluation for suspected obstructive sleep apnea (e.g., medical, neurological, or psychiatric disease that prohibits successful completion of a sleep study, patients for whom a sleep study would present a bigger risk than benefit or would pose an undue burden, dementia, patients previously diagnosed with osa and severity assessed by another provider, patients who decline ahi/rdi/rei measurement, patients who had a financial reason for not completing testing, test was ordered but not completed, patients decline because their insurance (payer) does not cover the expense)",HCPCS_Level_II,HCPC2026_JAN,2026
G8844,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi), or respiratory event index (rei) not documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8845,Positive airway pressure therapy prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8846,Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater),HCPCS_Level_II,HCPC2026_JAN,2026
G8848,Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15),HCPCS_Level_II,HCPC2026_JAN,2026
G8849,"Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)",HCPCS_Level_II,HCPC2026_JAN,2026
G8850,"Positive airway pressure therapy not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8851,"Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented)",HCPCS_Level_II,HCPC2026_JAN,2026
G8852,Positive airway pressure therapy was prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8853,Positive airway pressure therapy not prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8854,"Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy)",HCPCS_Level_II,HCPC2026_JAN,2026
G8855,"Adherence to therapy was not assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available), reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8856,Referral to a physician for an otologic evaluation performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8857,"Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)",HCPCS_Level_II,HCPC2026_JAN,2026
G8858,"Referral to a physician for an otologic evaluation not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8859,Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days,HCPCS_Level_II,HCPC2026_JAN,2026
G8860,Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days,HCPCS_Level_II,HCPC2026_JAN,2026
G8861,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed",HCPCS_Level_II,HCPC2026_JAN,2026
G8862,Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days,HCPCS_Level_II,HCPC2026_JAN,2026
G8863,"Patients not assessed for risk of bone loss, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8864,Pneumococcal vaccine administered or previously received,HCPCS_Level_II,HCPC2026_JAN,2026
G8865,"Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)",HCPCS_Level_II,HCPC2026_JAN,2026
G8866,"Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)",HCPCS_Level_II,HCPC2026_JAN,2026
G8867,"Pneumococcal vaccine not administered or previously received, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8868,Patients receiving a first course of anti-tnf therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G8869,Patient has documented immunity to hepatitis b and initiating anti-tnf therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G8870,Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G8871,Patient not receiving a first course of anti-tnf therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G8872,Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion,HCPCS_Level_II,HCPC2026_JAN,2026
G8873,"Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)",HCPCS_Level_II,HCPC2026_JAN,2026
G8874,Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesion,HCPCS_Level_II,HCPC2026_JAN,2026
G8875,Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method,HCPCS_Level_II,HCPC2026_JAN,2026
G8876,"Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)",HCPCS_Level_II,HCPC2026_JAN,2026
G8877,"Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8878,Sentinel lymph node biopsy procedure performed,HCPCS_Level_II,HCPC2026_JAN,2026
G8879,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G8880,"Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)",HCPCS_Level_II,HCPC2026_JAN,2026
G8881,Stage of breast cancer is greater than t1n0m0 or t2n0m0,HCPCS_Level_II,HCPC2026_JAN,2026
G8882,"Sentinel lymph node biopsy procedure not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8883,"Biopsy results reviewed, communicated, tracked and documented",HCPCS_Level_II,HCPC2026_JAN,2026
G8884,Clinician documented reason that patient's biopsy results were not reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
G8885,"Biopsy results not reviewed, communicated, tracked or documented",HCPCS_Level_II,HCPC2026_JAN,2026
G8886,Most recent blood pressure under control,HCPCS_Level_II,HCPC2026_JAN,2026
G8887,"Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8888,"Most recent blood pressure not under control, results documented and reviewed",HCPCS_Level_II,HCPC2026_JAN,2026
G8889,"No documentation of blood pressure measurement, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8890,"Most recent ldl-c under control, results documented and reviewed",HCPCS_Level_II,HCPC2026_JAN,2026
G8891,"Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate)",HCPCS_Level_II,HCPC2026_JAN,2026
G8892,Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate),HCPCS_Level_II,HCPC2026_JAN,2026
G8893,"Most recent ldl-c not under control, results documented and reviewed",HCPCS_Level_II,HCPC2026_JAN,2026
G8894,"Ldl-c not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8895,Oral aspirin or other antithrombotic therapy prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8896,"Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)",HCPCS_Level_II,HCPC2026_JAN,2026
G8897,"Oral aspirin or other antithrombotic therapy was not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8898,I intend to report the chronic obstructive pulmonary disease (copd) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8899,I intend to report the inflammatory bowel disease (ibd) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8900,I intend to report the sleep apnea measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8902,I intend to report the dementia measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8903,I intend to report the parkinson's disease measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8904,I intend to report the hypertension (htn) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8905,I intend to report the cardiovascular prevention measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8906,I intend to report the cataract measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8907,Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility,HCPCS_Level_II,HCPC2026_JAN,2026
G8908,Patient documented to have received a burn prior to discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8909,Patient documented not to have received a burn prior to discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G8910,Patient documented to have experienced a fall within asc,HCPCS_Level_II,HCPC2026_JAN,2026
G8911,Patient documented not to have experienced a fall within ambulatory surgical center,HCPCS_Level_II,HCPC2026_JAN,2026
G8912,"Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event",HCPCS_Level_II,HCPC2026_JAN,2026
G8913,"Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event",HCPCS_Level_II,HCPC2026_JAN,2026
G8914,Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc,HCPCS_Level_II,HCPC2026_JAN,2026
G8915,Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc,HCPCS_Level_II,HCPC2026_JAN,2026
G8916,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time",HCPCS_Level_II,HCPC2026_JAN,2026
G8917,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time",HCPCS_Level_II,HCPC2026_JAN,2026
G8918,Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis,HCPCS_Level_II,HCPC2026_JAN,2026
G8923,Current or prior left ventricular ejection fraction (lvef) <= 40% or documentation of moderately or severely depressed left ventricular systolic function,HCPCS_Level_II,HCPC2026_JAN,2026
G8924,Spirometry results documented (fev1/fvc < 70%),HCPCS_Level_II,HCPC2026_JAN,2026
G8925,"Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptoms",HCPCS_Level_II,HCPC2026_JAN,2026
G8926,"Spirometry test not performed or documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8927,"Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer",HCPCS_Level_II,HCPC2026_JAN,2026
G8928,"Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8929,"Adjuvant chemotherapy not prescribed or previously received, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8930,Assessment of depression severity at the initial evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
G8931,"Assessment of depression severity not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8932,Suicide risk assessed at the initial evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
G8933,"Suicide risk not assessed at the initial evaluation, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8934,Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic function,HCPCS_Level_II,HCPC2026_JAN,2026
G8935,Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G8936,"Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8937,"Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8938,"Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible",HCPCS_Level_II,HCPC2026_JAN,2026
G8939,"Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G8940,"Screening for depression documented as positive, a follow-up plan not completed, documented reason",HCPCS_Level_II,HCPC2026_JAN,2026
G8941,"Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G8942,"Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment",HCPCS_Level_II,HCPC2026_JAN,2026
G8943,Ldl-c result not present or not within 12 months prior,HCPCS_Level_II,HCPC2026_JAN,2026
G8944,Ajcc melanoma cancer stage 0 through iic melanoma,HCPCS_Level_II,HCPC2026_JAN,2026
G8946,"Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)",HCPCS_Level_II,HCPC2026_JAN,2026
G8947,One or more neuropsychiatric symptoms,HCPCS_Level_II,HCPC2026_JAN,2026
G8948,No neuropsychiatric symptoms,HCPCS_Level_II,HCPC2026_JAN,2026
G8949,"Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)",HCPCS_Level_II,HCPC2026_JAN,2026
G8950,"Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented",HCPCS_Level_II,HCPC2026_JAN,2026
G8951,"Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligible",HCPCS_Level_II,HCPC2026_JAN,2026
G8952,"Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8953,All quality actions for the applicable measures in the oncology measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G8955,Most recent assessment of adequacy of volume management documented,HCPCS_Level_II,HCPC2026_JAN,2026
G8956,Patient receiving maintenance hemodialysis in an outpatient dialysis facility,HCPCS_Level_II,HCPC2026_JAN,2026
G8957,Patient not receiving maintenance hemodialysis in an outpatient dialysis facility,HCPCS_Level_II,HCPC2026_JAN,2026
G8958,"Assessment of adequacy of volume management not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8959,Clinician treating major depressive disorder communicates to clinician treating comorbid condition,HCPCS_Level_II,HCPC2026_JAN,2026
G8960,"Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8961,Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G8962,Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G8963,Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years,HCPCS_Level_II,HCPC2026_JAN,2026
G8964,"Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)",HCPCS_Level_II,HCPC2026_JAN,2026
G8965,Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment,HCPCS_Level_II,HCPC2026_JAN,2026
G8966,Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment,HCPCS_Level_II,HCPC2026_JAN,2026
G8967,Fda approved oral anticoagulant is prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G8968,"Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment)",HCPCS_Level_II,HCPC2026_JAN,2026
G8969,"Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)",HCPCS_Level_II,HCPC2026_JAN,2026
G8970,No risk factors or one moderate risk factor for thromboembolism,HCPCS_Level_II,HCPC2026_JAN,2026
G8971,"Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8972,One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism,HCPCS_Level_II,HCPC2026_JAN,2026
G8973,Most recent hemoglobin (hgb) level < 10 g/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G8974,"Hemoglobin level measurement not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G8975,"Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G8976,Most recent hemoglobin (hgb) level >= 10 g/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G8977,I intend to report the oncology measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G8978,"Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8979,"Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8980,"Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8981,"Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8982,"Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8983,"Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8984,"Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8985,"Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8986,"Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8987,"Self care functional limitation, current status, at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8988,"Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8989,"Self care functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8990,"Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8991,"Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8992,"Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8993,"Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8994,"Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8995,"Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8996,"Swallowing functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G8997,"Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8998,"Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G8999,"Motor speech functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9,Monitored anesthesia care for patient who has history of severe cardio-pulmonary condition,HCPCS_Level_II,HCPC2026_JAN,2026
G9001,"Coordinated care fee, initial rate",HCPCS_Level_II,HCPC2026_JAN,2026
G9002,"Coordinated care fee, maintenance rate",HCPCS_Level_II,HCPC2026_JAN,2026
G9003,"Coordinated care fee, risk adjusted high, initial",HCPCS_Level_II,HCPC2026_JAN,2026
G9004,"Coordinated care fee, risk adjusted low, initial",HCPCS_Level_II,HCPC2026_JAN,2026
G9005,"Coordinated care fee, risk adjusted maintenance",HCPCS_Level_II,HCPC2026_JAN,2026
G9006,"Coordinated care fee, home monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
G9007,"Coordinated care fee, scheduled team conference",HCPCS_Level_II,HCPC2026_JAN,2026
G9008,"Coordinated care fee, physician coordinated care oversight services",HCPCS_Level_II,HCPC2026_JAN,2026
G9009,"Coordinated care fee, risk adjusted maintenance, level 3",HCPCS_Level_II,HCPC2026_JAN,2026
G9010,"Coordinated care fee, risk adjusted maintenance, level 4",HCPCS_Level_II,HCPC2026_JAN,2026
G9011,"Coordinated care fee, risk adjusted maintenance, level 5",HCPCS_Level_II,HCPC2026_JAN,2026
G9012,Other specified case management service not elsewhere classified,HCPCS_Level_II,HCPC2026_JAN,2026
G9013,Esrd demo basic bundle level i,HCPCS_Level_II,HCPC2026_JAN,2026
G9014,Esrd demo expanded bundle including venous access and related services,HCPCS_Level_II,HCPC2026_JAN,2026
G9016,"Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]",HCPCS_Level_II,HCPC2026_JAN,2026
G9017,"Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9018,"Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9019,"Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9020,"Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9033,"Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9034,"Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9035,"Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9036,"Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9037,Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutes,HCPCS_Level_II,HCPC2026_JAN,2026
G9038,"Co-management services with the following elements: new diagnosis or acute exacerbation and stabilization of existing condition; condition which may benefit from joint care planning; condition for which specialist is taking a co-management role; condition expected to last at least 3 months; comprehensive care plan established, implemented, revised or monitored in partnership with co-managing clinicians; ongoing communication and care coordination between co-managing clinicians furnishing care",HCPCS_Level_II,HCPC2026_JAN,2026
G9050,"Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9051,"Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9052,Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9053,Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9054,"Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9055,"Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9056,Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9057,Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9058,Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9059,"Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9060,Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9061,Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9062,Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project),HCPCS_Level_II,HCPC2026_JAN,2026
G9063,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9064,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9065,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9066,"Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9067,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9068,"Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9069,"Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9070,"Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9071,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9072,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9073,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9074,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9075,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9077,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9078,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9079,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9080,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9083,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9084,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9085,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9086,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9087,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9088,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9089,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9090,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9091,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9092,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9093,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9094,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9095,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9096,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9097,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9098,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9099,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9100,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9101,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9102,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9103,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9104,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9105,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9106,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9107,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9108,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9109,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9110,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9111,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9112,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9113,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9114,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9115,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9116,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9117,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9123,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9124,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9125,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9126,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9128,"Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9129,"Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9130,"Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9131,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9132,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9133,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9134,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9135,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9136,"Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9137,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9138,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9139,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)",HCPCS_Level_II,HCPC2026_JAN,2026
G9140,"Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours",HCPCS_Level_II,HCPC2026_JAN,2026
G9143,"Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)",HCPCS_Level_II,HCPC2026_JAN,2026
G9147,"Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration",HCPCS_Level_II,HCPC2026_JAN,2026
G9148,National committee for quality assurance - level 1 medical home,HCPCS_Level_II,HCPC2026_JAN,2026
G9149,National committee for quality assurance - level 2 medical home,HCPCS_Level_II,HCPC2026_JAN,2026
G9150,National committee for quality assurance - level 3 medical home,HCPCS_Level_II,HCPC2026_JAN,2026
G9151,Mapcp demonstration - state provided services,HCPCS_Level_II,HCPC2026_JAN,2026
G9152,Mapcp demonstration - community health teams,HCPCS_Level_II,HCPC2026_JAN,2026
G9153,Mapcp demonstration - physician incentive pool,HCPCS_Level_II,HCPC2026_JAN,2026
G9156,Evaluation for wheelchair requiring face to face visit with physician,HCPCS_Level_II,HCPC2026_JAN,2026
G9157,"Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes",HCPCS_Level_II,HCPC2026_JAN,2026
G9158,"Motor speech functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9159,"Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9160,"Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9161,"Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9162,"Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9163,"Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9164,"Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9165,"Attention functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9166,"Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9167,"Attention functional limitation, discharge status at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9168,"Memory functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9169,"Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9170,"Memory functional limitation, discharge status at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9171,"Voice functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9172,"Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9173,"Voice functional limitation, discharge status at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9174,"Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals",HCPCS_Level_II,HCPC2026_JAN,2026
G9175,"Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9176,"Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9186,"Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting",HCPCS_Level_II,HCPC2026_JAN,2026
G9187,"Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code",HCPCS_Level_II,HCPC2026_JAN,2026
G9188,"Beta-blocker therapy not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9189,Beta-blocker therapy prescribed or currently being taken,HCPCS_Level_II,HCPC2026_JAN,2026
G9190,"Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9191,"Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9192,"Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)",HCPCS_Level_II,HCPC2026_JAN,2026
G9193,Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depression,HCPCS_Level_II,HCPC2026_JAN,2026
G9194,Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phase,HCPCS_Level_II,HCPC2026_JAN,2026
G9195,Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phase,HCPCS_Level_II,HCPC2026_JAN,2026
G9196,"Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))",HCPCS_Level_II,HCPC2026_JAN,2026
G9197,Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxis,HCPCS_Level_II,HCPC2026_JAN,2026
G9198,"Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9199,"Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))",HCPCS_Level_II,HCPC2026_JAN,2026
G9200,"Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9201,Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admission,HCPCS_Level_II,HCPC2026_JAN,2026
G9202,Patients with a positive hepatitis c antibody test,HCPCS_Level_II,HCPC2026_JAN,2026
G9203,Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c,HCPCS_Level_II,HCPC2026_JAN,2026
G9204,"Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9205,Patient starting antiviral treatmentfor hepatitis c during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9206,Patient starting antiviral treatment for hepatitis c during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9207,Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c,HCPCS_Level_II,HCPC2026_JAN,2026
G9208,"Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9209,Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9210,"Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9211,"Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9212,Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
G9213,"Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9214,Cd4+ cell count or cd4+ cell percentage results documented,HCPCS_Level_II,HCPC2026_JAN,2026
G9215,"Cd4+ cell count or percentage not documented as performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9216,"Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9217,"Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9218,"Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9219,"Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)",HCPCS_Level_II,HCPC2026_JAN,2026
G9220,"Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)",HCPCS_Level_II,HCPC2026_JAN,2026
G9221,Pneumocystis jiroveci pneumonia prophlaxis prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9222,Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3,HCPCS_Level_II,HCPC2026_JAN,2026
G9223,Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%,HCPCS_Level_II,HCPC2026_JAN,2026
G9224,"Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)",HCPCS_Level_II,HCPC2026_JAN,2026
G9225,"Foot exam was not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9226,"Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)",HCPCS_Level_II,HCPC2026_JAN,2026
G9227,"Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter",HCPCS_Level_II,HCPC2026_JAN,2026
G9228,"Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)",HCPCS_Level_II,HCPC2026_JAN,2026
G9229,"Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)",HCPCS_Level_II,HCPC2026_JAN,2026
G9230,"Chlamydia, gonorrhea, and syphilis not screened, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9231,"Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9232,"Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9233,All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9234,I intend to report the total knee replacement measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9235,All quality actions for the applicable measures in the general surgery measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9236,All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9237,I intend to report the general surgery measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9238,I intend to report the optimizing patient exposure to ionizing radiation measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9239,"Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9240,Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated,HCPCS_Level_II,HCPC2026_JAN,2026
G9241,Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiated,HCPCS_Level_II,HCPC2026_JAN,2026
G9242,Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed,HCPCS_Level_II,HCPC2026_JAN,2026
G9243,Documentation of viral load less than 200 copies/ml,HCPCS_Level_II,HCPC2026_JAN,2026
G9244,Antiretroviral thereapy not prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9245,Antiretroviral therapy prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9246,Patient did not have two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart,HCPCS_Level_II,HCPC2026_JAN,2026
G9247,Patient had two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart,HCPCS_Level_II,HCPC2026_JAN,2026
G9248,Patient did not have a medical visit in the last 6 months,HCPCS_Level_II,HCPC2026_JAN,2026
G9249,Patient had a medical visit in the last 6 months,HCPCS_Level_II,HCPC2026_JAN,2026
G9250,Documentation of patient pain brought to a comfortable level within 48 hours from initial assessment,HCPCS_Level_II,HCPC2026_JAN,2026
G9251,Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessment,HCPCS_Level_II,HCPC2026_JAN,2026
G9252,Adenoma(s) or other neoplasm detected during screening colonoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G9253,Adenoma(s) or other neoplasm not detected during screening colonoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G9254,Documentation of patient discharged to home later than post-operative day 2 following cea or cas,HCPCS_Level_II,HCPC2026_JAN,2026
G9255,Documentation of patient discharged to home no later than post operative day 2 following cea or cas,HCPCS_Level_II,HCPC2026_JAN,2026
G9256,Documentation of patient death following cas,HCPCS_Level_II,HCPC2026_JAN,2026
G9257,Documentation of patient stroke following cas,HCPCS_Level_II,HCPC2026_JAN,2026
G9258,Documentation of patient stroke following cea,HCPCS_Level_II,HCPC2026_JAN,2026
G9259,Documentation of patient survival and absence of stroke following cas,HCPCS_Level_II,HCPC2026_JAN,2026
G9260,Documentation of patient death following cea,HCPCS_Level_II,HCPC2026_JAN,2026
G9261,Documentation of patient survival and absence of stroke following cea,HCPCS_Level_II,HCPC2026_JAN,2026
G9262,Documentation of patient death in the hospital following endovascular aaa repair,HCPCS_Level_II,HCPC2026_JAN,2026
G9263,Documentation of patient discharged alive following endovascular aaa repair,HCPCS_Level_II,HCPC2026_JAN,2026
G9264,"Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9265,Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular access,HCPCS_Level_II,HCPC2026_JAN,2026
G9266,Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular access,HCPCS_Level_II,HCPC2026_JAN,2026
G9267,Documentation of patient with one or more complications or mortality within 30 days,HCPCS_Level_II,HCPC2026_JAN,2026
G9268,Documentation of patient with one or more complications within 90 days,HCPCS_Level_II,HCPC2026_JAN,2026
G9269,Documentation of patient without one or more complications and without mortality within 30 days,HCPCS_Level_II,HCPC2026_JAN,2026
G9270,Documentation of patient without one or more complications within 90 days,HCPCS_Level_II,HCPC2026_JAN,2026
G9271,Ldl value < 100,HCPCS_Level_II,HCPC2026_JAN,2026
G9272,Ldl value >= 100,HCPCS_Level_II,HCPC2026_JAN,2026
G9273,Blood pressure has a systolic value of < 140 and a diastolic value of < 90,HCPCS_Level_II,HCPC2026_JAN,2026
G9274,Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90,HCPCS_Level_II,HCPC2026_JAN,2026
G9275,Documentation that patient is a current non-tobacco user,HCPCS_Level_II,HCPC2026_JAN,2026
G9276,Documentation that patient is a current tobacco user,HCPCS_Level_II,HCPC2026_JAN,2026
G9277,"Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)",HCPCS_Level_II,HCPC2026_JAN,2026
G9278,Documentation that the patient is not on daily aspirin or anti-platelet regimen,HCPCS_Level_II,HCPC2026_JAN,2026
G9279,Pneumococcal screening performed and documentation of vaccination received prior to discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9280,"Pneumococcal vaccination not administered prior to discharge, reason not specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9281,Screening performed and documentation that vaccination not indicated/patient refusal,HCPCS_Level_II,HCPC2026_JAN,2026
G9282,"Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9283,Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation,HCPCS_Level_II,HCPC2026_JAN,2026
G9284,Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation,HCPCS_Level_II,HCPC2026_JAN,2026
G9285,Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9286,Antibiotic regimen prescribed within 10 days after onset of symptoms,HCPCS_Level_II,HCPC2026_JAN,2026
G9287,Antibiotic regimen not prescribed within 10 days after onset of symptoms,HCPCS_Level_II,HCPC2026_JAN,2026
G9288,"Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9289,Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation,HCPCS_Level_II,HCPC2026_JAN,2026
G9290,Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation,HCPCS_Level_II,HCPC2026_JAN,2026
G9291,"Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos",HCPCS_Level_II,HCPC2026_JAN,2026
G9292,"Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9293,"Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate",HCPCS_Level_II,HCPC2026_JAN,2026
G9294,"Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate",HCPCS_Level_II,HCPC2026_JAN,2026
G9295,Specimen site other than anatomic cutaneous location,HCPCS_Level_II,HCPC2026_JAN,2026
G9296,"Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G9297,"Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9298,"Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)",HCPCS_Level_II,HCPC2026_JAN,2026
G9299,"Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)",HCPCS_Level_II,HCPC2026_JAN,2026
G9300,"Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)",HCPCS_Level_II,HCPC2026_JAN,2026
G9301,Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet,HCPCS_Level_II,HCPC2026_JAN,2026
G9302,"Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9303,"Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9304,"Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant",HCPCS_Level_II,HCPC2026_JAN,2026
G9305,Intervention for presence of leak of endoluminal contents through an anastomosis not required,HCPCS_Level_II,HCPC2026_JAN,2026
G9306,Intervention for presence of leak of endoluminal contents through an anastomosis required,HCPCS_Level_II,HCPC2026_JAN,2026
G9307,"No return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G9308,"Unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G9309,No unplanned hospital readmission within 30 days of principal procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9310,Unplanned hospital readmission within 30 days of principal procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9311,No surgical site infection,HCPCS_Level_II,HCPC2026_JAN,2026
G9312,Surgical site infection,HCPCS_Level_II,HCPC2026_JAN,2026
G9313,"Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason",HCPCS_Level_II,HCPC2026_JAN,2026
G9314,"Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9315,"Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis",HCPCS_Level_II,HCPC2026_JAN,2026
G9316,"Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family",HCPCS_Level_II,HCPC2026_JAN,2026
G9317,"Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed",HCPCS_Level_II,HCPC2026_JAN,2026
G9318,Imaging study named according to standardized nomenclature,HCPCS_Level_II,HCPC2026_JAN,2026
G9319,"Imaging study not named according to standardized nomenclature, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9320,"Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9321,Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study,HCPCS_Level_II,HCPC2026_JAN,2026
G9322,"Count of previous ct and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies not documented in the 12-month period prior to the current study, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9323,"Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9324,"All necessary data elements not included, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9325,"Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9326,"Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9327,Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements,HCPCS_Level_II,HCPC2026_JAN,2026
G9328,"Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9329,"Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9340,"Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study",HCPCS_Level_II,HCPC2026_JAN,2026
G9341,"Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed",HCPCS_Level_II,HCPC2026_JAN,2026
G9342,"Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9343,"Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9344,"Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)",HCPCS_Level_II,HCPC2026_JAN,2026
G9345,"Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors",HCPCS_Level_II,HCPC2026_JAN,2026
G9346,"Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9347,"Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9348,Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasons,HCPCS_Level_II,HCPC2026_JAN,2026
G9349,Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9350,Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9351,More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9352,"More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9353,"More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9354,One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9355,Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation),HCPCS_Level_II,HCPC2026_JAN,2026
G9356,Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation),HCPCS_Level_II,HCPC2026_JAN,2026
G9357,"Post-partum screenings, evaluations and education performed",HCPCS_Level_II,HCPC2026_JAN,2026
G9358,"Post-partum screenings, evaluations and education not performed",HCPCS_Level_II,HCPC2026_JAN,2026
G9359,Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifier,HCPCS_Level_II,HCPC2026_JAN,2026
G9360,No documentation of negative or managed positive tb screen,HCPCS_Level_II,HCPC2026_JAN,2026
G9361,"Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]",HCPCS_Level_II,HCPC2026_JAN,2026
G9362,"Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia record",HCPCS_Level_II,HCPC2026_JAN,2026
G9363,"Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record",HCPCS_Level_II,HCPC2026_JAN,2026
G9364,"Sinusitis caused by, or presumed to be caused by, bacterial infection",HCPCS_Level_II,HCPC2026_JAN,2026
G9365,One high-risk medication ordered,HCPCS_Level_II,HCPC2026_JAN,2026
G9366,One high-risk medication not ordered,HCPCS_Level_II,HCPC2026_JAN,2026
G9367,At least two orders for high-risk medications from the same drug class,HCPCS_Level_II,HCPC2026_JAN,2026
G9368,At least two orders for high-risk medications from the same drug class not ordered,HCPCS_Level_II,HCPC2026_JAN,2026
G9369,Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G9370,Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G9376,Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9377,Patient did not have the retina attached after 6 months following only one surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9378,Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month),HCPCS_Level_II,HCPC2026_JAN,2026
G9379,Patient did not achieve flat retinas six months post surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9380,Patient offered assistance with end of life issues or existing end of life plan was reviewed or updated during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9381,"Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9382,Patient not offered assistance with end of life issues or existing end of life plan was not reviewed or updated during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9383,Patient received screening for hcv infection within the 12 month reporting period,HCPCS_Level_II,HCPC2026_JAN,2026
G9384,"Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9385,"Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9386,"Screening for hcv infection not received within the 12 month reporting period, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9389,Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9390,No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9391,"Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit",HCPCS_Level_II,HCPC2026_JAN,2026
G9392,"Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visit",HCPCS_Level_II,HCPC2026_JAN,2026
G9393,Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five,HCPCS_Level_II,HCPC2026_JAN,2026
G9394,"Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period",HCPCS_Level_II,HCPC2026_JAN,2026
G9395,Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five,HCPCS_Level_II,HCPC2026_JAN,2026
G9396,Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days),HCPCS_Level_II,HCPC2026_JAN,2026
G9399,"Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G9400,Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasons,HCPCS_Level_II,HCPC2026_JAN,2026
G9401,"No documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment",HCPCS_Level_II,HCPC2026_JAN,2026
G9402,Patient received follow-up within 30 days after discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9403,"Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)",HCPCS_Level_II,HCPC2026_JAN,2026
G9404,Patient did not receive follow-up within 30 days after discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9405,Patient received follow-up within 7 days after discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9406,"Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)",HCPCS_Level_II,HCPC2026_JAN,2026
G9407,Patient did not receive follow-up within 7 days after discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9408,Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days,HCPCS_Level_II,HCPC2026_JAN,2026
G9409,Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days,HCPCS_Level_II,HCPC2026_JAN,2026
G9410,"Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",HCPCS_Level_II,HCPC2026_JAN,2026
G9411,"Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",HCPCS_Level_II,HCPC2026_JAN,2026
G9412,"Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",HCPCS_Level_II,HCPC2026_JAN,2026
G9413,"Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision",HCPCS_Level_II,HCPC2026_JAN,2026
G9414,"Patient had one dose of meningococcal vaccine (serogroups a, c, w, y or a, c, w, y, b) on or between the patient's 10th and 13th birthdays",HCPCS_Level_II,HCPC2026_JAN,2026
G9415,"Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y or a, c, w, y, b), on or between the patient's 10th and 13th birthdays",HCPCS_Level_II,HCPC2026_JAN,2026
G9416,"Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays",HCPCS_Level_II,HCPC2026_JAN,2026
G9417,"Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays",HCPCS_Level_II,HCPC2026_JAN,2026
G9418,Primary non-small cell lung cancer lung biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as nsclc-nos with an explanation,HCPCS_Level_II,HCPC2026_JAN,2026
G9419,"Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9420,Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9421,Primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow iaslc guidance or is classified as nsclc-nos but without an explanation,HCPCS_Level_II,HCPC2026_JAN,2026
G9422,"Primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and not nsclc-nos)",HCPCS_Level_II,HCPC2026_JAN,2026
G9423,"Documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens)]",HCPCS_Level_II,HCPC2026_JAN,2026
G9424,"Specimen site other than anatomic location of lung, or classified as nsclc-nos",HCPCS_Level_II,HCPC2026_JAN,2026
G9425,"Primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma)",HCPCS_Level_II,HCPC2026_JAN,2026
G9426,Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients,HCPCS_Level_II,HCPC2026_JAN,2026
G9427,Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients,HCPCS_Level_II,HCPC2026_JAN,2026
G9428,"Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors",HCPCS_Level_II,HCPC2026_JAN,2026
G9429,"Documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies, insufficient tissue, or other documented medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9430,Specimen site other than anatomic cutaneous location,HCPCS_Level_II,HCPC2026_JAN,2026
G9431,"Pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors",HCPCS_Level_II,HCPC2026_JAN,2026
G9432,"Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented",HCPCS_Level_II,HCPC2026_JAN,2026
G9433,"Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9434,"Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9435,Aspirin prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9436,"Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)",HCPCS_Level_II,HCPC2026_JAN,2026
G9437,Aspirin not prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9438,P2y inhibitor prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9439,"P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)",HCPCS_Level_II,HCPC2026_JAN,2026
G9440,P2y inhibitor not prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9441,Statin prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9442,"Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)",HCPCS_Level_II,HCPC2026_JAN,2026
G9443,Statin not prescribed at discharge,HCPCS_Level_II,HCPC2026_JAN,2026
G9448,Patients who were born in the years 1945 to 1965,HCPCS_Level_II,HCPC2026_JAN,2026
G9449,History of receiving blood transfusions prior to 1992,HCPCS_Level_II,HCPC2026_JAN,2026
G9450,History of injection drug use,HCPCS_Level_II,HCPC2026_JAN,2026
G9451,Patient received one-time screening for hcv infection,HCPCS_Level_II,HCPC2026_JAN,2026
G9452,Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy,HCPCS_Level_II,HCPC2026_JAN,2026
G9453,"Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9454,"One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9455,"Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc",HCPCS_Level_II,HCPC2026_JAN,2026
G9456,"Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)",HCPCS_Level_II,HCPC2026_JAN,2026
G9457,Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period,HCPCS_Level_II,HCPC2026_JAN,2026
G9458,"Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco user",HCPCS_Level_II,HCPC2026_JAN,2026
G9459,Currently a tobacco non-user,HCPCS_Level_II,HCPC2026_JAN,2026
G9460,"Tobacco assessment or tobacco cessation intervention not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9463,I intend to report the sinusitis measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9464,All quality actions for the applicable measures in the sinusitis measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9465,I intend to report the acute otitis externa (aoe) measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9466,All quality actions for the applicable measures in the aoe measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9467,Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve months,HCPCS_Level_II,HCPC2026_JAN,2026
G9468,Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills,HCPCS_Level_II,HCPC2026_JAN,2026
G9469,Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fills,HCPCS_Level_II,HCPC2026_JAN,2026
G9470,Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills,HCPCS_Level_II,HCPC2026_JAN,2026
G9471,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented",HCPCS_Level_II,HCPC2026_JAN,2026
G9472,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed",HCPCS_Level_II,HCPC2026_JAN,2026
G9473,"Services performed by chaplain in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9474,"Services performed by dietary counselor in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9475,"Services performed by other counselor in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9476,"Services performed by volunteer in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9477,"Services performed by care coordinator in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9478,"Services performed by other qualified therapist in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9479,"Services performed by qualified pharmacist in the hospice setting, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9480,Admission to medicare care choice model program (mccm),HCPCS_Level_II,HCPC2026_JAN,2026
G9481,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history;  a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9482,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination;  straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9483,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate severity.  typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9484,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9485,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9486,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9487,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9488,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9489,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9490,"Cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services.  (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code",HCPCS_Level_II,HCPC2026_JAN,2026
G9496,"Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma",HCPCS_Level_II,HCPC2026_JAN,2026
G9497,Received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9498,Antibiotic regimen prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9499,Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9500,Radiation exposure indices documented in final report for procedure using fluoroscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G9501,"Radiation exposure indices not documented in final report for procedure using fluoroscopy, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9502,"Documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)",HCPCS_Level_II,HCPC2026_JAN,2026
G9503,Patient taking tamsulosin hydrochloride,HCPCS_Level_II,HCPC2026_JAN,2026
G9504,"Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy",HCPCS_Level_II,HCPC2026_JAN,2026
G9505,Antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason,HCPCS_Level_II,HCPC2026_JAN,2026
G9506,Biologic immune response modifier prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9507,"Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)",HCPCS_Level_II,HCPC2026_JAN,2026
G9508,Documentation that the patient is not on a statin medication,HCPCS_Level_II,HCPC2026_JAN,2026
G9509,Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5,HCPCS_Level_II,HCPC2026_JAN,2026
G9510,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve  month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5,HCPCS_Level_II,HCPC2026_JAN,2026
G9511,Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period,HCPCS_Level_II,HCPC2026_JAN,2026
G9512,Individual had a pdc of 0.8 or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G9513,Individual did not have a pdc of 0.8 or greater,HCPCS_Level_II,HCPC2026_JAN,2026
G9514,Patient required a return to the operating room within 90 days of surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9515,Patient did not require a return to the operating room within 90 days of surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9516,"Patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery",HCPCS_Level_II,HCPC2026_JAN,2026
G9517,"Patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9518,Documentation of active injection drug use,HCPCS_Level_II,HCPC2026_JAN,2026
G9519,Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9520,Patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9521,Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months,HCPCS_Level_II,HCPC2026_JAN,2026
G9522,"Total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9523,Patient discontinued from hemodialysis or peritoneal dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
G9524,Patient was referred to hospice care,HCPCS_Level_II,HCPC2026_JAN,2026
G9525,"Documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9526,"Patient was not referred to hospice care, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9529,Patient with minor blunt head trauma had an appropriate indication(s) for a head ct,HCPCS_Level_II,HCPC2026_JAN,2026
G9530,Patient presented with a minor blunt head trauma  and had a head ct ordered for trauma by an emergency care provider,HCPCS_Level_II,HCPC2026_JAN,2026
G9531,"Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar",HCPCS_Level_II,HCPC2026_JAN,2026
G9532,Patient had a head ct for trauma ordered by someone other than an emergency care provider  or was ordered for a reason other than trauma,HCPCS_Level_II,HCPC2026_JAN,2026
G9533,Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct,HCPCS_Level_II,HCPC2026_JAN,2026
G9534,"Advanced brain imaging (cta, ct, mra or mri) was not ordered",HCPCS_Level_II,HCPC2026_JAN,2026
G9535,Patients with a normal neurological examination,HCPCS_Level_II,HCPC2026_JAN,2026
G9536,"Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms)",HCPCS_Level_II,HCPC2026_JAN,2026
G9537,Imaging needed as part of a clinical trial; or other clinician ordered the study,HCPCS_Level_II,HCPC2026_JAN,2026
G9538,"Advanced brain imaging (cta, ct, mra or mri) was ordered",HCPCS_Level_II,HCPC2026_JAN,2026
G9539,Intent for potential removal at time of placement,HCPCS_Level_II,HCPC2026_JAN,2026
G9540,Patient alive 3 months post procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9541,Filter removed within 3 months of placement,HCPCS_Level_II,HCPC2026_JAN,2026
G9542,Documented re-assessment for the appropriateness of filter removal within 3 months of placement,HCPCS_Level_II,HCPC2026_JAN,2026
G9543,Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement,HCPCS_Level_II,HCPC2026_JAN,2026
G9544,"Patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement",HCPCS_Level_II,HCPC2026_JAN,2026
G9547,"Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion  less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols",HCPCS_Level_II,HCPC2026_JAN,2026
G9548,Final reports for imaging studies stating no  follow-up imaging is recommended,HCPCS_Level_II,HCPC2026_JAN,2026
G9549,"Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))",HCPCS_Level_II,HCPC2026_JAN,2026
G9550,"Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up",HCPCS_Level_II,HCPC2026_JAN,2026
G9551,Final reports for imaging studies without an incidentally found lesion noted,HCPCS_Level_II,HCPC2026_JAN,2026
G9552,Incidental thyroid nodule < 1.0 cm noted in report,HCPCS_Level_II,HCPC2026_JAN,2026
G9553,Prior thyroid disease diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9554,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended",HCPCS_Level_II,HCPC2026_JAN,2026
G9555,"Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))",HCPCS_Level_II,HCPC2026_JAN,2026
G9556,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended",HCPCS_Level_II,HCPC2026_JAN,2026
G9557,"Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found",HCPCS_Level_II,HCPC2026_JAN,2026
G9558,Patient treated with a beta-lactam antibiotic as definitive therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9559,"Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)",HCPCS_Level_II,HCPC2026_JAN,2026
G9560,"Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9561,Patients prescribed opiates for longer than six weeks,HCPCS_Level_II,HCPC2026_JAN,2026
G9562,Patients who had a follow-up evaluation conducted at least every three months during opioid therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9563,Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9572,Index date phq-score greater than 9 documented during the twelve month denominator identification period,HCPCS_Level_II,HCPC2026_JAN,2026
G9573,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five,HCPCS_Level_II,HCPC2026_JAN,2026
G9574,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to five,HCPCS_Level_II,HCPC2026_JAN,2026
G9577,Patients prescribed opiates for longer than six weeks,HCPCS_Level_II,HCPC2026_JAN,2026
G9578,Documentation of signed opioid treatment agreement at least once during opioid therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9579,No documentation of signed an opioid treatment agreement at least once during opioid therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9580,Door to puncture time of 90 minutes or less,HCPCS_Level_II,HCPC2026_JAN,2026
G9581,"Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment)",HCPCS_Level_II,HCPC2026_JAN,2026
G9582,"Door to puncture time of greater than 90 minutes, no reason given",HCPCS_Level_II,HCPC2026_JAN,2026
G9583,Patients prescribed opiates for longer than six weeks,HCPCS_Level_II,HCPC2026_JAN,2026
G9584,"Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapy",HCPCS_Level_II,HCPC2026_JAN,2026
G9585,"Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapy",HCPCS_Level_II,HCPC2026_JAN,2026
G9593,Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules,HCPCS_Level_II,HCPC2026_JAN,2026
G9594,Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider,HCPCS_Level_II,HCPC2026_JAN,2026
G9595,"Patient has documentation of ventricular shunt, brain tumor, or coagulopathy",HCPCS_Level_II,HCPC2026_JAN,2026
G9596,Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than trauma,HCPCS_Level_II,HCPC2026_JAN,2026
G9597,Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules,HCPCS_Level_II,HCPC2026_JAN,2026
G9598,Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct,HCPCS_Level_II,HCPC2026_JAN,2026
G9599,Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct,HCPCS_Level_II,HCPC2026_JAN,2026
G9600,Symptomatic aaas that required urgent/emergent (non-elective) repair,HCPCS_Level_II,HCPC2026_JAN,2026
G9601,Patient discharge to home no later than post-operative day #7,HCPCS_Level_II,HCPC2026_JAN,2026
G9602,Patient not discharged to home by post-operative day #7,HCPCS_Level_II,HCPC2026_JAN,2026
G9603,Patient survey score improved from baseline following treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9604,Patient survey results not available,HCPCS_Level_II,HCPC2026_JAN,2026
G9605,Patient survey score did not improve from baseline following treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9606,Intraoperative cystoscopy performed to evaluate for lower tract injury,HCPCS_Level_II,HCPC2026_JAN,2026
G9607,"Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death",HCPCS_Level_II,HCPC2026_JAN,2026
G9608,Intraoperative cystoscopy not performed to evaluate for lower tract injury,HCPCS_Level_II,HCPC2026_JAN,2026
G9609,Documentation of an order for anti-platelet agents,HCPCS_Level_II,HCPC2026_JAN,2026
G9610,Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents,HCPCS_Level_II,HCPC2026_JAN,2026
G9611,"Order for anti-platelet agents was not documented in the patient's record, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9612,Photodocumentation of two or more cecal landmarks to establish a complete examination,HCPCS_Level_II,HCPC2026_JAN,2026
G9613,"Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
G9614,"Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination",HCPCS_Level_II,HCPC2026_JAN,2026
G9615,Preoperative assessment documented,HCPCS_Level_II,HCPC2026_JAN,2026
G9616,"Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9617,"Preoperative assessment not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9618,Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind,HCPCS_Level_II,HCPC2026_JAN,2026
G9619,"Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)",HCPCS_Level_II,HCPC2026_JAN,2026
G9620,"Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9621,Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling,HCPCS_Level_II,HCPC2026_JAN,2026
G9622,Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method,HCPCS_Level_II,HCPC2026_JAN,2026
G9623,"Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9624,Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user,HCPCS_Level_II,HCPC2026_JAN,2026
G9625,Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9626,"Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)",HCPCS_Level_II,HCPC2026_JAN,2026
G9627,Patient did not sustain bladder injury at the time of surgery nor discovered  subsequently up to 30 days post-surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9628,Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days  post-surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9629,"Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)",HCPCS_Level_II,HCPC2026_JAN,2026
G9630,Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9631,Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9632,"Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)",HCPCS_Level_II,HCPC2026_JAN,2026
G9633,Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9634,Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved,HCPCS_Level_II,HCPC2026_JAN,2026
G9635,"Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)",HCPCS_Level_II,HCPC2026_JAN,2026
G9636,Health-related quality of life not assessed with tool during at least two visits or quality of life score declined,HCPCS_Level_II,HCPC2026_JAN,2026
G9637,"Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)",HCPCS_Level_II,HCPC2026_JAN,2026
G9638,"Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)",HCPCS_Level_II,HCPC2026_JAN,2026
G9639,Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9640,Documentation of planned hybrid or staged procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9641,Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9642,"Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)",HCPCS_Level_II,HCPC2026_JAN,2026
G9643,Elective surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9644,Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9645,Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9646,Patients with 90 day mrs score of 0 to 2,HCPCS_Level_II,HCPC2026_JAN,2026
G9647,Patients in whom mrs score could not be obtained at 90 day follow-up,HCPCS_Level_II,HCPC2026_JAN,2026
G9648,Patients with 90 day mrs score greater than 2,HCPCS_Level_II,HCPC2026_JAN,2026
G9649,"Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))",HCPCS_Level_II,HCPC2026_JAN,2026
G9650,"Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi",HCPCS_Level_II,HCPC2026_JAN,2026
G9651,"Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented",HCPCS_Level_II,HCPC2026_JAN,2026
G9652,Patient has been treated with a systemic or biologic medication for psoriasis for at least six months,HCPCS_Level_II,HCPC2026_JAN,2026
G9653,Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months,HCPCS_Level_II,HCPC2026_JAN,2026
G9654,Monitored anesthesia care (mac),HCPCS_Level_II,HCPC2026_JAN,2026
G9655,A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used,HCPCS_Level_II,HCPC2026_JAN,2026
G9656,Patient transferred directly from anesthetizing location to pacu or other non-icu location,HCPCS_Level_II,HCPC2026_JAN,2026
G9657,Transfer of care during an anesthetic or to the intensive care unit,HCPCS_Level_II,HCPC2026_JAN,2026
G9658,A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used,HCPCS_Level_II,HCPC2026_JAN,2026
G9659,"Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits",HCPCS_Level_II,HCPC2026_JAN,2026
G9660,"Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)",HCPCS_Level_II,HCPC2026_JAN,2026
G9661,"Patients greater than or equal to 86 years of age who received a  colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions",HCPCS_Level_II,HCPC2026_JAN,2026
G9662,"Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G9663,Any ldl-c laboratory result >= 190 mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G9664,Patients who are currently statin therapy users or received an order (prescription) for statin therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9665,Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9666,Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G9667,"Documentation of medical reason(s) for not currently being a statin   therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)",HCPCS_Level_II,HCPC2026_JAN,2026
G9669,I intend to report the multiple chronic conditions measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9670,All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9671,I intend to report the diabetic retinopathy measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9672,All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9673,I intend to report the cardiovascular prevention measures group,HCPCS_Level_II,HCPC2026_JAN,2026
G9674,Patients with clinical ascvd diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9675,Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl,HCPCS_Level_II,HCPC2026_JAN,2026
G9676,Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9677,All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patient,HCPCS_Level_II,HCPC2026_JAN,2026
G9678,Oncology care model (ocm) monthly enhanced oncology services (meos) payment for  ocm enhanced services.  g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreement,HCPCS_Level_II,HCPC2026_JAN,2026
G9679,This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
G9680,This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
G9681,This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
G9682,This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
G9683,Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project,HCPCS_Level_II,HCPC2026_JAN,2026
G9684,This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary,HCPCS_Level_II,HCPC2026_JAN,2026
G9685,Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project,HCPCS_Level_II,HCPC2026_JAN,2026
G9686,"Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care team",HCPCS_Level_II,HCPC2026_JAN,2026
G9687,Hospice services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9688,Patients using hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9689,Patient admitted for performance of elective carotid intervention,HCPCS_Level_II,HCPC2026_JAN,2026
G9690,Patient receiving hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9691,Patient had hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9692,Hospice services received by patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9693,Patient use of hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9694,Hospice services utilized by patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9695,Long-acting inhaled bronchodilator prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9696,"Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., patient intolerance or history of side effects)",HCPCS_Level_II,HCPC2026_JAN,2026
G9697,Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilator,HCPCS_Level_II,HCPC2026_JAN,2026
G9698,"Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., cost of treatment or lack of insurance)",HCPCS_Level_II,HCPC2026_JAN,2026
G9699,"Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9700,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9701,Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was established,HCPCS_Level_II,HCPC2026_JAN,2026
G9702,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9703,Episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date,HCPCS_Level_II,HCPC2026_JAN,2026
G9704,Ajcc breast cancer stage i: t1 mic or t1a documented,HCPCS_Level_II,HCPC2026_JAN,2026
G9705,Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented,HCPCS_Level_II,HCPC2026_JAN,2026
G9706,"Low (or very low) risk of recurrence, prostate cancer",HCPCS_Level_II,HCPC2026_JAN,2026
G9707,Patient received hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9708,Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy,HCPCS_Level_II,HCPC2026_JAN,2026
G9709,Hospice services used by patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9710,Patient was provided hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9711,Patients with a diagnosis or past history of total colectomy or colorectal cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9712,"Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal   infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis",HCPCS_Level_II,HCPC2026_JAN,2026
G9713,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9714,Patient is using hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9715,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9716,"Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason",HCPCS_Level_II,HCPC2026_JAN,2026
G9717,Documentation stating the patient has had a diagnosis of bipolar disorder,HCPCS_Level_II,HCPC2026_JAN,2026
G9718,Hospice services for patient provided any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9719,"Patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
G9720,Hospice services for patient occurred any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9721,"Patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
G9722,"Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher",HCPCS_Level_II,HCPC2026_JAN,2026
G9723,Hospice services for patient received any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9724,Patients who had documentation of use of anticoagulant medications overlapping the measurement year,HCPCS_Level_II,HCPC2026_JAN,2026
G9725,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9726,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9727,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9728,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9729,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9730,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9731,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9732,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9733,"Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9734,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9735,"Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9736,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9737,"Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9738,Patient refused to participate,HCPCS_Level_II,HCPC2026_JAN,2026
G9739,"Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
G9740,Hospice services given to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9741,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9742,Psychiatric symptoms assessed,HCPCS_Level_II,HCPC2026_JAN,2026
G9743,"Psychiatric symptoms not assessed, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9744,Patient not eligible due to active diagnosis of hypertension,HCPCS_Level_II,HCPC2026_JAN,2026
G9745,Documented reason for not screening or recommending a follow-up for high blood pressure,HCPCS_Level_II,HCPC2026_JAN,2026
G9746,"Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9747,Patient is undergoing palliative dialysis with a catheter,HCPCS_Level_II,HCPC2026_JAN,2026
G9748,Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant,HCPCS_Level_II,HCPC2026_JAN,2026
G9749,Patient is undergoing palliative dialysis with a catheter,HCPCS_Level_II,HCPC2026_JAN,2026
G9750,Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplant,HCPCS_Level_II,HCPC2026_JAN,2026
G9751,Patient died at any time during the 24-month measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9752,Emergency surgery,HCPCS_Level_II,HCPC2026_JAN,2026
G9753,"Documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of the essence)",HCPCS_Level_II,HCPC2026_JAN,2026
G9754,A finding of an incidental pulmonary nodule,HCPCS_Level_II,HCPC2026_JAN,2026
G9755,"Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)",HCPCS_Level_II,HCPC2026_JAN,2026
G9756,Surgical procedures that included the use of silicone oil,HCPCS_Level_II,HCPC2026_JAN,2026
G9757,Surgical procedures that included the use of silicone oil,HCPCS_Level_II,HCPC2026_JAN,2026
G9758,Patient in hospice at any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9759,History of preoperative posterior capsule rupture,HCPCS_Level_II,HCPC2026_JAN,2026
G9760,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9761,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9762,Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays,HCPCS_Level_II,HCPC2026_JAN,2026
G9763,Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays,HCPCS_Level_II,HCPC2026_JAN,2026
G9764,Patient has been treated with a systemic medication for psoriasis vulgaris,HCPCS_Level_II,HCPC2026_JAN,2026
G9765,"Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi",HCPCS_Level_II,HCPC2026_JAN,2026
G9766,Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9767,Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9768,Patients who utilize hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9769,Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months,HCPCS_Level_II,HCPC2026_JAN,2026
G9770,Peripheral nerve block (pnb),HCPCS_Level_II,HCPC2026_JAN,2026
G9771,At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time,HCPCS_Level_II,HCPC2026_JAN,2026
G9772,"Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)",HCPCS_Level_II,HCPC2026_JAN,2026
G9773,"At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9774,Patients who have had a hysterectomy,HCPCS_Level_II,HCPC2026_JAN,2026
G9775,Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9776,"Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively  (e.g., intolerance or other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9777,Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9778,Patients who have a diagnosis of pregnancy at any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9779,Patients who are breastfeeding at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
G9780,Patients who have a diagnosis of rhabdomyolysis at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
G9781,"Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9782,History of or active diagnosis of familial hypercholesterolemia,HCPCS_Level_II,HCPC2026_JAN,2026
G9783,Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9784,Pathologists/dermatopathologists providing a second opinion on a biopsy,HCPCS_Level_II,HCPC2026_JAN,2026
G9785,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist",HCPCS_Level_II,HCPC2026_JAN,2026
G9786,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist",HCPCS_Level_II,HCPC2026_JAN,2026
G9787,Patient alive as of the last day of the measurement year,HCPCS_Level_II,HCPC2026_JAN,2026
G9788,Most recent bp is less than or equal to 130/80 mm hg,HCPCS_Level_II,HCPC2026_JAN,2026
G9789,"Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits",HCPCS_Level_II,HCPC2026_JAN,2026
G9790,"Most recent bp is greater than 130/80 mm hg, or blood pressure not documented",HCPCS_Level_II,HCPC2026_JAN,2026
G9791,Most recent tobacco status is tobacco free,HCPCS_Level_II,HCPC2026_JAN,2026
G9792,Most recent tobacco status is not tobacco free,HCPCS_Level_II,HCPC2026_JAN,2026
G9793,Patient is currently on a daily aspirin or other antiplatelet,HCPCS_Level_II,HCPC2026_JAN,2026
G9794,"Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)",HCPCS_Level_II,HCPC2026_JAN,2026
G9795,Patient is not currently on a daily aspirin or other antiplatelet,HCPCS_Level_II,HCPC2026_JAN,2026
G9796,Patient is currently on a high intensity statin therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9797,Patient is not on a high intensity statin therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9798,Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9799,Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure period,HCPCS_Level_II,HCPC2026_JAN,2026
G9800,Patients who are identified as having an intolerance or allergy to beta-blocker therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9801,Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9802,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9803,Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami,HCPCS_Level_II,HCPC2026_JAN,2026
G9804,Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for ami,HCPCS_Level_II,HCPC2026_JAN,2026
G9805,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9806,Patients who received cervical cytology or an hpv test,HCPCS_Level_II,HCPC2026_JAN,2026
G9807,Patients who did not receive cervical cytology or an hpv test,HCPCS_Level_II,HCPC2026_JAN,2026
G9808,Any patients who had no asthma controller medications dispensed during the measurement year,HCPCS_Level_II,HCPC2026_JAN,2026
G9809,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9810,Patient achieved a pdc of at least 75% for their asthma controller medication,HCPCS_Level_II,HCPC2026_JAN,2026
G9811,Patient did not achieve a pdc of at least 75% for their asthma controller medication,HCPCS_Level_II,HCPC2026_JAN,2026
G9812,"Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure",HCPCS_Level_II,HCPC2026_JAN,2026
G9813,Patient did not die within 30 days of the procedure or during the index hospitalization,HCPCS_Level_II,HCPC2026_JAN,2026
G9814,Death occurring during the index acute care hospitalization,HCPCS_Level_II,HCPC2026_JAN,2026
G9815,Death did not occur during the index acute care hospitalization,HCPCS_Level_II,HCPC2026_JAN,2026
G9816,Death occurring after discharge from the hospital but within 30 days post procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9817,Death did not occur after discharge from the hospital within 30 days post procedure,HCPCS_Level_II,HCPC2026_JAN,2026
G9818,Documentation of sexual activity,HCPCS_Level_II,HCPC2026_JAN,2026
G9819,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9820,Documentation of a chlamydia screening test with proper follow-up,HCPCS_Level_II,HCPC2026_JAN,2026
G9821,No documentation of a chlamydia screening test with proper follow-up,HCPCS_Level_II,HCPC2026_JAN,2026
G9822,Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date),HCPCS_Level_II,HCPC2026_JAN,2026
G9823,Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation,HCPCS_Level_II,HCPC2026_JAN,2026
G9824,Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation,HCPCS_Level_II,HCPC2026_JAN,2026
G9825,Her-2/neu negative or undocumented/unknown,HCPCS_Level_II,HCPC2026_JAN,2026
G9826,Patient transferred to practice after initiation of chemotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9827,Her2-targeted therapies not administered during the initial course of treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9828,Her2-targeted therapies administered during the initial course of treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9829,Breast adjuvant chemotherapy administered,HCPCS_Level_II,HCPC2026_JAN,2026
G9830,Her-2/neu positive,HCPCS_Level_II,HCPC2026_JAN,2026
G9831,Ajcc stage at breast cancer diagnosis = ii or iii,HCPCS_Level_II,HCPC2026_JAN,2026
G9832,Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis = t1c,HCPCS_Level_II,HCPC2026_JAN,2026
G9833,Patient transfer to practice after initiation of chemotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9834,Patient has metastatic disease at diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9835,Trastuzumab administered within 12 months of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9836,"Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)",HCPCS_Level_II,HCPC2026_JAN,2026
G9837,Trastuzumab not administered within 12 months of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9838,Patient has metastatic disease at diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9839,Anti-egfr monoclonal antibody therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9840,Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab,HCPCS_Level_II,HCPC2026_JAN,2026
G9841,Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab,HCPCS_Level_II,HCPC2026_JAN,2026
G9842,Patient has metastatic disease at diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
G9843,Ras (kras or nras) gene mutation,HCPCS_Level_II,HCPC2026_JAN,2026
G9844,Patient did not receive anti-egfr monoclonal antibody therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9845,Patient received anti-egfr monoclonal antibody therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9846,Patients who died from cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9847,Patient received systemic cancer-directed therapy in the last 14 days of life,HCPCS_Level_II,HCPC2026_JAN,2026
G9848,Patient did not receive systemic cancer-directed therapy in the last 14 days of life,HCPCS_Level_II,HCPC2026_JAN,2026
G9849,Patients who died from cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9850,Patient had more than one emergency department visit in the last 30 days of life,HCPCS_Level_II,HCPC2026_JAN,2026
G9851,Patient had one or less emergency department visits in the last 30 days of life,HCPCS_Level_II,HCPC2026_JAN,2026
G9852,Patients who died from cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9853,Patient admitted to the icu in the last 30 days of life,HCPCS_Level_II,HCPC2026_JAN,2026
G9854,Patient was not admitted to the icu in the last 30 days of life,HCPCS_Level_II,HCPC2026_JAN,2026
G9855,Patients who died from cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9856,Patient was not admitted to hospice,HCPCS_Level_II,HCPC2026_JAN,2026
G9857,Patient admitted to hospice,HCPCS_Level_II,HCPC2026_JAN,2026
G9858,Patient enrolled in hospice,HCPCS_Level_II,HCPC2026_JAN,2026
G9859,Patients who died from cancer,HCPCS_Level_II,HCPC2026_JAN,2026
G9860,Patient spent less than three days in hospice care,HCPCS_Level_II,HCPC2026_JAN,2026
G9861,Patient spent greater than or equal to three days in hospice care,HCPCS_Level_II,HCPC2026_JAN,2026
G9862,"Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
G9868,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9869,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, 10-20 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9870,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more than 20 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9871,"Behavioral counseling for diabetes prevention, online, 60 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9873,First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,HCPCS_Level_II,HCPC2026_JAN,2026
G9874,Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,HCPCS_Level_II,HCPC2026_JAN,2026
G9875,Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions,HCPCS_Level_II,HCPC2026_JAN,2026
G9876,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9",HCPCS_Level_II,HCPC2026_JAN,2026
G9877,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12",HCPCS_Level_II,HCPC2026_JAN,2026
G9878,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9",HCPCS_Level_II,HCPC2026_JAN,2026
G9879,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12",HCPCS_Level_II,HCPC2026_JAN,2026
G9880,The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session,HCPCS_Level_II,HCPC2026_JAN,2026
G9881,"The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session",HCPCS_Level_II,HCPC2026_JAN,2026
G9882,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15",HCPCS_Level_II,HCPC2026_JAN,2026
G9883,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18",HCPCS_Level_II,HCPC2026_JAN,2026
G9884,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21",HCPCS_Level_II,HCPC2026_JAN,2026
G9885,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24",HCPCS_Level_II,HCPC2026_JAN,2026
G9886,"Behavioral counseling for diabetes prevention, in-person, group, 60 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9887,"Behavioral counseling for diabetes prevention, distance learning, 60 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
G9888,Maintenance 5% wl from baseline weight in months 7-12,HCPCS_Level_II,HCPC2026_JAN,2026
G9890,"Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model.  a supplier may only receive one bridge payment per mdpp beneficiary",HCPCS_Level_II,HCPC2026_JAN,2026
G9891,Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em)  hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only),HCPCS_Level_II,HCPC2026_JAN,2026
G9892,Documentation of patient reason(s) for not performing a dilated macular examination,HCPCS_Level_II,HCPC2026_JAN,2026
G9893,"Dilated macular exam was not performed, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9894,Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate,HCPCS_Level_II,HCPC2026_JAN,2026
G9895,"Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)",HCPCS_Level_II,HCPC2026_JAN,2026
G9896,Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate,HCPCS_Level_II,HCPC2026_JAN,2026
G9897,"Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9898,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9899,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed",HCPCS_Level_II,HCPC2026_JAN,2026
G9900,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9901,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9902,Patient screened for tobacco use and identified as a tobacco user,HCPCS_Level_II,HCPC2026_JAN,2026
G9903,Patient screened for tobacco use and identified as a tobacco non-user,HCPCS_Level_II,HCPC2026_JAN,2026
G9904,"Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9905,Patient not screened for tobacco use,HCPCS_Level_II,HCPC2026_JAN,2026
G9906,Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),HCPCS_Level_II,HCPC2026_JAN,2026
G9907,"Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9908,Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),HCPCS_Level_II,HCPC2026_JAN,2026
G9909,"Documentation of medical reason(s) for not  providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9910,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9911,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant  systemic therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9912,Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy,HCPCS_Level_II,HCPC2026_JAN,2026
G9913,"Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9914,Patient initiated an anti-tnf agent,HCPCS_Level_II,HCPC2026_JAN,2026
G9915,No record of hbv results documented,HCPCS_Level_II,HCPC2026_JAN,2026
G9916,Functional status  performed once in the last 12 months,HCPCS_Level_II,HCPC2026_JAN,2026
G9917,Documentation of advanced stage dementia and caregiver knowledge is limited,HCPCS_Level_II,HCPC2026_JAN,2026
G9918,"Functional status not performed, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9919,Screening performed and positive and provision of recommendations,HCPCS_Level_II,HCPC2026_JAN,2026
G9920,Screening performed and negative,HCPCS_Level_II,HCPC2026_JAN,2026
G9921,"No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9922,Safety concerns screen provided and if positive then documented mitigation recommendations,HCPCS_Level_II,HCPC2026_JAN,2026
G9923,Safety concerns screen provided and negative,HCPCS_Level_II,HCPC2026_JAN,2026
G9924,"Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9925,"Safety concerns screening not provided, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
G9926,"Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources",HCPCS_Level_II,HCPC2026_JAN,2026
G9927,Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatment,HCPCS_Level_II,HCPC2026_JAN,2026
G9928,"Fda-approved anticoagulant not prescribed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
G9929,"Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)",HCPCS_Level_II,HCPC2026_JAN,2026
G9930,Patients who are receiving comfort care only,HCPCS_Level_II,HCPC2026_JAN,2026
G9931,"Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women",HCPCS_Level_II,HCPC2026_JAN,2026
G9932,"Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)",HCPCS_Level_II,HCPC2026_JAN,2026
G9933,Adenoma(s) or colorectal cancer detected during screening colonoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G9934,"Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenoma",HCPCS_Level_II,HCPC2026_JAN,2026
G9935,Adenoma(s) or colorectal cancer not detected during screening colonoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G9936,"Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anus",HCPCS_Level_II,HCPC2026_JAN,2026
G9937,Diagnostic colonoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
G9938,"Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
G9939,Pathologists/dermatopathologists is the same clinician who performed the biopsy,HCPCS_Level_II,HCPC2026_JAN,2026
G9940,"Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)",HCPCS_Level_II,HCPC2026_JAN,2026
G9941,Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9942,Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy,HCPCS_Level_II,HCPC2026_JAN,2026
G9943,Back pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9944,Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year  (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9945,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular,  idiopathic or congenital lumbar scoliosis",HCPCS_Level_II,HCPC2026_JAN,2026
G9946,Back pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9947,Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9948,Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomy,HCPCS_Level_II,HCPC2026_JAN,2026
G9949,Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9954,Patient exhibits 2 or more risk factors for post-operative vomiting,HCPCS_Level_II,HCPC2026_JAN,2026
G9955,Cases in which an inhalational anesthetic is used only for induction,HCPCS_Level_II,HCPC2026_JAN,2026
G9956,Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9957,"Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)",HCPCS_Level_II,HCPC2026_JAN,2026
G9958,Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
G9959,Systemic antimicrobials not prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9960,Documentation of medical reason(s) for prescribing systemic antimicrobials,HCPCS_Level_II,HCPC2026_JAN,2026
G9961,Systemic antimicrobials prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
G9962,Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy,HCPCS_Level_II,HCPC2026_JAN,2026
G9963,Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy,HCPCS_Level_II,HCPC2026_JAN,2026
G9964,Patient received at least one well-child visit with a pcp during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
G9965,Patient did not receive at least one well-child visit with a pcp during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
G9966,"Children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
G9967,"Children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and report",HCPCS_Level_II,HCPC2026_JAN,2026
G9968,Patient was referred to another clinician or specialist during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9969,Clinician who referred the patient to another clinician received a report from the clinician to whom the patient was referred,HCPCS_Level_II,HCPC2026_JAN,2026
G9970,Clinician who referred the patient to another clinician did not receive a report from the clinician to whom the patient was referred,HCPCS_Level_II,HCPC2026_JAN,2026
G9974,"Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity",HCPCS_Level_II,HCPC2026_JAN,2026
G9975,Documentation of medical reason(s) for not performing a dilated macular examination,HCPCS_Level_II,HCPC2026_JAN,2026
G9978,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9979,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: an expanded problem focused history;  an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9980,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting  problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9981,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9982,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9983,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9984,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9985,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a detailed history;  a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9986,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology",HCPCS_Level_II,HCPC2026_JAN,2026
G9987,"Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary  connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code",HCPCS_Level_II,HCPC2026_JAN,2026
G9988,Palliative care services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9989,"Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine)",HCPCS_Level_II,HCPC2026_JAN,2026
G9990,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9991,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9992,Palliative care services used by patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9993,Patient was provided palliative care services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9994,Patient is using palliative care services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9995,Patients who use palliative care services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
G9996,Documentation stating the patient has received or is currently receiving palliative or hospice care,HCPCS_Level_II,HCPC2026_JAN,2026
G9997,Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter,HCPCS_Level_II,HCPC2026_JAN,2026
G9998,"Documentation of medical reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, piecemeal removal of adenomas, or sessile serrated polyps >= 20 mm in size, last colonoscopy found greater than 10 adenomas, lower gastrointestinal bleeding, or patient at high risk for colon cancer due to underlying medical history ([i.e. crohn's disease, ulcerative colitis, personal or family history of colon cancer, hereditary colorectal cancer syndromes])",HCPCS_Level_II,HCPC2026_JAN,2026
G9999,"Documentation of system reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., unable to locate previous colonoscopy report, patient cannot provide precise date or details from previous colonoscopy, previous colonoscopy report was incomplete)",HCPCS_Level_II,HCPC2026_JAN,2026
GA,"Waiver of liability statement issued as required by payer policy, individual case",HCPCS_Level_II,HCPC2026_JAN,2026
GB,Claim being re-submitted for payment because it is no longer covered under a global payment demonstration,HCPCS_Level_II,HCPC2026_JAN,2026
GC,This service has been performed in part by a resident under the direction of a teaching physician,HCPCS_Level_II,HCPC2026_JAN,2026
GD,Units of service exceeds medically unlikely edit value and represents reasonable and necessary services,HCPCS_Level_II,HCPC2026_JAN,2026
GE,This service has been performed by a resident without the presence of a teaching physician under the primary care exception,HCPCS_Level_II,HCPC2026_JAN,2026
GF,"Non-physician (e.g. nurse practitioner (np), certified registered nurse anesthetist (crna), certified registered nurse (crn), clinical nurse specialist (cns), physician assistant (pa)) services in a critical access hospital",HCPCS_Level_II,HCPC2026_JAN,2026
GG,"Performance and payment of a screening mammogram and diagnostic mammogram on the same patient, same day",HCPCS_Level_II,HCPC2026_JAN,2026
GH,Diagnostic mammogram converted from screening mammogram on same day,HCPCS_Level_II,HCPC2026_JAN,2026
GJ,"""opt out"" physician or practitioner emergency or urgent service",HCPCS_Level_II,HCPC2026_JAN,2026
GK,Reasonable and necessary item/service associated with a ga or gz modifier,HCPCS_Level_II,HCPC2026_JAN,2026
GL,"Medically unnecessary upgrade provided instead of non-upgraded item, no charge, no advance beneficiary notice (abn)",HCPCS_Level_II,HCPC2026_JAN,2026
GM,Multiple patients on one ambulance trip,HCPCS_Level_II,HCPC2026_JAN,2026
GN,Services delivered under an outpatient speech language pathology plan of care,HCPCS_Level_II,HCPC2026_JAN,2026
GO,Services delivered under an outpatient occupational therapy plan of care,HCPCS_Level_II,HCPC2026_JAN,2026
GP,Services delivered under an outpatient physical therapy plan of care,HCPCS_Level_II,HCPC2026_JAN,2026
GQ,Via asynchronous telecommunications system,HCPCS_Level_II,HCPC2026_JAN,2026
GR,"This service was performed in whole or in part by a resident in a department of veterans affairs medical center or clinic, supervised in accordance with va policy",HCPCS_Level_II,HCPC2026_JAN,2026
GS,Dosage of erythropoietin stimulating agent has been reduced and maintained in response to hematocrit or hemoglobin level,HCPCS_Level_II,HCPC2026_JAN,2026
GT,Via interactive audio and video telecommunication systems,HCPCS_Level_II,HCPC2026_JAN,2026
GU,"Waiver of liability statement issued as required by payer policy, routine notice",HCPCS_Level_II,HCPC2026_JAN,2026
GV,Attending physician not employed or paid under arrangement by the patient's hospice provider,HCPCS_Level_II,HCPC2026_JAN,2026
GW,Service not related to the hospice patient's terminal condition,HCPCS_Level_II,HCPC2026_JAN,2026
GX,"Notice of liability issued, voluntary under payer policy",HCPCS_Level_II,HCPC2026_JAN,2026
GXXX1,"Bhv couns dm prev, onln 60 m",HCPCS_Level_II,RVU2026A,2026
GY,"Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit",HCPCS_Level_II,HCPC2026_JAN,2026
GZ,Item or service expected to be denied as not reasonable and necessary,HCPCS_Level_II,HCPC2026_JAN,2026
H0001,Alcohol and/or drug assessment,HCPCS_Level_II,HCPC2026_JAN,2026
H0002,Behavioral health screening to determine eligibility for admission to treatment program,HCPCS_Level_II,HCPC2026_JAN,2026
H0003,Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs,HCPCS_Level_II,HCPC2026_JAN,2026
H0004,"Behavioral health counseling and therapy, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H0005,Alcohol and/or drug services; group counseling by a clinician,HCPCS_Level_II,HCPC2026_JAN,2026
H0006,Alcohol and/or drug services; case management,HCPCS_Level_II,HCPC2026_JAN,2026
H0007,Alcohol and/or drug services; crisis intervention (outpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0008,Alcohol and/or drug services; sub-acute detoxification (hospital inpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0009,Alcohol and/or drug services; acute detoxification (hospital inpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0010,Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0011,Alcohol and/or drug services; acute detoxification (residential addiction program inpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0012,Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0013,Alcohol and/or drug services; acute detoxification (residential addiction program outpatient),HCPCS_Level_II,HCPC2026_JAN,2026
H0014,Alcohol and/or drug services; ambulatory detoxification,HCPCS_Level_II,HCPC2026_JAN,2026
H0015,"Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education",HCPCS_Level_II,HCPC2026_JAN,2026
H0016,Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting),HCPCS_Level_II,HCPC2026_JAN,2026
H0017,"Behavioral health; residential (hospital residential treatment program), without room and board, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0018,"Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0019,"Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0020,Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program),HCPCS_Level_II,HCPC2026_JAN,2026
H0021,Alcohol and/or drug training service (for staff and personnel not employed by providers),HCPCS_Level_II,HCPC2026_JAN,2026
H0022,Alcohol and/or drug intervention service (planned facilitation),HCPCS_Level_II,HCPC2026_JAN,2026
H0023,Behavioral health outreach service (planned approach to reach a targeted population),HCPCS_Level_II,HCPC2026_JAN,2026
H0024,Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude),HCPCS_Level_II,HCPC2026_JAN,2026
H0025,"Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)",HCPCS_Level_II,HCPC2026_JAN,2026
H0026,"Alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)",HCPCS_Level_II,HCPC2026_JAN,2026
H0027,Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law),HCPCS_Level_II,HCPC2026_JAN,2026
H0028,"Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment",HCPCS_Level_II,HCPC2026_JAN,2026
H0029,"Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)",HCPCS_Level_II,HCPC2026_JAN,2026
H0030,Behavioral health hotline service,HCPCS_Level_II,HCPC2026_JAN,2026
H0031,"Mental health assessment, by non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
H0032,Mental health service plan development by non-physician,HCPCS_Level_II,HCPC2026_JAN,2026
H0033,"Oral medication administration, direct observation",HCPCS_Level_II,HCPC2026_JAN,2026
H0034,"Medication training and support, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H0035,"Mental health partial hospitalization, treatment, less than 24 hours",HCPCS_Level_II,HCPC2026_JAN,2026
H0036,"Community psychiatric supportive treatment, face-to-face, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H0037,"Community psychiatric supportive treatment program, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0038,"Self-help/peer services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H0039,"Assertive community treatment, face-to-face, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H0040,"Assertive community treatment program, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0041,"Foster care, child, non-therapeutic, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0042,"Foster care, child, non-therapeutic, per month",HCPCS_Level_II,HCPC2026_JAN,2026
H0043,"Supported housing, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0044,"Supported housing, per month",HCPCS_Level_II,HCPC2026_JAN,2026
H0045,"Respite care services, not in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H0046,"Mental health services, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
H0047,"Alcohol and/or other drug abuse services, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
H0048,"Alcohol and/or other drug testing: collection and handling only, specimens other than blood",HCPCS_Level_II,HCPC2026_JAN,2026
H0049,Alcohol and/or drug screening,HCPCS_Level_II,HCPC2026_JAN,2026
H0050,"Alcohol and/or drug services, brief intervention, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H0051,Traditional healing service,HCPCS_Level_II,HCPC2026_JAN,2026
H0052,Missing and murdered indigenous persons (mmip) mental health and clinical care,HCPCS_Level_II,HCPC2026_JAN,2026
H0053,Historical trauma (ht) mental health and clinical care for indigenous persons,HCPCS_Level_II,HCPC2026_JAN,2026
H1000,"Prenatal care, at-risk assessment",HCPCS_Level_II,HCPC2026_JAN,2026
H1001,"Prenatal care, at-risk enhanced service; antepartum management",HCPCS_Level_II,HCPC2026_JAN,2026
H1002,"Prenatal care, at risk enhanced service; care coordination",HCPCS_Level_II,HCPC2026_JAN,2026
H1003,"Prenatal care, at-risk enhanced service; education",HCPCS_Level_II,HCPC2026_JAN,2026
H1004,"Prenatal care, at-risk enhanced service; follow-up home visit",HCPCS_Level_II,HCPC2026_JAN,2026
H1005,"Prenatal care, at-risk enhanced service package (includes h1001-h1004)",HCPCS_Level_II,HCPC2026_JAN,2026
H1010,"Non-medical family planning education, per session",HCPCS_Level_II,HCPC2026_JAN,2026
H1011,Family assessment by licensed behavioral health professional for state defined purposes,HCPCS_Level_II,HCPC2026_JAN,2026
H2000,Comprehensive multidisciplinary evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
H2001,"Rehabilitation program, per 1/2 day",HCPCS_Level_II,HCPC2026_JAN,2026
H2010,"Comprehensive medication services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2011,"Crisis intervention service, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2012,"Behavioral health day treatment, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
H2013,"Psychiatric health facility service, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2014,"Skills training and development, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2015,"Comprehensive community support services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2016,"Comprehensive community support services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2017,"Psychosocial rehabilitation services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2018,"Psychosocial rehabilitation services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2019,"Therapeutic behavioral services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2020,"Therapeutic behavioral services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2021,"Community-based wrap-around services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2022,"Community-based wrap-around services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2023,"Supported employment, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2024,"Supported employment, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2025,"Ongoing support to maintain employment, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2026,"Ongoing support to maintain employment, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2027,"Psychoeducational service, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2028,"Sexual offender treatment service, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2029,"Sexual offender treatment service, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2030,"Mental health clubhouse services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2031,"Mental health clubhouse services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2032,"Activity therapy, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2033,"Multisystemic therapy for juveniles, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2034,"Alcohol and/or drug abuse halfway house services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2035,"Alcohol and/or other drug treatment program, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
H2036,"Alcohol and/or other drug treatment program, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2037,"Developmental delay prevention activities, dependent child of client, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
H2038,"Skills training and development, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
H2040,"Coordinated specialty care, team-based, for first episode psychosis, per month",HCPCS_Level_II,HCPC2026_JAN,2026
H2041,"Coordinated specialty care, team-based, for first episode psychosis, per encounter",HCPCS_Level_II,HCPC2026_JAN,2026
H9,Court-ordered,HCPCS_Level_II,HCPC2026_JAN,2026
HA,Child/adolescent program,HCPCS_Level_II,HCPC2026_JAN,2026
HB,"Adult program, non geriatric",HCPCS_Level_II,HCPC2026_JAN,2026
HC,"Adult program, geriatric",HCPCS_Level_II,HCPC2026_JAN,2026
HD,Pregnant/parenting women's program,HCPCS_Level_II,HCPC2026_JAN,2026
HE,Mental health program,HCPCS_Level_II,HCPC2026_JAN,2026
HF,Substance abuse program,HCPCS_Level_II,HCPC2026_JAN,2026
HG,Opioid addiction treatment program,HCPCS_Level_II,HCPC2026_JAN,2026
HH,Integrated mental health/substance abuse program,HCPCS_Level_II,HCPC2026_JAN,2026
HI,Integrated mental health and intellectual disability/developmental disabilities program,HCPCS_Level_II,HCPC2026_JAN,2026
HJ,Employee assistance program,HCPCS_Level_II,HCPC2026_JAN,2026
HK,Specialized mental health programs for high-risk populations,HCPCS_Level_II,HCPC2026_JAN,2026
HL,Intern,HCPCS_Level_II,HCPC2026_JAN,2026
HM,Less than bachelor degree level,HCPCS_Level_II,HCPC2026_JAN,2026
HN,Bachelors degree level,HCPCS_Level_II,HCPC2026_JAN,2026
HO,Masters degree level,HCPCS_Level_II,HCPC2026_JAN,2026
HP,Doctoral level,HCPCS_Level_II,HCPC2026_JAN,2026
HQ,Group setting,HCPCS_Level_II,HCPC2026_JAN,2026
HR,Family/couple with client present,HCPCS_Level_II,HCPC2026_JAN,2026
HS,Family/couple without client present,HCPCS_Level_II,HCPC2026_JAN,2026
HT,Multi-disciplinary team,HCPCS_Level_II,HCPC2026_JAN,2026
HU,Funded by child welfare agency,HCPCS_Level_II,HCPC2026_JAN,2026
HV,Funded state addictions agency,HCPCS_Level_II,HCPC2026_JAN,2026
HW,Funded by state mental health agency,HCPCS_Level_II,HCPC2026_JAN,2026
HX,Funded by county/local agency,HCPCS_Level_II,HCPC2026_JAN,2026
HY,Funded by juvenile justice agency,HCPCS_Level_II,HCPC2026_JAN,2026
HZ,Funded by criminal justice agency,HCPCS_Level_II,HCPC2026_JAN,2026
J0013,"Esketamine, nasal spray, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0120,"Injection, tetracycline, up to 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0121,"Injection, omadacycline, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0122,"Injection, eravacycline, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0129,"Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J0130,"Injection abciximab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0131,"Injection, acetaminophen, not otherwise specified,10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0132,"Injection, acetylcysteine, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0133,"Injection, acyclovir, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0134,"Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0135,"Injection, adalimumab, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0136,"Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0137,"Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0138,"Injection, acetaminophen 10 mg and ibuprofen 3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0139,"Injection, adalimumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0150,"Injection, adenosine for therapeutic use,  6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)",HCPCS_Level_II,HCPC2026_JAN,2026
J0151,"Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)",HCPCS_Level_II,HCPC2026_JAN,2026
J0153,"Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)",HCPCS_Level_II,HCPC2026_JAN,2026
J0162,"Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0163,"Injection, epinephrine in sodium chloride (endo), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0164,"Injection, epinephrine in sodium chloride (baxter), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0165,"Injection, epinephrine, not otherwise specified, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0166,"Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0167,"Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0168,"Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0169,"Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0171,"Injection, adrenalin, epinephrine, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0172,"Injection, aducanumab-avwa, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0173,"Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0174,"Injection, lecanemab-irmb, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0175,"Injection, donanemab-azbt, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0177,"Injection, aflibercept hd, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0178,"Injection, aflibercept, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0179,"Injection, brolucizumab-dbll, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0180,"Injection, agalsidase beta, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0184,"Injection, amisulpride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0185,"Injection, aprepitant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0190,"Injection, biperiden lactate, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0200,"Injection, alatrofloxacin mesylate, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0202,"Injection, alemtuzumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0205,"Injection, alglucerase, per 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0206,"Injection, allopurinol sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0207,"Injection, amifostine, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0208,"Injection, sodium thiosulfate (pedmark), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0209,"Injection, sodium thiosulfate (hope), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0210,"Injection, methyldopate hcl, up to 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0211,"Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)",HCPCS_Level_II,HCPC2026_JAN,2026
J0215,"Injection, alefacept, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0216,"Injection, alfentanil hydrochloride, 500 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J0217,"Injection, velmanase alfa-tycv, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0218,"Injection, olipudase alfa-rpcp, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0219,"Injection, avalglucosidase alfa-ngpt, 4 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0220,"Injection, alglucosidase alfa, 10 mg, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
J0221,"Injection, alglucosidase alfa, (lumizyme), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0222,"Injection, patisiran, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0223,"Injection, givosiran, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0224,"Injection, lumasiran, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0225,"Injection, vutrisiran, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0248,"Injection, remdesivir, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0256,"Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0257,"Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0270,"Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J0275,"Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J0278,"Injection, amikacin sulfate, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0280,"Injection, aminophyllin, up to 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0281,"Injection, aminocaproic acid, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J0282,"Injection, amiodarone hydrochloride, 30 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0283,"Injection, amiodarone hydrochloride (nexterone), 30 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0285,"Injection, amphotericin b, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0287,"Injection, amphotericin b lipid complex, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0288,"Injection, amphotericin b cholesteryl sulfate complex, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0289,"Injection, amphotericin b liposome, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0290,"Injection, ampicillin sodium, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0291,"Injection, plazomicin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0295,"Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J0300,"Injection, amobarbital, up to 125 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0330,"Injection, succinylcholine chloride, up to 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0348,"Injection, anidulafungin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0349,"Injection, rezafungin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0350,"Injection, anistreplase, per 30 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0360,"Injection, hydralazine hcl, up to 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0364,"Injection, apomorphine hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0365,"Injection, aprotonin, 10,000 kiu",HCPCS_Level_II,HCPC2026_JAN,2026
J0380,"Injection, metaraminol bitartrate, per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0390,"Injection, chloroquine hydrochloride, up to 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0391,"Injection, artesunate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0395,"Injection, arbutamine hcl, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0400,"Injection, aripiprazole, intramuscular, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0401,"Injection, aripiprazole (abilify maintena), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0402,"Injection, aripiprazole (abilify asimtufii), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0456,"Injection, azithromycin, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0457,"Injection, aztreonam, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0458,"Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)",HCPCS_Level_II,HCPC2026_JAN,2026
J0461,"Injection, atropine sulfate, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0462,"Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0470,"Injection, dimercaprol, per 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0475,"Injection, baclofen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0476,"Injection, baclofen, 50 mcg for intrathecal trial",HCPCS_Level_II,HCPC2026_JAN,2026
J0480,"Injection, basiliximab, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0485,"Injection, belatacept, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0490,"Injection, belimumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0491,"Injection, anifrolumab-fnia, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0500,"Injection, dicyclomine hcl, up to 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0515,"Injection, benztropine mesylate, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0517,"Injection, benralizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0520,"Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0525,"Injection, cefotetan disodium, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0558,"Injection, penicillin g benzathine and penicillin g procaine, 100,000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0561,"Injection, penicillin g benzathine, 100,000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0565,"Injection, bezlotoxumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0567,"Injection, cerliponase alfa, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0570,"Buprenorphine implant, 74.2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0571,"Buprenorphine, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0572,"Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine",HCPCS_Level_II,HCPC2026_JAN,2026
J0573,"Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine",HCPCS_Level_II,HCPC2026_JAN,2026
J0574,"Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine",HCPCS_Level_II,HCPC2026_JAN,2026
J0575,"Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine",HCPCS_Level_II,HCPC2026_JAN,2026
J0576,"Injection, buprenorphine extended-release (brixadi), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0577,"Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy",HCPCS_Level_II,HCPC2026_JAN,2026
J0578,"Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy",HCPCS_Level_II,HCPC2026_JAN,2026
J0582,"Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0583,"Injection, bivalirudin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0584,"Injection, burosumab-twza 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0585,"Injection, onabotulinumtoxina, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J0586,"Injection, abobotulinumtoxina, 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0587,"Injection, rimabotulinumtoxinb, 100 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0588,"Injection, incobotulinumtoxin a, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J0589,"Injection, daxibotulinumtoxina-lanm, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J0591,"Injection, deoxycholic acid, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0592,"Injection, buprenorphine hydrochloride, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0593,"Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J0594,"injection, busulfan, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0595,"Injection, butorphanol tartrate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0596,"Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0597,"Injection, c-1 esterase inhibitor (human), berinert, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0598,"Injection, c-1 esterase inhibitor (human), cinryze, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0599,"Injection, c-1 esterase inhibitor (human), (haegarda), 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0600,"Injection, edetate calcium disodium, up to 1000 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0601,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0602,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0603,"Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0604,"Cinacalcet, oral, 1 mg, (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0605,"Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0606,"Injection, etelcalcetide, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0607,"Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0608,"Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0609,"Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0610,"Injection, calcium gluconate (fresenius kabi), per 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J0611,"Injection, calcium gluconate (wg critical care), per 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J0612,"Injection, calcium gluconate, not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0613,"Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0614,"Injection, treosulfan, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0615,"Calcium acetate, oral, 23 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0616,"Injection, metoprolol tartrate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0618,"Injection, calcium chloride, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0620,"Injection, calcium glycerophosphate and calcium lactate, per 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J0630,"Injection, calcitonin salmon, up to 400 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0636,"Injection, calcitriol, 0.1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J0637,"Injection, caspofungin acetate, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0638,"Injection, canakinumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0640,"Injection, leucovorin calcium, per 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0641,"Injection, levoleucovorin, not otherwise specified, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0642,"Injection, levoleucovorin (khapzory), 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0650,"Injection, levothyroxine sodium, not otherwise specified, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J0651,"Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J0652,"Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J0654,"Injection, liothyronine, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J0665,"Injection, bupivicaine, not otherwise specified, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0666,"Injection, bupivacaine liposome, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0668,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0670,"Injection, mepivacaine hydrochloride, per 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J0675,"Injection, carboprost tromethamine, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0681,"Injection, ceftobiprole medocaril sodium, 3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0687,"Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0688,"Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0689,"Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0690,"Injection, cefazolin sodium, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0691,"Injection, lefamulin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0692,"Injection, cefepime hydrochloride, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0693,"Injection, cefiderocol, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0694,"Injection, cefoxitin sodium, 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J0695,"Injection, ceftolozane 50 mg and tazobactam 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0696,"Injection, ceftriaxone sodium, per 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0697,"Injection, sterile cefuroxime sodium, per 750 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0698,"Injection, cefotaxime sodium, per gm",HCPCS_Level_II,HCPC2026_JAN,2026
J0699,"Injection, cefiderocol, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0701,"Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0702,"Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0703,"Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0706,"Injection, caffeine citrate, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0710,"Injection, cephapirin sodium, up to 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J0712,"Injection, ceftaroline fosamil, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0713,"Injection, ceftazidime, per 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0714,"Injection, ceftazidime and avibactam, 0.5 g/0.125 g",HCPCS_Level_II,HCPC2026_JAN,2026
J0715,"Injection, ceftizoxime sodium, per 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0716,"Injection, centruroides immune f(ab)2, up to 120 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J0717,"Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J0720,"Injection, chloramphenicol sodium succinate, up to 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J0725,"Injection, chorionic gonadotropin, per 1,000 usp units",HCPCS_Level_II,HCPC2026_JAN,2026
J0735,"Injection, clonidine hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0736,"Injection, clindamycin phosphate, 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0737,"Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0738,"Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)",HCPCS_Level_II,HCPC2026_JAN,2026
J0739,"Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)",HCPCS_Level_II,HCPC2026_JAN,2026
J0740,"Injection, cidofovir, 375 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0741,"Injection, cabotegravir and rilpivirine, 2mg/3mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0742,"Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0743,"Injection, cilastatin sodium; imipenem, per 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0744,"Injection, ciprofloxacin for intravenous infusion, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0745,"Injection, codeine phosphate, per 30 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0750,"Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)",HCPCS_Level_II,HCPC2026_JAN,2026
J0751,"Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)",HCPCS_Level_II,HCPC2026_JAN,2026
J0752,"Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)",HCPCS_Level_II,HCPC2026_JAN,2026
J0759,"Injection, clevidipine butyrate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0760,"Injection, colchicine, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0770,"Injection, colistimethate sodium, up to 150 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0775,"Injection, collagenase, clostridium histolyticum, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0780,"Injection, prochlorperazine, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0791,"Injection, crizanlizumab-tmca, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0795,"Injection, corticorelin ovine triflutate, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J0799,"Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
J0800,"Injection, corticotropin, up to 40 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0801,"Injection, corticotropin (acthar gel), up to 40 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0802,"Injection, corticotropin (ani), up to 40 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0833,"Injection, cosyntropin, not otherwise specified, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0834,"Injection, cosyntropin, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0840,"Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J0841,"Injection, crotalidae immune f(ab')2 (equine), 120 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0850,"Injection, cytomegalovirus immune globulin intravenous (human), per vial",HCPCS_Level_II,HCPC2026_JAN,2026
J0870,"Injection, imetelstat, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0872,"Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0873,"Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0874,"Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0875,"Injection, dalbavancin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0877,"Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0878,"Injection, daptomycin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0879,"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0881,"Injection, darbepoetin alfa, 1 microgram (non-esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
J0882,"Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0883,"Injection, argatroban, 1 mg (for non-esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
J0884,"Injection, argatroban, 1 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0885,"Injection, epoetin alfa, (for non-esrd use), 1000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J0886,"Injection, epoetin alfa, 1000 units (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0887,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0888,"Injection, epoetin beta, 1 microgram, (for non esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
J0889,"Daprodustat, oral, 1 mg, (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0890,"Injection, peginesatide, 0.1 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0891,"Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
J0892,"Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0893,"Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0894,"Injection, decitabine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0895,"Injection, deferoxamine mesylate, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0896,"Injection, luspatercept-aamt, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0897,"Injection, denosumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J0898,"Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
J0899,"Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0900,"Injection, testosterone enanthate and estradiol valerate, up to 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J0901,"Vadadustat, oral, 1 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0911,"Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
J0945,"Injection, brompheniramine maleate, per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1,Competitive acquisition program no-pay submission for a prescription number,HCPCS_Level_II,HCPC2026_JAN,2026
J1000,"Injection, depo-estradiol cypionate, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1010,"Injection, methylprednisolone acetate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1020,"Injection, methylprednisolone acetate, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1030,"Injection, methylprednisolone acetate, 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1040,"Injection, methylprednisolone acetate, 80 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1050,"Injection, medroxyprogesterone acetate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1060,"Injection, testosterone cypionate and estradiol cypionate, up to 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J1070,"Injection, testosterone cypionate, up to 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1071,"Injection, testosterone cypionate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1072,"Injection, testosterone cypionate (azmiro), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1073,"Testosterone pellet, implant, 75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1080,"Injection, testosterone cypionate, 1 cc, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1094,"Injection, dexamethasone acetate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1095,"Injection, dexamethasone 9 percent, intraocular, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J1096,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1097,"Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J1100,"Injection, dexamethasone sodium phosphate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1105,"Dexmedetomidine, oral, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J1110,"Injection, dihydroergotamine mesylate, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1120,"Injection, acetazolamide sodium, up to 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1130,"Injection, diclofenac sodium, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1160,"Injection, digoxin, up to 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1162,"Injection, digoxin immune fab (ovine), per vial",HCPCS_Level_II,HCPC2026_JAN,2026
J1163,"Injection, diltiazem hydrochloride, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1165,"Injection, phenytoin sodium, per 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1170,"Injection, hydromorphone, up to 4 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1171,"Injection, hydromorphone, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1180,"Injection, dyphylline, up to 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1190,"Injection, dexrazoxane hydrochloride, per 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1200,"Injection, diphenhydramine hcl, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1201,"Injection, cetirizine hydrochloride, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1202,"Miglustat, oral, 65 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1203,"Injection, cipaglucosidase alfa-atga, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1205,"Injection, chlorothiazide sodium, per 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1212,"Injection, dmso, dimethyl sulfoxide, 50%, 50 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J1230,"Injection, methadone hcl, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1240,"Injection, dimenhydrinate, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1245,"Injection, dipyridamole, per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1250,"Injection, dobutamine hydrochloride, per 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1260,"Injection, dolasetron mesylate, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1265,"Injection, dopamine hcl, 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1267,"Injection, doripenem, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1270,"Injection, doxercalciferol, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J1271,"Injection, doxycycline hyclate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1290,"Injection, ecallantide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1299,"Injection, eculizumab, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1300,"Injection, eculizumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1301,"Injection, edaravone, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1302,"Injection, sutimlimab-jome, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1303,"Injection, ravulizumab-cwvz, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1304,"Injection, tofersen, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1305,"Injection, evinacumab-dgnb, 5mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1306,"Injection, inclisiran, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1307,"Injection, crovalimab-akkz, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1308,"Injection, famotidine, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1320,"Injection, amitriptyline hcl, up to 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1322,"Injection, elosulfase alfa, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1323,"Injection, elranatamab-bcmm, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1324,"Injection, enfuvirtide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1325,"Injection, epoprostenol, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1326,"Injection, zolbetuximab-clzb, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1327,"Injection, eptifibatide, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1330,"Injection, ergonovine maleate, up to 0.2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1335,"Injection, ertapenem sodium, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1364,"Injection, erythromycin lactobionate, per 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1370,"Injection, esomeprazole sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1380,"Injection, estradiol valerate, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1410,"Injection, estrogen conjugated, per 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1411,"Injection, etranacogene dezaparvovec-drlb, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
J1412,"Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes",HCPCS_Level_II,HCPC2026_JAN,2026
J1413,"Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
J1414,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
J1426,"Injection, casimersen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1427,"Injection, viltolarsen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1428,"Injection, eteplirsen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1429,"Injection, golodirsen, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1430,"Injection, ethanolamine oleate, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1434,"Injection, fosaprepitant (focinvez), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1435,"Injection, estrone, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1436,"Injection, etidronate disodium, per 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1437,"Injection, ferric derisomaltose, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1438,"Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J1439,"Injection, ferric carboxymaltose, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1440,"Fecal microbiota, live - jslm, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J1442,"Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J1443,"Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron",HCPCS_Level_II,HCPC2026_JAN,2026
J1444,"Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron",HCPCS_Level_II,HCPC2026_JAN,2026
J1445,"Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron",HCPCS_Level_II,HCPC2026_JAN,2026
J1446,"Injection, tbo-filgrastim, 5 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J1447,"Injection, tbo-filgrastim, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J1448,"Injection, trilaciclib, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1449,"Injection, eflapegrastim-xnst, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1450,"Injection fluconazole, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1451,"Injection, fomepizole, 15 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1452,"Injection, fomivirsen sodium, intraocular, 1.65 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1453,"Injection, fosaprepitant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1454,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1455,"Injection, foscarnet sodium, per 1000 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1456,"Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1457,"Injection, gallium nitrate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1458,"Injection, galsulfase, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1459,"Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1460,"Injection, gamma globulin, intramuscular, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J1551,"Injection, immune globulin (cutaquig), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1552,"Injection, immune globulin (alyglo), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1554,"Injection, immune globulin (asceniv), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1555,"Injection, immune globulin (cuvitru), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1556,"Injection, immune globulin (bivigam), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1557,"Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1558,"Injection, immune globulin (xembify), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1559,"Injection, immune globulin (hizentra), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1560,"Injection, gamma globulin, intramuscular, over 10 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J1561,"Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1562,"Injection, immune globulin (vivaglobin), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1566,"Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1568,"Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1569,"Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1570,"Injection, ganciclovir sodium, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1571,"Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J1572,"Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1573,"Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J1574,"Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1575,"Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin",HCPCS_Level_II,HCPC2026_JAN,2026
J1576,"Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1580,"Injection, garamycin, gentamicin, up to 80 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1590,"Injection, gatifloxacin, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1595,"Injection, glatiramer acetate, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1596,"Injection, glycopyrrolate, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1597,"Injection, glycopyrrolate (glyrx-pf), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1598,"Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1599,"Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1600,"Injection, gold sodium thiomalate, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1602,"Injection, golimumab, 1 mg, for intravenous use",HCPCS_Level_II,HCPC2026_JAN,2026
J1610,"Injection, glucagon hydrochloride, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1611,"Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1612,"Injection, glucagon (gvoke), 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1620,"Injection, gonadorelin hydrochloride, per 100 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J1626,"Injection, granisetron hydrochloride, 100 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J1627,"Injection, granisetron, extended-release, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1628,"Injection, guselkumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1630,"Injection, haloperidol, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1631,"Injection, haloperidol decanoate, per 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1632,"Injection, brexanolone, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1640,"Injection, hemin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1642,"Injection, heparin sodium, (heparin lock flush), per 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1643,"Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1644,"Injection, heparin sodium, per 1000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1645,"Injection, dalteparin sodium, per 2500 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J1650,"Injection, enoxaparin sodium, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1652,"Injection, fondaparinux sodium, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1655,"Injection, tinzaparin sodium, 1000 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J1670,"Injection, tetanus immune globulin, human, up to 250 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1675,"Injection, histrelin acetate, 10 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J1700,"Injection, hydrocortisone acetate, up to 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1710,"Injection, hydrocortisone sodium phosphate, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1720,"Injection, hydrocortisone sodium succinate, up to 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1725,"Injection, hydroxyprogesterone caproate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1726,"Injection, hydroxyprogesterone caproate, (makena), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1729,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1730,"Injection, diazoxide, up to 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1736,"Injection, meloxicam (delova), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1737,"Injection, meloxicam (azurity), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1738,"Injection, meloxicam, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1740,"Injection, ibandronate sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1741,"Injection, ibuprofen, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1742,"Injection, ibutilide fumarate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1743,"Injection, idursulfase, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1744,"Injection, icatibant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1745,"Injection, infliximab, excludes biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1746,"Injection, ibalizumab-uiyk, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1747,"Injection, spesolimab-sbzo, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1748,"Injection, infliximab-dyyb (zymfentra), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1749,"Injection, iloprost, 0.1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J1750,"Injection, iron dextran, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1756,"Injection, iron sucrose, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1786,"Injection, imiglucerase, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1790,"Injection, droperidol, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1800,"Injection, propranolol hcl, up to 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1805,"Injection, esmolol hydrochloride, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1806,"Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1807,"Injection, ethacrynate sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1808,"Injection, folic acid, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1809,"Injection, fosdenopterin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1810,"Injection, droperidol and fentanyl citrate, up to 2 ml ampule",HCPCS_Level_II,HCPC2026_JAN,2026
J1811,"Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1812,"Insulin (fiasp), per 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1813,"Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1814,"Insulin (lyumjev), per 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1815,"Injection, insulin, per 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1817,"Insulin for administration through dme (i.e., insulin pump) per 50 units",HCPCS_Level_II,HCPC2026_JAN,2026
J1823,"Injection, inebilizumab-cdon, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1826,"Injection, interferon beta-1a, 30 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J1830,"Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J1833,"Injection, isavuconazonium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1834,"Injection, isoniazid, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1835,"Injection, itraconazole, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1836,"Injection, metronidazole, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1837,"Injection, posaconazole, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1840,"Injection, kanamycin sulfate, up to 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1850,"Injection, kanamycin sulfate, up to 75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1885,"Injection, ketorolac tromethamine, per 15 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1890,"Injection, cephalothin sodium, up to 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J1920,"Injection, labetalol hydrochloride, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1921,"Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1930,"Injection, lanreotide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1931,"Injection, laronidase, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1932,"Injection, lanreotide, (cipla), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1938,"Injection, furosemide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1939,"Injection, bumetanide, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1940,"Injection, furosemide, up to 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1941,"Injection, furosemide (furoscix), 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1942,"Injection, aripiprazole lauroxil, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1943,"Injection, aripiprazole lauroxil, (aristada initio), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1944,"Injection, aripiprazole lauroxil, (aristada), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1945,"Injection, lepirudin, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1950,"Injection, leuprolide acetate (for depot suspension), per 3.75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1951,"Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1952,"Leuprolide injectable, camcevi, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1953,"Injection, levetiracetam, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1954,"Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1955,"Injection, levocarnitine, per 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J1956,"Injection, levofloxacin, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1960,"Injection, levorphanol tartrate, up to 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1961,"Injection, lenacapavir (only for use as hiv treatment), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1980,"Injection, hyoscyamine sulfate, up to 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J1990,"Injection, chlordiazepoxide hcl, up to 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2,"Competitive acquisition program, restocking of emergency drugs after emergency administration",HCPCS_Level_II,HCPC2026_JAN,2026
J2001,"Injection, lidocaine hcl for intravenous infusion, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2002,"Injection, lidocaine hcl in 5% dextrose, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2003,"Injection, lidocaine hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2004,"Injection, lidocaine hcl with epinephrine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2010,"Injection, lincomycin hcl, up to 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2020,"Injection, linezolid, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2021,"Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2060,"Injection, lorazepam, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2062,"Loxapine for inhalation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2150,"Injection, mannitol, 25% in 50 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2151,"Injection, mannitol, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2170,"Injection, mecasermin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2175,"Injection, meperidine hydrochloride, per 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2180,"Injection, meperidine and promethazine hcl, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2182,"Injection, mepolizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2183,"Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2184,"Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2185,"Injection, meropenem, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2186,"Injection, meropenem and vaborbactam, 10mg/10mg (20mg)",HCPCS_Level_II,HCPC2026_JAN,2026
J2210,"Injection, methylergonovine maleate, up to 0.2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2212,"Injection, methylnaltrexone, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2246,"Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2247,"Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2248,"Injection, micafungin sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2249,"Injection, remimazolam, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2250,"Injection, midazolam hydrochloride, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2251,"Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2252,"Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2253,"Injection, midazolam (seizalam), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2260,"Injection, milrinone lactate, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2265,"Injection, minocycline hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2267,"Injection, mirikizumab-mrkz, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2270,"Injection, morphine sulfate, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2271,"Injection, morphine sulfate, 100mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2272,"Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2274,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2275,"Injection, morphine sulfate (preservative-free sterile solution), per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2277,"Injection, motixafortide, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2278,"Injection, ziconotide, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J2280,"Injection, moxifloxacin, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2281,"Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2290,"Injection, nafcillin sodium, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2291,"Injection, nafcillin sodium (baxter), 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2300,"Injection, nalbuphine hydrochloride, per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2305,"Injection, nitroglycerin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2310,"Injection, naloxone hydrochloride, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2311,"Injection, naloxone hydrochloride (zimhi), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2312,"Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2313,"Injection, naloxone hydrochloride (zimhi), 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2315,"Injection, naltrexone, depot form, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2320,"Injection, nandrolone decanoate, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2323,"Injection, natalizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2325,"Injection, nesiritide, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2326,"Injection, nusinersen, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2327,"Injection, risankizumab-rzaa, intravenous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2329,"Injection, ublituximab-xiiy, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2350,"Injection, ocrelizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2351,"Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq",HCPCS_Level_II,HCPC2026_JAN,2026
J2353,"Injection, octreotide, depot form for intramuscular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2354,"Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J2355,"Injection, oprelvekin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2356,"Injection, tezepelumab-ekko, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2357,"Injection, omalizumab, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2358,"Injection, olanzapine, long-acting, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2359,"Injection, olanzapine, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2360,"Injection, orphenadrine citrate, up to 60 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2370,"Injection, phenylephrine hcl, up to 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2371,"Injection, phenylephrine hydrochloride, 20 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2372,"Injection, phenylephrine hydrochloride (biorphen), 20 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2373,"Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2400,"Injection, chloroprocaine hydrochloride, per 30 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2401,"Injection, chloroprocaine hydrochloride, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2402,"Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2403,"Chloroprocaine hcl ophthalmic, 3% gel, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2404,"Injection, nicardipine, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2405,"Injection, ondansetron hydrochloride, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2406,"Injection, oritavancin (kimyrsa), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2407,"Injection, oritavancin (orbactiv), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2410,"Injection, oxymorphone hcl, up to 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2425,"Injection, palifermin, 50 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2426,"Injection, paliperidone palmitate extended release (invega sustenna), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2427,"Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2428,"Injection, paliperidone palmitate extended release (erzofri), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2430,"Injection, pamidronate disodium, per 30 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2440,"Injection, papaverine hcl, up to 60 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2460,"Injection, oxytetracycline hcl, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2468,"Injection, palonosetron hydrochloride (posfrea), 25 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2469,"Injection, palonosetron hcl, 25 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J2470,"Injection, pantoprazole sodium, 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2471,"Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2472,"Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2501,"Injection, paricalcitol, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J2502,"Injection, pasireotide long acting, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2503,"Injection, pegaptanib sodium, 0.3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2504,"Injection, pegademase bovine, 25 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J2505,"Injection, pegfilgrastim, 6 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2506,"Injection, pegfilgrastim, excludes biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2507,"Injection, pegloticase, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2508,"Injection, pegunigalsidase alfa-iwxj, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2510,"Injection, penicillin g procaine, aqueous, up to 600,000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J2513,"Injection, pentastarch, 10% solution, 100 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2515,"Injection, pentobarbital sodium, per 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2516,"Injection, pentamidine isethionate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2540,"Injection, penicillin g potassium, up to 600,000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J2543,"Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)",HCPCS_Level_II,HCPC2026_JAN,2026
J2545,"Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2547,"Injection, peramivir, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2550,"Injection, promethazine hcl, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2560,"Injection, phenobarbital sodium, up to 120 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2561,"Injection, phenobarbital sodium (sezaby), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2562,"Injection, plerixafor, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2590,"Injection, oxytocin, up to 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J2596,"Injection, vasopressin (long grove), not therapeutically equivalent to j2598, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J2597,"Injection, desmopressin acetate, per 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J2598,"Injection, vasopressin, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J2599,"Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J2601,"Injection, vasopressin (baxter), 1 unit",HCPCS_Level_II,HCPC2026_JAN,2026
J2650,"Injection, prednisolone acetate, up to 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2670,"Injection, tolazoline hcl, up to 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2675,"Injection, progesterone, per 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2679,"Injection, fluphenazine hcl, 1.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2680,"Injection, fluphenazine decanoate, up to 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2690,"Injection, procainamide hcl, up to 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J2700,"Injection, oxacillin sodium, up to 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2704,"Injection, propofol, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2710,"Injection, neostigmine methylsulfate, up to 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2711,"Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2720,"Injection, protamine sulfate, per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2724,"Injection, protein c concentrate, intravenous, human, 10 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J2725,"Injection, protirelin, per 250 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J2730,"Injection, pralidoxime chloride, up to 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J2760,"Injection, phentolamine mesylate, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2765,"Injection, metoclopramide hcl, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2770,"Injection, quinupristin/dalfopristin, 500 mg (150/350)",HCPCS_Level_II,HCPC2026_JAN,2026
J2777,"Injection, faricimab-svoa, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2778,"Injection, ranibizumab, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2779,"Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2780,"Injection, ranitidine hydrochloride, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2781,"Injection, pegcetacoplan, intravitreal, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2782,"Injection, avacincaptad pegol, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2783,"Injection, rasburicase, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2785,"Injection, regadenoson, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2786,"Injection, reslizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2787,"Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2788,"Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)",HCPCS_Level_II,HCPC2026_JAN,2026
J2790,"Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)",HCPCS_Level_II,HCPC2026_JAN,2026
J2791,"Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J2792,"Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J2793,"Injection, rilonacept, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2794,"Injection, risperidone (risperdal consta), 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2795,"Injection, ropivacaine hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2796,"Injection, romiplostim, 10 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2797,"Injection, rolapitant, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2798,"Injection, risperidone, (perseris), 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2799,"Injection, risperidone (uzedy), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2800,"Injection, methocarbamol, up to 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J2801,"Injection, risperidone (rykindo), 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2802,"Injection, romiplostim, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J2804,"Injection, rifampin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2805,"Injection, sincalide, 5 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2806,"Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J2810,"Injection, theophylline, per 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2820,"Injection, sargramostim (gm-csf), 50 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J2840,"Injection, sebelipase alfa, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2850,"Injection, secretin, synthetic, human, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J2860,"Injection, siltuximab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2865,"Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2910,"Injection, aurothioglucose, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2916,"Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2919,"Injection, methylprednisolone sodium succinate, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2920,"Injection, methylprednisolone sodium succinate, up to 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2930,"Injection, methylprednisolone sodium succinate, up to 125 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2940,"Injection, somatrem, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2941,"Injection, somatropin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2950,"Injection, promazine hcl, up to 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2993,"Injection, reteplase, 18.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2995,"Injection, streptokinase, per 250,000 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J2997,"Injection, alteplase recombinant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J2998,"Injection, plasminogen, human-tvmh, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3,"Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology",HCPCS_Level_II,HCPC2026_JAN,2026
J3000,"Injection, streptomycin, up to 1 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J3010,"Injection, fentanyl citrate, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3030,"Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J3031,"Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)",HCPCS_Level_II,HCPC2026_JAN,2026
J3032,"Injection, eptinezumab-jjmr, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3055,"Injection, talquetamab-tgvs, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3060,"Injection, taliglucerase alfa, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J3070,"Injection, pentazocine, 30 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3090,"Injection, tedizolid phosphate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3095,"Injection, telavancin, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3101,"Injection, tenecteplase, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3105,"Injection, terbutaline sulfate, up to 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3110,"Injection, teriparatide, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J3111,"Injection, romosozumab-aqqg, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3120,"Injection, testosterone enanthate, up to 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3121,"Injection, testosterone enanthate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3130,"Injection, testosterone enanthate, up to 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3140,"Injection, testosterone suspension, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3145,"Injection, testosterone undecanoate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3150,"Injection, testosterone propionate, up to 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3230,"Injection, chlorpromazine hcl, up to 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3240,"Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial",HCPCS_Level_II,HCPC2026_JAN,2026
J3241,"Injection, teprotumumab-trbw, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3243,"Injection, tigecycline, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3244,"Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3245,"Injection, tildrakizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3246,"Injection, tirofiban hcl, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3247,"Injection, secukinumab, intravenous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3250,"Injection, trimethobenzamide hcl, up to 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3260,"Injection, tobramycin sulfate, up to 80 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3262,"Injection, tocilizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3263,"Injection, toripalimab-tpzi, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3265,"Injection, torsemide, 10 mg/ml",HCPCS_Level_II,HCPC2026_JAN,2026
J3280,"Injection, thiethylperazine maleate, up to 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3285,"Injection, treprostinil, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3290,"Injection, tranexamic acid, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3291,"Injection, tranexamic acid in sodium chloride, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3299,"Injection, triamcinolone acetonide (xipere), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3300,"Injection, triamcinolone acetonide, preservative free, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3301,"Injection, triamcinolone acetonide, not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3302,"Injection, triamcinolone diacetate, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3303,"Injection, triamcinolone hexacetonide, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3304,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3305,"Injection, trimetrexate glucuronate, per 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3310,"Injection, perphenazine, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3315,"Injection, triptorelin pamoate, 3.75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3316,"Injection, triptorelin, extended-release, 3.75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3320,"Injection, spectinomycin dihydrochloride, up to 2 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J3350,"Injection, urea, up to 40 gm",HCPCS_Level_II,HCPC2026_JAN,2026
J3355,"Injection, urofollitropin, 75 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J3357,"Ustekinumab, for subcutaneous injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3358,"Ustekinumab, for intravenous injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3360,"Injection, diazepam, up to 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3364,"Injection, urokinase, 5000 iu vial",HCPCS_Level_II,HCPC2026_JAN,2026
J3365,"Injection, iv, urokinase, 250,000 i.u. vial",HCPCS_Level_II,HCPC2026_JAN,2026
J3370,"Injection, vancomycin hcl, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3371,"Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3372,"Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3373,"Injection, vancomycin hydrochloride, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3374,"Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3375,"Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3376,"Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3379,"Injection, valproate sodium, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3380,"Injection, vedolizumab, intravenous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3385,"Injection, velaglucerase alfa, 100 units",HCPCS_Level_II,HCPC2026_JAN,2026
J3387,"Injection, elivaldogene autotemcel, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
J3389,"Topical administration, prademagene zamikeracel, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
J3391,"Injection, atidarsagene autotemcel, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
J3392,"Injection, exagamglogene autotemcel, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
J3393,"Injection, betibeglogene autotemcel, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
J3394,"Injection, lovotibeglogene autotemcel, per treatment",HCPCS_Level_II,HCPC2026_JAN,2026
J3396,"Injection, verteporfin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3397,"Injection, vestronidase alfa-vjbk, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3398,"Injection, voretigene neparvovec-rzyl, 1 billion vector genomes",HCPCS_Level_II,HCPC2026_JAN,2026
J3399,"Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes",HCPCS_Level_II,HCPC2026_JAN,2026
J3400,"Injection, triflupromazine hcl, up to 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3401,"Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J3402,"Injection, remestemcel-l-rknd, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
J3403,"Revakinagene taroretcel-lwey, per implant",HCPCS_Level_II,HCPC2026_JAN,2026
J3410,"Injection, hydroxyzine hcl, up to 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3411,"Injection, thiamine hcl, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3415,"Injection, pyridoxine hcl, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3420,"Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J3424,"Injection, hydroxocobalamin, intravenous, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3425,"Injection, hydroxocobalamin, intramuscular, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J3430,"Injection, phytonadione (vitamin k), per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3465,"Injection, voriconazole, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3470,"Injection, hyaluronidase, up to 150 units",HCPCS_Level_II,HCPC2026_JAN,2026
J3471,"Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)",HCPCS_Level_II,HCPC2026_JAN,2026
J3472,"Injection, hyaluronidase, ovine, preservative free, per 1000 usp units",HCPCS_Level_II,HCPC2026_JAN,2026
J3473,"Injection, hyaluronidase, recombinant, 1 usp unit",HCPCS_Level_II,HCPC2026_JAN,2026
J3475,"Injection, magnesium sulfate, per 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3480,"Injection, potassium chloride, per 2 meq",HCPCS_Level_II,HCPC2026_JAN,2026
J3485,"Injection, zidovudine, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3486,"Injection, ziprasidone mesylate, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3489,"Injection, zoledronic acid, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3490,Unclassified drugs,HCPCS_Level_II,HCPC2026_JAN,2026
J3520,"Edetate disodium, per 150 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J3530,Nasal vaccine inhalation,HCPCS_Level_II,HCPC2026_JAN,2026
J3535,Drug administered through a metered dose inhaler,HCPCS_Level_II,HCPC2026_JAN,2026
J3570,"Laetrile, amygdalin, vitamin b17",HCPCS_Level_II,HCPC2026_JAN,2026
J3590,Unclassified biologics,HCPCS_Level_II,HCPC2026_JAN,2026
J3591,Unclassified drug or biological used for esrd on dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
J4,Dmepos item subject to dmepos competitive bidding program that is furnished by a hospital upon discharge,HCPCS_Level_II,HCPC2026_JAN,2026
J5,Off-the-shelf orthotic subject to dmepos competitive bidding program that is furnished as part of a physical therapist or occupational therapist professional service,HCPCS_Level_II,HCPC2026_JAN,2026
J7030,"Infusion, normal saline solution , 1000 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J7040,"Infusion, normal saline solution, sterile (500 ml = 1 unit)",HCPCS_Level_II,HCPC2026_JAN,2026
J7042,5% dextrose/normal saline (500 ml = 1 unit),HCPCS_Level_II,HCPC2026_JAN,2026
J7050,"Infusion, normal saline solution, 250 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J7060,5% dextrose/water (500 ml = 1 unit),HCPCS_Level_II,HCPC2026_JAN,2026
J7070,"Infusion, d5w, 1000 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J7100,"Infusion, dextran 40, 500 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J7110,"Infusion, dextran 75, 500 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J7120,"Ringers lactate infusion, up to 1000 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J7121,"5% dextrose in lactated ringers infusion, up to 1000 cc",HCPCS_Level_II,HCPC2026_JAN,2026
J7131,"Hypertonic saline solution, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J7165,"Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity",HCPCS_Level_II,HCPC2026_JAN,2026
J7168,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity",HCPCS_Level_II,HCPC2026_JAN,2026
J7169,"Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7170,"Injection, emicizumab-kxwh, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7171,"Injection, adamts13, recombinant-krhn, 10 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7172,"Injection, marstacimab-hncq, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7173,"Injection, concizumab-mtci, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7174,"Injection, fitusiran, 0.04 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7175,"Injection, factor x, (human), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7177,"Injection, human fibrinogen concentrate (fibryga), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7178,"Injection, human fibrinogen concentrate, not otherwise specified, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7179,"Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco",HCPCS_Level_II,HCPC2026_JAN,2026
J7180,"Injection, factor xiii (antihemophilic factor, human), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7181,"Injection, factor xiii a-subunit, (recombinant), per iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7182,"Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7183,"Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco",HCPCS_Level_II,HCPC2026_JAN,2026
J7185,"Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7186,"Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7187,"Injection, von willebrand factor complex (humate-p), per iu vwf:rco",HCPCS_Level_II,HCPC2026_JAN,2026
J7188,"Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7189,"Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J7190,"Factor viii (antihemophilic factor, human) per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7191,"Factor viii (antihemophilic factor (porcine)), per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7192,"Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
J7193,"Factor ix (antihemophilic factor, purified, non-recombinant) per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7194,"Factor ix, complex, per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7195,"Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
J7196,"Injection, antithrombin recombinant, 50 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7197,"Antithrombin iii (human), per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7198,"Anti-inhibitor, per i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7199,"Hemophilia clotting factor, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
J7200,"Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7201,"Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7202,"Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7203,"Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7204,"Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7205,"Injection, factor viii fc fusion protein (recombinant), per iu",HCPCS_Level_II,HCPC2026_JAN,2026
J7207,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7208,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7209,"Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7210,"Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7211,"Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7212,"Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J7213,"Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7214,"Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u.",HCPCS_Level_II,HCPC2026_JAN,2026
J7294,"Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each",HCPCS_Level_II,HCPC2026_JAN,2026
J7295,"Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each",HCPCS_Level_II,HCPC2026_JAN,2026
J7296,"Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7297,"Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7298,"Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7299,Intrauterine copper contraceptive (miudella),HCPCS_Level_II,HCPC2026_JAN,2026
J7300,Intrauterine copper contraceptive (paragard),HCPCS_Level_II,HCPC2026_JAN,2026
J7301,"Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7302,"Levonorgestrel-releasing intrauterine contraceptive system, 52 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7303,"Contraceptive supply, hormone containing vaginal ring, each",HCPCS_Level_II,HCPC2026_JAN,2026
J7304,"Contraceptive supply, hormone containing patch, each",HCPCS_Level_II,HCPC2026_JAN,2026
J7306,"Levonorgestrel (contraceptive) implant system, including implants and supplies",HCPCS_Level_II,HCPC2026_JAN,2026
J7307,"Etonogestrel (contraceptive) implant system, including implant and supplies",HCPCS_Level_II,HCPC2026_JAN,2026
J7308,"Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)",HCPCS_Level_II,HCPC2026_JAN,2026
J7309,"Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J7310,"Ganciclovir, 4.5 mg, long-acting implant",HCPCS_Level_II,HCPC2026_JAN,2026
J7311,"Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7312,"Injection, dexamethasone, intravitreal implant, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7313,"Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7314,"Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7315,"Mitomycin, ophthalmic, 0.2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7316,"Injection, ocriplasmin, 0.125 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7318,"Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7320,"Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7321,"Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
J7322,"Hyaluronan or derivative, hymovis or hymovis one, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7323,"Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
J7324,"Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
J7325,"Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7326,"Hyaluronan or derivative, gel-one, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
J7327,"Hyaluronan or derivative, monovisc, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
J7328,"Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7329,"Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7330,"Autologous cultured chondrocytes, implant",HCPCS_Level_II,HCPC2026_JAN,2026
J7331,"Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7332,"Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7333,"Hyaluronan or derivative, visco-3, for intra-articular injection, per dose",HCPCS_Level_II,HCPC2026_JAN,2026
J7335,"Capsaicin 8% patch, per 10 square centimeters",HCPCS_Level_II,HCPC2026_JAN,2026
J7336,"Capsaicin 8% patch, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
J7340,"Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J7342,"Instillation, ciprofloxacin otic suspension, 6 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7345,"Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7351,"Injection, bimatoprost, intracameral implant, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J7352,"Afamelanotide implant, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7353,"Anacaulase-bcdb, 8.8% gel, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J7354,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)",HCPCS_Level_II,HCPC2026_JAN,2026
J7355,"Injection, travoprost, intracameral implant, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J7356,"Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7401,"Mometasone furoate sinus implant, 10 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J7402,"Mometasone furoate sinus implant, (sinuva), 10 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J7500,"Azathioprine, oral, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7501,"Azathioprine, parenteral, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7502,"Cyclosporine, oral, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7503,"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7504,"Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7505,"Muromonab-cd3, parenteral, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7506,"Prednisone, oral, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7507,"Tacrolimus, immediate release, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7508,"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7509,"Methylprednisolone oral, per 4 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7510,"Prednisolone oral, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7511,"Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7512,"Prednisone, immediate release or delayed release, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7513,"Daclizumab, parenteral, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7514,"Mycophenolate mofetil (myhibbin), oral suspension, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7515,"Cyclosporine, oral, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7516,"Injection, cyclosporine, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7517,"Mycophenolate mofetil, oral, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7518,"Mycophenolic acid, oral, 180 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7519,"Injection, mycophenolate mofetil, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7520,"Sirolimus, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7521,"Tacrolimus, granules, oral suspension, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7525,"Tacrolimus, parenteral, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7527,"Everolimus, oral, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7528,"Mycophenolate mofetil, for suspension, oral, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7599,"Immunosuppressive drug, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
J7601,"Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7604,"Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram",HCPCS_Level_II,HCPC2026_JAN,2026
J7605,"Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J7606,"Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J7607,"Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7608,"Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram",HCPCS_Level_II,HCPC2026_JAN,2026
J7609,"Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7610,"Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7611,"Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7612,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7613,"Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7614,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7615,"Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7620,"Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme",HCPCS_Level_II,HCPC2026_JAN,2026
J7622,"Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7624,"Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7626,"Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7627,"Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7628,"Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7629,"Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7631,"Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7632,"Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7633,"Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7634,"Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7635,"Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7636,"Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7637,"Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7638,"Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7639,"Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7640,"Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J7641,"Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7642,"Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7643,"Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7644,"Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7645,"Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7647,"Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7648,"Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7649,"Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7650,"Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7657,"Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7658,"Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7659,"Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7660,"Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7665,"Mannitol, administered through an inhaler, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7667,"Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7668,"Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7669,"Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7670,"Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7674,"Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7676,"Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7677,"Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J7680,"Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7681,"Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7682,"Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7683,"Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7684,"Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram",HCPCS_Level_II,HCPC2026_JAN,2026
J7685,"Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams",HCPCS_Level_II,HCPC2026_JAN,2026
J7686,"Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J7699,"Noc drugs, inhalation solution administered through dme",HCPCS_Level_II,HCPC2026_JAN,2026
J7799,"Noc drugs, other than inhalation drugs, administered through dme",HCPCS_Level_II,HCPC2026_JAN,2026
J7999,"Compounded drug, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
J8498,"Antiemetic drug, rectal/suppository, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
J8499,"Prescription drug, oral, non chemotherapeutic, nos",HCPCS_Level_II,HCPC2026_JAN,2026
J8501,"Aprepitant, oral, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8510,"Busulfan; oral, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8515,"Cabergoline, oral, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8520,"Capecitabine, oral, 150 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8521,"Capecitabine, oral, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8522,"Capecitabine, oral, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8530,"Cyclophosphamide; oral, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8540,"Dexamethasone, oral, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8541,"Dexamethasone (hemady), oral, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8560,"Etoposide; oral, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8562,"Fludarabine phosphate, oral, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8565,"Gefitinib, oral, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8597,"Antiemetic drug, oral, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
J8600,"Melphalan; oral, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8610,"Methotrexate; oral, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8611,"Methotrexate (jylamvo), oral, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8612,"Methotrexate (xatmep), oral, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8650,"Nabilone, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8655,"Netupitant 300 mg and palonosetron 0.5 mg, oral",HCPCS_Level_II,HCPC2026_JAN,2026
J8670,"Rolapitant, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8700,"Temozolomide, oral, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8705,"Topotecan, oral, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J8999,"Prescription drug, oral, chemotherapeutic, nos",HCPCS_Level_II,HCPC2026_JAN,2026
J9000,"Injection, doxorubicin hydrochloride, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9010,"Injection, alemtuzumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9011,"Injection, datopotamab deruxtecan-dlnk, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9015,"Injection, aldesleukin, per single use vial",HCPCS_Level_II,HCPC2026_JAN,2026
J9017,"Injection, arsenic trioxide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9019,"Injection, asparaginase (erwinaze), 1,000 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J9020,"Injection, asparaginase, not otherwise specified, 10,000 units",HCPCS_Level_II,HCPC2026_JAN,2026
J9021,"Injection, asparaginase, recombinant, (rylaze), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9022,"Injection, atezolizumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9023,"Injection, avelumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9024,"Injection, atezolizumab, 5 mg and hyaluronidase-tqjs",HCPCS_Level_II,HCPC2026_JAN,2026
J9025,"Injection, azacitidine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9026,"Injection, tarlatamab-dlle, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9027,"Injection, clofarabine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9028,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J9029,"Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
J9030,"Bcg live intravesical instillation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9031,Bcg (intravesical) per instillation,HCPCS_Level_II,HCPC2026_JAN,2026
J9032,"Injection, belinostat, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9033,"Injection, bendamustine hydrochloride, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9034,"Injection, bendamustine hcl (bendeka), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9035,"Injection, bevacizumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9036,"Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9037,"Injection, belantamab mafodotin-blmf, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9038,"Injection, axatilimab-csfr, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9039,"Injection, blinatumomab, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J9040,"Injection, bleomycin sulfate, 15 units",HCPCS_Level_II,HCPC2026_JAN,2026
J9041,"Injection, bortezomib, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9042,"Injection, brentuximab vedotin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9043,"Injection, cabazitaxel, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9044,"Injection, bortezomib, not otherwise specified, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9045,"Injection, carboplatin, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9046,"Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9047,"Injection, carfilzomib, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9048,"Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9049,"Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9050,"Injection, carmustine, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9051,"Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9052,"Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9054,"Injection, bortezomib (boruzu), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9055,"Injection, cetuximab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9056,"Injection, bendamustine hydrochloride (vivimusta), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9057,"Injection, copanlisib, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9058,"Injection, bendamustine hydrochloride (apotex), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9059,"Injection, bendamustine hydrochloride (baxter), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9060,"Injection, cisplatin, powder or solution, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9061,"Injection, amivantamab-vmjw, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9063,"Injection, mirvetuximab soravtansine-gynx, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9064,"Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9065,"Injection, cladribine, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9070,"Cyclophosphamide, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9071,"Injection, cyclophosphamide (auromedics), 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9072,"Injection, cyclophosphamide (frindovyx), 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9073,"Injection, cyclophosphamide (dr. reddy's), 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9074,"Injection, cyclophosphamide (sandoz), 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9075,"Injection, cyclophosphamide, not otherwise specified, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9076,"Injection, cyclophosphamide (baxter), 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9098,"Injection, cytarabine liposome, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9100,"Injection, cytarabine, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9118,"Injection, calaspargase pegol-mknl, 10 units",HCPCS_Level_II,HCPC2026_JAN,2026
J9119,"Injection, cemiplimab-rwlc, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9120,"Injection, dactinomycin, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9130,"Dacarbazine, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9144,"Injection, daratumumab, 10 mg and hyaluronidase-fihj",HCPCS_Level_II,HCPC2026_JAN,2026
J9145,"Injection, daratumumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9150,"Injection, daunorubicin, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9151,"Injection, daunorubicin citrate, liposomal formulation, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9153,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine",HCPCS_Level_II,HCPC2026_JAN,2026
J9155,"Injection, degarelix, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9160,"Injection, denileukin diftitox, 300 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J9161,"Injection, denileukin diftitox-cxdl, 1 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J9165,"Injection, diethylstilbestrol diphosphate, 250 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9171,"Injection, docetaxel, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9172,"Injection, docetaxel (docivyx), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9173,"Injection, durvalumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9174,"Injection, docetaxel (beizray), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9175,"Injection, elliotts' b solution, 1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
J9176,"Injection, elotuzumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9177,"Injection, enfortumab vedotin-ejfv, 0.25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9178,"Injection, epirubicin hcl, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9179,"Injection, eribulin mesylate, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9181,"Injection, etoposide, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9184,"Injection, gemcitabine hydrochloride (avyxa), 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9185,"Injection, fludarabine phosphate, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9190,"Injection, fluorouracil, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9196,"Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9198,"Injection, gemcitabine hydrochloride, (infugem), 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9199,"Injection, gemcitabine hydrochloride (infugem), 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9200,"Injection, floxuridine, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9201,"Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9202,"Goserelin acetate implant, per 3.6 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9203,"Injection, gemtuzumab ozogamicin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9204,"Injection, mogamulizumab-kpkc, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9205,"Injection, irinotecan liposome, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9206,"Injection, irinotecan, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9207,"Injection, ixabepilone, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9208,"Injection, ifosfamide, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J9209,"Injection, mesna, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9210,"Injection, emapalumab-lzsg, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9211,"Injection, idarubicin hydrochloride, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9212,"Injection, interferon alfacon-1, recombinant, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J9213,"Injection, interferon, alfa-2a, recombinant, 3 million units",HCPCS_Level_II,HCPC2026_JAN,2026
J9214,"Injection, interferon, alfa-2b, recombinant, 1 million units",HCPCS_Level_II,HCPC2026_JAN,2026
J9215,"Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu",HCPCS_Level_II,HCPC2026_JAN,2026
J9216,"Injection, interferon, gamma 1-b, 3 million units",HCPCS_Level_II,HCPC2026_JAN,2026
J9217,"Leuprolide acetate (for depot suspension), 7.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9218,"Leuprolide acetate, per 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9219,"Leuprolide acetate implant, 65 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9220,"Injection, indigotindisulfonate sodium, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9223,"Injection, lurbinectedin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9225,"Histrelin implant (vantas), 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9226,"Histrelin implant (supprelin la), 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9227,"Injection, isatuximab-irfc, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9228,"Injection, ipilimumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9229,"Injection, inotuzumab ozogamicin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9230,"Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9245,"Injection, melphalan hydrochloride, not otherwise specified, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9246,"Injection, melphalan (evomela), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9247,"Injection, melphalan flufenamide, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9248,"Injection, melphalan (hepzato), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9249,"Injection, melphalan (apotex), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9250,"Methotrexate sodium, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9255,"Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9256,"Injection, nipocalimab-aahu, 3 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9258,"Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9259,"Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9260,"Injection, methotrexate sodium, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9261,"Injection, nelarabine, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9262,"Injection, omacetaxine mepesuccinate, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9263,"Injection, oxaliplatin, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9264,"Injection, paclitaxel protein-bound particles, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9265,"Injection, paclitaxel, 30 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9266,"Injection, pegaspargase, per single dose vial",HCPCS_Level_II,HCPC2026_JAN,2026
J9267,"Injection, paclitaxel, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9268,"Injection, pentostatin, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9269,"Injection, tagraxofusp-erzs, 10 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
J9270,"Injection, plicamycin, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9271,"Injection, pembrolizumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9272,"Injection, dostarlimab-gxly, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9273,"Injection, tisotumab vedotin-tftv, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9274,"Injection, tebentafusp-tebn, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
J9275,"Injection, cosibelimab-ipdl, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9276,"Injection, zanidatamab-hrii, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9280,"Injection, mitomycin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9281,"Mitomycin pyelocalyceal instillation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9282,"Mitomycin, intravesical instillation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9285,"Injection, olaratumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9286,"Injection, glofitamab-gxbm, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9289,"Injection, nivolumab, 2 mg and hyaluronidase-nvhy",HCPCS_Level_II,HCPC2026_JAN,2026
J9292,"Injection, pemetrexed dipotassium, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9293,"Injection, mitoxantrone hydrochloride, per 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9294,"Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9295,"Injection, necitumumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9296,"Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9297,"Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9298,"Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9299,"Injection, nivolumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9300,"Injection, gemtuzumab ozogamicin, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9301,"Injection, obinutuzumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9302,"Injection, ofatumumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9303,"Injection, panitumumab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9304,"Injection, pemetrexed (pemfexy), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9305,"Injection, pemetrexed, not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9306,"Injection, pertuzumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9307,"Injection, pralatrexate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9308,"Injection, ramucirumab, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9309,"Injection, polatuzumab vedotin-piiq, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9310,"Injection, rituximab, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9311,"Injection, rituximab 10 mg and hyaluronidase",HCPCS_Level_II,HCPC2026_JAN,2026
J9312,"Injection, rituximab, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9313,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9314,"Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9315,"Injection, romidepsin, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9316,"Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9317,"Injection, sacituzumab govitecan-hziy, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9318,"Injection, romidepsin, non-lyophilized, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9319,"Injection, romidepsin, lyophilized, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9320,"Injection, streptozocin, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
J9321,"Injection, epcoritamab-bysp, 0.16 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9322,"Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9323,"Injection, pemetrexed ditromethamine, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9324,"Injection, pemetrexed (pemrydi rtu), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9325,"Injection, talimogene laherparepvec, per 1 million plaque forming units",HCPCS_Level_II,HCPC2026_JAN,2026
J9326,"Injection, telisotuzumab vedotin-tllv, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9328,"Injection, temozolomide, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9329,"Injection, tislelizumab-jsgr, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9330,"Injection, temsirolimus, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9331,"Injection, sirolimus protein-bound particles, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9332,"Injection, efgartigimod alfa-fcab, 2mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9333,"Injection, rozanolixizumab-noli, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9334,"Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc",HCPCS_Level_II,HCPC2026_JAN,2026
J9340,"Injection, thiotepa, 15 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9341,"Injection, thiotepa (tepylute), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9342,"Injection, thiotepa, not otherwise specified, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9345,"Injection, retifanlimab-dlwr, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9347,"Injection, tremelimumab-actl, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9348,"Injection, naxitamab-gqgk, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9349,"Injection, tafasitamab-cxix, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9350,"Injection, mosunetuzumab-axgb, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9351,"Injection, topotecan, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9352,"Injection, trabectedin, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9353,"Injection, margetuximab-cmkb, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9354,"Injection, ado-trastuzumab emtansine, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9355,"Injection, trastuzumab, excludes biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9356,"Injection, trastuzumab, 10 mg and hyaluronidase-oysk",HCPCS_Level_II,HCPC2026_JAN,2026
J9357,"Injection, valrubicin, intravesical, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9358,"Injection, fam-trastuzumab deruxtecan-nxki, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9359,"Injection, loncastuximab tesirine-lpyl, 0.075 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9360,"Injection, vinblastine sulfate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9361,"Injection, efbemalenograstim alfa-vuxw, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9370,"Vincristine sulfate, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9371,"Injection, vincristine sulfate liposome, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9376,"Injection, pozelimab-bbfg, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9380,"Injection, teclistamab-cqyv, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9381,"Injection, teplizumab-mzwv, 5 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
J9382,"Injection, zenocutuzumab-zbco, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9390,"Injection, vinorelbine tartrate, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9393,"Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9394,"Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9395,"Injection, fulvestrant, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9400,"Injection, ziv-aflibercept, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9600,"Injection, porfimer sodium, 75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
J9999,"Not otherwise classified, antineoplastic drugs",HCPCS_Level_II,HCPC2026_JAN,2026
JA,Administered intravenously,HCPCS_Level_II,HCPC2026_JAN,2026
JB,Administered subcutaneously,HCPCS_Level_II,HCPC2026_JAN,2026
JC,Skin substitute used as a graft,HCPCS_Level_II,HCPC2026_JAN,2026
JD,Skin substitute not used as a graft,HCPCS_Level_II,HCPC2026_JAN,2026
JE,Administered via dialysate,HCPCS_Level_II,HCPC2026_JAN,2026
JF,Compounded drug,HCPCS_Level_II,HCPC2026_JAN,2026
JG,"Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes",HCPCS_Level_II,HCPC2026_JAN,2026
JK,One month supply or less of drug or biological,HCPCS_Level_II,HCPC2026_JAN,2026
JL,Three month supply of drug or biological,HCPCS_Level_II,HCPC2026_JAN,2026
JW,Drug amount discarded/not administered to any patient,HCPCS_Level_II,HCPC2026_JAN,2026
JZ,Zero drug amount discarded/not administered to any patient,HCPCS_Level_II,HCPC2026_JAN,2026
K0,Lower extremity prosthesis functional level 0 - does not have the ability or potential to ambulate or transfer safely with or without assistance and a prosthesis does not enhance their quality of life or mobility.,HCPCS_Level_II,HCPC2026_JAN,2026
K0001,Standard wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0002,Standard hemi (low seat) wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0003,Lightweight wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0004,"High strength, lightweight wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
K0005,Ultralightweight wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0006,Heavy duty wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0007,Extra heavy duty wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0008,Custom manual wheelchair/base,HCPCS_Level_II,HCPC2026_JAN,2026
K0009,Other manual wheelchair/base,HCPCS_Level_II,HCPC2026_JAN,2026
K0010,Standard - weight frame motorized/power wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0011,"Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking",HCPCS_Level_II,HCPC2026_JAN,2026
K0012,Lightweight portable motorized/power wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
K0013,Custom motorized/power wheelchair base,HCPCS_Level_II,HCPC2026_JAN,2026
K0014,Other motorized/power wheelchair base,HCPCS_Level_II,HCPC2026_JAN,2026
K0015,"Detachable, non-adjustable height armrest, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0017,"Detachable, adjustable height armrest, base, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0018,"Detachable, adjustable height armrest, upper portion, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0019,"Arm pad, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0020,"Fixed, adjustable height armrest, pair",HCPCS_Level_II,HCPC2026_JAN,2026
K0037,"High mount flip-up footrest, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0038,"Leg strap, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0039,"Leg strap, h style, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0040,"Adjustable angle footplate, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0041,"Large size footplate, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0042,"Standard size footplate, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0043,"Footrest, lower extension tube, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0044,"Footrest, upper hanger bracket, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0045,"Footrest, complete assembly, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0046,"Elevating legrest, lower extension tube, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0047,"Elevating legrest, upper hanger bracket, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0050,"Ratchet assembly, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
K0051,"Cam release assembly, footrest or legrest, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0052,"Swingaway, detachable footrests, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0053,"Elevating footrests, articulating (telescoping), each",HCPCS_Level_II,HCPC2026_JAN,2026
K0056,"Seat height less than 17"" or equal to or greater than 21"" for a high strength, lightweight, or ultralightweight wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
K0065,"Spoke protectors, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0069,"Rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0070,"Rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0071,"Front caster assembly, complete, with pneumatic tire, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0072,"Front caster assembly, complete, with semi-pneumatic tire, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0073,"Caster pin lock, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0077,"Front caster assembly, complete, with solid tire, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0098,"Drive belt for power wheelchair, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
K0105,"Iv hanger, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0108,"Wheelchair component or accessory, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
K0195,"Elevating leg rests, pair (for use with capped rental wheelchair base)",HCPCS_Level_II,HCPC2026_JAN,2026
K0455,"Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)",HCPCS_Level_II,HCPC2026_JAN,2026
K0462,"Temporary replacement for patient owned equipment being repaired, any type",HCPCS_Level_II,HCPC2026_JAN,2026
K0552,"Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0553,"Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service",HCPCS_Level_II,HCPC2026_JAN,2026
K0554,"Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor system",HCPCS_Level_II,HCPC2026_JAN,2026
K0601,"Replacement battery for external infusion pump owned by patient, silver oxide, 1.5 volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0602,"Replacement battery for external infusion pump owned by patient, silver oxide, 3 volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0603,"Replacement battery for external infusion pump owned by patient, alkaline, 1.5 volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0604,"Replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0605,"Replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0606,"Automatic external defibrillator, with integrated electrocardiogram analysis, garment type",HCPCS_Level_II,HCPC2026_JAN,2026
K0607,"Replacement battery for automated external defibrillator, garment type only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0608,"Replacement garment for use with automated external defibrillator, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0609,"Replacement electrodes for use with automated external defibrillator, garment type only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0669,"Wheelchair accessory, wheelchair seat or back cushion, does not meet specific code criteria or no written coding verification from dme pdac",HCPCS_Level_II,HCPC2026_JAN,2026
K0672,"Addition to lower extremity orthosis, removable soft interface, all components, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K0730,Controlled dose inhalation drug delivery system,HCPCS_Level_II,HCPC2026_JAN,2026
K0733,"Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)",HCPCS_Level_II,HCPC2026_JAN,2026
K0738,"Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing",HCPCS_Level_II,HCPC2026_JAN,2026
K0739,"Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
K0740,"Repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
K0743,"Suction pump, home model, portable, for use on wounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0744,"Absorptive wound dressing for use with suction pump, home model, portable, pad size 16 square inches or less",HCPCS_Level_II,HCPC2026_JAN,2026
K0745,"Absorptive wound dressing for use with suction pump, home model, portable, pad size more than 16 square inches but less than or equal to 48 square inches",HCPCS_Level_II,HCPC2026_JAN,2026
K0746,"Absorptive wound dressing for use with suction pump, home model, portable, pad size greater than 48 square inches",HCPCS_Level_II,HCPC2026_JAN,2026
K0800,"Power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0801,"Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0802,"Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0806,"Power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0807,"Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0808,"Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0812,"Power operated vehicle, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
K0813,"Power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0814,"Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0815,"Power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0816,"Power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0820,"Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0821,"Power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0822,"Power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0823,"Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0824,"Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0825,"Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0826,"Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0827,"Power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0828,"Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more",HCPCS_Level_II,HCPC2026_JAN,2026
K0829,"Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more",HCPCS_Level_II,HCPC2026_JAN,2026
K0830,"Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0831,"Power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0835,"Power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0836,"Power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0837,"Power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0838,"Power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0839,"Power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0840,"Power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more",HCPCS_Level_II,HCPC2026_JAN,2026
K0841,"Power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0842,"Power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0843,"Power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0848,"Power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0849,"Power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0850,"Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0851,"Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0852,"Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0853,"Power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0854,"Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more",HCPCS_Level_II,HCPC2026_JAN,2026
K0855,"Power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more",HCPCS_Level_II,HCPC2026_JAN,2026
K0856,"Power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0857,"Power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0858,"Power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0859,"Power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0860,"Power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0861,"Power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0862,"Power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0863,"Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0864,"Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more",HCPCS_Level_II,HCPC2026_JAN,2026
K0868,"Power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0869,"Power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0870,"Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0871,"Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0877,"Power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0878,"Power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0879,"Power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0880,"Power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0884,"Power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0885,"Power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0886,"Power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0890,"Power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0891,"Power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds",HCPCS_Level_II,HCPC2026_JAN,2026
K0898,"Power wheelchair, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
K0899,"Power mobility device, not coded by dme pdac or does not meet criteria",HCPCS_Level_II,HCPC2026_JAN,2026
K0900,"Customized durable medical equipment, other than wheelchair",HCPCS_Level_II,HCPC2026_JAN,2026
K0901,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
K0902,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
K0903,"For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each",HCPCS_Level_II,HCPC2026_JAN,2026
K1,Lower extremity prosthesis functional level 1 - has the ability or potential to use a prosthesis for transfers or ambulation on level surfaces at fixed cadence. typical of the limited and unlimited household ambulator.,HCPCS_Level_II,HCPC2026_JAN,2026
K1001,"Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type",HCPCS_Level_II,HCPC2026_JAN,2026
K1002,"Cranial electrotherapy stimulation (ces) system, any type",HCPCS_Level_II,HCPC2026_JAN,2026
K1003,"Whirlpool tub, walk-in, portable",HCPCS_Level_II,HCPC2026_JAN,2026
K1004,Low frequency ultrasonic diathermy treatment device for home use,HCPCS_Level_II,HCPC2026_JAN,2026
K1005,"Disposable collection and storage bag for breast milk, any size, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
K1006,"Suction pump, home model, portable or stationary, electric, any type, for use with external urine management system",HCPCS_Level_II,HCPC2026_JAN,2026
K1007,"Bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright(s), knee joints any type, with or without ankle joints any type, includes all components and accessories, motors, microprocessors, sensors",HCPCS_Level_II,HCPC2026_JAN,2026
K1009,"Speech volume modulation system, any type, including all components and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
K1010,"Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K1011,"Activation device for intraurethral drainage device with valve, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K1012,"Charger and base station for intraurethral activation device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
K1013,"Enema tube, with or without adapter, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
K1014,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
K1015,"Foot, adductus positioning device, adjustable",HCPCS_Level_II,HCPC2026_JAN,2026
K1016,Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve,HCPCS_Level_II,HCPC2026_JAN,2026
K1017,Monthly supplies for use of device coded at k1016,HCPCS_Level_II,HCPC2026_JAN,2026
K1018,External upper limb tremor stimulator of the peripheral nerves of the wrist,HCPCS_Level_II,HCPC2026_JAN,2026
K1019,Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist,HCPCS_Level_II,HCPC2026_JAN,2026
K1020,Non-invasive vagus nerve stimulator,HCPCS_Level_II,HCPC2026_JAN,2026
K1021,"Exsufflation belt, includes all supplies and accessories",HCPCS_Level_II,HCPC2026_JAN,2026
K1022,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type",HCPCS_Level_II,HCPC2026_JAN,2026
K1023,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm",HCPCS_Level_II,HCPC2026_JAN,2026
K1024,Non-pneumatic compression controller with sequential calibrated gradient pressure,HCPCS_Level_II,HCPC2026_JAN,2026
K1025,"Non-pneumatic sequential compression garment, full arm",HCPCS_Level_II,HCPC2026_JAN,2026
K1026,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical",HCPCS_Level_II,HCPC2026_JAN,2026
K1027,"Oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
K1028,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application",HCPCS_Level_II,HCPC2026_JAN,2026
K1029,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply",HCPCS_Level_II,HCPC2026_JAN,2026
K1030,"External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
K1031,Non-pneumatic compression controller without calibrated gradient pressure,HCPCS_Level_II,HCPC2026_JAN,2026
K1032,"Non-pneumatic sequential compression garment, full leg",HCPCS_Level_II,HCPC2026_JAN,2026
K1033,"Non-pneumatic sequential compression garment, half leg",HCPCS_Level_II,HCPC2026_JAN,2026
K1034,"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count",HCPCS_Level_II,HCPC2026_JAN,2026
K1035,"Molecular diagnostic test reader, nonprescription self-administered and self-collected use, fda approved, authorized or cleared",HCPCS_Level_II,HCPC2026_JAN,2026
K1036,"Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month",HCPCS_Level_II,HCPC2026_JAN,2026
K1037,Docking station for use with oral device/appliance used to reduce upper airway collapsibility,HCPCS_Level_II,HCPC2026_JAN,2026
K2,"Lower extremity prosthesis functional level 2 - has the ability or potential for ambulation with the ability to traverse low level environmental barriers such as curbs, stairs or uneven surfaces.  typical of the limited community ambulator.",HCPCS_Level_II,HCPC2026_JAN,2026
K3,"Lower extremity prosthesis functional level 3 - has the ability or potential for ambulation with variable cadence.  typical of the community ambulator who has the ability to transverse most environmental barriers and may have vocational, therapeutic, or exercise activity that demands prosthetic utilization beyond simple locomotion.",HCPCS_Level_II,HCPC2026_JAN,2026
K4,"Lower extremity prosthesis functional level 4 - has the ability or potential for prosthetic ambulation that exceeds the basic ambulation skills, exhibiting high impact, stress, or energy levels, typical of the prosthetic demands of the child, active adult, or athlete.",HCPCS_Level_II,HCPC2026_JAN,2026
KA,Add on option/accessory for wheelchair,HCPCS_Level_II,HCPC2026_JAN,2026
KB,"Beneficiary requested upgrade for abn, more than 4 modifiers identified on claim",HCPCS_Level_II,HCPC2026_JAN,2026
KC,Replacement of special power wheelchair interface,HCPCS_Level_II,HCPC2026_JAN,2026
KD,Drug or biological infused through dme,HCPCS_Level_II,HCPC2026_JAN,2026
KE,Bid under round one of the dmepos competitive bidding program for use with non-competitive bid base equipment,HCPCS_Level_II,HCPC2026_JAN,2026
KF,Item designated by fda as class iii device,HCPCS_Level_II,HCPC2026_JAN,2026
KG,Dmepos item subject to dmepos competitive bidding program number 1,HCPCS_Level_II,HCPC2026_JAN,2026
KH,"Dmepos item, initial claim, purchase or first month rental",HCPCS_Level_II,HCPC2026_JAN,2026
KI,"Dmepos item, second or third month rental",HCPCS_Level_II,HCPC2026_JAN,2026
KJ,"Dmepos item, parenteral enteral nutrition (pen) pump or capped rental, months four to fifteen",HCPCS_Level_II,HCPC2026_JAN,2026
KK,Dmepos item subject to dmepos competitive bidding program number 2,HCPCS_Level_II,HCPC2026_JAN,2026
KL,Dmepos item delivered via mail,HCPCS_Level_II,HCPC2026_JAN,2026
KM,Replacement of facial prosthesis including new impression/moulage,HCPCS_Level_II,HCPC2026_JAN,2026
KN,Replacement of facial prosthesis using previous master model,HCPCS_Level_II,HCPC2026_JAN,2026
KO,Single drug unit dose formulation,HCPCS_Level_II,HCPC2026_JAN,2026
KP,First drug of a multiple drug unit dose formulation,HCPCS_Level_II,HCPC2026_JAN,2026
KQ,Second or subsequent drug of a multiple drug unit dose formulation,HCPCS_Level_II,HCPC2026_JAN,2026
KR,"Rental item, billing for partial month",HCPCS_Level_II,HCPC2026_JAN,2026
KS,Glucose monitor supply for diabetic beneficiary not treated with insulin,HCPCS_Level_II,HCPC2026_JAN,2026
KT,Beneficiary resides in a competitive bidding area and travels outside that competitive bidding area and receives a competitive bid item,HCPCS_Level_II,HCPC2026_JAN,2026
KU,Dmepos item subject to dmepos competitive bidding program number 3,HCPCS_Level_II,HCPC2026_JAN,2026
KV,Dmepos item subject to dmepos competitive bidding program that is furnished as part of a professional service,HCPCS_Level_II,HCPC2026_JAN,2026
KW,Dmepos item subject to dmepos competitive bidding program number 4,HCPCS_Level_II,HCPC2026_JAN,2026
KX,Requirements specified in the medical policy have been met,HCPCS_Level_II,HCPC2026_JAN,2026
KY,Dmepos item subject to dmepos competitive bidding program number 5,HCPCS_Level_II,HCPC2026_JAN,2026
KZ,New coverage not implemented by managed care,HCPCS_Level_II,HCPC2026_JAN,2026
L0112,"Cranial cervical orthosis, congenital torticollis type, with or without soft interface material, adjustable range of motion joint, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0113,"Cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0120,"Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar)",HCPCS_Level_II,HCPC2026_JAN,2026
L0130,"Cervical, flexible, thermoplastic collar, molded to patient",HCPCS_Level_II,HCPC2026_JAN,2026
L0140,"Cervical, semi-rigid, adjustable (plastic collar)",HCPCS_Level_II,HCPC2026_JAN,2026
L0150,"Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)",HCPCS_Level_II,HCPC2026_JAN,2026
L0160,"Cervical, semi-rigid, wire frame occipital/mandibular support, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0170,"Cervical, collar, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L0172,"Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0174,"Cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic extension, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0180,"Cervical, multiple post collar, occipital/mandibular supports, adjustable",HCPCS_Level_II,HCPC2026_JAN,2026
L0190,"Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars (somi, guilford, taylor types)",HCPCS_Level_II,HCPC2026_JAN,2026
L0200,"Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars, and thoracic extension",HCPCS_Level_II,HCPC2026_JAN,2026
L0220,"Thoracic, rib belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0450,"Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0452,"Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0454,"Tlso flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0455,"Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0456,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0457,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0458,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0460,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0462,"Tlso, triplanar control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0464,"Tlso, triplanar control, modular segmented spinal system, four rigid plastic shells, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0466,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0467,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0468,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal, and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0469,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0470,"Tlso, triplanar control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction to scapula, lateral strength provided by pelvic, thoracic, and lateral frame pieces, rotational strength provided by subclavicular extensions, restricts gross trunk motion in sagittal, coronal, and transverse planes, provides intracavitary pressure to reduce load on the intervertebral disks, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0472,"Tlso, triplanar control, hyperextension, rigid anterior and lateral frame extends from symphysis pubis to sternal notch with two anterior components (one pubic and one sternal), posterior and lateral pads with straps and closures, limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0480,"Tlso, triplanar control, one piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0482,"Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0484,"Tlso, triplanar control, two piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0486,"Tlso, triplanar control, two piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0488,"Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0490,"Tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping reinforced anterior, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior extends from symphysis pubis to xiphoid, anterior opening, restricts gross trunk motion in sagittal and coronal planes, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0491,"Tlso, sagittal-coronal control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0492,"Tlso, sagittal-coronal control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0621,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0622,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0623,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0624,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels placed over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0625,"Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0626,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0627,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0628,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0629,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0630,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0631,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0632,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0633,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0634,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0635,"Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L0636,"Lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panels, lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0637,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0638,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0639,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0640,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L0641,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0642,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0643,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0648,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0649,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0650,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0651,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L0700,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, molded to patient model, (minerva type)",HCPCS_Level_II,HCPC2026_JAN,2026
L0710,"Ctlso, anterior-posterior-lateral-control, molded to patient model, with interface material, (minerva type)",HCPCS_Level_II,HCPC2026_JAN,2026
L0720,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L0810,"Halo procedure, cervical halo incorporated into jacket vest",HCPCS_Level_II,HCPC2026_JAN,2026
L0820,"Halo procedure, cervical halo incorporated into plaster body jacket",HCPCS_Level_II,HCPC2026_JAN,2026
L0830,"Halo procedure, cervical halo incorporated into milwaukee type orthosis",HCPCS_Level_II,HCPC2026_JAN,2026
L0859,"Addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material",HCPCS_Level_II,HCPC2026_JAN,2026
L0861,"Addition to halo procedure, replacement liner/interface material",HCPCS_Level_II,HCPC2026_JAN,2026
L0970,"Tlso, corset front",HCPCS_Level_II,HCPC2026_JAN,2026
L0972,"Lso, corset front",HCPCS_Level_II,HCPC2026_JAN,2026
L0974,"Tlso, full corset",HCPCS_Level_II,HCPC2026_JAN,2026
L0976,"Lso, full corset",HCPCS_Level_II,HCPC2026_JAN,2026
L0978,Axillary crutch extension,HCPCS_Level_II,HCPC2026_JAN,2026
L0980,"Peroneal straps, prefabricated, off-the-shelf, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L0982,"Stocking supporter grips, prefabricated, off-the-shelf, set of four (4)",HCPCS_Level_II,HCPC2026_JAN,2026
L0984,"Protective body sock, prefabricated, off-the-shelf, each",HCPCS_Level_II,HCPC2026_JAN,2026
L0999,"Addition to spinal orthosis, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L1,Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps,HCPCS_Level_II,HCPC2026_JAN,2026
L1000,"Cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of furnishing initial orthosis, including model",HCPCS_Level_II,HCPC2026_JAN,2026
L1001,"Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1005,"Tension based scoliosis orthosis and accessory pads, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1006,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1007,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla, to trochanter, includes all accessory pads, straps, and interface, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1010,"Addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis orthosis, axilla sling",HCPCS_Level_II,HCPC2026_JAN,2026
L1020,"Addition to ctlso or scoliosis orthosis, kyphosis pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1025,"Addition to ctlso or scoliosis orthosis, kyphosis pad, floating",HCPCS_Level_II,HCPC2026_JAN,2026
L1030,"Addition to ctlso or scoliosis orthosis, lumbar bolster pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1040,"Addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1050,"Addition to ctlso or scoliosis orthosis, sternal pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1060,"Addition to ctlso or scoliosis orthosis, thoracic pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1070,"Addition to ctlso or scoliosis orthosis, trapezius sling",HCPCS_Level_II,HCPC2026_JAN,2026
L1080,"Addition to ctlso or scoliosis orthosis, outrigger",HCPCS_Level_II,HCPC2026_JAN,2026
L1085,"Addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical extensions",HCPCS_Level_II,HCPC2026_JAN,2026
L1090,"Addition to ctlso or scoliosis orthosis, lumbar sling",HCPCS_Level_II,HCPC2026_JAN,2026
L1100,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather",HCPCS_Level_II,HCPC2026_JAN,2026
L1110,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L1120,"Addition to ctlso, scoliosis orthosis, cover for upright, each",HCPCS_Level_II,HCPC2026_JAN,2026
L1200,"Thoracic-lumbar-sacral-orthosis (tlso), inclusive of furnishing initial orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L1210,"Addition to tlso, (low profile), lateral thoracic extension",HCPCS_Level_II,HCPC2026_JAN,2026
L1220,"Addition to tlso, (low profile), anterior thoracic extension",HCPCS_Level_II,HCPC2026_JAN,2026
L1230,"Addition to tlso, (low profile), milwaukee type superstructure",HCPCS_Level_II,HCPC2026_JAN,2026
L1240,"Addition to tlso, (low profile), lumbar derotation pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1250,"Addition to tlso, (low profile), anterior asis pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1260,"Addition to tlso, (low profile), anterior thoracic derotation pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1270,"Addition to tlso, (low profile), abdominal pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1280,"Addition to tlso, (low profile), rib gusset (elastic), each",HCPCS_Level_II,HCPC2026_JAN,2026
L1290,"Addition to tlso, (low profile), lateral trochanteric pad",HCPCS_Level_II,HCPC2026_JAN,2026
L1300,"Other scoliosis procedure, body jacket molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L1310,"Other scoliosis procedure, post-operative body jacket",HCPCS_Level_II,HCPC2026_JAN,2026
L1320,"Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1499,"Spinal orthosis, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L1600,"Hip orthosis, abduction control of hip joints, flexible, frejka type with cover, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an inidividual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1610,"Hip orthosis, abduction control of hip joints, flexible, (frejka cover only), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1620,"Hip orthosis, abduction control of hip joints, flexible, (pavlik harness), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1630,"Hip orthosis, abduction control of hip joints, semi-flexible (von rosen type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1640,"Hip orthosis, abduction control of hip joints, static, pelvic band or spreader bar, thigh cuffs, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1650,"Hip orthosis, abduction control of hip joints, static, adjustable, (ilfled type), prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1652,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1653,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1660,"Hip orthosis, abduction control of hip joints, static, plastic, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1680,"Hip orthosis, abduction control of hip joints, dynamic, pelvic control, adjustable hip motion control, thigh cuffs (rancho hip action type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1681,"Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1685,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1686,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1690,"Combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction and internal rotation control, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1700,"Legg perthes orthosis, (toronto type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1710,"Legg perthes orthosis, (newington type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1720,"Legg perthes orthosis, trilateral, (tachdijan type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1730,"Legg perthes orthosis, (scottish rite type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1755,"Legg perthes orthosis, (patten bottom type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1810,"Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1812,"Knee orthosis, elastic with joints, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1820,"Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1821,"Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1830,"Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1831,"Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1832,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1833,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1834,"Knee orthosis, without knee joint, rigid, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1836,"Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1840,"Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1843,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1844,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1845,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1846,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1847,"Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1848,"Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1850,"Knee orthosis, swedish type, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1851,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1852,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1860,"Knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk)",HCPCS_Level_II,HCPC2026_JAN,2026
L1900,"Ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1902,"Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1904,"Ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1906,"Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1907,"Ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1910,"Ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1920,"Ankle foot orthosis, single upright with static or adjustable stop (phelps or perlstein type), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1930,"Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1932,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1933,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1940,"Ankle foot orthosis, plastic or other material, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1945,"Ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1950,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1951,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L1952,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L1960,"Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1970,"Ankle foot orthosis, plastic with ankle joint, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1971,"Ankle foot orthosis, plastic or other material with ankle joint, with or without dorsiflexion assist, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L1980,"Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L1990,"Ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup, calf band/cuff (double bar 'bk' orthosis), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2000,"Knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2005,"Knee ankle foot orthosis, any material, single or double upright, stance control, automatic lock and swing phase release, any type activation, includes ankle joint, any type, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2006,"Knee ankle foot device, any material, single or double upright, swing and stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2010,"Knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), without knee joint, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2020,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs (double bar 'ak' orthosis), custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2030,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs, (double bar 'ak' orthosis), without knee joint, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2034,"Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2035,"Knee ankle foot orthosis, full plastic, static (pediatric size), without free motion ankle, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2036,"Knee ankle foot orthosis, full plastic, double upright, with or without free motion knee, with or without free motion ankle, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2037,"Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, with or without free motion ankle, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2038,"Knee ankle foot orthosis, full plastic, with or without free motion knee, multi-axis ankle, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2040,"Hip knee ankle foot orthosis, torsion control, bilateral rotation straps, pelvic band/belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2050,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip joint, pelvic band/belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2060,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball bearing hip joint, pelvic band/ belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2070,"Hip knee ankle foot orthosis, torsion control, unilateral rotation straps, pelvic band/belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2080,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip joint, pelvic band/belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2090,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball bearing hip joint, pelvic band/ belt, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2106,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, thermoplastic type casting material, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2108,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2112,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2114,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2116,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2126,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, thermoplastic type casting material, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2128,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L2132,"Kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2134,"Kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2136,"Kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L2180,"Addition to lower extremity fracture orthosis, plastic shoe insert with ankle joints",HCPCS_Level_II,HCPC2026_JAN,2026
L2182,"Addition to lower extremity fracture orthosis, drop lock knee joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2184,"Addition to lower extremity fracture orthosis, limited motion knee joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2186,"Addition to lower extremity fracture orthosis, adjustable motion knee joint, lerman type",HCPCS_Level_II,HCPC2026_JAN,2026
L2188,"Addition to lower extremity fracture orthosis, quadrilateral brim",HCPCS_Level_II,HCPC2026_JAN,2026
L2190,"Addition to lower extremity fracture orthosis, waist belt",HCPCS_Level_II,HCPC2026_JAN,2026
L2192,"Addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh flange, and pelvic belt",HCPCS_Level_II,HCPC2026_JAN,2026
L2200,"Addition to lower extremity, limited ankle motion, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2210,"Addition to lower extremity, dorsiflexion assist (plantar flexion resist), each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2220,"Addition to lower extremity, dorsiflexion and plantar flexion assist/resist, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2230,"Addition to lower extremity, split flat caliper stirrups and plate attachment",HCPCS_Level_II,HCPC2026_JAN,2026
L2232,"Addition to lower extremity orthosis, rocker bottom for total contact ankle foot orthosis, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L2240,"Addition to lower extremity, round caliper and plate attachment",HCPCS_Level_II,HCPC2026_JAN,2026
L2250,"Addition to lower extremity, foot plate, molded to patient model, stirrup attachment",HCPCS_Level_II,HCPC2026_JAN,2026
L2260,"Addition to lower extremity, reinforced solid stirrup (scott-craig type)",HCPCS_Level_II,HCPC2026_JAN,2026
L2265,"Addition to lower extremity, long tongue stirrup",HCPCS_Level_II,HCPC2026_JAN,2026
L2270,"Addition to lower extremity, varus/valgus correction ('t') strap, padded/lined or malleolus pad",HCPCS_Level_II,HCPC2026_JAN,2026
L2275,"Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined",HCPCS_Level_II,HCPC2026_JAN,2026
L2280,"Addition to lower extremity, molded inner boot",HCPCS_Level_II,HCPC2026_JAN,2026
L2300,"Addition to lower extremity, abduction bar (bilateral hip involvement), jointed, adjustable",HCPCS_Level_II,HCPC2026_JAN,2026
L2310,"Addition to lower extremity, abduction bar-straight",HCPCS_Level_II,HCPC2026_JAN,2026
L2320,"Addition to lower extremity, non-molded lacer, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L2330,"Addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L2335,"Addition to lower extremity, anterior swing band",HCPCS_Level_II,HCPC2026_JAN,2026
L2340,"Addition to lower extremity, pre-tibial shell, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L2350,"Addition to lower extremity, prosthetic type, (bk) socket, molded to patient model, (used for 'ptb' 'afo' orthoses)",HCPCS_Level_II,HCPC2026_JAN,2026
L2360,"Addition to lower extremity, extended steel shank",HCPCS_Level_II,HCPC2026_JAN,2026
L2370,"Addition to lower extremity, patten bottom",HCPCS_Level_II,HCPC2026_JAN,2026
L2375,"Addition to lower extremity, torsion control, ankle joint and half solid stirrup",HCPCS_Level_II,HCPC2026_JAN,2026
L2380,"Addition to lower extremity, torsion control, straight knee joint, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2385,"Addition to lower extremity, straight knee joint, heavy duty, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2387,"Addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2390,"Addition to lower extremity, offset knee joint, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2395,"Addition to lower extremity, offset knee joint, heavy duty, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2397,"Addition to lower extremity orthosis, suspension sleeve",HCPCS_Level_II,HCPC2026_JAN,2026
L2405,"Addition to knee joint, drop lock, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2415,"Addition to knee lock with integrated release mechanism (bail, cable, or equal), any material, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2425,"Addition to knee joint, disc or dial lock for adjustable knee flexion, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2430,"Addition to knee joint, ratchet lock for active and progressive knee extension, each joint",HCPCS_Level_II,HCPC2026_JAN,2026
L2492,"Addition to knee joint, lift loop for drop lock ring",HCPCS_Level_II,HCPC2026_JAN,2026
L2500,"Addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight bearing, ring",HCPCS_Level_II,HCPC2026_JAN,2026
L2510,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L2520,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom fitted",HCPCS_Level_II,HCPC2026_JAN,2026
L2525,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L2526,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim, custom fitted",HCPCS_Level_II,HCPC2026_JAN,2026
L2530,"Addition to lower extremity, thigh-weight bearing, lacer, non-molded",HCPCS_Level_II,HCPC2026_JAN,2026
L2540,"Addition to lower extremity, thigh/weight bearing, lacer, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L2550,"Addition to lower extremity, thigh/weight bearing, high roll cuff",HCPCS_Level_II,HCPC2026_JAN,2026
L2570,"Addition to lower extremity, pelvic control, hip joint, clevis type two position joint, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2580,"Addition to lower extremity, pelvic control, pelvic sling",HCPCS_Level_II,HCPC2026_JAN,2026
L2600,"Addition to lower extremity, pelvic control, hip joint, clevis type, or thrust bearing, free, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2610,"Addition to lower extremity, pelvic control, hip joint, clevis or thrust bearing, lock, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2620,"Addition to lower extremity, pelvic control, hip joint, heavy duty, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2622,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2624,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, extension, abduction control, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2627,"Addition to lower extremity, pelvic control, plastic, molded to patient model, reciprocating hip joint and cables",HCPCS_Level_II,HCPC2026_JAN,2026
L2628,"Addition to lower extremity, pelvic control, metal frame, reciprocating hip joint and cables",HCPCS_Level_II,HCPC2026_JAN,2026
L2630,"Addition to lower extremity, pelvic control, band and belt, unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
L2640,"Addition to lower extremity, pelvic control, band and belt, bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
L2650,"Addition to lower extremity, pelvic and thoracic control, gluteal pad, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2660,"Addition to lower extremity, thoracic control, thoracic band",HCPCS_Level_II,HCPC2026_JAN,2026
L2670,"Addition to lower extremity, thoracic control, paraspinal uprights",HCPCS_Level_II,HCPC2026_JAN,2026
L2680,"Addition to lower extremity, thoracic control, lateral support uprights",HCPCS_Level_II,HCPC2026_JAN,2026
L2750,"Addition to lower extremity orthosis, plating chrome or nickel, per bar",HCPCS_Level_II,HCPC2026_JAN,2026
L2755,"Addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, per segment, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L2760,"Addition to lower extremity orthosis, extension, per extension, per bar (for lineal adjustment for growth)",HCPCS_Level_II,HCPC2026_JAN,2026
L2768,"Orthotic side bar disconnect device, per bar",HCPCS_Level_II,HCPC2026_JAN,2026
L2780,"Addition to lower extremity orthosis, non-corrosive finish, per bar",HCPCS_Level_II,HCPC2026_JAN,2026
L2785,"Addition to lower extremity orthosis, drop lock retainer, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2795,"Addition to lower extremity orthosis, knee control, full kneecap",HCPCS_Level_II,HCPC2026_JAN,2026
L2800,"Addition to lower extremity orthosis, knee control, knee cap, medial or lateral pull, for use with custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L2810,"Addition to lower extremity orthosis, knee control, condylar pad",HCPCS_Level_II,HCPC2026_JAN,2026
L2820,"Addition to lower extremity orthosis, soft interface for molded plastic, below knee section",HCPCS_Level_II,HCPC2026_JAN,2026
L2830,"Addition to lower extremity orthosis, soft interface for molded plastic, above knee section",HCPCS_Level_II,HCPC2026_JAN,2026
L2840,"Addition to lower extremity orthosis, tibial length sock, fracture or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2850,"Addition to lower extremity orthosis, femoral length sock, fracture or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2861,"Addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L2999,"Lower extremity orthoses, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L3000,"Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3001,"Foot, insert, removable, molded to patient model, spenco, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3002,"Foot, insert, removable, molded to patient model, plastazote or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3003,"Foot, insert, removable, molded to patient model, silicone gel, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3010,"Foot, insert, removable, molded to patient model, longitudinal arch support, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3020,"Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3030,"Foot, insert, removable, formed to patient foot, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3031,"Foot, insert/plate, removable, addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3040,"Foot, arch support, removable, premolded, longitudinal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3050,"Foot, arch support, removable, premolded, metatarsal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3060,"Foot, arch support, removable, premolded, longitudinal/ metatarsal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3070,"Foot, arch support, non-removable attached to shoe, longitudinal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3080,"Foot, arch support, non-removable attached to shoe, metatarsal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3090,"Foot, arch support, non-removable attached to shoe, longitudinal/metatarsal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3100,"Hallus-valgus night dynamic splint, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3140,"Foot, abduction rotation bar, including shoes",HCPCS_Level_II,HCPC2026_JAN,2026
L3150,"Foot, abduction rotation bar, without shoes",HCPCS_Level_II,HCPC2026_JAN,2026
L3160,"Foot, adjustable shoe-styled positioning device",HCPCS_Level_II,HCPC2026_JAN,2026
L3161,"Foot, adductus positioning device, adjustable",HCPCS_Level_II,HCPC2026_JAN,2026
L3170,"Foot, plastic, silicone or equal, heel stabilizer, prefabricated, off-the-shelf, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3201,"Orthopedic shoe, oxford with supinator or pronator, infant",HCPCS_Level_II,HCPC2026_JAN,2026
L3202,"Orthopedic shoe, oxford with supinator or pronator, child",HCPCS_Level_II,HCPC2026_JAN,2026
L3203,"Orthopedic shoe, oxford with supinator or pronator, junior",HCPCS_Level_II,HCPC2026_JAN,2026
L3204,"Orthopedic shoe, hightop with supinator or pronator, infant",HCPCS_Level_II,HCPC2026_JAN,2026
L3206,"Orthopedic shoe, hightop with supinator or pronator, child",HCPCS_Level_II,HCPC2026_JAN,2026
L3207,"Orthopedic shoe, hightop with supinator or pronator, junior",HCPCS_Level_II,HCPC2026_JAN,2026
L3208,"Surgical boot, each, infant",HCPCS_Level_II,HCPC2026_JAN,2026
L3209,"Surgical boot, each, child",HCPCS_Level_II,HCPC2026_JAN,2026
L3211,"Surgical boot, each, junior",HCPCS_Level_II,HCPC2026_JAN,2026
L3212,"Benesch boot, pair, infant",HCPCS_Level_II,HCPC2026_JAN,2026
L3213,"Benesch boot, pair, child",HCPCS_Level_II,HCPC2026_JAN,2026
L3214,"Benesch boot, pair, junior",HCPCS_Level_II,HCPC2026_JAN,2026
L3215,"Orthopedic footwear, ladies shoe, oxford, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3216,"Orthopedic footwear, ladies shoe, depth inlay, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3217,"Orthopedic footwear, ladies shoe, hightop, depth inlay, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3219,"Orthopedic footwear, mens shoe, oxford, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3221,"Orthopedic footwear, mens shoe, depth inlay, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3222,"Orthopedic footwear, mens shoe, hightop, depth inlay, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3224,"Orthopedic footwear, woman's shoe, oxford, used as an integral part of a brace (orthosis)",HCPCS_Level_II,HCPC2026_JAN,2026
L3225,"Orthopedic footwear, man's shoe, oxford, used as an integral part of a brace (orthosis)",HCPCS_Level_II,HCPC2026_JAN,2026
L3230,"Orthopedic footwear, custom shoe, depth inlay, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3250,"Orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3251,"Foot, shoe molded to patient model, silicone shoe, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3252,"Foot, shoe molded to patient model, plastazote (or similar), custom fabricated, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3253,"Foot, molded shoe plastazote (or similar) custom fitted, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3254,Non-standard size or width,HCPCS_Level_II,HCPC2026_JAN,2026
L3255,Non-standard size or length,HCPCS_Level_II,HCPC2026_JAN,2026
L3257,"Orthopedic footwear, additional charge for split size",HCPCS_Level_II,HCPC2026_JAN,2026
L3260,"Surgical boot/shoe, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3265,"Plastazote sandal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3300,"Lift, elevation, heel, tapered to metatarsals, per inch",HCPCS_Level_II,HCPC2026_JAN,2026
L3310,"Lift, elevation, heel and sole, neoprene, per inch",HCPCS_Level_II,HCPC2026_JAN,2026
L3320,"Lift, elevation, heel and sole, cork, per inch",HCPCS_Level_II,HCPC2026_JAN,2026
L3330,"Lift, elevation, metal extension (skate)",HCPCS_Level_II,HCPC2026_JAN,2026
L3332,"Lift, elevation, inside shoe, tapered, up to one-half inch",HCPCS_Level_II,HCPC2026_JAN,2026
L3334,"Lift, elevation, heel, per inch",HCPCS_Level_II,HCPC2026_JAN,2026
L3340,"Heel wedge, sach",HCPCS_Level_II,HCPC2026_JAN,2026
L3350,Heel wedge,HCPCS_Level_II,HCPC2026_JAN,2026
L3360,"Sole wedge, outside sole",HCPCS_Level_II,HCPC2026_JAN,2026
L3370,"Sole wedge, between sole",HCPCS_Level_II,HCPC2026_JAN,2026
L3380,Clubfoot wedge,HCPCS_Level_II,HCPC2026_JAN,2026
L3390,Outflare wedge,HCPCS_Level_II,HCPC2026_JAN,2026
L3400,"Metatarsal bar wedge, rocker",HCPCS_Level_II,HCPC2026_JAN,2026
L3410,"Metatarsal bar wedge, between sole",HCPCS_Level_II,HCPC2026_JAN,2026
L3420,"Full sole and heel wedge, between sole",HCPCS_Level_II,HCPC2026_JAN,2026
L3430,"Heel, counter, plastic reinforced",HCPCS_Level_II,HCPC2026_JAN,2026
L3440,"Heel, counter, leather reinforced",HCPCS_Level_II,HCPC2026_JAN,2026
L3450,"Heel, sach cushion type",HCPCS_Level_II,HCPC2026_JAN,2026
L3455,"Heel, new leather, standard",HCPCS_Level_II,HCPC2026_JAN,2026
L3460,"Heel, new rubber, standard",HCPCS_Level_II,HCPC2026_JAN,2026
L3465,"Heel, thomas with wedge",HCPCS_Level_II,HCPC2026_JAN,2026
L3470,"Heel, thomas extended to ball",HCPCS_Level_II,HCPC2026_JAN,2026
L3480,"Heel, pad and depression for spur",HCPCS_Level_II,HCPC2026_JAN,2026
L3485,"Heel, pad, removable for spur",HCPCS_Level_II,HCPC2026_JAN,2026
L3500,"Orthopedic shoe addition, insole, leather",HCPCS_Level_II,HCPC2026_JAN,2026
L3510,"Orthopedic shoe addition, insole, rubber",HCPCS_Level_II,HCPC2026_JAN,2026
L3520,"Orthopedic shoe addition, insole, felt covered with leather",HCPCS_Level_II,HCPC2026_JAN,2026
L3530,"Orthopedic shoe addition, sole, half",HCPCS_Level_II,HCPC2026_JAN,2026
L3540,"Orthopedic shoe addition, sole, full",HCPCS_Level_II,HCPC2026_JAN,2026
L3550,"Orthopedic shoe addition, toe tap standard",HCPCS_Level_II,HCPC2026_JAN,2026
L3560,"Orthopedic shoe addition, toe tap, horseshoe",HCPCS_Level_II,HCPC2026_JAN,2026
L3570,"Orthopedic shoe addition, special extension to instep (leather with eyelets)",HCPCS_Level_II,HCPC2026_JAN,2026
L3580,"Orthopedic shoe addition, convert instep to velcro closure",HCPCS_Level_II,HCPC2026_JAN,2026
L3590,"Orthopedic shoe addition, convert firm shoe counter to soft counter",HCPCS_Level_II,HCPC2026_JAN,2026
L3595,"Orthopedic shoe addition, march bar",HCPCS_Level_II,HCPC2026_JAN,2026
L3600,"Transfer of an orthosis from one shoe to another, caliper plate, existing",HCPCS_Level_II,HCPC2026_JAN,2026
L3610,"Transfer of an orthosis from one shoe to another, caliper plate, new",HCPCS_Level_II,HCPC2026_JAN,2026
L3620,"Transfer of an orthosis from one shoe to another, solid stirrup, existing",HCPCS_Level_II,HCPC2026_JAN,2026
L3630,"Transfer of an orthosis from one shoe to another, solid stirrup, new",HCPCS_Level_II,HCPC2026_JAN,2026
L3640,"Transfer of an orthosis from one shoe to another, dennis browne splint (riveton), both shoes",HCPCS_Level_II,HCPC2026_JAN,2026
L3649,"Orthopedic shoe, modification, addition or transfer, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L3650,"Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3660,"Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3670,"Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3671,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3674,"Shoulder orthosis, abduction positioning (airplane design), thoracic component and support bar, with or without nontorsion joint/turnbuckle, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3675,"Shoulder orthosis, vest type abduction restrainer, canvas webbing type or equal, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3677,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3678,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3702,"Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3710,"Elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3720,"Elbow orthosis, double upright with forearm/arm cuffs, free motion, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L3730,"Elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion assist, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L3740,"Elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock with active control, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L3760,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific  patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3761,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3762,"Elbow orthosis, rigid, without joints, includes soft interface material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3763,"Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3764,"Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3765,"Elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3766,"Elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3806,"Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3807,"Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3808,"Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3809,"Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L3891,"Addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3900,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, wrist or finger driven, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L3901,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, cable driven, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L3904,"Wrist hand finger orthosis, external powered, electric, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L3905,"Wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3906,"Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3908,"Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3912,"Hand finger orthosis (hfo), flexion glove with elastic finger control, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3913,"Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3915,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3916,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3917,"Hand orthosis, metacarpal fracture orthosis, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3918,"Hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3919,"Hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3921,"Hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3923,"Hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3924,"Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3925,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), non torsion joint/spring, extension/flexion, may include soft interface material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3927,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3929,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L3930,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L3931,"Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3933,"Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3935,"Finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3956,"Addition of joint to upper extremity orthosis, any material; per joint",HCPCS_Level_II,HCPC2026_JAN,2026
L3960,"Shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3961,"Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3962,"Shoulder elbow wrist hand orthosis, abduction positioning, erb's palsey design, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3967,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3971,"Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3973,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3975,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3976,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3977,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3978,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3980,"Upper extremity fracture orthosis, humeral, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3981,"Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments",HCPCS_Level_II,HCPC2026_JAN,2026
L3982,"Upper extremity fracture orthosis, radius/ulnar, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3984,"Upper extremity fracture orthosis, wrist, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L3995,"Addition to upper extremity orthosis, sock, fracture or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L3999,"Upper limb orthosis, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L4000,Replace girdle for spinal orthosis (ctlso or so),HCPCS_Level_II,HCPC2026_JAN,2026
L4002,"Replacement strap, any orthosis, includes all components, any length, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L4010,Replace trilateral socket brim,HCPCS_Level_II,HCPC2026_JAN,2026
L4020,"Replace quadrilateral socket brim, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L4030,"Replace quadrilateral socket brim, custom fitted",HCPCS_Level_II,HCPC2026_JAN,2026
L4040,"Replace molded thigh lacer, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L4045,"Replace non-molded thigh lacer, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L4050,"Replace molded calf lacer, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L4055,"Replace non-molded calf lacer, for custom fabricated orthosis only",HCPCS_Level_II,HCPC2026_JAN,2026
L4060,Replace high roll cuff,HCPCS_Level_II,HCPC2026_JAN,2026
L4070,Replace proximal and distal upright for kafo,HCPCS_Level_II,HCPC2026_JAN,2026
L4080,"Replace metal bands kafo, proximal thigh",HCPCS_Level_II,HCPC2026_JAN,2026
L4090,"Replace metal bands kafo-afo, calf or distal thigh",HCPCS_Level_II,HCPC2026_JAN,2026
L4100,"Replace leather cuff kafo, proximal thigh",HCPCS_Level_II,HCPC2026_JAN,2026
L4110,"Replace leather cuff kafo-afo, calf or distal thigh",HCPCS_Level_II,HCPC2026_JAN,2026
L4130,Replace pretibial shell,HCPCS_Level_II,HCPC2026_JAN,2026
L4205,"Repair of orthotic device, labor component, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
L4210,"Repair of orthotic device, repair or replace minor parts",HCPCS_Level_II,HCPC2026_JAN,2026
L4350,"Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L4360,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L4361,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L4370,"Pneumatic full leg splint, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L4386,"Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L4387,"Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L4392,"Replacement, soft interface material, static afo",HCPCS_Level_II,HCPC2026_JAN,2026
L4394,"Replace soft interface material, foot drop splint",HCPCS_Level_II,HCPC2026_JAN,2026
L4396,"Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise",HCPCS_Level_II,HCPC2026_JAN,2026
L4397,"Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L4398,"Foot drop splint, recumbent positioning device, prefabricated, off-the-shelf",HCPCS_Level_II,HCPC2026_JAN,2026
L4631,"Ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom, anterior tibial shell, soft interface, custom arch support, plastic or other material, includes straps and closures, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L5000,"Partial foot, shoe insert with longitudinal arch, toe filler",HCPCS_Level_II,HCPC2026_JAN,2026
L5010,"Partial foot, molded socket, ankle height, with toe filler",HCPCS_Level_II,HCPC2026_JAN,2026
L5020,"Partial foot, molded socket, tibial tubercle height, with toe filler",HCPCS_Level_II,HCPC2026_JAN,2026
L5050,"Ankle, symes, molded socket, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5060,"Ankle, symes, metal frame, molded leather socket, articulated ankle/foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5100,"Below knee, molded socket, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5105,"Below knee, plastic socket, joints and thigh lacer, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5150,"Knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5160,"Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5200,"Above knee, molded socket, single axis constant friction knee, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5210,"Above knee, short prosthesis, no knee joint ('stubbies'), with foot blocks, no ankle joints, each",HCPCS_Level_II,HCPC2026_JAN,2026
L5220,"Above knee, short prosthesis, no knee joint ('stubbies'), with articulated ankle/foot, dynamically aligned, each",HCPCS_Level_II,HCPC2026_JAN,2026
L5230,"Above knee, for proximal femoral focal deficiency, constant friction knee, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5250,"Hip disarticulation, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5270,"Hip disarticulation, tilt table type; molded socket, locking hip joint, single axis constant friction knee, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5280,"Hemipelvectomy, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5301,"Below knee, molded socket, shin, sach foot, endoskeletal system",HCPCS_Level_II,HCPC2026_JAN,2026
L5312,"Knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system",HCPCS_Level_II,HCPC2026_JAN,2026
L5321,"Above knee, molded socket, open end, sach foot, endoskeletal system, single axis knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5331,"Hip disarticulation, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5341,"Hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5400,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5410,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee, each additional cast change and realignment",HCPCS_Level_II,HCPC2026_JAN,2026
L5420,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change 'ak' or knee disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L5430,"Immediate post surgical or early fitting, application of initial rigid dressing, incl. fitting, alignment and supension, 'ak' or knee disarticulation, each additional cast change and realignment",HCPCS_Level_II,HCPC2026_JAN,2026
L5450,"Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, below knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5460,"Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, above knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5500,"Initial, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L5505,"Initial, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L5510,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model",HCPCS_Level_II,HCPC2026_JAN,2026
L5520,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L5530,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model",HCPCS_Level_II,HCPC2026_JAN,2026
L5535,"Preparatory, below knee 'ptb' type socket, non-alignable system, no cover, sach foot, prefabricated, adjustable open end socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5540,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, laminated socket, molded to model",HCPCS_Level_II,HCPC2026_JAN,2026
L5560,"Preparatory, above knee- knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model",HCPCS_Level_II,HCPC2026_JAN,2026
L5570,"Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L5580,"Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model",HCPCS_Level_II,HCPC2026_JAN,2026
L5585,"Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open end socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5590,"Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon no cover, sach foot, laminated socket, molded to model",HCPCS_Level_II,HCPC2026_JAN,2026
L5595,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, thermoplastic or equal, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L5600,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, laminated socket, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L5610,"Addition to lower extremity, endoskeletal system, above knee, hydracadence system",HCPCS_Level_II,HCPC2026_JAN,2026
L5611,"Addition to lower extremity, endoskeletal system, above knee - knee disarticulation, 4 bar linkage, with friction swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5613,"Addition to lower extremity, endoskeletal system, above knee-knee disarticulation, 4 bar linkage, with hydraulic swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5614,"Addition to lower extremity, exoskeletal system, above knee-knee disarticulation, 4 bar linkage, with pneumatic swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5615,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5616,"Addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5617,"Addition to lower extremity, quick change self-aligning unit, above knee or below knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L5618,"Addition to lower extremity, test socket, symes",HCPCS_Level_II,HCPC2026_JAN,2026
L5620,"Addition to lower extremity, test socket, below knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5622,"Addition to lower extremity, test socket, knee disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L5624,"Addition to lower extremity, test socket, above knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5626,"Addition to lower extremity, test socket, hip disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L5628,"Addition to lower extremity, test socket, hemipelvectomy",HCPCS_Level_II,HCPC2026_JAN,2026
L5629,"Addition to lower extremity, below knee, acrylic socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5630,"Addition to lower extremity, symes type, expandable wall socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5631,"Addition to lower extremity, above knee or knee disarticulation, acrylic socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5632,"Addition to lower extremity, symes type, 'ptb' brim design socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5634,"Addition to lower extremity, symes type, posterior opening (canadian) socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5636,"Addition to lower extremity, symes type, medial opening socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5637,"Addition to lower extremity, below knee, total contact",HCPCS_Level_II,HCPC2026_JAN,2026
L5638,"Addition to lower extremity, below knee, leather socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5639,"Addition to lower extremity, below knee, wood socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5640,"Addition to lower extremity, knee disarticulation, leather socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5642,"Addition to lower extremity, above knee, leather socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5643,"Addition to lower extremity, hip disarticulation, flexible inner socket, external frame",HCPCS_Level_II,HCPC2026_JAN,2026
L5644,"Addition to lower extremity, above knee, wood socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5645,"Addition to lower extremity, below knee, flexible inner socket, external frame",HCPCS_Level_II,HCPC2026_JAN,2026
L5646,"Addition to lower extremity, below knee, air, fluid, gel or equal, cushion socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5647,"Addition to lower extremity, below knee suction socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5648,"Addition to lower extremity, above knee, air, fluid, gel or equal, cushion socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5649,"Addition to lower extremity, ischial containment/narrow m-l socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5650,"Additions to lower extremity, total contact, above knee or knee disarticulation socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5651,"Addition to lower extremity, above knee, flexible inner socket, external frame",HCPCS_Level_II,HCPC2026_JAN,2026
L5652,"Addition to lower extremity, suction suspension, above knee or knee disarticulation socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5653,"Addition to lower extremity, knee disarticulation, expandable wall socket",HCPCS_Level_II,HCPC2026_JAN,2026
L5654,"Addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast, plastazote or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5655,"Addition to lower extremity, socket insert, below knee (kemblo, pelite, aliplast, plastazote or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5656,"Addition to lower extremity, socket insert, knee disarticulation (kemblo, pelite, aliplast, plastazote or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5657,"Addition to lower extremity prosthesis, manual/automated adjustable air, fluid, gel or equal socket insert for limb volume management, any materials",HCPCS_Level_II,HCPC2026_JAN,2026
L5658,"Addition to lower extremity, socket insert, above knee (kemblo, pelite, aliplast, plastazote or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5661,"Addition to lower extremity, socket insert, multi-durometer symes",HCPCS_Level_II,HCPC2026_JAN,2026
L5665,"Addition to lower extremity, socket insert, multi-durometer, below knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5666,"Addition to lower extremity, below knee, cuff suspension",HCPCS_Level_II,HCPC2026_JAN,2026
L5668,"Addition  to lower extremity, below knee, molded distal cushion",HCPCS_Level_II,HCPC2026_JAN,2026
L5670,"Addition to lower extremity, below knee, molded supracondylar suspension ('pts' or similar)",HCPCS_Level_II,HCPC2026_JAN,2026
L5671,"Addition to lower extremity, below knee / above knee suspension locking mechanism (shuttle, lanyard or equal), excludes socket insert",HCPCS_Level_II,HCPC2026_JAN,2026
L5672,"Addition to lower extremity, below knee, removable medial brim suspension",HCPCS_Level_II,HCPC2026_JAN,2026
L5673,"Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric, or equal, with or without perforations, with or without breathable material, for use with locking mechanism",HCPCS_Level_II,HCPC2026_JAN,2026
L5676,"Additions to lower extremity, below knee, knee joints, single axis, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L5677,"Additions to lower extremity, below knee, knee joints, polycentric, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L5678,"Additions to lower extremity, below knee, joint covers, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L5679,"Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric, or equal, with or without perforations, with or without breathable material, not for use with locking mechanism",HCPCS_Level_II,HCPC2026_JAN,2026
L5680,"Addition to lower extremity, below knee, thigh lacer, nonmolded",HCPCS_Level_II,HCPC2026_JAN,2026
L5681,"Addition to lower extremity, below knee/above knee, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)",HCPCS_Level_II,HCPC2026_JAN,2026
L5682,"Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded",HCPCS_Level_II,HCPC2026_JAN,2026
L5683,"Addition to lower extremity, below knee/above knee, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)",HCPCS_Level_II,HCPC2026_JAN,2026
L5684,"Addition to lower extremity, below knee, fork strap",HCPCS_Level_II,HCPC2026_JAN,2026
L5685,"Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with or without valve, any material, each",HCPCS_Level_II,HCPC2026_JAN,2026
L5686,"Addition to lower extremity, below knee, back check (extension control)",HCPCS_Level_II,HCPC2026_JAN,2026
L5688,"Addition to lower extremity, below knee, waist belt, webbing",HCPCS_Level_II,HCPC2026_JAN,2026
L5690,"Addition to lower extremity, below knee, waist belt, padded and lined",HCPCS_Level_II,HCPC2026_JAN,2026
L5692,"Addition to lower extremity, above knee, pelvic control belt, light",HCPCS_Level_II,HCPC2026_JAN,2026
L5694,"Addition to lower extremity, above knee, pelvic control belt, padded and lined",HCPCS_Level_II,HCPC2026_JAN,2026
L5695,"Addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L5696,"Addition to lower extremity, above knee or knee disarticulation, pelvic joint",HCPCS_Level_II,HCPC2026_JAN,2026
L5697,"Addition to lower extremity, above knee or knee disarticulation, pelvic band",HCPCS_Level_II,HCPC2026_JAN,2026
L5698,"Addition to lower extremity, above knee or knee disarticulation, silesian bandage",HCPCS_Level_II,HCPC2026_JAN,2026
L5699,"All lower extremity prostheses, shoulder harness",HCPCS_Level_II,HCPC2026_JAN,2026
L5700,"Replacement, socket, below knee, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L5701,"Replacement, socket, above knee/knee disarticulation, including attachment plate, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L5702,"Replacement, socket, hip disarticulation, including hip joint, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L5703,"Ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L5704,"Custom shaped protective cover, below knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5705,"Custom shaped protective cover, above knee",HCPCS_Level_II,HCPC2026_JAN,2026
L5706,"Custom shaped protective cover, knee disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L5707,"Custom shaped protective cover, hip disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L5710,"Addition, exoskeletal knee-shin system, single axis, manual lock",HCPCS_Level_II,HCPC2026_JAN,2026
L5711,"Additions exoskeletal knee-shin system, single axis, manual lock, ultra-light material",HCPCS_Level_II,HCPC2026_JAN,2026
L5712,"Addition, exoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)",HCPCS_Level_II,HCPC2026_JAN,2026
L5714,"Addition, exoskeletal knee-shin system, single axis, variable friction swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5716,"Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock",HCPCS_Level_II,HCPC2026_JAN,2026
L5718,"Addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5722,"Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5724,"Addition, exoskeletal knee-shin system, single axis, fluid swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5726,"Addition, exoskeletal knee-shin system, single axis, external joints fluid swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5728,"Addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5780,"Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5781,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system",HCPCS_Level_II,HCPC2026_JAN,2026
L5782,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system, heavy duty",HCPCS_Level_II,HCPC2026_JAN,2026
L5783,"Addition to lower extremity, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)",HCPCS_Level_II,HCPC2026_JAN,2026
L5785,"Addition, exoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5790,"Addition, exoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5795,"Addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5810,"Addition, endoskeletal knee-shin system, single axis, manual lock",HCPCS_Level_II,HCPC2026_JAN,2026
L5811,"Addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light material",HCPCS_Level_II,HCPC2026_JAN,2026
L5812,"Addition, endoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)",HCPCS_Level_II,HCPC2026_JAN,2026
L5814,"Addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase control, mechanical stance phase lock",HCPCS_Level_II,HCPC2026_JAN,2026
L5816,"Addition, endoskeletal knee-shin system, polycentric, mechanical stance phase lock",HCPCS_Level_II,HCPC2026_JAN,2026
L5818,"Addition, endoskeletal knee-shin system, polycentric, friction swing, and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5822,"Addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5824,"Addition, endoskeletal knee-shin system, single axis, fluid swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5826,"Addition, endoskeletal knee-shin system, single axis, hydraulic swing phase control, with miniature high activity frame",HCPCS_Level_II,HCPC2026_JAN,2026
L5827,"Endoskeletal knee-shin system, single axis, electromechanical swing and stance phase control, with or without shock absorption and stance extension damping",HCPCS_Level_II,HCPC2026_JAN,2026
L5828,"Addition, endoskeletal knee-shin system, single axis, fluid swing and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5830,"Addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5840,"Addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic swing phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5841,"Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control",HCPCS_Level_II,HCPC2026_JAN,2026
L5845,"Addition, endoskeletal, knee-shin system, stance flexion feature, adjustable",HCPCS_Level_II,HCPC2026_JAN,2026
L5848,"Addition to endoskeletal knee-shin system, fluid stance extension, dampening feature, with or without adjustability",HCPCS_Level_II,HCPC2026_JAN,2026
L5850,"Addition, endoskeletal system, above knee or hip disarticulation, knee extension assist",HCPCS_Level_II,HCPC2026_JAN,2026
L5855,"Addition, endoskeletal system, hip disarticulation, mechanical hip extension assist",HCPCS_Level_II,HCPC2026_JAN,2026
L5856,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type",HCPCS_Level_II,HCPC2026_JAN,2026
L5857,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type",HCPCS_Level_II,HCPC2026_JAN,2026
L5858,"Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type",HCPCS_Level_II,HCPC2026_JAN,2026
L5859,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)",HCPCS_Level_II,HCPC2026_JAN,2026
L5910,"Addition, endoskeletal system, below knee, alignable system",HCPCS_Level_II,HCPC2026_JAN,2026
L5920,"Addition, endoskeletal system, above knee or hip disarticulation, alignable system",HCPCS_Level_II,HCPC2026_JAN,2026
L5925,"Addition, endoskeletal system, above knee, knee disarticulation or hip disarticulation, manual lock",HCPCS_Level_II,HCPC2026_JAN,2026
L5926,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L5930,"Addition, endoskeletal system, high activity knee control frame",HCPCS_Level_II,HCPC2026_JAN,2026
L5940,"Addition, endoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5950,"Addition, endoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5960,"Addition, endoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5961,"Addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic control, rotation control, with or without flexion and/or extension control",HCPCS_Level_II,HCPC2026_JAN,2026
L5962,"Addition, endoskeletal system, below knee, flexible protective outer surface covering system",HCPCS_Level_II,HCPC2026_JAN,2026
L5964,"Addition, endoskeletal system, above knee, flexible protective outer surface covering system",HCPCS_Level_II,HCPC2026_JAN,2026
L5966,"Addition, endoskeletal system, hip disarticulation, flexible protective outer surface covering system",HCPCS_Level_II,HCPC2026_JAN,2026
L5968,"Addition to lower limb prosthesis, multiaxial ankle with swing phase active dorsiflexion feature",HCPCS_Level_II,HCPC2026_JAN,2026
L5969,"Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)",HCPCS_Level_II,HCPC2026_JAN,2026
L5970,"All lower extremity prostheses, foot, external keel, sach foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5971,"All lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L5972,"All lower extremity prostheses, foot, flexible keel",HCPCS_Level_II,HCPC2026_JAN,2026
L5973,"Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source",HCPCS_Level_II,HCPC2026_JAN,2026
L5974,"All lower extremity prostheses, foot, single axis ankle/foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5975,"All lower extremity prosthesis, combination single axis ankle and flexible keel foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5976,"All lower extremity prostheses, energy storing foot (seattle carbon copy ii or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5978,"All lower extremity prostheses, foot, multiaxial ankle/foot",HCPCS_Level_II,HCPC2026_JAN,2026
L5979,"All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece system",HCPCS_Level_II,HCPC2026_JAN,2026
L5980,"All lower extremity prostheses, flex foot system",HCPCS_Level_II,HCPC2026_JAN,2026
L5981,"All lower extremity prostheses, flex-walk system or equal",HCPCS_Level_II,HCPC2026_JAN,2026
L5982,"All exoskeletal lower extremity prostheses, axial rotation unit",HCPCS_Level_II,HCPC2026_JAN,2026
L5984,"All endoskeletal lower extremity prosthesis, axial rotation unit, with or without adjustability",HCPCS_Level_II,HCPC2026_JAN,2026
L5985,"All endoskeletal lower extremity prostheses, dynamic prosthetic pylon",HCPCS_Level_II,HCPC2026_JAN,2026
L5986,"All lower extremity prostheses, multi-axial rotation unit ('mcp' or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L5987,"All lower extremity prosthesis, shank foot system with vertical loading pylon",HCPCS_Level_II,HCPC2026_JAN,2026
L5988,"Addition to lower limb prosthesis, vertical shock reducing pylon feature",HCPCS_Level_II,HCPC2026_JAN,2026
L5990,"Addition to lower extremity prosthesis, user adjustable heel height",HCPCS_Level_II,HCPC2026_JAN,2026
L5991,"Addition to lower extremity prostheses, osseointegrated external prosthetic connector",HCPCS_Level_II,HCPC2026_JAN,2026
L5999,"Lower extremity prosthesis, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L6000,"Partial hand, thumb remaining",HCPCS_Level_II,HCPC2026_JAN,2026
L6010,"Partial hand, little and/or ring finger remaining",HCPCS_Level_II,HCPC2026_JAN,2026
L6020,"Partial hand, no finger remaining",HCPCS_Level_II,HCPC2026_JAN,2026
L6025,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6026,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)",HCPCS_Level_II,HCPC2026_JAN,2026
L6028,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at metacarpal level, including flexible or non-flexible interface, molded to patient model, including palm, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692",HCPCS_Level_II,HCPC2026_JAN,2026
L6029,"Upper extremity addition, test socket/interface, partial hand including fingers",HCPCS_Level_II,HCPC2026_JAN,2026
L6030,"Upper extremity addition, external frame, partial hand including fingers",HCPCS_Level_II,HCPC2026_JAN,2026
L6031,"Replacement socket/interface, partial hand including fingers, molded to patient model, for use with or without external power",HCPCS_Level_II,HCPC2026_JAN,2026
L6032,"Addition to upper extremity prosthesis, partial hand including fingers, ultralight material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L6033,"Addition to upper extremity prosthesis, partial hand including fingers, acrylic material",HCPCS_Level_II,HCPC2026_JAN,2026
L6034,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at distal to metacarpal joint, including flexible or non-flexible interface, molded to patient model, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692",HCPCS_Level_II,HCPC2026_JAN,2026
L6035,"Single prosthetic digit, mechanical, can include metacarpophalangeal (mcp), proximal interphalangeal (pip), and/or distal interphalangeal (dip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L6036,"Prosthetic thumb, mechanical, can include metacarpophalangeal (mcp), interphalangeal (ip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L6037,"Immediate post-surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, partial hand including fingers",HCPCS_Level_II,HCPC2026_JAN,2026
L6038,"Addition to single prosthetic digit or thumb, mechanical, attachment, multiaxial and/or internal/external rotation/abduction/adduction mechanism, with or without locking feature, any material",HCPCS_Level_II,HCPC2026_JAN,2026
L6039,"Passive prosthetic digit or thumb prosthesis not including hand restoration partial hand, full or partial, custom made, any material, initial or replacement, per single passive prosthetic digit or thumb",HCPCS_Level_II,HCPC2026_JAN,2026
L6050,"Wrist disarticulation, molded socket, flexible elbow hinges, triceps pad",HCPCS_Level_II,HCPC2026_JAN,2026
L6055,"Wrist disarticulation, molded socket with expandable interface, flexible elbow hinges, triceps pad",HCPCS_Level_II,HCPC2026_JAN,2026
L6100,"Below elbow, molded socket, flexible elbow hinge, triceps pad",HCPCS_Level_II,HCPC2026_JAN,2026
L6110,"Below elbow, molded socket, (muenster or northwestern suspension types)",HCPCS_Level_II,HCPC2026_JAN,2026
L6120,"Below elbow, molded double wall split socket, step-up hinges, half cuff",HCPCS_Level_II,HCPC2026_JAN,2026
L6130,"Below elbow, molded double wall split socket, stump activated locking hinge, half cuff",HCPCS_Level_II,HCPC2026_JAN,2026
L6200,"Elbow disarticulation, molded socket, outside locking hinge, forearm",HCPCS_Level_II,HCPC2026_JAN,2026
L6205,"Elbow disarticulation, molded socket with expandable interface, outside locking hinges, forearm",HCPCS_Level_II,HCPC2026_JAN,2026
L6250,"Above elbow, molded double wall socket, internal locking elbow, forearm",HCPCS_Level_II,HCPC2026_JAN,2026
L6300,"Shoulder disarticulation, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm",HCPCS_Level_II,HCPC2026_JAN,2026
L6310,"Shoulder disarticulation, passive restoration (complete prosthesis)",HCPCS_Level_II,HCPC2026_JAN,2026
L6320,"Shoulder disarticulation, passive restoration (shoulder cap only)",HCPCS_Level_II,HCPC2026_JAN,2026
L6350,"Interscapular thoracic, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm",HCPCS_Level_II,HCPC2026_JAN,2026
L6360,"Interscapular thoracic, passive restoration (complete prosthesis)",HCPCS_Level_II,HCPC2026_JAN,2026
L6370,"Interscapular thoracic, passive restoration (shoulder cap only)",HCPCS_Level_II,HCPC2026_JAN,2026
L6380,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, wrist disarticulation or below elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6382,"Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, elbow disarticulation or above elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6384,"Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, shoulder disarticulation or interscapular thoracic",HCPCS_Level_II,HCPC2026_JAN,2026
L6386,"Immediate post surgical or early fitting, each additional cast change and realignment",HCPCS_Level_II,HCPC2026_JAN,2026
L6388,"Immediate post surgical or early fitting, application of rigid dressing only",HCPCS_Level_II,HCPC2026_JAN,2026
L6400,"Below elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping",HCPCS_Level_II,HCPC2026_JAN,2026
L6450,"Elbow disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping",HCPCS_Level_II,HCPC2026_JAN,2026
L6500,"Above elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping",HCPCS_Level_II,HCPC2026_JAN,2026
L6550,"Shoulder disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping",HCPCS_Level_II,HCPC2026_JAN,2026
L6570,"Interscapular thoracic, molded socket, endoskeletal system, including soft prosthetic tissue shaping",HCPCS_Level_II,HCPC2026_JAN,2026
L6580,"Preparatory, wrist disarticulation or below elbow, single wall plastic socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L6582,"Preparatory, wrist disarticulation or below elbow, single wall socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L6584,"Preparatory, elbow disarticulation or above elbow, single wall plastic socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L6586,"Preparatory, elbow disarticulation or above elbow, single wall socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L6588,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall plastic socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L6590,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, direct formed",HCPCS_Level_II,HCPC2026_JAN,2026
L6600,"Upper extremity additions, polycentric hinge, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L6605,"Upper extremity additions, single pivot hinge, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L6610,"Upper extremity additions, flexible metal hinge, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L6611,"Addition to upper extremity prosthesis, external powered, additional switch, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L6615,"Upper extremity addition, disconnect locking wrist unit",HCPCS_Level_II,HCPC2026_JAN,2026
L6616,"Upper extremity addition, additional disconnect insert for locking wrist unit, each",HCPCS_Level_II,HCPC2026_JAN,2026
L6620,"Upper extremity addition, flexion/extension wrist unit, with or without friction",HCPCS_Level_II,HCPC2026_JAN,2026
L6621,"Upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6623,"Upper extremity addition, spring assisted rotational wrist unit with latch release",HCPCS_Level_II,HCPC2026_JAN,2026
L6624,"Upper extremity addition, flexion/extension and rotation wrist unit",HCPCS_Level_II,HCPC2026_JAN,2026
L6625,"Upper extremity addition, rotation wrist unit with cable lock",HCPCS_Level_II,HCPC2026_JAN,2026
L6628,"Upper extremity addition, quick disconnect hook adapter, otto bock or equal",HCPCS_Level_II,HCPC2026_JAN,2026
L6629,"Upper extremity addition, quick disconnect lamination collar with coupling piece, otto bock or equal",HCPCS_Level_II,HCPC2026_JAN,2026
L6630,"Upper extremity addition, stainless steel, any wrist",HCPCS_Level_II,HCPC2026_JAN,2026
L6632,"Upper extremity addition, latex suspension sleeve, each",HCPCS_Level_II,HCPC2026_JAN,2026
L6635,"Upper extremity addition, lift assist for elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6637,"Upper extremity addition, nudge control elbow lock",HCPCS_Level_II,HCPC2026_JAN,2026
L6638,"Upper extremity addition to prosthesis, electric locking feature, only for use with manually powered elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6640,"Upper extremity additions, shoulder abduction joint, pair",HCPCS_Level_II,HCPC2026_JAN,2026
L6641,"Upper extremity addition, excursion amplifier, pulley type",HCPCS_Level_II,HCPC2026_JAN,2026
L6642,"Upper extremity addition, excursion amplifier, lever type",HCPCS_Level_II,HCPC2026_JAN,2026
L6645,"Upper extremity addition, shoulder flexion-abduction joint, each",HCPCS_Level_II,HCPC2026_JAN,2026
L6646,"Upper extremity addition, shoulder joint, multipositional locking, flexion, adjustable abduction friction control, for use with body powered or external powered system",HCPCS_Level_II,HCPC2026_JAN,2026
L6647,"Upper extremity addition, shoulder lock mechanism, body powered actuator",HCPCS_Level_II,HCPC2026_JAN,2026
L6648,"Upper extremity addition, shoulder lock mechanism, external powered actuator",HCPCS_Level_II,HCPC2026_JAN,2026
L6650,"Upper extremity addition, shoulder universal joint, each",HCPCS_Level_II,HCPC2026_JAN,2026
L6655,"Upper extremity addition, standard control cable, extra",HCPCS_Level_II,HCPC2026_JAN,2026
L6660,"Upper extremity addition, heavy duty control cable",HCPCS_Level_II,HCPC2026_JAN,2026
L6665,"Upper extremity addition, teflon, or equal, cable lining",HCPCS_Level_II,HCPC2026_JAN,2026
L6670,"Upper extremity addition, hook to hand, cable adapter",HCPCS_Level_II,HCPC2026_JAN,2026
L6672,"Upper extremity addition, harness, chest or shoulder, saddle type",HCPCS_Level_II,HCPC2026_JAN,2026
L6675,"Upper extremity addition, harness, (e.g., figure of eight type), single cable design",HCPCS_Level_II,HCPC2026_JAN,2026
L6676,"Upper extremity addition, harness, (e.g., figure of eight type), dual cable design",HCPCS_Level_II,HCPC2026_JAN,2026
L6677,"Upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6680,"Upper extremity addition, test socket, wrist disarticulation or below elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6682,"Upper extremity addition, test socket, elbow disarticulation or above elbow",HCPCS_Level_II,HCPC2026_JAN,2026
L6684,"Upper extremity addition, test socket, shoulder disarticulation or interscapular thoracic",HCPCS_Level_II,HCPC2026_JAN,2026
L6686,"Upper extremity addition, suction socket",HCPCS_Level_II,HCPC2026_JAN,2026
L6687,"Upper extremity addition, frame type socket, below elbow or wrist disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L6688,"Upper extremity addition, frame type socket, above elbow or elbow disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L6689,"Upper extremity addition, frame type socket, shoulder disarticulation",HCPCS_Level_II,HCPC2026_JAN,2026
L6690,"Upper extremity addition, frame type socket, interscapular-thoracic",HCPCS_Level_II,HCPC2026_JAN,2026
L6691,"Upper extremity addition, removable insert, each",HCPCS_Level_II,HCPC2026_JAN,2026
L6692,"Upper extremity addition, silicone gel insert or equal, with or without locking mechanism, each",HCPCS_Level_II,HCPC2026_JAN,2026
L6693,"Upper extremity addition, locking elbow, forearm counterbalance",HCPCS_Level_II,HCPC2026_JAN,2026
L6694,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism",HCPCS_Level_II,HCPC2026_JAN,2026
L6695,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism",HCPCS_Level_II,HCPC2026_JAN,2026
L6696,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)",HCPCS_Level_II,HCPC2026_JAN,2026
L6697,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)",HCPCS_Level_II,HCPC2026_JAN,2026
L6698,"Addition to upper extremity prosthesis, lock mechanism, excludes socket insert",HCPCS_Level_II,HCPC2026_JAN,2026
L6700,"Upper extremity addition, external powered feature, myoelectronic control module, additional emg inputs, pattern-recognition decoding intent movement",HCPCS_Level_II,HCPC2026_JAN,2026
L6703,"Terminal device, passive hand/mitt, any material, any size",HCPCS_Level_II,HCPC2026_JAN,2026
L6704,"Terminal device, sport/recreational/work attachment, any material, any size",HCPCS_Level_II,HCPC2026_JAN,2026
L6706,"Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined",HCPCS_Level_II,HCPC2026_JAN,2026
L6707,"Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined",HCPCS_Level_II,HCPC2026_JAN,2026
L6708,"Terminal device, hand, mechanical, voluntary opening, any material, any size",HCPCS_Level_II,HCPC2026_JAN,2026
L6709,"Terminal device, hand, mechanical, voluntary closing, any material, any size",HCPCS_Level_II,HCPC2026_JAN,2026
L6711,"Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
L6712,"Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
L6713,"Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
L6714,"Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
L6715,"Terminal device, multiple articulating digit, includes motor(s), initial issue or replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L6721,"Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined",HCPCS_Level_II,HCPC2026_JAN,2026
L6722,"Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined",HCPCS_Level_II,HCPC2026_JAN,2026
L6805,"Addition to terminal device, modifier wrist unit",HCPCS_Level_II,HCPC2026_JAN,2026
L6810,"Addition to terminal device, precision pinch device",HCPCS_Level_II,HCPC2026_JAN,2026
L6880,"Electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)",HCPCS_Level_II,HCPC2026_JAN,2026
L6881,"Automatic grasp feature, addition to upper limb electric prosthetic terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6882,"Microprocessor control feature, addition to upper limb prosthetic terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6883,"Replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power",HCPCS_Level_II,HCPC2026_JAN,2026
L6884,"Replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power",HCPCS_Level_II,HCPC2026_JAN,2026
L6885,"Replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power",HCPCS_Level_II,HCPC2026_JAN,2026
L6890,"Addition to upper extremity prosthesis, glove for terminal device, any material, prefabricated, includes fitting and adjustment",HCPCS_Level_II,HCPC2026_JAN,2026
L6895,"Addition to upper extremity prosthesis, glove for terminal device, any material, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L6900,"Hand restoration (casts, shading and measurements included), partial hand, with glove, thumb or one finger remaining",HCPCS_Level_II,HCPC2026_JAN,2026
L6905,"Hand restoration (casts, shading and measurements included), partial hand, with glove, multiple fingers remaining",HCPCS_Level_II,HCPC2026_JAN,2026
L6910,"Hand restoration (casts, shading and measurements included), partial hand, with glove, no fingers remaining",HCPCS_Level_II,HCPC2026_JAN,2026
L6915,"Hand restoration (shading, and measurements included), replacement glove for above",HCPCS_Level_II,HCPC2026_JAN,2026
L6920,"Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal, switch, cables, two batteries and one charger, switch control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6925,"Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6930,"Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6935,"Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6940,"Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6945,"Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6950,"Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6955,"Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6960,"Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6965,"Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6970,"Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L6975,"Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L7007,"Electric hand, switch or myoelectric controlled, adult",HCPCS_Level_II,HCPC2026_JAN,2026
L7008,"Electric hand, switch or myoelectric, controlled, pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
L7009,"Electric hook, switch or myoelectric controlled, adult",HCPCS_Level_II,HCPC2026_JAN,2026
L7040,"Prehensile actuator, switch controlled",HCPCS_Level_II,HCPC2026_JAN,2026
L7045,"Electric hook, switch or myoelectric controlled, pediatric",HCPCS_Level_II,HCPC2026_JAN,2026
L7170,"Electronic elbow, hosmer or equal, switch controlled",HCPCS_Level_II,HCPC2026_JAN,2026
L7180,"Electronic elbow, microprocessor sequential control of elbow and terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L7181,"Electronic elbow, microprocessor simultaneous control of elbow and terminal device",HCPCS_Level_II,HCPC2026_JAN,2026
L7185,"Electronic elbow, adolescent, variety village or equal, switch controlled",HCPCS_Level_II,HCPC2026_JAN,2026
L7186,"Electronic elbow, child, variety village or equal, switch controlled",HCPCS_Level_II,HCPC2026_JAN,2026
L7190,"Electronic elbow, adolescent, variety village or equal, myoelectronically controlled",HCPCS_Level_II,HCPC2026_JAN,2026
L7191,"Electronic elbow, child, variety village or equal, myoelectronically controlled",HCPCS_Level_II,HCPC2026_JAN,2026
L7259,"Electronic wrist rotator, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L7260,"Electronic wrist rotator, otto bock or equal",HCPCS_Level_II,HCPC2026_JAN,2026
L7261,"Electronic wrist rotator, for utah arm",HCPCS_Level_II,HCPC2026_JAN,2026
L7360,"Six volt battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
L7362,"Battery charger, six volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
L7364,"Twelve volt battery, each",HCPCS_Level_II,HCPC2026_JAN,2026
L7366,"Battery charger, twelve volt, each",HCPCS_Level_II,HCPC2026_JAN,2026
L7367,"Lithium ion battery, rechargeable, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L7368,"Lithium ion battery charger, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L7400,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L7401,"Addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L7402,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)",HCPCS_Level_II,HCPC2026_JAN,2026
L7403,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material",HCPCS_Level_II,HCPC2026_JAN,2026
L7404,"Addition to upper extremity prosthesis, above elbow disarticulation, acrylic material",HCPCS_Level_II,HCPC2026_JAN,2026
L7405,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material",HCPCS_Level_II,HCPC2026_JAN,2026
L7406,"Addition to upper extremity prosthesis, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)",HCPCS_Level_II,HCPC2026_JAN,2026
L7499,"Upper extremity prosthesis, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L7510,"Repair of prosthetic device, repair or replace minor parts",HCPCS_Level_II,HCPC2026_JAN,2026
L7520,"Repair prosthetic device, labor component, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
L7600,"Prosthetic donning sleeve, any material, each",HCPCS_Level_II,HCPC2026_JAN,2026
L7700,"Gasket or seal, for use with prosthetic socket insert, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
L7900,Male vacuum erection system,HCPCS_Level_II,HCPC2026_JAN,2026
L7902,"Tension ring, for vacuum erection device, any type, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8000,"Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8001,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8002,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8010,"Breast prosthesis, mastectomy sleeve",HCPCS_Level_II,HCPC2026_JAN,2026
L8015,"External breast prosthesis garment, with mastectomy form, post mastectomy",HCPCS_Level_II,HCPC2026_JAN,2026
L8020,"Breast prosthesis, mastectomy form",HCPCS_Level_II,HCPC2026_JAN,2026
L8030,"Breast prosthesis, silicone or equal, without integral adhesive",HCPCS_Level_II,HCPC2026_JAN,2026
L8031,"Breast prosthesis, silicone or equal, with integral adhesive",HCPCS_Level_II,HCPC2026_JAN,2026
L8032,"Nipple prosthesis, prefabricated, reusable, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8033,"Nipple prosthesis, custom fabricated, reusable, any material, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8035,"Custom breast prosthesis, post mastectomy, molded to patient model",HCPCS_Level_II,HCPC2026_JAN,2026
L8039,"Breast prosthesis, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L8040,"Nasal prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8041,"Midfacial prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8042,"Orbital prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8043,"Upper facial prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8044,"Hemi-facial prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8045,"Auricular prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8046,"Partial facial prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8047,"Nasal septal prosthesis, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8048,"Unspecified maxillofacial prosthesis, by report, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8049,"Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
L8300,"Truss, single with standard pad",HCPCS_Level_II,HCPC2026_JAN,2026
L8310,"Truss, double with standard pads",HCPCS_Level_II,HCPC2026_JAN,2026
L8320,"Truss, addition to standard pad, water pad",HCPCS_Level_II,HCPC2026_JAN,2026
L8330,"Truss, addition to standard pad, scrotal pad",HCPCS_Level_II,HCPC2026_JAN,2026
L8400,"Prosthetic sheath, below knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8410,"Prosthetic sheath, above knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8415,"Prosthetic sheath, upper limb, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8417,"Prosthetic sheath/sock, including a gel cushion layer, below knee or above knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8420,"Prosthetic sock, multiple ply, below knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8430,"Prosthetic sock, multiple ply, above knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8435,"Prosthetic sock, multiple ply, upper limb, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8440,"Prosthetic shrinker, below knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8460,"Prosthetic shrinker, above knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8465,"Prosthetic shrinker, upper limb, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8470,"Prosthetic sock, single ply, fitting, below knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8480,"Prosthetic sock, single ply, fitting, above knee, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8485,"Prosthetic sock, single ply, fitting, upper limb, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8499,Unlisted procedure for miscellaneous prosthetic services,HCPCS_Level_II,HCPC2026_JAN,2026
L8500,"Artificial larynx, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8501,Tracheostomy speaking valve,HCPCS_Level_II,HCPC2026_JAN,2026
L8505,"Artificial larynx replacement battery / accessory, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8507,"Tracheo-esophageal voice prosthesis, patient inserted, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8509,"Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8510,Voice amplifier,HCPCS_Level_II,HCPC2026_JAN,2026
L8511,"Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8512,"Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10",HCPCS_Level_II,HCPC2026_JAN,2026
L8513,"Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8514,"Tracheoesophageal puncture dilator, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8515,"Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8600,"Implantable breast prosthesis, silicone or equal",HCPCS_Level_II,HCPC2026_JAN,2026
L8603,"Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies",HCPCS_Level_II,HCPC2026_JAN,2026
L8604,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies",HCPCS_Level_II,HCPC2026_JAN,2026
L8605,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies",HCPCS_Level_II,HCPC2026_JAN,2026
L8606,"Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies",HCPCS_Level_II,HCPC2026_JAN,2026
L8607,"Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies",HCPCS_Level_II,HCPC2026_JAN,2026
L8608,"Miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system",HCPCS_Level_II,HCPC2026_JAN,2026
L8609,Artificial cornea,HCPCS_Level_II,HCPC2026_JAN,2026
L8610,Ocular implant,HCPCS_Level_II,HCPC2026_JAN,2026
L8612,Aqueous shunt,HCPCS_Level_II,HCPC2026_JAN,2026
L8613,Ossicula implant,HCPCS_Level_II,HCPC2026_JAN,2026
L8614,"Cochlear device, includes all internal and external components",HCPCS_Level_II,HCPC2026_JAN,2026
L8615,"Headset/headpiece for use with cochlear implant device, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8616,"Microphone for use with cochlear implant device, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8617,"Transmitting coil for use with cochlear implant device, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8618,"Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8619,"Cochlear implant, external speech processor and controller, integrated system, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8621,"Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8622,"Alkaline battery for use with cochlear implant device, any size, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8623,"Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8624,"Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8625,"External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8627,"Cochlear implant, external speech processor, component, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8628,"Cochlear implant, external controller component, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8629,"Transmitting coil and cable, integrated, for use with cochlear implant device, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8630,Metacarpophalangeal joint implant,HCPCS_Level_II,HCPC2026_JAN,2026
L8631,"Metacarpal phalangeal joint replacement, two or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon), for surgical implantation (all sizes, includes entire system)",HCPCS_Level_II,HCPC2026_JAN,2026
L8641,Metatarsal joint implant,HCPCS_Level_II,HCPC2026_JAN,2026
L8642,Hallux implant,HCPCS_Level_II,HCPC2026_JAN,2026
L8658,"Interphalangeal joint spacer, silicone or equal, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8659,"Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size",HCPCS_Level_II,HCPC2026_JAN,2026
L8670,"Vascular graft material, synthetic, implant",HCPCS_Level_II,HCPC2026_JAN,2026
L8678,"Electrical stimulator supplies (external) for use with implantable neurostimulator, per month",HCPCS_Level_II,HCPC2026_JAN,2026
L8679,"Implantable neurostimulator, pulse generator, any type",HCPCS_Level_II,HCPC2026_JAN,2026
L8680,"Implantable neurostimulator electrode, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8681,"Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L8682,Implantable neurostimulator radiofrequency receiver,HCPCS_Level_II,HCPC2026_JAN,2026
L8683,Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver,HCPCS_Level_II,HCPC2026_JAN,2026
L8684,"Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement",HCPCS_Level_II,HCPC2026_JAN,2026
L8685,"Implantable neurostimulator pulse generator, single array, rechargeable, includes extension",HCPCS_Level_II,HCPC2026_JAN,2026
L8686,"Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension",HCPCS_Level_II,HCPC2026_JAN,2026
L8687,"Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension",HCPCS_Level_II,HCPC2026_JAN,2026
L8688,"Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension",HCPCS_Level_II,HCPC2026_JAN,2026
L8689,"External recharging system for battery (internal) for use with implantable neurostimulator, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L8690,"Auditory osseointegrated device, includes all internal and external components",HCPCS_Level_II,HCPC2026_JAN,2026
L8691,"Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8692,"Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment",HCPCS_Level_II,HCPC2026_JAN,2026
L8693,"Auditory osseointegrated device abutment, any length, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L8694,"Auditory osseointegrated device, transducer/actuator, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8695,"External recharging system for battery (external) for use with implantable neurostimulator, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
L8696,"Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
L8698,"Miscellaneous component, supply or accessory for use with total artificial heart system",HCPCS_Level_II,HCPC2026_JAN,2026
L8699,"Prosthetic implant, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
L8701,"Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L8702,"Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated",HCPCS_Level_II,HCPC2026_JAN,2026
L8720,"External lower extremity sensory prosthetic device, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg",HCPCS_Level_II,HCPC2026_JAN,2026
L8721,"Receptor sole for use with l8720, replacement, each",HCPCS_Level_II,HCPC2026_JAN,2026
L9900,"Orthotic and prosthetic supply, accessory, and/or service component of another hcpcs ""l"" code",HCPCS_Level_II,HCPC2026_JAN,2026
LC,Left circumflex coronary artery,HCPCS_Level_II,HCPC2026_JAN,2026
LD,Left anterior descending coronary artery,HCPCS_Level_II,HCPC2026_JAN,2026
LL,Lease/rental (use the 'll' modifier when dme equipment rental is to be applied against the purchase price),HCPCS_Level_II,HCPC2026_JAN,2026
LM,Left main coronary artery,HCPCS_Level_II,HCPC2026_JAN,2026
LR,Laboratory round trip,HCPCS_Level_II,HCPC2026_JAN,2026
LS,Fda-monitored intraocular lens implant,HCPCS_Level_II,HCPC2026_JAN,2026
LT,Left side (used to identify procedures performed on the left side of the body),HCPCS_Level_II,HCPC2026_JAN,2026
LU,Fractionated payment,HCPCS_Level_II,HCPC2026_JAN,2026
M0001,Advancing cancer care mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
M0002,Optimal care for kidney health mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
M0003,Optimal care for patients with episodic neurological conditions mips value pathways,HCPCS_Level_II,HCPC2026_JAN,2026
M0004,Quality care for patients with neurological conditions mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M0005,Value in primary care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M0010,Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services,HCPCS_Level_II,HCPC2026_JAN,2026
M0064,Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disorders,HCPCS_Level_II,HCPC2026_JAN,2026
M0075,Cellular therapy,HCPCS_Level_II,HCPC2026_JAN,2026
M0076,Prolotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
M0100,Intragastric hypothermia using gastric freezing,HCPCS_Level_II,HCPC2026_JAN,2026
M0201,"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home",HCPCS_Level_II,HCPC2026_JAN,2026
M0220,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0221,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",HCPCS_Level_II,HCPC2026_JAN,2026
M0222,"Intravenous injection, bebtelovimab, includes injection and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0223,"Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",HCPCS_Level_II,HCPC2026_JAN,2026
M0224,"Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0235,"Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose",HCPCS_Level_II,HCPC2026_JAN,2026
M0236,"Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose",HCPCS_Level_II,HCPC2026_JAN,2026
M0237,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",HCPCS_Level_II,HCPC2026_JAN,2026
M0238,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",HCPCS_Level_II,HCPC2026_JAN,2026
M0239,"Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0240,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses",HCPCS_Level_II,HCPC2026_JAN,2026
M0241,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses",HCPCS_Level_II,HCPC2026_JAN,2026
M0243,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0244,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",HCPCS_Level_II,HCPC2026_JAN,2026
M0245,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0246,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergency",HCPCS_Level_II,HCPC2026_JAN,2026
M0247,"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring",HCPCS_Level_II,HCPC2026_JAN,2026
M0248,"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency",HCPCS_Level_II,HCPC2026_JAN,2026
M0249,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",HCPCS_Level_II,HCPC2026_JAN,2026
M0250,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",HCPCS_Level_II,HCPC2026_JAN,2026
M0300,Iv chelation therapy (chemical endarterectomy),HCPCS_Level_II,HCPC2026_JAN,2026
M0301,Fabric wrapping of abdominal aneurysm,HCPCS_Level_II,HCPC2026_JAN,2026
M1000,Pain screened as moderate to severe,HCPCS_Level_II,HCPC2026_JAN,2026
M1001,Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinician,HCPCS_Level_II,HCPC2026_JAN,2026
M1002,"Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1003,Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy,HCPCS_Level_II,HCPC2026_JAN,2026
M1004,"Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)",HCPCS_Level_II,HCPC2026_JAN,2026
M1005,"Tb screening not performed or results not interpreted, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1006,"Disease activity not assessed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1007,>=50% of total number of a patient's outpatient ra encounters assessed,HCPCS_Level_II,HCPC2026_JAN,2026
M1008,<50% of total number of a patient's outpatient ra encounters assessed,HCPCS_Level_II,HCPC2026_JAN,2026
M1009,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1010,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1011,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1012,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1013,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1014,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1015,Discharge/discontinuation of the episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1016,Female patients unable to bear children,HCPCS_Level_II,HCPC2026_JAN,2026
M1017,Patient admitted to palliative care services,HCPCS_Level_II,HCPC2026_JAN,2026
M1018,"Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients",HCPCS_Level_II,HCPC2026_JAN,2026
M1019,Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5,HCPCS_Level_II,HCPC2026_JAN,2026
M1020,Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5,HCPCS_Level_II,HCPC2026_JAN,2026
M1021,Patient had only urgent care visits during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1022,Patients who were in hospice at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1023,Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five,HCPCS_Level_II,HCPC2026_JAN,2026
M1024,Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five,HCPCS_Level_II,HCPC2026_JAN,2026
M1025,Patients who were in hospice at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1026,Patients who were in hospice at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1027,Imaging of the head (ct or mri) was obtained,HCPCS_Level_II,HCPC2026_JAN,2026
M1028,Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained,HCPCS_Level_II,HCPC2026_JAN,2026
M1029,"Imaging of the head (ct or mri) was not obtained, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1030,Patients with clinical indications for imaging of the head,HCPCS_Level_II,HCPC2026_JAN,2026
M1031,Patients with no clinical indications for imaging of the head,HCPCS_Level_II,HCPC2026_JAN,2026
M1032,Adults currently taking pharmacotherapy for oud,HCPCS_Level_II,HCPC2026_JAN,2026
M1033,Pharmacotherapy for oud initiated after june 30th of performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1034,Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days,HCPCS_Level_II,HCPC2026_JAN,2026
M1035,Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment,HCPCS_Level_II,HCPC2026_JAN,2026
M1036,Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days,HCPCS_Level_II,HCPC2026_JAN,2026
M1037,Patients with a diagnosis of lumbar spine region cancer at the time of the procedure,HCPCS_Level_II,HCPC2026_JAN,2026
M1038,Patients with a diagnosis of lumbar spine region fracture at the time of the procedure,HCPCS_Level_II,HCPC2026_JAN,2026
M1039,Patients with a diagnosis of lumbar spine region infection at the time of the procedure,HCPCS_Level_II,HCPC2026_JAN,2026
M1040,Patients with a diagnosis of lumbar idiopathic or congenital scoliosis,HCPCS_Level_II,HCPC2026_JAN,2026
M1041,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis",HCPCS_Level_II,HCPC2026_JAN,2026
M1042,Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1043,Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1044,Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1045,"Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71",HCPCS_Level_II,HCPC2026_JAN,2026
M1046,"Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively",HCPCS_Level_II,HCPC2026_JAN,2026
M1047,Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1048,Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1049,Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1050,Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1051,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis",HCPCS_Level_II,HCPC2026_JAN,2026
M1052,Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1053,Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively,HCPCS_Level_II,HCPC2026_JAN,2026
M1054,Patient had only urgent care visits during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1055,Aspirin or another antiplatelet therapy used,HCPCS_Level_II,HCPC2026_JAN,2026
M1056,"Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease",HCPCS_Level_II,HCPC2026_JAN,2026
M1057,"Aspirin or another antiplatelet therapy not used, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1058,Patient was a permanent nursing home resident at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1059,Patient was in hospice or receiving palliative care at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1060,Patient died prior to the end of the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1061,Patient pregnancy,HCPCS_Level_II,HCPC2026_JAN,2026
M1062,Patient immunocompromised,HCPCS_Level_II,HCPC2026_JAN,2026
M1063,Patients receiving high doses of immunosuppressive therapy,HCPCS_Level_II,HCPC2026_JAN,2026
M1064,Shingrix vaccine documented as administered or previously received,HCPCS_Level_II,HCPC2026_JAN,2026
M1065,"Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1066,"Shingrix vaccine not documented as administered, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1067,Hospice services for patient provided any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1068,Adults who are not ambulatory,HCPCS_Level_II,HCPC2026_JAN,2026
M1069,Patient screened for future fall risk,HCPCS_Level_II,HCPC2026_JAN,2026
M1070,"Patient not screened for future fall risk, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1071,Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomy,HCPCS_Level_II,HCPC2026_JAN,2026
M1106,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1107,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1108,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1109,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1110,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1111,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1112,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1113,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1114,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1115,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1116,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1117,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1118,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1119,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1120,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1121,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1122,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1123,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1124,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1125,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1126,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1127,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1128,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1129,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1130,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1131,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1132,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1133,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1134,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1135,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1136,The start of an episode of care documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1137,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care",HCPCS_Level_II,HCPC2026_JAN,2026
M1138,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)",HCPCS_Level_II,HCPC2026_JAN,2026
M1139,"Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1140,"Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalized",HCPCS_Level_II,HCPC2026_JAN,2026
M1141,"Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively",HCPCS_Level_II,HCPC2026_JAN,2026
M1142,Emergent cases,HCPCS_Level_II,HCPC2026_JAN,2026
M1143,"Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment",HCPCS_Level_II,HCPC2026_JAN,2026
M1144,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only",HCPCS_Level_II,HCPC2026_JAN,2026
M1145,"Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)",HCPCS_Level_II,HCPC2026_JAN,2026
M1146,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record",HCPCS_Level_II,HCPC2026_JAN,2026
M1147,"Ongoing care not medically possible because the patient was  discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery",HCPCS_Level_II,HCPC2026_JAN,2026
M1148,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)",HCPCS_Level_II,HCPC2026_JAN,2026
M1149,"Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available",HCPCS_Level_II,HCPC2026_JAN,2026
M1150,Current or prior left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function,HCPCS_Level_II,HCPC2026_JAN,2026
M1151,Patients with a history of heart transplant or with a left ventricular assist device (lvad),HCPCS_Level_II,HCPC2026_JAN,2026
M1152,Patients with a history of heart transplant or with a left ventricular assist device (lvad),HCPCS_Level_II,HCPC2026_JAN,2026
M1153,Patient with diagnosis of osteoporosis on date of encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1154,Hospice services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1155,Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1156,Patient received active chemotherapy any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1157,Patient received bone marrow transplant any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1158,Patient had history of immunocompromising conditions prior to or during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1159,Hospice services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1160,Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday,HCPCS_Level_II,HCPC2026_JAN,2026
M1161,"Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday",HCPCS_Level_II,HCPC2026_JAN,2026
M1162,"Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday",HCPCS_Level_II,HCPC2026_JAN,2026
M1163,Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday,HCPCS_Level_II,HCPC2026_JAN,2026
M1164,Patients with dementia any time during the patient's history through the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1165,Patients who use hospice services any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1166,Pathology report for tissue specimens produced from wide local excisions or re-excisions,HCPCS_Level_II,HCPC2026_JAN,2026
M1167,In hospice or using hospice services during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1168,Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1169,"Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)",HCPCS_Level_II,HCPC2026_JAN,2026
M1170,Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1171,Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1172,"Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)",HCPCS_Level_II,HCPC2026_JAN,2026
M1173,Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1174,"Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
M1175,"Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)",HCPCS_Level_II,HCPC2026_JAN,2026
M1176,"Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) on october 20, 2017, through the end of the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
M1177,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1178,"Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)",HCPCS_Level_II,HCPC2026_JAN,2026
M1179,"Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
M1180,Patients on immune checkpoint inhibitor therapy,HCPCS_Level_II,HCPC2026_JAN,2026
M1181,Grade 2 or above diarrhea and/or grade 2 or above colitis,HCPCS_Level_II,HCPC2026_JAN,2026
M1182,"Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)",HCPCS_Level_II,HCPC2026_JAN,2026
M1183,Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered,HCPCS_Level_II,HCPC2026_JAN,2026
M1184,"Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)",HCPCS_Level_II,HCPC2026_JAN,2026
M1185,"Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1186,Patients who have an order for or are receiving hospice or palliative care,HCPCS_Level_II,HCPC2026_JAN,2026
M1187,Patients with a diagnosis of end stage renal disease (esrd),HCPCS_Level_II,HCPC2026_JAN,2026
M1188,Patients with a diagnosis of chronic kidney disease (ckd) stage 5,HCPCS_Level_II,HCPC2026_JAN,2026
M1189,Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed,HCPCS_Level_II,HCPC2026_JAN,2026
M1190,Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr),HCPCS_Level_II,HCPC2026_JAN,2026
M1191,Hospice services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1192,Patients with an existing diagnosis of squamous cell carcinoma of the esophagus,HCPCS_Level_II,HCPC2026_JAN,2026
M1193,"Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both",HCPCS_Level_II,HCPC2026_JAN,2026
M1194,"Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)",HCPCS_Level_II,HCPC2026_JAN,2026
M1195,"Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1196,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4",HCPCS_Level_II,HCPC2026_JAN,2026
M1197,Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score,HCPCS_Level_II,HCPC2026_JAN,2026
M1198,Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1199,Patients receiving rrt,HCPCS_Level_II,HCPC2026_JAN,2026
M1200,Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1201,"Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1202,"Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1203,"Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1204,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4",HCPCS_Level_II,HCPC2026_JAN,2026
M1205,Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score,HCPCS_Level_II,HCPC2026_JAN,2026
M1206,Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1207,"Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety",HCPCS_Level_II,HCPC2026_JAN,2026
M1208,"Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety",HCPCS_Level_II,HCPC2026_JAN,2026
M1209,"At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses",HCPCS_Level_II,HCPC2026_JAN,2026
M1210,"At least two orders for high-risk medications from the same drug class, (table 4), not ordered",HCPCS_Level_II,HCPC2026_JAN,2026
M1211,Most recent glycemic status assessment (hba1c or gmi) level > 9.0%,HCPCS_Level_II,HCPC2026_JAN,2026
M1212,"Glycemic status assessment (hba1c or gmi) level is missing, or was not performed during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
M1213,No history of spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) and present spirometry is >= 70%,HCPCS_Level_II,HCPC2026_JAN,2026
M1214,Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
M1215,"Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)",HCPCS_Level_II,HCPC2026_JAN,2026
M1216,No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1217,"Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)",HCPCS_Level_II,HCPC2026_JAN,2026
M1218,"Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)",HCPCS_Level_II,HCPC2026_JAN,2026
M1219,Anaphylaxis due to the vaccine on or before the date of the encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1220,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy,HCPCS_Level_II,HCPC2026_JAN,2026
M1221,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy,HCPCS_Level_II,HCPC2026_JAN,2026
M1222,"Glaucoma plan of care not documented, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
M1223,Glaucoma plan of care documented,HCPCS_Level_II,HCPC2026_JAN,2026
M1224,Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level,HCPCS_Level_II,HCPC2026_JAN,2026
M1225,Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level,HCPCS_Level_II,HCPC2026_JAN,2026
M1226,"Iop measurement not documented, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
M1227,Evidence-based therapy was prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
M1228,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test",HCPCS_Level_II,HCPC2026_JAN,2026
M1229,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection",HCPCS_Level_II,HCPC2026_JAN,2026
M1230,"Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1231,Patient receives hcv antibody test with nonreactive result,HCPCS_Level_II,HCPC2026_JAN,2026
M1232,Patient receives hcv antibody test with reactive result,HCPCS_Level_II,HCPC2026_JAN,2026
M1233,"Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1234,"Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia",HCPCS_Level_II,HCPC2026_JAN,2026
M1235,Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1236,Baseline mrs > 2,HCPCS_Level_II,HCPC2026_JAN,2026
M1237,"Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1238,"Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)",HCPCS_Level_II,HCPC2026_JAN,2026
M1239,Patient did not respond to the question of patient felt heard and understood by this provider and team,HCPCS_Level_II,HCPC2026_JAN,2026
M1240,Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care,HCPCS_Level_II,HCPC2026_JAN,2026
M1241,"Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem",HCPCS_Level_II,HCPC2026_JAN,2026
M1242,Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life,HCPCS_Level_II,HCPC2026_JAN,2026
M1243,"Patient provided a response other than ""completely true"" for the question of patient felt heard and understood by this provider and team",HCPCS_Level_II,HCPC2026_JAN,2026
M1244,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team put my best interests first when making recommendations about my care",HCPCS_Level_II,HCPC2026_JAN,2026
M1245,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem",HCPCS_Level_II,HCPC2026_JAN,2026
M1246,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team understood what is important to me in my life",HCPCS_Level_II,HCPC2026_JAN,2026
M1247,"Patient responded ""completely true"" for the question of patient felt this provider and team put my best interests first when making recommendations about my care",HCPCS_Level_II,HCPC2026_JAN,2026
M1248,"Patient responded ""completely true"" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem",HCPCS_Level_II,HCPC2026_JAN,2026
M1249,"Patient responded ""completely true"" for the question of patient felt this provider and team understood what is important to me in my life",HCPCS_Level_II,HCPC2026_JAN,2026
M1250,"Patient responded as ""completely true"" for the question of patient felt heard and understood by this provider and team",HCPCS_Level_II,HCPC2026_JAN,2026
M1251,Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement),HCPCS_Level_II,HCPC2026_JAN,2026
M1252,Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit,HCPCS_Level_II,HCPC2026_JAN,2026
M1253,Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal),HCPCS_Level_II,HCPC2026_JAN,2026
M1254,Patients who were deceased when the hu survey reached them,HCPCS_Level_II,HCPC2026_JAN,2026
M1255,"Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)",HCPCS_Level_II,HCPC2026_JAN,2026
M1256,Prior history of known cvd,HCPCS_Level_II,HCPC2026_JAN,2026
M1257,"Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
M1258,"Cvd risk assessment performed, have a documented calculated risk score",HCPCS_Level_II,HCPC2026_JAN,2026
M1259,Patient status documented within the first year of initiating dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
M1260,Patient status not documented within the first year of initiating dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
M1261,Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
M1262,Patients who had a transplant prior to initiation of dialysis,HCPCS_Level_II,HCPC2026_JAN,2026
M1263,Patients in hospice on their initiation of dialysis date or during the month of evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
M1264,Patients age 75 or older on their initiation of dialysis date,HCPCS_Level_II,HCPC2026_JAN,2026
M1265,Cms medical evidence form 2728 for dialysis patients: initial form completed,HCPCS_Level_II,HCPC2026_JAN,2026
M1266,Patients admitted to a skilled nursing facility (snf),HCPCS_Level_II,HCPC2026_JAN,2026
M1267,Patients not observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1268,Patients observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1269,Receiving esrd mcp dialysis services by the provider on the last day of the reporting month,HCPCS_Level_II,HCPC2026_JAN,2026
M1270,Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1271,Patients with dementia at any time prior to or during the month,HCPCS_Level_II,HCPC2026_JAN,2026
M1272,Patients observed on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1273,Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 form,HCPCS_Level_II,HCPC2026_JAN,2026
M1274,Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that month,HCPCS_Level_II,HCPC2026_JAN,2026
M1275,Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting period,HCPCS_Level_II,HCPC2026_JAN,2026
M1276,"Bmi documented outside normal parameters, no follow-up plan documented, no reason given",HCPCS_Level_II,HCPC2026_JAN,2026
M1277,Colorectal cancer screening results documented and reviewed,HCPCS_Level_II,HCPC2026_JAN,2026
M1278,"Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented",HCPCS_Level_II,HCPC2026_JAN,2026
M1279,"Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1280,Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy,HCPCS_Level_II,HCPC2026_JAN,2026
M1281,"Blood pressure reading not documented, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1282,Patient screened for tobacco use and identified as a tobacco non-user,HCPCS_Level_II,HCPC2026_JAN,2026
M1283,Patient screened for tobacco use and identified as a tobacco user,HCPCS_Level_II,HCPC2026_JAN,2026
M1284,"Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
M1285,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
M1286,"Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason",HCPCS_Level_II,HCPC2026_JAN,2026
M1287,Bmi is documented below normal parameters and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
M1288,Documented reason for not screening or recommending a follow-up for high blood pressure,HCPCS_Level_II,HCPC2026_JAN,2026
M1289,Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),HCPCS_Level_II,HCPC2026_JAN,2026
M1290,Patient not eligible due to active diagnosis of hypertension,HCPCS_Level_II,HCPC2026_JAN,2026
M1291,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1292,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1293,Bmi is documented above normal parameters and a follow-up plan is documented,HCPCS_Level_II,HCPC2026_JAN,2026
M1294,"Normal blood pressure reading documented, follow-up not required",HCPCS_Level_II,HCPC2026_JAN,2026
M1295,Patients with a diagnosis or past history of total colectomy or colorectal cancer,HCPCS_Level_II,HCPC2026_JAN,2026
M1296,Bmi is documented within normal parameters and no follow-up plan is required,HCPCS_Level_II,HCPC2026_JAN,2026
M1297,Bmi not documented due to medical reason or patient refusal of height or weight measurement,HCPCS_Level_II,HCPC2026_JAN,2026
M1298,Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1299,Influenza immunization administered or previously received,HCPCS_Level_II,HCPC2026_JAN,2026
M1300,"Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1301,Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy),HCPCS_Level_II,HCPC2026_JAN,2026
M1302,"Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed",HCPCS_Level_II,HCPC2026_JAN,2026
M1303,Hospice services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1304,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1305,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1306,Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1307,Documentation stating the patient has received or is currently receiving palliative or hospice care,HCPCS_Level_II,HCPC2026_JAN,2026
M1308,"Influenza immunization was not administered, reason not given",HCPCS_Level_II,HCPC2026_JAN,2026
M1309,Palliative care services provided to patient any time during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1310,"Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user",HCPCS_Level_II,HCPC2026_JAN,2026
M1311,Anaphylaxis due to the vaccine on or before the date of the encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1312,Patient not screened for tobacco use,HCPCS_Level_II,HCPC2026_JAN,2026
M1313,Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1314,Bmi not documented and no reason is given,HCPCS_Level_II,HCPC2026_JAN,2026
M1315,Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified,HCPCS_Level_II,HCPC2026_JAN,2026
M1316,Current tobacco non-user,HCPCS_Level_II,HCPC2026_JAN,2026
M1317,Patients who are counseled on connection with a csp and explicitly opt out,HCPCS_Level_II,HCPC2026_JAN,2026
M1318,Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp,HCPCS_Level_II,HCPC2026_JAN,2026
M1319,Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening,HCPCS_Level_II,HCPC2026_JAN,2026
M1320,Patients who screened positive for at least 1 of the 5 hrsns,HCPCS_Level_II,HCPC2026_JAN,2026
M1321,Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg,HCPCS_Level_II,HCPC2026_JAN,2026
M1322,Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye,HCPCS_Level_II,HCPC2026_JAN,2026
M1323,Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented,HCPCS_Level_II,HCPC2026_JAN,2026
M1324,"Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)",HCPCS_Level_II,HCPC2026_JAN,2026
M1325,"Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)",HCPCS_Level_II,HCPC2026_JAN,2026
M1326,Patients with a diagnosis of hypotony,HCPCS_Level_II,HCPC2026_JAN,2026
M1327,Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks,HCPCS_Level_II,HCPC2026_JAN,2026
M1328,Patients with a diagnosis of acute vitreous hemorrhage,HCPCS_Level_II,HCPC2026_JAN,2026
M1329,Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1330,"Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)",HCPCS_Level_II,HCPC2026_JAN,2026
M1331,Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam,HCPCS_Level_II,HCPC2026_JAN,2026
M1332,Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks,HCPCS_Level_II,HCPC2026_JAN,2026
M1333,Acute vitreous hemorrhage,HCPCS_Level_II,HCPC2026_JAN,2026
M1334,Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1335,"Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)",HCPCS_Level_II,HCPC2026_JAN,2026
M1336,Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks,HCPCS_Level_II,HCPC2026_JAN,2026
M1337,Acute pvd,HCPCS_Level_II,HCPC2026_JAN,2026
M1338,Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1339,Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1340,Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period,HCPCS_Level_II,HCPC2026_JAN,2026
M1341,Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1342,Patients who died during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1343,Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses,HCPCS_Level_II,HCPC2026_JAN,2026
M1344,Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score,HCPCS_Level_II,HCPC2026_JAN,2026
M1345,Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score,HCPCS_Level_II,HCPC2026_JAN,2026
M1346,Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period,HCPCS_Level_II,HCPC2026_JAN,2026
M1347,Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing),HCPCS_Level_II,HCPC2026_JAN,2026
M1348,Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent),HCPCS_Level_II,HCPC2026_JAN,2026
M1349,Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period,HCPCS_Level_II,HCPC2026_JAN,2026
M1350,"Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter",HCPCS_Level_II,HCPC2026_JAN,2026
M1351,"Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation",HCPCS_Level_II,HCPC2026_JAN,2026
M1352,Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment,HCPCS_Level_II,HCPC2026_JAN,2026
M1353,"Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter",HCPCS_Level_II,HCPC2026_JAN,2026
M1354,"Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation",HCPCS_Level_II,HCPC2026_JAN,2026
M1355,Suicide risk based on their clinician's evaluation or a clinician-rated tool,HCPCS_Level_II,HCPC2026_JAN,2026
M1356,Patients who died during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1357,Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment,HCPCS_Level_II,HCPC2026_JAN,2026
M1358,Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment,HCPCS_Level_II,HCPC2026_JAN,2026
M1359,Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained,HCPCS_Level_II,HCPC2026_JAN,2026
M1360,Suicidal ideation and/or behavior symptoms based on the c-ssrs,HCPCS_Level_II,HCPC2026_JAN,2026
M1361,Suicide risk based on their clinician's evaluation or a clinician-rated tool,HCPCS_Level_II,HCPC2026_JAN,2026
M1362,Patients who died during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1363,Patients who did not have a follow-up assessment within 120 days of the index assessment,HCPCS_Level_II,HCPC2026_JAN,2026
M1364,Calculated 10-year ascvd risk score of >= 20 percent during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1365,Patient encounter during the performance period with hospice and palliative care specialty code 17,HCPCS_Level_II,HCPC2026_JAN,2026
M1366,Focusing on women's health mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1367,"Quality care for the treatment of ear, nose, and throat disorders mips value pathway",HCPCS_Level_II,HCPC2026_JAN,2026
M1368,Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1369,Quality care in mental health and substance use disorders mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1370,Rehabilitative support for musculoskeletal care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1371,Most recent glycemic status assessment (hba1c or gmi) level < 7.0%,HCPCS_Level_II,HCPC2026_JAN,2026
M1372,Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%,HCPCS_Level_II,HCPC2026_JAN,2026
M1373,Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%,HCPCS_Level_II,HCPC2026_JAN,2026
M1374,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1375,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1376,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1377,Recommended follow-up interval for repeat colonoscopy of 10 years documented  in colonoscopy report and communicated with patient,HCPCS_Level_II,HCPC2026_JAN,2026
M1378,"Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1379,"A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
M1380,"Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under ""denominator note"" or the long-acting injectable antipsychotic medications listed under ""denominator note""",HCPCS_Level_II,HCPC2026_JAN,2026
M1381,"Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure",HCPCS_Level_II,HCPC2026_JAN,2026
M1382,Patient encounter during the performance period with place of service code 11,HCPCS_Level_II,HCPC2026_JAN,2026
M1383,Acute pvd,HCPCS_Level_II,HCPC2026_JAN,2026
M1384,Patients who died during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1385,"Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up",HCPCS_Level_II,HCPC2026_JAN,2026
M1386,"Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period",HCPCS_Level_II,HCPC2026_JAN,2026
M1387,Patients who died during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1388,Patients with documentation of an exam performed for recurrence of melanoma,HCPCS_Level_II,HCPC2026_JAN,2026
M1390,Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1391,All patients who were diagnosed with recurrent melanoma during the current performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1392,"Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)",HCPCS_Level_II,HCPC2026_JAN,2026
M1393,Patients who were not diagnosed with recurrent melanoma during the current performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1394,Stages i-iii breast cancer,HCPCS_Level_II,HCPC2026_JAN,2026
M1395,Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group,HCPCS_Level_II,HCPC2026_JAN,2026
M1396,Patients on a therapeutic clinical trial,HCPCS_Level_II,HCPC2026_JAN,2026
M1397,Patients with recurrence/disease progression,HCPCS_Level_II,HCPC2026_JAN,2026
M1398,Patients with baseline and follow-up promis surveys documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1399,Patients who leave the practice during the follow-up period,HCPCS_Level_II,HCPC2026_JAN,2026
M1400,Patients who died during the follow-up period,HCPCS_Level_II,HCPC2026_JAN,2026
M1401,Stages i-iii breast cancer,HCPCS_Level_II,HCPC2026_JAN,2026
M1402,Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group,HCPCS_Level_II,HCPC2026_JAN,2026
M1403,Patients with baseline and follow-up promis surveys documented in the medical record,HCPCS_Level_II,HCPC2026_JAN,2026
M1404,Patients on a therapeutic clinical trial,HCPCS_Level_II,HCPC2026_JAN,2026
M1405,Patients with recurrence/disease progression,HCPCS_Level_II,HCPC2026_JAN,2026
M1406,Patients who leave the practice during the follow-up period,HCPCS_Level_II,HCPC2026_JAN,2026
M1407,Patients who died during the follow-up period,HCPCS_Level_II,HCPC2026_JAN,2026
M1408,"Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer",HCPCS_Level_II,HCPC2026_JAN,2026
M1409,Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
M1410,Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis,HCPCS_Level_II,HCPC2026_JAN,2026
M1411,Currently on first-line immune checkpoint inhibitors without chemotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
M1412,"Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement",HCPCS_Level_II,HCPC2026_JAN,2026
M1413,Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy,HCPCS_Level_II,HCPC2026_JAN,2026
M1414,"Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)",HCPCS_Level_II,HCPC2026_JAN,2026
M1415,Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy,HCPCS_Level_II,HCPC2026_JAN,2026
M1416,Patient received hospice services any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1417,Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination,HCPCS_Level_II,HCPC2026_JAN,2026
M1418,Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician,HCPCS_Level_II,HCPC2026_JAN,2026
M1419,Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination,HCPCS_Level_II,HCPC2026_JAN,2026
M1420,Complete ophthalmologic care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1421,Dermatological care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1422,Gastroenterology care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1423,Optimal care for patients with urologic conditions mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1424,Pulmonology care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1425,Surgical care mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1426,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1427,"Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons)",HCPCS_Level_II,HCPC2026_JAN,2026
M1428,Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1429,"Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented",HCPCS_Level_II,HCPC2026_JAN,2026
M1430,Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year),HCPCS_Level_II,HCPC2026_JAN,2026
M1431,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1432,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1433,Patient on oral chemotherapy on or within 30 days before denominator eligible encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1434,Patient on oral chemotherapy on or within 30 days after denominator eligible encounter,HCPCS_Level_II,HCPC2026_JAN,2026
M1435,Patient on oral chemotherapy during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1436,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1437,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1438,Time last known well to hospital arrival less than or equal to 3.5 hours (<= 210 minutes),HCPCS_Level_II,HCPC2026_JAN,2026
M1439,Significant ocular conditions that impact the visual outcome of surgery,HCPCS_Level_II,HCPC2026_JAN,2026
M1440,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1441,Encounter corresponds to initial diagnosis of sleep apnea or first contact with sleep apnea diagnosed patient,HCPCS_Level_II,HCPC2026_JAN,2026
M1442,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1443,Encounters conducted via telehealth,HCPCS_Level_II,HCPC2026_JAN,2026
M1444,Delivery at < 39 weeks of gestation,HCPCS_Level_II,HCPC2026_JAN,2026
M1445,Postpartum care visit before or at 12 weeks of giving birth,HCPCS_Level_II,HCPC2026_JAN,2026
M1446,Patients who died any time prior to the end of the measure assessment period,HCPCS_Level_II,HCPC2026_JAN,2026
M1447,Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period,HCPCS_Level_II,HCPC2026_JAN,2026
M1448,Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period,HCPCS_Level_II,HCPC2026_JAN,2026
M1449,Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period,HCPCS_Level_II,HCPC2026_JAN,2026
M1450,Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period,HCPCS_Level_II,HCPC2026_JAN,2026
M1451,Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period,HCPCS_Level_II,HCPC2026_JAN,2026
M1452,Patient ever had a diagnosis of dementia,HCPCS_Level_II,HCPC2026_JAN,2026
M1453,Patients with a pre-operative visual acuity better than 20/40,HCPCS_Level_II,HCPC2026_JAN,2026
M1454,New cied,HCPCS_Level_II,HCPC2026_JAN,2026
M1455,Replaced or revised cied,HCPCS_Level_II,HCPC2026_JAN,2026
M1456,Patient had a heart transplant,HCPCS_Level_II,HCPC2026_JAN,2026
M1457,Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1458,Patient died prior to the end of the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1459,Patient was in hospice or receiving palliative care services at any time during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1460,"Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure",HCPCS_Level_II,HCPC2026_JAN,2026
M1461,Patient diagnosis for chronic hepatitis c,HCPCS_Level_II,HCPC2026_JAN,2026
M1462,Patients with clinical indications for imaging of the head,HCPCS_Level_II,HCPC2026_JAN,2026
M1463,Documentation of at least two attempts to follow up with patient within 180 days of treatment,HCPCS_Level_II,HCPC2026_JAN,2026
M1464,No documentation of at least two attempts to follow up with patient within 180 days of treatment,HCPCS_Level_II,HCPC2026_JAN,2026
M1465,Patient follow up more than 180 days after treatment,HCPCS_Level_II,HCPC2026_JAN,2026
M1466,Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure,HCPCS_Level_II,HCPC2026_JAN,2026
M1467,Patients with an existing diagnosis of lynch syndrome,HCPCS_Level_II,HCPC2026_JAN,2026
M1468,Patient received recommended doses of hepatitis b vaccination based on age,HCPCS_Level_II,HCPC2026_JAN,2026
M1469,"Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period",HCPCS_Level_II,HCPC2026_JAN,2026
M1470,"Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine)",HCPCS_Level_II,HCPC2026_JAN,2026
M1471,Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules,HCPCS_Level_II,HCPC2026_JAN,2026
M1472,Patient did not receive recommended doses of hepatitis b vaccination based on age,HCPCS_Level_II,HCPC2026_JAN,2026
M1473,"Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders",HCPCS_Level_II,HCPC2026_JAN,2026
M1474,Patients with diagnosis of dementia,HCPCS_Level_II,HCPC2026_JAN,2026
M1475,Patients with diagnosis of huntington's disease,HCPCS_Level_II,HCPC2026_JAN,2026
M1476,Patients with diagnosis of cognitive impairment or alzheimer's disease,HCPCS_Level_II,HCPC2026_JAN,2026
M1477,Diagnosis of delirium,HCPCS_Level_II,HCPC2026_JAN,2026
M1478,Psychoactive substance abuse,HCPCS_Level_II,HCPC2026_JAN,2026
M1479,"Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders",HCPCS_Level_II,HCPC2026_JAN,2026
M1480,"Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders",HCPCS_Level_II,HCPC2026_JAN,2026
M1481,Patients receiving hospice or palliative care or who died during the measurement period,HCPCS_Level_II,HCPC2026_JAN,2026
M1482,Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period,HCPCS_Level_II,HCPC2026_JAN,2026
M1483,Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period,HCPCS_Level_II,HCPC2026_JAN,2026
M1484,"Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)",HCPCS_Level_II,HCPC2026_JAN,2026
M1485,Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period,HCPCS_Level_II,HCPC2026_JAN,2026
M1486,Patients admitted to a skilled nursing facility (snf) during the period of evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
M1487,Patients in hospice in the year before or during the period of evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
M1488,Patients with a diagnosis for dementia in the year before or during the period of evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
M1489,Patient status documented,HCPCS_Level_II,HCPC2026_JAN,2026
M1490,Patient status not documented,HCPCS_Level_II,HCPC2026_JAN,2026
M1491,Receiving esrd mcp dialysis services by the provider during the performance period,HCPCS_Level_II,HCPC2026_JAN,2026
M1492,Patients who did not report a fall,HCPCS_Level_II,HCPC2026_JAN,2026
M1493,"Documentation of falls not performed due to medical reasons  (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy)",HCPCS_Level_II,HCPC2026_JAN,2026
M1494,Patients that reported a fall since the last visit,HCPCS_Level_II,HCPC2026_JAN,2026
M1495,Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall,HCPCS_Level_II,HCPC2026_JAN,2026
M1496,Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls,HCPCS_Level_II,HCPC2026_JAN,2026
M1497,"Documentation of falls not performed due to medical reasons  (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy)",HCPCS_Level_II,HCPC2026_JAN,2026
M1498,Diagnostic radiology mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1499,Interventional radiology mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1500,Neuropsychology mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1501,Pathology mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1502,Podiatry mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M1503,Vascular surgery mips value pathway,HCPCS_Level_II,HCPC2026_JAN,2026
M2,Medicare secondary payer (msp),HCPCS_Level_II,HCPC2026_JAN,2026
MA,Ordering professional is not required to consult a clinical decision support mechanism due to service being rendered to a patient with a suspected or confirmed emergency medical condition,HCPCS_Level_II,HCPC2026_JAN,2026
MB,Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of insufficient internet access,HCPCS_Level_II,HCPC2026_JAN,2026
MC,Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of electronic health record or clinical decision support mechanism vendor issues,HCPCS_Level_II,HCPC2026_JAN,2026
MD,Ordering professional is not required to consult a clinical decision support mechanism due to the significant hardship exception of extreme and uncontrollable circumstances,HCPCS_Level_II,HCPC2026_JAN,2026
ME,The order for this service adheres to appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional,HCPCS_Level_II,HCPC2026_JAN,2026
MF,The order for this service does not adhere to the appropriate use criteria in the clinical decision support mechanism consulted by the ordering professional,HCPCS_Level_II,HCPC2026_JAN,2026
MG,The order for this service does not have applicable appropriate use criteria in the qualified clinical decision support mechanism consulted by the ordering professional,HCPCS_Level_II,HCPC2026_JAN,2026
MH,"Unknown if ordering professional consulted a clinical decision support mechanism for this service, related information was not provided to the furnishing professional or provider",HCPCS_Level_II,HCPC2026_JAN,2026
MS,Six month maintenance and servicing fee for reasonable and necessary parts and labor which are not covered under any manufacturer or supplier warranty,HCPCS_Level_II,HCPC2026_JAN,2026
N1,Group 1 oxygen coverage criteria met,HCPCS_Level_II,HCPC2026_JAN,2026
N2,Group 2 oxygen coverage criteria met,HCPCS_Level_II,HCPC2026_JAN,2026
N3,Group 3 oxygen coverage criteria met,HCPCS_Level_II,HCPC2026_JAN,2026
NB,"Nebulizer system, any type, fda-cleared for use with specific drug",HCPCS_Level_II,HCPC2026_JAN,2026
NR,New when rented (use the 'nr' modifier when dme which was new at the time of rental is subsequently purchased),HCPCS_Level_II,HCPC2026_JAN,2026
NU,New equipment,HCPCS_Level_II,HCPC2026_JAN,2026
P1,A normal healthy patient,HCPCS_Level_II,HCPC2026_JAN,2026
P2,A patient with mild systemic disease,HCPCS_Level_II,HCPC2026_JAN,2026
P2028,"Cephalin floculation, blood",HCPCS_Level_II,HCPC2026_JAN,2026
P2029,"Congo red, blood",HCPCS_Level_II,HCPC2026_JAN,2026
P2031,Hair analysis (excluding arsenic),HCPCS_Level_II,HCPC2026_JAN,2026
P2033,"Thymol turbidity, blood",HCPCS_Level_II,HCPC2026_JAN,2026
P2038,"Mucoprotein, blood (seromucoid) (medical necessity procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
P3,A patient with severe systemic disease,HCPCS_Level_II,HCPC2026_JAN,2026
P3000,"Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision",HCPCS_Level_II,HCPC2026_JAN,2026
P3001,"Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician",HCPCS_Level_II,HCPC2026_JAN,2026
P4,A patient with severe systemic disease that is a constant threat to life,HCPCS_Level_II,HCPC2026_JAN,2026
P5,A moribund patient who is not expected to survive without the operation,HCPCS_Level_II,HCPC2026_JAN,2026
P6,A declared brain-dead patient whose organs are being removed for donor purposes,HCPCS_Level_II,HCPC2026_JAN,2026
P7001,"Culture, bacterial, urine; quantitative, sensitivity study",HCPCS_Level_II,HCPC2026_JAN,2026
P9010,"Blood (whole), for transfusion, per unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9011,"Blood, split unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9012,"Cryoprecipitate, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9016,"Red blood cells, leukocytes reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9017,"Fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9019,"Platelets, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9020,"Platelet rich plasma, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9021,"Red blood cells, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9022,"Red blood cells, washed, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9023,"Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9025,"Plasma, cryoprecipitate reduced, pathogen reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9026,"Cryoprecipitated fibrinogen complex, pathogen reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9027,"Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9031,"Platelets, leukocytes reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9032,"Platelets, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9033,"Platelets, leukocytes reduced, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9034,"Platelets, pheresis, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9035,"Platelets, pheresis, leukocytes reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9036,"Platelets, pheresis, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9037,"Platelets, pheresis, leukocytes reduced, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9038,"Red blood cells, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9039,"Red blood cells, deglycerolized, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9040,"Red blood cells, leukocytes reduced, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9041,"Infusion, albumin (human), 5%, 50 ml",HCPCS_Level_II,HCPC2026_JAN,2026
P9043,"Infusion, plasma protein fraction (human), 5%, 50 ml",HCPCS_Level_II,HCPC2026_JAN,2026
P9044,"Plasma, cryoprecipitate reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9045,"Infusion, albumin (human), 5%, 250 ml",HCPCS_Level_II,HCPC2026_JAN,2026
P9046,"Infusion, albumin (human), 25%, 20 ml",HCPCS_Level_II,HCPC2026_JAN,2026
P9047,"Infusion, albumin (human), 25%, 50 ml",HCPCS_Level_II,HCPC2026_JAN,2026
P9048,"Infusion, plasma protein fraction (human), 5%, 250 ml",HCPCS_Level_II,HCPC2026_JAN,2026
P9050,"Granulocytes, pheresis, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9051,"Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9052,"Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9053,"Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9054,"Whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9055,"Platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9056,"Whole blood, leukocytes reduced, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9057,"Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9058,"Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9059,"Fresh frozen plasma between 8-24 hours of collection, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9060,"Fresh frozen plasma, donor retested, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9070,"Plasma, pooled multiple donor, pathogen reduced, frozen, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9071,"Plasma (single donor), pathogen reduced, frozen, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9072,"Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9073,"Platelets, pheresis, pathogen-reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
P9099,Blood component or product not otherwise classified,HCPCS_Level_II,HCPC2026_JAN,2026
P9100,Pathogen(s) test for platelets,HCPCS_Level_II,HCPC2026_JAN,2026
P9603,Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled,HCPCS_Level_II,HCPC2026_JAN,2026
P9604,Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge,HCPCS_Level_II,HCPC2026_JAN,2026
P9612,"Catheterization for collection of specimen, single patient, all places of service",HCPCS_Level_II,HCPC2026_JAN,2026
P9615,Catheterization for collection of specimen(s) (multiple patients),HCPCS_Level_II,HCPC2026_JAN,2026
PA,Surgical or other invasive procedure on wrong body part,HCPCS_Level_II,HCPC2026_JAN,2026
PB,Surgical or other invasive procedure on wrong patient,HCPCS_Level_II,HCPC2026_JAN,2026
PC,Wrong surgery or other invasive procedure on patient,HCPCS_Level_II,HCPC2026_JAN,2026
PD,Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days,HCPCS_Level_II,HCPC2026_JAN,2026
PI,Positron emission tomography (pet) or pet/computed tomography (ct) to inform the initial treatment strategy of tumors that are biopsy proven or strongly suspected of being cancerous based on other diagnostic testing,HCPCS_Level_II,HCPC2026_JAN,2026
PL,Progressive addition lenses,HCPCS_Level_II,HCPC2026_JAN,2026
PM,Post mortem,HCPCS_Level_II,HCPC2026_JAN,2026
PN,"Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital",HCPCS_Level_II,HCPC2026_JAN,2026
PO,"Excepted service provided at an off-campus, outpatient, provider-based department of a hospital",HCPCS_Level_II,HCPC2026_JAN,2026
PS,Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary's treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy,HCPCS_Level_II,HCPC2026_JAN,2026
PT,Colorectal cancer screening test; converted to diagnostic test or other procedure,HCPCS_Level_II,HCPC2026_JAN,2026
Q0,Investigational clinical service provided in a clinical research study that is in an approved clinical research study,HCPCS_Level_II,HCPC2026_JAN,2026
Q0035,Cardiokymography,HCPCS_Level_II,HCPC2026_JAN,2026
Q0081,"Infusion therapy, using other than chemotherapeutic drugs, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
Q0083,"Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit",HCPCS_Level_II,HCPC2026_JAN,2026
Q0084,"Chemotherapy administration by infusion technique only, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
Q0085,"Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit",HCPCS_Level_II,HCPC2026_JAN,2026
Q0091,"Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory",HCPCS_Level_II,HCPC2026_JAN,2026
Q0092,Set-up portable x-ray equipment,HCPCS_Level_II,HCPC2026_JAN,2026
Q0111,"Wet mounts, including preparations of vaginal, cervical or skin specimens",HCPCS_Level_II,HCPC2026_JAN,2026
Q0112,All potassium hydroxide (koh) preparations,HCPCS_Level_II,HCPC2026_JAN,2026
Q0113,Pinworm examinations,HCPCS_Level_II,HCPC2026_JAN,2026
Q0114,Fern test,HCPCS_Level_II,HCPC2026_JAN,2026
Q0115,"Post-coital direct, qualitative examinations of vaginal or cervical mucous",HCPCS_Level_II,HCPC2026_JAN,2026
Q0138,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
Q0139,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
Q0144,"Azithromycin dihydrate, oral, capsules/powder, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
Q0155,"Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0161,"Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0162,"Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0163,"Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0164,"Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0166,"Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0167,"Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0169,"Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0173,"Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0174,"Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0175,"Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0177,"Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0180,"Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0181,"Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen",HCPCS_Level_II,HCPC2026_JAN,2026
Q0220,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0221,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0222,"Injection, bebtelovimab, 175 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0224,"Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0235,"Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0237,"Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0239,"Injection, bamlanivimab-xxxx, 700 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0240,"Injection, casirivimab and imdevimab, 600 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0243,"Injection, casirivimab and imdevimab, 2400 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0244,"Injection, casirivimab and imdevimab, 1200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0245,"Injection, bamlanivimab and etesevimab, 2100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0247,"Injection, sotrovimab, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0249,"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q0477,"Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0478,"Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type",HCPCS_Level_II,HCPC2026_JAN,2026
Q0479,"Power module for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0480,"Driver for use with pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0481,"Microprocessor control unit for use with electric ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0482,"Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0483,"Monitor/display module for use with electric ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0484,"Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0485,"Monitor control cable for use with electric ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0486,"Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0487,"Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0488,"Power pack base for use with electric ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0489,"Power pack base for use with electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0490,"Emergency power source for use with electric ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0491,"Emergency power source for use with electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0492,"Emergency power supply cable for use with electric ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0493,"Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0494,"Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0495,"Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0496,"Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0497,"Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0498,"Holster for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0499,"Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0500,"Filters for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0501,"Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0502,"Mobility cart for pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0503,"Battery for pneumatic ventricular assist device, replacement only, each",HCPCS_Level_II,HCPC2026_JAN,2026
Q0504,"Power adapter for pneumatic ventricular assist device, replacement only, vehicle type",HCPCS_Level_II,HCPC2026_JAN,2026
Q0506,"Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only",HCPCS_Level_II,HCPC2026_JAN,2026
Q0507,Miscellaneous supply or accessory for use with an external ventricular assist device,HCPCS_Level_II,HCPC2026_JAN,2026
Q0508,Miscellaneous supply or accessory for use with an implanted ventricular assist device,HCPCS_Level_II,HCPC2026_JAN,2026
Q0509,Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a,HCPCS_Level_II,HCPC2026_JAN,2026
Q0510,"Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant",HCPCS_Level_II,HCPC2026_JAN,2026
Q0511,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period",HCPCS_Level_II,HCPC2026_JAN,2026
Q0512,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period",HCPCS_Level_II,HCPC2026_JAN,2026
Q0513,Pharmacy dispensing fee for inhalation drug(s); per 30 days,HCPCS_Level_II,HCPC2026_JAN,2026
Q0514,Pharmacy dispensing fee for inhalation drug(s); per 90 days,HCPCS_Level_II,HCPC2026_JAN,2026
Q0515,"Injection, sermorelin acetate, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
Q0516,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days",HCPCS_Level_II,HCPC2026_JAN,2026
Q0517,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days",HCPCS_Level_II,HCPC2026_JAN,2026
Q0518,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days",HCPCS_Level_II,HCPC2026_JAN,2026
Q0519,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days",HCPCS_Level_II,HCPC2026_JAN,2026
Q0520,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days",HCPCS_Level_II,HCPC2026_JAN,2026
Q0521,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription,HCPCS_Level_II,HCPC2026_JAN,2026
Q1,Routine clinical service provided in a clinical research study that is in an approved clinical research study,HCPCS_Level_II,HCPC2026_JAN,2026
Q1004,New technology intraocular lens category 4 as defined in federal register notice,HCPCS_Level_II,HCPC2026_JAN,2026
Q1005,New technology intraocular lens category 5 as defined in federal register notice,HCPCS_Level_II,HCPC2026_JAN,2026
Q2,Demonstration procedure/service,HCPCS_Level_II,HCPC2026_JAN,2026
Q2004,"Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q2009,"Injection, fosphenytoin, 50 mg phenytoin equivalent",HCPCS_Level_II,HCPC2026_JAN,2026
Q2017,"Injection, teniposide, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q2026,"Injection, radiesse, 0.1 ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q2028,"Injection, sculptra, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q2034,"Influenza virus vaccine, split virus, for intramuscular use (agriflu)",HCPCS_Level_II,HCPC2026_JAN,2026
Q2035,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)",HCPCS_Level_II,HCPC2026_JAN,2026
Q2036,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)",HCPCS_Level_II,HCPC2026_JAN,2026
Q2037,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)",HCPCS_Level_II,HCPC2026_JAN,2026
Q2038,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)",HCPCS_Level_II,HCPC2026_JAN,2026
Q2039,"Influenza virus vaccine, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
Q2040,"Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion",HCPCS_Level_II,HCPC2026_JAN,2026
Q2041,"Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2042,"Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2043,"Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion",HCPCS_Level_II,HCPC2026_JAN,2026
Q2049,"Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q2050,"Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q2052,"Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)",HCPCS_Level_II,HCPC2026_JAN,2026
Q2053,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2054,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2055,"Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2056,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2057,"Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q2058,"Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion",HCPCS_Level_II,HCPC2026_JAN,2026
Q3,Live kidney donor surgery and related services,HCPCS_Level_II,HCPC2026_JAN,2026
Q3001,"Radioelements for brachytherapy, any type, each",HCPCS_Level_II,HCPC2026_JAN,2026
Q3014,Telehealth originating site facility fee,HCPCS_Level_II,HCPC2026_JAN,2026
Q3027,"Injection, interferon beta-1a, 1 mcg for intramuscular use",HCPCS_Level_II,HCPC2026_JAN,2026
Q3028,"Injection, interferon beta-1a, 1 mcg for subcutaneous use",HCPCS_Level_II,HCPC2026_JAN,2026
Q3031,Collagen skin test,HCPCS_Level_II,HCPC2026_JAN,2026
Q4,Service for ordering/referring physician qualifies as a service exemption,HCPCS_Level_II,HCPC2026_JAN,2026
Q4001,"Casting supplies, body cast adult, with or without head, plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4002,"Cast supplies, body cast adult, with or without head, fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4003,"Cast supplies, shoulder cast, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4004,"Cast supplies, shoulder cast, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4005,"Cast supplies, long arm cast, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4006,"Cast supplies, long arm cast, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4007,"Cast supplies, long arm cast, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4008,"Cast supplies, long arm cast, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4009,"Cast supplies, short arm cast, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4010,"Cast supplies, short arm cast, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4011,"Cast supplies, short arm cast, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4012,"Cast supplies, short arm cast, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4013,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4014,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4015,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4016,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4017,"Cast supplies, long arm splint, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4018,"Cast supplies, long arm splint, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4019,"Cast supplies, long arm splint, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4020,"Cast supplies, long arm splint, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4021,"Cast supplies, short arm splint, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4022,"Cast supplies, short arm splint, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4023,"Cast supplies, short arm splint, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4024,"Cast supplies, short arm splint, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4025,"Cast supplies, hip spica (one or both legs), adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4026,"Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4027,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4028,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4029,"Cast supplies, long leg cast, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4030,"Cast supplies, long leg cast, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4031,"Cast supplies, long leg cast, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4032,"Cast supplies, long leg cast, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4033,"Cast supplies, long leg cylinder cast, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4034,"Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4035,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4036,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4037,"Cast supplies, short leg cast, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4038,"Cast supplies, short leg cast, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4039,"Cast supplies, short leg cast, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4040,"Cast supplies, short leg cast, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4041,"Cast supplies, long leg splint, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4042,"Cast supplies, long leg splint, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4043,"Cast supplies, long leg splint, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4044,"Cast supplies, long leg splint, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4045,"Cast supplies, short leg splint, adult (11 years +), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4046,"Cast supplies, short leg splint, adult (11 years +), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4047,"Cast supplies, short leg splint, pediatric (0-10 years), plaster",HCPCS_Level_II,HCPC2026_JAN,2026
Q4048,"Cast supplies, short leg splint, pediatric (0-10 years), fiberglass",HCPCS_Level_II,HCPC2026_JAN,2026
Q4049,"Finger splint, static",HCPCS_Level_II,HCPC2026_JAN,2026
Q4050,"Cast supplies, for unlisted types and materials of casts",HCPCS_Level_II,HCPC2026_JAN,2026
Q4051,"Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4074,"Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
Q4081,"Injection, epoetin alfa, 100 units (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4082,"Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4100,"Skin substitute, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
Q4101,"Apligraf, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4102,"Oasis wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4103,"Oasis burn matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4104,"Integra bilayer matrix wound dressing (bmwd), per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4105,"Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4106,"Dermagraft, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4107,"Graftjacket, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4108,"Integra matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4110,"Primatrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4111,"Gammagraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4112,"Cymetra, injectable, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4113,"Graftjacket xpress, injectable, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4114,"Integra flowable wound matrix, injectable, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4115,"Alloskin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4116,"Alloderm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4117,"Hyalomatrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4118,"Matristem micromatrix, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4119,"Matristem wound matrix, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4120,"Matristem burn matrix, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4121,"Theraskin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4122,"Dermacell, dermacell awm or dermacell awm porous, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4123,"Alloskin rt, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4124,"Oasis ultra tri-layer wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4125,"Arthroflex, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4126,"Memoderm, dermaspan, tranzgraft or integuply, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4127,"Talymed, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4128,"Flex hd, or allopatch hd, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4129,"Unite biomatrix, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4130,"Strattice tm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4131,"Epifix or epicord, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4132,"Grafix core and grafixpl core, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4133,"Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4134,"Hmatrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4135,"Mediskin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4136,"Ez-derm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4137,"Amnioexcel, amnioexcel plus or biodexcel, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4138,"Biodfence dryflex, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4139,"Amniomatrix or biodmatrix, injectable, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4140,"Biodfence, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4141,"Alloskin ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4142,"Xcm biologic tissue matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4143,"Repriza, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4145,"Epifix, injectable, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4146,"Tensix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4147,"Architect, architect px, or architect fx, extracellular matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4148,"Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4149,"Excellagen, 0.1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4150,"Allowrap ds or dry, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4151,"Amnioband or guardian, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4152,"Dermapure, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4153,"Dermavest and plurivest, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4154,"Biovance, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4155,"Neoxflo or clarixflo, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4156,"Neox 100 or clarix 100, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4157,"Revitalon, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4158,"Kerecis omega3, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4159,"Affinity, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4160,"Nushield, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4161,"Bio-connekt wound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4162,"Woundex flow, bioskin flow, 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4163,"Woundex, bioskin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4164,"Helicoll, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4165,"Keramatrix or kerasorb, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4166,"Cytal, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4167,"Truskin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4168,"Amnioband, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4169,"Artacent wound, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4170,"Cygnus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4171,"Interfyl, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4172,"Puraply or puraply am, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4173,"Palingen or palingen xplus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4174,"Palingen or promatrx, 0.36 mg per 0.25 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4175,"Miroderm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4176,"Neopatch or therion, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4177,"Floweramnioflo, 0.1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4178,"Floweramniopatch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4179,"Flowerderm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4180,"Revita, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4181,"Amnio wound, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4182,"Transcyte, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4183,"Surgigraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4184,"Cellesta or cellesta duo, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4185,Cellesta flowable amnion (25 mg per cc); per 0.5 cc,HCPCS_Level_II,HCPC2026_JAN,2026
Q4186,"Epifix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4187,"Epicord, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4188,"Amnioarmor, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4189,"Artacent ac, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4190,"Artacent ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4191,"Restorigin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4192,"Restorigin, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4193,"Coll-e-derm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4194,"Novachor, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4195,"Puraply, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4196,"Puraply am, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4197,"Puraply xt, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4198,"Genesis amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4199,"Cygnus matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4200,"Skin te, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4201,"Matrion, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4202,"Keroxx (2.5g/cc), 1cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4203,"Derma-gide, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4204,"Xwrap, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4205,"Membrane graft or membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4206,"Fluid flow or fluid gf, 1 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4208,"Novafix, per square cenitmeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4209,"Surgraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4210,"Axolotl graft or axolotl dualgraft, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4211,"Amnion bio or axobiomembrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4212,"Allogen, per cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4213,"Ascent, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4214,"Cellesta cord, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4215,"Axolotl ambient or axolotl cryo, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4216,"Artacent cord, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4217,"Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4218,"Surgicord, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4219,"Surgigraft-dual, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4220,"Bellacell hd or surederm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4221,"Amniowrap2, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4222,"Progenamatrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4224,"Human health factor 10 amniotic patch (hhf10-p), per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4225,"Amniobind or dermabind tl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4226,"Myown skin, includes harvesting and preparation procedures, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4227,"Amniocore, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4228,"Bionextpatch, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4229,"Cogenex amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4230,"Cogenex flowable amnion, per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4231,"Corplex p, per cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4232,"Corplex, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4233,"Surfactor or nudyn, per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4234,"Xcellerate, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4235,"Amniorepair or altiply, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4236,"Carepatch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4237,"Cryo-cord, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4238,"Derm-maxx, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4239,"Amnio-maxx or amnio-maxx lite, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4240,"Corecyte, for topical use only, per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4241,"Polycyte, for topical use only, per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4242,"Amniocyte plus, per 0.5 cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4244,"Procenta, per 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4245,"Amniotext, per cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4246,"Coretext or protext, per cc",HCPCS_Level_II,HCPC2026_JAN,2026
Q4247,"Amniotext patch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4248,"Dermacyte amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4249,"Amniply, for topical use only, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4250,"Amnioamp-mp, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4251,"Vim, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4252,"Vendaje, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4253,"Zenith amniotic membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4254,"Novafix dl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4255,"Reguard, for topical use only, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4256,"Mlg-complete, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4257,"Relese, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4258,"Enverse, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4259,"Celera dual layer or celera dual membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4260,"Signature apatch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4261,"Tag, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4262,"Dual layer impax membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4263,"Surgraft tl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4264,"Cocoon membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4265,"Neostim tl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4266,"Neostim membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4267,"Neostim dl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4268,"Surgraft ft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4269,"Surgraft xt, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4270,"Complete sl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4271,"Complete ft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4272,"Esano a, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4273,"Esano aaa, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4274,"Esano ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4275,"Esano aca, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4276,"Orion, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4277,"Woundplus membrane or e-graft, per square centimeter",HCPCS_Level_II,HCPC2026_JAN,2026
Q4278,"Epieffect, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4279,"Vendaje ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4280,"Xcell amnio matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4281,"Barrera sl or barrera dl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4282,"Cygnus dual, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4283,"Biovance tri-layer or biovance 3l, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4284,"Dermabind sl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4285,"Nudyn dl or nudyn dl mesh, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4286,"Nudyn sl or nudyn slw, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4287,"Dermabind dl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4288,"Dermabind ch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4289,"Revoshield + amniotic barrier, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4290,"Membrane wrap-hydro, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4291,"Lamellas xt, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4292,"Lamellas, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4293,"Acesso dl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4294,"Amnio quad-core, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4295,"Amnio tri-core amniotic, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4296,"Rebound matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4297,"Emerge matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4298,"Amniocore pro, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4299,"Amniocore pro+, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4300,"Acesso tl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4301,"Activate matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4302,"Complete aca, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4303,"Complete aa, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4304,"Grafix plus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4305,"American amnion ac tri-layer, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4306,"American amnion ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4307,"American amnion, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4308,"Sanopellis, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4309,"Via matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4310,"Procenta, per 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q4311,"Acesso, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4312,"Acesso ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4313,"Dermabind fm, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4314,"Reeva ft, per square cenitmeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4315,"Regenelink amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4316,"Amchoplast, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4317,"Vitograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4318,"E-graft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4319,"Sanograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4320,"Pellograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4321,"Renograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4322,"Caregraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4323,"Alloply, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4324,"Amniotx, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4325,"Acapatch, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4326,"Woundplus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4327,"Duoamnion, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4328,"Most, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4329,"Singlay, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4330,"Total, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4331,"Axolotl graft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4332,"Axolotl dualgraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4333,"Ardeograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4334,"Amnioplast 1, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4335,"Amnioplast 2, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4336,"Artacent c, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4337,"Artacent trident, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4338,"Artacent velos, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4339,"Artacent vericlen, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4340,"Simpligraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4341,"Simplimax, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4342,"Theramend, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4343,"Dermacyte ac matrix amniotic membrane allograft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4344,"Tri-membrane wrap, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4345,"Matrix hd allograft dermis, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4346,"Shelter dm matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4347,"Rampart dl matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4348,"Sentry sl matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4349,"Mantle dl matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4350,"Palisade dm matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4351,"Enclose tl matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4352,"Overlay sl matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4353,"Xceed tl matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4354,"Palingen dual-layer membrane and dual-layer palingen x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4355,"Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4356,"Abiomend membrane and abiomend hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4357,"Xwrap plus, per square  centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4358,"Xwrap dual, per square  centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4359,"Choriply, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4360,"Amchoplast fd, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4361,"Epixpress, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4362,"Cygnus disk, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4363,"Amnio burgeon membrane and hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4364,"Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4365,"Amnio burgeon dual-layer membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4366,"Dual layer amnio burgeon x-membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4367,"Amniocore sl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4368,"Amchothick, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4369,"Amnioplast 3, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4370,"Aeroguard, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4371,"Neoguard, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4372,"Amchoplast excel, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4373,"Membrane wrap lite, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4375,"Duograft ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4376,"Duograft aa, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4377,"Trigraft ft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4378,"Renew ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4379,"Amniodefend ft matrix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4380,"Advograft one, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4382,"Advograft dual, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4383,"Axolotl graft ultra, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4384,"Axolotl dualgraft ultra, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4385,"Apollo ft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4386,"Acesso trifaca, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4387,"Neothelium ft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4388,"Neothelium 4l, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4389,"Neothelium 4l+, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4390,"Ascendion, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4391,"Amnioplast double, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4392,"Grafix duo, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4393,"Surgraft ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4394,"Surgraft aca, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4395,"Acelagraft, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4396,"Natalin, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4397,"Summit aaa, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4398,"Summit ac, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4399,"Summit fx, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4400,"Polygon3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4401,"Absolv3 membrane, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4402,"Xwrap 2.0, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4403,"Xwrap dual plus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4404,"Xwrap hydro plus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4405,"Xwrap fenestra plus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4406,"Xwrap fenestra, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4407,"Xwrap tribus, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4408,"Xwrap hydro, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4409,"Amniomatrixf3x, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4410,"Amchomatrixdl, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4411,"Amniomatrixf4x, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4412,"Choriofix, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4413,"Cygnus solo, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4414,"Simplichor, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4415,"Alexiguard sl-t, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4416,"Alexiguard tl-t, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4417,"Alexiguard dl-t, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4420,"Nuform, per square centimeter (add-on, list separately in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4431,"Pma skin substitute product, not otherwise specified (list in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4432,"510(k) skin substitute product, not otherwise specified (list in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q4433,"361 hct/p skin substitute product, not otherwise specified (list in addition to primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
Q5,"Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area",HCPCS_Level_II,HCPC2026_JAN,2026
Q5001,Hospice or home health care provided in patient's home/residence,HCPCS_Level_II,HCPC2026_JAN,2026
Q5002,Hospice or home health care provided in assisted living facility,HCPCS_Level_II,HCPC2026_JAN,2026
Q5003,Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf),HCPCS_Level_II,HCPC2026_JAN,2026
Q5004,Hospice care provided in skilled nursing facility (snf),HCPCS_Level_II,HCPC2026_JAN,2026
Q5005,Hospice care provided in inpatient hospital,HCPCS_Level_II,HCPC2026_JAN,2026
Q5006,Hospice care provided in inpatient hospice facility,HCPCS_Level_II,HCPC2026_JAN,2026
Q5007,Hospice care provided in long term care facility,HCPCS_Level_II,HCPC2026_JAN,2026
Q5008,Hospice care provided in inpatient psychiatric facility,HCPCS_Level_II,HCPC2026_JAN,2026
Q5009,Hospice or home health care provided in place not otherwise specified (nos),HCPCS_Level_II,HCPC2026_JAN,2026
Q5010,Hospice home care provided in a hospice facility,HCPCS_Level_II,HCPC2026_JAN,2026
Q5098,"Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5099,"Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5100,"Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5101,"Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
Q5102,"Injection, infliximab, biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5103,"Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5104,"Injection, infliximab-abda, biosimilar, (renflexis), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5105,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units",HCPCS_Level_II,HCPC2026_JAN,2026
Q5106,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units",HCPCS_Level_II,HCPC2026_JAN,2026
Q5107,"Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5108,"Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5109,"Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5110,"Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
Q5111,"Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5112,"Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5113,"Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5114,"Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5115,"Injection, rituximab-abbs, biosimilar, (truxima), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5116,"Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5117,"Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5118,"Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5119,"Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5120,"Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5121,"Injection, infliximab-axxq, biosimilar, (avsola), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5122,"Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5123,"Injection, rituximab-arrx, biosimilar, (riabni), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5124,"Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5125,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
Q5126,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5127,"Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5128,"Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5129,"Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5130,"Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5131,"Injection, adalimumab-aacf (idacio), biosimilar, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5132,"Injection, adalimumab-afzb (abrilada), biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5133,"Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5134,"Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5135,"Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5136,"Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5137,"Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5138,"Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5139,"Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5140,"Injection, adalimumab-fkjp, biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5141,"Injection, adalimumab-aaty, biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5142,"Injection, adalimumab-ryvk biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5143,"Injection, adalimumab-adbm, biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5144,"Injection, adalimumab-aacf (idacio), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5145,"Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5146,"Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5147,"Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5148,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
Q5149,"Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5150,"Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5151,"Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5152,"Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5153,"Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5154,"Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5155,"Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5156,"Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5157,"Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5158,"Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5159,"Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q5160,"Injection, bevacizumab-nwgd (jobevne), biosimilar, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q6,"Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area",HCPCS_Level_II,HCPC2026_JAN,2026
Q7,One class a finding,HCPCS_Level_II,HCPC2026_JAN,2026
Q8,Two class b findings,HCPCS_Level_II,HCPC2026_JAN,2026
Q9,One class b and two class c findings,HCPCS_Level_II,HCPC2026_JAN,2026
Q9001,Assessment by chaplain services,HCPCS_Level_II,HCPC2026_JAN,2026
Q9002,"Counseling, individual, by chaplain services",HCPCS_Level_II,HCPC2026_JAN,2026
Q9003,"Counseling, group, by chaplain services",HCPCS_Level_II,HCPC2026_JAN,2026
Q9004,Department of veterans affairs whole health partner services,HCPCS_Level_II,HCPC2026_JAN,2026
Q9950,"Injection, sulfur hexafluoride lipid microspheres, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9951,"Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9953,"Injection, iron-based magnetic resonance contrast agent, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9954,"Oral magnetic resonance contrast agent, per 100 ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9955,"Injection, perflexane lipid microspheres, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9956,"Injection, octafluoropropane microspheres, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9957,"Injection, perflutren lipid microspheres, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9958,"High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9959,"High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9960,"High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9961,"High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9962,"High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9963,"High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9964,"High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9965,"Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9966,"Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9967,"Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml",HCPCS_Level_II,HCPC2026_JAN,2026
Q9968,"Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9969,"Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
Q9970,"Injection, ferric carboxymaltose, 1mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9972,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)",HCPCS_Level_II,HCPC2026_JAN,2026
Q9973,"Injection, epoetin beta, 1 microgram, (non-esrd use)",HCPCS_Level_II,HCPC2026_JAN,2026
Q9974,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9975,"Injection, factor viii fc fusion protein (recombinant), per iu",HCPCS_Level_II,HCPC2026_JAN,2026
Q9976,"Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron",HCPCS_Level_II,HCPC2026_JAN,2026
Q9977,"Compounded drug, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
Q9978,Netupitant 300 mg and palonosetron 0.5 mg,HCPCS_Level_II,HCPC2026_JAN,2026
Q9979,"Injection, alemtuzumab, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9980,"Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9981,"Rolapitant, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9982,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
Q9983,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries",HCPCS_Level_II,HCPC2026_JAN,2026
Q9984,"Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9985,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9986,"Injection, hydroxyprogesterone caproate, (makena), 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9987,Pathogen(s) test for platelets,HCPCS_Level_II,HCPC2026_JAN,2026
Q9988,"Platelets, pheresis, pathogen-reduced, each unit",HCPCS_Level_II,HCPC2026_JAN,2026
Q9989,"Ustekinumab, for intravenous injection, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9991,"Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9992,"Injection, buprenorphine extended-release (sublocade), greater than 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9993,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9994,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each",HCPCS_Level_II,HCPC2026_JAN,2026
Q9995,"Injection, emicizumab-kxwh, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9996,"Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9997,"Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9998,"Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
Q9999,"Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
QA,Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm),HCPCS_Level_II,HCPC2026_JAN,2026
QB,Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts exceeds 4 liters per minute (lpm) and portable oxygen is prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
QC,Single channel monitoring,HCPCS_Level_II,HCPC2026_JAN,2026
QD,Recording and storage in solid state memory by a digital recorder,HCPCS_Level_II,HCPC2026_JAN,2026
QE,Prescribed amount of stationary oxygen while at rest is less than 1 liter per minute (lpm),HCPCS_Level_II,HCPC2026_JAN,2026
QF,Prescribed amount of stationary oxygen while at rest exceeds 4 liters per minute (lpm) and portable oxygen is prescribed,HCPCS_Level_II,HCPC2026_JAN,2026
QG,Prescribed amount of stationary oxygen while at rest is greater than 4 liters per minute (lpm),HCPCS_Level_II,HCPC2026_JAN,2026
QH,Oxygen conserving device is being used with an oxygen delivery system,HCPCS_Level_II,HCPC2026_JAN,2026
QJ,"Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)",HCPCS_Level_II,HCPC2026_JAN,2026
QK,"Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals",HCPCS_Level_II,HCPC2026_JAN,2026
QL,Patient pronounced dead after ambulance called,HCPCS_Level_II,HCPC2026_JAN,2026
QM,Ambulance service provided under arrangement by a provider of services,HCPCS_Level_II,HCPC2026_JAN,2026
QN,Ambulance service furnished directly by a provider of services,HCPCS_Level_II,HCPC2026_JAN,2026
QP,"Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060.",HCPCS_Level_II,HCPC2026_JAN,2026
QQ,Ordering professional consulted a qualified clinical decision support mechanism for this service and the related data was provided to the furnishing professional,HCPCS_Level_II,HCPC2026_JAN,2026
QR,Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is greater than 4 liters per minute (lpm),HCPCS_Level_II,HCPC2026_JAN,2026
QS,Monitored anesthesia care service,HCPCS_Level_II,HCPC2026_JAN,2026
QT,Recording and storage on tape by an analog tape recorder,HCPCS_Level_II,HCPC2026_JAN,2026
QW,Clia waived test,HCPCS_Level_II,HCPC2026_JAN,2026
QX,Crna service: with medical direction by a physician,HCPCS_Level_II,HCPC2026_JAN,2026
QY,Medical direction of one certified registered nurse anesthetist (crna) by an anesthesiologist,HCPCS_Level_II,HCPC2026_JAN,2026
QZ,Crna service: without medical direction by a physician,HCPCS_Level_II,HCPC2026_JAN,2026
R0070,"Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen",HCPCS_Level_II,HCPC2026_JAN,2026
R0075,"Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen",HCPCS_Level_II,HCPC2026_JAN,2026
R0076,"Transportation of portable ekg to facility or location, per patient",HCPCS_Level_II,HCPC2026_JAN,2026
RA,"Replacement of a dme, orthotic or prosthetic item",HCPCS_Level_II,HCPC2026_JAN,2026
RB,"Replacement of a part of a dme, orthotic or prosthetic item furnished as part of a repair",HCPCS_Level_II,HCPC2026_JAN,2026
RC,Right coronary artery,HCPCS_Level_II,HCPC2026_JAN,2026
RD,"Drug provided to beneficiary, but not administered ""incident-to""",HCPCS_Level_II,HCPC2026_JAN,2026
RE,Furnished in full compliance with fda-mandated risk evaluation and mitigation strategy (rems),HCPCS_Level_II,HCPC2026_JAN,2026
RI,Ramus intermedius coronary artery,HCPCS_Level_II,HCPC2026_JAN,2026
RR,Rental (use the 'rr' modifier when dme is to be rented),HCPCS_Level_II,HCPC2026_JAN,2026
RT,Right side (used to identify procedures performed on the right side of the body),HCPCS_Level_II,HCPC2026_JAN,2026
S0012,"Butorphanol tartrate, nasal spray, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0013,"Esketamine, nasal spray, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0014,"Tacrine hydrochloride, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0017,"Injection, aminocaproic acid, 5 grams",HCPCS_Level_II,HCPC2026_JAN,2026
S0020,"Injection, bupivicaine hydrochloride, 30 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S0021,"Injection, cefoperazone sodium, 1 gram",HCPCS_Level_II,HCPC2026_JAN,2026
S0023,"Injection, cimetidine hydrochloride, 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0028,"Injection, famotidine, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0030,"Injection, metronidazole, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0032,"Injection, nafcillin sodium, 2 grams",HCPCS_Level_II,HCPC2026_JAN,2026
S0034,"Injection, ofloxacin, 400 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0039,"Injection, sulfamethoxazole and trimethoprim, 10 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S0040,"Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams",HCPCS_Level_II,HCPC2026_JAN,2026
S0073,"Injection, aztreonam, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0074,"Injection, cefotetan disodium, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0077,"Injection, clindamycin phosphate, 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0078,"Injection, fosphenytoin sodium, 750 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0080,"Injection, pentamidine isethionate, 300 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0081,"Injection, piperacillin sodium, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0088,"Imatinib, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0090,"Sildenafil citrate, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0091,"Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)",HCPCS_Level_II,HCPC2026_JAN,2026
S0092,"Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)",HCPCS_Level_II,HCPC2026_JAN,2026
S0093,"Injection, morphine sulfate, 500 mg (loading dose for infusion pump)",HCPCS_Level_II,HCPC2026_JAN,2026
S0104,"Zidovudine, oral, 100 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0106,"Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets",HCPCS_Level_II,HCPC2026_JAN,2026
S0108,"Mercaptopurine, oral, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0109,"Methadone, oral, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0117,"Tretinoin, topical, 5 grams",HCPCS_Level_II,HCPC2026_JAN,2026
S0119,"Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)",HCPCS_Level_II,HCPC2026_JAN,2026
S0122,"Injection, menotropins, 75 iu",HCPCS_Level_II,HCPC2026_JAN,2026
S0126,"Injection, follitropin alfa, 75 iu",HCPCS_Level_II,HCPC2026_JAN,2026
S0128,"Injection, follitropin beta, 75 iu",HCPCS_Level_II,HCPC2026_JAN,2026
S0132,"Injection, ganirelix acetate, 250 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
S0136,"Clozapine, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0137,"Didanosine (ddi), 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0138,"Finasteride, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0139,"Minoxidil, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0140,"Saquinavir, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0142,"Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0144,"Injection, propofol, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0145,"Injection, pegylated interferon alfa-2a, 180 mcg per ml",HCPCS_Level_II,HCPC2026_JAN,2026
S0148,"Injection, pegylated interferon alfa-2b, 10 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
S0155,"Sterile dilutant for epoprostenol, 50 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S0156,"Exemestane, 25 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0157,"Becaplermin gel 0.01%, 0.5 gm",HCPCS_Level_II,HCPC2026_JAN,2026
S0160,"Dextroamphetamine sulfate, 5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0164,"Injection, pantoprazole sodium, 40 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0166,"Injection, olanzapine, 2.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0169,"Calcitrol, 0.25 microgram",HCPCS_Level_II,HCPC2026_JAN,2026
S0170,"Anastrozole, oral, 1 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0171,"Injection, bumetanide, 0.5 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0172,"Chlorambucil, oral, 2 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0174,"Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)",HCPCS_Level_II,HCPC2026_JAN,2026
S0175,"Flutamide, oral, 125 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0176,"Hydroxyurea, oral, 500 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0177,"Levamisole hydrochloride, oral, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0178,"Lomustine, oral, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0179,"Megestrol acetate, oral, 20 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0182,"Procarbazine hydrochloride, oral, 50 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0183,"Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)",HCPCS_Level_II,HCPC2026_JAN,2026
S0187,"Tamoxifen citrate, oral, 10 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0189,"Testosterone pellet, 75 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0190,"Mifepristone, oral, 200 mg",HCPCS_Level_II,HCPC2026_JAN,2026
S0191,"Misoprostol, oral, 200 mcg",HCPCS_Level_II,HCPC2026_JAN,2026
S0194,"Dialysis/stress vitamin supplement, oral, 100 capsules",HCPCS_Level_II,HCPC2026_JAN,2026
S0195,"Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccine",HCPCS_Level_II,HCPC2026_JAN,2026
S0197,"Prenatal vitamins, 30-day supply",HCPCS_Level_II,HCPC2026_JAN,2026
S0199,"Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs",HCPCS_Level_II,HCPC2026_JAN,2026
S0201,"Partial hospitalization services, less than 24 hours, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S0207,"Paramedic intercept, non-hospital-based als service (non-voluntary), non-transport",HCPCS_Level_II,HCPC2026_JAN,2026
S0208,"Paramedic intercept, hospital-based als service (non-voluntary), non-transport",HCPCS_Level_II,HCPC2026_JAN,2026
S0209,"Wheelchair van, mileage, per mile",HCPCS_Level_II,HCPC2026_JAN,2026
S0215,"Non-emergency transportation; mileage, per mile",HCPCS_Level_II,HCPC2026_JAN,2026
S0220,Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes,HCPCS_Level_II,HCPC2026_JAN,2026
S0221,Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes,HCPCS_Level_II,HCPC2026_JAN,2026
S0250,Comprehensive geriatric assessment and treatment planning performed by assessment team,HCPCS_Level_II,HCPC2026_JAN,2026
S0255,"Hospice referral visit (advising patient and family of care options) performed by nurse, social worker, or other designated staff",HCPCS_Level_II,HCPC2026_JAN,2026
S0257,"Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service)",HCPCS_Level_II,HCPC2026_JAN,2026
S0260,History and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service),HCPCS_Level_II,HCPC2026_JAN,2026
S0265,"Genetic counseling, under physician supervision, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S0270,"Physician management of patient home care, standard monthly case rate (per 30 days)",HCPCS_Level_II,HCPC2026_JAN,2026
S0271,"Physician management of patient home care, hospice monthly case rate (per 30 days)",HCPCS_Level_II,HCPC2026_JAN,2026
S0272,"Physician management of patient home care, episodic care monthly case rate (per 30 days)",HCPCS_Level_II,HCPC2026_JAN,2026
S0273,"Physician visit at member's home, outside of a capitation arrangement",HCPCS_Level_II,HCPC2026_JAN,2026
S0274,"Nurse practitioner visit at member's home, outside of a capitation arrangement",HCPCS_Level_II,HCPC2026_JAN,2026
S0280,"Medical home program, comprehensive care coordination and planning, initial plan",HCPCS_Level_II,HCPC2026_JAN,2026
S0281,"Medical home program, comprehensive care coordination and planning, maintenance of plan",HCPCS_Level_II,HCPC2026_JAN,2026
S0285,Colonoscopy consultation performed prior to a screening colonoscopy procedure,HCPCS_Level_II,HCPC2026_JAN,2026
S0302,Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service),HCPCS_Level_II,HCPC2026_JAN,2026
S0310,Hospitalist services (list separately in addition to code for appropriate evaluation and management service),HCPCS_Level_II,HCPC2026_JAN,2026
S0311,"Comprehensive management and care coordination for advanced illness, per calendar month",HCPCS_Level_II,HCPC2026_JAN,2026
S0315,Disease management program; initial assessment and initiation of the program,HCPCS_Level_II,HCPC2026_JAN,2026
S0316,"Disease management program, follow-up/reassessment",HCPCS_Level_II,HCPC2026_JAN,2026
S0317,Disease management program; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
S0320,Telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month,HCPCS_Level_II,HCPC2026_JAN,2026
S0340,"Lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage",HCPCS_Level_II,HCPC2026_JAN,2026
S0341,"Lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage",HCPCS_Level_II,HCPC2026_JAN,2026
S0342,"Lifestyle modification program for management of coronary artery disease, including all supportive services; fourth quarter / stage",HCPCS_Level_II,HCPC2026_JAN,2026
S0353,"Treatment planning and care coordination management for cancer, initial treatment",HCPCS_Level_II,HCPC2026_JAN,2026
S0354,"Treatment planning and care coordination management for cancer, established patient with a change of regimen",HCPCS_Level_II,HCPC2026_JAN,2026
S0390,"Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit",HCPCS_Level_II,HCPC2026_JAN,2026
S0395,Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic,HCPCS_Level_II,HCPC2026_JAN,2026
S0400,Global fee for extracorporeal shock wave lithotripsy treatment of kidney stone(s),HCPCS_Level_II,HCPC2026_JAN,2026
S0500,"Disposable contact lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0504,"Single vision prescription lens (safety, athletic, or sunglass), per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0506,"Bifocal vision prescription lens (safety, athletic, or sunglass), per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0508,"Trifocal vision prescription lens (safety, athletic, or sunglass), per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0510,"Non-prescription lens (safety, athletic, or sunglass), per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0512,"Daily wear specialty contact lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0514,"Color contact lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0515,"Scleral lens, liquid bandage device, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
S0516,Safety eyeglass frames,HCPCS_Level_II,HCPC2026_JAN,2026
S0518,Sunglasses frames,HCPCS_Level_II,HCPC2026_JAN,2026
S0580,Polycarbonate lens (list this code in addition to the basic code for the lens),HCPCS_Level_II,HCPC2026_JAN,2026
S0581,Nonstandard lens (list this code in addition to the basic code for the lens),HCPCS_Level_II,HCPC2026_JAN,2026
S0590,"Integral lens service, miscellaneous services reported separately",HCPCS_Level_II,HCPC2026_JAN,2026
S0592,Comprehensive contact lens evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
S0595,Dispensing new spectacle lenses for patient supplied frame,HCPCS_Level_II,HCPC2026_JAN,2026
S0596,Phakic intraocular lens for correction of refractive error,HCPCS_Level_II,HCPC2026_JAN,2026
S0601,Screening proctoscopy,HCPCS_Level_II,HCPC2026_JAN,2026
S0610,"Annual gynecological examination, new patient",HCPCS_Level_II,HCPC2026_JAN,2026
S0612,"Annual gynecological examination, established patient",HCPCS_Level_II,HCPC2026_JAN,2026
S0613,Annual gynecological examination; clinical breast examination without pelvic evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
S0618,Audiometry for hearing aid evaluation to determine the level and degree of hearing loss,HCPCS_Level_II,HCPC2026_JAN,2026
S0620,Routine ophthalmological examination including refraction; new patient,HCPCS_Level_II,HCPC2026_JAN,2026
S0621,Routine ophthalmological examination including refraction; established patient,HCPCS_Level_II,HCPC2026_JAN,2026
S0622,"Physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)",HCPCS_Level_II,HCPC2026_JAN,2026
S0630,Removal of sutures; by a physician other than the physician who originally closed the wound,HCPCS_Level_II,HCPC2026_JAN,2026
S0800,Laser in situ keratomileusis (lasik),HCPCS_Level_II,HCPC2026_JAN,2026
S0810,Photorefractive keratectomy (prk),HCPCS_Level_II,HCPC2026_JAN,2026
S0812,Phototherapeutic keratectomy (ptk),HCPCS_Level_II,HCPC2026_JAN,2026
S1001,"Deluxe item, patient aware (list in addition to code for basic item)",HCPCS_Level_II,HCPC2026_JAN,2026
S1002,Customized item (list in addition to code for basic item),HCPCS_Level_II,HCPC2026_JAN,2026
S1015,Iv tubing extension set,HCPCS_Level_II,HCPC2026_JAN,2026
S1016,"Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel",HCPCS_Level_II,HCPC2026_JAN,2026
S1030,"Continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)",HCPCS_Level_II,HCPC2026_JAN,2026
S1031,"Continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)",HCPCS_Level_II,HCPC2026_JAN,2026
S1034,"Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices",HCPCS_Level_II,HCPC2026_JAN,2026
S1035,"Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system",HCPCS_Level_II,HCPC2026_JAN,2026
S1036,"Transmitter; external, for use with artificial pancreas device system",HCPCS_Level_II,HCPC2026_JAN,2026
S1037,"Receiver (monitor); external, for use with artificial pancreas device system",HCPCS_Level_II,HCPC2026_JAN,2026
S1040,"Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)",HCPCS_Level_II,HCPC2026_JAN,2026
S1090,"Mometasone furoate sinus implant, 370 micrograms",HCPCS_Level_II,HCPC2026_JAN,2026
S1091,"Stent, non-coronary, temporary, with delivery system (propel)",HCPCS_Level_II,HCPC2026_JAN,2026
S2053,Transplantation of small intestine and liver allografts,HCPCS_Level_II,HCPC2026_JAN,2026
S2054,Transplantation of multivisceral organs,HCPCS_Level_II,HCPC2026_JAN,2026
S2055,"Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor",HCPCS_Level_II,HCPC2026_JAN,2026
S2060,Lobar lung transplantation,HCPCS_Level_II,HCPC2026_JAN,2026
S2061,"Donor lobectomy (lung) for transplantation, living donor",HCPCS_Level_II,HCPC2026_JAN,2026
S2065,Simultaneous pancreas kidney transplantation,HCPCS_Level_II,HCPC2026_JAN,2026
S2066,"Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
S2067,"Breast reconstruction of a single breast with ""stacked"" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
S2068,"Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral",HCPCS_Level_II,HCPC2026_JAN,2026
S2070,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)",HCPCS_Level_II,HCPC2026_JAN,2026
S2079,Laparoscopic esophagomyotomy (heller type),HCPCS_Level_II,HCPC2026_JAN,2026
S2080,Laser-assisted uvulopalatoplasty (laup),HCPCS_Level_II,HCPC2026_JAN,2026
S2083,Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline,HCPCS_Level_II,HCPC2026_JAN,2026
S2095,"Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres",HCPCS_Level_II,HCPC2026_JAN,2026
S2102,Islet cell tissue transplant from pancreas; allogeneic,HCPCS_Level_II,HCPC2026_JAN,2026
S2103,Adrenal tissue transplant to brain,HCPCS_Level_II,HCPC2026_JAN,2026
S2107,"Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment",HCPCS_Level_II,HCPC2026_JAN,2026
S2112,"Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)",HCPCS_Level_II,HCPC2026_JAN,2026
S2115,"Osteotomy, periacetabular, with internal fixation",HCPCS_Level_II,HCPC2026_JAN,2026
S2117,"Arthroereisis, subtalar",HCPCS_Level_II,HCPC2026_JAN,2026
S2118,"Metal-on-metal total hip resurfacing, including acetabular and femoral components",HCPCS_Level_II,HCPC2026_JAN,2026
S2120,Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation,HCPCS_Level_II,HCPC2026_JAN,2026
S2140,"Cord blood harvesting for transplantation, allogeneic",HCPCS_Level_II,HCPC2026_JAN,2026
S2142,"Cord blood-derived stem-cell transplantation, allogeneic",HCPCS_Level_II,HCPC2026_JAN,2026
S2150,"Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; marrow ablative therapy; drugs, supplies, hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition",HCPCS_Level_II,HCPC2026_JAN,2026
S2152,"Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition",HCPCS_Level_II,HCPC2026_JAN,2026
S2202,Echosclerotherapy,HCPCS_Level_II,HCPC2026_JAN,2026
S2205,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft",HCPCS_Level_II,HCPC2026_JAN,2026
S2206,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts",HCPCS_Level_II,HCPC2026_JAN,2026
S2207,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft",HCPCS_Level_II,HCPC2026_JAN,2026
S2208,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft",HCPCS_Level_II,HCPC2026_JAN,2026
S2209,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft",HCPCS_Level_II,HCPC2026_JAN,2026
S2225,"Myringotomy, laser-assisted",HCPCS_Level_II,HCPC2026_JAN,2026
S2230,Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear,HCPCS_Level_II,HCPC2026_JAN,2026
S2235,Implantation of auditory brain stem implant,HCPCS_Level_II,HCPC2026_JAN,2026
S2260,"Induced abortion, 17 to 24 weeks",HCPCS_Level_II,HCPC2026_JAN,2026
S2265,"Induced abortion, 25 to 28 weeks",HCPCS_Level_II,HCPC2026_JAN,2026
S2266,"Induced abortion, 29 to 31 weeks",HCPCS_Level_II,HCPC2026_JAN,2026
S2267,"Induced abortion, 32 weeks or greater",HCPCS_Level_II,HCPC2026_JAN,2026
S2300,"Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy",HCPCS_Level_II,HCPC2026_JAN,2026
S2325,Hip core decompression,HCPCS_Level_II,HCPC2026_JAN,2026
S2340,Chemodenervation of abductor muscle(s) of vocal cord,HCPCS_Level_II,HCPC2026_JAN,2026
S2341,Chemodenervation of adductor muscle(s) of vocal cord,HCPCS_Level_II,HCPC2026_JAN,2026
S2342,"Nasal endoscopy for post-operative debridement following functional endoscopic sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
S2348,"Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar",HCPCS_Level_II,HCPC2026_JAN,2026
S2350,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace",HCPCS_Level_II,HCPC2026_JAN,2026
S2351,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)",HCPCS_Level_II,HCPC2026_JAN,2026
S2360,"Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervical",HCPCS_Level_II,HCPC2026_JAN,2026
S2361,Each additional cervical vertebral body (list separately in addition to code for primary procedure),HCPCS_Level_II,HCPC2026_JAN,2026
S2400,"Repair, congenital diaphragmatic hernia in the fetus using temporary tracheal occlusion, procedure performed in utero",HCPCS_Level_II,HCPC2026_JAN,2026
S2401,"Repair, urinary tract obstruction in the fetus, procedure performed in utero",HCPCS_Level_II,HCPC2026_JAN,2026
S2402,"Repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero",HCPCS_Level_II,HCPC2026_JAN,2026
S2403,"Repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero",HCPCS_Level_II,HCPC2026_JAN,2026
S2404,"Repair, myelomeningocele in the fetus, procedure performed in utero",HCPCS_Level_II,HCPC2026_JAN,2026
S2405,"Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero",HCPCS_Level_II,HCPC2026_JAN,2026
S2409,"Repair, congenital malformation of fetus, procedure performed in utero, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
S2411,Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome,HCPCS_Level_II,HCPC2026_JAN,2026
S2900,Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure),HCPCS_Level_II,HCPC2026_JAN,2026
S3000,"Diabetic indicator; retinal eye exam, dilated, bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
S3005,"Performance measurement, evaluation of patient self assessment, depression",HCPCS_Level_II,HCPC2026_JAN,2026
S3600,Stat laboratory request (situations other than s3601),HCPCS_Level_II,HCPC2026_JAN,2026
S3601,Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility,HCPCS_Level_II,HCPC2026_JAN,2026
S3620,"Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis;  hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)",HCPCS_Level_II,HCPC2026_JAN,2026
S3630,"Eosinophil count, blood, direct",HCPCS_Level_II,HCPC2026_JAN,2026
S3645,Hiv-1 antibody testing of oral mucosal transudate,HCPCS_Level_II,HCPC2026_JAN,2026
S3650,"Saliva test, hormone level; during menopause",HCPCS_Level_II,HCPC2026_JAN,2026
S3652,"Saliva test, hormone level; to assess preterm labor risk",HCPCS_Level_II,HCPC2026_JAN,2026
S3655,Antisperm antibodies test (immunobead),HCPCS_Level_II,HCPC2026_JAN,2026
S3708,Gastrointestinal fat absorption study,HCPCS_Level_II,HCPC2026_JAN,2026
S3721,Prostate cancer antigen 3 (pca3) testing,HCPCS_Level_II,HCPC2026_JAN,2026
S3722,"Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil",HCPCS_Level_II,HCPC2026_JAN,2026
S3800,Genetic testing for amyotrophic lateral sclerosis (als),HCPCS_Level_II,HCPC2026_JAN,2026
S3840,Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2,HCPCS_Level_II,HCPC2026_JAN,2026
S3841,Genetic testing for retinoblastoma,HCPCS_Level_II,HCPC2026_JAN,2026
S3842,Genetic testing for von hippel-lindau disease,HCPCS_Level_II,HCPC2026_JAN,2026
S3844,"Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness",HCPCS_Level_II,HCPC2026_JAN,2026
S3845,Genetic testing for alpha-thalassemia,HCPCS_Level_II,HCPC2026_JAN,2026
S3846,Genetic testing for hemoglobin e beta-thalassemia,HCPCS_Level_II,HCPC2026_JAN,2026
S3849,Genetic testing for niemann-pick disease,HCPCS_Level_II,HCPC2026_JAN,2026
S3850,Genetic testing for sickle cell anemia,HCPCS_Level_II,HCPC2026_JAN,2026
S3852,Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease,HCPCS_Level_II,HCPC2026_JAN,2026
S3853,Genetic testing for myotonic muscular dystrophy,HCPCS_Level_II,HCPC2026_JAN,2026
S3854,Gene expression profiling panel for use in the management of breast cancer treatment,HCPCS_Level_II,HCPC2026_JAN,2026
S3855,Genetic testing for detection of mutations in the presenilin - 1 gene,HCPCS_Level_II,HCPC2026_JAN,2026
S3861,"Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome",HCPCS_Level_II,HCPC2026_JAN,2026
S3865,Comprehensive gene sequence analysis for hypertrophic cardiomyopathy,HCPCS_Level_II,HCPC2026_JAN,2026
S3866,Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family,HCPCS_Level_II,HCPC2026_JAN,2026
S3870,"Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability",HCPCS_Level_II,HCPC2026_JAN,2026
S3890,"Dna analysis, fecal, for colorectal cancer screening",HCPCS_Level_II,HCPC2026_JAN,2026
S3900,Surface electromyography (emg),HCPCS_Level_II,HCPC2026_JAN,2026
S3902,Ballistocardiogram,HCPCS_Level_II,HCPC2026_JAN,2026
S3904,Masters two step,HCPCS_Level_II,HCPC2026_JAN,2026
S4005,Interim labor facility global (labor occurring but not resulting in delivery),HCPCS_Level_II,HCPC2026_JAN,2026
S4011,"In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development",HCPCS_Level_II,HCPC2026_JAN,2026
S4013,"Complete cycle, gamete intrafallopian transfer (gift), case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4014,"Complete cycle, zygote intrafallopian transfer (zift), case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4015,"Complete in vitro fertilization cycle, not otherwise specified, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4016,"Frozen in vitro fertilization cycle, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4017,"Incomplete cycle, treatment cancelled prior to stimulation, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4018,"Frozen embryo transfer procedure cancelled before transfer, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4020,"In vitro fertilization procedure cancelled before aspiration, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4021,"In vitro fertilization procedure cancelled after aspiration, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4022,"Assisted oocyte fertilization, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4023,"Donor egg cycle, incomplete, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4024,"Air polymer-type a intrauterine foam, per study dose",HCPCS_Level_II,HCPC2026_JAN,2026
S4025,"Donor services for in vitro fertilization (sperm or embryo), case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4026,Procurement of donor sperm from sperm bank,HCPCS_Level_II,HCPC2026_JAN,2026
S4027,Storage of previously frozen embryos,HCPCS_Level_II,HCPC2026_JAN,2026
S4028,Microsurgical epididymal sperm aspiration (mesa),HCPCS_Level_II,HCPC2026_JAN,2026
S4030,Sperm procurement and cryopreservation services; initial visit,HCPCS_Level_II,HCPC2026_JAN,2026
S4031,Sperm procurement and cryopreservation services; subsequent visit,HCPCS_Level_II,HCPC2026_JAN,2026
S4035,"Stimulated intrauterine insemination (iui), case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4037,"Cryopreserved embryo transfer, case rate",HCPCS_Level_II,HCPC2026_JAN,2026
S4040,"Monitoring and storage of cryopreserved embryos, per 30 days",HCPCS_Level_II,HCPC2026_JAN,2026
S4042,"Management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle",HCPCS_Level_II,HCPC2026_JAN,2026
S4981,Insertion of levonorgestrel-releasing intrauterine system,HCPCS_Level_II,HCPC2026_JAN,2026
S4988,"Penile contracture device, manual, greater than 3 lbs traction force",HCPCS_Level_II,HCPC2026_JAN,2026
S4989,"Contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies",HCPCS_Level_II,HCPC2026_JAN,2026
S4990,"Nicotine patches, legend",HCPCS_Level_II,HCPC2026_JAN,2026
S4991,"Nicotine patches, non-legend",HCPCS_Level_II,HCPC2026_JAN,2026
S4993,Contraceptive pills for birth control,HCPCS_Level_II,HCPC2026_JAN,2026
S4995,Smoking cessation gum,HCPCS_Level_II,HCPC2026_JAN,2026
S5000,"Prescription drug, generic",HCPCS_Level_II,HCPC2026_JAN,2026
S5001,"Prescription drug, brand name",HCPCS_Level_II,HCPC2026_JAN,2026
S5010,"5% dextrose and 0.45% normal saline, 1000 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S5011,"5% dextrose in lactated ringer's, 1000 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S5012,"5% dextrose with potassium chloride, 1000 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S5013,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1000 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S5014,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml",HCPCS_Level_II,HCPC2026_JAN,2026
S5035,"Home infusion therapy, routine service of infusion device (e.g., pump maintenance)",HCPCS_Level_II,HCPC2026_JAN,2026
S5036,"Home infusion therapy, repair of infusion device (e.g., pump repair)",HCPCS_Level_II,HCPC2026_JAN,2026
S5100,"Day care services, adult; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5101,"Day care services, adult; per half day",HCPCS_Level_II,HCPC2026_JAN,2026
S5102,"Day care services, adult; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5105,"Day care services, center-based; services not included in program fee, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5108,"Home care training to home care client, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5109,"Home care training to home care client, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S5110,"Home care training, family; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5111,"Home care training, family; per session",HCPCS_Level_II,HCPC2026_JAN,2026
S5115,"Home care training, non-family; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5116,"Home care training, non-family; per session",HCPCS_Level_II,HCPC2026_JAN,2026
S5120,Chore services; per 15 minutes,HCPCS_Level_II,HCPC2026_JAN,2026
S5121,Chore services; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
S5125,Attendant care services; per 15 minutes,HCPCS_Level_II,HCPC2026_JAN,2026
S5126,Attendant care services; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
S5130,"Homemaker service, nos; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5131,"Homemaker service, nos; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5135,"Companion care, adult (e.g., iadl/adl); per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5136,"Companion care, adult (e.g., iadl/adl); per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5140,"Foster care, adult; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5141,"Foster care, adult; per month",HCPCS_Level_II,HCPC2026_JAN,2026
S5145,"Foster care, therapeutic, child; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5146,"Foster care, therapeutic, child; per month",HCPCS_Level_II,HCPC2026_JAN,2026
S5150,"Unskilled respite care, not hospice; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S5151,"Unskilled respite care, not hospice; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5160,Emergency response system; installation and testing,HCPCS_Level_II,HCPC2026_JAN,2026
S5161,"Emergency response system; service fee, per month (excludes installation and testing)",HCPCS_Level_II,HCPC2026_JAN,2026
S5162,Emergency response system; purchase only,HCPCS_Level_II,HCPC2026_JAN,2026
S5165,Home modifications; per service,HCPCS_Level_II,HCPC2026_JAN,2026
S5170,"Home delivered meals, including preparation; per meal",HCPCS_Level_II,HCPC2026_JAN,2026
S5175,"Laundry service, external, professional; per order",HCPCS_Level_II,HCPC2026_JAN,2026
S5180,"Home health respiratory therapy, initial evaluation",HCPCS_Level_II,HCPC2026_JAN,2026
S5181,"Home health respiratory therapy, nos, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5185,"Medication reminder service, non-face-to-face; per month",HCPCS_Level_II,HCPC2026_JAN,2026
S5190,"Wellness assessment, performed by non-physician",HCPCS_Level_II,HCPC2026_JAN,2026
S5199,"Personal care item, nos, each",HCPCS_Level_II,HCPC2026_JAN,2026
S5497,"Home infusion therapy, catheter care / maintenance, not otherwise classified; includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5498,"Home infusion therapy, catheter care / maintenance, simple (single lumen), includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5501,"Home infusion therapy, catheter care / maintenance, complex (more than one lumen), includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S5502,"Home infusion therapy, catheter care / maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (use this code for interim maintenance of vascular access not currently in use)",HCPCS_Level_II,HCPC2026_JAN,2026
S5517,"Home infusion therapy, all supplies necessary for restoration of catheter patency or declotting",HCPCS_Level_II,HCPC2026_JAN,2026
S5518,"Home infusion therapy, all supplies necessary for catheter repair",HCPCS_Level_II,HCPC2026_JAN,2026
S5520,"Home infusion therapy, all supplies (including catheter) necessary for a peripherally inserted central venous catheter (picc) line insertion",HCPCS_Level_II,HCPC2026_JAN,2026
S5521,"Home infusion therapy, all supplies (including catheter) necessary for a midline catheter insertion",HCPCS_Level_II,HCPC2026_JAN,2026
S5522,"Home infusion therapy, insertion of peripherally inserted central venous catheter (picc), nursing services only (no supplies or catheter included)",HCPCS_Level_II,HCPC2026_JAN,2026
S5523,"Home infusion therapy, insertion of midline venous catheter, nursing services only (no supplies or catheter included)",HCPCS_Level_II,HCPC2026_JAN,2026
S5550,"Insulin, rapid onset, 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
S5551,"Insulin, most rapid onset (lispro or aspart); 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
S5552,"Insulin, intermediate acting (nph or lente); 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
S5553,"Insulin, long acting; 5 units",HCPCS_Level_II,HCPC2026_JAN,2026
S5560,"Insulin delivery device, reusable pen; 1.5 ml size",HCPCS_Level_II,HCPC2026_JAN,2026
S5561,"Insulin delivery device, reusable pen; 3 ml size",HCPCS_Level_II,HCPC2026_JAN,2026
S5565,Insulin cartridge for use in insulin delivery device other than pump; 150 units,HCPCS_Level_II,HCPC2026_JAN,2026
S5566,Insulin cartridge for use in insulin delivery device other than pump; 300 units,HCPCS_Level_II,HCPC2026_JAN,2026
S5570,"Insulin delivery device, disposable pen (including insulin); 1.5 ml size",HCPCS_Level_II,HCPC2026_JAN,2026
S5571,"Insulin delivery device, disposable pen (including insulin); 3 ml size",HCPCS_Level_II,HCPC2026_JAN,2026
S8030,Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy,HCPCS_Level_II,HCPC2026_JAN,2026
S8032,Low-dose computed tomography for lung cancer screening,HCPCS_Level_II,HCPC2026_JAN,2026
S8035,Magnetic source imaging,HCPCS_Level_II,HCPC2026_JAN,2026
S8037,Magnetic resonance cholangiopancreatography (mrcp),HCPCS_Level_II,HCPC2026_JAN,2026
S8040,Topographic brain mapping,HCPCS_Level_II,HCPC2026_JAN,2026
S8042,"Magnetic resonance imaging (mri), low-field",HCPCS_Level_II,HCPC2026_JAN,2026
S8055,"Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)",HCPCS_Level_II,HCPC2026_JAN,2026
S8080,"Scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical",HCPCS_Level_II,HCPC2026_JAN,2026
S8085,Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan),HCPCS_Level_II,HCPC2026_JAN,2026
S8092,"Electron beam computed tomography (also known as ultrafast ct, cine ct)",HCPCS_Level_II,HCPC2026_JAN,2026
S8096,Portable peak flow meter,HCPCS_Level_II,HCPC2026_JAN,2026
S8097,"Asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer)",HCPCS_Level_II,HCPC2026_JAN,2026
S8100,Holding chamber or spacer for use with an inhaler or nebulizer; without mask,HCPCS_Level_II,HCPC2026_JAN,2026
S8101,Holding chamber or spacer for use with an inhaler or nebulizer; with mask,HCPCS_Level_II,HCPC2026_JAN,2026
S8110,Peak expiratory flow rate (physician services),HCPCS_Level_II,HCPC2026_JAN,2026
S8120,"Oxygen contents, gaseous, 1 unit equals 1 cubic foot",HCPCS_Level_II,HCPC2026_JAN,2026
S8121,"Oxygen contents, liquid, 1 unit equals 1 pound",HCPCS_Level_II,HCPC2026_JAN,2026
S8130,"Interferential current stimulator, 2 channel",HCPCS_Level_II,HCPC2026_JAN,2026
S8131,"Interferential current stimulator, 4 channel",HCPCS_Level_II,HCPC2026_JAN,2026
S8185,Flutter device,HCPCS_Level_II,HCPC2026_JAN,2026
S8186,Swivel adapter,HCPCS_Level_II,HCPC2026_JAN,2026
S8189,"Tracheostomy supply, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
S8210,Mucus trap,HCPCS_Level_II,HCPC2026_JAN,2026
S8262,"Mandibular orthopedic repositioning device, each",HCPCS_Level_II,HCPC2026_JAN,2026
S8265,Haberman feeder for cleft lip/palate,HCPCS_Level_II,HCPC2026_JAN,2026
S8270,"Enuresis alarm, using auditory buzzer and/or vibration device",HCPCS_Level_II,HCPC2026_JAN,2026
S8301,"Infection control supplies, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
S8415,Supplies for home delivery of infant,HCPCS_Level_II,HCPC2026_JAN,2026
S8420,"Gradient pressure aid (sleeve and glove combination), custom made",HCPCS_Level_II,HCPC2026_JAN,2026
S8421,"Gradient pressure aid (sleeve and glove combination), ready made",HCPCS_Level_II,HCPC2026_JAN,2026
S8422,"Gradient pressure aid (sleeve), custom made, medium weight",HCPCS_Level_II,HCPC2026_JAN,2026
S8423,"Gradient pressure aid (sleeve), custom made, heavy weight",HCPCS_Level_II,HCPC2026_JAN,2026
S8424,"Gradient pressure aid (sleeve), ready made",HCPCS_Level_II,HCPC2026_JAN,2026
S8425,"Gradient pressure aid (glove), custom made, medium weight",HCPCS_Level_II,HCPC2026_JAN,2026
S8426,"Gradient pressure aid (glove), custom made, heavy weight",HCPCS_Level_II,HCPC2026_JAN,2026
S8427,"Gradient pressure aid (glove), ready made",HCPCS_Level_II,HCPC2026_JAN,2026
S8428,"Gradient pressure aid (gauntlet), ready made",HCPCS_Level_II,HCPC2026_JAN,2026
S8429,Gradient pressure exterior wrap,HCPCS_Level_II,HCPC2026_JAN,2026
S8430,"Padding for compression bandage, roll",HCPCS_Level_II,HCPC2026_JAN,2026
S8431,"Compression bandage, roll",HCPCS_Level_II,HCPC2026_JAN,2026
S8450,"Splint, prefabricated, digit (specify digit by use of modifier)",HCPCS_Level_II,HCPC2026_JAN,2026
S8451,"Splint, prefabricated, wrist or ankle",HCPCS_Level_II,HCPC2026_JAN,2026
S8452,"Splint, prefabricated, elbow",HCPCS_Level_II,HCPC2026_JAN,2026
S8460,"Camisole, post-mastectomy",HCPCS_Level_II,HCPC2026_JAN,2026
S8490,"Insulin syringes (100 syringes, any size)",HCPCS_Level_II,HCPC2026_JAN,2026
S8930,Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient,HCPCS_Level_II,HCPC2026_JAN,2026
S8940,"Equestrian/hippotherapy, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S8948,Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes,HCPCS_Level_II,HCPC2026_JAN,2026
S8950,"Complex lymphedema therapy, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S8990,Physical or manipulative therapy performed for maintenance rather than restoration,HCPCS_Level_II,HCPC2026_JAN,2026
S8999,Resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event),HCPCS_Level_II,HCPC2026_JAN,2026
S9001,Home uterine monitor with or without associated nursing services,HCPCS_Level_II,HCPC2026_JAN,2026
S9002,"Intra-vaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device",HCPCS_Level_II,HCPC2026_JAN,2026
S9007,Ultrafiltration monitor,HCPCS_Level_II,HCPC2026_JAN,2026
S9015,Automated eeg monitoring,HCPCS_Level_II,HCPC2026_JAN,2026
S9024,Paranasal sinus ultrasound,HCPCS_Level_II,HCPC2026_JAN,2026
S9025,Omnicardiogram/cardiointegram,HCPCS_Level_II,HCPC2026_JAN,2026
S9034,"Extracorporeal shockwave lithotripsy for gall stones (if performed with ercp, use 43265)",HCPCS_Level_II,HCPC2026_JAN,2026
S9055,Procuren or other growth factor preparation to promote wound healing,HCPCS_Level_II,HCPC2026_JAN,2026
S9056,Coma stimulation per diem,HCPCS_Level_II,HCPC2026_JAN,2026
S9061,"Home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9083,Global fee urgent care centers,HCPCS_Level_II,HCPC2026_JAN,2026
S9088,Services provided in an urgent care center (list in addition to code for service),HCPCS_Level_II,HCPC2026_JAN,2026
S9090,"Vertebral axial decompression, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9097,Home visit for wound care,HCPCS_Level_II,HCPC2026_JAN,2026
S9098,"Home visit, phototherapy services (e.g., bili-lite), including equipment rental, nursing services, blood draw, supplies, and other services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9110,"Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month",HCPCS_Level_II,HCPC2026_JAN,2026
S9117,"Back school, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
S9122,"Home health aide or certified nurse assistant, providing care in the home; per hour",HCPCS_Level_II,HCPC2026_JAN,2026
S9123,"Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)",HCPCS_Level_II,HCPC2026_JAN,2026
S9124,"Nursing care, in the home; by licensed practical nurse, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
S9125,"Respite care, in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9126,"Hospice care, in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9127,"Social work visit, in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9128,"Speech therapy, in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9129,"Occupational therapy, in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9131,"Physical therapy; in the home, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9140,"Diabetic management program, follow-up visit to non-md provider",HCPCS_Level_II,HCPC2026_JAN,2026
S9141,"Diabetic management program, follow-up visit to md provider",HCPCS_Level_II,HCPC2026_JAN,2026
S9145,"Insulin pump initiation, instruction in initial use of pump (pump not included)",HCPCS_Level_II,HCPC2026_JAN,2026
S9150,Evaluation by ocularist,HCPCS_Level_II,HCPC2026_JAN,2026
S9152,"Speech therapy, re-evaluation",HCPCS_Level_II,HCPC2026_JAN,2026
S9208,"Home management of preterm labor, including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9209,"Home management of preterm premature rupture of membranes (pprom), including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9211,"Home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9212,"Home management of postpartum hypertension, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9213,"Home management of preeclampsia, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately); per diem (do not use this code with any home infusion per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9214,"Home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9325,"Home infusion therapy, pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (do not use this code with s9326, s9327 or s9328)",HCPCS_Level_II,HCPC2026_JAN,2026
S9326,"Home infusion therapy, continuous (twenty-four hours or more) pain management infusion; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9327,"Home infusion therapy, intermittent (less than twenty-four hours) pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9328,"Home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9329,"Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)",HCPCS_Level_II,HCPC2026_JAN,2026
S9330,"Home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9331,"Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9335,"Home therapy, hemodialysis; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9336,"Home infusion therapy, continuous anticoagulant infusion therapy (e.g., heparin), administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9338,"Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9339,"Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9340,"Home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9341,"Home therapy; enteral nutrition via gravity; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9342,"Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9343,"Home therapy; enteral nutrition via bolus; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9345,"Home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor viii); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9346,"Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9347,"Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9348,"Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9349,"Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9351,"Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9353,"Home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9355,"Home infusion therapy, chelation therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9357,"Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9359,"Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9361,"Home infusion therapy, diuretic intravenous therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9363,"Home infusion therapy, anti-spasmotic therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9364,"Home infusion therapy, total parenteral nutrition (tpn); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem (do not use with home infusion codes s9365-s9368 using daily volume scales)",HCPCS_Level_II,HCPC2026_JAN,2026
S9365,"Home infusion therapy, total parenteral nutrition (tpn); one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9366,"Home infusion therapy, total parenteral nutrition (tpn); more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9367,"Home infusion therapy, total parenteral nutrition (tpn); more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9368,"Home infusion therapy, total parenteral nutrition (tpn); more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9370,"Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9372,"Home therapy; intermittent anticoagulant injection therapy (e.g., heparin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code for flushing of infusion devices with heparin to maintain patency)",HCPCS_Level_II,HCPC2026_JAN,2026
S9373,"Home infusion therapy, hydration therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use with hydration therapy codes s9374-s9377 using daily volume scales)",HCPCS_Level_II,HCPC2026_JAN,2026
S9374,"Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9375,"Home infusion therapy, hydration therapy; more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9376,"Home infusion therapy, hydration therapy; more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9377,"Home infusion therapy, hydration therapy; more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9379,"Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9381,"Delivery or service to high risk areas requiring escort or extra protection, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
S9401,"Anticoagulation clinic, inclusive of all services except laboratory tests, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9430,Pharmacy compounding and dispensing services,HCPCS_Level_II,HCPC2026_JAN,2026
S9432,Medical foods for non-inborn errors of metabolism,HCPCS_Level_II,HCPC2026_JAN,2026
S9433,"Medical food nutritionally complete, administered orally, providing 100% of nutritional intake",HCPCS_Level_II,HCPC2026_JAN,2026
S9434,Modified solid food supplements for inborn errors of metabolism,HCPCS_Level_II,HCPC2026_JAN,2026
S9435,Medical foods for inborn errors of metabolism,HCPCS_Level_II,HCPC2026_JAN,2026
S9436,"Childbirth preparation/lamaze classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9437,"Childbirth refresher classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9438,"Cesarean birth classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9439,"Vbac (vaginal birth after cesarean) classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9441,"Asthma education, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9442,"Birthing classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9443,"Lactation classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9444,"Parenting classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9445,"Patient education, not otherwise classified, non-physician provider, individual, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9446,"Patient education, not otherwise classified, non-physician provider, group, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9447,"Infant safety (including cpr) classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9449,"Weight management classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9451,"Exercise classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9452,"Nutrition classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9453,"Smoking cessation classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9454,"Stress management classes, non-physician provider, per session",HCPCS_Level_II,HCPC2026_JAN,2026
S9455,"Diabetic management program, group session",HCPCS_Level_II,HCPC2026_JAN,2026
S9460,"Diabetic management program, nurse visit",HCPCS_Level_II,HCPC2026_JAN,2026
S9465,"Diabetic management program, dietitian visit",HCPCS_Level_II,HCPC2026_JAN,2026
S9470,"Nutritional counseling, dietitian visit",HCPCS_Level_II,HCPC2026_JAN,2026
S9472,"Cardiac rehabilitation program, non-physician provider, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9473,"Pulmonary rehabilitation program, non-physician provider, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9474,"Enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9475,"Ambulatory setting substance abuse treatment or detoxification services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9476,"Vestibular rehabilitation program, non-physician provider, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9480,"Intensive outpatient psychiatric services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9482,"Family stabilization services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
S9484,"Crisis intervention mental health services, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
S9485,"Crisis intervention mental health services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9490,"Home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9494,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504)",HCPCS_Level_II,HCPC2026_JAN,2026
S9497,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 3 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9500,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9501,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9502,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9503,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 6 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9504,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 4 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9529,"Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient",HCPCS_Level_II,HCPC2026_JAN,2026
S9537,"Home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin, g-csf, gm-csf); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9538,"Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9542,"Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9558,"Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9559,"Home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9560,"Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9562,"Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9563,"Home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9590,"Home therapy, irrigation therapy (e.g., sterile irrigation of an organ or anatomical cavity); including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9810,"Home therapy; professional pharmacy services for provision of infusion, specialty drug administration, and/or disease state management, not otherwise classified, per hour (do not use this code with any per diem code)",HCPCS_Level_II,HCPC2026_JAN,2026
S9900,"Services by a journal-listed christian science practitioner for the purpose of healing, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9901,"Services by a journal-listed christian science nurse, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
S9960,"Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)",HCPCS_Level_II,HCPC2026_JAN,2026
S9961,"Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)",HCPCS_Level_II,HCPC2026_JAN,2026
S9970,"Health club membership, annual",HCPCS_Level_II,HCPC2026_JAN,2026
S9975,"Transplant related lodging, meals and transportation, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
S9976,"Lodging, per diem, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
S9977,"Meals, per diem, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
S9981,"Medical records copying fee, administrative",HCPCS_Level_II,HCPC2026_JAN,2026
S9982,"Medical records copying fee, per page",HCPCS_Level_II,HCPC2026_JAN,2026
S9986,Not medically necessary service (patient is aware that service not medically necessary),HCPCS_Level_II,HCPC2026_JAN,2026
S9988,Services provided as part of a phase i clinical trial,HCPCS_Level_II,HCPC2026_JAN,2026
S9989,Services provided outside of the united states of america (list in addition to code(s) for service(s)),HCPCS_Level_II,HCPC2026_JAN,2026
S9990,Services provided as part of a phase ii clinical trial,HCPCS_Level_II,HCPC2026_JAN,2026
S9991,Services provided as part of a phase iii clinical trial,HCPCS_Level_II,HCPC2026_JAN,2026
S9992,"Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion",HCPCS_Level_II,HCPC2026_JAN,2026
S9994,"Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion",HCPCS_Level_II,HCPC2026_JAN,2026
S9996,Meals for clinical trial participant and one caregiver/companion,HCPCS_Level_II,HCPC2026_JAN,2026
S9999,Sales tax,HCPCS_Level_II,HCPC2026_JAN,2026
SA,Nurse practitioner rendering service in collaboration with a physician,HCPCS_Level_II,HCPC2026_JAN,2026
SB,Nurse midwife,HCPCS_Level_II,HCPC2026_JAN,2026
SC,Medically necessary service or supply,HCPCS_Level_II,HCPC2026_JAN,2026
SD,"Services provided by registered nurse with specialized, highly technical home infusion training",HCPCS_Level_II,HCPC2026_JAN,2026
SE,State and/or federally-funded programs/services,HCPCS_Level_II,HCPC2026_JAN,2026
SF,"Second opinion ordered by a professional review organization (pro) per section 9401, p.l. 99-272 (100% reimbursement - no medicare deductible or coinsurance)",HCPCS_Level_II,HCPC2026_JAN,2026
SG,Ambulatory surgical center (asc) facility service,HCPCS_Level_II,HCPC2026_JAN,2026
SH,Second concurrently administered infusion therapy,HCPCS_Level_II,HCPC2026_JAN,2026
SJ,Third or more concurrently administered infusion therapy,HCPCS_Level_II,HCPC2026_JAN,2026
SK,Member of high risk population (use only with codes for immunization),HCPCS_Level_II,HCPC2026_JAN,2026
SL,State supplied vaccine,HCPCS_Level_II,HCPC2026_JAN,2026
SM,Second surgical opinion,HCPCS_Level_II,HCPC2026_JAN,2026
SN,Third surgical opinion,HCPCS_Level_II,HCPC2026_JAN,2026
SQ,Item ordered by home health,HCPCS_Level_II,HCPC2026_JAN,2026
SS,Home infusion services provided in the infusion suite of the iv therapy provider,HCPCS_Level_II,HCPC2026_JAN,2026
ST,Related to trauma or injury,HCPCS_Level_II,HCPC2026_JAN,2026
SU,Procedure performed in physician's office (to denote use of facility and equipment),HCPCS_Level_II,HCPC2026_JAN,2026
SV,Pharmaceuticals delivered to patient's home but not utilized,HCPCS_Level_II,HCPC2026_JAN,2026
SW,Services provided by a certified diabetic educator,HCPCS_Level_II,HCPC2026_JAN,2026
SY,Persons who are in close contact with member of high-risk population (use only with codes for immunization),HCPCS_Level_II,HCPC2026_JAN,2026
SZ,Habilitative services,HCPCS_Level_II,HCPC2026_JAN,2026
T1,"Left foot, second digit",HCPCS_Level_II,HCPC2026_JAN,2026
T1000,"Private duty / independent nursing service(s) - licensed, up to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1001,Nursing assessment / evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
T1002,"Rn services, up to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1003,"Lpn/lvn services, up to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1004,"Services of a qualified nursing aide, up to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1005,"Respite care services, up to 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1006,"Alcohol and/or substance abuse services, family/couple counseling",HCPCS_Level_II,HCPC2026_JAN,2026
T1007,"Alcohol and/or substance abuse services, treatment plan development and/or modification",HCPCS_Level_II,HCPC2026_JAN,2026
T1009,Child sitting services for children of the individual receiving alcohol and/or substance abuse services,HCPCS_Level_II,HCPC2026_JAN,2026
T1010,Meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program),HCPCS_Level_II,HCPC2026_JAN,2026
T1012,"Alcohol and/or substance abuse services, skills development",HCPCS_Level_II,HCPC2026_JAN,2026
T1013,"Sign language or oral interpretive services, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1014,"Telehealth transmission, per minute, professional services bill separately",HCPCS_Level_II,HCPC2026_JAN,2026
T1015,"Clinic visit/encounter, all-inclusive",HCPCS_Level_II,HCPC2026_JAN,2026
T1016,"Case management, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1017,"Targeted case management, each 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1018,"School-based individualized education program (iep) services, bundled",HCPCS_Level_II,HCPC2026_JAN,2026
T1019,"Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",HCPCS_Level_II,HCPC2026_JAN,2026
T1020,"Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",HCPCS_Level_II,HCPC2026_JAN,2026
T1021,"Home health aide or certified nurse assistant, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
T1022,"Contracted home health agency services, all services provided under contract, per day",HCPCS_Level_II,HCPC2026_JAN,2026
T1023,"Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter",HCPCS_Level_II,HCPC2026_JAN,2026
T1024,"Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter",HCPCS_Level_II,HCPC2026_JAN,2026
T1025,"Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T1026,"Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per hour",HCPCS_Level_II,HCPC2026_JAN,2026
T1027,"Family training and counseling for child development, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1028,"Assessment of home, physical and family environment, to determine suitability to meet patient's medical needs",HCPCS_Level_II,HCPC2026_JAN,2026
T1029,"Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling",HCPCS_Level_II,HCPC2026_JAN,2026
T1030,"Nursing care, in the home, by registered nurse, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T1031,"Nursing care, in the home, by licensed practical nurse, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T1032,"Services performed by a doula birth worker, per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T1033,"Services performed by a doula birth worker, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T1040,"Medicaid certified community behavioral health clinic services, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T1041,"Medicaid certified community behavioral health clinic services, per month",HCPCS_Level_II,HCPC2026_JAN,2026
T1502,"Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
T1503,"Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit",HCPCS_Level_II,HCPC2026_JAN,2026
T1505,"Electronic medication compliance management device, includes all components and accessories, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
T1999,"Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in ""remarks""",HCPCS_Level_II,HCPC2026_JAN,2026
T2,"Left foot, third digit",HCPCS_Level_II,HCPC2026_JAN,2026
T2001,Non-emergency transportation; patient attendant/escort,HCPCS_Level_II,HCPC2026_JAN,2026
T2002,Non-emergency transportation; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
T2003,Non-emergency transportation; encounter/trip,HCPCS_Level_II,HCPC2026_JAN,2026
T2004,"Non-emergency transport; commercial carrier, multi-pass",HCPCS_Level_II,HCPC2026_JAN,2026
T2005,Non-emergency transportation; stretcher van,HCPCS_Level_II,HCPC2026_JAN,2026
T2007,"Transportation waiting time, air ambulance and non-emergency vehicle, one-half (1/2) hour increments",HCPCS_Level_II,HCPC2026_JAN,2026
T2010,"Preadmission screening and resident review (pasrr) level i identification screening, per screen",HCPCS_Level_II,HCPC2026_JAN,2026
T2011,"Preadmission screening and resident review (pasrr) level ii evaluation, per evaluation",HCPCS_Level_II,HCPC2026_JAN,2026
T2012,"Habilitation, educational; waiver, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2013,"Habilitation, educational, waiver; per hour",HCPCS_Level_II,HCPC2026_JAN,2026
T2014,"Habilitation, prevocational, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2015,"Habilitation, prevocational, waiver; per hour",HCPCS_Level_II,HCPC2026_JAN,2026
T2016,"Habilitation, residential, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2017,"Habilitation, residential, waiver; 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2018,"Habilitation, supported employment, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2019,"Habilitation, supported employment, waiver; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2020,"Day habilitation, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2021,"Day habilitation, waiver; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2022,"Case management, per month",HCPCS_Level_II,HCPC2026_JAN,2026
T2023,Targeted case management; per month,HCPCS_Level_II,HCPC2026_JAN,2026
T2024,"Service assessment/plan of care development, waiver",HCPCS_Level_II,HCPC2026_JAN,2026
T2025,Waiver services; not otherwise specified (nos),HCPCS_Level_II,HCPC2026_JAN,2026
T2026,"Specialized childcare, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2027,"Specialized childcare, waiver; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2028,"Specialized supply, not otherwise specified, waiver",HCPCS_Level_II,HCPC2026_JAN,2026
T2029,"Specialized medical equipment, not otherwise specified, waiver",HCPCS_Level_II,HCPC2026_JAN,2026
T2030,"Assisted living, waiver; per month",HCPCS_Level_II,HCPC2026_JAN,2026
T2031,"Assisted living; waiver, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2032,"Residential care, not otherwise specified (nos), waiver; per month",HCPCS_Level_II,HCPC2026_JAN,2026
T2033,"Residential care, not otherwise specified (nos), waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2034,"Crisis intervention, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2035,"Utility services to support medical equipment and assistive technology/devices, waiver",HCPCS_Level_II,HCPC2026_JAN,2026
T2036,"Therapeutic camping, overnight, waiver; each session",HCPCS_Level_II,HCPC2026_JAN,2026
T2037,"Therapeutic camping, day, waiver; each session",HCPCS_Level_II,HCPC2026_JAN,2026
T2038,"Community transition, waiver; per service",HCPCS_Level_II,HCPC2026_JAN,2026
T2039,"Vehicle modifications, waiver; per service",HCPCS_Level_II,HCPC2026_JAN,2026
T2040,"Financial management, self-directed, waiver; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2041,"Supports brokerage, self-directed, waiver; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2042,Hospice routine home care; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
T2043,Hospice continuous home care; per hour,HCPCS_Level_II,HCPC2026_JAN,2026
T2044,Hospice inpatient respite care; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
T2045,Hospice general inpatient care; per diem,HCPCS_Level_II,HCPC2026_JAN,2026
T2046,"Hospice long term care, room and board only; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2047,"Habilitation, prevocational, waiver; per 15 minutes",HCPCS_Level_II,HCPC2026_JAN,2026
T2048,"Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2049,"Non-emergency transportation; stretcher van, mileage; per mile",HCPCS_Level_II,HCPC2026_JAN,2026
T2050,"Financial management, self-directed, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2051,"Supports brokerage, self-directed, waiver; per diem",HCPCS_Level_II,HCPC2026_JAN,2026
T2101,"Human breast milk processing, storage and distribution only",HCPCS_Level_II,HCPC2026_JAN,2026
T3,"Left foot, fourth digit",HCPCS_Level_II,HCPC2026_JAN,2026
T4,"Left foot, fifth digit",HCPCS_Level_II,HCPC2026_JAN,2026
T4521,"Adult sized disposable incontinence product, brief/diaper, small, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4522,"Adult sized disposable incontinence product, brief/diaper, medium, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4523,"Adult sized disposable incontinence product, brief/diaper, large, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4524,"Adult sized disposable incontinence product, brief/diaper, extra large, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4525,"Adult sized disposable incontinence product, protective underwear/pull-on, small size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4526,"Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4527,"Adult sized disposable incontinence product, protective underwear/pull-on, large size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4528,"Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4529,"Pediatric sized disposable incontinence product, brief/diaper, small/medium size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4530,"Pediatric sized disposable incontinence product, brief/diaper, large size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4531,"Pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4532,"Pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4533,"Youth sized disposable incontinence product, brief/diaper, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4534,"Youth sized disposable incontinence product, protective underwear/pull-on, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4535,"Disposable liner/shield/guard/pad/undergarment, for incontinence, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4536,"Incontinence product, protective underwear/pull-on, reusable, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4537,"Incontinence product, protective underpad, reusable, bed size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4538,"Diaper service, reusable diaper, each diaper",HCPCS_Level_II,HCPC2026_JAN,2026
T4539,"Incontinence product, diaper/brief, reusable, any size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4540,"Incontinence product, protective underpad, reusable, chair size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4541,"Incontinence product, disposable underpad, large, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4542,"Incontinence product, disposable underpad, small size, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4543,"Adult sized disposable incontinence product, protective brief/diaper, above extra large, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4544,"Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each",HCPCS_Level_II,HCPC2026_JAN,2026
T4545,"Incontinence product, disposable, penile wrap, each",HCPCS_Level_II,HCPC2026_JAN,2026
T5,"Right foot, great toe",HCPCS_Level_II,HCPC2026_JAN,2026
T5001,Positioning seat for persons with special orthopedic needs,HCPCS_Level_II,HCPC2026_JAN,2026
T5999,"Supply, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
T6,"Right foot, second digit",HCPCS_Level_II,HCPC2026_JAN,2026
T7,"Right foot, third digit",HCPCS_Level_II,HCPC2026_JAN,2026
T8,"Right foot, fourth digit",HCPCS_Level_II,HCPC2026_JAN,2026
T9,"Right foot, fifth digit",HCPCS_Level_II,HCPC2026_JAN,2026
TA,"Left foot, great toe",HCPCS_Level_II,HCPC2026_JAN,2026
TB,"Drug or biological acquired with 340b drug pricing program discount, reported for informational purposes",HCPCS_Level_II,HCPC2026_JAN,2026
TC,"Technical component; under certain circumstances, a charge may be made for the technical component alone;  under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles",HCPCS_Level_II,HCPC2026_JAN,2026
TD,Rn,HCPCS_Level_II,HCPC2026_JAN,2026
TE,Lpn/lvn,HCPCS_Level_II,HCPC2026_JAN,2026
TF,Intermediate level of care,HCPCS_Level_II,HCPC2026_JAN,2026
TG,Complex/high tech level of care,HCPCS_Level_II,HCPC2026_JAN,2026
TH,"Obstetrical treatment/services, prenatal or postpartum",HCPCS_Level_II,HCPC2026_JAN,2026
TJ,"Program group, child and/or adolescent",HCPCS_Level_II,HCPC2026_JAN,2026
TK,"Extra patient or passenger, non-ambulance",HCPCS_Level_II,HCPC2026_JAN,2026
TL,Early intervention/individualized family service plan (ifsp),HCPCS_Level_II,HCPC2026_JAN,2026
TM,Individualized education program (iep),HCPCS_Level_II,HCPC2026_JAN,2026
TN,Rural/outside providers' customary service area,HCPCS_Level_II,HCPC2026_JAN,2026
TP,"Medical transport, unloaded vehicle",HCPCS_Level_II,HCPC2026_JAN,2026
TQ,Basic life support transport by a volunteer ambulance provider,HCPCS_Level_II,HCPC2026_JAN,2026
TR,School-based individualized education program (iep) services provided outside the public school district responsible for the student,HCPCS_Level_II,HCPC2026_JAN,2026
TS,Follow-up service,HCPCS_Level_II,HCPC2026_JAN,2026
TT,Individualized service provided to more than one patient in same setting,HCPCS_Level_II,HCPC2026_JAN,2026
TU,"Special payment rate, overtime",HCPCS_Level_II,HCPC2026_JAN,2026
TV,"Special payment rates, holidays/weekends",HCPCS_Level_II,HCPC2026_JAN,2026
TW,Back-up equipment,HCPCS_Level_II,HCPC2026_JAN,2026
U0001,Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel,HCPCS_Level_II,HCPC2026_JAN,2026
U0002,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc",HCPCS_Level_II,HCPC2026_JAN,2026
U0003,"Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by  cms-2020-01-r",HCPCS_Level_II,HCPC2026_JAN,2026
U0004,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r",HCPCS_Level_II,HCPC2026_JAN,2026
U0005,"Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2",HCPCS_Level_II,HCPC2026_JAN,2026
U1,"Medicaid level of care 1, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U2,"Medicaid level of care 2, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U3,"Medicaid level of care 3, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U4,"Medicaid level of care 4, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U5,"Medicaid level of care 5, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U6,"Medicaid level of care 6, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U7,"Medicaid level of care 7, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U8,"Medicaid level of care 8, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
U9,"Medicaid level of care 9, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
UA,"Medicaid level of care 10, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
UB,"Medicaid level of care 11, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
UC,"Medicaid level of care 12, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
UD,"Medicaid level of care 13, as defined by each state",HCPCS_Level_II,HCPC2026_JAN,2026
UE,Used durable medical equipment,HCPCS_Level_II,HCPC2026_JAN,2026
UF,Services provided in the morning,HCPCS_Level_II,HCPC2026_JAN,2026
UG,Services provided in the afternoon,HCPCS_Level_II,HCPC2026_JAN,2026
UH,Services provided in the evening,HCPCS_Level_II,HCPC2026_JAN,2026
UJ,Services provided at night,HCPCS_Level_II,HCPC2026_JAN,2026
UK,Services provided on behalf of the client to someone other than the client (collateral relationship),HCPCS_Level_II,HCPC2026_JAN,2026
UN,Two patients served,HCPCS_Level_II,HCPC2026_JAN,2026
UP,Three patients served,HCPCS_Level_II,HCPC2026_JAN,2026
UQ,Four patients served,HCPCS_Level_II,HCPC2026_JAN,2026
UR,Five patients served,HCPCS_Level_II,HCPC2026_JAN,2026
US,Six or more patients served,HCPCS_Level_II,HCPC2026_JAN,2026
V1,Demonstration modifier 1,HCPCS_Level_II,HCPC2026_JAN,2026
V2,Demonstration modifier 2,HCPCS_Level_II,HCPC2026_JAN,2026
V2020,"Frames, purchases",HCPCS_Level_II,HCPC2026_JAN,2026
V2025,Deluxe frame,HCPCS_Level_II,HCPC2026_JAN,2026
V2100,"Sphere, single vision, plano to plus or minus 4.00, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2101,"Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2102,"Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2103,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2104,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2105,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2106,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2107,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2108,"Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2109,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2110,"Spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2111,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2112,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2113,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2114,"Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2115,"Lenticular, (myodisc), per lens, single vision",HCPCS_Level_II,HCPC2026_JAN,2026
V2118,"Aniseikonic lens, single vision",HCPCS_Level_II,HCPC2026_JAN,2026
V2121,"Lenticular lens, per lens, single",HCPCS_Level_II,HCPC2026_JAN,2026
V2199,"Not otherwise classified, single vision lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2200,"Sphere, bifocal, plano to plus or minus 4.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2201,"Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2202,"Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2203,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2204,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2205,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2206,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2207,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2208,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2209,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2210,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2211,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2212,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2213,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2214,"Spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2215,"Lenticular (myodisc), per lens, bifocal",HCPCS_Level_II,HCPC2026_JAN,2026
V2218,"Aniseikonic, per lens, bifocal",HCPCS_Level_II,HCPC2026_JAN,2026
V2219,Bifocal seg width over 28 mm,HCPCS_Level_II,HCPC2026_JAN,2026
V2220,Bifocal add over 3.25d,HCPCS_Level_II,HCPC2026_JAN,2026
V2221,"Lenticular lens, per lens, bifocal",HCPCS_Level_II,HCPC2026_JAN,2026
V2299,Specialty bifocal (by report),HCPCS_Level_II,HCPC2026_JAN,2026
V2300,"Sphere, trifocal, plano to plus or minus 4.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2301,"Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2302,"Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2303,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2304,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2305,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00 cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2306,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2307,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12 to 2.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2308,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2309,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2310,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2311,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2312,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2313,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2314,"Spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2315,"Lenticular, (myodisc), per lens, trifocal",HCPCS_Level_II,HCPC2026_JAN,2026
V2318,"Aniseikonic lens, trifocal",HCPCS_Level_II,HCPC2026_JAN,2026
V2319,Trifocal seg width over 28 mm,HCPCS_Level_II,HCPC2026_JAN,2026
V2320,Trifocal add over 3.25d,HCPCS_Level_II,HCPC2026_JAN,2026
V2321,"Lenticular lens, per lens, trifocal",HCPCS_Level_II,HCPC2026_JAN,2026
V2399,Specialty trifocal (by report),HCPCS_Level_II,HCPC2026_JAN,2026
V2410,"Variable asphericity lens, single vision, full field, glass or plastic, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2430,"Variable asphericity lens, bifocal, full field, glass or plastic, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2499,"Variable sphericity lens, other type",HCPCS_Level_II,HCPC2026_JAN,2026
V2500,"Contact lens, pmma, spherical, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2501,"Contact lens, pmma, toric or prism ballast, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2502,"Contact lens, pmma, bifocal, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2503,"Contact lens, pmma, color vision deficiency, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2510,"Contact lens, gas permeable, spherical, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2511,"Contact lens, gas permeable, toric, prism ballast, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2512,"Contact lens, gas permeable, bifocal, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2513,"Contact lens, gas permeable, extended wear, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2520,"Contact lens, hydrophilic, spherical, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2521,"Contact lens, hydrophilic, toric, or prism ballast, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2522,"Contact lens, hydrophilic, bifocal, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2523,"Contact lens, hydrophilic, extended wear, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2524,"Contact lens, hydrophilic, spherical, photochromic additive, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2525,"Contact lens, hydrophilic, dual focus, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2526,"Contact lens, hydrophilic, with blue-violet filter, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2530,"Contact lens, scleral, gas impermeable, per lens (for contact lens modification, see 92325)",HCPCS_Level_II,HCPC2026_JAN,2026
V2531,"Contact lens, scleral, gas permeable, per lens (for contact lens modification, see 92325)",HCPCS_Level_II,HCPC2026_JAN,2026
V2599,"Contact lens, other type",HCPCS_Level_II,HCPC2026_JAN,2026
V2600,Hand held low vision aids and other nonspectacle mounted aids,HCPCS_Level_II,HCPC2026_JAN,2026
V2610,Single lens spectacle mounted low vision aids,HCPCS_Level_II,HCPC2026_JAN,2026
V2615,"Telescopic and other compound lens system, including distance vision telescopic, near vision telescopes and compound microscopic lens system",HCPCS_Level_II,HCPC2026_JAN,2026
V2623,"Prosthetic eye, plastic, custom",HCPCS_Level_II,HCPC2026_JAN,2026
V2624,Polishing/resurfacing of ocular prosthesis,HCPCS_Level_II,HCPC2026_JAN,2026
V2625,Enlargement of ocular prosthesis,HCPCS_Level_II,HCPC2026_JAN,2026
V2626,Reduction of ocular prosthesis,HCPCS_Level_II,HCPC2026_JAN,2026
V2627,Scleral cover shell,HCPCS_Level_II,HCPC2026_JAN,2026
V2628,Fabrication and fitting of ocular conformer,HCPCS_Level_II,HCPC2026_JAN,2026
V2629,"Prosthetic eye, other type",HCPCS_Level_II,HCPC2026_JAN,2026
V2630,Anterior chamber intraocular lens,HCPCS_Level_II,HCPC2026_JAN,2026
V2631,Iris supported intraocular lens,HCPCS_Level_II,HCPC2026_JAN,2026
V2632,Posterior chamber intraocular lens,HCPCS_Level_II,HCPC2026_JAN,2026
V2700,"Balance lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2702,Deluxe lens feature,HCPCS_Level_II,HCPC2026_JAN,2026
V2710,"Slab off prism, glass or plastic, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2715,"Prism, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2718,"Press-on lens, fresnell prism, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2730,"Special base curve, glass or plastic, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2744,"Tint, photochromatic, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2745,"Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2750,"Anti-reflective coating, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2755,"U-v lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2756,Eye glass case,HCPCS_Level_II,HCPC2026_JAN,2026
V2760,"Scratch resistant coating, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2761,"Mirror coating, any type, solid, gradient or equal, any lens material, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2762,"Polarization, any lens material, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2770,"Occluder lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2780,"Oversize lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2781,"Progressive lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2782,"Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2783,"Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2784,"Lens, polycarbonate or equal, any index, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2785,"Processing, preserving and transporting corneal tissue",HCPCS_Level_II,HCPC2026_JAN,2026
V2786,"Specialty occupational multifocal lens, per lens",HCPCS_Level_II,HCPC2026_JAN,2026
V2787,Astigmatism correcting function of intraocular lens,HCPCS_Level_II,HCPC2026_JAN,2026
V2788,Presbyopia correcting function of intraocular lens,HCPCS_Level_II,HCPC2026_JAN,2026
V2790,"Amniotic membrane for surgical reconstruction, per procedure",HCPCS_Level_II,HCPC2026_JAN,2026
V2797,"Vision supply, accessory and/or service component of another hcpcs vision code",HCPCS_Level_II,HCPC2026_JAN,2026
V2799,"Vision item or service, miscellaneous",HCPCS_Level_II,HCPC2026_JAN,2026
V3,Demonstration modifier 3,HCPCS_Level_II,HCPC2026_JAN,2026
V4,Demonstration modifier 4,HCPCS_Level_II,HCPC2026_JAN,2026
V5,Vascular catheter (alone or with any other vascular access),HCPCS_Level_II,HCPC2026_JAN,2026
V5008,Hearing screening,HCPCS_Level_II,HCPC2026_JAN,2026
V5010,Assessment for hearing aid,HCPCS_Level_II,HCPC2026_JAN,2026
V5011,Fitting/orientation/checking of hearing aid,HCPCS_Level_II,HCPC2026_JAN,2026
V5014,Repair/modification of a hearing aid,HCPCS_Level_II,HCPC2026_JAN,2026
V5020,Conformity evaluation,HCPCS_Level_II,HCPC2026_JAN,2026
V5030,"Hearing aid, monaural, body worn, air conduction",HCPCS_Level_II,HCPC2026_JAN,2026
V5040,"Hearing aid, monaural, body worn, bone conduction",HCPCS_Level_II,HCPC2026_JAN,2026
V5050,"Hearing aid, monaural, in the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5060,"Hearing aid, monaural, behind the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5070,"Glasses, air conduction",HCPCS_Level_II,HCPC2026_JAN,2026
V5080,"Glasses, bone conduction",HCPCS_Level_II,HCPC2026_JAN,2026
V5090,"Dispensing fee, unspecified hearing aid",HCPCS_Level_II,HCPC2026_JAN,2026
V5095,Semi-implantable middle ear hearing prosthesis,HCPCS_Level_II,HCPC2026_JAN,2026
V5100,"Hearing aid, bilateral, body worn",HCPCS_Level_II,HCPC2026_JAN,2026
V5110,"Dispensing fee, bilateral",HCPCS_Level_II,HCPC2026_JAN,2026
V5120,"Binaural, body",HCPCS_Level_II,HCPC2026_JAN,2026
V5130,"Binaural, in the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5140,"Binaural, behind the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5150,"Binaural, glasses",HCPCS_Level_II,HCPC2026_JAN,2026
V5160,"Dispensing fee, binaural",HCPCS_Level_II,HCPC2026_JAN,2026
V5170,"Hearing aid, cros, in the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5171,"Hearing aid, contralateral routing device, monaural, in the ear (ite)",HCPCS_Level_II,HCPC2026_JAN,2026
V5172,"Hearing aid, contralateral routing device, monaural, in the canal (itc)",HCPCS_Level_II,HCPC2026_JAN,2026
V5180,"Hearing aid, cros, behind the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5181,"Hearing aid, contralateral routing device, monaural, behind the ear (bte)",HCPCS_Level_II,HCPC2026_JAN,2026
V5190,"Hearing aid, contralateral routing, monaural, glasses",HCPCS_Level_II,HCPC2026_JAN,2026
V5200,"Dispensing fee, contralateral, monaural",HCPCS_Level_II,HCPC2026_JAN,2026
V5210,"Hearing aid, bicros, in the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5211,"Hearing aid, contralateral routing system, binaural, ite/ite",HCPCS_Level_II,HCPC2026_JAN,2026
V5212,"Hearing aid, contralateral routing system, binaural, ite/itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5213,"Hearing aid, contralateral routing system, binaural, ite/bte",HCPCS_Level_II,HCPC2026_JAN,2026
V5214,"Hearing aid, contralateral routing system, binaural, itc/itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5215,"Hearing aid, contralateral routing system, binaural, itc/bte",HCPCS_Level_II,HCPC2026_JAN,2026
V5220,"Hearing aid, bicros, behind the ear",HCPCS_Level_II,HCPC2026_JAN,2026
V5221,"Hearing aid, contralateral routing system, binaural, bte/bte",HCPCS_Level_II,HCPC2026_JAN,2026
V5230,"Hearing aid, contralateral routing system, binaural, glasses",HCPCS_Level_II,HCPC2026_JAN,2026
V5240,"Dispensing fee, contralateral routing system, binaural",HCPCS_Level_II,HCPC2026_JAN,2026
V5241,"Dispensing fee, monaural hearing aid, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5242,"Hearing aid, analog, monaural, cic (completely in the ear canal)",HCPCS_Level_II,HCPC2026_JAN,2026
V5243,"Hearing aid, analog, monaural, itc (in the canal)",HCPCS_Level_II,HCPC2026_JAN,2026
V5244,"Hearing aid, digitally programmable analog, monaural, cic",HCPCS_Level_II,HCPC2026_JAN,2026
V5245,"Hearing aid, digitally programmable, analog, monaural, itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5246,"Hearing aid, digitally programmable analog, monaural, ite (in the ear)",HCPCS_Level_II,HCPC2026_JAN,2026
V5247,"Hearing aid, digitally programmable analog, monaural, bte (behind the ear)",HCPCS_Level_II,HCPC2026_JAN,2026
V5248,"Hearing aid, analog, binaural, cic",HCPCS_Level_II,HCPC2026_JAN,2026
V5249,"Hearing aid, analog, binaural, itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5250,"Hearing aid, digitally programmable analog, binaural, cic",HCPCS_Level_II,HCPC2026_JAN,2026
V5251,"Hearing aid, digitally programmable analog, binaural, itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5252,"Hearing aid, digitally programmable, binaural, ite",HCPCS_Level_II,HCPC2026_JAN,2026
V5253,"Hearing aid, digitally programmable, binaural, bte",HCPCS_Level_II,HCPC2026_JAN,2026
V5254,"Hearing aid, digital, monaural, cic",HCPCS_Level_II,HCPC2026_JAN,2026
V5255,"Hearing aid, digital, monaural, itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5256,"Hearing aid, digital, monaural, ite",HCPCS_Level_II,HCPC2026_JAN,2026
V5257,"Hearing aid, digital, monaural, bte",HCPCS_Level_II,HCPC2026_JAN,2026
V5258,"Hearing aid, digital, binaural, cic",HCPCS_Level_II,HCPC2026_JAN,2026
V5259,"Hearing aid, digital, binaural, itc",HCPCS_Level_II,HCPC2026_JAN,2026
V5260,"Hearing aid, digital, binaural, ite",HCPCS_Level_II,HCPC2026_JAN,2026
V5261,"Hearing aid, digital, binaural, bte",HCPCS_Level_II,HCPC2026_JAN,2026
V5262,"Hearing aid, disposable, any type, monaural",HCPCS_Level_II,HCPC2026_JAN,2026
V5263,"Hearing aid, disposable, any type, binaural",HCPCS_Level_II,HCPC2026_JAN,2026
V5264,"Ear mold/insert, not disposable, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5265,"Ear mold/insert, disposable, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5266,Battery for use in hearing device,HCPCS_Level_II,HCPC2026_JAN,2026
V5267,"Hearing aid or assistive listening device/supplies/accessories, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
V5268,"Assistive listening device, telephone amplifier, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5269,"Assistive listening device, alerting, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5270,"Assistive listening device, television amplifier, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5271,"Assistive listening device, television caption decoder",HCPCS_Level_II,HCPC2026_JAN,2026
V5272,"Assistive listening device, tdd",HCPCS_Level_II,HCPC2026_JAN,2026
V5273,"Assistive listening device, for use with cochlear implant",HCPCS_Level_II,HCPC2026_JAN,2026
V5274,"Assistive listening device, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
V5275,"Ear impression, each",HCPCS_Level_II,HCPC2026_JAN,2026
V5281,"Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5282,"Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5283,"Assistive listening device, personal fm/dm neck, loop induction receiver",HCPCS_Level_II,HCPC2026_JAN,2026
V5284,"Assistive listening device, personal fm/dm, ear level receiver",HCPCS_Level_II,HCPC2026_JAN,2026
V5285,"Assistive listening device, personal fm/dm, direct audio input receiver",HCPCS_Level_II,HCPC2026_JAN,2026
V5286,"Assistive listening device, personal blue tooth fm/dm receiver",HCPCS_Level_II,HCPC2026_JAN,2026
V5287,"Assistive listening device, personal fm/dm receiver, not otherwise specified",HCPCS_Level_II,HCPC2026_JAN,2026
V5288,"Assistive listening device, personal fm/dm transmitter assistive listening device",HCPCS_Level_II,HCPC2026_JAN,2026
V5289,"Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5290,"Assistive listening device, transmitter microphone, any type",HCPCS_Level_II,HCPC2026_JAN,2026
V5298,"Hearing aid, not otherwise classified",HCPCS_Level_II,HCPC2026_JAN,2026
V5299,"Hearing service, miscellaneous",HCPCS_Level_II,HCPC2026_JAN,2026
V5336,Repair/modification of augmentative communicative system or device (excludes adaptive hearing aid),HCPCS_Level_II,HCPC2026_JAN,2026
V5362,Speech screening,HCPCS_Level_II,HCPC2026_JAN,2026
V5363,Language screening,HCPCS_Level_II,HCPC2026_JAN,2026
V5364,Dysphagia screening,HCPCS_Level_II,HCPC2026_JAN,2026
V6,Arteriovenous graft (or other vascular access not including a vascular catheter),HCPCS_Level_II,HCPC2026_JAN,2026
V7,Arteriovenous fistula only (in use with two needles),HCPCS_Level_II,HCPC2026_JAN,2026
V8,Infection present,HCPCS_Level_II,HCPC2026_JAN,2026
V9,No infection present,HCPCS_Level_II,HCPC2026_JAN,2026
VM,Medicare diabetes prevention program (mdpp) virtual make-up session,HCPCS_Level_II,HCPC2026_JAN,2026
VP,Aphakic patient,HCPCS_Level_II,HCPC2026_JAN,2026
X1,"Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care",HCPCS_Level_II,HCPC2026_JAN,2026
X2,Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services,HCPCS_Level_II,HCPC2026_JAN,2026
X3,Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital,HCPCS_Level_II,HCPC2026_JAN,2026
X4,"Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period",HCPCS_Level_II,HCPC2026_JAN,2026
X5,"Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician",HCPCS_Level_II,HCPC2026_JAN,2026
XE,"Separate encounter, a service that is distinct because it occurred during a separate encounter",HCPCS_Level_II,HCPC2026_JAN,2026
XP,"Separate practitioner, a service that is distinct because it was performed by a different practitioner",HCPCS_Level_II,HCPC2026_JAN,2026
XS,"Separate structure, a service that is distinct because it was performed on a separate organ/structure",HCPCS_Level_II,HCPC2026_JAN,2026
XU,"Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service",HCPCS_Level_II,HCPC2026_JAN,2026
ZA,Novartis/sandoz,HCPCS_Level_II,HCPC2026_JAN,2026
ZB,Pfizer/hospira,HCPCS_Level_II,HCPC2026_JAN,2026
ZC,Merck/samsung bioepis,HCPCS_Level_II,HCPC2026_JAN,2026
